["https://www.prnasia.com/story/190865-1.shtml", "https://www.prnasia.com/story/190957-1.shtml", "https://www.prnewswire.com/news-releases/prep-biopharm-limited-announces-successful-completion-of-prep-001-toxicology-study-enabling-phase-2b-field-study-of-prep-001-against-all-respiratory-viruses-301194520.html", "https://www.prnewswire.com/news-releases/chop-researchers-find-ntrk-fusions-more-common-than-expected-in-pediatric-tumors-301209371.html", "https://www.prnasia.com/story/190334-1.shtml", "https://www.prnasia.com/story/191468-1.shtml", "https://www.prnewswire.com/news-releases/isha-jain-joins-gladstone-institutes-301194565.html", "https://www.prnasia.com/story/191577-1.shtml", "https://www.prnewswire.com/news-releases/amgen-submits-sotorasib-new-drug-application-to-us-fda-for-advanced-or-metastatic-non-small-cell-lung-cancer-with-kras-g12c-mutation-301194511.html", "https://www.prnasia.com/story/191495-1.shtml", "https://www.prnasia.com/story/191597-1.shtml", "https://www.prnasia.com/story/182626-1.shtml", "https://www.prnewswire.com/news-releases/matrix-medical-network-announces-the-integration-of-biocerna-301194457.html", "https://www.prnasia.com/story/191466-1.shtml", "https://www.prnasia.com/story/191242-1.shtml", "https://www.prnasia.com/story/182749-1.shtml", "https://www.prnasia.com/story/191453-1.shtml", "https://www.prnewswire.com/news-releases/therapeutic-solutions-international-signs-letter-of-intent-with-premier-adipose-stem-cell-company-synova-life-sciences-to-file-ind-for-suicide-prevention-301194504.html", "https://www.prnewswire.com/news-releases/senhwa-biosciences-presents-positive-cholangiocarcinoma-data-301209103.html", "https://www.prnewswire.com/news-releases/covid-19-vaccines-common-solution-not-competition-301209137.html", "https://www.prnewswire.com/news-releases/everest-medicines-announces-amended-agreement-with-spero-therapeutics-301209958.html", "https://www.prnasia.com/story/46488-1.shtml", "https://www.prnasia.com/story/46673-1.shtml", "https://www.prnasia.com/story/191900-1.shtml", "https://www.prnewswire.com/news-releases/jubilant-therapeutics-annonce-une-collaboration-de-recherche-avec-l-institut-wistar-pour-evaluer-l-activite-des-nouveaux-inhibiteurs-de-pad4-afin-de-reduire-la-gravite-clinique-de-la-covid-19-842212021.html", "https://www.prnasia.com/story/47546-1.shtml", "https://www.prnewswire.com/news-releases/tessa-therapeutics-receives-prime-designation-from-european-medicines-agency-for-cd30-car-t-therapy-301209979.html", "https://www.prnewswire.com/news-releases/grifols-begins-clinical-trial-of-a-new-treatment-that-would-provide-immediate-immunity-against-covid-19-301209976.html", "https://www.prnewswire.com/news-releases/sirnaomics-announces-first-patient-dosed-in-phase-2a-study-of-stp705-for-treatment-of-cutaneous-basal-cell-carcinoma-301208927.html", "https://www.prnasia.com/story/47344-1.shtml", "https://www.prnasia.com/story/46327-1.shtml", "https://www.prnasia.com/story/47533-1.shtml", "https://www.prnasia.com/story/47541-1.shtml", "https://www.prnewswire.com/news-releases/positive-phase-1-results-in-high-dose-setanaxib-trial-301209899.html", "https://www.prnasia.com/story/47053-1.shtml", "https://www.prnasia.com/story/46857-1.shtml", "https://www.prnasia.com/story/47172-1.shtml", "https://cnmobile.prnasia.com/story/46656-1.shtml", "https://www.prnewswire.com/news-releases/more-adults-with-vision-loss-seeking-help-staying-connected-during-pandemic-301209793.html", "https://www.prnewswire.com/news-releases/blue-matter-announces-acquisition-of-aim-a-leading-european-supply-chain-consulting-firm-301207261.html", "https://www.prnewswire.com/news-releases/phase-ii-research-against-covid-19-launched-in-france-with-debiopharms-antiviral-alisporivir-301210056.html", "https://www.prnewswire.com/news-releases/global-1-25-billion-filgrastim-biosimilars-market-to-2030-increase-in-patent-expiration-government-initiatives-increased-expenditure-low-cost-of-biosimilars-strong-pipeline-of-drugs-301209977.html", "https://www.prnasia.com/story/47950-1.shtml", "https://www.prnasia.com/story/30835-1.shtml", "https://www.prnasia.com/story/47206-1.shtml", "https://www.prnewswire.com/news-releases/tennor-enters-research-collaboration-with-janssen-for-potential-new-treatments-for-nontuberculous-mycobacteria-diseases-301209716.html", "https://www.prnasia.com/story/31510-1.shtml", "https://www.prnasia.com/story/47652-1.shtml", "https://www.prnasia.com/story/31293-1.shtml", "https://www.prnewswire.com/news-releases/biohaven-provides-update-on-phase-23-trial-and-alzheimers-disease-program-301210022.html", "https://www.prnewswire.com/news-releases/valeo-pharma-announces-major-addition-to-its-senior-management-team-301209905.html", "https://www.prnewswire.com/news-releases/hanmi-pharmaceutical-erwartet-fda-zulassung-fur-2-neue-medikamente-in-den-usa-819721592.html", "https://www.prnewswire.com/news-releases/hanmi-pharmaceutical-attend-l-approbation-de-la-fda-pour-2-nouveaux-medicaments-824534686.html", "https://www.prnasia.com/story/31523-1.shtml", "https://www.prnewswire.com/news-releases/hanmi-pharmaceutical-espera-la-aprobacion-de-la-fda-de-ee-uu-para-2-nuevos-medicamentos-848674806.html", "https://www.prnasia.com/story/47632-1.shtml", "https://www.prnasia.com/story/47791-1.shtml", "https://www.prnasia.com/story/31048-1.shtml", "https://www.prnewswire.com/news-releases/new-mgma-report-identifies-biggest-lessons-and-priorities-for-medical-practices-in-2021-301210201.html", "https://www.prnewswire.com/news-releases/biohaven-signs-cody-ware-as-driver-for-nurtec-odt-chevrolet-for-the-2021-nascar-cup-series-season-301210092.html", "https://www.prnewswire.com/news-releases/aruvant-chooses-lonza-to-manufacture-aru-1801-a-potentially-curative-treatment-for-sickle-cell-disease-for-pivotal-trial-301209619.html", "https://www.prnasia.com/story/48740-1.shtml", "https://www.prnasia.com/story/48461-1.shtml", "https://www.prnewswire.com/news-releases/hanmi-pharmaceutical-expects-us-fda-approval-for-2-new-drugs-301209167.html", "https://www.prnasia.com/story/48026-1.shtml", "https://www.prnasia.com/story/48719-1.shtml", "https://www.prnasia.com/story/48460-1.shtml", "https://www.prnasia.com/story/48661-1.shtml", "https://www.prnewswire.com/news-releases/impresiv-health-and-bluestream-health-announce-strategic-partnership-to-provide-telehealth-services-301210828.html", "https://www.prnasia.com/story/31788-1.shtml", "https://www.prnewswire.com/news-releases/medibio-granted-ce-mark-approval-for-mebsleep-301210519.html", "https://www.prnasia.com/story/31649-1.shtml", "https://www.prnasia.com/story/48682-1.shtml", "https://www.prnewswire.com/news-releases/oncosec-enters-into-option-agreement-with-sirtex-medical-to-co-promote-tavo-301210487.html", "https://www.prnasia.com/story/31762-1.shtml", "https://www.prnasia.com/story/32476-1.shtml", "https://www.prnasia.com/story/31610-1.shtml", "https://www.prnasia.com/story/49298-1.shtml", "https://www.prnewswire.com/news-releases/global-customized-procedure-trays-market-to-grow-as-the-medical-industry-acquires-research-excellence-says-tmr-301210766.html", "https://www.prnasia.com/story/49136-1.shtml", "https://www.prnasia.com/story/49811-1.shtml", "https://www.prnasia.com/story/32494-1.shtml", "https://www.prnasia.com/story/50588-1.shtml", "https://www.prnasia.com/story/49458-1.shtml", "https://www.prnasia.com/story/50856-1.shtml", "https://www.prnasia.com/story/50016-1.shtml", "https://www.prnasia.com/story/50368-1.shtml", "https://www.prnasia.com/story/49557-1.shtml", "https://www.prnasia.com/story/50429-1.shtml", "https://www.prnasia.com/story/50478-1.shtml", "https://www.prnewswire.com/news-releases/health-canada-approves-theralight-photobiomodulation-systems-301210395.html", "https://www.prnasia.com/story/50264-1.shtml", "https://www.prnewswire.com/news-releases/ifc-national-marketing-expands-integrity-platform-to-help-americans-on-their-healthcare-journey-301210638.html", "https://www.prnewswire.com/news-releases/nc-based-behavioral-healthcare-company-acquires-operations-in-sc-301210882.html", "https://www.prnasia.com/story/51464-1.shtml", "https://www.prnewswire.com/news-releases/withings-joins-decentralized-trials--research-alliance-dtra-to-democratize-and-accelerate-clinical-trials-301209779.html", "https://www.prnasia.com/story/32707-1.shtml", "https://www.prnewswire.com/news-releases/neucyte-and-mount-sinai-enter-collaboration-agreement-301210206.html", "https://www.prnasia.com/story/32963-1.shtml", "https://www.prnewswire.com/news-releases/hillrom-announces-planned-acquisition-of-bardy-diagnostics-inc-301210529.html", "https://www.prnewswire.com/news-releases/removery-announces-strategic-investment-from-elliott-investment-management-to-accelerate-growth-301210862.html", "https://www.prnasia.com/story/33592-1.shtml", "https://www.prnasia.com/story/32854-1.shtml", "https://www.prnasia.com/story/51918-1.shtml", "https://www.prnewswire.com/news-releases/intelivideo-and-les-mills-launch-strategic-partnership-301210262.html", "https://www.prnasia.com/story/32609-1.shtml", "https://www.prnewswire.com/news-releases/therapeutic-solutions-international-reports-successful-treatment-of-breast-cancer-using-stemvacs-cellular-immunotherapy-301210088.html", "https://www.prnewswire.com/news-releases/goodwill-nynj-and-per-scholas-launch-bridge-pathway-pilot-to-prepare-new-yorkers-for-advanced-technology-training-programs-301210918.html", "https://www.prnasia.com/story/33018-1.shtml", "https://www.prnasia.com/story/52040-1.shtml", "https://www.prnasia.com/story/51810-1.shtml", "https://www.prnasia.com/story/52087-1.shtml", "https://www.prnewswire.com/news-releases/henry-ford-cancer-institute-set-to-begin-patient-care-at-brigitte-harris-cancer-pavilion-301210908.html", "https://www.prnewswire.com/news-releases/sirtex-medical-announces-collaboration-update-with-oncosec-medical-301210378.html", "https://www.prnewswire.com/news-releases/haemonetics-to-acquire-cardiva-medical-inc-to-expand-hospital-portfolio-301211337.html", "https://www.prnasia.com/story/52682-1.shtml", "https://www.prnewswire.com/news-releases/mindmed-announces-the-start-of-the-first-ever-clinical-trial-combining-mdma-and-lsd-301211436.html", "https://www.prnasia.com/story/51467-1.shtml", "https://www.prnewswire.com/news-releases/exact-therapeutics-announces-innovative-probe-development-collaboration-with-ge-healthcare-301211639.html", "https://www.prnewswire.com/news-releases/bioinvent-to-host-key-opinion-leader-call-on-bi-1206-for-relapsed-or-refractory-non-hodgkins-lymphoma-301211611.html", "https://www.prnewswire.com/news-releases/neuvogen-announces-next-generation-cancer-vaccine-strategy-to-transform-how-solid-tumors-are-treated-301211429.html", "https://www.prnewswire.com/news-releases/clarivate-enhances-cortellis-cmc-intelligence-platform-with-addition-of-comprehensive-biologics-content-301211404.html", "https://www.prnasia.com/story/52454-1.shtml", "https://www.prnasia.com/story/52017-1.shtml", "https://www.prnewswire.com/news-releases/calliditas-announces-clinical-development-plan-for-setanaxib-and-comments-on-data-from-part-a-of-nefigard-study-at-todays-rd-day-301211542.html", "https://www.prnewswire.com/news-releases/biomica-announces-participation-at-the-5th-microbiome-movement-drug-development-europe-conference-on-january-28-29-2021-virtual-conference-301211580.html", "https://www.prnasia.com/story/52687-1.shtml", "https://www.prnewswire.com/news-releases/doptelet-avatrombopag-approved-in-the-eu-for-treatment-of-itp-301211559.html", "https://www.prnasia.com/story/52143-1.shtml", "https://www.prnewswire.com/news-releases/nexelis-acquires-the-gsk-vaccines-clinical-bioanalytical-laboratory-located-in-marburg--germany-and-enters-into-a-5-year-strategic-agreement-with-gsk-301211211.html", "https://www.prnewswire.com/news-releases/tris-pharma-presents-positive-results-from-phase-3-study-of-amphetamine-extended-release-tablet-in-adults-with-adhd-301211263.html", "https://cnmobile.prnasia.com/story/51843-1.shtml", "https://www.prnasia.com/story/52994-1.shtml", "https://www.prnasia.com/story/36970-1.shtml", "https://www.prnasia.com/story/54896-1.shtml", "https://www.prnasia.com/story/36638-1.shtml", "https://www.prnasia.com/story/54749-1.shtml", "https://www.prnasia.com/story/54870-1.shtml", "https://www.prnewswire.com/news-releases/impel-neuropharma-announces-us-food--drug-administration-acceptance-of-new-drug-application-for-inp104-for-the-acute-treatment-of-migraine-301211380.html", "https://www.prnasia.com/story/36652-1.shtml", "https://www.prnasia.com/story/36516-1.shtml", "https://www.prnewswire.com/news-releases/pressure-biosciences-ultra-shear-technology-nanoemulsions-platform-targets-revolution-in-effectiveness-of-therapeutics-via-improved-drug-delivery-and-dosing-safety-301211713.html", "https://www.prnasia.com/story/37441-1.shtml", "https://cnmobile.prnasia.com/story/37152-1.shtml", "https://www.prnewswire.com/news-releases/seneca-biopharma-inc-announces-top-line-data-from-phase-2-clinical-study-in-china-for-the-treatment-of-ischemic-stroke-301211384.html", "https://www.prnasia.com/story/53055-1.shtml", "https://www.prnewswire.com/news-releases/renovorx-announces-studies-that-further-advance-the-science-of-pancreatic-cancer-treatment-presented-at-the-2021-asco-gastrointestinal-cancers-symposium-301211437.html", "https://www.prnewswire.com/news-releases/one-industry-set-to-flourish-as-the-new-administration-takes-the-wheel-301211465.html", "https://www.prnasia.com/story/55385-1.shtml", "https://cnmobile.prnasia.com/story/37201-1.shtml", "https://www.prnasia.com/story/55494-1.shtml", "https://www.prnasia.com/story/55459-1.shtml", "https://www.prnasia.com/story/55502-1.shtml", "https://www.prnewswire.com/news-releases/hoth-therapeutics-announces-positive-initial-mechanism-of-action-data-for-ht-003-in-pursuit-for-acne-treatment-indication-301211360.html", "https://www.prnasia.com/story/37738-1.shtml", "https://www.prnasia.com/story/37850-1.shtml", "https://www.prnewswire.com/news-releases/modern-technology-injects-more-flexibility-into-healthcare-systems-301211466.html", "https://www.prnewswire.com/news-releases/merck-kgaa-darmstadt-germany-announces-update-on-the-intrpid-clinical-program-including-lung-037-study-301211771.html", "https://www.prnasia.com/story/55202-1.shtml", "https://www.prnewswire.com/news-releases/fyllo-expands-its-cloud-based-platform-for-highly-regulated-industries-with-acquisition-of-dataowl-301211752.html", "https://www.prnasia.com/story/37872-1.shtml", "https://www.prnasia.com/story/38272-1.shtml", "https://www.prnewswire.com/news-releases/brainstorm-announces-the-publication-of-preclinical-data-highlighting-the-potential-of-a-nurown-derived-exosome-based-treatment-for-covid-19-ards-301211736.html", "https://www.prnasia.com/story/39458-1.shtml", "https://www.prnasia.com/story/37915-1.shtml", "https://www.prnasia.com/story/39493-1.shtml", "https://www.prnasia.com/story/39135-1.shtml", "https://www.prnasia.com/story/37802-1.shtml", "https://www.prnasia.com/story/39176-1.shtml", "https://www.prnasia.com/story/39134-1.shtml", "https://www.prnewswire.com/news-releases/varsity-brands-surpasses-10-million-raised-for-st-jude-childrens-research-hospital-301214168.html", "https://www.prnasia.com/story/37707-1.shtml", "https://www.prnasia.com/story/58602-1.shtml", "https://www.prnewswire.com/news-releases/nanoscope-therapeutics-receives-orphan-drug-designation-for-gene-therapy-of-blindness-301214242.html", "https://www.prnasia.com/story/57991-1.shtml", "https://www.prnasia.com/story/58620-1.shtml", "https://www.prnasia.com/story/39974-1.shtml", "https://www.prnasia.com/story/58120-1.shtml", "https://www.prnasia.com/story/40234-1.shtml", "https://www.prnasia.com/story/40354-1.shtml", "https://www.prnewswire.com/news-releases/adeno-associated-virus-aav-vector-based-gene-therapy-market-expected-to-grow-at-a-significant-cagr-of-43-4-during-the-study-period-2019-30--301213850.html", "https://www.prnewswire.com/news-releases/biontech-and-fosun-pharma-receive-authorization-for-emergency-use-in-hong-kong-for-covid-19-vaccine-301214218.html", "https://www.prnasia.com/story/39805-1.shtml", "https://www.prnasia.com/story/58894-1.shtml", "https://www.prnewswire.com/news-releases/unmet-need-in-lupus-nephritis-finally-addressed-with-new-fda-approvals-for-glaxosmithklines-benlysta-belimumab-and-aurinia-pharmaceuticals-lupkynis-voclosporin-301214381.html", "https://www.prnasia.com/story/41260-1.shtml", "https://www.prnewswire.com/news-releases/worldwide-biosimilars-industry-to-2026---key-players-include-amgen-axxo-and-biogen-among-others-301213998.html", "https://www.prnewswire.com/news-releases/tevogen-bio-secures-funding-from-team-of-doctors-to-support-clinical-trials-of-its-investigational-curative-t-cell-therapy-for-covid-19-301214284.html", "https://www.prnasia.com/story/40928-1.shtml", "https://www.prnewswire.com/news-releases/through-a-500-million-partnership-with-the-state-of-ohio-jobsohio-and-ohio-development-services-agency-cleveland-clinic-forms-global-center-for-pathogen-research--human-health-301214321.html", "https://www.prnasia.com/story/42159-1.shtml", "https://www.prnewswire.com/news-releases/i-mab-and-morphosys-announce-first-patient-dosed-in-us-phase-1-study-of-tj210mor210-in-patients-with-advanced-cancer-301214143.html", "https://cnmobile.prnasia.com/story/40951-1.shtml", "https://www.prnewswire.com/news-releases/henry-ford-health-system-and-michigan-state-university-partner-to-improve-access-outcomes-to-health-care-through-research-education-and-addressing-health-inequities-and-disparities-301214268.html", "https://www.prnasia.com/story/41188-1.shtml", "https://www.prnasia.com/story/40803-1.shtml", "https://www.prnewswire.com/news-releases/butterfly-network-inc-and-longview-acquisition-corp-announce-dr-todd-fruchterman-to-become-president-and-ceo-of-the-combined-company-301214396.html", "https://www.prnewswire.com/news-releases/phio-pharmaceuticals-announces-closing-of-14-0-million-private-placement-priced-at-the-market-301214475.html", "https://www.prnasia.com/story/59856-1.shtml", "https://www.prnasia.com/story/41753-1.shtml", "https://www.prnasia.com/story/41697-1.shtml", "https://www.prnasia.com/story/59698-1.shtml", "https://www.prnewswire.com/news-releases/loccitane-inc-to-optimize-us-store-footprint-to-best-position-business-for-the-future-301214724.html", "https://www.prnasia.com/story/59947-1.shtml", "https://www.prnasia.com/story/41455-1.shtml", "https://www.prnewswire.com/news-releases/photocure-partners-with-asieris-meditech-to-commercialize-hexvix-in-mainland-china-and-taiwan-301214709.html", "https://www.prnewswire.com/news-releases/biocompatible-materials-market-to-reach-us-347-bn-by-2030-covid-19-restrictions-to-moderately-affect-growth-prospects-in-near-term---persistence-market-research-301213163.html", "https://www.prnasia.com/story/43269-1.shtml", "https://www.prnasia.com/story/42009-1.shtml", "https://www.prnewswire.com/news-releases/healthcare-contract-manufacturing-market-size-worth-323-6-billion-by-2028-grand-view-research-inc-301214134.html", "https://www.prnewswire.com/news-releases/first-patient-treated-in-phase-ii-combination-trial-of-isa-pharmaceuticals-lead-immunotherapy-isa101b-with-keytruda-301214448.html", "https://www.prnasia.com/story/42268-1.shtml", "https://www.prnewswire.com/news-releases/asieris-and-photocure-expand-strategic-partnership-to-bladder-cancer-diagnosis-and-surgery-in-mainland-china-and-taiwan-301214744.html", "https://www.prnasia.com/story/42176-1.shtml", "https://www.prnasia.com/story/42349-1.shtml", "https://www.prnasia.com/story/42226-1.shtml", "https://www.prnewswire.com/news-releases/new-study-by-the-university-of-calgary-and-curelator-reveals-surprising-lack-of-association-between-stress-and-migraine-301212865.html", "https://www.prnewswire.com/news-releases/meharry-medical-college-ushers-in-the-new-year-by-prioritizing-student-safety-with-thermal-screening-solution-from-infrared-cameras-inc-301213018.html", "https://www.prnasia.com/story/42008-1.shtml", "https://www.prnewswire.com/news-releases/dynacure-announces-issuance-of-us-patent-for-dyn101-for-the-treatment-of-myotubular-and-centronuclear-myopathies-cnm-301214513.html", "https://www.prnasia.com/story/59755-1.shtml", "https://www.prnasia.com/story/42427-1.shtml", "https://www.prnewswire.com/news-releases/greater-omaha-chamber-announces-nearly-500-million-in-2020-capital-investment-301213019.html", "https://www.prnewswire.com/news-releases/amyris-acquiring-terasana-brand-to-offer-clean-cannabinoid-consumer-products-301213067.html", "https://www.prnasia.com/story/60505-1.shtml", "https://www.prnasia.com/story/60267-1.shtml", "https://www.prnewswire.com/news-releases/neurosigma-successfully-obtains-hcpcs-codes-from-cms-for-the-monarch-etns-system-301213027.html", "https://www.prnasia.com/story/42774-1.shtml", "https://www.prnasia.com/story/60352-1.shtml", "https://www.prnewswire.com/news-releases/liberty-health-sciences-continues-expansion-in-floridas-southwest-with-opening-of-its-29th-store-in-fort-meyers-301213166.html", "https://www.prnasia.com/story/42451-1.shtml", "https://www.prnewswire.com/news-releases/global-pulmonary-arterial-hypertension-2020-to-2025---by-drug-class-route-of-administration-distribution-mode-and-geography-301213194.html", "https://www.prnasia.com/story/61215-1.shtml", "https://www.prnasia.com/story/61030-1.shtml", "https://www.prnewswire.com/news-releases/lilly-completes-acquisition-of-prevail-therapeutics-301213219.html", "https://www.prnasia.com/story/60918-1.shtml", "https://www.prnasia.com/story/61247-1.shtml", "https://www.prnasia.com/story/61173-1.shtml", "https://www.prnasia.com/story/60685-1.shtml", "https://www.prnewswire.com/news-releases/birchbiomed-inc-announces-positive-topline-data-from-phase-2-study-of-fs2-for-treatment-of-keloid-scars-301213375.html", "https://www.prnasia.com/story/61638-1.shtml", "https://www.prnasia.com/story/42536-1.shtml", "https://www.prnewswire.com/news-releases/cansortium-announces-shares-for-debt-settlement-and-issuance-of-stock-options-301213487.html", "https://www.prnewswire.com/news-releases/lupus-research-alliance-hails-approval-of-aurinias-lupkynistm-voclosporin-301213507.html", "https://www.prnewswire.com/news-releases/ubc-virtual-assistant-linda-demonstrates-improvement-in-patient-engagement-and-therapy-adherence-in-patient-support-programs-301213372.html", "https://www.prnewswire.com/news-releases/biolinerx-announces-closing-of-34-5-million-bought-deal-offering-and-full-exercise-of-the-option-of-the-underwriter-301213408.html", "https://cnmobile.prnasia.com/story/60982-1.shtml", "https://www.prnewswire.com/news-releases/lupus-foundation-of-america-congratulates-aurinia-pharmaceuticals-on-fda-approval-of-lupkynis-voclosporin-to-treat-lupus-nephritis-301213505.html", "https://www.prnasia.com/story/9100-1.shtml", "https://www.prnewswire.com/news-releases/elasmogen-announces-a-panel-of-novel-potent-anti-covid-19-therapeutic-candidates-identified-through-collaboration-with-us-research-partners-301213428.html", "https://www.prnasia.com/story/8927-1.shtml", "https://www.prnasia.com/story/9065-1.shtml", "https://www.prnewswire.com/news-releases/elasmogen-annonce-la-creation-d-un-panel-de-candidats-therapeutiques-novateurs-efficaces-contre-le-covid-19-identifies-en-collaboration-avec-des-partenaires-de-recherche-americains-883192368.html", "https://www.prnewswire.com/news-releases/inspired-spine-announces-trident-si-joint-screw-system-secures-fda-510k-approval-301215489.html", "https://www.prnasia.com/story/8523-1.shtml", "https://www.prnewswire.com/news-releases/first-of-its-kind-truth-campaign-follows-young-vapers-quit-e-cigarettes-live-on-social-media-301215487.html", "https://www.prnewswire.com/news-releases/biopharmaceuticals-contract-manufacturing-market-size-worth-25-1-billion-by-2028-grand-view-research-inc-301213757.html", "https://www.prnewswire.com/news-releases/clearlake-backed-symplr-to-acquire-phynd-301213758.html", "https://www.prnewswire.com/news-releases/new-clinical-data-shows-bd-antigen-test-may-be-more-selective-in-detecting-infectious-covid-19-patients-than-molecular-tests-301213568.html", "https://www.prnewswire.com/news-releases/european-commission-approves-bavencio-avelumab-for-first-line-maintenance-treatment-of-locally-advanced-or-metastatic-urothelial-carcinoma-301213683.html", "https://www.prnasia.com/story/8757-1.shtml", "https://www.prnasia.com/story/8650-1.shtml", "https://www.prnasia.com/story/9582-1.shtml", "https://www.prnewswire.com/news-releases/maplewood-senior-living-recognized-among-nations-top-providers-with-five-communities-selected-as-2021-best-of-assisted-living-award-winners-301215545.html", "https://www.prnasia.com/story/8362-1.shtml", "https://www.prnewswire.com/news-releases/exogenesis-nanomesh-llc-a-subsidiary-of-exogenesis-corporation--announces-completion-of-production-validation-for-exogenesis-nanomesh-301215529.html", "https://www.prnasia.com/story/44594-1.shtml", "https://www.prnewswire.com/news-releases/masa-mts-is-growing--increasing-partnership-opportunities-301215517.html", "https://www.prnasia.com/story/9171-1.shtml", "https://www.prnasia.com/story/44549-1.shtml", "https://www.prnasia.com/story/44358-1.shtml", "https://www.prnasia.com/story/44645-1.shtml", "https://www.prnewswire.com/news-releases/amgen-to-webcast-investor-meeting-at-2020-world-conference-on-lung-cancer-301215566.html", "https://www.prnasia.com/story/43944-1.shtml", "https://www.prnewswire.com/news-releases/encompass-health-reports-results-for-fourth-quarter-2020-and-issues-full-year-2021-guidance-and-longer-term-growth-targets-301215611.html", "https://www.prnewswire.com/news-releases/samsung-biologics-national-oncoventure-and-eutilex-obtain-ind-approval-from-fda-301215739.html", "https://www.prnewswire.com/news-releases/healthcor-catalio-acquisition-corp-announces-pricing-of-upsized-180-million-initial-public-offering-301215767.html", "https://www.prnewswire.com/news-releases/stem-cell-recruitment-therapy-registration-awarded-by-us-patent--trademark-office-for-russell-health-301215797.html", "https://www.prnasia.com/story/9178-1.shtml", "https://www.prnasia.com/story/44886-1.shtml", "https://www.prnasia.com/story/44991-1.shtml", "https://www.prnasia.com/story/45504-1.shtml", "https://www.prnewswire.com/news-releases/calliditas-therapeutics-launches-proposed-global-offering-301215664.html", "https://www.prnasia.com/story/45427-1.shtml", "https://www.prnasia.com/story/15086-1.shtml", "https://www.prnewswire.com/news-releases/mgb-biopharma---successful-end-of-phase-2-meeting-with-fda-for-mgb-bp-3-a-potential-new-gold-standard-first-line-treatment-for-clostridioides-difficile-infection-cdi-301215669.html", "https://www.prnasia.com/story/44647-1.shtml", "https://www.prnewswire.com/news-releases/bioarctic-receives-european-patent-for-new-antibodies-targeting-alzheimers-disease-301215908.html", "https://www.prnasia.com/story/15342-1.shtml", "https://www.prnewswire.com/news-releases/bill-and-melinda-gates-release-2021-annual-letter-the-year-global-health-went-local-301213509.html", "https://www.prnasia.com/story/45045-1.shtml", "https://www.prnewswire.com/news-releases/medeon-announces-positive-clinical-results-for-xflo-minimally-invasive-bph-treatment-device-301215987.html", "https://www.prnewswire.com/news-releases/benevolentai-and-astrazeneca-achieve-collaboration-milestone-with-novel-ai-generated-chronic-kidney-disease-target-301215406.html", "https://www.prnasia.com/story/14920-1.shtml", "https://www.prnewswire.com/news-releases/orexo-strengthens-ip-rights-for-overdose-rescue-drug-ox124-301215910.html", "https://www.prnasia.com/story/15701-1.shtml", "https://www.prnasia.com/story/15079-1.shtml", "https://www.prnewswire.com/news-releases/smithnephews-pico-single-use-negative-pressure-wound-therapy-system-again-shown-to-significantly-reduce-surgical-site-complications-301215907.html", "https://www.prnasia.com/story/16018-1.shtml", "https://www.prnewswire.com/news-releases/bill-et-melinda-gates-publient-leur-lettre-annuelle-2021-l-annee-ou-la-sante-mondiale-a-ete-pensee-a-l-echelle-locale--848407452.html", "https://www.prnewswire.com/news-releases/nuvalent-launches-with-50m-series-a-financing-from-deerfield-management-to-develop-precisely-targeted-kinase-inhibitors-for-treatment-resistant-cancers-301215762.html", "https://www.prnewswire.com/news-releases/lilly-vir-biotechnology-and-gsk-announce-first-patient-dosed-in-expanded-blaze-4-trial-evaluating-bamlanivimab-ly-cov555-with-vir-7831-gsk4182136-for-covid-19-301216017.html", "https://www.prnewswire.com/news-releases/ajinomoto-bio-pharma-services-and-humanigen-expand-manufacturing-agreement-to-support-fill-finish-for-investigational-covid-19-therapeutic-lenzilumab-nearing-completion-of-phase-3-study-301215721.html", "https://www.prnasia.com/story/16106-1.shtml", "https://www.prnewswire.com/news-releases/seacoast-capital-exits-non-control-growth-capital-investment-in-righttime-medical-care-301215702.html", "https://www.prnasia.com/story/15912-1.shtml", "https://www.prnasia.com/story/15289-1.shtml", "https://www.prnewswire.com/news-releases/regen-cov-antibody-cocktail-is-active-against-sars-cov-2-variants-first-identified-in-the-uk-and-south-africa-301215816.html", "https://www.prnewswire.com/news-releases/global-mrd-minimal-residual-disease-testing-markets-2020-2025-opportunities-in-potential-long-term-cost-savings--technological-evolution-of-testing-301216057.html", "https://www.prnewswire.com/news-releases/vera-therapeutics-launches-with-80-million-series-c-financing-to-develop-phase-2b-novel-biologic-for-kidney-disease-301209607.html", "https://www.prnewswire.com/news-releases/conserv-bioscience-and-lawrence-livermore-national-laboratory-to-collaborate-on-development-of-broad-spectrum-coronavirus-vaccine-301210239.html", "https://www.prnasia.com/story/2124-1.shtml", "https://www.prnasia.com/story/1998-1.shtml", "https://www.prnasia.com/story/2701-1.shtml", "https://www.prnewswire.com/news-releases/intravacc-announces-completion-of-formulation-and-manufacturing-process-development-of-prv-101-vaccine-candidate-for-provention-bio-301210217.html", "https://www.prnasia.com/story/17570-1.shtml", "https://www.prnewswire.com/news-releases/dinaqor-acquires-eht-technologies-gmbh-to-advance-engineered-heart-tissue-rd-capabilities-301210477.html", "https://www.prnewswire.com/news-releases/aledade-raises-100-million-series-d-to-help-more-primary-care-practices-thrive-in-value-based-care-301209969.html", "https://www.prnewswire.com/news-releases/dr-arteros-lab-researching-on-microrna-based-treatments-for-myotonic-dystrophy-type-1-by-translational-genomics-group-301210311.html", "https://cnmobile.prnasia.com/story/17023-1.shtml", "https://www.prnewswire.com/news-releases/gracell-biotechnologies-receives-ind-approval-from-china-nmpa-for-gc019f-a-fastcar-enabled-car-t-therapy-for-the-treatment-of-relapsed-or-refractory-adult-b-all-301209901.html", "https://www.prnasia.com/story/17361-1.shtml", "https://www.prnasia.com/story/2290-1.shtml", "https://www.prnasia.com/story/17482-1.shtml", "https://www.prnewswire.com/news-releases/spelman-college-and-ideaya-biosciences-announce-partnership-for-professional-development-of-the-next-generation-of-female-african-american-leaders-in-the-biotechnology-industry-301209801.html", "https://www.prnasia.com/story/18025-1.shtml", "https://www.prnewswire.com/news-releases/lilly-and-merus-nv-announce-collaboration-to-discover-novel-t-cell-re-directing-bispecific-antibodies-301210513.html", "https://www.prnasia.com/story/17793-1.shtml", "https://www.prnasia.com/story/17822-1.shtml", "https://www.prnasia.com/story/2233-1.shtml", "https://www.prnewswire.com/news-releases/bausch--lomb-completes-enrollment-of-first-phase-3-study-for-nov03-perfluorohexyloctane-301210541.html", "https://www.prnewswire.com/news-releases/caris-life-sciences-accurately-identifies-21-cancer-types-using-artificial-intelligence-derived-molecular-signatures-301210497.html", "https://www.prnewswire.com/news-releases/centene-launches-youth-impact-award-for-vaping-prevention-301210565.html", "https://www.prnasia.com/story/19122-1.shtml", "https://www.prnasia.com/story/18871-1.shtml", "https://www.prnewswire.com/news-releases/clinical-data-presented-at-2021-north-american-neuromodulation-society-nans-virtual-meeting-reinforce-significant-benefits-of-nevros-hf10-therapy-301210545.html", "https://www.prnasia.com/story/18946-1.shtml", "https://www.prnewswire.com/news-releases/calyx-supports-breakthrough-therapy-approvals-for-oncology-treatments-301210430.html", "https://www.prnasia.com/story/19189-1.shtml", "https://www.prnewswire.com/news-releases/primerx-offers-direct-integration-with-surescripts-real-time-prescription-benefit-tool-301210362.html", "https://www.prnewswire.com/news-releases/soligenix-announces-investor-webcast-event-us-commercialization-of-sgx301-in-the-treatment-of-cutaneous-t-cell-lymphoma-301209662.html", "https://www.prnewswire.com/news-releases/invixa-announces-licensing-deal-with-university-of-california-davis-for-the-commercialization-of-novel-inhaled-statins-for-the-treatment-of-covid-19-301210657.html", "https://www.prnasia.com/story/18688-1.shtml", "https://www.prnewswire.com/news-releases/scopus-biopharma-announces-completion-of-clinical-lot-manufacture-301210492.html", "https://www.prnasia.com/story/18533-1.shtml", "https://www.prnewswire.com/news-releases/seven-year-data-shows-accuray-tomotherapy-system-provides-excellent-long-term-control-of-low-risk-breast-cancer-301210300.html", "https://www.prnasia.com/story/18802-1.shtml", "https://www.prnewswire.com/news-releases/bird--israel-us-binational-industrial-rd-foundation-to-invest-7-45-million-in-eight-new-projects-301210673.html", "https://www.prnewswire.com/news-releases/creative-medical-technology-holdings-announces-positive-data-and-patent-filing-using-immcelz-to-treat-type-1-diabetes-301210593.html", "https://www.prnasia.com/story/18691-1.shtml", "https://www.prnewswire.com/news-releases/chemistree-investee-immunoflex-receives-health-canada-approval-for-flex-10-product-301210781.html", "https://www.prnasia.com/story/18810-1.shtml", "https://www.prnasia.com/story/18226-1.shtml", "https://www.prnewswire.com/news-releases/cytosorbents-announces-approval-of-cytosorb-in-korea-in-collaboration-with-partner-fresenius-medical-care-301210583.html", "https://www.prnewswire.com/news-releases/mindup-invests-in-its-13th-portfolio-company-cogme-a-holistic-solution-to-detect-and-prevent-delirium-301210746.html", "https://www.prnasia.com/story/18121-1.shtml", "https://www.prnewswire.com/news-releases/bioeclipse-initiates-enrollment-in-phase-1-dose-escalation-clinical-trial-for-crx100-at-honorhealth-research-institute-301210569.html", "https://www.prnewswire.com/news-releases/galmed-hosting-kol-symposium-and-pipeline-update-301210736.html", "https://www.prnasia.com/story/3106-1.shtml", "https://www.prnasia.com/story/19002-1.shtml", "https://www.prnewswire.com/news-releases/realself-acquires-tajmeelicom-to-serve-arabic-speaking-medical-aesthetics-market-301210484.html", "https://www.prnasia.com/story/4021-1.shtml", "https://www.prnewswire.com/news-releases/biondvax-announces-launch-of-proposed-underwritten-follow-on-offering-of-american-depositary-shares-301217796.html", "https://www.prnasia.com/story/3724-1.shtml", "https://www.prnewswire.com/news-releases/new-amivantamab-data-from-chrysalis-study-show-robust-clinical-activity-and-durable-responses-in-patients-with-metastatic-or-unresectable-non-small-cell-lung-cancer-and-egfr-exon-20-insertion-mutations-301217851.html", "https://www.prnewswire.com/news-releases/neurobo-pharmaceuticals-announces-10-0-million-private-placement-301210620.html", "https://www.prnasia.com/story/19525-1.shtml", "https://www.prnasia.com/story/4214-1.shtml", "https://www.prnewswire.com/news-releases/ascentage-pharma-announces-the-fifth-orphan-drug-designation-granted-to-bcl-2-inhibitor-apg-2575-by-the-us-fda-and-the-tenth-obtained-by-the-company-301217807.html", "https://www.prnewswire.com/news-releases/farapulse-receives-european-approval-to-commercialize-its-leading-pulsed-field-ablation-system-to-treat-paroxysmal-atrial-fibrillation-301217824.html", "https://www.prnasia.com/story/4003-1.shtml", "https://www.prnasia.com/story/2851-1.shtml", "https://www.prnasia.com/story/5883-1.shtml", "https://www.prnasia.com/story/4683-1.shtml", "https://www.prnewswire.com/news-releases/cathvision-clinical-results-to-be-presented-at-the-af-symposium-301217738.html", "https://www.prnasia.com/story/5343-1.shtml", "https://www.prnewswire.com/news-releases/aware-recovery-care-announces-growth-investment-from-health-enterprise-partners-301217863.html", "https://www.prnasia.com/story/5047-1.shtml", "https://www.prnasia.com/story/4352-1.shtml", "https://www.prnasia.com/story/4534-1.shtml", "https://www.prnasia.com/story/5176-1.shtml", "https://www.prnewswire.com/news-releases/biondvax-announces-pricing-of-12-1-million-follow-on-underwritten-offering-of-american-depositary-shares-301218081.html", "https://www.prnewswire.com/news-releases/karyopharm-receives-positive-chmp-opinion-for-nexpovio-selinexor-for-the-treatment-of-patients-with-refractory-multiple-myeloma-301218116.html", "https://www.prnewswire.com/news-releases/moberg-pharma-announcement-of-terms-for-the-fully-guaranteed-rights-issue-in-oncozenge-timetable-for-the-listing-and-record-date-for-lex-asea-301218039.html", "https://www.prnasia.com/story/4676-1.shtml", "https://www.prnewswire.com/news-releases/johnson--johnson-announces-single-shot-janssen-covid-19-vaccine-candidate-met-primary-endpoints-in-interim-analysis-of-its-phase-3-ensemble-trial-301218035.html", "https://www.prnewswire.com/news-releases/redhill-biopharma-announces-positive-dsmb-futility-review-for-phase-23-covid-19-study-of-opaganib-301218000.html", "https://www.prnasia.com/story/4600-1.shtml", "https://www.prnewswire.com/news-releases/phase-1-drug-candidate-glr2007-developed-by-gan--lee-has-been-granted-fast-track-designation-by-the-us-fda-301218146.html", "https://www.prnasia.com/story/20747-1.shtml", "https://www.prnewswire.com/news-releases/hmp-global-to-acquire-two-prominent-addiction-education-events-from-c4-recovery-foundation-301218152.html", "https://www.prnewswire.com/news-releases/medtronic-receives-fda-approval-of-diamondtemp-ablation-system-for-the-treatment-of-patients-with-atrial-fibrillation-301217710.html", "https://www.prnasia.com/story/20848-1.shtml", "https://www.prnewswire.com/news-releases/moleculin-announces-reverse-stock-split-301218101.html", "https://www.prnasia.com/story/21073-1.shtml", "https://www.prnasia.com/story/20541-1.shtml", "https://www.prnasia.com/story/6054-1.shtml", "https://www.prnewswire.com/news-releases/cenobamate-receives-positive-chmp-opinion-for-adjunctive-treatment-of-focal-onset-partial-onset-seizures-301218227.html", "https://www.prnasia.com/story/21151-1.shtml", "https://www.prnasia.com/story/20566-1.shtml", "https://www.prnewswire.com/news-releases/ehealth-announces-strategic-investment-from-hig-capital-301218125.html", "https://www.prnewswire.com/news-releases/ehealth-inc-announces-preliminary-results-for-the-fourth-quarter-and-fiscal-year-2020-301218109.html", "https://www.prnewswire.com/news-releases/orexo-expects-fda-filing-of-ox124-mid-2022-301218203.html", "https://www.prnasia.com/story/6060-1.shtml", "https://www.prnasia.com/story/6350-1.shtml", "https://www.prnasia.com/story/21164-1.shtml", "https://www.prnasia.com/story/6309-1.shtml", "https://www.prnewswire.com/news-releases/global-virus-network-gvn-adds-four-preeminent-academic-institutions-to-strengthen-global-collaboration-in-viral-research-and-response-to-pandemics-301218196.html", "https://www.prnasia.com/story/21175-1.shtml", "https://www.prnasia.com/story/21163-1.shtml", "https://www.prnasia.com/story/6324-1.shtml", "https://www.prnewswire.com/news-releases/clinical-trial-of-proxalutamides-trial-of-hospitalized-covid-19-patients-was-approved-in-brazil-301217114.html", "https://www.prnewswire.com/news-releases/casi-pharmaceuticals-partner-bioinvent-presents-phase-iiia-data-that-suggests-bi-1206-restores-activity-of-rituximab-in-relapsed-non-hodgkins-lymphoma-patients-301217013.html", "https://www.prnasia.com/story/6174-1.shtml", "https://www.prnasia.com/story/21483-1.shtml", "https://www.prnasia.com/story/6571-1.shtml", "https://www.prnewswire.com/news-releases/bio-techne-announces-strategic-investment-in-eminence-301217000.html", "https://www.prnewswire.com/news-releases/neuraxpharm-selected-for-prestigious-pilot-program-to-supply-medical-cannabis-in-france-301217161.html", "https://www.prnasia.com/story/6097-1.shtml", "https://www.prnasia.com/story/21480-1.shtml", "https://www.prnasia.com/story/21497-1.shtml", "https://www.prnasia.com/story/21859-1.shtml", "https://www.prnewswire.com/news-releases/medical-composites-market-size-impacted-by-covid-19-to-reach-us-771-million-in-2026-says-stratview-research-301217124.html", "https://www.prnasia.com/story/21586-1.shtml", "https://www.prnasia.com/story/6339-1.shtml", "https://www.prnasia.com/story/21620-1.shtml", "https://cnmobile.prnasia.com/story/6182-1.shtml", "https://www.prnasia.com/story/21987-1.shtml", "https://www.prnewswire.com/news-releases/national-taiwan-university-hospital-presents-data-on-nuq-assay-performance-at-the-world-conference-on-lung-cancer-301217090.html", "https://www.prnewswire.com/news-releases/berkshire-biomedical-raises-3-million-in-first-third-party-financing-301217005.html", "https://www.prnasia.com/story/22087-1.shtml", "https://www.prnewswire.com/news-releases/clearlake-capital-completes-acquisition-of-nthrives-technology-division-301217014.html", "https://www.prnasia.com/story/22984-1.shtml", "https://www.prnasia.com/story/21727-1.shtml", "https://www.prnewswire.com/news-releases/apsard-and-tris-pharma-announce-the-2021-tris-research-award-in-adhd-301216870.html", "https://www.prnasia.com/story/22789-1.shtml", "https://www.prnewswire.com/news-releases/sai-life-sciences-announces-plans-to-double-headcount-and-expand-capabilities-in-manchester-uk-301216905.html", "https://www.prnewswire.com/news-releases/redhill-biopharma-further-expands-opaganib-manufacturing-capacity-for-covid-19-with-cosmo-pharmaceuticals-301217169.html", "https://www.prnasia.com/story/21542-1.shtml", "https://www.prnasia.com/story/21827-1.shtml", "https://www.prnewswire.com/news-releases/government-database-shows-7-844-injuries-and-181-deaths-following-covid-vaccine-as-of-jan-15-says-childrens-health-defense-301217037.html", "https://www.prnasia.com/story/21880-1.shtml", "https://www.prnewswire.com/news-releases/health-insurer-zilveren-kruis-boosts-efficiency-and-reduces-operational-costs-via-new-portals-built-with-the-mendix-low-code-platform-301217024.html", "https://www.prnasia.com/story/23478-1.shtml", "https://www.prnasia.com/story/23271-1.shtml", "https://www.prnasia.com/story/7576-1.shtml", "https://www.prnasia.com/story/23026-1.shtml", "https://www.prnasia.com/story/23773-1.shtml", "https://www.prnewswire.com/news-releases/covid-t-clinical-development-program-initiated-regulatory-advisory-group-engaged-301217231.html", "https://www.prnasia.com/story/23612-1.shtml", "https://www.prnewswire.com/news-releases/15-million-people-will-be-eligible-for-the-special-enrollment-period--heres-how-they-can-pick-the-right-health-insurance-plan-301216881.html", "https://www.prnewswire.com/news-releases/hoth-therapeutics-expands-research-collaboration-agreement-with-weill-cornell-medicine-to-continue-the-advancement-of-ht-003-for-acne-treatment-research-301217046.html", "https://www.prnasia.com/story/23450-1.shtml", "https://www.prnasia.com/story/7714-1.shtml", "https://www.prnewswire.com/news-releases/studies-indicating-t-cells-may-be-needed-for-long-term-protection-from-the-sars-cov-2-virus-301216948.html", "https://www.prnasia.com/story/7593-1.shtml", "https://www.prnewswire.com/news-releases/jtv-pulmonx-corporation--respiratory-health-association-launch-2021-catch-your-breath-campaign-301217311.html", "https://www.prnasia.com/story/23036-1.shtml", "https://www.prnasia.com/story/23684-1.shtml", "https://www.prnasia.com/story/7528-1.shtml", "https://www.prnewswire.com/news-releases/om1-heart-failure-registry-reaches-more-than-140-000-patients-prospectively-followed-with-deep-clinical-data-301216904.html", "https://www.prnasia.com/story/24753-1.shtml", "https://www.prnasia.com/story/8005-1.shtml", "https://www.prnewswire.com/news-releases/immunoforges-pf1801-is-designated-as-orphan-drug-by-fda-301214644.html", "https://www.prnasia.com/story/8248-1.shtml", "https://www.prnasia.com/story/7928-1.shtml", "https://www.prnewswire.com/news-releases/almirall-and-happify-health-enter-into-strategic-partnership-to-develop-evidence-supported-digital-therapeutics-solutions-for-psoriasis-patients-301216719.html", "https://www.prnasia.com/story/8001-1.shtml", "https://www.prnasia.com/story/7586-1.shtml", "https://www.prnewswire.com/news-releases/calliditas-announces-termination-of-the-proposed-global-offering-301217338.html", "https://www.prnasia.com/story/8212-1.shtml", "https://www.prnewswire.com/news-releases/emitbio-announces-positive-clinical-results-supporting-a-novel-therapeutic-for-covid-19-301217266.html", "https://cnmobile.prnasia.com/story/23951-1.shtml", "https://www.prnewswire.com/news-releases/covid-19-resources-added-to-award-winning-fair-health-consumer-website-301210845.html", "https://www.prnewswire.com/news-releases/virgo-investment-group-announces-20m-growth-capital-investment-in-apricus-health-301210165.html", "https://www.prnewswire.com/news-releases/alice-pomponio-named-managing-director-of-american-cancer-societys-brightedge-301209770.html", "https://www.prnewswire.com/news-releases/verasci-partners-with-actigraph-to-expand-the-use-of-wearables-in-clinical-trials-301210962.html", "https://www.prnasia.com/story/7844-1.shtml", "https://www.prnewswire.com/news-releases/parent-project-muscular-dystrophy-invests-1-million-in-satellos-bioscience-to-support-new-regenerative-medicine-technology-301210627.html", "https://cnmobile.prnasia.com/story/24731-1.shtml", "https://www.prnasia.com/story/25807-1.shtml", "https://www.prnasia.com/story/24813-1.shtml", "https://www.prnasia.com/story/9627-1.shtml", "https://www.prnasia.com/story/25008-1.shtml", "https://www.prnewswire.com/news-releases/the-blocpartners-honored-with-the-selection-of-two-jurors-for-the-clio-health-awards-301217335.html", "https://www.prnasia.com/story/25332-1.shtml", "https://www.prnasia.com/story/9614-1.shtml", "https://www.prnewswire.com/news-releases/pfizers-covid-19-vaccine-aided-by-cedarville-pharmacy-grad-301217025.html", "https://www.prnasia.com/story/9746-1.shtml", "https://www.prnewswire.com/news-releases/canon-virginia-inc-serves-as-rebions-manufacturer-of-the-blinq-vision-scanner-301217342.html", "https://www.prnewswire.com/news-releases/avista-capital-partners-announces-completion-of-solmetex-acquisition-301211062.html", "https://www.prnasia.com/story/26866-1.shtml", "https://www.prnasia.com/story/26932-1.shtml", "https://www.prnasia.com/story/24889-1.shtml", "https://www.prnewswire.com/news-releases/carexm-announces-acquisition-of-touchpointcare-301211053.html", "https://www.prnewswire.com/news-releases/hpone-announces-addition-of-key-c-suite-executives-builds-on-strategic-objectives-following-2020-growth-recapitalization-301211107.html", "https://www.prnasia.com/story/26860-1.shtml", "https://www.prnasia.com/story/10277-1.shtml", "https://www.prnasia.com/story/27338-1.shtml", "https://www.prnewswire.com/news-releases/fda-marks-historic-public-health-milestone-with-finalization-of-two-key-rules-for-companies-seeking-to-market-new-tobacco-products-301211273.html", "https://www.prnewswire.com/news-releases/biolinerx-announces-10-million-bought-deal-offering-301211288.html", "https://www.prnasia.com/story/11121-1.shtml", "https://www.prnasia.com/story/11168-1.shtml", "https://www.prnasia.com/story/10251-1.shtml", "https://www.prnasia.com/story/27810-1.shtml", "https://www.prnewswire.com/news-releases/lightpoint-medical-receives-ce-mark-for-worlds-first-approved-robotic-gamma-probe-301210129.html", "https://www.prnewswire.com/news-releases/genesis-medtech-collaborates-with-penumbra-to-expand-neurovascular-market-in-china-301211406.html", "https://www.prnewswire.com/news-releases/innodem-neurosciences-erhalt-6-millionen-us-dollar-finanzierung-von-der-morningside-group-856804177.html", "https://www.prnasia.com/story/11452-1.shtml", "https://www.prnewswire.com/news-releases/jemincare-initiates-phase-i-clinical-trial-of-anti-sars-cov-2-neutralizing-antibody-jmb2002-301211484.html", "https://www.prnasia.com/story/28353-1.shtml", "https://www.prnasia.com/story/28451-1.shtml", "https://www.prnewswire.com/news-releases/new-guide-shares-patient-experience-trends--innovations-in-light-of-covid-19-301217068.html", "https://www.prnewswire.com/news-releases/biolinerx-increases-previously-announced-bought-deal-offering-to-30-million-301211410.html", "https://www.prnewswire.com/news-releases/branford-castle-shocks-equine-veterinary-world-with-new-acquisition-301217473.html", "https://www.prnasia.com/story/28634-1.shtml", "https://cnmobile.prnasia.com/story/28229-1.shtml", "https://www.prnasia.com/story/28754-1.shtml", "https://www.prnasia.com/story/12017-1.shtml", "https://www.prnasia.com/story/11780-1.shtml", "https://www.prnasia.com/story/11673-1.shtml", "https://www.prnasia.com/story/11795-1.shtml", "https://www.prnasia.com/story/11781-1.shtml", "https://www.prnasia.com/story/12517-1.shtml", "https://www.prnewswire.com/news-releases/12-month-below-the-knee-data-with-medalliances-selution-slr-presented-as-late-breaking-trial-at-linc-301217498.html", "https://www.prnasia.com/story/11794-1.shtml", "https://www.prnasia.com/story/11738-1.shtml", "https://www.prnasia.com/story/12185-1.shtml", "https://www.prnasia.com/story/12351-1.shtml", "https://www.prnewswire.com/news-releases/microgem-acquires-jump-start-expands-manufacturing-to-accelerate-production-of-portable-covid-19-saliva-test-301216766.html", "https://www.prnasia.com/story/254515-1.shtml", "https://www.prnewswire.com/news-releases/how-will-you-show-your-stripes-in-30-days-301217592.html", "https://www.prnasia.com/story/13712-1.shtml", "https://www.prnasia.com/story/13872-1.shtml", "https://www.prnasia.com/story/13276-1.shtml", "https://www.prnasia.com/story/13626-1.shtml", "https://www.prnewswire.com/news-releases/sharecare-acquires-docai-to-expand-engineering-expertise-accelerate-digital-transformation-of-healthcare-through-innovative-ai-platform-301217502.html", "https://www.prnasia.com/story/13492-1.shtml", "https://www.prnasia.com/story/254266-1.shtml", "https://www.prnasia.com/story/13403-1.shtml", "https://www.prnasia.com/story/13295-1.shtml", "https://www.prnewswire.com/news-releases/amgens-investigational-kras-g12c-inhibitor-sotorasib-demonstrated-rapid-deep-and-durable-responses-in-previously-treated-patients-with-advanced-non-small-cell-lung-cancer-301217636.html", "https://www.prnasia.com/story/256402-1.shtml", "https://www.prnasia.com/story/255312-1.shtml", "https://www.prnasia.com/story/256269-1.shtml", "https://www.prnasia.com/story/255142-1.shtml", "https://www.prnasia.com/story/255132-1.shtml", "https://www.prnasia.com/story/256571-1.shtml", "https://www.prnasia.com/story/255056-1.shtml", "https://cnmobile.prnasia.com/story/13061-1.shtml", "https://www.prnasia.com/story/255628-1.shtml", "https://www.prnasia.com/story/178-1.shtml", "https://www.prnewswire.com/news-releases/azzur-group-welcomes-fda-veteran-kimberley-buytaert-hoefen-phd-as-director-of-preclinical-consulting-301217706.html", "https://www.prnewswire.com/news-releases/research-marketing-and-advertising-rma-expands-marketing-services-to-clinical-research-industry-nationwide-301211813.html", "https://www.prnasia.com/story/198-1.shtml", "https://www.prnasia.com/story/255169-1.shtml", "https://www.prnasia.com/story/256380-1.shtml", "https://www.prnewswire.com/news-releases/saluda-medical-announces-highlights-from-2021-north-american-neuromodulation-society-nans-meeting-301211980.html", "https://www.prnasia.com/story/553-1.shtml", "https://www.prnasia.com/story/255880-1.shtml", "https://www.prnasia.com/story/277804-1.shtml", "https://www.prnasia.com/story/277481-1.shtml", "https://www.prnasia.com/story/277215-1.shtml", "https://www.prnewswire.com/news-releases/ardx-expands-executive-team-301211793.html", "https://www.prnasia.com/story/277778-1.shtml", "https://www.prnasia.com/story/324-1.shtml", "https://www.prnasia.com/story/278076-1.shtml", "https://www.prnasia.com/story/278196-1.shtml", "https://www.prnasia.com/story/277108-1.shtml", "https://www.prnasia.com/story/279733-1.shtml", "https://www.prnasia.com/story/279375-1.shtml", "https://www.prnewswire.com/news-releases/precisionos-hosts-world-leading-hip-surgeons-for-the-first-live-virtual-surgery-webinar-in-collaboration-with-the-arthroscopy-association-of-north-america-aana-and-conmed-301211917.html", "https://www.prnasia.com/story/277608-1.shtml", "https://www.prnasia.com/story/279286-1.shtml", "https://www.prnasia.com/story/279371-1.shtml", "https://www.prnasia.com/story/279543-1.shtml", "https://www.prnewswire.com/news-releases/efficacy-and-safety-of-ruxolitinib-and-steroids-for-treating-patients-with-relapsed-or-refractory-multiple-myeloma-rrmm-results-from-the-i-rux-study-published-in-ash2020-301211984.html", "https://www.prnasia.com/story/277483-1.shtml", "https://www.prnasia.com/story/279785-1.shtml", "https://www.prnasia.com/story/279514-1.shtml", "https://www.prnasia.com/story/279781-1.shtml", "https://www.prnewswire.com/news-releases/canntrust-announces-restructuring-support-agreement-with-key-class-action-plaintiffs-and-their-counsel-301211985.html", "https://www.prnasia.com/story/279267-1.shtml", "https://www.prnasia.com/story/277665-1.shtml", "https://www.prnasia.com/story/278469-1.shtml", "https://www.prnasia.com/story/278030-1.shtml", "https://www.prnasia.com/story/277898-1.shtml", "https://www.prnasia.com/story/280270-1.shtml", "https://www.prnasia.com/story/280182-1.shtml", "https://www.prnasia.com/story/280748-1.shtml", "https://www.prnewswire.com/news-releases/pneumagen-announces-2-5m-fundraising-to-advance-universal-treatment-for-viral-respiratory-infections-into-the-clinic-this-year-301210969.html", "https://www.prnasia.com/story/279798-1.shtml", "https://www.prnewswire.com/news-releases/seegene-to-advance-business-in-latin-america-in-the-new-year-301212127.html", "https://www.prnasia.com/story/279792-1.shtml", "https://www.prnasia.com/story/279369-1.shtml", "https://www.prnasia.com/story/280403-1.shtml", "https://www.prnasia.com/story/262731-1.shtml", "https://www.prnewswire.com/news-releases/lumiradx-receives-sars-cov-2-antigen-test-authorization-in-japan-and-brazil-italy-recommends-expansion-of-microfluidic-antigen-testing-301212106.html", "https://www.prnasia.com/story/262564-1.shtml", "https://www.prnasia.com/story/263327-1.shtml", "https://www.prnasia.com/story/263519-1.shtml", "https://www.prnasia.com/story/262558-1.shtml", "https://www.prnasia.com/story/264555-1.shtml", "https://www.prnasia.com/story/264209-1.shtml", "https://www.prnasia.com/story/280699-1.shtml", "https://www.prnasia.com/story/262771-1.shtml", "https://www.prnasia.com/story/264507-1.shtml", "https://www.prnewswire.com/news-releases/calliditas-announces-full-enrollment-of-the-phase-3-nefigard-trial-301212339.html", "https://www.prnewswire.com/news-releases/cphi--p-mec-china-gives-a-glimpse-of-the-success-returning-pharma-events-will-deliver-in-2021-301212141.html", "https://www.prnewswire.com/news-releases/ministry-of-health-of-the-uae-has-approved-the-use-of-sputnik-v-vaccine-301212466.html", "https://www.prnewswire.com/news-releases/puro-lighting-continues-to-build-momentum-with-record-growth-in-2020-301211924.html", "https://www.prnewswire.com/news-releases/galaxy-medical-centauri-pef-system-to-be-displayed-at-af-symposium-recorded-case-presentation-301212240.html", "https://www.prnasia.com/story/263632-1.shtml", "https://www.prnasia.com/story/246035-1.shtml", "https://www.prnasia.com/story/264025-1.shtml", "https://www.prnewswire.com/news-releases/boston-scientific-announces-agreement-to-acquire-preventice-solutions-inc-301212218.html", "https://www.prnasia.com/story/246175-1.shtml", "https://www.prnasia.com/story/246134-1.shtml", "https://www.prnasia.com/story/247484-1.shtml", "https://www.prnasia.com/story/245862-1.shtml", "https://www.prnewswire.com/news-releases/sutro-biopharma-announces-first-patient-dosed-in-the-dose-expansion-study-of-stro-002-in-patients-with-ovarian-cancer-301212230.html", "https://www.prnewswire.com/news-releases/south-koreas-mfds-approves-lumify-eye-drops-301212137.html", "https://www.prnewswire.com/news-releases/medolife-rx-inc-has-submitted-applications-of-their--scorpion-venom-to-help-fight-against-cancer-and-covid-19-with-the-fda-in-the-dominican-republic-the-fda-is-in-the-process-of-investigation-and-conducting-their-due-diligence--301212256.html", "https://www.prnewswire.com/news-releases/lillys-neutralizing-antibody-bamlanivimab-ly-cov555-prevented-covid-19-at-nursing-homes-in-the-blaze-2-trial-reducing-risk-by-up-to-80-percent-for-residents-301212159.html", "https://www.prnasia.com/story/245946-1.shtml", "https://www.prnasia.com/story/262933-1.shtml", "https://www.prnasia.com/story/246057-1.shtml", "https://www.prnewswire.com/news-releases/berkshire-biomedical-announces-acceptance-of-510k-premarket-submission-of-computerized-oral-prescription-administration-copa-system-301212234.html", "https://www.prnasia.com/story/246563-1.shtml", "https://cnmobile.prnasia.com/story/280431-1.shtml", "https://www.prnewswire.com/news-releases/dermata-therapeutics-presents-positive-data-from-its-phase-2b-clinical-study-of-dmt310-for-the-treatment-of-moderate-to-severe-acne-at-the-2021-maui-derm-for-dermatologists-annual-conference-301212019.html", "https://www.prnasia.com/story/263152-1.shtml", "https://www.prnasia.com/story/245942-1.shtml", "https://www.prnasia.com/story/246004-1.shtml", "https://www.prnasia.com/story/246667-1.shtml", "https://www.prnasia.com/story/247353-1.shtml", "https://www.prnasia.com/story/248722-1.shtml", "https://www.prnewswire.com/news-releases/science-37-launches-science-37-certifieda-partnership-program-enabling-cros-to-effectively-execute-decentralized-clinical-trials-301212185.html", "https://www.prnasia.com/story/283804-1.shtml", "https://www.prnasia.com/story/248333-1.shtml", "https://www.prnasia.com/story/248646-1.shtml", "https://www.prnewswire.com/news-releases/casi-pharmaceuticals-partner-bioinvent-to-host-key-opinion-leader-call-on-bi-1206-for-relapsed-or-refractory-non-hodgkins-lymphoma-301212249.html", "https://www.prnasia.com/story/250124-1.shtml", "https://www.prnasia.com/story/249295-1.shtml", "https://www.prnasia.com/story/249920-1.shtml", "https://www.prnasia.com/story/247963-1.shtml", "https://www.prnewswire.com/news-releases/wesana-health-closes-4-million-convertible-note-round-301212481.html", "https://www.prnasia.com/story/248542-1.shtml", "https://www.prnasia.com/story/248769-1.shtml", "https://www.prnasia.com/story/247801-1.shtml", "https://www.prnewswire.com/news-releases/oramed-doses-patients-across-multiple-sites-in-phase-3-oral-insulin-study-301212437.html", "https://www.prnasia.com/story/248042-1.shtml", "https://www.prnewswire.com/news-releases/creative-medical-technology-holdings-recruits-founder-of-inc-500-clinical-trials-company-dr-boris-reznik-to-accelerate-development-of-immcelz-through-fda-301212298.html", "https://www.prnewswire.com/news-releases/plexium-announces-35m-financing-to-advance-pipeline-of-novel-protein-degraders-301212177.html", "https://www.prnasia.com/story/283832-1.shtml", "https://www.prnasia.com/story/283899-1.shtml", "https://www.prnasia.com/story/248783-1.shtml", "https://www.prnasia.com/story/249571-1.shtml", "https://www.prnasia.com/story/283952-1.shtml", "https://www.prnasia.com/story/248470-1.shtml", "https://www.prnewswire.com/news-releases/flexpoint-ford-expands-senior-investment-team-with-promotions-to-managing-director-and-principal-301212166.html", "https://www.prnasia.com/story/285599-1.shtml", "https://www.prnasia.com/story/250218-1.shtml", "https://www.prnasia.com/story/284529-1.shtml", "https://www.prnewswire.com/news-releases/heron-therapeutics-announces-publication-of-results-from-epoch-1-follow-on-study-of-htx-011-in-patients-undergoing-bunionectomy-surgery-301212178.html", "https://www.prnasia.com/story/249692-1.shtml", "https://www.prnewswire.com/news-releases/biotech-is-fueling-an-all-new-cannabis-boom-301212208.html", "https://www.prnasia.com/story/284586-1.shtml", "https://www.prnasia.com/story/249865-1.shtml", "https://www.prnasia.com/story/284411-1.shtml", "https://www.prnewswire.com/news-releases/mitsubishi-tanabe-pharma-america-and-aquestive-therapeutics-announce-us-licensing-and-supply-deal-for-riluzole-oral-film-for-als-treatment-301212571.html", "https://www.prnewswire.com/news-releases/auris-health-announces-publication-of-results-from-benefit-study-of-monarch-platform-in-chest-301211202.html", "https://www.prnasia.com/story/285469-1.shtml", "https://www.prnasia.com/story/283732-1.shtml", "https://www.prnasia.com/story/284329-1.shtml", "https://www.prnasia.com/story/284720-1.shtml", "https://www.prnasia.com/story/286626-1.shtml", "https://www.prnasia.com/story/284653-1.shtml", "https://www.prnasia.com/story/286120-1.shtml", "https://www.prnewswire.com/news-releases/fda-authorizes-monoclonal-antibodies-for-treatment-of-covid-19-301212201.html", "https://www.prnasia.com/story/285234-1.shtml", "https://www.prnasia.com/story/285849-1.shtml", "https://www.prnasia.com/story/286407-1.shtml", "https://www.prnasia.com/story/286834-1.shtml", "https://www.prnasia.com/story/286346-1.shtml", "https://www.prnewswire.com/news-releases/surface-ophthalmics-announces-positive-top-line-results-from-phase-ii-trial-for-surf-201-betamethasone-0-2-in-klarity-vehicle-for-the-treatment-of-post-cataract-surgery-pain-and-inflammation-301212617.html", "https://www.prnasia.com/story/285275-1.shtml", "https://www.prnasia.com/story/285768-1.shtml", "https://www.prnasia.com/story/284969-1.shtml", "https://www.prnasia.com/story/285773-1.shtml", "https://www.prnasia.com/story/284469-1.shtml", "https://www.prnasia.com/story/250403-1.shtml", "https://www.prnasia.com/story/250614-1.shtml", "https://www.prnewswire.com/news-releases/hcap-partners-announces-new-investment-in-83bar-301212323.html", "https://www.prnasia.com/story/250547-1.shtml", "https://www.prnasia.com/story/286494-1.shtml", "https://www.prnasia.com/story/250893-1.shtml", "https://www.prnewswire.com/news-releases/nls-pharmaceutics-ltd--announces-notice-of-allowance-of-a-new-technology-patent-covering-attention-deficit-hyperactivity-disorder--narcolepsy-301212576.html", "https://www.prnewswire.com/news-releases/the-fedeli-group-enters-medicare-space-announces-acquisition-of-kaz-company-301212472.html", "https://www.prnasia.com/story/250954-1.shtml", "https://www.prnasia.com/story/251384-1.shtml", "https://www.prnewswire.com/news-releases/synaptogenix-announces-14-0-million-private-placement-301212583.html", "https://www.prnasia.com/story/250687-1.shtml", "https://www.prnasia.com/story/289059-1.shtml", "https://www.prnasia.com/story/288011-1.shtml", "https://www.prnasia.com/story/251221-1.shtml", "https://www.prnasia.com/story/288674-1.shtml", "https://www.prnasia.com/story/250916-1.shtml", "https://www.prnasia.com/story/287405-1.shtml", "https://www.prnewswire.com/news-releases/curefit-acquires-digital-fitness-company-onyx-aims-to-accelerate-international-offering-301212500.html", "https://www.prnasia.com/story/288935-1.shtml", "https://www.prnewswire.com/news-releases/ayurvedic-remedy-outperforms-pharmaceuticals-in-coronavirus-comparative-clinical-trial-301212626.html", "https://www.prnasia.com/story/251469-1.shtml", "https://www.prnasia.com/story/251484-1.shtml", "https://www.prnewswire.com/news-releases/rigel-awarded-16-5-million-from-us-department-of-defense-for-phase-3-clinical-trial-of-fostamatinib-in-covid-19-patients-301218290.html", "https://www.prnasia.com/story/287541-1.shtml", "https://www.prnasia.com/story/251761-1.shtml", "https://www.prnasia.com/story/287898-1.shtml", "https://www.prnasia.com/story/251972-1.shtml", "https://www.prnasia.com/story/251570-1.shtml", "https://www.prnewswire.com/news-releases/pm360-announces-winners-of-2020-pharma-choice-awards-301211499.html", "https://cnmobile.prnasia.com/story/288085-1.shtml", "https://cnmobile.prnasia.com/story/288581-1.shtml", "https://www.prnasia.com/story/252156-1.shtml", "https://www.prnasia.com/story/289709-1.shtml", "https://www.prnasia.com/story/252172-1.shtml", "https://www.prnasia.com/story/251855-1.shtml", "https://www.prnasia.com/story/251951-1.shtml", "https://www.prnasia.com/story/253024-1.shtml", "https://www.prnewswire.com/news-releases/amgen-announces-breakthrough-therapy-designation-granted-for-sotorasib-in-china-301218228.html", "https://www.prnasia.com/story/252282-1.shtml", "https://www.prnasia.com/story/290079-1.shtml", "https://www.prnasia.com/story/252405-1.shtml", "https://www.prnasia.com/story/290002-1.shtml", "https://www.prnasia.com/story/252986-1.shtml", "https://www.prnasia.com/story/253339-1.shtml", "https://www.prnasia.com/story/251944-1.shtml", "https://www.prnasia.com/story/253162-1.shtml", "https://www.prnasia.com/story/252665-1.shtml", "https://www.prnasia.com/story/252366-1.shtml", "https://www.prnewswire.com/news-releases/clover-and-dynavax-announce-planned-global-phase-23-efficacy-trial-of-adjuvanted-covid-19-vaccine-candidate-301218639.html", "https://www.prnasia.com/story/252154-1.shtml", "https://www.prnewswire.com/news-releases/pioneering-in-home-and-personal-care-start-up-elunow-raises-investment-from-bolt-and-pipedrive-founders-to-launch-in-london-301218276.html", "https://www.prnasia.com/story/252491-1.shtml", "https://cnmobile.prnasia.com/story/253099-1.shtml", "https://www.prnewswire.com/news-releases/montefiore-notifies-patients-about-security-breach--potential-identify-theft-301218195.html", "https://www.prnasia.com/story/252693-1.shtml", "https://www.prnewswire.com/news-releases/clover-biopharmaceuticals-announces-publication-of-phase-1-clinical-trial-data-for-its-adjuvanted-covid-19-vaccine-candidates-in-the-lancet-301218618.html", "https://www.prnasia.com/story/252197-1.shtml", "https://www.prnewswire.com/news-releases/von-gan-amp-lee-entwickelter-phase-1-medikamentenkandidat-glr2007-erhalt-fast-track-zulassung-durch-die-u-s-amerikanische-zulassungsbehorde-fda-845828186.html", "https://www.prnasia.com/story/289957-1.shtml", "https://www.prnewswire.com/news-releases/cytiva-acquires-vanrx-pharmasystems-canadian-aseptic-filling-innovator-301218409.html", "https://www.prnasia.com/story/289073-1.shtml", "https://www.prnasia.com/story/253545-1.shtml", "https://www.prnasia.com/story/290963-1.shtml", "https://www.prnewswire.com/news-releases/protagonist-therapeutics-reports-granting-of-inducement-award-301218385.html", "https://www.prnasia.com/story/291173-1.shtml", "https://www.prnasia.com/story/291815-1.shtml", "https://www.prnasia.com/story/291011-1.shtml", "https://www.prnasia.com/story/291202-1.shtml", "https://www.prnasia.com/story/291575-1.shtml", "https://www.prnewswire.com/news-releases/x-bolt-features-in-largest-ever-hip-fracture-fixation-trial-publication-301218119.html", "https://www.prnasia.com/story/253357-1.shtml", "https://www.prnewswire.com/news-releases/new-scientific-publications-show-diadems-blood-based-alzosure-biomarker-test-can-predict-which-patients-will-progress-to-alzheimers-disease-years-before-symptoms-occur-301218605.html", "https://www.prnasia.com/story/291549-1.shtml", "https://www.prnasia.com/story/253619-1.shtml", "https://www.prnasia.com/story/253812-1.shtml", "https://www.prnewswire.com/news-releases/positive-data-from-phase-ii-study-attract-in-patients-with-covid-19-published-online-vicore-pharma-holding-301218676.html", "https://www.prnasia.com/story/291034-1.shtml", "https://www.prnewswire.com/news-releases/twistle-recognized-as-a-standout-vendor-for-its-virtual-care-capabilities-in-new-klas-patient-engagement-report-301218022.html", "https://www.prnewswire.com/news-releases/sifi-gibt-die-veroffentlichung-der-phase-1-seiner-studie-uber-polihexanid-in-dem-british-journal-of-ophthalmology-bekannt-870667822.html", "https://www.prnasia.com/story/290389-1.shtml", "https://www.prnasia.com/story/254109-1.shtml", "https://www.prnasia.com/story/291401-1.shtml", "https://www.prnewswire.com/news-releases/sifi-announces-the-publication-of-its-phase-i-study-on-polihexanide-in-the-british-journal-of-ophthalmology-301218444.html", "https://www.prnewswire.com/news-releases/regenxbio-announces-presentations-at-the-17th-annual-worldsymposium-2021-301218589.html", "https://www.prnewswire.com/news-releases/lupin-announces-partnership-with-phil-inc-in-support-of-solosec-secnidazole-301218874.html", "https://www.prnasia.com/story/290849-1.shtml", "https://www.prnasia.com/story/253594-1.shtml", "https://www.prnasia.com/story/253889-1.shtml", "https://www.prnasia.com/story/253609-1.shtml", "https://www.prnasia.com/story/291964-1.shtml", "https://www.prnasia.com/story/253859-1.shtml", "https://www.prnewswire.com/news-releases/clover-and-dynavax-announce-planned-global-phase-23-efficacy-trial-of-adjuvanted-covid-19-vaccine-candidate-301218633.html", "https://www.prnasia.com/story/293106-1.shtml", "https://www.prnewswire.com/news-releases/dynavax-announces-exercise-of-option-to-reserve-additional-cpg-1018-to-produce-40-million-doses-of-valnevas-inactivated-adjuvanted-covid-19-vaccine-candidate-for-the-uk-government-301218666.html", "https://www.prnasia.com/story/293040-1.shtml", "https://www.prnasia.com/story/293193-1.shtml", "https://www.prnasia.com/story/293786-1.shtml", "https://www.prnasia.com/story/293316-1.shtml", "https://www.prnasia.com/story/292258-1.shtml", "https://www.prnasia.com/story/256683-1.shtml", "https://www.prnewswire.com/news-releases/pharvaris-to-present-clinical-data-of-pha121-for-the-treatment-of-hereditary-angioedema-at-the-2021-aaaai-annual-meeting-301218795.html", "https://www.prnasia.com/story/292281-1.shtml", "https://www.prnasia.com/story/256680-1.shtml", "https://www.prnasia.com/story/293660-1.shtml", "https://www.prnasia.com/story/292231-1.shtml", "https://www.prnewswire.com/news-releases/protalix-biotherapeutics-announces-presentations-at-the-17th-annual-worldsymposium-2021-301218819.html", "https://www.prnasia.com/story/256810-1.shtml", "https://www.prnasia.com/story/292448-1.shtml", "https://www.prnewswire.com/news-releases/kadimastem-announces-executive-management-changes-301218825.html", "https://www.prnewswire.com/news-releases/hillrom-announces-acquisition-of-contact-free-continuous-monitoring-technology-from-earlysense-301218606.html", "https://www.prnewswire.com/news-releases/dynavax-and-cepi-announce-99-million-in-funding-for-cpg-1018-adjuvant-manufacturing-to-support-the-global-covid-19-response-301218641.html", "https://www.prnasia.com/story/292107-1.shtml", "https://www.prnasia.com/story/293014-1.shtml", "https://www.prnasia.com/story/257499-1.shtml", "https://www.prnasia.com/story/293678-1.shtml", "https://www.prnewswire.com/news-releases/soligenix-receives-hong-kong-patent-for-therapeutic-use-of-synthetic-hypericin-to-treat-cutaneous-t-cell-lymphoma-301218547.html", "https://www.prnasia.com/story/293814-1.shtml", "https://www.prnasia.com/story/294000-1.shtml", "https://www.prnasia.com/story/257110-1.shtml", "https://www.prnasia.com/story/256928-1.shtml", "https://www.prnasia.com/story/293110-1.shtml", "https://www.prnasia.com/story/293359-1.shtml", "https://www.prnasia.com/story/293750-1.shtml", "https://www.prnasia.com/story/294302-1.shtml", "https://www.prnasia.com/story/256875-1.shtml", "https://www.prnasia.com/story/295386-1.shtml", "https://www.prnasia.com/story/258512-1.shtml", "https://www.prnasia.com/story/296675-1.shtml", "https://www.prnasia.com/story/257935-1.shtml", "https://www.prnasia.com/story/295989-1.shtml", "https://www.prnasia.com/story/258465-1.shtml", "https://www.prnasia.com/story/296335-1.shtml", "https://www.prnasia.com/story/295360-1.shtml", "https://www.prnasia.com/story/294292-1.shtml", "https://www.prnasia.com/story/295722-1.shtml", "https://www.prnasia.com/story/257858-1.shtml", "https://www.prnasia.com/story/258689-1.shtml", "https://www.prnasia.com/story/295339-1.shtml", "https://www.prnasia.com/story/296236-1.shtml", "https://www.prnasia.com/story/294315-1.shtml", "https://www.prnasia.com/story/258817-1.shtml", "https://www.prnasia.com/story/296539-1.shtml", "https://www.prnasia.com/story/258163-1.shtml", "https://www.prnasia.com/story/295241-1.shtml", "https://www.prnasia.com/story/257817-1.shtml", "https://www.prnasia.com/story/296715-1.shtml", "https://www.prnasia.com/story/258536-1.shtml", "https://www.prnasia.com/story/296138-1.shtml", "https://www.prnasia.com/story/294787-1.shtml", "https://www.prnewswire.com/news-releases/menarini-receives-european-commission-approval-of-elzonris-tagraxofusp-for-the-treatment-of-blastic-plasmacytoid-dendritic-cell-neoplasm-bpdcn-301212702.html", "https://cnmobile.prnasia.com/story/296318-1.shtml", "https://www.prnasia.com/story/294959-1.shtml", "https://www.prnewswire.com/news-releases/statement-of-the-national-alliance-for-hispanic-health-on-selection-of-janet-woodcock-md-as-acting-commissioner-of-the-us-food-and-drug-administration-fda-301212790.html", "https://www.prnasia.com/story/299013-1.shtml", "https://www.prnasia.com/story/298002-1.shtml", "https://www.prnasia.com/story/299168-1.shtml", "https://www.prnasia.com/story/259067-1.shtml", "https://www.prnasia.com/story/297586-1.shtml", "https://www.prnasia.com/story/259209-1.shtml", "https://www.prnewswire.com/news-releases/healogics-launches-program-to-make-2021-the-year-of-healing-for-chronic-wounds-a-condition-affecting-6-7-million-americans-and-a-leading-cause-of-amputation-301212815.html", "https://www.prnewswire.com/news-releases/home-care-pulse-acquires-home-care-institute-building-an-800-course-employee-training-library-for-post-acute-care-301212792.html", "https://www.prnasia.com/story/260136-1.shtml", "https://www.prnasia.com/story/259488-1.shtml", "https://www.prnasia.com/story/297505-1.shtml", "https://www.prnasia.com/story/259817-1.shtml", "https://www.prnasia.com/story/297990-1.shtml", "https://www.prnewswire.com/news-releases/fda-approves-first-extended-release-injectable-drug-regimen-for-adults-living-with-hiv-301212892.html", "https://www.prnasia.com/story/297320-1.shtml", "https://www.prnewswire.com/news-releases/helix-launches-a-covid-19-viral-surveillance-dashboard-to-track-emergence-and-prevalence-of-new-sars-cov-2-variants-301212794.html", "https://www.prnasia.com/story/298788-1.shtml", "https://www.prnewswire.com/news-releases/anivive-announces-fda-conditional-approval-of-laverdiatm-ca1-verdinexor--the-first-and-only-oral-tablet-to-treat-lymphoma-in-dogs-301212763.html", "https://www.prnasia.com/story/259258-1.shtml", "https://www.prnasia.com/story/299221-1.shtml", "https://www.prnasia.com/story/299292-1.shtml", "https://www.prnewswire.com/news-releases/worldwide-medical-tourism-industry-to-2027---overseas-promotional-offices-are-a-key-source-of-medical-tourists-301212538.html", "https://www.prnasia.com/story/300130-1.shtml", "https://www.prnasia.com/story/260314-1.shtml", "https://www.prnasia.com/story/260396-1.shtml", "https://www.prnasia.com/story/300577-1.shtml", "https://www.prnewswire.com/news-releases/worldwide-hiv-drugs-industry-to-2027---impact-analysis-of-covid-19-301212547.html", "https://cnmobile.prnasia.com/story/259934-1.shtml", "https://www.prnewswire.com/news-releases/phio-pharmaceuticals-announces-14-0-million-private-placement-priced-at-the-market-301212860.html", "https://www.prnewswire.com/news-releases/neurobo-pharmaceuticals-closes-10-0-million-private-placement-301212397.html", "https://www.prnasia.com/story/260360-1.shtml", "https://www.prnasia.com/story/260257-1.shtml", "https://www.prnewswire.com/news-releases/scp--co-healthcare-acquisition-company-a-spac-focused-on-acquiring-a-digital-health-business-announces-pricing-of-upsized-200-million-initial-public-offering-301212950.html", "https://www.prnasia.com/story/299310-1.shtml", "https://www.prnasia.com/story/300043-1.shtml", "https://www.prnasia.com/story/300266-1.shtml", "https://cnmobile.prnasia.com/story/258862-1.shtml", "https://www.prnasia.com/story/260150-1.shtml", "https://www.prnasia.com/story/299917-1.shtml", "https://www.prnewswire.com/news-releases/boston-scientific-receives-fda-approval-for-the-vercise-genus-deep-brain-stimulation-system-301213017.html", "https://www.prnasia.com/story/300606-1.shtml", "https://www.prnasia.com/story/259722-1.shtml", "https://www.prnasia.com/story/301234-1.shtml", "https://www.prnasia.com/story/300338-1.shtml", "https://www.prnasia.com/story/301374-1.shtml", "https://www.prnewswire.com/news-releases/nanoforms-clinical-study-indicates-positive-interim-results-301213028.html", "https://www.prnasia.com/story/301338-1.shtml", "https://www.prnasia.com/story/303250-1.shtml", "https://www.prnewswire.com/news-releases/aurora-cannabis-inc-announces-us125-million-bought-deal-financing-301212935.html", "https://www.prnasia.com/story/302948-1.shtml", "https://www.prnasia.com/story/300747-1.shtml", "https://www.prnasia.com/story/301828-1.shtml", "https://www.prnewswire.com/news-releases/nj-couple-donates-more-than-100-000-masks-to-frontline-workers-and-families-in-need-through-collaboration-with-feeding-america-in-masking-up-from-coast-to-coast-campaign-301212907.html", "https://www.prnewswire.com/news-releases/haemonetics-welcomes-new-fda-guidance-on-viscoelastic-testing-during-covid-19-pandemic-301212981.html", "https://www.prnasia.com/story/302415-1.shtml", "https://www.prnasia.com/story/301851-1.shtml", "https://www.prnasia.com/story/301339-1.shtml", "https://www.prnewswire.com/news-releases/senhwa-announces-the-first-patient-enrolled-in-an-investigator-initiated-trial-of-silmitasertib-as-a-treatment-for-patients-with-severe-covid-19-301213001.html", "https://www.prnasia.com/story/300655-1.shtml", "https://www.prnasia.com/story/302236-1.shtml", "https://www.prnasia.com/story/301762-1.shtml", "https://www.prnewswire.com/news-releases/janssen-announces-us-fda-approval-of-cabenuva-rilpivirine-and-cabotegravir-the-first-long-acting-regimen-for-the-treatment-of-hiv-301213000.html", "https://www.prnasia.com/story/303057-1.shtml", "https://www.prnasia.com/story/302478-1.shtml", "https://cnmobile.prnasia.com/story/301243-1.shtml", "https://www.prnewswire.com/news-releases/celularity-and-gx-acquisition-corp-announce-merger-agreement-to-create-a-publicly-listed-leader-in-allogeneic-cellular-therapy-301203341.html", "https://cnmobile.prnasia.com/story/302397-1.shtml", "https://www.prnasia.com/story/302106-1.shtml", "https://www.prnasia.com/story/301976-1.shtml", "https://www.prnewswire.com/news-releases/global-metabolomics-market-2020-to-2025---biomarker-development-presents-opportunities-301203319.html", "https://www.prnasia.com/story/303047-1.shtml", "https://www.prnasia.com/story/300607-1.shtml", "https://www.prnewswire.com/news-releases/avidity-biosciences-announces-2021-pipeline-updates-and-research-collaboration-with-myokardia-301203170.html", "https://www.prnasia.com/story/302985-1.shtml", "https://www.prnasia.com/story/304470-1.shtml", "https://www.prnasia.com/story/303221-1.shtml", "https://www.prnewswire.com/news-releases/atp-and-biolojic-design-launch-aulos-bioscience-to-develop-highly-differentiated-il-2-antibody-approach-to-fighting-cancer-301203224.html", "https://www.prnasia.com/story/304991-1.shtml", "https://www.prnasia.com/story/304770-1.shtml", "https://www.prnasia.com/story/303105-1.shtml", "https://www.prnasia.com/story/268050-1.shtml", "https://www.prnewswire.com/news-releases/first-patient-dosed-in-biomarker-guided-phase-3-study-of-db102-enzastaurin-in-patients-with-newly-diagnosed-glioblastoma-gbm-301202417.html", "https://www.prnewswire.com/news-releases/neurocrine-biosciences-provides-preliminary-fourth-quarter-and-full-year-2020-net-product-sales-results-and-2021-program-milestones-301203297.html", "https://www.prnasia.com/story/267707-1.shtml", "https://www.prnewswire.com/news-releases/emulate-announces-organ-on-a-chip-application-and-services-roadmap-301203263.html", "https://www.prnasia.com/story/305199-1.shtml", "https://www.prnewswire.com/news-releases/global-pancreatic-cancer-opportunity-analysis-and-forecasts-2019-2020--2029-cp-613-devimistat-and-tak-931-simurosertib-are-the-lead-pipeline-candidates-in-1l-setting-301203317.html", "https://www.prnasia.com/story/305224-1.shtml", "https://www.prnewswire.com/news-releases/versameb-announces-management-update-301203287.html", "https://www.prnewswire.com/news-releases/inmed-announces-results-of-second-phase-1-clinical-trial-of-inm-755-cbn-cream-in-healthy-subjects-301203160.html", "https://www.prnasia.com/story/305044-1.shtml", "https://www.prnewswire.com/news-releases/vireo-health-launches-amplifi-the-first-terpene-enhanced-brand-of-dry-cannabis-flower-301203281.html", "https://www.prnasia.com/story/305335-1.shtml", "https://www.prnasia.com/story/267444-1.shtml", "https://www.prnasia.com/story/267751-1.shtml", "https://www.prnewswire.com/news-releases/oncosec-announces-first-patient-dosed-in-phase-2-trial-of-tavo-plus-opdivo-as-neoadjuvant-therapy-for-melanoma-301203279.html", "https://www.prnasia.com/story/304658-1.shtml", "https://www.prnasia.com/story/305243-1.shtml", "https://www.prnasia.com/story/267963-1.shtml", "https://www.prnasia.com/story/304189-1.shtml", "https://www.prnasia.com/story/267474-1.shtml", "https://www.prnasia.com/story/304318-1.shtml", "https://www.prnasia.com/story/267534-1.shtml", "https://www.prnasia.com/story/267416-1.shtml", "https://www.prnewswire.com/news-releases/cannara-biotech-receives-sales-licence-from-health-canada-301203137.html", "https://www.prnasia.com/story/305364-1.shtml", "https://www.prnasia.com/story/305028-1.shtml", "https://www.prnasia.com/story/267462-1.shtml", "https://www.prnasia.com/story/268199-1.shtml", "https://www.prnewswire.com/news-releases/adventure-with-purpose-301203132.html", "https://www.prnasia.com/story/306096-1.shtml", "https://www.prnasia.com/story/304874-1.shtml", "https://www.prnewswire.com/news-releases/ai-gives-you-a-chance-to-prevent-alzheimers-dementia-301203391.html", "https://www.prnasia.com/story/306528-1.shtml", "https://www.prnasia.com/story/306442-1.shtml", "https://www.prnasia.com/story/307392-1.shtml", "https://www.prnasia.com/story/305508-1.shtml", "https://www.prnasia.com/story/242528-1.shtml", "https://www.prnasia.com/story/268266-1.shtml", "https://www.prnasia.com/story/268097-1.shtml", "https://www.prnasia.com/story/268137-1.shtml", "https://www.prnasia.com/story/306510-1.shtml", "https://www.prnewswire.com/news-releases/pye-barker-fire--safety-acquires-nardini-fire-equipment-company-301203216.html", "https://www.prnasia.com/story/242574-1.shtml", "https://www.prnasia.com/story/268559-1.shtml", "https://www.prnasia.com/story/268276-1.shtml", "https://www.prnasia.com/story/306031-1.shtml", "https://www.prnasia.com/story/306775-1.shtml", "https://www.prnewswire.com/news-releases/kintors-proxalutamide-gt0918-covid-19-clinical-trial-shows-positive-preliminary-results-in-treatment-of-female-patients-301204743.html", "https://www.prnasia.com/story/307343-1.shtml", "https://www.prnewswire.com/news-releases/ralphs-pharmacies-provide-first-doses-of-covid-19-vaccine-to-health-care-professionals-in-southern-california-301203471.html", "https://www.prnasia.com/story/242774-1.shtml", "https://www.prnasia.com/story/243797-1.shtml", "https://www.prnasia.com/story/243605-1.shtml", "https://www.prnewswire.com/news-releases/classaura-announces-cobra-sexual-health-class-action-settlement-301203645.html", "https://www.prnasia.com/story/243567-1.shtml", "https://www.prnasia.com/story/243363-1.shtml", "https://www.prnasia.com/story/243767-1.shtml", "https://www.prnasia.com/story/243221-1.shtml", "https://www.prnewswire.com/news-releases/leon-medical-centers-llc-provides-notice-of-data-security-incident-301203601.html", "https://www.prnasia.com/story/243379-1.shtml", "https://www.prnasia.com/story/243897-1.shtml", "https://www.prnewswire.com/news-releases/researchers-seek-to-better-understand-psychedelics-role-in-new-therapies-301205907.html", "https://www.prnasia.com/story/243051-1.shtml", "https://www.prnasia.com/story/243393-1.shtml", "https://www.prnewswire.com/news-releases/recombinetics-inc--announces-neurofibromatosis-type-1-research-collaboration-with-astrazeneca-301205934.html", "https://www.prnasia.com/story/243790-1.shtml", "https://www.prnewswire.com/news-releases/amgen-to-showcase-next-frontier-of-innovation-in-lung-cancer-therapies-at-wclc-2020-301205809.html", "https://www.prnasia.com/story/242964-1.shtml", "https://www.prnasia.com/story/270732-1.shtml", "https://www.prnewswire.com/news-releases/liminal-biosciences-receives-fda-approval-for-its-us-based-plasma-collection-center-301206095.html", "https://www.prnasia.com/story/243531-1.shtml", "https://www.prnewswire.com/news-releases/expanded-use-of-innovative-brain-tumor-treatment-exemplified-in-gt-medical-technologies-2020-gammatile-therapy-elite-member-roster-301206365.html", "https://www.prnasia.com/story/272256-1.shtml", "https://www.prnasia.com/story/271180-1.shtml", "https://www.prnewswire.com/news-releases/jud-care-obtains-fda-approval-for-its-portable-ward-sroom-301206462.html", "https://www.prnasia.com/story/272854-1.shtml", "https://www.prnasia.com/story/271762-1.shtml", "https://www.prnasia.com/story/272834-1.shtml", "https://www.prnasia.com/story/271852-1.shtml", "https://www.prnasia.com/story/271122-1.shtml", "https://www.prnasia.com/story/273587-1.shtml", "https://www.prnewswire.com/news-releases/st-croix-hospice-expands-care-in-nebraska-with-norfolk-office-301205917.html", "https://www.prnasia.com/story/272803-1.shtml", "https://www.prnasia.com/story/270731-1.shtml", "https://www.prnasia.com/story/272782-1.shtml", "https://www.prnewswire.com/news-releases/integrity-acquires-connexion-point-one-of-the-nations-largest-senior-health-insurance-call-centers-focused-on-serving-the-medicare-market-301205994.html", "https://www.prnewswire.com/news-releases/natera-to-present-new-colorectal-cancer-data-at-the-2021-asco-gi-symposium-301206018.html", "https://www.prnasia.com/story/270648-1.shtml", "https://www.prnewswire.com/news-releases/taiho-oncology-and-servier-to-present-data-on-lonsurf-trifluridine-and-tipiracil-at-2021-asco-gastrointestinal-cancers-symposium-asco-gi-301206346.html", "https://www.prnasia.com/story/273470-1.shtml", "https://www.prnasia.com/story/273426-1.shtml", "https://www.prnasia.com/story/271174-1.shtml", "https://www.prnasia.com/story/272695-1.shtml", "https://www.prnasia.com/story/272620-1.shtml", "https://www.prnasia.com/story/273693-1.shtml", "https://www.prnasia.com/story/273711-1.shtml", "https://www.prnasia.com/story/272892-1.shtml", "https://www.prnasia.com/story/274206-1.shtml", "https://www.prnasia.com/story/270582-1.shtml", "https://www.prnasia.com/story/226990-1.shtml", "https://www.prnasia.com/story/273744-1.shtml", "https://www.prnasia.com/story/225254-1.shtml", "https://www.prnasia.com/story/226933-1.shtml", "https://www.prnasia.com/story/274382-1.shtml", "https://www.prnasia.com/story/225531-1.shtml", "https://www.prnasia.com/story/226473-1.shtml", "https://www.prnasia.com/story/274128-1.shtml", "https://www.prnasia.com/story/226759-1.shtml", "https://www.prnasia.com/story/225188-1.shtml", "https://www.prnasia.com/story/226786-1.shtml", "https://www.prnewswire.com/news-releases/first-ever-0-00-9-thc-cannabis-plant-approved-panakeia-receives-approval-by-florida-am-university-301206240.html", "https://www.prnasia.com/story/225241-1.shtml", "https://www.prnasia.com/story/210222-1.shtml", "https://www.prnasia.com/story/274269-1.shtml", "https://www.prnasia.com/story/210223-1.shtml", "https://www.prnasia.com/story/226130-1.shtml", "https://www.prnasia.com/story/226726-1.shtml", "https://cnmobile.prnasia.com/story/274118-1.shtml", "https://www.prnewswire.com/news-releases/medical-microinstruments-nombra-consejero-delegado-al-veterano-de-la-industria-sanitaria-mark-toland-803093227.html", "https://www.prnasia.com/story/274264-1.shtml", "https://www.prnewswire.com/news-releases/algaenergy-and-laboratoire-m2-sign-global-strategic-partnership-agreements-for-distribution-and-product-development-301205914.html", "https://www.prnasia.com/story/210230-1.shtml", "https://www.prnasia.com/story/210249-1.shtml", "https://cnmobile.prnasia.com/story/226864-1.shtml", "https://www.prnewswire.com/news-releases/flagship-pioneering-unveils-pioneering-medicines-301206548.html", "https://www.prnewswire.com/news-releases/gt-biopharma-announces-eighth-patient-begins-treatment-of-gtb-3550-301206543.html", "https://www.prnasia.com/story/210218-1.shtml", "https://www.prnewswire.com/news-releases/ces-2021-meet-the-next-generation-thermometer-taiwanese-startup-iweecares-iot-wearable-makes-temperature-checks-easy-301206558.html", "https://www.prnasia.com/story/214954-1.shtml", "https://www.prnasia.com/story/214898-1.shtml", "https://www.prnasia.com/story/214919-1.shtml", "https://www.prnasia.com/story/214873-1.shtml", "https://cnmobile.prnasia.com/story/210253-1.shtml", "https://www.prnewswire.com/news-releases/29-of-americans-lost-their-health-insurance-in-2020-more-than-half-remain-uninsured-in-2021-301208068.html", "https://www.prnewswire.com/news-releases/acelrx-announces-year-end-2020-metrics-and-review-of-2020-achievements-301208257.html", "https://cnmobile.prnasia.com/story/210334-1.shtml", "https://www.prnasia.com/story/210355-1.shtml", "https://www.prnasia.com/story/214782-1.shtml", "https://www.prnasia.com/story/209713-1.shtml", "https://www.prnasia.com/story/209610-1.shtml", "https://www.prnasia.com/story/214985-1.shtml", "https://www.prnasia.com/story/215065-1.shtml", "https://www.prnewswire.com/news-releases/medtronic-launches-first-of-its-kind-adaptive-deep-brain-stimulation-adbs-trial-in-parkinsons-disease-patients-301207921.html", "https://www.prnasia.com/story/209661-1.shtml", "https://www.prnasia.com/story/209728-1.shtml", "https://www.prnasia.com/story/215037-1.shtml", "https://www.prnasia.com/story/215601-1.shtml", "https://www.prnewswire.com/news-releases/valuehealth-expands-network-in-chicago-with-its-most-recent-acquisition-of-kendall-pointe-surgery-center-301208231.html", "https://www.prnasia.com/story/215521-1.shtml", "https://www.prnasia.com/story/216976-1.shtml", "https://www.prnewswire.com/news-releases/precision-medicine-group-significantly-expands-cell-and-gene-therapy-expertise-with-acquisition-of-project-farma-301207227.html", "https://www.prnewswire.com/news-releases/heritage-group-launches-300-million-oversubscribed-third-fund-301207976.html", "https://www.prnasia.com/story/215881-1.shtml", "https://www.prnasia.com/story/215323-1.shtml", "https://www.prnewswire.com/news-releases/mitsubishi-tanabe-pharma-america-announces-enhancements-to-out-of-pocket-assistance-program-for-eligible-als-patients-treated-with-radicava-edaravone-301208541.html", "https://www.prnasia.com/story/215885-1.shtml", "https://www.prnasia.com/story/216546-1.shtml", "https://www.prnasia.com/story/216388-1.shtml", "https://www.prnasia.com/story/209782-1.shtml", "https://www.prnasia.com/story/216915-1.shtml", "https://www.prnewswire.com/news-releases/ampio-pharmaceuticals-ongoing-phase-i-clinical-trial-for-inhalation-treatment-of-covid-19-with-ampion-is-55-enrolled-301208409.html", "https://www.prnasia.com/story/209792-1.shtml", "https://www.prnewswire.com/news-releases/pulmonary-fibrosis-foundation-announces-sponsorship-by-united-therapeutics-301208585.html", "https://www.prnasia.com/story/216307-1.shtml", "https://cnmobile.prnasia.com/story/216932-1.shtml", "https://www.prnasia.com/story/215466-1.shtml", "https://www.prnasia.com/story/215542-1.shtml", "https://www.prnasia.com/story/217166-1.shtml", "https://www.prnasia.com/story/217168-1.shtml", "https://www.prnasia.com/story/215717-1.shtml", "https://www.prnasia.com/story/217126-1.shtml", "https://www.prnasia.com/story/217547-1.shtml", "https://www.prnasia.com/story/217284-1.shtml", "https://www.prnasia.com/story/217409-1.shtml", "https://www.prnasia.com/story/217182-1.shtml", "https://www.prnewswire.com/news-releases/trialcard-reports-third-consecutive-year-of-double-digit-growth-301208407.html", "https://www.prnasia.com/story/218499-1.shtml", "https://www.prnasia.com/story/218347-1.shtml", "https://www.prnewswire.com/news-releases/biohaven-announces-preliminary-4q2020-net-product-revenue-for-nurtec-odt-301213705.html", "https://www.prnasia.com/story/218428-1.shtml", "https://www.prnewswire.com/news-releases/citius-pharmaceuticals-announces-20-0-million-private-placement-priced-at-the-market-301213766.html", "https://www.prnasia.com/story/217180-1.shtml", "https://cnmobile.prnasia.com/story/216998-1.shtml", "https://www.prnasia.com/story/218191-1.shtml", "https://www.prnasia.com/story/218376-1.shtml", "https://www.prnewswire.com/news-releases/multi-specialty-healthcare-receives-growth-investment-from-bain-capital-double-impact-301213769.html", "https://www.prnasia.com/story/217885-1.shtml", "https://www.prnewswire.com/news-releases/global-cellular-immunotherapy-markets-2020-2030---focus-on-----tumour-infiltrating-lymphocyte-engineered-t-cell-receptor-chimeric-antigen-receptor-car-t-cell--natural-killer-nk-cell-therapy-301213891.html", "https://www.prnasia.com/story/217081-1.shtml", "https://www.prnasia.com/story/217608-1.shtml", "https://www.prnasia.com/story/217062-1.shtml", "https://www.prnewswire.com/news-releases/the-valens-company-expands-cannabis-2-0--3-0-footprint-with-the-acquisition-of-leading-canadian-edibles-manufacturer-lyf-food-technologies-inc-301213738.html", "https://www.prnasia.com/story/218244-1.shtml", "https://www.prnewswire.com/news-releases/cognate-bioservices-announces-major-expansion-of-manufacturing-facilities-in-us-and-europe-301208422.html", "https://www.prnasia.com/story/217353-1.shtml", "https://www.prnasia.com/story/218526-1.shtml", "https://www.prnewswire.com/news-releases/hollister-biosciences-inc-commends-the-state-of-arizona-for-starting-adult-use-cannabis-sales-ahead-of-schedule-venom-extracts-its-100-owned-subsidiary-is-a-category-leader-with-over-4-million-grams-sold-throughout-the-state-i-301213859.html", "https://www.prnewswire.com/news-releases/missed-medicares-annual-enrollment-period-301213545.html", "https://www.prnasia.com/story/217103-1.shtml", "https://www.prnasia.com/story/219019-1.shtml", "https://www.prnasia.com/story/212752-1.shtml", "https://www.prnasia.com/story/219110-1.shtml", "https://www.prnasia.com/story/219248-1.shtml", "https://www.prnasia.com/story/212857-1.shtml", "https://www.prnewswire.com/news-releases/eiger-biopharmaceuticals-announces-us-commercial-availability-of-zokinvy-lonafarnib-the-first-and-only-treatment-approved-for-progeria-and-processing-deficient-progeroid-laminopathies-301213799.html", "https://www.prnasia.com/story/212952-1.shtml", "https://www.prnasia.com/story/212801-1.shtml", "https://www.prnewswire.com/news-releases/4front-ventures-receives-approval-to-begin-construction-of-mission-dispensary-in-brookline-massachusetts-301213739.html", "https://www.prnasia.com/story/212937-1.shtml", "https://www.prnasia.com/story/218734-1.shtml", "https://www.prnewswire.com/news-releases/fda-approves-theranicas-nerivio-for-acute-treatment-of-migraine-in-adolescents-301213967.html", "https://www.prnasia.com/story/218832-1.shtml", "https://www.prnewswire.com/news-releases/biovaxys-announces-initiation-of-cancer-vaccine-eu-clinical-program-completion-of-bvx-0320-preclinical-program-301214004.html", "https://www.prnasia.com/story/218787-1.shtml", "https://www.prnasia.com/story/212730-1.shtml", "https://www.prnasia.com/story/212938-1.shtml", "https://www.prnasia.com/story/219262-1.shtml", "https://www.prnasia.com/story/218712-1.shtml", "https://www.prnasia.com/story/219040-1.shtml", "https://www.prnewswire.com/news-releases/durect-corporation-announces-first-patient-dosed-in-phase-2b-ahfirm-study-of-dur-928-in-severe-alcohol-associated-hepatitis-301213808.html", "https://www.prnewswire.com/news-releases/medigen-vaccine-biologics-covid-19-vaccine-adjuvanted-with-dynavaxs-cpg-1018-announces-first-participant-dosed-in-phase-2-clinical-trial-in-taiwan-301213721.html", "https://www.prnewswire.com/news-releases/orthospin-ltd-receives-fda-regulatory-clearance-for-its-g2-system-301213919.html", "https://www.prnasia.com/story/220345-1.shtml", "https://www.prnasia.com/story/219608-1.shtml", "https://cnmobile.prnasia.com/story/209828-1.shtml", "https://www.prnasia.com/story/220010-1.shtml", "https://www.prnasia.com/story/220113-1.shtml", "https://www.prnasia.com/story/219654-1.shtml", "https://www.prnasia.com/story/220642-1.shtml", "https://www.prnasia.com/story/209927-1.shtml", "https://www.prnasia.com/story/220695-1.shtml", "https://www.prnasia.com/story/209814-1.shtml", "https://www.prnasia.com/story/210037-1.shtml", "https://www.prnewswire.com/news-releases/consumers-continue-flocking-to-immune-boosting-supplements-as-health-crisis-rage-on-301213609.html", "https://www.prnasia.com/story/220648-1.shtml", "https://www.prnewswire.com/news-releases/immunotherapy-using-immune-checkpoint-inhibitors-ici-modulators-are-revolutionizing-oncology-industry-301213701.html", "https://www.prnasia.com/story/210062-1.shtml", "https://www.prnasia.com/story/210044-1.shtml", "https://www.prnasia.com/story/210087-1.shtml", "https://www.prnewswire.com/news-releases/american-cell-therapies-company-selects-valgenesis-vlms-to-digitize-multiple-validation-lifecycle-processes-301213232.html", "https://www.prnewswire.com/news-releases/piramal-pharma-solutions-announces-sterile-fillfinish-program-with-theratechnologies-inc-for-th1902-peptide-drug-conjugate-301213841.html", "https://www.prnasia.com/story/209910-1.shtml", "https://www.prnasia.com/story/224747-1.shtml", "https://www.prnasia.com/story/209974-1.shtml", "https://www.prnewswire.com/news-releases/lyfebulb-and-csl-behring-launch-transplantlyfe-a-first-of-its-kind-community-engagement-platform-for-transplant-patients-301213644.html", "https://www.prnasia.com/story/222889-1.shtml", "https://www.prnasia.com/story/210036-1.shtml", "https://www.prnasia.com/story/224164-1.shtml", "https://www.prnasia.com/story/209899-1.shtml", "https://www.prnewswire.com/news-releases/kona-gold-beverage-inc-announces-acquisition-of-ss-beverage-301213449.html", "https://www.prnewswire.com/news-releases/the-water-bottle-company-fighting-against-pollution-301213843.html", "https://www.prnasia.com/story/209933-1.shtml", "https://www.prnasia.com/story/222395-1.shtml", "https://www.prnasia.com/story/222940-1.shtml", "https://www.prnasia.com/story/223458-1.shtml", "https://www.prnasia.com/story/224349-1.shtml", "https://www.prnasia.com/story/223487-1.shtml", "https://cnmobile.prnasia.com/story/223445-1.shtml", "https://www.prnewswire.com/news-releases/volitionrx-limited-opens-its-new-manufacturing-facility-in-belgium-301214006.html", "https://www.prnasia.com/story/223709-1.shtml", "https://www.prnasia.com/story/210792-1.shtml", "https://www.prnewswire.com/news-releases/the-paul-g-allen-family-foundation-continues-support-for-vulnerable-communities-during-covid-19-301213506.html", "https://www.prnasia.com/story/225114-1.shtml", "https://www.prnasia.com/story/210785-1.shtml", "https://www.prnasia.com/story/231013-1.shtml", "https://www.prnewswire.com/news-releases/alcami-expands-oral-solid-capabilities-with-investment-in-wilmington-301202456.html", "https://www.prnasia.com/story/231176-1.shtml", "https://www.prnasia.com/story/225127-1.shtml", "https://www.prnasia.com/story/210948-1.shtml", "https://www.prnasia.com/story/210874-1.shtml", "https://www.prnasia.com/story/210858-1.shtml", "https://www.prnasia.com/story/230863-1.shtml", "https://www.prnewswire.com/news-releases/bluerock-therapeutics-in-collaboration-with-memorial-sloan-kettering-cancer-center-receives-ind-clearance-for-da01-in-parkinsons-disease-301202742.html", "https://www.prnasia.com/story/210958-1.shtml", "https://www.prnasia.com/story/210597-1.shtml", "https://www.prnewswire.com/news-releases/built-in-honors-gohealth-in-its-esteemed-2021-best-places-to-work-awards-301214086.html", "https://www.prnasia.com/story/230892-1.shtml", "https://www.prnasia.com/story/231900-1.shtml", "https://www.prnewswire.com/news-releases/therapeutic-solutions-international-reports-regression-of-glioma-lung-cancer-and-colorectal-cancer-using-stemvacs-in-animal-models-301214018.html", "https://www.prnasia.com/story/231120-1.shtml", "https://www.prnewswire.com/news-releases/gemoab-announces-clinical-data-presentations-on-their-lead-asset-unicar-t-cd123-in-relapsedrefractory-aml-at-the-upcoming-eha-ebmt-3rd-european-car-t-cell-meeting-301201927.html", "https://www.prnasia.com/story/231640-1.shtml", "https://www.prnasia.com/story/231525-1.shtml", "https://www.prnasia.com/story/231986-1.shtml", "https://www.prnasia.com/story/232439-1.shtml", "https://www.prnasia.com/story/232499-1.shtml", "https://www.prnasia.com/story/231699-1.shtml", "https://www.prnasia.com/story/232703-1.shtml", "https://www.prnasia.com/story/211144-1.shtml", "https://www.prnasia.com/story/232338-1.shtml", "https://www.prnasia.com/story/211158-1.shtml", "https://www.prnewswire.com/news-releases/ontario-brain-institute-increases-investment-in-diamond-therapeutics-to-accelerate-innovation-in-mental-health-301202433.html", "https://www.prnewswire.com/news-releases/caprion-histogenex-acquires-clinical-logistics-inc-a-virtual-central-specimen-management-cro-and-expands-its-support-of-clinical-trials-specimen-logistics-301202510.html", "https://www.prnasia.com/story/233230-1.shtml", "https://www.prnasia.com/story/232088-1.shtml", "https://www.prnewswire.com/news-releases/dynavax-announces-final-immunogenicity-and-interim-safety-results-from-clinical-trial-evaluating-heplisav-b-in-patients-undergoing-hemodialysis-301202453.html", "https://www.prnasia.com/story/231811-1.shtml", "https://www.prnewswire.com/news-releases/eiger-biopharmaceuticals-updates-on-2020-progress-and-2021-plans-301202583.html", "https://www.prnasia.com/story/211205-1.shtml", "https://www.prnewswire.com/news-releases/genuity-science-and-emory-university-announce-key-research-agreement-collaboration-designed-to-speed-insights-into-major-neurodegenerative-diseases-301202362.html", "https://www.prnasia.com/story/211240-1.shtml", "https://www.prnasia.com/story/211022-1.shtml", "https://www.prnasia.com/story/232078-1.shtml", "https://www.prnewswire.com/news-releases/net-healths-foto-approved-by-cms-as-a-qualified-clinical-data-registry-for-third-consecutive-year-301202405.html", "https://www.prnewswire.com/news-releases/advarra-acquires-yourencore-a-leading-provider-of-drug-development-and-commercialization-advisory-and-consulting-services-301202566.html", "https://www.prnasia.com/story/211229-1.shtml", "https://www.prnewswire.com/news-releases/logicbio-announces-extension-of-collaboration-with-childrens-medical-research-institute-301202762.html", "https://www.prnasia.com/story/211115-1.shtml", "https://www.prnasia.com/story/211344-1.shtml", "https://www.prnasia.com/story/211412-1.shtml", "https://www.prnasia.com/story/211479-1.shtml", "https://www.prnasia.com/story/235634-1.shtml", "https://www.prnewswire.com/news-releases/two-thought-leaders-in-the-longevity-economy-and-life-sciences-partner-for-a-series-of--events-focused-on-early-stage-investment-in-health-and-innovation-for-people-ages-50-301202629.html", "https://www.prnasia.com/story/211538-1.shtml", "https://www.prnewswire.com/news-releases/carisma-therapeutics-completes-series-b-funding-for-47-million-to-advance-development-of-novel-car-macrophage-immunotherapies-301202746.html", "https://www.prnasia.com/story/235653-1.shtml", "https://www.prnasia.com/story/236018-1.shtml", "https://www.prnasia.com/story/211351-1.shtml", "https://www.prnewswire.com/news-releases/strontium89-now-reimbursed-in-hospital-and-outpatient-settings-for-metastatic-bone-pain-treatment-301202795.html", "https://www.prnasia.com/story/236627-1.shtml", "https://www.prnewswire.com/news-releases/kinderhook-invests-105-million-in-absolutecare-a-leading-value-based-primary-care-provider-301202083.html", "https://www.prnewswire.com/news-releases/risankizumab-skyrizi-demonstrates-significant-improvements-in-clinical-remission-and-endoscopic-response-in-two-phase-3-induction-studies-in-patients-with-crohns-disease-301202802.html", "https://www.prnasia.com/story/211519-1.shtml", "https://www.prnewswire.com/news-releases/simplify-asc-acquires-phybus-revenue-services-301202757.html", "https://www.prnasia.com/story/236301-1.shtml", "https://www.prnasia.com/story/237167-1.shtml", "https://www.prnasia.com/story/236986-1.shtml", "https://www.prnasia.com/story/236771-1.shtml", "https://www.prnewswire.com/news-releases/explora-biolabs-to-open-its-first-east-coast-facility-in-boston-301202738.html", "https://www.prnasia.com/story/235766-1.shtml", "https://www.prnewswire.com/news-releases/nalu-bio-has-successfully-synthesized-pure-high-quality-cbd-for-scale-and-closed-its-seed-financing-round-301202509.html", "https://www.prnasia.com/story/211707-1.shtml", "https://www.prnasia.com/story/236101-1.shtml", "https://www.prnasia.com/story/236784-1.shtml", "https://www.prnasia.com/story/211725-1.shtml", "https://www.prnasia.com/story/236062-1.shtml", "https://www.prnasia.com/story/211594-1.shtml", "https://www.prnasia.com/story/211627-1.shtml", "https://www.prnewswire.com/news-releases/first-patient-in-treatment-in-rhovacs-clinical-phase-iib-study-in-united-kingdom-301202827.html", "https://www.prnasia.com/story/211868-1.shtml", "https://www.prnasia.com/story/211718-1.shtml", "https://www.prnasia.com/story/237093-1.shtml", "https://www.prnewswire.com/news-releases/mitsubishi-tanabe-pharma-america-revises-refine-als-biomarker-study-process-to-enable-remote-participation-301202809.html", "https://www.prnasia.com/story/237956-1.shtml", "https://www.prnasia.com/story/211785-1.shtml", "https://cnmobile.prnasia.com/story/237164-1.shtml", "https://www.prnasia.com/story/239331-1.shtml", "https://www.prnewswire.com/news-releases/integrated-oncology-network-announces-strategic-partnership-with-southwest-urology-301202643.html", "https://www.prnewswire.com/news-releases/bioinvent-has-enrolled-first-patient-in-a-phase-iiia-trial-of-the-first-in-class-anti-tnfr2-antibody-bi-1808-for-the-treatment-of-patients-with-solid-tumors-and-ctcl-301214878.html", "https://www.prnasia.com/story/211824-1.shtml", "https://www.prnewswire.com/news-releases/further-research-into-psilocybin-opens-new-doors-for-treatment-301202498.html", "https://www.prnasia.com/story/211839-1.shtml", "https://www.prnewswire.com/news-releases/worldwide-industry-for-direct-to-consumer-testing-to-2025---impact-analysis-of-covid-19-301214819.html", "https://www.prnewswire.com/news-releases/new-data-show-treatment-with-lillys-neutralizing-antibodies-bamlanivimab-ly-cov555-and-etesevimab-ly-cov016-together-reduced-risk-of-covid-19-hospitalizations-and-death--by-70-percent-301214598.html", "https://www.prnasia.com/story/241001-1.shtml", "https://www.prnasia.com/story/241709-1.shtml", "https://www.prnasia.com/story/241146-1.shtml", "https://www.prnewswire.com/news-releases/johnson--johnson-reports-2020-fourth-quarter-and-full-year-results-301214853.html", "https://www.prnasia.com/story/239372-1.shtml", "https://www.prnasia.com/story/241581-1.shtml", "https://www.prnasia.com/story/241642-1.shtml", "https://www.prnasia.com/story/241521-1.shtml", "https://www.prnasia.com/story/241755-1.shtml", "https://www.prnasia.com/story/239250-1.shtml", "https://www.prnasia.com/story/240992-1.shtml", "https://www.prnasia.com/story/241386-1.shtml", "https://www.prnewswire.com/news-releases/regeneron-reports-positive-interim-data-with-regen-cov-antibody-cocktail-used-as-passive-vaccine-to-prevent-covid-19-301214619.html", "https://www.prnasia.com/story/238818-1.shtml", "https://www.prnasia.com/story/240663-1.shtml", "https://www.prnasia.com/story/240605-1.shtml", "https://www.prnasia.com/story/238776-1.shtml", "https://www.prnewswire.com/news-releases/parent-project-muscular-dystrophys-duchenne-registry-participant-response-rate-increases-exponentially-in-2020-utilizing-thread-301214529.html", "https://www.prnasia.com/story/240037-1.shtml", "https://www.prnasia.com/story/213241-1.shtml", "https://www.prnasia.com/story/213307-1.shtml", "https://www.prnewswire.com/news-releases/element5-and-lbmc-announce-strategic-partnership-to-bring-greater-security-to-automation-for-post-acute-care-301214771.html", "https://www.prnasia.com/story/238508-1.shtml", "https://www.prnewswire.com/news-releases/soc-telemed-launches-new-telepulmonology-service-line-301214837.html", "https://www.prnasia.com/story/213286-1.shtml", "https://www.prnasia.com/story/213327-1.shtml", "https://www.prnasia.com/story/242164-1.shtml", "https://www.prnewswire.com/news-releases/cardiff-oncology-receives-study-may-proceed-from-fda-to-initiate-phase-2-trial-of-onvansertib-in-metastatic-pancreatic-ductal-adenocarcinoma-pdac-301214877.html", "https://www.prnasia.com/story/214470-1.shtml", "https://www.prnasia.com/story/241786-1.shtml", "https://www.prnasia.com/story/214546-1.shtml", "https://www.prnasia.com/story/213457-1.shtml", "https://www.prnasia.com/story/241916-1.shtml", "https://www.prnewswire.com/news-releases/q-biomeds-uttroside-b-receives-additional-patent-coverage-in-canada-and-japan-301214454.html", "https://www.prnasia.com/story/242287-1.shtml", "https://www.prnewswire.com/news-releases/grant-avenue-capital-acquires-valeo-home-health-and-hospice-301214223.html", "https://www.prnasia.com/story/213460-1.shtml", "https://www.prnasia.com/story/214421-1.shtml", "https://www.prnasia.com/story/213488-1.shtml", "https://www.prnasia.com/story/213300-1.shtml", "https://www.prnewswire.com/news-releases/enzychem-lifesciences-receives-nasa-grant-funding-to-evaluate-ec-18-as-a-protective-agent-for-radiation-and-pathogen-induced-tissue-damage-and-inflammation-in-space-301214574.html", "https://www.prnasia.com/story/214604-1.shtml", "https://www.prnasia.com/story/214425-1.shtml", "https://www.prnewswire.com/news-releases/apollo-medical-holdings-inc-and-caipa-mso-llc-announce-strategic-alliance-in-new-york-301214981.html", "https://www.prnewswire.com/news-releases/soliton-announces-collaboration-with-us-navy-to-conduct-proof-of-concept-study-for-fibrotic-scars-301214420.html", "https://www.prnewswire.com/news-releases/apollo-medical-holdings-inc-and-caipa-mso-llc-announce-strategic-alliance-in-new-york-301215094.html", "https://www.prnewswire.com/news-releases/worldwide-industry-for-ai-enabled-medical-imaging-solutions-to-2030---rapidly-evolving-deep-learning-techniques-presents-opportunities-301214838.html", "https://www.prnasia.com/story/205937-1.shtml", "https://www.prnasia.com/story/205938-1.shtml", "https://www.prnewswire.com/news-releases/subversive-announces-qualifying-transaction-with-intercure-israels-leading-and-fastest-growing-cannabis-company-301215121.html", "https://www.prnasia.com/story/214731-1.shtml", "https://www.prnasia.com/story/213515-1.shtml", "https://www.prnewswire.com/news-releases/galderma-announces-launch-of-face-for-change-program-301214615.html", "https://www.prnasia.com/story/205925-1.shtml", "https://www.prnewswire.com/news-releases/100-of-2020-graduating-class-of-platt-college-tulsas-practical-nursing-pn-program-pass-state-licensing-exam-301214253.html", "https://www.prnasia.com/story/206165-1.shtml", "https://www.prnewswire.com/news-releases/services-pmi-at-57-2-december-2020-services-ism-report-on-business-301202370.html", "https://www.prnasia.com/story/214757-1.shtml", "https://www.prnewswire.com/news-releases/new-study-demonstrates-bryostatin-normalizes-autistic-spectrum-behaviors-in-mice-301215137.html", "https://cnmobile.prnasia.com/story/205930-1.shtml", "https://www.prnasia.com/story/206192-1.shtml", "https://www.prnasia.com/story/206108-1.shtml", "https://www.prnewswire.com/news-releases/os-therapies-receives-trial-approval-from-childrens-oncology-group-for-aost2121--ost31-164-01-an-open-label-phase-2-study-of-maintenance-therapy-with-ost31-164-after-resection-of-recurrent-osteosarcoma-301214754.html", "https://www.prnasia.com/story/206670-1.shtml", "https://www.prnewswire.com/news-releases/chromatography-instruments-market-worth-11-0-billion-by-2025--exclusive-report-by-marketsandmarkets-301202661.html", "https://www.prnewswire.com/news-releases/investis-digital-announces-strategic-partnership-with-clinpal-301214732.html", "https://www.prnasia.com/story/206463-1.shtml", "https://www.prnasia.com/story/206649-1.shtml", "https://www.prnewswire.com/news-releases/parent-project-muscular-dystrophy-announces-2021-certified-duchenne-care-center-inter-institutional-collaboration-grant-program-301202650.html", "https://cnmobile.prnasia.com/story/206184-1.shtml", "https://cnmobile.prnasia.com/story/206092-1.shtml", "https://www.prnewswire.com/news-releases/qualigen-therapeutics-announces-completion-of-milestone-related-to-the-license-and-technology-transfer-of-its-fastpack-diagnostics-products-in-china-301215088.html", "https://www.prnasia.com/story/214627-1.shtml", "https://www.prnewswire.com/news-releases/villagemd-to-acquire-primary-care-medical-associates-in-chicago-301215119.html", "https://www.prnasia.com/story/184934-1.shtml", "https://www.prnasia.com/story/185385-1.shtml", "https://www.prnewswire.com/news-releases/bonne-sante-group-names-alan-bergman-cpa-as-chief-financial-officer-301202885.html", "https://www.prnasia.com/story/200179-1.shtml", "https://www.prnasia.com/story/185048-1.shtml", "https://www.prnasia.com/story/200158-1.shtml", "https://www.prnewswire.com/news-releases/worldwide-industry-for-car-t-cell-therapy-2021-to-2027---players-profiled-include-aleta-biotherapeutics-anixa-biosciences-and-biontech-among-others-301202853.html", "https://www.prnewswire.com/news-releases/mirion-technologies-acquires-sun-nuclear-corporation-301202531.html", "https://cnmobile.prnasia.com/story/185156-1.shtml", "https://www.prnasia.com/story/200881-1.shtml", "https://www.prnasia.com/story/200065-1.shtml", "https://www.prnewswire.com/news-releases/research-centers-of-america-expedite-broad-study-on-modernas-covid-19-vaccine-301202925.html", "https://www.prnasia.com/story/200189-1.shtml", "https://www.prnasia.com/story/200050-1.shtml", "https://www.prnasia.com/story/201688-1.shtml", "https://www.prnewswire.com/news-releases/neuros-medical-announces-key-milestones-in-the-quest-pivotal-clinical-study-for-chronic-post-amputation-pain-301202950.html", "https://www.prnasia.com/story/201716-1.shtml", "https://www.prnasia.com/story/201589-1.shtml", "https://www.prnasia.com/story/200562-1.shtml", "https://www.prnewswire.com/news-releases/cathworks-announces-30-million-in-new-financing-301202985.html", "https://www.prnewswire.com/news-releases/samaritans-purse-accepts-first-patient-at-western-north-carolina-emergency-field-hospital-301203023.html", "https://www.prnewswire.com/news-releases/surface-ophthalmics-previews-important-clinical-progress-in-2021-301202917.html", "https://www.prnasia.com/story/201663-1.shtml", "https://www.prnasia.com/story/200759-1.shtml", "https://www.prnasia.com/story/201715-1.shtml", "https://www.prnasia.com/story/201729-1.shtml", "https://www.prnewswire.com/news-releases/global-adc-antibody-drug-conjugates-contract-manufacturing-markets-2020-2030-current-scenario-and-future-potential--capabilities-of-contract-services-providers-301202881.html", "https://www.prnewswire.com/news-releases/felix-biotechnology-announces-initiation-of-the-cyphy-phase-12-study-at-yale-for-its-lead-asset-targeting-p-aeruginosa-infections-301203098.html", "https://www.prnasia.com/story/201818-1.shtml", "https://www.prnewswire.com/news-releases/parvizi-surgical-innovation-announces-investment-and-partnership-with-precisionos-301203154.html", "https://www.prnasia.com/story/183619-1.shtml", "https://www.prnewswire.com/news-releases/ent-partners-announces-acquisition-of-arlington-ent--head--neck-and-facial-plastic-surgery-301203151.html", "https://www.prnasia.com/story/184308-1.shtml", "https://www.prnasia.com/story/183224-1.shtml", "https://www.prnasia.com/story/183622-1.shtml", "https://www.prnasia.com/story/183235-1.shtml", "https://www.prnewswire.com/news-releases/new-wave-announces-that-n2-logics-will-be-spearheading-way-of-will-e-commerce-platform-to-optimize-their-online-sales-301214997.html", "https://www.prnasia.com/story/184334-1.shtml", "https://www.prnewswire.com/news-releases/medicure-announces-pivotal-phase-3-trial-ind-filing-with-fda-for-treatment-of-seizures-associated-with-pyridoxamine-5-phosphate-oxidase-pnpo-deficiency-301203117.html", "https://www.prnewswire.com/news-releases/elevian-adds-deep-scientific-and-business-expertise-301214895.html", "https://www.prnasia.com/story/183621-1.shtml", "https://www.prnasia.com/story/184790-1.shtml", "https://www.prnasia.com/story/184187-1.shtml", "https://www.prnewswire.com/news-releases/report-finds-orphan-drug-manufacturers-struggle-with-data-management-301215099.html", "https://www.prnewswire.com/news-releases/gram-makes-major-investment-in-additional-advanced-equipment-to-meet-continued-demand-301215168.html", "https://www.prnewswire.com/news-releases/nice-pak-receives-epa-approval-for-disinfecting-wipes-use-against-virus-causing-covid-19-301215201.html", "https://www.prnasia.com/story/184580-1.shtml", "https://www.prnasia.com/story/183609-1.shtml", "https://www.prnasia.com/story/203695-1.shtml", "https://www.prnasia.com/story/203936-1.shtml", "https://www.prnasia.com/story/203620-1.shtml", "https://www.prnewswire.com/news-releases/therapeutic-solutions-international-reports-enhancement-of-stemvacs-immune-stimulating-activity-using-neuromodulatory-compound-homotaurine-301215167.html", "https://www.prnasia.com/story/204023-1.shtml", "https://www.prnewswire.com/news-releases/unprecedented-international-achievement-for-panaxia-selected-as-one-of-the-four-main-winners-in-the-french-government-tender-for-regulation-of-the-medical-cannabis-industry-301215259.html", "https://www.prnasia.com/story/205133-1.shtml", "https://www.prnasia.com/story/204838-1.shtml", "https://www.prnasia.com/story/205139-1.shtml", "https://www.prnasia.com/story/204008-1.shtml", "https://www.prnewswire.com/news-releases/smarthealth-paycard-and-synergen-health-collaborate-to-expand-healthcare-payment-and-collection-options-for-patients-and-providers-301215291.html", "https://www.prnasia.com/story/205200-1.shtml", "https://www.prnasia.com/story/204543-1.shtml", "https://www.prnewswire.com/news-releases/biocytogen-subsidiary-eucure-biopharma-reports-first-patient-enrolled-in-anti-ctla4-phase-i-trial-in-china-301215110.html", "https://www.prnewswire.com/news-releases/regenerx-comments-on-arise-3-clinical-trial-301215318.html", "https://www.prnewswire.com/news-releases/futuro-health-to-invest-in-behavioral-health-occupations-in-2021-training-roadmap-301214452.html", "https://www.prnasia.com/story/205383-1.shtml", "https://www.prnewswire.com/news-releases/erdal-can-alkoclar-to-renew-antiviral-license-for-actopharma-301215301.html", "https://www.prnewswire.com/news-releases/health-systems-use-clearbalance-patient-financing-as-a-crucial-component-of-revenue-recovery-301215410.html", "https://cnmobile.prnasia.com/story/205050-1.shtml", "https://www.prnasia.com/story/205573-1.shtml", "https://www.prnewswire.com/news-releases/north-america-6-1-billion-addictions-therapeutics-market-to-2027-market-opportunity-in-the-rising-demand-for-rd-from-contract-organizations-301214925.html", "https://www.prnasia.com/story/205727-1.shtml", "https://www.prnasia.com/story/205505-1.shtml", "https://www.prnasia.com/story/205675-1.shtml", "https://www.prnasia.com/story/205412-1.shtml", "https://www.prnewswire.com/news-releases/concorde-career-colleges-to-open-campus-at-st-joseph-medical-center-301215464.html", "https://www.prnasia.com/story/187381-1.shtml", "https://www.prnasia.com/story/205433-1.shtml", "https://www.prnasia.com/story/187246-1.shtml", "https://www.prnasia.com/story/187171-1.shtml", "https://www.prnewswire.com/news-releases/io-biotech-completes-oversubscribed-eur-127-million-series-b-financing-to-accelerate-clinical-programs-in-oncology-301207100.html", "https://www.prnewswire.com/news-releases/novo-seeds-portfolio-company-io-biotech-completes-oversubscribed-eur-127m-series-b-financing-to-accelerate-clinical-programs-in-oncology-301207223.html", "https://www.prnasia.com/story/187218-1.shtml", "https://www.prnasia.com/story/188008-1.shtml", "https://www.prnasia.com/story/187186-1.shtml", "https://www.prnewswire.com/news-releases/west-atlantic-partners-closes-acquisition-of-precisionmed-inc-301207160.html", "https://www.prnasia.com/story/187308-1.shtml", "https://www.prnewswire.com/news-releases/significant-progress-made-in-new-covid-19-vaccine-developed-by-the-team-of-prof-salanti-301207197.html", "https://www.prnasia.com/story/187279-1.shtml", "https://www.prnewswire.com/news-releases/evoq-therapeutics-announces-a-license-and-collaboration-agreement-with-amgen-301207118.html", "https://www.prnasia.com/story/207639-1.shtml", "https://www.prnasia.com/story/207607-1.shtml", "https://www.prnasia.com/story/207744-1.shtml", "https://www.prnewswire.com/news-releases/resolutions-at-the-extraordinary-general-meeting-in-medivir-on-13-january-2021-301207392.html", "https://www.prnewswire.com/news-releases/talkspace-to-merge-with-hudson-executive-investment-corp-forming-the-only-publicly-traded-pure-play-virtual-behavioral-health-company-301207080.html", "https://www.prnewswire.com/news-releases/holmusk-national-healthcare-group-and-institute-of-mental-health-outline-strategic-collaboration-to-strengthen-mental-healthcare-in-singapore-301207185.html", "https://www.prnasia.com/story/207707-1.shtml", "https://www.prnewswire.com/news-releases/marker-therapeutics-announces-completion-of-new-manufacturing-facility-to-support-clinical-development-of-multitaa-specific-t-cell-therapy-product-candidates-301207240.html", "https://www.prnasia.com/story/207725-1.shtml", "https://www.prnasia.com/story/207799-1.shtml", "https://www.prnewswire.com/news-releases/essa-pharma-announces-clinical-collaboration-with-janssen-to-evaluate-epi-7386-combination-for-patients-with-metastatic-castration-resistant-prostate-cancer-301207078.html", "https://www.prnewswire.com/news-releases/the-fertility-partners-welcomes-another-ivf-centre-to-its-growing-network-the-toronto-institute-for-reproductive-medicine-and-acquires-sperm-bank-repromed-301206932.html", "https://www.prnewswire.com/news-releases/actinium-and-astellas-announce-research-collaboration-focused-on-novel-actinium-225-based-targeted-radiotherapies-301207122.html", "https://www.prnasia.com/story/188386-1.shtml", "https://www.prnewswire.com/news-releases/fda-schvalila-prenosne-izolacni-koje-sroom-firmy-jud-care-863899028.html", "https://www.prnasia.com/story/207843-1.shtml", "https://www.prnasia.com/story/188214-1.shtml", "https://www.prnewswire.com/news-releases/hibercell-and-biodesix-initiate-broad-collaboration-for-companion-diagnostic-discovery-development-and-commercialization-301207115.html", "https://www.prnasia.com/story/207930-1.shtml", "https://www.prnasia.com/story/207955-1.shtml", "https://www.prnasia.com/story/188393-1.shtml", "https://www.prnewswire.com/news-releases/poluchenie-kompaniei-jud-care-odobreniia-ot-upravleniia-po-kontroliu-za-produktami-i-lekarstvami-ssha-fda-na-ikh-reshenie-mobil-naia-meditsiskaia-palata-portable-ward-sroom--854155874.html", "https://www.prnasia.com/story/207798-1.shtml", "https://www.prnewswire.com/news-releases/mentice-to-enhance-its-organization-with-several-new-key-positions-301207450.html", "https://www.prnewswire.com/news-releases/global-antibiotics-technologies-and-markets-2018-2019-data-2020-estimates--forecasts-to-2025-301207352.html", "https://www.prnasia.com/story/188479-1.shtml", "https://www.prnasia.com/story/209300-1.shtml", "https://www.prnewswire.com/news-releases/item-9-labs-reports-record-revenue-for-fiscal-year-2020-301207161.html", "https://www.prnasia.com/story/209289-1.shtml", "https://www.prnewswire.com/news-releases/evolent-health-enters-agreement-with-bright-healthcare-for-bright-healthcare-to-acquire-true-health-new-mexico-301207235.html", "https://www.prnasia.com/story/188228-1.shtml", "https://www.prnasia.com/story/209314-1.shtml", "https://www.prnewswire.com/news-releases/miravo-healthcare-announces-the-canadian-commercial-launch-of-neovisc-and-neovisc-one-for-the-treatment-of-pain-and-improvement-of-joint-functionality-of-the-knee-301207095.html", "https://www.prnasia.com/story/188309-1.shtml", "https://www.prnewswire.com/news-releases/butterfly-network-and-access-afya-recognized-by-the-world-bank-group-ces-global-tech-challenge-for-work-around-solving-for-accessible-affordable-healthcare-through-innovative-telehealth-model-in-kenya-301207498.html", "https://www.prnewswire.com/news-releases/china-nmpa-grants-approval-for-the-registrational-phase-12-clinical-study-for-gc007g---an-allogeneic-car-t-cell-therapy-for-the-treatment-of-relapsed-or-refractory-b-all-301206086.html", "https://www.prnasia.com/story/208141-1.shtml", "https://www.prnasia.com/story/208127-1.shtml", "https://cnmobile.prnasia.com/story/209173-1.shtml", "https://www.prnasia.com/story/209494-1.shtml", "https://www.prnewswire.com/news-releases/heska-corporation-to-acquire-lacuna-diagnostics-a-pioneer-and-market-leader-in-point-of-care-digital-cytology-301207213.html", "https://www.prnewswire.com/news-releases/nanoview-biosciences-strengthens-executive-team-301207135.html", "https://www.prnewswire.com/news-releases/fda-grants-hoth-therapeutics-pre-ind-meeting-regarding-proposed-drug-development-plan-for-ht-001-treatment-for-cancer-patients-301207307.html", "https://www.prnasia.com/story/208050-1.shtml", "https://www.prnewswire.com/news-releases/nutriband-inc-files-pro-forma-financials-consolidating-the-recent-acquisition-of-pocono-coated-products-transdermal-and-topical-business-and-active-intelligence-301207021.html", "https://www.prnewswire.com/news-releases/adastra-pharmaceuticals-announces-positive-top-line-data-from-phase-1b-clinical-trial-of-zotiraciclib-in-the-treatment-of-recurrent-high-grade-gliomas-301207282.html", "https://www.prnasia.com/story/208165-1.shtml", "https://www.prnasia.com/story/209511-1.shtml", "https://www.prnasia.com/story/209407-1.shtml", "https://www.prnewswire.com/news-releases/omega-therapeutics-announces-the-industrys-first-programmable-epigenetic-medicine-in-development-and-2021-priorities-301206992.html", "https://www.prnasia.com/story/208229-1.shtml", "https://www.prnasia.com/story/208099-1.shtml", "https://www.prnasia.com/story/208084-1.shtml", "https://www.prnewswire.com/news-releases/kintara-announces-initiation-of-patient-recruitment-for-val-083s-study-arm-in-the-gbm-agile-trial-301207295.html", "https://www.prnasia.com/story/208413-1.shtml", "https://cnmobile.prnasia.com/story/209296-1.shtml", "https://www.prnewswire.com/news-releases/spolocnost-jud-care-ziskala-schvalenie-fda-pre-svoju-prenosnu-nemocnicnu-izbu-sroom-836284206.html", "https://www.prnewswire.com/news-releases/aon-and-elements-of-genius-announce-strategic-collaboration-in-ai-powered-healthcare-301216378.html", "https://cnmobile.prnasia.com/story/209179-1.shtml", "https://www.prnasia.com/story/208570-1.shtml", "https://www.prnasia.com/story/208471-1.shtml", "https://www.prnasia.com/story/208480-1.shtml", "https://www.prnewswire.com/news-releases/air-purifier-to-protect-new-yorks-first-responders-301216218.html", "https://www.prnasia.com/story/208439-1.shtml", "https://www.prnasia.com/story/208661-1.shtml", "https://www.prnewswire.com/news-releases/delta-dental-of-arkansas-covid-19-relief-funding-exceeded-27-million-in-2020-301216404.html", "https://www.prnasia.com/story/208246-1.shtml", "https://www.prnasia.com/story/208762-1.shtml", "https://www.prnasia.com/story/208684-1.shtml", "https://www.prnewswire.com/news-releases/nord-state-report-card-grades-states-on-policy-issues-critical-to-rare-disease-patients-301216427.html", "https://www.prnewswire.com/news-releases/dr-reddys-and-gra-announce-clinically-meaningful-data-from-avigan-pivotal-studies-301216562.html", "https://www.prnasia.com/story/208434-1.shtml", "https://www.prnasia.com/story/191901-1.shtml", "https://www.prnasia.com/story/208338-1.shtml", "https://www.prnasia.com/story/208781-1.shtml", "https://www.prnasia.com/story/192047-1.shtml", "https://www.prnasia.com/story/208748-1.shtml", "https://www.prnasia.com/story/208606-1.shtml", "https://cnmobile.prnasia.com/story/192020-1.shtml", "https://www.prnewswire.com/news-releases/transnetyx-one-codex-build-strategic-partnership-to-provide-a-complete-microbiome-analysis-service-for-both-mice-and-humans-301216560.html", "https://www.prnasia.com/story/208958-1.shtml", "https://www.prnasia.com/story/208801-1.shtml", "https://www.prnasia.com/story/192566-1.shtml", "https://www.prnasia.com/story/209063-1.shtml", "https://www.prnewswire.com/news-releases/medicure-announces-early-completion-of-enrollment-for-ispasm-a-phase-12a-exploratory-clinical-trial-of-aggrastat-tirofiban-hydrochloride-injection-vs-placebo-for-induced-suppression-of-platelets-activity-in-aneurysmal-subara-301216718.html", "https://www.prnasia.com/story/192386-1.shtml", "https://www.prnewswire.com/news-releases/liminal-biosciences-provides-update-on-business-strategy-and-focus-on-small-molecule-therapeutics-301216732.html", "https://www.prnasia.com/story/209123-1.shtml", "https://www.prnewswire.com/news-releases/antengene-announces-the-acceptance-of-atg-010-selinexor-nda-by-the-nmpa-for-the-treatment-of-rrmm-301216226.html", "https://www.prnasia.com/story/209116-1.shtml", "https://cnmobile.prnasia.com/story/192383-1.shtml", "https://cnmobile.prnasia.com/story/209093-1.shtml", "https://www.prnasia.com/story/192367-1.shtml", "https://www.prnasia.com/story/209082-1.shtml", "https://www.prnasia.com/story/209057-1.shtml", "https://www.prnewswire.com/news-releases/harbour-biomeds-batoclimab-hbm9161-receives-china-cde-breakthrough-therapy-designation-for-treatment-of-adult-patients-with-myasthenia-gravis-301216848.html", "https://cnmobile.prnasia.com/story/208892-1.shtml", "https://www.prnewswire.com/news-releases/edwards-lifesciences-reports-fourth-quarter-results-301216600.html", "https://www.prnasia.com/story/194177-1.shtml", "https://www.prnasia.com/story/194368-1.shtml", "https://www.prnasia.com/story/194284-1.shtml", "https://www.prnasia.com/story/194566-1.shtml", "https://www.prnewswire.com/news-releases/humanco-acquisition-corp-announces-the-separate-trading-of-its-shares-of-class-a-common-stock-and-redeemable-warrants-commencing-january-28-2021-301216601.html", "https://www.prnasia.com/story/195370-1.shtml", "https://www.prnasia.com/story/194858-1.shtml", "https://www.prnewswire.com/news-releases/erdal-can-alkoclar-renouvelle-la-licence-des-antiviraux-pour-actopharma-877048648.html", "https://www.prnasia.com/story/194780-1.shtml", "https://www.prnasia.com/story/194745-1.shtml", "https://www.prnewswire.com/news-releases/medlumics-proprietary-technology-to-be-presented-at-26th-annual-international-af-symposium-301216952.html", "https://www.prnasia.com/story/193459-1.shtml", "https://www.prnewswire.com/news-releases/abbott-reports-fourth-quarter-2020-results-issues-strong-double-digit-growth-forecast-for-2021-301216123.html", "https://www.prnewswire.com/news-releases/q-biomeds-uttroside-b-receives-us-fda-orphan-drug-designation-in-the-treatment-of-liver-cancer-301215876.html", "https://cnmobile.prnasia.com/story/193530-1.shtml", "https://www.prnewswire.com/news-releases/armata-pharmaceuticals-announces-20-million-investment-to-support-advancement-of-the-companys-bacteriophage-development-programs-301215981.html", "https://www.prnewswire.com/news-releases/bioinvent-phase-iiia-data-suggest-bi-1206-restores-activity-of-rituximab-in-relapsed-non-hodgkins-lymphoma-patients-301216922.html", "https://www.prnewswire.com/news-releases/creative-medical-technology-holdings-files-patent-based-on-positive-data-on-renal-failure-using-immcelz-regenerative-immunotherapy-301216021.html", "https://www.prnasia.com/story/194909-1.shtml", "https://www.prnewswire.com/news-releases/cromsource-consolidates-strategic-site-support-service-301216465.html", "https://www.prnewswire.com/news-releases/orexo-q4-2020-incl-full-year-report-301216928.html", "https://www.prnasia.com/story/195409-1.shtml", "https://www.prnasia.com/story/195402-1.shtml", "https://www.prnewswire.com/news-releases/united-therapeutics-announces-breeze-study-of-investigational-tyvaso-dpi-meets-primary-objective-301216857.html", "https://www.prnasia.com/story/195827-1.shtml", "https://www.prnewswire.com/news-releases/seniorlinks-caregiver-homes-of-indiana-expands-pilot-with-cicoa-aging--in-home-solutions-after-successful-launch-of-its-technology-enabled-care-management-program-301215851.html", "https://www.prnasia.com/story/196006-1.shtml", "https://www.prnewswire.com/news-releases/artio-medical-announces-successful-first-human-use-of-the-amplifi-vein-dilation-system-301216214.html", "https://www.prnewswire.com/news-releases/seelos-therapeutics-announces-its-inclusion-in-the-first-psychedelic-exchange-traded-fund-etf-301216111.html", "https://www.prnasia.com/story/151799-1.shtml", "https://www.prnasia.com/story/150827-1.shtml", "https://www.prnasia.com/story/195503-1.shtml", "https://www.prnasia.com/story/151060-1.shtml", "https://www.prnewswire.com/news-releases/cody-expands-health-plan-technology-and-consulting-capabilities-with-7-3-million-madena-acquisition-301215842.html", "https://www.prnasia.com/story/195394-1.shtml", "https://www.prnasia.com/story/151774-1.shtml", "https://www.prnasia.com/story/151846-1.shtml", "https://www.prnasia.com/story/151911-1.shtml", "https://www.prnewswire.com/news-releases/surface-ophthalmics-announces-first-patient-dosed-in-landmark-head-to-head-phase-ii-trial-for-surf-100-for-chronic-dry-eye-disease-301215738.html", "https://www.prnasia.com/story/195996-1.shtml", "https://www.prnewswire.com/news-releases/pharvaris-announces-phase-1-clinical-data-of-pha121-an-oral-b2-receptor-antagonist-under-development-for-the-treatment-of-hereditary-angioedema-301216003.html", "https://www.prnewswire.com/news-releases/nutrition21s-noolvl-earns-top-spot-in-player1-launch-301215873.html", "https://www.prnasia.com/story/152091-1.shtml", "https://www.prnasia.com/story/151835-1.shtml", "https://www.prnewswire.com/news-releases/national-kidney-foundation-honors-unitedhealth-group-with-2021-corporate-innovator-award-301216028.html", "https://www.prnewswire.com/news-releases/lumen-bioscience-receives-carb-x-award-to-develop-preventative-for-deadly-diarrheal-diseases-and-details-broad-potential-of-spirulina-platform-301216014.html", "https://www.prnasia.com/story/196380-1.shtml", "https://www.prnasia.com/story/196266-1.shtml", "https://www.prnewswire.com/news-releases/scientists-still-relentlessly-working-to-develop-newest-more-advanced-antiviral-therapies-for-covid-19-treatments-301215872.html", "https://www.prnasia.com/story/196227-1.shtml", "https://www.prnasia.com/story/151744-1.shtml", "https://www.prnewswire.com/news-releases/ehealth-supports-proposal-to-re-open-aca-enrollment-for-americans-impacted-by-covid-19-301216220.html", "https://www.prnewswire.com/news-releases/research-and-development-moves-the-psychedelics-market-forward-301215888.html", "https://www.prnasia.com/story/150916-1.shtml", "https://www.prnasia.com/story/151962-1.shtml", "https://www.prnewswire.com/news-releases/oncosec-announces-first-subjects-dosed-in-phase-1-trial-of-corvax12-oncosecs-covid-19-vaccine-candidate-combining-interleukin-12-il-12-with-an-enhanced-sars-cov-2-spike-protein-301216247.html", "https://www.prnewswire.com/news-releases/american-papr-receives-full-approval-from-niosh-for-high-efficiency-he-papr-301216147.html", "https://www.prnasia.com/story/156097-1.shtml", "https://www.prnasia.com/story/155721-1.shtml", "https://www.prnewswire.com/news-releases/chesapeake-urology-treats-first-patient-in-maryland-in-the-oasis-clinical-trial-for-overactive-bladder-301215913.html", "https://www.prnasia.com/story/196387-1.shtml", "https://www.prnewswire.com/news-releases/theralink-technologies-announces-milestone-eventthe-commencement-of-testing-on-its-first-patients-301216110.html", "https://www.prnasia.com/story/155954-1.shtml", "https://www.prnewswire.com/news-releases/hyperice-acquires-recoverx-301215857.html", "https://www.prnasia.com/story/166595-1.shtml", "https://www.prnasia.com/story/196660-1.shtml", "https://www.prnewswire.com/news-releases/shasqi-announces-publication-of-preclinical-data-demonstrating-proof-of-principle-for-click-activated-approach-to-cancer-treatment-301215944.html", "https://www.prnasia.com/story/155861-1.shtml", "https://www.prnewswire.com/news-releases/scopus-biopharma-announces-exchange-offer-301216307.html", "https://www.prnasia.com/story/155862-1.shtml", "https://www.prnasia.com/story/196684-1.shtml", "https://www.prnasia.com/story/166372-1.shtml", "https://www.prnasia.com/story/156022-1.shtml", "https://www.prnasia.com/story/167328-1.shtml", "https://www.prnewswire.com/news-releases/exact-sciences-licenses-targeted-digital-sequencing-method-to-extend-leadership-in-precision-oncology-301207819.html", "https://www.prnasia.com/story/166737-1.shtml", "https://www.prnasia.com/story/166605-1.shtml", "https://www.prnewswire.com/news-releases/bioclinica-adds-etmf-functionality-to-ctms-301216241.html", "https://www.prnasia.com/story/166857-1.shtml", "https://www.prnasia.com/story/156639-1.shtml", "https://www.prnasia.com/story/166695-1.shtml", "https://www.prnasia.com/story/167142-1.shtml", "https://www.prnewswire.com/news-releases/memorialcare-acquires-oc-blood--cancer-care-301207958.html", "https://www.prnasia.com/story/167244-1.shtml", "https://www.prnasia.com/story/156867-1.shtml", "https://www.prnasia.com/story/166755-1.shtml", "https://www.prnewswire.com/news-releases/precigen-provides-pipeline-updates-at-the-39th-annual-jp-morgan-healthcare-conference-301207917.html", "https://www.prnasia.com/story/156874-1.shtml", "https://www.prnasia.com/story/167268-1.shtml", "https://www.prnewswire.com/news-releases/united-therapeutics-announces-new-england-journal-of-medicine-publication-of-the-increase-study-evaluating-tyvaso-in-pulmonary-hypertension-associated-with-interstitial-lung-disease-301207790.html", "https://www.prnasia.com/story/156962-1.shtml", "https://www.prnewswire.com/news-releases/ces-2021-mission-for-the-human-race-pulxions-early-detection-technology-is-here-to-save-lives-301208205.html", "https://www.prnasia.com/story/157220-1.shtml", "https://www.prnewswire.com/news-releases/ascentage-pharma-presents-updates-on-its-global-clinical-development-at-the-jp-morgan-39th-annual-healthcare-conference-301208020.html", "https://www.prnasia.com/story/167837-1.shtml", "https://www.prnasia.com/story/167727-1.shtml", "https://www.prnasia.com/story/157069-1.shtml", "https://www.prnasia.com/story/157059-1.shtml", "https://www.prnewswire.com/news-releases/ntc-accorde-a-zhaoke-des-droits-exclusifs-de-licence-et-de-distribution-en-asie-pour-le-ntc014-un-medicament-innovant-contre-la-conjonctivite-bacterienne-869698055.html", "https://cnmobile.prnasia.com/story/168063-1.shtml", "https://www.prnasia.com/story/157303-1.shtml", "https://www.prnewswire.com/news-releases/health-carousel-announces-acquisition-of-vitruvian-medical-301207907.html", "https://www.prnasia.com/story/173740-1.shtml", "https://www.prnasia.com/story/157526-1.shtml", "https://cnmobile.prnasia.com/story/167403-1.shtml", "https://www.prnewswire.com/news-releases/nida-funded-study-evaluating-extended-release-injectable-naltrexone-plus-bupropion-for-the-treatment-of-methamphetamine-use-disorder-published-in-new-england-journal-of-medicine-301208061.html", "https://www.prnewswire.com/news-releases/global-proteomics-technologies-competitive-landscape--markets-2019-2020--projections-to-2024--2029-301208399.html", "https://www.prnewswire.com/news-releases/nevro-to-highlight-new-clinical-evidence-at-the-2021-north-american-neuromodulation-society-nans-virtual-meeting-301207909.html", "https://www.prnasia.com/story/173833-1.shtml", "https://www.prnewswire.com/news-releases/marizyme-announces-approval-for-duragraft-in-india-301207922.html", "https://www.prnewswire.com/news-releases/mindmed-adds-chief-development-officer-with-fda-phase-2-psilocybin-clinical-trial-experience-301208199.html", "https://www.prnasia.com/story/174353-1.shtml", "https://www.prnewswire.com/news-releases/fda-approves-first-adjuvant-therapy-for-most-common-type-of-lung-cancer-301196261.html", "https://www.prnasia.com/story/163094-1.shtml", "https://www.prnasia.com/story/173979-1.shtml", "https://www.prnasia.com/story/164206-1.shtml", "https://www.prnasia.com/story/174091-1.shtml", "https://www.prnewswire.com/news-releases/global-activated-carbon-market-overview-2017-2026---biological-activated-carbon-treatment-gaining-traction-for-advanced-water-and-wastewater-treatment-301196115.html", "https://www.prnewswire.com/news-releases/qualigen-therapeutics-inc-announces-closing-of-12-million-registered-direct-offering-301196217.html", "https://www.prnasia.com/story/162587-1.shtml", "https://www.prnasia.com/story/164785-1.shtml", "https://www.prnewswire.com/news-releases/lilly-to-begin-pragmatic-study-of-neutralizing-antibody-bamlanivimab-ly-cov555-for-covid-19-in-new-mexico-301196256.html", "https://www.prnewswire.com/news-releases/oncobeta-announces-approval-and-artg-listing-of-rhenium-sct-rhenium-188-paste-in-australia-for-the-treatment-of-skin-cancer-lesions-and-skin-tumors-301196262.html", "https://www.prnasia.com/story/163042-1.shtml", "https://www.prnasia.com/story/165047-1.shtml", "https://cnmobile.prnasia.com/story/164140-1.shtml", "https://www.prnewswire.com/news-releases/sirnaomics-reports-positive-data-from-phase-2a-study-of-stp705-for-treatment-of-squamous-cell-skin-cancer-301196389.html", "https://www.prnasia.com/story/159393-1.shtml", "https://www.prnasia.com/story/163571-1.shtml", "https://www.prnewswire.com/news-releases/fda-takes-additional-action-in-fight-against-covid-19-by-issuing-emergency-use-authorization-for-second-covid-19-vaccine-301196303.html", "https://www.prnasia.com/story/163981-1.shtml", "https://www.prnasia.com/story/159455-1.shtml", "https://www.prnewswire.com/news-releases/positive-results-show-that-c21-can-become-an-important-complement-to-covid-19-vaccines-301196578.html", "https://www.prnewswire.com/news-releases/immunemeds-hzvsf-v13-covid-19-clinical-trials-accelerate-development-of-the-treatment-301196512.html", "https://www.prnasia.com/story/146494-1.shtml", "https://www.prnasia.com/story/161138-1.shtml", "https://www.prnasia.com/story/160618-1.shtml", "https://www.prnasia.com/story/159472-1.shtml", "https://www.prnasia.com/story/159445-1.shtml", "https://www.prnewswire.com/news-releases/medit-announces-straumann-group-as-a-distributor-for-its-intraoral-scanners-301196544.html", "https://www.prnewswire.com/news-releases/bioinvent-and-transgene-receive-cta-approval-for-phase-llla-trial-of-oncolytic-virus-bt-001-in-solid-tumors-301196595.html", "https://www.prnewswire.com/news-releases/autobahn-labs-and-ucsf-announce-strategic-drug-discovery-collaboration-301196335.html", "https://www.prnewswire.com/news-releases/antengene-announces-its-us-partner-karyopharm-therapeutics-inc-has-received-fda-approval-of-xpovio-selinexor-as-a-treatment-for-patients-with-multiple-myeloma-after-at-least-one-prior-therapy-301196488.html", "https://www.prnewswire.com/news-releases/first-dosing-of-nanoformed-drug-successfully-accomplished-301196587.html", "https://www.prnewswire.com/news-releases/wuxi-biologics-to-acquire-drug-substance-facility-in-wuppertal-germany-from-bayer-301196735.html", "https://cnmobile.prnasia.com/story/164791-1.shtml", "https://www.prnewswire.com/news-releases/revelstoke-capital-partners-invests-in-affiliate-of-family-care-center-to-expand-access-to-mental-healthcare-301196690.html", "https://www.prnewswire.com/news-releases/hzvsf-v13-de-immunemed-los-ensayos-clinicos-de-covid-19-aceleran-el-desarrollo-del-tratamiento-860276694.html", "https://www.prnasia.com/story/168396-1.shtml", "https://www.prnasia.com/story/160646-1.shtml", "https://www.prnasia.com/story/146554-1.shtml", "https://www.prnewswire.com/news-releases/miravo-healthcare-ireland-enters-into-suvexx-license-and-supply-agreement-with-orion-corporation-for-select-eu-markets-301196460.html", "https://www.prnasia.com/story/160833-1.shtml", "https://www.prnewswire.com/news-releases/janssen-initiates-rolling-submission-of-a-biologics-license-application-to-us-fda-for-bcma-car-t-therapy-ciltacabtagene-autoleucel-cilta-cel-for-the-treatment-of-relapsed-andor-refractory-multiple-myeloma-301196517.html", "https://www.prnewswire.com/news-releases/onkos-surgical-continues-its-innovation-in-musculoskeletal-oncology-and-complex-orthopaedic-reconstruction-with-the-launch-of-the-eleos-proximal-tibia-with-biogrip-technology-301196502.html", "https://www.prnewswire.com/news-releases/bioeclipse-initiates-enrollment-in-phase-1-dose-escalation-clinical-trial-for-crx100-301196556.html", "https://www.prnasia.com/story/168402-1.shtml", "https://www.prnewswire.com/news-releases/capstone-holdings-inc-invests-25-million-in-ilera-healthcare-301196572.html", "https://www.prnewswire.com/news-releases/formula787-cbd-amp-cbg-flower-is-available-by-mail-in-puerto-rico-yes-not-thc-weed-but-cbg-cbd-weed-873695537.html", "https://www.prnasia.com/story/149841-1.shtml", "https://www.prnewswire.com/news-releases/sifi-launches-well-fusion-a-novel-presbyopia-correcting-system-301195792.html", "https://www.prnasia.com/story/168661-1.shtml", "https://www.prnewswire.com/news-releases/websafety-signs-agreement-to-acquire-purveyor-of-walk-through-disinfecting-booths-301196565.html", "https://www.prnewswire.com/news-releases/biovaxys-vaccine-platform-stimulates-robust-t-cell-response-against-viral-antigens-301196285.html", "https://www.prnewswire.com/news-releases/neurana-pharmaceuticals-announces-first-patient-enrolled-in-phase-3-resume-1-study-301196283.html", "https://www.prnasia.com/story/150740-1.shtml", "https://www.prnewswire.com/news-releases/emulate-unveils-brain-chip-to-enhance-neuroinflammatory-disease-research-and-drug-discovery-301196468.html", "https://www.prnasia.com/story/169264-1.shtml", "https://www.prnasia.com/story/149790-1.shtml", "https://www.prnewswire.com/news-releases/longevity-acquisition-corporation-announces-4d-pharma-joining-landmark-parkinsons-progression-markers-initiative-301196472.html", "https://www.prnasia.com/story/169567-1.shtml", "https://www.prnewswire.com/news-releases/lipocine-announces-open-label-extension-to-ongoing-lpcn-1144-lift-study-301199071.html", "https://www.prnasia.com/story/168754-1.shtml", "https://www.prnasia.com/story/169270-1.shtml", "https://www.prnasia.com/story/150714-1.shtml", "https://www.prnewswire.com/news-releases/moebius-medical-announces-fda-clearance-of-ind-application-for-phase-iib-clinical-trial-of-mm-ii-a-novel-treatment-for-knee-osteoarthritis-pain-301196765.html", "https://www.prnasia.com/story/169053-1.shtml", "https://www.prnewswire.com/news-releases/world-whole-genome-and-exome-sequencing-markets-report-2021-2025-including-the-whole-genome-sequence-of-sars-cov-2-301199276.html", "https://www.prnewswire.com/news-releases/bactiguard-new-order-from-china-301199306.html", "https://www.prnewswire.com/news-releases/anixa-biosciences-and-cleveland-clinic-announce-fda-clearance-to-initiate-clinical-trial-of-breast-cancer-vaccine-301196402.html", "https://www.prnasia.com/story/170085-1.shtml", "https://www.prnasia.com/story/150508-1.shtml", "https://www.prnewswire.com/news-releases/biomarin-announces-benefit-maintained-for-over-two-years-in-children-with-achondroplasia-treated-with-vosoritide-in-phase-3-extension-study-301196598.html", "https://www.prnasia.com/story/171039-1.shtml", "https://www.prnasia.com/story/152098-1.shtml", "https://www.prnasia.com/story/169942-1.shtml", "https://www.prnewswire.com/news-releases/flagship-healthcare-properties-announces-new-leadership-and-investment-in-its-reit-301199241.html", "https://www.prnasia.com/story/170681-1.shtml", "https://www.prnasia.com/story/171108-1.shtml", "https://www.prnewswire.com/news-releases/olympus-acquires-veran-medical-technologies-inc-301199197.html", "https://www.prnasia.com/story/170676-1.shtml", "https://www.prnasia.com/story/170328-1.shtml", "https://www.prnasia.com/story/170527-1.shtml", "https://www.prnewswire.com/news-releases/lygenesis-receives-fda-clearance-to-begin-phase-2a-trial-of-its-cell-therapy-for-patients-with-end-stage-liver-disease-and-also-closes-11-million-convertible-debt-financing-301199042.html", "https://www.prnasia.com/story/152117-1.shtml", "https://www.prnasia.com/story/170896-1.shtml", "https://www.prnewswire.com/news-releases/freedom-healthcare-earns-spots-on-two-of-sias-annual-staffing-industry-lists-301199368.html", "https://www.prnasia.com/story/170186-1.shtml", "https://www.prnewswire.com/news-releases/emmes-acquires-neox-sro-a-clinical-research-organization-headquartered-in-the-czech-republic-301199330.html", "https://www.prnasia.com/story/170730-1.shtml", "https://www.prnewswire.com/news-releases/stem-holdings-inc-closes-acquisition-of-driven-deliveries-inc-301199231.html", "https://www.prnewswire.com/news-releases/usana-biomega-supplement-is-of-fish-ially-consumerlabcom-approved-301199161.html", "https://www.prnasia.com/story/152607-1.shtml", "https://www.prnasia.com/story/152548-1.shtml", "https://www.prnasia.com/story/153424-1.shtml", "https://www.prnewswire.com/news-releases/wize-pharma-and-cosmos-capital-enter-into-bid-implementation-agreement-301199333.html", "https://www.prnasia.com/story/153530-1.shtml", "https://www.prnasia.com/story/152865-1.shtml", "https://www.prnasia.com/story/152209-1.shtml", "https://www.prnasia.com/story/152898-1.shtml", "https://www.prnasia.com/story/153629-1.shtml", "https://www.prnasia.com/story/152255-1.shtml", "https://www.prnasia.com/story/153340-1.shtml", "https://www.prnasia.com/story/152421-1.shtml", "https://www.prnewswire.com/news-releases/inland-empire-health-plan-earns-2020-energy-star-certification-301199372.html", "https://www.prnasia.com/story/153309-1.shtml", "https://www.prnewswire.com/news-releases/direct-biologics-announces-first-patient-treated-under-phase-ii-expanded-access-protocol-using-exoflo-to-treat-covid-19-301199474.html", "https://www.prnewswire.com/news-releases/snanf-investor-alert-bernstein-liebhard-llp-announces-that-a-securities-class-action-lawsuit-has-been-filed-against-sona-nanotech-inc-301199426.html", "https://www.prnasia.com/story/171889-1.shtml", "https://www.prnasia.com/story/171584-1.shtml", "https://www.prnasia.com/story/171764-1.shtml", "https://www.prnewswire.com/news-releases/thermo-fisher-scientific-acquires-programmable-dye-platform-pioneer-phitonex-301199506.html", "https://www.prnewswire.com/news-releases/sqi-diagnostics-announces-4-million-funding-via-warrant-exercise-by-insiders-301199467.html", "https://www.prnasia.com/story/172451-1.shtml", "https://www.prnewswire.com/news-releases/early-treatment-can-stem-the-tide-of-covid-19-hospitalizations-and-deaths-states-the-association-of-american-physicians--surgeons-aaps-301199575.html", "https://www.prnasia.com/story/153919-1.shtml", "https://www.prnewswire.com/news-releases/creative-medical-technology-holdings-announces-patent-filing-based-on-preclinical-data-in-model-of-heart-attack-using-immcelz-regenerative-immunotherapy-301199599.html", "https://cnmobile.prnasia.com/story/154072-1.shtml", "https://www.prnasia.com/story/172637-1.shtml", "https://www.prnasia.com/story/173047-1.shtml", "https://www.prnasia.com/story/154015-1.shtml", "https://www.prnasia.com/story/171393-1.shtml", "https://www.prnasia.com/story/172110-1.shtml", "https://www.prnasia.com/story/173461-1.shtml", "https://www.prnewswire.com/news-releases/immvira-announces-series-c-financing-with-leading-specialist-investors-301199619.html", "https://www.prnewswire.com/news-releases/hoth-therapeutics-announces-production-of-ht-001-for-cancer-treatment-301199561.html", "https://www.prnasia.com/story/173244-1.shtml", "https://www.prnewswire.com/news-releases/bold-therapeutics-secures-funding-to-prepare-bold-100-for-covid-19-clinical-trials-301201518.html", "https://www.prnewswire.com/news-releases/chris-jackson-joins-national-kidney-foundation-as-chief-people-officer-to-lead-nkfs-diversity-equity--inclusion-efforts-301201551.html", "https://www.prnewswire.com/news-releases/panalgos-ihd-platform-to-be-used-by-the-european-medicines-agency-for-real-world-data-analytics-301201161.html", "https://www.prnewswire.com/news-releases/volitionrx-limited-awarded-an-additional-4-million-in-non-dilutive-funding-301201984.html", "https://www.prnasia.com/story/173302-1.shtml", "https://www.prnasia.com/story/175114-1.shtml", "https://www.prnewswire.com/news-releases/tigerconnect-acquires-critical-alert-ends-2020-with-second-major-acquisition-301201663.html", "https://www.prnasia.com/story/174962-1.shtml", "https://www.prnewswire.com/news-releases/mj-analytics-an-akerna-product-built-on-domos-modern-bi-platform-generates-six-figure-sales-increase-301201777.html", "https://www.prnasia.com/story/173336-1.shtml", "https://www.prnewswire.com/news-releases/get-the-skinny-on-the-revolutionary-weight-loss-movement-designed-to-take-the-negative-out-of-skinny-301201793.html", "https://www.prnewswire.com/news-releases/tonic-bioventures-and-cssi-lifesciences-enter-partnership-to-form-a-new-life-sciences-fund-301201546.html", "https://www.prnewswire.com/news-releases/genesis-drug-discovery-and-development-expands-its-presence-in-the-clinical-space-by-acquiring-statking-clinical-services-301200991.html", "https://www.prnewswire.com/news-releases/everest-medicines-announces-cta-approval-by-china-nmpa-for-phase-3-trial-of-sacituzumab-govitecan-hziy-for-metastatic-urothelial-cancer-301202010.html", "https://www.prnewswire.com/news-releases/seelos-therapeutics-announces-year-end-2020-business-update-301201900.html", "https://www.prnewswire.com/news-releases/neurobo-pharmaceuticals-acquires-ana-therapeutics-for-late-stage-oral-antiviral-development-program-301201781.html", "https://www.prnewswire.com/news-releases/intraprise-health-acquires-hipaa-one-301201530.html", "https://www.prnasia.com/story/177223-1.shtml", "https://www.prnasia.com/story/175381-1.shtml", "https://www.prnasia.com/story/157765-1.shtml", "https://www.prnasia.com/story/178805-1.shtml", "https://www.prnasia.com/story/177799-1.shtml", "https://www.prnasia.com/story/157951-1.shtml", "https://www.prnasia.com/story/157771-1.shtml", "https://www.prnasia.com/story/177838-1.shtml", "https://www.prnewswire.com/news-releases/bioworkshops-successfully-passed-eu-qp-audit-301201753.html", "https://www.prnewswire.com/news-releases/exostar-receives-kantara-initiatives-identity-assurance-trust-framework-certification-achieves-healthcare-and-life-science-community-milestones-301201671.html", "https://www.prnasia.com/story/158253-1.shtml", "https://www.prnewswire.com/news-releases/crunch-welcomes-back-gym-goers-in-2021-301201463.html", "https://www.prnasia.com/story/158550-1.shtml", "https://www.prnewswire.com/news-releases/nsf-international-acquires-global-trust-certification-301201543.html", "https://www.prnasia.com/story/158231-1.shtml", "https://www.prnasia.com/story/158015-1.shtml", "https://www.prnasia.com/story/179484-1.shtml", "https://www.prnasia.com/story/179540-1.shtml", "https://www.prnewswire.com/news-releases/bioclinica-acquires-saliency-to-accelerate-digital-diagnostic-development-301202036.html", "https://www.prnasia.com/story/179803-1.shtml", "https://www.prnewswire.com/news-releases/cambia-health-solutions-commits-11-5-million-to-address-mental-health-needs-in-rural-communities-301201832.html", "https://www.prnasia.com/story/179695-1.shtml", "https://www.prnewswire.com/news-releases/steward-st-elizabeths-medical-center-opens-new-englands-first-pritikin-icr-cardiac-rehab-program-301202041.html", "https://www.prnewswire.com/news-releases/telehealth-claim-lines-increase-3-060-percent-nationally-when-comparing-october-2019-to-october-2020--301201834.html", "https://cnmobile.prnasia.com/story/179986-1.shtml", "https://www.prnasia.com/story/180379-1.shtml", "https://www.prnasia.com/story/181218-1.shtml", "https://www.prnewswire.com/news-releases/breakthrough-study-supports-genetic-editing-as-a-potential-treatment-for-rare-rapid-aging-disease-progeria-301202059.html", "https://www.prnewswire.com/news-releases/apara-autism-centers-announces-acquisition-of-behavior-pioneers-301201555.html", "https://www.prnasia.com/story/181552-1.shtml", "https://www.prnewswire.com/news-releases/boxunion-acquires-title-boxing-club-to-form-nations-premier-omni-channel-fitness-brand-301202227.html", "https://cnmobile.prnasia.com/story/181150-1.shtml", "https://www.prnasia.com/story/161320-1.shtml", "https://www.prnasia.com/story/161593-1.shtml", "https://www.prnasia.com/story/161527-1.shtml", "https://www.prnasia.com/story/161197-1.shtml", "https://www.prnasia.com/story/161198-1.shtml", "https://www.prnasia.com/story/161284-1.shtml", "https://www.prnasia.com/story/162427-1.shtml", "https://www.prnasia.com/story/162233-1.shtml", "https://www.prnasia.com/story/161967-1.shtml", "https://www.prnasia.com/story/162482-1.shtml", "https://www.prnasia.com/story/162301-1.shtml", "https://www.prnewswire.com/news-releases/seran-bioscience-announces-investment-by-vivo-capital-301202219.html", "https://www.prnasia.com/story/162458-1.shtml", "https://www.prnasia.com/story/161336-1.shtml", "https://cnmobile.prnasia.com/story/181567-1.shtml", "https://www.prnewswire.com/news-releases/turbine-raises-eur-5-7m-to-advance-simulation-first-oncology-pipeline-301202620.html", "https://www.prnewswire.com/news-releases/winhealth-pharma-und-twib-gehen-strategische-lizenzpartnerschaft-fur-ac-203-ein-884688636.html", "https://www.prnewswire.com/news-releases/winhealth-pharma-et-twib-concluent-un-partenariat-de-licence-strategique-sur-l-ac-203-844002835.html", "https://www.prnewswire.com/news-releases/theolytics-raises-6-8-million-series-a-round-co-led-by-epidarex-capital-and-taiho-ventures-to-advance-viral-cancer-therapies-301202026.html", "https://www.prnewswire.com/news-releases/union-therapeutics-as-receives-fda-approval-for-ind-of-oral-next-generation-pde4-inhibitor-orismilast-for-investigation-in-plaque-psoriasis-301202575.html", "https://www.prnewswire.com/news-releases/protective-immunity-against-sars-cov-2-could-last-eight-months-or-more-301202223.html", "https://www.prnewswire.com/news-releases/imaginab-announces-license-and-supply-agreement-with-pfizer-for-cd8-immunopet-technology-301202156.html", "https://www.prnewswire.com/news-releases/novo-holdings-participates-in-biogeneration-ventures-iv-fund-301202291.html", "https://www.prnewswire.com/news-releases/fujifilm-to-invest-over-200-billion-yen-2-billion-usd-to-establish-new-large-scale-cell-culture-manufacturing-site-for-biopharmaceuticals-in-the-usa-301202418.html", "https://www.prnewswire.com/news-releases/kaist-mobile-clinic-module-to-fill-negative-pressure-ward-shortage-301201846.html", "https://www.prnewswire.com/news-releases/milliporesigma-acquires-amptec-to-expand-mrna-capabilities-for-vaccines-treatments-and-diagnostics-301202323.html", "https://www.prnewswire.com/news-releases/global-142-2-billion-pharmaceutical-contract-development--manufacturing-market-to-2025--301202694.html", "https://www.prnewswire.com/news-releases/respicardia-announces-highmark-coverage-for-the-remed-system-in-patients-with-central-sleep-apnea-301202449.html", "https://www.prnewswire.com/news-releases/werewolf-therapeutics-completes-72-million-series-b-financing-to-advance-a-novel-class-of-cancer-biotherapeutics-to-the-clinic-301202490.html", "https://www.prnewswire.com/news-releases/kira-pharmaceuticals-announces-53-5-million-series-b-financing-to-advance-logic-drug-discovery-platform-and-pipeline-of-complement-targeted-therapies-301202708.html", "https://www.prnewswire.com/news-releases/built-in-honors-bwell-connected-health-with-2021-best-places-to-work-award-301202454.html", "https://www.prnewswire.com/news-releases/visen-pharmaceuticals-receives-ind-approval-to-initiate-phase-2-clinical-trial-of-transcon--cnp-in-achondroplasia-ach-in-china-301202688.html", "https://www.prnewswire.com/news-releases/oyagen-inc-publishes-study-on-its-oya1-as-a-highly-effective-experimental-drug-candidate-for-treating-infections-by-the-ebola-virus-301202527.html", "https://www.prnewswire.com/news-releases/global-future-proof-pharma-labels-market-outlook-2020-2027-drivers-constraints-opportunities-threats-challenges-investment-opportunities-301202681.html", "https://www.prnewswire.com/news-releases/arctic-vision-obtains-the-first-ind-approval-for-the-treatment-of-ume-in-china-suprachoroidal-space-scs-injection-potentially-brings-more-benefits-to-patients-301198489.html", "https://www.prnewswire.com/news-releases/united-therapeutics-announces-agreement-to-acquire-priority-review-voucher-301198443.html", "https://www.prnewswire.com/news-releases/alligator-bioscience-submits-cta-for-the-mitazalimab-phase-ii-study-optimize-1-301198592.html", "https://www.prnewswire.com/news-releases/poor-hygiene-in-low-income-countries-to-impact-growth-of-enteric-disease-testing-market-positively-through-forecast-period-of-2019-2027-tmr-301198581.html", "https://www.prnewswire.com/news-releases/innovent-announces-the-nmpa-granted-new-indication-approval-for-byvasda-bevacizumab-biosimilar-for-the-treatment-of-adult-recurrent-glioblastoma-301198508.html", "https://www.prnewswire.com/news-releases/first-subject-dosed-with-gannexs-fxr-agonist-asc42-in-a-us-phase-i-trial-301198537.html", "https://www.prnewswire.com/news-releases/aanp-announces-loretta-ford-centennial-scholarships-honoring-co-founder-of-nurse-practitioner-np-role-on-her-100th-birthday-301198351.html", "https://www.prnewswire.com/news-releases/gt-biopharma-announces-trike-for-the-treatment-of-breast-and-gi-cancers-301198536.html", "https://www.prnewswire.com/news-releases/soligenix-announces-1-5-million-nih-small-business-innovation-research-award-advancing-covid-19-vaccine-development-301197725.html", "https://www.prnewswire.com/news-releases/introducing-comirnaty-the-eu-brand-name-for-pfizer--biontechs-covid-19-vaccine-developed-by-brand-institute-301198522.html", "https://www.prnewswire.com/news-releases/nevro-announces-fda-submission-for-hf10-therapy-in-patients-with-painful-diabetic-neuropathy-301198773.html", "https://www.prnewswire.com/news-releases/deadline-tomorrow-the-schall-law-firm-announces-the-filing-of-a-class-action-lawsuit-against-celsion-corporation-and-encourages-investors-with-losses-in-excess-of-100-000-to-contact-the-firm-301198707.html", "https://www.prnewswire.com/news-releases/olympus-acquires-onsite-visualizes-further-growth-301198685.html", "https://www.prnewswire.com/news-releases/discovery-behavioral-health-acquires-prosperity-wellness-center-301198740.html", "https://www.prnewswire.com/news-releases/fda-accepts-alkermes-resubmission-of-new-drug-application-for-alks-3831-301198736.html", "https://www.prnewswire.com/news-releases/healthcare-services-acquisition-corporation-closes-upsized-initial-public-offering-of-331-2-million-301198807.html", "https://www.prnewswire.com/news-releases/lavie-bio-provides-product-pipeline-update-for-2020-301198936.html", "https://www.prnewswire.com/news-releases/alligator-bioscience-recruits-new-chief-medical-officer-301198908.html", "https://www.prnewswire.com/news-releases/smartbreast-acquires-molecular-breast-imaging-assets-from-dilon-technologies-301198844.html", "https://www.prnewswire.com/news-releases/collagen-matrix-acquires-the-guidor-synthetic-bone-graft--membrane-business-from-sunstar-301198680.html", "https://www.prnewswire.com/news-releases/lipocine-announces-update-on-jury-trial-in-patent-infringement-lawsuit-against-clarus-therapeutics-301198776.html", "https://www.prnewswire.com/news-releases/actinium-announces-successful-pre-planned-ad-hoc-interim-analysis-of-phase-3-sierra-trial-301198869.html", "https://www.prnewswire.com/news-releases/aivita-biomedical-closes-25-million-financing-round-301198879.html", "https://www.prnewswire.com/news-releases/global-markets-for-alzheimers-disease-therapeutics-2020-with-profiles-of-key-players-abbvie-allergan-plc-glaxosmithkline-plc-pfizer-inc-torrent-pharmaceuticals-ltd-and-more-301198953.html", "https://www.prnewswire.com/news-releases/creative-medical-technology-holdings-announces-reversion-of-liver-failure-using-immcelz-personalized-cellular-immunotherapy-in-preclinical-model-301198904.html", "https://www.prnewswire.com/news-releases/moleculin-announces-annamycin-receives-fda-orphan-drug-designation-for-soft-tissue-sarcomas-301198841.html", "https://www.prnewswire.com/news-releases/ampio-receives-feedback-from-the-fda-on-ampios-proposed-modifications-to-the-special-protocol-assessment-for-ampion-treatment-of-severe-osteoarthritis-of-the-knee-301198986.html", "https://www.prnewswire.com/news-releases/matrix-fitness-and-ifit-announce-strategic-partnership-to-bring-ifit-powered-content-to-premium-matrix-home-fitness-equipment-301198994.html", "https://www.prnewswire.com/news-releases/new-wave-applauds-luckboxs-recent-successful-listing-301198765.html", "https://www.prnewswire.com/news-releases/lui-franciosi-of-franciosi-consulting-launches-new-website-301199164.html", "https://www.prnewswire.com/news-releases/world-cancer-gene-therapy-market-industry-forecasts-to-2030-301199074.html", "https://www.prnewswire.com/news-releases/insilico-enters-into-a-collaboration-with-aprinoia-to-apply-novel-generative-ai-powered-system-to-discover-novel-compounds-for-neurodegenerative-diseases-301199026.html", "https://www.prnewswire.com/news-releases/protalix-biotherapeutics-and-chiesi-global-rare-diseases-announce-final-results-of-bridge-phase-iii-open-label-switch-over-clinical-trial-evaluating-pegunigalsidase-alfa-for-the-treatment-of-fabry-disease-301199281.html", "https://www.prnewswire.com/news-releases/neurorx-relief-and-quantum-leap-announce-the-inclusion-of-zyesami-rlf-100-aviptadil-in-the-i-spy-covid-19-trial-301204909.html", "https://www.prnewswire.com/news-releases/pivotal-phase-iii-clinical-trial-ind-submission-of-the-original-innovative-anticancer-drug-chiauranib-for-the-treatment-of-small-cell-lung-cancer-was-accepted-by-the-center-of-drug-evaluation-of-the-nmpa-301204841.html", "https://www.prnewswire.com/news-releases/ascentage-pharma-officially-included-in-shenzhen-hong-kong-stock-connect-program-301199272.html", "https://www.prnewswire.com/news-releases/cdc-2020-in-review-301199183.html", "https://www.prnewswire.com/news-releases/centene-completes-acquisition-of-pantherx-rare-pharmacy-pantherx-301199187.html", "https://www.prnewswire.com/news-releases/regeneron-announces-encouraging-initial-data-from-covid-19-antibody-cocktail-trial-in-hospitalized-patients-on-low-flow-oxygen-301199163.html", "https://www.prnewswire.com/news-releases/hansa-biopharma-provides-business-update-incl-certain-key-financials-ahead-of-the-jp-morgan-global-healthcare-conference-301204955.html", "https://www.prnewswire.com/news-releases/exact-sciences-announces-preliminary-fourth-quarter-2020-results-301204799.html", "https://www.prnewswire.com/news-releases/neurorx-and-relief-conclude-enrollment-in-their-phase-2b3-trial-of-rlf-100-for-critical-covid-19-with-respiratory-failure-301199129.html", "https://www.prnewswire.com/news-releases/announcing-calyx-advancing-clinical-research-through-technology-enabled-services-301204791.html", "https://www.prnewswire.com/news-releases/ideaya-biosciences-announces-submission-of-ind-application-for-mat2a-development-candidate-ide397-with-the-us-fda-301204730.html", "https://www.prnewswire.com/news-releases/fresenius-medical-cares-frenova-enrolls-patients-in-initiative-to-build-worlds-largest-genomic-registry-targeting-kidney-disease-301204788.html", "https://www.prnewswire.com/news-releases/ptc-therapeutics-provides-update-on-rd-pipeline-and-commercial-progress-at-39th-annual-jp-morgan-healthcare-conference-301204949.html", "https://www.prnewswire.com/news-releases/nevro-announces-preliminary-unaudited-fourth-quarter-and-full-year-2020-revenue-301204937.html", "https://www.prnewswire.com/news-releases/qualitas-healthiwi-raises-10m-in-first-close-of-new-investment-round-301205104.html", "https://www.prnewswire.com/news-releases/organ-on-chip-ooc-market-size-is-usd-303-6-million-by-2026-at-cagr-39-9--valuates-reports-301205107.html", "https://www.prnewswire.com/news-releases/redhills-partner-cosmo-pharmaceuticals-successfully-completes-phase-2-study-of-rifamycin-sv-mmx-600mg-in-ibs-d-301205143.html", "https://www.prnewswire.com/news-releases/rakuten-medical-inc-acquires-key-assets-and-manufacturing-technology-from-li-cor-biosciences-301204950.html", "https://www.prnewswire.com/news-releases/rigel-pharmaceuticals-provides-business-update-301204977.html", "https://www.prnewswire.com/news-releases/lillys-donanemab-slows-clinical-decline-of-alzheimers-disease-in-positive-phase-2-trial-301204830.html", "https://www.prnewswire.com/news-releases/medical-guardian-receives-growth-investment-from-water-street-healthcare-partners-301204814.html", "https://www.prnewswire.com/news-releases/engage-partners-with-klas-arch-collaborative-for-implementation-success-301204923.html", "https://www.prnewswire.com/news-releases/codagenix-and-serum-institute-of-india-initiate-dosing-in-phase-1-trial-of-covi-vac-a-single-dose-intranasal-live-attenuated-vaccine-for-covid-19-301203130.html", "https://www.prnewswire.com/news-releases/valo-raises-190-million-in-series-b-financing-and-unveils-select-therapeutic-programs-301204965.html", "https://www.prnewswire.com/news-releases/halozyme-provides-2021-financial-guidance-highlighted-by-strong-revenue-and-eps-growth-301204808.html", "https://www.prnewswire.com/news-releases/karyopharm-announces-preliminary-unaudited-fourth-quarter-and-full-year-2020-total-revenues-and-provides-commercial-update-301204826.html", "https://www.prnewswire.com/news-releases/jupiter-orphan-therapeutics-announces-first-patient-dosed-in-phase-i-dose-escalation-study-of-jotrol-301205240.html", "https://www.prnewswire.com/news-releases/exuma-biotech-announces-collaboration-with-moffitt-cancer-center-for-the-development-of-a-rapid-point-of-care-sc-car-t-program-301204749.html", "https://www.prnewswire.com/news-releases/hoth-therapeutics-to-initiate-ind-enabling-studies-of-ht-001-treatment-for-cancer-patients-301205202.html", "https://www.prnewswire.com/news-releases/protom-international-signed-a-strategic-distribution-and-licensing-agreement-to-distribute-with-ghgk-in-china-301205108.html", "https://www.prnewswire.com/news-releases/heron-therapeutics-highlights-progress-in-pain-management-and-cinv-franchises-and-announces-new-development-program-301204895.html", "https://www.prnewswire.com/news-releases/us-fda-accepts-supplemental-new-drug-application-for-jardiance-empagliflozin-for-adults-with-heart-failure-with-reduced-ejection-fraction-301203589.html", "https://www.prnewswire.com/news-releases/histosonics-receives-approval-to-begin-european-hope4liver-clinical-study-301204775.html", "https://www.prnewswire.com/news-releases/nuprobe-closes-42m-fundraising-301203540.html", "https://www.prnewswire.com/news-releases/bazelet-launches-first-of-the-kind-proprietary-terpene-enriched-medical-cannabis-oils-specially-designed-for-medical-needs-such-as-women-health-pain-treatment-improved-sleep-and-special-needs-of-the-elderly-population-301205225.html", "https://www.prnewswire.com/news-releases/cvs-health-names-laurie-havanec-chief-people-officer-301205248.html", "https://www.prnewswire.com/news-releases/helix-laboratory-platform-granted-the-first-and-only-fda-authorization-for-a-whole-exome-sequencing-platform-301204899.html", "https://www.prnewswire.com/news-releases/cardiofocus-announces-expanded-distribution-partnership-with-microport-crm-to-include-spain-and-portugal-301203650.html", "https://www.prnewswire.com/news-releases/echo-health-ventures-introduces-new-innovation-alliance-bringing-together-three-national-health-care-leaders-to-collectively-invest-in-transforming-health-care-301205337.html", "https://www.prnewswire.com/news-releases/corneat-visions-first-patient-regains-sight-following-artificial-cornea-implantation-at-rabin-medical-center-ending-a-decade-of-blindness-301205312.html", "https://www.prnewswire.com/news-releases/clinedge-and-btc-network-companies-announce-integration-301205363.html", "https://www.prnewswire.com/news-releases/first-patient-enrolls-in-precisions-study-for-treatment-of-idiopathic-pulmonary-fibrosis-301205409.html", "https://www.prnewswire.com/news-releases/clearmind-biomedicals-axonpen-neuroendoscope-receives-510k-clearance-301205122.html", "https://www.prnewswire.com/news-releases/global-immuno-oncology-markets-2020-2024-car-t-therapies---the-future-of-cancer-care-301205162.html", "https://www.prnewswire.com/news-releases/nuvo-pharmaceuticals-announces-corporate-rebranding-as-miravo-healthcare-301195702.html", "https://www.prnewswire.com/news-releases/blue-shield-of-california-expands-collaboration-with-dignity-health-hospitals-to-make-billing-and-payment-easier-for-patients-providers-301203664.html", "https://www.prnewswire.com/news-releases/brainstorm-announces-completion-of-all-dosing-in-nurown-phase-2-ms-study-301195880.html", "https://www.prnewswire.com/news-releases/worlds-largest-manufacturer-of-rapid-antigen-tests-acquires-california-based-biolab-301195841.html", "https://www.prnewswire.com/news-releases/antengene-announces-approval-of-ind-application-in-china-for-a-phase-3-clinical-trial-of-atg-010-selinexor-in-combination-with-bortezomib-and-dexamethasone-svd-for-the-treatment-of-rrmm-301195807.html", "https://www.prnewswire.com/news-releases/centene-corporation-announces-2021-guidance-301195742.html", "https://www.prnewswire.com/news-releases/cns-pharmaceuticals-call-to-discuss-fda-ind-approval-and-phase-2-trial-for-berubicin-today-at-830am-et-301195866.html", "https://www.prnewswire.com/news-releases/global-bioengineered-skin-substitutes-markets-2020-2030-focus-on-allogenic-autologous-xenogeneic--acellular-products-301195954.html", "https://www.prnewswire.com/news-releases/villagemd-expands-into-austin-and-acquires-a-primary-care-practice-301195908.html", "https://www.prnewswire.com/news-releases/teijin-pharma-and-transthera-biosciences-form-strategic-rd-collaboration-301193807.html", "https://www.prnewswire.com/news-releases/dxterity-offers-covid-19-tests-in-strategic-collaboration-with-amazon-301196057.html", "https://www.prnewswire.com/news-releases/rhia-ventures-invests-in-ocon-healthcares-ballerine-the-first-ever-3d-spherical-copper-intrauterine-contraceptive-with-a-superior-safety-profile-a-breakthrough-in-womens-hormone-free-birth-control-options-301196098.html", "https://www.prnewswire.com/news-releases/world-antiviral-therapeutics-technologies-markets--companies-report-2020-profiles-of-195-with-179-collaborations--110-covid-19-drugs-and-vaccine-candidates-in-development-301195971.html", "https://www.prnewswire.com/news-releases/fda-approves-first-oral-hormone-therapy-for-treating-advanced-prostate-cancer-301196146.html", "https://www.prnewswire.com/news-releases/alert-rowley-law-pllc-is-investigating-proposed-acquisition-of-seneca-biopharma-inc-301196182.html", "https://www.prnewswire.com/news-releases/karyopharm-announces-fda-approval-of-xpovio-selinexor-as-a-treatment-for-patients-with-multiple-myeloma-after-at-least-one-prior-therapy-301196120.html", "https://www.prnewswire.com/news-releases/medical-drones-market-size-is-projected-to-reach-usd-186-580-million-by-2026-at-cagr-14-0--valuates-reports-301196021.html", "https://www.prnewswire.com/news-releases/rxe2-agrees-to-acquire-habitu-to-form-the-first-ai-driven-pharmacist-led-clinical-trial-platform-301205384.html", "https://www.prnewswire.com/news-releases/fda-conditionally-approves-first-oral-tablet-to-treat-lymphoma-in-dogs-301205576.html", "https://www.prnewswire.com/news-releases/genalyte-announces-oversubscribed-50-million-financing-round-to-expand-testing-menu-and-deploy-platform-301205549.html", "https://www.prnewswire.com/news-releases/force-10-partners-steers-acquisition-of-yogaworks-in-section-363-sale-301205536.html", "https://www.prnewswire.com/news-releases/gannex-announces-positive-phase-i-clinical-results-on-its-thr--agonist-asc41-301205745.html", "https://www.prnewswire.com/news-releases/amgen-to-achieve-carbon-neutrality-by-2027-301205666.html", "https://www.prnewswire.com/news-releases/redhill-biopharma-announces-10-million-bought-deal-offering-301205668.html", "https://www.prnewswire.com/news-releases/darwinhealth-scientists-publish-foundational-research-identifying-regulatory-mechanisms-controlling-cancer-cell-states-and-drug-response-301205720.html", "https://www.prnewswire.com/news-releases/innovent-announces-nmpa-acceptance-of-a-supplemental-new-drug-application-for-sintilimab-as-second-line-therapy-for-squamous-non-small-cell-lung-cancer-301205888.html", "https://www.prnewswire.com/news-releases/irras-announces-collaboration-with-karolinska-university-hospital-301205965.html", "https://www.prnewswire.com/news-releases/beactica-therapeutics-and-university-of-dundee-announce-collaboration-to-develop-wrn-inhibitors-to-target-cancer-301206004.html", "https://www.prnewswire.com/news-releases/neuraxpharm-launches-first-product-in-japan-301205469.html", "https://www.prnewswire.com/news-releases/mind-cure-signs-loi-to-acquire-an-ownership-interest-in-psychedelic-treatment-center-atma-selected-by-section-56-exempt-patient-for-psilocybin-therapy-301205985.html", "https://www.prnewswire.com/news-releases/medivir-presents-miv-818-data-at-asco-gastrointestinal-cancers-symposium-301205983.html", "https://www.prnewswire.com/news-releases/seelos-therapeutics-announces-issuance-of-a-patent-for-trehalose-sls-005-in-israel-301196427.html", "https://www.prnewswire.com/news-releases/luminex-corporation-pre-release-of-4th-quarter-2020-revenue-301205732.html", "https://www.prnewswire.com/news-releases/optimism-building-as-additional-covid-19-vaccines-are-expected-to-be-released-globally-301196573.html", "https://www.prnewswire.com/news-releases/worldwide-trispecific-antibodies-industry-to-2024---by-country-indication-organization-and-patient-segment-301196727.html", "https://www.prnewswire.com/news-releases/student-transfer-decreased-sharply-during-the-pandemic-potentially-causing-a-lasting-impact-on-postsecondary-attainment-301196590.html", "https://www.prnewswire.com/news-releases/ohios-hospice-and-ascend-innovations-announce-new-strategic-partnership-301196449.html", "https://www.prnewswire.com/news-releases/leiber-and-mbp-solutions-enter-a-strategic-partnership-301196407.html", "https://www.prnewswire.com/news-releases/cannabics-pharmaceuticals-initiates-in-vivo-animal-studies-for-fda-pre-ind-meeting-package-301196808.html", "https://www.prnewswire.com/news-releases/kindred-biosciences-announces-positive-results-from-pilot-field-effectiveness-study-for-anti-tnf-antibody-for-canine-inflammatory-bowel-disease-301196541.html", "https://www.prnewswire.com/news-releases/q-biomed-technology-partner-mannin-research-inc-announced-as-member-of-canadian-national-covid-19-consortium-301196800.html", "https://www.prnewswire.com/news-releases/psychedelics-industry-gearing-up-for-an-even-bigger-2021-301196567.html", "https://www.prnewswire.com/news-releases/correction-aphex-biocleanse-systems-signs-european-supply-and-private-label-agreement-for-dermaphex-and-sanaphex-products-301196509.html", "https://www.prnewswire.com/news-releases/global-clinical-manufacturing-service-provider-benchmarking-report-2020-301196773.html", "https://www.prnewswire.com/news-releases/canopy-growth-announces-plan-of-arrangement-with-canopy-rivers-301196803.html", "https://www.prnewswire.com/news-releases/femtech-startup-ocon-healthcare-completes-funding-round-and-appoints-dr-anula-jayasuriya-to-chairwoman-301196710.html", "https://www.prnewswire.com/news-releases/lt1001-naldebainr-an-extended-release-analgesic-injection-received-its-second-approval-from-singapores-hsa-301196794.html", "https://www.prnewswire.com/news-releases/tracelink-announces-second-round-of-grant-recipients-for-covid-19-relief-funding-301196456.html", "https://www.prnewswire.com/news-releases/medexus-mdpv-expands-specialty-pharmaceuticals-portfolio-301196839.html", "https://www.prnewswire.com/news-releases/aprecia-establishes-a-long-term-partnership-with-battelle-301196825.html", "https://www.prnewswire.com/news-releases/elizabethtown-college-stem-and-health-programs-growing-amidst-pandemic-301196852.html", "https://www.prnewswire.com/news-releases/pierre-fabre-selects-agc-biologics-as-cdmo-to-manufacture-the-orphan-drug-er-004-301196379.html", "https://www.prnewswire.com/news-releases/peptilogics-closes-35-4-million-series-b-financing-to-further-advance-proprietary-computational-peptide-drug-design-and-discovery-platform-301196867.html", "https://www.prnewswire.com/news-releases/first-patient-enrolled-in-olympus-study-of-the-soltive-laser-system-301196837.html", "https://www.prnewswire.com/news-releases/dla-piper-advises-arlington-capital-partners-in-majority-investment-in-everest-clinical-research-corporation-301196864.html", "https://www.prnewswire.com/news-releases/worldwide-car-t-cell-therapy-industry-to-2030---players-include-legend-biotech-novartis--pfizer-among-others-301196756.html", "https://www.prnewswire.com/news-releases/oncopeptides-enrolls-the-first-patient-in-the-phase-3-lighthouse-combination-study-in-multiple-myeloma-301196875.html", "https://www.prnewswire.com/news-releases/gt-biopharma-announces-fda-data---gtb-3550-trike-reduces-cancer-cells-by-61-7-for-a-high-risk-myelodysplastic-syndromes-hr-mds-patient-301196659.html", "https://www.prnewswire.com/news-releases/orthogrid-systems-inc-announces-new-clinical-data-supporting-the-use-of-its-analog-and-digital-technology-for-orthopedic-surgery-301196904.html", "https://www.prnewswire.com/news-releases/innovaccer-receives-the-highest-grade-a-in-overall-phm-performance-in-klass-population-health-data-acquisition--analysis-2020-301196882.html", "https://www.prnewswire.com/news-releases/the-creative-engagement-group-acquires-vitiello-communications-group-301205735.html", "https://www.prnewswire.com/news-releases/health-canada-authorizes-cytosorb-for-use-in-hospitalized-covid-19-patients-301206034.html", "https://www.prnewswire.com/news-releases/dragonfly-therapeutics-announces-abbvie-opt-in-of-trinket-immunotherapy-drug-candidate-301205963.html", "https://www.prnewswire.com/news-releases/valeo-pharma-highlights-mdbriefcase-newsletter-comparing-hesperidin-and-vitamin-c-for-covid-19-301206174.html", "https://www.prnewswire.com/news-releases/boston-scientific-announces-preliminary-unaudited-sales-for-the-fourth-quarter-and-full-year-2020-301205872.html", "https://www.prnewswire.com/news-releases/hsi-acquires-elearning-provider-ej4-301205665.html", "https://www.prnewswire.com/news-releases/central-logic-acquires-acuity-link-for-intelligent-transport--announces-new-bed-visibility-capability-advancing-mission-to-enable-health-systems-to-operate-as-one-through-improved-access-and-orchestration-301206017.html", "https://www.prnewswire.com/news-releases/nxgen-brands-inc-announces-partnership-with-digital-supply-chain-and-blockchain-developer-to-create-a-proprietary-cloud-based-framework-for-delivery-services-and-licensing-to-mj-dispensaries-nationwide-301205958.html", "https://www.prnewswire.com/news-releases/soc-telemed-hires-top-executive-roles-from-global-leaders-in-healthcare-and-tech-301206094.html", "https://www.prnewswire.com/news-releases/lipocine-announces-positive-topline-phase-2-results-from-lpcn-1144-ongoing-lift-study-in-biopsy-confirmed-nash-subjects-301205908.html", "https://www.prnewswire.com/news-releases/wm-partners-announces-acquisition-of-jade-leaf-llc-301205661.html", "https://www.prnewswire.com/news-releases/strategic-healthcare-investment-partners-closes-128m-debut-medical-devices-and-digital-health-venture-fund-and-rebrands-itself-as-treo-ventures-301205833.html", "https://www.prnewswire.com/news-releases/delfi-diagnostics-announces-100-million-series-a-financing-to-develop-a-new-class-of-early-detection-liquid-biopsy-for-multiple-cancers-301206102.html", "https://www.prnewswire.com/news-releases/creative-medical-technology-holdings-files-investigational-new-drug-application-ind-with-fda-for-treatment-of-stroke-using-immcelz-regenerative-immunotherapy-301206267.html", "https://www.prnewswire.com/news-releases/neurosense-therapeutics-receives-european-orphan-drug-designation-for-als-drug-301206188.html", "https://www.prnewswire.com/news-releases/absci-announces-acquisition-of-deep-learning-company-denovium-301206116.html", "https://www.prnewswire.com/news-releases/smithnephew-partners-with-movemedical-to-streamline-inventory-management-and-improve-customer-experience-301206093.html", "https://www.prnewswire.com/news-releases/atai-life-sciences-acquires-majority-stake-in-recognify-life-sciences-to-develop-novel-treatment-for-cognitive-impairment-associated-with-schizophrenia-301205876.html", "https://www.prnewswire.com/news-releases/aflac-expands-product-offerings-with-new-dental-and-vision-insurance-301206417.html", "https://www.prnewswire.com/news-releases/gtcr-and-cole-parmer-announce-acquisition-of-zeptometrix-301206376.html", "https://www.prnewswire.com/news-releases/net-health-acquires-pointright-301205875.html", "https://www.prnewswire.com/news-releases/mental-health-demand-for-development-of-psychedelic-drug-therapies-is-increasing-301205928.html", "https://www.prnewswire.com/news-releases/caprion-histogenex-expands-its-histological-biomarker-franchise-by-joining-forces-with-mosaic-laboratories-301205838.html", "https://www.prnewswire.com/news-releases/longuevue-capital-onboards-dedicated-life-sciences-operating-partner-adrian-otte-and-completes-investment-in-kps-life-llc-301206156.html", "https://www.prnewswire.com/news-releases/kps-life-llc-announces-investment-from-longuevue-capital-and-adrian-otte-with-adrian-joining-the-companys-board-of-directors-301206168.html", "https://www.prnewswire.com/news-releases/redhill-biopharma-increases-previously-announced-bought-deal-to-25-million-301206452.html", "https://www.prnewswire.com/news-releases/open-book-extracts-and-case-western-reserve-university-school-of-medicine-announce-research-agreement-for-novel-rare-cannabinoid-therapeutics-301206305.html", "https://www.prnewswire.com/news-releases/runway-growth-capital-announces-a-senior-secured-term-loan-of-50-million-to-gynesonics-301206571.html", "https://www.prnewswire.com/news-releases/turn-biotechnologies-licenses-revolutionary-technology-to-unwind-the-effects-of-aging-at-a-cellular-level-301206370.html", "https://www.prnewswire.com/news-releases/runway-growth-capital-announces-a-senior-secured-term-loan-of-50-million-to-vero-biotech-301206522.html", "https://www.prnewswire.com/news-releases/monarchbio-continues-to-build-substantial-thin-film-nitinol-patent-portfolio-301205996.html", "https://www.prnewswire.com/news-releases/nuspine-thrives-in-a-challenging-2020-awarding-84-licenses-301205516.html", "https://www.prnewswire.com/news-releases/healco-and-choosing-therapy-tackle-mental-health-crisis-through-strategic-partnership-301206755.html", "https://www.prnewswire.com/news-releases/tmrw-adds-three-high-profile-hires-to-its-senior-executive-team-301206672.html", "https://www.prnewswire.com/news-releases/leading-corporations-and-foundations-come-together-to-support-national-covid-19-vaccine-education-effort-from-the-ad-council-and-covid-collaborative-301206697.html", "https://www.prnewswire.com/news-releases/health-canada-approves-lundbecks-prvyepti-eptinezumabthe-first-and-only-intravenous-preventive-treatment-for-migraine-301206816.html", "https://www.prnewswire.com/news-releases/jud-care-uzyskuje-zgode-fda-na-przenosne-sale-oddzialowe-sroom-803822849.html", "https://www.prnewswire.com/news-releases/ibsa-reacquires-commercial-rights-to-the-flector-brand-in-the-us-301205698.html", "https://www.prnewswire.com/news-releases/jud-care-obtiene-aprobacion-de-la-fda-para-su-sala-portatil-sroom-831729621.html", "https://www.prnewswire.com/news-releases/orthos-vitros-sars-cov-2-antigen-test-for-accurate-mass-scale-covid-19-testing-is-the-first-high-volume-test-to-receive-fda-emergency-use-authorization-301206766.html", "https://www.prnewswire.com/news-releases/episode-solutions-acquires-fusion5-healthcare-solutions-to-create-national-value-based-healthcare-solutions-platform-301206876.html", "https://www.prnewswire.com/news-releases/direct-biologics-announces-new-advanced-tool-in-regenerative-medicine-with-launch-of-amniowrap-placental-allograft-301206833.html", "https://www.prnewswire.com/news-releases/new-prospective-data-demonstrate-low-false-positive-rate-for-screening-average-risk-people-age-45-49-for-colorectal-cancer-with-cologuard-301206831.html", "https://www.prnewswire.com/news-releases/advanced-medical-pricing-solutions-amps-expands-healthcare-cost-management-suite-with-acquisition-of-drexi-301206749.html", "https://www.prnewswire.com/news-releases/ntracts-and-sullivancotter-join-in-exclusive-partnership-301206947.html", "https://www.prnewswire.com/news-releases/regeneron-announces-us-government-agreement-to-purchase-additional-covid-19-antibody-cocktail-doses-301206988.html", "https://www.prnewswire.com/news-releases/janssen-to-highlight-commitment-to-lung-cancer-science-and-innovation-with-eight-data-presentations-at-the-international-association-for-the-study-of-lung-cancers-2020-world-conference-on-lung-cancer-301207007.html", "https://www.prnewswire.com/news-releases/allergan-aesthetics-enters-into-option-to-acquire-cypris-medical-301206886.html", "https://www.prnewswire.com/news-releases/innovent-announces-nmpa-acceptance-of-a-supplemental-new-drug-application-for-tyvyt-sintilimab-injection-in-combination-with-byvasda-bevacizumab-injection-as-first-line-therapy-in-hepatocellular-carcinoma-hcc-301206595.html", "https://www.prnewswire.com/news-releases/hanmi-presents-solution-package-strategy-to-potentially-overcome-covid-19-at-the-39th-jp-morgan-healthcare-conference-301207006.html", "https://www.prnewswire.com/news-releases/scone-medical-solutions-inc-receives-fda-emergency-use-authorization-eua-for-self-contained-negative-pressure-environment-scone-301197015.html", "https://www.prnewswire.com/news-releases/the-worldwide-breast-lesion-localization-methods-industry-is-expected-to-grow-at-a-cagr-of-7-5-between-2020--2025--301196938.html", "https://www.prnewswire.com/news-releases/melaleuca-expands-invests-in-missouri-301197088.html", "https://www.prnewswire.com/news-releases/protiviti-acquires-identropy-a-leading-identity-access-management-firm-301197149.html", "https://www.prnewswire.com/news-releases/amcp-partnership-forum-develops-innovative-strategies-to-support-biosimilar-use-and-development-301197135.html", "https://www.prnewswire.com/news-releases/peloton-signs-agreement-to-acquire-precor-301197115.html", "https://www.prnewswire.com/news-releases/alterity-and-uniquest-partner-to-reverse-bacterial-resistance-to-antibiotics-301197110.html", "https://www.prnewswire.com/news-releases/msa-safety-donates-300-reusable-elastomeric-half-mask-respirators-to-new-york-city-based-covid-courage-301197050.html", "https://www.prnewswire.com/news-releases/peijia-medical-et-highlife-concluent-un-accord-de-licence-et-de-transfert-de-technologie-pour-le-remplacement-de-la-valve-mitrale-transseptale-en-grande-chine-834759331.html", "https://www.prnewswire.com/news-releases/overweight-and-obese-subjects-dosed-with-asc41-tablets-in-a-phase-ib-trial-301197467.html", "https://www.prnewswire.com/news-releases/ascentage-pharmas-licensee-unity-biotechnology-announces-milestone-reached-in-clinical-development-of-treatments-for-age-related-disease-leading-to-milestone-payment-301197410.html", "https://www.prnewswire.com/news-releases/update-on-source-phase-3-trial-for-tezepelumab-in-patients-with-severe-oral-corticosteroid-dependent-asthma-301197136.html", "https://www.prnewswire.com/news-releases/signifier-medical-technologies-announces-award-of-uk-nhs-supply-chain-tender-301197060.html", "https://www.prnewswire.com/news-releases/redhills-phase-23-covid-19-study-of-opaganib-passes-second-dsmb-with-unanimous-recommendation-to-continue-301197482.html", "https://www.prnewswire.com/news-releases/nust-misis-scientists-use-indian-plant-to-fight-lung-cancer-301196828.html", "https://www.prnewswire.com/news-releases/kidney-patients-hail-us-senate-move-on-transplant-drugs-301197255.html", "https://www.prnewswire.com/news-releases/liberty-health-sciences-announces-strategic-acquisition-by-ayr-strategies-unlocking-significant-value-for-shareholders-301197488.html", "https://www.prnewswire.com/news-releases/amo-pharma-announces-initiation-of-pivotal-reach-cdm-clinical-trial-for-amo-02-in-treatment-of-congenital-myotonic-dystrophy-301197195.html", "https://www.prnewswire.com/news-releases/soligenix-announces-topline-results-from-its-phase-3-clinical-trial-of-sgx942-for-the-treatment-of-oral-mucositis-in-head-and-neck-cancer-patients-301197121.html", "https://www.prnewswire.com/news-releases/nice-publishes-briefing-on-saludas-evoke-closed-loop-spinal-cord-stimulation-scs-system-301197224.html", "https://www.prnewswire.com/news-releases/4c-medical-technologies-announces-completion-of-a-10-million-over-subscribed-convertible-note-financing-301197242.html", "https://www.prnewswire.com/news-releases/synthetic-biologics-announces-washington-university-school-of-medicine-in-st-louis-irb-approval-of-the-syn-004-ribaxamase-phase-1b2a-clinical-protocol-301197187.html", "https://www.prnewswire.com/news-releases/creative-medical-technology-holdings-identifies-mechanism-of-action-of-immcelz-stroke-regenerative-activity-301197267.html", "https://www.prnewswire.com/news-releases/theranica-reports-positive-study-results-of-nerivio-for-adolescent-migraine-patients-301197453.html", "https://www.prnewswire.com/news-releases/acell-announces-ce-mark-approval-301197286.html", "https://www.prnewswire.com/news-releases/quanta-announces-acquisition-of-51-of-medolife-rx-301197192.html", "https://www.prnewswire.com/news-releases/ajinomoto-bio-pharma-services-and-revance-therapeutics-announce-manufacturing-agreement-for-supply-of-daxibotulinumtoxina-for-injection-301197277.html", "https://www.prnewswire.com/news-releases/dalrada-financial-corporation-announces-up-list-to-otcqb-market-301197298.html", "https://www.prnewswire.com/news-releases/evolent-health-announces-cooperation-agreement-with-engaged-capital-301197260.html", "https://www.prnewswire.com/news-releases/magicmed-industries-announces-the-establishment-of-psilocybin-derivatives-portfolio-and-launch-of-candidate-selection-program-301197178.html", "https://www.prnewswire.com/news-releases/cecilia-jones-joins-logicbio-therapeutics-as-chief-financial-officer-301197292.html", "https://www.prnewswire.com/news-releases/nektar-therapeutics-announces-agreement-with-healthcare-royalty-to-sell-adynovate-and-movantik-royalties-for-150-million-301197350.html", "https://www.prnewswire.com/news-releases/kindred-biosciences-initiates-pivotal-efficacy-study-of-tirnovetmab-interleukin-31-monoclonal-antibody-for-canine-atopic-dermatitis-301197089.html", "https://www.prnewswire.com/news-releases/mozzaz-and-giupedi-llc-sign-strategic-partnership-for-workers-compensation-and-personal-injury-clinical-care-coordination-301197188.html", "https://www.prnewswire.com/news-releases/amgen-submits-sotorasib-marketing-authorization-application-to-the-european-medicines-agency-301196985.html", "https://www.prnewswire.com/news-releases/integrity-extends-reach-in-the-northwestern-united-states-with-addition-of-best-value-insurance-301197279.html", "https://www.prnewswire.com/news-releases/mitsubishi-tanabe-pharma-america-announces-initiation-of-open-label-extension-study-of-oral-edaravone-in-als-301197549.html", "https://www.prnewswire.com/news-releases/as-vaccines-roll-out-americans-see-covid-19-testing-as-important-partner-301197237.html", "https://www.prnewswire.com/news-releases/carecapital-acquires-neoss-to-invest-in-innovation-301197379.html", "https://www.prnewswire.com/news-releases/infor-and-mphrx-announce-global-solution-to-help-healthcare-organizations-manage-covid-19-vaccine-innoculation-with-real-world-clinical-data-301197357.html", "https://www.prnewswire.com/news-releases/compugroup-medical-successfully-completes-acquisition-of-emds-in-the-us-301197576.html", "https://www.prnewswire.com/news-releases/nephron-announces-fda-approval-of-ketorolac-signaling-new-phase-of-growth-301197581.html", "https://www.prnewswire.com/news-releases/leap-therapeutics-announces-publication-of-dkn-01-mechanism-of-action-data-in-molecular-cancer-research-301197601.html", "https://www.prnewswire.com/news-releases/kradle-calming-cbd-toppers-product-named-pet-product-news-editors-choice-award-for-2020-301197629.html", "https://www.prnewswire.com/news-releases/atriomx-health-announces-10-million-series-a-financing-301197542.html", "https://www.prnewswire.com/news-releases/menon-advances-as-finalist-in-6-million-xprize-rapid-covid-testing-competition-with-molecular-mirror-platform-technology-301197616.html", "https://www.prnewswire.com/news-releases/the-fertility-partners-acquires-two-additional-clinics-301197591.html", "https://www.prnewswire.com/news-releases/ibh-population-health-solutions-completes-acquisition-of-hmc-healthworks-301197002.html", "https://www.prnewswire.com/news-releases/heartland-dental-grows-national-network-of-supported-offices-with-acquisition-of-tru-family-dental-301197661.html", "https://www.prnewswire.com/news-releases/rosen-respected-investor-counsel-reminds-intercept-pharmaceuticals-inc-investors-of-important-january-4-deadline-in-securities-class-action-encourages-investors-with-losses-in-excess-of-100k-to-contact-the-firm--icpt-301197655.html", "https://www.prnewswire.com/news-releases/fda-warns-companies-illegally-selling-cbd-products-301197756.html", "https://www.prnewswire.com/news-releases/material-technologies-facilitating-targeted-drug-delivery-2020-report---nanomaterials-are-gaining-research-focus-for-targeted-drug-delivery-301197704.html", "https://www.prnewswire.com/news-releases/astho-applauds-congress-on-approval-of-much-needed-covid-19-resources-and-increases-to-public-health-in-the-consolidated-appropriations-act-of-2021-301197771.html", "https://www.prnewswire.com/news-releases/regenxbio-announces-agreement-to-monetize-portion-of-zolgensma-royalties-for-200-million-301197818.html", "https://www.prnewswire.com/news-releases/nevro-to-host-virtual-investor-briefing-at-2021-north-american-neuromodulation-society-nans-virtual-conference-301197807.html", "https://www.prnewswire.com/news-releases/innovent-announces-nmpa-granted-new-indication-approvals-for-sulinno-adalimumab-injection-for-the-treatment-of-pediatric-plaque-psoriasis-and-non-infectious-uveitis-301197917.html", "https://www.prnewswire.com/news-releases/healthcare-services-acquisition-corporation-announces-pricing-of-upsized-288-million-initial-public-offering-301197873.html", "https://www.prnewswire.com/news-releases/bioinvent-receives-3-million-payment-related-to-selection-of-antibodies-under-collaboration-with-pfizer-inc-301197924.html", "https://www.prnewswire.com/news-releases/transcenta-closes-105-million-in-crossover-financing-301197487.html", "https://www.prnewswire.com/news-releases/halozyme-announces-roche-receives-european-commission-approval-for-phesgo-fixed-dose-combination-of-perjeta-and-herceptin-for-subcutaneous-injection-utilizing-halozymes-enhanze-technology-for-the-treatment-of-patients-with--301197980.html", "https://www.prnewswire.com/news-releases/the-retinal-vein-occlusion-market-to-grow-with-a-cagr-of-6-39-for-the-study-period-2017-30--301197995.html", "https://www.prnewswire.com/news-releases/rakuten-medical-enrolls-first-patient-in-the-us-clinical-trial-for-its-lead-product-asp-1929-in-combination-with-anti-pd1-therapy-for-head-and-neck-cancer-or-cutaneous-squamous-cell-carcinoma-301197881.html", "https://www.prnewswire.com/news-releases/stupid-strong-charitable-foundation-pledges-250-000-to-support-gastric-cancer-research-at-md-anderson-cancer-center-301197908.html", "https://www.prnewswire.com/news-releases/symplr-closes-acquisition-of-tractmanager-301197905.html", "https://www.prnewswire.com/news-releases/dermoq-oxygen-lab-closes-acquisition-of-echo2-plus-oxygen-facial-treatment-product-line-from-skin-products-inc-301197896.html", "https://www.prnewswire.com/news-releases/imbruvica-ibrutinib-us-prescribing-information-updated-to-include-long-term-data-for-waldenstroms-macroglobulinemia-wm-301197891.html", "https://www.prnewswire.com/news-releases/compugen-announces-first-development-milestone-in-license-agreement-with-astrazeneca-for-the-development-of-bispecific-and-multi-specific-antibody-products-301198009.html", "https://www.prnewswire.com/news-releases/serum-institute-of-india-and-dynavax-announce-first-participants-dosed-in-the-phase-12-clinical-trial-for-a-covid-19-vaccine-301197984.html", "https://www.prnewswire.com/news-releases/canonic-announces-signing-of-first-cultivation-agreement-for-its-medical-cannabis-varieties-301198026.html", "https://www.prnewswire.com/news-releases/philogen-announces-the-completion-of-a-second-interim-analysis-of-its-phase-iii-clinical-program-with-nidlegy-for-the-treatment-of-melanoma-301207544.html", "https://www.prnewswire.com/news-releases/growgeneration-acquires-assets-of-canopy-crop-management-301197883.html", "https://www.prnewswire.com/news-releases/agility-recovery-acquires-recoveryplanner-a-gartner-leader-for-business-continuity-management-program-solutions-301207499.html", "https://www.prnewswire.com/news-releases/eyelock-combines-physical-and-logical-biometric-access-control-in-the-latest-version-of-its-identity-management-application-301207395.html", "https://www.prnewswire.com/news-releases/oramed-reports-positive-first-in-human-data-from-oral-leptin-study-301198022.html", "https://www.prnewswire.com/news-releases/new-research-in-jnccn-highlights-dangerous-disparities-for-life-saving-cancer-screening-301207011.html", "https://www.prnewswire.com/news-releases/inhibrx-granted-fast-track-designation-for-inbrx-109-for-the-treatment-of-unresectable-or-metastatic-conventional-chondrosarcoma-patients-301207158.html", "https://www.prnewswire.com/news-releases/signify-healths-biopharmaceutical-clinical-and-caregiver-support-services-remove-barriers-to-treatment-associated-with-complex-drug-therapies-301207418.html", "https://www.prnewswire.com/news-releases/kwivik-therapeutics-partners-with-eirmed-to-accelerate-product-commercialization-301207548.html", "https://www.prnewswire.com/news-releases/bioclinica-and-ikcon-pharma-partner-to-deliver-best-in-class-eclinical-solutions-to-pharma-industrysponsors-301207568.html", "https://www.prnewswire.com/news-releases/balance-point-capital-announces-its-investment-in-eventus-wholehealth-301206960.html", "https://www.prnewswire.com/news-releases/stay-on-top-of-new-years-resolutions-with-latest-tools-from-the-galveston-diet-301207534.html", "https://www.prnewswire.com/news-releases/jud-care-erhalt-fda-zulassung-fur-seine-tragbare-krankenstation-sroom-861121826.html", "https://www.prnewswire.com/news-releases/jud-care-obtient-l-approbation-de-la-fda-pour-sa-chambre-portable-sroom-855949905.html", "https://www.prnewswire.com/news-releases/therapeutic-solutions-international-announces-positive-early-clinical-data-from-ongoing-suicidal-ideation-blood-biomarker-clinical-trial-with-spinoff-campbell-neurosciences-301207555.html", "https://www.prnewswire.com/news-releases/cognitive-assessment--training-in-healthcare-market-could-reach-45-billion-by-2026-301197953.html", "https://www.prnewswire.com/news-releases/m3-wake-research-partners-with-rip-medical-debt-to-help-relieve-americans-of-1-million-of-medical-bills-301197875.html", "https://www.prnewswire.com/news-releases/conbercept-new-generation-of-product-for-treatment-of-namd-completes-36-week-primary-endpoint-visits-of-phase-iii-trial-301197992.html", "https://www.prnewswire.com/news-releases/a2-biotherapeutics-enters-into-collaboration-agreement-with-merck-to-develop-allogeneic-cell-therapy-for-solid-tumor-cancers-301197998.html", "https://www.prnewswire.com/news-releases/hoth-therapeutics-submits-request-for-a-pre-investigational-new-drug-pre-ind-meeting-for-ht-001-treatment-for-cancer-patients-301197951.html", "https://www.prnewswire.com/news-releases/ulab-surpasses-another-milestone-301207752.html", "https://www.prnewswire.com/news-releases/cedar-gate-technologies-announces-strategic-investment-from-cobalt-ventures-301198182.html", "https://www.prnewswire.com/news-releases/helpsystems-acquires-vera-to-broaden-data-security-portfolio-301198212.html", "https://www.prnewswire.com/news-releases/acquis-announces-investment-in-venture-company-ssi-strategy-from-amulet-capital-partners-301198137.html", "https://www.prnewswire.com/news-releases/neurology-patients-faced-with-rising-out-of-pocket-costs-for-tests-office-visits-301198294.html", "https://www.prnewswire.com/news-releases/people-in-rural-areas-less-likely-to-receive-specialty-care-for-neurologic-conditions-301198297.html", "https://www.prnewswire.com/news-releases/senhwa-biosciences-receives-us-fda-study-may-proceed-letter-to-treat-brca2-or-palb2-solid-tumors-with-cx-5461-301198347.html", "https://www.prnewswire.com/news-releases/global-pcr-markets-report-2021-2025-new-levels-of-sensitivity-have-implications-for-liquid-biopsy-and-cancer-screening-markets-301198067.html", "https://www.prnewswire.com/news-releases/chiesi-global-rare-diseases-announces-first-patient-treated-in-expanded-access-program-for-pegunigalsidase-alfa-for-proposed-treatment-of-fabry-disease-301198290.html", "https://www.prnewswire.com/news-releases/foresee-pharmaceuticals-announces-completion-of-us47-million-financing-301198388.html", "https://www.prnewswire.com/news-releases/365-retail-markets-announces-majority-investment-from-providence-equity-partners-301198339.html", "https://www.prnewswire.com/news-releases/swk-holdings-subsidiary-enteris-biopharma-receives-second-milestone-payment-from-cara-therapeutics-301198333.html", "https://www.prnewswire.com/news-releases/building-neurological-integrity-301198386.html", "https://www.prnewswire.com/news-releases/interscope-announces-fda-de-novo-marketing-authorization-of-the-endorotor-system-for-direct-endoscopic-necrosectomy-den-301198411.html", "https://www.prnewswire.com/news-releases/inovio-announces-publication-of-phase-1-data-from-its-covid-19-dna-vaccine-candidate-ino-4800-in-the-lancets-eclinicalmedicine-301198408.html", "https://www.prnewswire.com/news-releases/paog-sets-2021-cannabis-biopharmaceutical-revenue-goals-301208685.html", "https://www.prnewswire.com/news-releases/global-crohns-disease-market-analysis--forecasts-2020-2027-treatment-epidemiology-pipeline-key-regulatory-events-licensing--asset-acquisitions-trends-and-upcoming-events-301208638.html", "https://www.prnewswire.com/news-releases/redhill-biopharma-announces-closing-of-25-million-bought-deal-offering-301208791.html", "https://www.prnewswire.com/news-releases/fda-grants-first-conditional-approval-under-expanded-authority-to-control-seizures-in-dogs-with-idiopathic-epilepsy-301208788.html", "https://www.prnewswire.com/news-releases/omid-provides-fourth-quarter-financial-highlights-301208188.html", "https://www.prnewswire.com/news-releases/osf-healthcare-helping-rural-hospitals-adopt-telehealth-solutions-301208827.html", "https://www.prnewswire.com/news-releases/victorville-community-resource-center-named-california-hud-envision-center-301208866.html", "https://www.prnewswire.com/news-releases/hyde-engineering-consulting-anuncia-el-nombramiento-de-su-consejera-delegada-834227493.html", "https://www.prnewswire.com/news-releases/drug-development-in-rare-diseases-2021-report-focus-on-clinical-trials-and-the-regulatory-landscape---orphan-drug-industry-is-gaining-importance-as-a-significant-and-rewarding-market-301208675.html", "https://www.prnewswire.com/news-releases/hyde-engineering-consulting-gibt-die-ernennung-eines-neuen-vorstandsvorsitzenden-bekannt-819120056.html", "https://www.prnewswire.com/news-releases/fda-grants-fast-track-designation-to-padeliporfin-impact-for-steba-biotech-301208876.html", "https://www.prnewswire.com/news-releases/thermo-fisher-scientific-acquires-viral-vector-manufacturing-business-from-novasep-301209241.html", "https://www.prnewswire.com/news-releases/-1-8-billion-clinical-decision-support-systems-cdss-markets---global-forecast-to-2025-rising-prominence-and-usage-of-big-data-and-mhealth-tools-301209215.html", "https://www.prnewswire.com/news-releases/altpep-raises-23m-jumpstarting-work-on-alzheimers-disease-301209013.html", "https://www.prnewswire.com/news-releases/tris-pharma-to-debut-amphetamine-extended-release-tablet-efficacy-and-safety-data-at-the-2021-apsard-annual-meeting-301209014.html", "https://www.prnewswire.com/news-releases/dynacure-announces-publication-of-hierarchical-bayesian-modelling-of-disease-progression-in-orphanet-journal-of-rare-diseases-301209290.html", "https://www.prnewswire.com/news-releases/medscape-study-in-collaboration-with-23andme-finds-primary-care-physicians-are-increasingly-more-comfortable-with-direct-to-consumer-genetic-health-testing-301208988.html", "https://www.prnewswire.com/news-releases/jubilant-therapeutics-announces-research-collaboration-with-the-wistar-institute-to-evaluate-the-activity-of-novel-pad4-inhibitors-to-reduce-clinical-severity-of-covid-19-301209152.html", "https://www.prnewswire.com/news-releases/isofol-to-present-gene-expression-results-from-the-completed-phase-iiia-iso-cc-005-study-today-at-asco-gi-2021-and-updates-of-the-timing-of-the-interim-analysis-in-the-agent-study-301209313.html", "https://www.prnewswire.com/news-releases/isofol-to-present-gene-expression-results-from-the-completed-phase-iiia-iso-cc-005-study-today-at-asco-gi-2021-and-updates-of-the-timing-of-the-interim-analysis-in-the-agent-study-301209316.html", "https://www.prnewswire.com/news-releases/titan-pharmaceuticals-announces-pricing-of-9-7-million-registered-direct-offering-301209330.html", "https://www.prnewswire.com/news-releases/seelos-therapeutics-announces-dosing-of-the-first-patients-in-a-study-of-sls-002-intranasal-racemic-ketamine-for-acute-suicidal-ideation-and-behavior-in-patients-with-major-depressive-disorder-301208880.html", "https://www.prnewswire.com/news-releases/gracell-biotechnologies-receives-medical-products-manufacturing-certificate-for-car-t-cell-therapy-products-301206090.html", "https://www.prnewswire.com/news-releases/cardiff-oncology-presents-data-that-continues-to-demonstrate-the-clinical-benefit-of-onvansertib-in-kras-mutated-mcrc-and-initial-findings-from-its-expanded-access-program-301209151.html", "https://www.prnewswire.com/news-releases/global-938-million-glycobiology-market-to-2025-301209231.html", "https://www.prnewswire.com/news-releases/the-russian-direct-investment-fund-la-vacuna-sputnik-v-registrada-en-paraguay-897959246.html", "https://www.prnewswire.com/news-releases/enveric-biosciences-inc-announces-closing-of-10-million-registered-direct-offering-301209502.html", "https://www.prnewswire.com/news-releases/gamma-biosciences-to-acquire-biomagnetic-solutions-adding-novel-immunomagnetic-cell-separation-platform-to-bioseparation-portfolio-301209395.html", "https://www.prnewswire.com/news-releases/inland-empire-health-plan-supports-primary-care-doctor-visits-301209421.html", "https://www.prnewswire.com/news-releases/halozyme-announces-janssen-receives-fda-approval-of-darzalex-faspro-daratumumab-and-hyaluronidase-fihj-as-treatment-for-newly-diagnosed-patients-with-light-chain-al-amyloidosis-301209576.html", "https://www.prnewswire.com/news-releases/denovo-biopharma-acquires-a-novel-late-stage-oncology-drug-and-expands-into-protein-therapeutics-301190258.html", "https://www.prnewswire.com/news-releases/fusion-pharmaceuticals-initiates-multi-dose-portion-of-phase-1-trial-of-fpi-1434-in-patients-with-advanced-solid-tumors-301190376.html", "https://www.prnewswire.com/news-releases/inovio-and-advaccine-announce-first-dosing-of-subject-in-phase-2-clinical-trial-for-covid-19-dna-vaccine-candidate-ino-4800-in-china-301190178.html", "https://www.prnewswire.com/news-releases/bpea-closes-bpea-strategic-healthcare-fund-at-352-million-with-16-taft-hartley-investors-301190035.html", "https://www.prnewswire.com/news-releases/rinvoq-upadacitinib-achieved-superiority-versus-dupixent-dupilumab-for-primary-and-all-ranked-secondary-endpoints-in-phase-3b-head-to-head-study-in-adults-with-atopic-dermatitis-301190344.html", "https://www.prnewswire.com/news-releases/acelrx-pharmaceuticals-announces-publication-of-clinical-data-on-decreased-postoperative-opioid-requirements-and-enhanced-postanesthesia-recovery-following-perioperative-use-of-dsuvia-301190454.html", "https://www.prnewswire.com/news-releases/largest-ever-study-on-childrens-soft-contact-lens-wear-safety-shows-very-low-complication-rates-301190194.html", "https://www.prnewswire.com/news-releases/detect-program-studies-validate-clinical-relevance-of-ctc-her2-phenotypes-in-metastatic-breast-cancer-patients-with-her2-negative-primary-tumor-and-positive-impact-of-reference-anti-her2-treatment-on-overall-survival-301190407.html", "https://www.prnewswire.com/news-releases/nutriband-inc-receives-notice-of-allowance-from-korean-intellectual-property-office-kipo-for-its-abuse-and-misuse-deterrent-transdermal-system-patent-301189919.html", "https://www.prnewswire.com/news-releases/fda-approves-novadoz-pharmaceuticals-toremifene-and-aminocaproic-acid-bolstering-their-continued-growth-in-generics-301190223.html", "https://www.prnewswire.com/news-releases/vistagen-announces-korean-intellectual-property-office-decision-to-grant-ph10-patent-for-treatment-of-depression-301190322.html", "https://www.prnewswire.com/news-releases/facit-fuels-promising-made-in-ontario-breast-cancer-therapeutic-and-medtech-innovations-through-prospects-oncology-fund-301189899.html", "https://www.prnewswire.com/news-releases/edwards-lifesciences-outlines-growth-strategy-at-annual-investor-conference-301190053.html", "https://www.prnewswire.com/news-releases/cityblock-health-raises-160m-series-c-to-address-systemic-healthcare-inequity-301190536.html", "https://www.prnewswire.com/news-releases/lipac-oncology-announces-major-partnering-milestone-achieved-in-its-license-agreement-with-huons-co-ltd-301190016.html", "https://www.prnewswire.com/news-releases/new-wave-holdings-congratulates-therapsils-advocacy-to-bring-psilocybin-therapy-to-palliative-care-for-canadian-patients-301190323.html", "https://www.prnewswire.com/news-releases/evommune-and-axcelead-drug-discovery-partners-launch-a-collaboration-on-a-pkctheta-program-to-kick-off-evommunes-inflammation-pipeline-301190217.html", "https://www.prnewswire.com/news-releases/gilead-sciences-to-acquire-myr-gmbh-301190500.html", "https://www.prnewswire.com/news-releases/ampio-enters-into-collaborative-research-agreements-to-explore-additional-clinical-indications-for-its-immunomodulatory-drug-ampion-301190462.html", "https://www.prnewswire.com/news-releases/ert-and-bioclinica-to-merge-creating-a-global-leader-in-clinical-trial-endpoint-technology-301190410.html", "https://www.prnewswire.com/news-releases/atropos-health-announces-launch-and-seed-funding-round-to-bring-real-world-data-driven-digital-evidence-to-the-point-of-care-301190311.html", "https://www.prnewswire.com/news-releases/oncosec-strengthens-ip-portfolio-with-allowance-of-two-european-patent-applications-covering-tavo-and-its-gene-electrotransfer-technology-301190398.html", "https://www.prnewswire.com/news-releases/truth-initiative-and-kaiser-permanente-in-collaboration-with-the-american-heart-association-join-forces-with-everfi-to-give-americas-youth-the-facts-about-vaping-301190474.html", "https://www.prnewswire.com/news-releases/adexusdx-covid-19-antibody-test-filed-for-point-of-care-emergency-use-authorization-301190393.html", "https://www.prnewswire.com/news-releases/kazia-to-collaborate-with-pacific-pediatric-neuro-oncology-consortium-pnoc-for-new-paxalisib-combination-study-in-dipg-301190108.html", "https://www.prnewswire.com/news-releases/orthofi-and-orthobanc-combine-forces-to-become-the-leader-in-orthodontic-patient-acquisition-and-financial-management-301199683.html", "https://www.prnewswire.com/news-releases/pm360-announces-the-selections-for-its-9th-annual-innovations-issue-301190533.html", "https://www.prnewswire.com/news-releases/redhill-biopharma-announces-positive-top-line-safety-and-efficacy-data-from-phase-2-covid-19-study-of-opaganib-301199664.html", "https://www.prnewswire.com/news-releases/cost-information-increases-utility-of-decision-aids-for-shared-decision-making-301190547.html", "https://www.prnewswire.com/news-releases/us-radiology-acquires-imagesouth-expanding-national-radiology-footprint-301190397.html", "https://www.prnewswire.com/news-releases/antengene-submits-nda-for-atg-010-selinexor-in-south-korea-for-rrmm-and-rrdlbcl-301199927.html", "https://www.prnewswire.com/news-releases/hart-medical-equipment-acquires-mclaren-home-medical-equipment-301199724.html", "https://www.prnewswire.com/news-releases/epivax-and-epivax-therapeutics-advance-covid-19-vaccine-program-epv-cov-19-301199765.html", "https://www.prnewswire.com/news-releases/vision-innovation-partners-completes-17th-acquisition-eyes-of-york-301200028.html", "https://www.prnewswire.com/news-releases/health-canada-authorizes-cytosorb-for-use-in-hospitalized-covid-19-patients-301200073.html", "https://www.prnewswire.com/news-releases/viewray-announces-preliminary-fourth-quarter-and-full-year-2020-results-301199981.html", "https://www.prnewswire.com/news-releases/forge-biologics-announces-fda-clearance-of-investigational-new-drug-application-for-phase-12-clinical-trial-reskue-of-fbx-101-gene-therapy-for-patients-with-krabbe-disease-301200016.html", "https://www.prnewswire.com/news-releases/kanazawa-university-research-high-speed-atomic-force-microscopy-visualizes-cell-protein-factories-301200165.html", "https://www.prnewswire.com/news-releases/worldwide-industry-for-genetic-testing-to-2025---pharmacogenomics-is-driving-further-growth-301200096.html", "https://www.prnewswire.com/news-releases/kedrion-biopharma-phase-iii-trial-cares10-achieves-important-milestone-last-patient-treated-301198143.html", "https://www.prnewswire.com/news-releases/4cable-tv-international-inc-announces-acquisition-of-healthcare-and-wellness-clinics-of-america-llc-and-corporation-clinic-llc-as-the-retail-arms-and-distribution-of-cbd-based-products-301200032.html", "https://www.prnewswire.com/news-releases/mei-pharma-announces-expansion-of-phase-1b-study-evaluating-zandelisib-and-clinical-pipeline-update-301199577.html", "https://www.prnewswire.com/news-releases/global-neuroprotection-report-2020-methods-drugs-markets-and-competitive-landscape-forecasts-to-2024--2029-301200107.html", "https://www.prnewswire.com/news-releases/at-cagr-of-6-71--healthcare-consulting-industry-expected-to-cross-20-usd-billion-by-2025-says-brandessence-market-research-301200108.html", "https://www.prnewswire.com/news-releases/provention-bio-announces-us-fda-filing-of-a-biologics-license-application-bla-and-priority-review-for-teplizumab-for-the-delay-or-prevention-of-clinical-type-1-diabetes-in-at-risk-individuals-301199992.html", "https://www.prnewswire.com/news-releases/inovio-and-advaccine-announce-exclusive-partnership-to-commercialize-covid-19-dna-vaccine-candidate-ino-4800-in-greater-china-301200000.html", "https://www.prnewswire.com/news-releases/centene-signs-definitive-agreement-to-acquire-magellan-health-301200111.html", "https://www.prnewswire.com/news-releases/lantern-pharma-announces-launch-of-antibody-drug-conjugate-adc-program-to-target-solid-tumors--blood-cancers-through-agreement-with-califia-pharma-301200136.html", "https://www.prnewswire.com/news-releases/biohaven-begins-pivotal-phase-3-trial-of-troriluzole-in-obsessive-compulsive-disorder-301199932.html", "https://www.prnewswire.com/news-releases/happiness-biotech-announces-registered-direct-offering-of-up-to-4-2-million-ordinary-shares-to-strategic-investors-301200018.html", "https://www.prnewswire.com/news-releases/hoth-therapeutics-announces-licensing-agreement-and-collaboration-with-us-army-medical-research-and-development-command-usamrdc-for-treating-multi-drug-resistant-bacterial-lung-infections-301199938.html", "https://www.prnewswire.com/news-releases/marimed-inc-to-webcast-live-at-virtualinvestorconferencescom-january-7th-301199697.html", "https://www.prnewswire.com/news-releases/global-pharmaceuticals-contract-development--manufacturing-market-2020-to-2025---by-service-end-user-and-geography-301200124.html", "https://www.prnewswire.com/news-releases/fda-grants-arx788-fast-track-designation-for-her2-positive-metastatic-breast-cancer-301199951.html", "https://www.prnewswire.com/news-releases/insmed-initiates-frontline-clinical-trial-program-for-arikayce-amikacin-liposome-inhalation-suspension-in-patients-with-mac-lung-disease-301198251.html", "https://www.prnewswire.com/news-releases/inhibikase-therapeutics-announces-partnership-with-clintrex-research-corporation-c-warren-olanow-md-to-serve-as-interim-chief-medical-officer-301200048.html", "https://www.prnewswire.com/news-releases/neogen-acquires-food-quality-diagnostics-company-301200180.html", "https://www.prnewswire.com/news-releases/3d-bioprinting-market-size-usd-9956-9-million-by-2026-at-cagr-18-8--valuates-reports-301200153.html", "https://www.prnewswire.com/news-releases/wize-pharma-receives-bonus-biogroup-shares-from-escrow-and-additional-bonus-biogroup-shares-totaling-1-3-million-301200230.html", "https://www.prnewswire.com/news-releases/durect-corporation-announces-closing-of-lactel-absorbable-polymer-product-line-sale-to-evonik-and-receipt-of-15-million-301200052.html", "https://www.prnewswire.com/news-releases/ampio-provides-update-on-clinical-trials-for-ampion-treatment-of-covid-19-patients-301199940.html", "https://www.prnewswire.com/news-releases/odyssey-behavioral-healthcare-acquires-shoreline-center-for-eating-disorder-treatment-301199931.html", "https://www.prnewswire.com/news-releases/forge-biologics-anuncia-la-aprobacion-de-la-fda-de-la-solicitud-de-nuevo-farmaco-para-la-enfermedad-de-krabbe-802569523.html", "https://www.prnewswire.com/news-releases/novo-nordisk-extends-covid-19-patient-assistance-program-encourages-people-facing-affordability-challenges-to-visit-novocarecom-301200105.html", "https://www.prnewswire.com/news-releases/nextgen-announce-ground-breaking-clinical-trial-rapid-breath-test-for-covid-19-detection-to-evaluate-the-efficacy-of-the-vaccines-including-the-pfizer-biontechs-vaccine-301200227.html", "https://www.prnewswire.com/news-releases/bioniz-announces-positive-end-of-phase-2-meeting-with-the-fda-for-bnz-1-for-the-treatment-of-refractory-cutaneous-t-cell-lymphoma-301199939.html", "https://www.prnewswire.com/news-releases/gt-biopharma-otcqb-gtbp-announces-corporate-update-conference-call-301200147.html", "https://www.prnewswire.com/news-releases/agc-biologics-confirms-cell-and-gene-therapy-commercial-expertise-as-manufacturer-of-orchard-therapeutics-newly-approved-libmeldy-301200004.html", "https://www.prnewswire.com/news-releases/legwork-three-predictions-that-impact-dentists-in-2021-301199741.html", "https://www.prnewswire.com/news-releases/russell-health-most-promising-bio-tech-startups-2020-301200383.html", "https://www.prnewswire.com/news-releases/glancy-prongay--murray-llp-reminds-investors-of-looming-deadline-in-the-class-action-lawsuit-against-biogen-inc-biib-301200338.html", "https://www.prnewswire.com/news-releases/horizon-technology-finance-and-silicon-valley-bank-provide-20-million-venture-loan-facility-for-canary-medical-301200493.html", "https://www.prnewswire.com/news-releases/selvita-completes-acquisition-of-fidelta-from-galapagos-301200466.html", "https://www.prnewswire.com/news-releases/sosei-heptares-to-regain-worldwide-rights-to-muscarinic-agonist-programs-301200754.html", "https://www.prnewswire.com/news-releases/chiauranib-an-anti-tumor-drug-developed-by-chipscreen-is-given-cde-breakthrough-therapy-designation-301200869.html", "https://www.prnewswire.com/news-releases/antengene-announces-submission-of-ind-application-in-china-for-a-global-phase-3-trial-of-atg-010-selinexor-in-advanced-or-recurrent-endometrial-cancer-301200160.html", "https://www.prnewswire.com/news-releases/ideaya-biosciences-doses-first-patient-in-a-phase-1-combination-study-of-ide196-and-crizotinib-a-cmet-inhibitor-301199950.html", "https://www.prnewswire.com/news-releases/minnesota-dentists-offering-free-dental-care-for-children-in-need-february-5--6-2021-301200528.html", "https://www.prnewswire.com/news-releases/forge-biologics-annonce-l-approbation-par-la-fda-food-drug-administration-de-la-demande-de-nouveau-medicament-experimental-pour-l-essai-clinique-de-phase-1-2-reskue-de-la-therapie-genique-fbx-101-pour-les-patients-atteints-de-la-maladie-de--866283515.html", "https://www.prnewswire.com/news-releases/cerracap-ventures-invests-in-biopharma-ai-company-totient-inc-301200855.html", "https://www.prnewswire.com/news-releases/fujifilm-to-invest-40-million-to-establish-a-new-state-of-the-art-viral-vector-and-advanced-therapy-process-development-and-manufacturing-facility-301200427.html", "https://www.prnewswire.com/news-releases/healthcare-services-acquisition-corporation-announces-the-separate-trading-of-its-class-a-common-stock-and-redeemable-warrants-commencing-january-5-2021-301200572.html", "https://www.prnewswire.com/news-releases/ascentage-pharma-announces-its-9th-orphan-drug-designation-from-the-us-fda-in-2020-setting-a-record-for-chinese-biopharmaceutical-companies-301200596.html", "https://www.prnewswire.com/news-releases/huami-enters-in-definitive-agreement-to-acquire-a-minority-stake-in-jiangsu-yitong-high-tech-co-ltd-to-expand-the-healthcare-ecosystem-for-chinese-market-301200978.html", "https://www.prnewswire.com/news-releases/provident-healthcare-partners-advises-companion-hospice-in-its-acquisition-by-bristol-hospice-301201002.html", "https://www.prnewswire.com/news-releases/accuray-receives-510k-fda-clearance-for-clearrt-helical-kvct-imaging-for-the-radixact-treatment-delivery-system-301200783.html", "https://www.prnewswire.com/news-releases/florida-supreme-court-approves-the-florida-justice-center-as-the-first-criminal-legal-aid-organization-in-the-state-301200737.html", "https://www.prnewswire.com/news-releases/cora-physical-therapy-expands-presence-in-north-carolina-with-acquisition-of-three-clinics-in-the-charlotte-market-301200780.html", "https://www.prnewswire.com/news-releases/revitope-oncology-announces-strategic-collaboration-with-janssen-to-leverage-its-unique-t-cell-engager-platform-301200578.html", "https://www.prnewswire.com/news-releases/sebela-pharmaceuticals-announces-us-launch-of-sutab-tablets-an-alternative-to-liquid-colonoscopy-preparation-301200642.html", "https://www.prnewswire.com/news-releases/stero-biotechs-supports-an-exploratory-study-of-cbd-based-treatment-for-covid-19-severe-patients-301200798.html", "https://www.prnewswire.com/news-releases/simplivia-healthcare-ltd-announced-today-the-first-acquisition-as-part-of-its-accelerated-growth-strategy-301200932.html", "https://www.prnewswire.com/news-releases/marker-therapeutics-announces-fda-lifted-partial-clinical-hold-on-phase-2-aml-clinical-trial-301200600.html", "https://www.prnewswire.com/news-releases/cedar-gate-technologies-acquires-enli-health-intelligence-301200616.html", "https://www.prnewswire.com/news-releases/precigen-announces-clearance-of-ind-to-initiate-phase-i-study-of-prgn-2012-adenoverse-immunotherapy-in-patients-with-recurrent-respiratory-papillomatosis-rrp-301200592.html", "https://www.prnewswire.com/news-releases/the-vitamin-shoppe-and-ww-announce-strategic-partnership-to-support-healthy-living-301200823.html", "https://www.prnewswire.com/news-releases/genezen-laboratories-receives-growth-equity-investment-from-ampersand-capital-partners-301200683.html", "https://www.prnewswire.com/news-releases/chemomab-announces-positive-phase-ib-results-of-its-spark-study-testing-cm-101-in-nafld-patients-301201043.html", "https://www.prnewswire.com/news-releases/exact-sciences-completes-acquisition-of-thrive-earlier-detection-creating-a-leader-in-blood-based-multi-cancer-screening-301201061.html", "https://www.prnewswire.com/news-releases/healthmine-expands-partnership-with-blue-cross-and-blue-shield-of-kansas-city-301200591.html", "https://www.prnewswire.com/news-releases/serial-healthcare-entrepreneur-amir-belson-md-joins-ceretrieve-as-chairman-301200821.html", "https://www.prnewswire.com/news-releases/risankizumab-skyrizi-phase-3-results-demonstrate-improvements-in-disease-activity-across-joint-and-skin-symptoms-among-psoriatic-arthritis-patients-301201081.html", "https://www.prnewswire.com/news-releases/volta-medical-raises-28-million-usd-to-revolutionize-persistent-afib-ablation-301201018.html", "https://www.prnewswire.com/news-releases/american-foundation-for-suicide-prevention-invests-5-5m-in-scientific-research-to-prevent-leading-cause-of-death-301201026.html", "https://www.prnewswire.com/news-releases/inhibrx-announces-phase-1-dose-escalation-results-of-inbrx-106-a-novel-hexavalent-ox40-agonist-301200639.html", "https://www.prnewswire.com/news-releases/therapix-biosciences-and-cyntar-ventures-entered-a-non-binding-letter-of-intent-for-the-distribution-of-therapea-in-canada-301201046.html", "https://www.prnewswire.com/news-releases/new-ocean-addresses-us-surge-in-anxiety-and-depression-with-a-247-mental-health-solution-powered-by-digitally-embedded-coaching-301200588.html", "https://www.prnewswire.com/news-releases/peripheral-nerve-injury-market-sets-to-soar-high-with-a-cagr-of-4-77-for-the-study-period-2017-30--301201087.html", "https://www.prnewswire.com/news-releases/akston-biosciences-and-lakepharma-announce-strategic-partnership-to-manufacture-second-generation-covid-19-vaccine-301200460.html", "https://www.prnewswire.com/news-releases/schweiger-dermatology-group-announces-acquisition-of-montgomery-dermatology-in-king-of-prussia-and-audubon-pennsylvania-and-dr-joseph-newmark-in-vestal-new-york-301200485.html", "https://www.prnewswire.com/news-releases/world-market-outlook-for-regenerative-medicine-in-pharma----regulatory-and-market-access-301200943.html", "https://www.prnewswire.com/news-releases/diakard-makes-key-acquisition-in-the-creation-of-a-global-network-of-diakard-centers-of-excellence-301201120.html", "https://www.prnewswire.com/news-releases/biohavens-nurtec-odt-partners-with-rick-ware-racing-for-24-hours-of-daytona-entry-301201140.html", "https://www.prnewswire.com/news-releases/2-5-million-investment-propels-expansion-of-nextsteps-care-crisis-and-worker-displacement-solution-301200968.html", "https://www.prnewswire.com/news-releases/insurecom-survey-finds-most-people-dont-think-high-deductible-health-plans-save-money-301201014.html", "https://www.prnewswire.com/news-releases/clincapture-transforms-clinical-trials-with-virtual-data-capture-301201144.html", "https://www.prnewswire.com/news-releases/vynes-state-of-the-dental-industry-report-2021-301201090.html", "https://www.prnewswire.com/news-releases/impact-nrs-llc-creates-plantae-biosciences-ltd-to-develop-and-commercialize-highly-impactful-multidisciplinary-discoveries-in-plant-sciences-in-collaboration-with-yeda-the-commercial-arm-of-the-weizmann-institute-of-science-301201100.html", "https://www.prnewswire.com/news-releases/apex-innovative-sciences-supports-three-major-covid-19-vaccine-trials-301201192.html", "https://www.prnewswire.com/news-releases/inland-empire-health-plan-placed-in-99th-percentile-for-provider-satisfaction-301201242.html", "https://www.prnewswire.com/news-releases/care-angel-launches-carevax-vaccine-tracking-program-301201150.html", "https://www.prnewswire.com/news-releases/traditions-health-acquires-four-agencies-301201339.html", "https://www.prnewswire.com/news-releases/forge-biologics-gibt-fda-genehmigung-fur-klinische-phase-1-2-studie-reskue-der-gentherapie-fbx-101-fur-patienten-mit-morbus-krabbe-bekannt-857186262.html", "https://www.prnewswire.com/news-releases/regenxbio-announces-update-on-rgx-314-and-pivotal-program-for-the-treatment-of-wet-amd-and-new-gene-therapy-program-for-the-treatment-of-duchenne-muscular-dystrophy-301201378.html", "https://www.prnewswire.com/news-releases/cristal-therapeutics-and-intravacc-announce-strategic-collaboration-to-advance-novel-vaccine-platforms-301201514.html", "https://www.prnewswire.com/news-releases/stealth-biotherapeutics-granted-pre-nda-meeting-for-elamipretide-as-a-treatment-for-cardiomyopathy-in-barth-syndrome-301201550.html", "https://www.prnewswire.com/news-releases/novo-seeds-portfolio-company-corwave-raises-eur-35-million-for-breakthrough-heart-pump-301201342.html", "https://www.prnewswire.com/news-releases/targovax-grants-iovaxis-3-months-extension-to-the-exclusive-license-option-for-tg-mutant-ras-vaccines-in-greater-china-and-singapore-301201725.html", "https://www.prnewswire.com/news-releases/us-court-of-appeals-considers-expert-witness-michael-f-arrigos-opinions-in-fraud-case-vacates-and-remands-lower-courts-ruling-301201571.html", "https://www.prnewswire.com/news-releases/sartorius-stedim-biotech-to-acquire-novaseps-chromatography-process-equipment-division-301201829.html", "https://www.prnewswire.com/news-releases/myeloid-therapeutics-launches-with-over-50-million-in-financing-and-two-clinical-trials-301201589.html", "https://www.prnewswire.com/news-releases/simplivia-healthcare-ltd-a-annonce-aujourd-hui-la-premiere-acquisition-dans-le-cadre-de-sa-strategie-de-croissance-acceleree-849907278.html", "https://www.prnewswire.com/news-releases/sartorius-to-acquire-novaseps-chromatography-process-equipment-division-301201842.html", "https://www.prnewswire.com/news-releases/ultromics-receives-fda-clearance-for-a-first-of-kind-solution-in-echocardiography-to-help-clinicians-diagnose-disease-301201517.html", "https://www.prnewswire.com/news-releases/revelstoke-capital-partners-invests-in-empire-portfolio-group-holdings-301201740.html", "https://www.prnewswire.com/news-releases/halo-health-continues-investment-in-scaling-for-growth-steve-smerz-joins-as-chief-technology-officer-301201660.html", "https://www.prnewswire.com/news-releases/redhill-biopharmas-rhb-204-granted-fda-fast-track-designation-for-ntm-disease-301201897.html", "https://www.prnewswire.com/news-releases/brickbio-enters-into-antibody-drug-conjugate-adc-co-development-partnership-with-a-large-pharmaceutical-company-301201516.html", "https://www.prnewswire.com/news-releases/dewpoint-announces-collaboration-with-pfizer-to-develop-potential-therapies-for-a-rare-form-of-muscular-dystrophy-301201553.html", "https://www.prnewswire.com/news-releases/encompass-health-and-unitypoint-health--trinity-announce-future-inpatient-rehabilitation-hospital-in-moline-illinois-301201750.html", "https://www.prnewswire.com/news-releases/fda-accepts-for-priority-review-the-new-drug-application-for-mirabegron-for-oral-suspension-and-supplemental-new-drug-application-for-myrbetriq-mirabegron-tablets-in-pediatric-patients-301201635.html", "https://www.prnewswire.com/news-releases/insight-service-group-isg-acquires-the-first-party-clinical-services-operation-of-auto-injury-solutions-ais-a-ccc-company-301201579.html", "https://www.prnewswire.com/news-releases/windtree-announces-first-patient-dosed-in-its-phase-2-clinical-trial-studying-kl4-surfactant-in-acute-lung-injury-in-adults-with-covid-19-301201949.html", "https://www.prnewswire.com/news-releases/immcelz-stem-cell-component-demonstrated-efficacious-in-fda-double-blind-placebo-controlled-clinical-trial-of-advanced-covid-19-patients-301201752.html", "https://www.prnewswire.com/news-releases/main-street-announces-new-portfolio-investment-301201443.html", "https://www.prnewswire.com/news-releases/northstar-anesthesia-completes-transition-to-serve-beaumont-health-301201734.html", "https://www.prnewswire.com/news-releases/aikido-pharma-inc-executes-licensing-agreement-for-psilocybin-for-cancer-applications-301201491.html", "https://www.prnewswire.com/news-releases/dr-david-berger-of-tampa-to-address-fda-covid-19-vaccine-approval-committee-regarding-public-concerns-and-hesitations-301189323.html", "https://www.prnewswire.com/news-releases/inovios-vgx-3100-demonstrates-positive-phase-2-efficacy-in-treatment-of-precancerous-vulvar-dysplasia-caused-by-hpv-1618-301201664.html", "https://www.prnewswire.com/news-releases/taiho-oncology-inc-announces-establishment-of-european-headquarters-301188841.html", "https://www.prnewswire.com/news-releases/rxponder-study-results-demonstrate-that-the-oncotype-dx-test-can-now-spare-chemotherapy-use-in-the-majority-of-women-with-node-positive-early-stage-breast-cancer-301189156.html", "https://www.prnewswire.com/news-releases/neurotrope-inc-completes-independent-spin-off-of-neurotrope-bioscience-inc-and-is-renamed-synaptogenix-inc-301189355.html", "https://www.prnewswire.com/news-releases/advanced-testing-options-help-alter-the-fight-against-cancer-301189192.html", "https://www.prnewswire.com/news-releases/innovations-in-disinfection-technology-aid-the-return-of-workers-301189284.html", "https://www.prnewswire.com/news-releases/lilly-presents-positive-primary-outcome-data-from-monarche-that-builds-on-previous-definitive-analysis-for-verzenio-301188842.html", "https://www.prnewswire.com/news-releases/bolt-biotherapeutics-presents-ongoing-clinical-trial-poster-at-san-antonio-breast-cancer-symposium-2020-virtual-meeting-301189421.html", "https://www.prnewswire.com/news-releases/sirtex-medical-announces-strategic-investment-in-blackswan-vascular-inc-301189119.html", "https://www.prnewswire.com/news-releases/pharmabcine-presents-the-latest-data-of-the-ongoing-phase-ib-mtnbc-trial-at-sabcs-2020-301187940.html", "https://www.prnewswire.com/news-releases/new-signatera-data-to-be-presented-at-the-2020-esmo-io-congress-from-the-phase-iii-imvigor010-trial-301189115.html", "https://www.prnewswire.com/news-releases/novartis-kisqali-demonstrates-nearly-five-years-median-overall-survival-in-metastatic-breast-cancer-301188951.html", "https://www.prnewswire.com/news-releases/precisionxtract-acquires-industry-leading-ehr-solution-platform-and-launches-enhanced-personalized-messaging-solution-301189493.html", "https://www.prnewswire.com/news-releases/oncolytics-and-solti-report-clinical-synergy-of-pelareorep-with-checkpoint-inhibitors-at-the-2020-san-antonio-breast-cancer-symposium-301189190.html", "https://www.prnewswire.com/news-releases/aikido-pharma-announces-publication-of-artificial-intelligence-machine-learning-sponsored-research-program-for-pancreatic-cancer-301189567.html", "https://www.prnewswire.com/news-releases/rslv-132-demonstrates-clinically-meaningful-improvement-in-patients-with-systemic-lupus-erythematosus-in-phase-2a-clinical-trial-301189541.html", "https://www.prnewswire.com/news-releases/citius-pharmaceuticals-receives-fda-response-and-guidance-to-pre-ind-consultation-submission-for-mino-wrap-301189525.html", "https://www.prnewswire.com/news-releases/pelareorep-along-with-checkpoint-inhibitors-proving-critically-important-for-early-stage-breast-cancer-301189174.html", "https://www.prnewswire.com/news-releases/therapeutic-solutions-international-division-of-campbell-neurosciences-files-patent-on-quadramune-for-treatment-of-major-depressive-disorder-301189517.html", "https://www.prnewswire.com/news-releases/tvax-biomedical-announces-major-advancements-in-potential-glioblastoma-cure-301189098.html", "https://www.prnewswire.com/news-releases/aca-open-enrollment-more-vital-than-ever-as-deadline-looms-for-most-states-301189596.html", "https://www.prnewswire.com/news-releases/ellevet-sciences-announces-results-of-atopic-dermatitis-study-using-its-cbdcbda-oil-on-dogs-301189648.html", "https://www.prnewswire.com/news-releases/myos-corp-announces-positive-results-from-mobility-and-quality-of-life-study-in-geriatric-and-arthritic-dogs-at-kansas-state-university-301189586.html", "https://www.prnewswire.com/news-releases/phynd-announces-provider-data-connect-for-epic-app-orchard-301189594.html", "https://www.prnewswire.com/news-releases/tobin-scientific-and-phcbi-collaborate-on-solution-for-regional-distribution-of-covid-19-vaccine-to-address-ultra-low-temperature-requirements-301189595.html", "https://www.prnewswire.com/news-releases/top-line-final-data-from-cantrixil-phase-i-study-confirms-prior-positive-efficacy-and-safety-signals-301188916.html", "https://www.prnewswire.com/news-releases/fda-approves-interhospital-patient-transport-use-of-vero-biotechs-genosyl-delivery-system-resulting-in-the-broadest-label-in-the-inhaled-nitric-oxide-space-301192519.html", "https://www.prnewswire.com/news-releases/inovio-to-develop-dna-encoded-monoclonal-antibody-dmab-candidates-to-treat-covid-19-with-funding-from-the-defense-advanced-research-projects-agency-darpa-and-the-department-of-defenses-dod-joint-program-executive-office-fo-301192706.html", "https://www.prnewswire.com/news-releases/first-patient-dosed-in-emalex-biosciences-phase-2-clinical-trial-for-stuttering-301192450.html", "https://www.prnewswire.com/news-releases/kadimastem-announces-encouraging-results-of-cohort-b-of-its-phase-12a-clinical-trial-of-astrorx-for-als-301192839.html", "https://www.prnewswire.com/news-releases/prometheus-biosciences-announces-fda-acceptance-of-ind-application-for-pra023-and-commences-dosing-in-phase-1a-clinical-study-301192895.html", "https://www.prnewswire.com/news-releases/unisys-launches-latest-version-of-stealthidentity-featuring-enhanced-biometric-identity-management-and-authentication-301192497.html", "https://www.prnewswire.com/news-releases/driven-deliveries-announces-new-e-commerce-delivery-hub-in-central-california-301192933.html", "https://www.prnewswire.com/news-releases/horiba-medical-receives-fda-clearance-and-health-canada-clearance-for-the-yumizen-c1200-clinical-chemistry-system-designed-to-help-labs-deliver-faster-results-to-clinicians-and-patients-301192479.html", "https://www.prnewswire.com/news-releases/harmony-biosciences-enrolls-first-patient-in-phase-2-trial-evaluating-pitolisant-for-excessive-daytime-sleepiness-in-patients-with-prader-willi-syndrome-301192466.html", "https://www.prnewswire.com/news-releases/nccn-announces-research-projects-exploring-axitinib-in-various-cancers-in-collaboration-with-pfizer-301192209.html", "https://www.prnewswire.com/news-releases/push-for-alternative-therapies-prods-researchers-towards-psilocybin-301192743.html", "https://www.prnewswire.com/news-releases/adc-therapeutics-and-overland-pharma-form-strategic-jv-to-expand-adc-drugs-development-and-commercialization-in-greater-china-and-singapore-advised-by-msq-ventures-301192815.html", "https://www.prnewswire.com/news-releases/oncopeptides-strengthens-its-organization-by-appointing-linda-holmstrom-as-director-of-investor-relations-301192952.html", "https://www.prnewswire.com/news-releases/seelos-therapeutics-announces-the-selection-of-sls-005-trehalose-for-the-healey-als-platform-trial-for-amyotrophic-lateral-sclerosis-led-by-the-harvard-medical-school-301192478.html", "https://www.prnewswire.com/news-releases/nektar-therapeutics-announces-dosing-of-first-patients-in-phase-12-study-of-its-il-15-agonist-nktr-255-in-combination-with-cetuximab-in-patients-with-head-and-neck-squamous-cell-carcinoma-or-colorectal-cancer-301192592.html", "https://www.prnewswire.com/news-releases/new-research-on-the-science-of-cellular-decline-presented-at-the-gerontological-society-of-america-2020-annual-scientific-meeting-301192953.html", "https://www.prnewswire.com/news-releases/berg-deepens-research-collaboration-with-adventhealth-to-advance-aging-metabolism-and-nash-research-301192593.html", "https://www.prnewswire.com/news-releases/cardiofocus-announces-10-000-patients-treated-worldwide-301192498.html", "https://www.prnewswire.com/news-releases/explora-biolabs-to-open-three-new-facilities-in-san-francisco-region-301192375.html", "https://www.prnewswire.com/news-releases/simplepractice-launches-professional-website-builder-301192846.html", "https://www.prnewswire.com/news-releases/synaptogenix-schedules-business-update-conference-call-301192939.html", "https://www.prnewswire.com/news-releases/twinstrand-biosciences-announces-peer-reviewed-publication-of-study-results-highlighting-ability-of-duplex-sequencing-technology-to-rapidly-detect-the-mutagenic-activity-of-chemicals-301192486.html", "https://www.prnewswire.com/news-releases/singlera-genomics-raises-150-million-in-series-b-financing-to-promote-the-development-and-commercialization-of-early-cancer-screening-products-301192505.html", "https://www.prnewswire.com/news-releases/abbott-receives-ce-mark-for-its-covid-19-igg-quantitative-antibody-blood-test-301192417.html", "https://www.prnewswire.com/news-releases/qualigen-therapeutics-announces-issuance-of-us-patent-for-expanded-applications-of-alan-anticancer-platform-technology-301192908.html", "https://www.prnewswire.com/news-releases/the-food-and-drug-administration-fda-grants-io-biotech-breakthrough-therapy-designation-for-io102-and-io103-in-combination-with-anti-pd-1-in-unresectable-metastatic-melanoma-301193038.html", "https://www.prnewswire.com/news-releases/aditum-bio-announces-formation-of-third-company-anteris-bio-301193067.html", "https://www.prnewswire.com/news-releases/why-transdermal-drug-delivery-systems-are-outweighing-advantages-of-traditional-methods-301192723.html", "https://www.prnewswire.com/news-releases/industrial-bank-of-korea-and-nuance-create-first-biometrics-solution-for-banking-video-calls-301192338.html", "https://www.prnewswire.com/news-releases/consejosano-raises-17-million-in-series-b-funding-to-support-technology-based-solutions-that-help-reduce-health-disparities-among-multicultural-populations-301193072.html", "https://www.prnewswire.com/news-releases/clarity-pharmaceuticals-closes-25m-capital-raising-301192496.html", "https://www.prnewswire.com/news-releases/medivir-strengthens-its-business-development-possibilities-through-a-renegotiated-agreement-with-tetralogic-regarding-birinapant-301191026.html", "https://www.prnewswire.com/news-releases/mitsubishi-tanabe-pharma-america-presents-real-world-experience-outcomes-during-iv-edaravone-treatment-at-virtual-31st-international-symposium-on-alsmnd-301191155.html", "https://www.prnewswire.com/news-releases/liminal-biosciences-announces-first-subject-dosed-in-phase-1-multiple-ascending-dose-clinical-trial-of-fezagepras-301192700.html", "https://www.prnewswire.com/news-releases/diadem-presents-clinical-data-and-commercialization-plans-for-its-alzosure-prognostic-biomarker-test-at-2020-alzheimers-disease-international-conference-301191008.html", "https://www.prnewswire.com/news-releases/notice-of-extraordinary-general-meeting-of-medivir-ab-publ-301191037.html", "https://www.prnewswire.com/news-releases/kintor-pharmaceutical-announces-preliminary-results-from-the-proxalutamides-clinical-trial-301191153.html", "https://www.prnewswire.com/news-releases/grdg-sciences-announces-preclinical-success-of-crst-1-medical-food-as-a-pim-inhibitor-301191220.html", "https://www.prnewswire.com/news-releases/immunoprecise-collaboration-enables-preclinical-manufacturing-of-lead-antibodies-targeting-sars-cov-2-301191080.html", "https://www.prnewswire.com/news-releases/new-data-at-sabcs-2020-highlight-the-role-of-the-oncotype-dx-breast-recurrence-score-test-in-shaping-clinical-practice-301191235.html", "https://www.prnewswire.com/news-releases/bavencio-avelumab-receives-positive-chmp-opinion-for-first-line-maintenance-treatment-of-locally-advanced-or-metastatic-urothelial-carcinoma-301191189.html", "https://www.prnewswire.com/news-releases/arena-pharmaceuticals-to-present-data-from-the-phase-2b-advise-trial--late-breaker-at-revolutionizing-atopic-dermatitis-conference-301191045.html", "https://www.prnewswire.com/news-releases/v2act-therapeutics-llc-announces-fda-clearance-of-an-ind-application-to-proceed-with-a-phase-12a-study-of-v2act-for-the-treatment-of-pancreatic-cancer-301191039.html", "https://www.prnewswire.com/news-releases/cipla-announces-settlement-of-revlimid-lenalidomide-capsules-patent-litigation-301191203.html", "https://www.prnewswire.com/news-releases/alkermes-syneos-health-neuro-behavioral-clinical-research-depression-bipolar-and-support-alliance-and-matthew-shapiro-win-the-starr-coalition-starr-of-excellence-2020-awards-301190960.html", "https://www.prnewswire.com/news-releases/pharmablock-enters-strategic-partnership-with-ascentage-pharma-301191023.html", "https://www.prnewswire.com/news-releases/chmp-recommends-the-approvals-of-rinvoq-upadacitinib-for-the-treatment-of-adults-with-active-psoriatic-arthritis-and-ankylosing-spondylitis-301191192.html", "https://www.prnewswire.com/news-releases/ese-entertainment-announces-distribution-arrangement-for-esports-and-athletics-supplement-over-power-in-collaboration-with-european-pharmaceutical-company-pharmovit-and-professional-esports-athlete-puki-style-301191093.html", "https://www.prnewswire.com/news-releases/evofem-biosciences-announces-orange-book-listing-of-two-us-patents-for-phexxi-301191140.html", "https://www.prnewswire.com/news-releases/kindred-biosciences-announces-agreement-granting-elanco-exclusive-global-rights-for-its-parvovirus-monoclonal-antibody-301191004.html", "https://www.prnewswire.com/news-releases/karyopharm-announces-national-comprehensive-cancer-network-adds-three-xpovio-selinexor-treatment-regimens-to-its-clinical-practice-guidelines-in-oncology-for-multiple-myeloma-301191344.html", "https://www.prnewswire.com/news-releases/lovelace-biomedical-provides-research-to-find-new-formulation-for-lung-cancer-treatment-301189706.html", "https://www.prnewswire.com/news-releases/alaska-airlines-introduces-hawaii-pre-clear-program-301191343.html", "https://www.prnewswire.com/news-releases/data-from-actt-2-trial-of-baricitinib-in-hospitalized-covid-19-patients-supportive-of-the-eua-published-in-new-england-journal-of-medicine-301191422.html", "https://www.prnewswire.com/news-releases/kainos-capital-completes-acquisition-of-nutrisystem-for-575-million-301189771.html", "https://www.prnewswire.com/news-releases/caamtech-expands-successful-next-gen-drug-research-collaboration-with-umass-dartmouth-301189090.html", "https://www.prnewswire.com/news-releases/stealth-biotherapeutics-announces-elamipretide-clinical-data-to-be-presented-at-the-13th-international-conference-on-cachexia-sarcopenia-and-wasting-diseases-301189822.html", "https://www.prnewswire.com/news-releases/sartorius-stedim-biotech-acquires-filtration-expert-watersep-bioseparations-301189841.html", "https://www.prnewswire.com/news-releases/tivity-health-completes-divestiture-of-nutrition-business-301189753.html", "https://www.prnewswire.com/news-releases/sartorius-acquires-filtration-expert-watersep-bioseparations-301189837.html", "https://www.prnewswire.com/news-releases/veterinary-integration-solutions-presents-a-unique-consolidator-maturity-model---the-ultimate-guide-for-sustainable-acquisition-and-integration-of-veterinary-practices-301189793.html", "https://www.prnewswire.com/news-releases/oblato-announces-discussion-outcome-with-fda-for-development-of-okn-007-for-diffuse-intrinsic-pontine-glioma-301189989.html", "https://www.prnewswire.com/news-releases/calliditas-wins-the-2020-swedenbio-award-301190083.html", "https://www.prnewswire.com/news-releases/coronavirus-covid-19-update-fda-authorizes-first-direct-to-consumer-covid-19-test-system-301189959.html", "https://www.prnewswire.com/news-releases/ascentage-pharma-announces-updates-on-the-clinical-development-of-apg-2575-including-an-orr-of-70-in-patients-with-relapsedrefractory-chronic-lymphocytic-leukemia-301189960.html", "https://www.prnewswire.com/news-releases/full-data-set-of-oncopeptides-phase-2-horizon-study-in-multiple-myeloma-published-in-the-journal-of-clinical-oncology-301189987.html", "https://www.prnewswire.com/news-releases/bill-et-melinda-gates-appellent-a-la-collaboration-et-a-la-poursuite-des-innovations-pour-relever-les-defis-et-faire-profiter-au-monde-entier-des-decouvertes-scientifiques-contre-la-covid-19-891951168.html", "https://www.prnewswire.com/news-releases/recor-medical-announces-positive-results-in-radiance-htn-trio-study-and-breakthrough-device-designation-for-paradise-ultrasound-renal-denervation-system-301190082.html", "https://www.prnewswire.com/news-releases/alligator-bioscience-launches-alligator-fab--a-novel-human-antibody-library-301190100.html", "https://www.prnewswire.com/news-releases/regenxbio-announces-dosing-of-first-patient-in-phase-ii-altitude-trial-of-rgx-314-for-the-treatment-of-diabetic-retinopathy-using-suprachoroidal-delivery-301190019.html", "https://www.prnewswire.com/news-releases/rani-therapeutics-raises-69-million-series-e-to-advance-clinical-trials-and-manufacturing-of-robotic-pill-301190347.html", "https://www.prnewswire.com/news-releases/emapalumab-submission-in-china-for-primary-hlh-301190141.html", "https://www.prnewswire.com/news-releases/collplant-to-supply-rhcollagen-to-stemcell-technologies-for-use-in-a-broad-range-of-cell-culture-applications-301190172.html", "https://www.prnewswire.com/news-releases/irras-announces-expansion-of-irraflow-launch-to-latin-america-301190088.html", "https://www.prnewswire.com/news-releases/sobi-and-apellis-report-positive-top-line-results-at-48-weeks-from-the-phase-3-pegasus-study-of-pegcetacoplan-in-pnh-301190278.html", "https://www.prnewswire.com/news-releases/fibrogenesis-will-use-apple-watch-to-leverage-pneumoblast-covid-19-related-ards-study-301190015.html", "https://www.prnewswire.com/news-releases/concert-genetics-and-trapelo-health-partner-to-advance-molecular-oncology-decision-support-301190599.html", "https://www.prnewswire.com/news-releases/elation-health-announces-40m-series-c-to-power-independent-primary-care-301189974.html", "https://www.prnewswire.com/news-releases/phagenova-bio-inc-announces-publication-describing-identification-of-a-safe-and-effective-method-of-delivering-medicines-to-the-lungs-301190596.html", "https://www.prnewswire.com/news-releases/studies-reveal-potential-weaknesses-in-sars-cov-2-infection-301190052.html", "https://www.prnewswire.com/news-releases/hoth-therapeutics-receives-approval-to-commence-phase-1b-clinical-trial-of-biolexa-for-the-treatment-of-atopic-dermatitis-in-humans-301190549.html", "https://www.prnewswire.com/news-releases/medically-correct-marks-10-years-of-cannabis-infused-innovation-301190128.html", "https://www.prnewswire.com/news-releases/tredence-announces-30-million-in-funding-from-chicago-pacific-founders-301190701.html", "https://www.prnewswire.com/news-releases/physical-rehabilitation-network-acquires-south-dakota-based-peloton-physical-therapy-301190646.html", "https://www.prnewswire.com/news-releases/ambrx-presents-phase-1-trial-data-update-and-phase-23-clinical-trial-in-progress-for-lead-program-arx788-at-the-2020-san-antonio-breast-cancer-symposium-301190668.html", "https://www.prnewswire.com/news-releases/revelstokes-the-care-team-acquires-intelicare-home-health-and-hospice-301190652.html", "https://www.prnewswire.com/news-releases/ehealth-technologies-announces-expansion-in-virginia-301190692.html", "https://www.prnewswire.com/news-releases/nccn-patient-advocacy-summit-emphasizes-treating-every-cancer-patient-as-an-individual-301190615.html", "https://www.prnewswire.com/news-releases/a-potential-therapy-for-one-of-the-leading-causes-of-heart-disease-301190837.html", "https://www.prnewswire.com/news-releases/braeburn-announces-arbitration-determination-that-it-did-not-materially-breach-its-license-agreement-with-camurus-ab-301190739.html", "https://www.prnewswire.com/news-releases/cenexel-clinical-research-joins-decentralized-trials--research-alliance-dtra-301190884.html", "https://www.prnewswire.com/news-releases/antengene-announces-acceptance-of-ind-application-in-china-for-a-phase-3-clinical-trial-of-atg-010-selinexor-in-combination-with-bortezomib-and-dexamethasone-svd-for-the-treatment-of-rrmm-301190334.html", "https://www.prnewswire.com/news-releases/european-chmp-adopts-positive-opinion-for-heplisav-b-dynavaxs-two-dose-adult-hepatitis-b-adjuvanted-vaccine-301190681.html", "https://www.prnewswire.com/news-releases/emmes-announces-its-contribution-to-second-remdesivir-clinical-trial-for-covid-19-301191761.html", "https://www.prnewswire.com/news-releases/leading-cardiologist-from-la-jolla-joins-partner-in-offering-patients-the-hybrid-choice-concierge-program-from-concierge-choice-physicians-301190838.html", "https://www.prnewswire.com/news-releases/innovent-announces-first-patient-dosed-in-phase-2-pivotal-trial-of-ibi310-ctla-4-combined-with-tyvyt-sintilimab-injection-for-the-treatment-of-second-line-or-above-advanced-cervical-cancer-301190931.html", "https://www.prnewswire.com/news-releases/national-safety-council-statement-on-the-fda-advisory-panel-approval-of-covid-19-vaccine-and-employers-subsequent-role-301190937.html", "https://www.prnewswire.com/news-releases/aflac-incorporated-announces-25-million-commitment-to-invest-in-liscs-black-economic-development-fund-301190848.html", "https://www.prnewswire.com/news-releases/pdl-biopharma-enters-into-51-4-million-capital-provision-agreement-with-epps-investments-llc-regarding-pdls-previously-announced-settlement-agreement-with-wellstat-301191664.html", "https://www.prnewswire.com/news-releases/collaboration-driving-progress-lls-forms-alliances-with-leading-cancer-institutions-and-foundations-to-co-fund-nearly-17-million-in-new-research-grants-301191663.html", "https://www.prnewswire.com/news-releases/global-outlook-for-the-minimally-invasive-neurosurgical-systems-market-2020-2030-featuring-key-playersb-braun-melsungen-ag-medtronic-plc-and-stryker-corporation-301192001.html", "https://www.prnewswire.com/news-releases/well-enters-next-phase-of-growth-in-digital-health-and-continues-commitment-to-delivering-differentiated-health-improvement-301191410.html", "https://www.prnewswire.com/news-releases/sunshine-guojian-selects-verseaus-vsig4-targeted-antibody-as-the-second-partnered-macrophage-checkpoint-modulator-in-immuno-oncology-collaboration-301192130.html", "https://www.prnewswire.com/news-releases/growing-medical-support-helps-buoy-psychedelic-research-301191851.html", "https://www.prnewswire.com/news-releases/mitsubishi-tanabe-pharma-america-announces-initiation-of-postmarketing-commitment-study-assessing-daily-dosing-of-oral-edaravone-in-patients-with-als-301192096.html", "https://www.prnewswire.com/news-releases/medical-cannabis-and-cbd-regulations-are-becoming-a-crucial-global-patchwork-to-operations-301192131.html", "https://www.prnewswire.com/news-releases/fda-ignores-rfk-jrs-pleas-for-vaccine-safety-oversight-concerning-peg-suspected-to-cause-anaphylaxis-301192173.html", "https://www.prnewswire.com/news-releases/resurrection-university-launches-school-of-emerging-education-to-deliver-cutting-edge-instruction-301192270.html", "https://www.prnewswire.com/news-releases/redhills-phase-23-covid-19-candidate-opaganib-reduces-ards-related-blood-clotting-in-preclinical-model-301193097.html", "https://www.prnewswire.com/news-releases/fda-approves-first-of-its-kind-intentional-genomic-alteration-in-line-of-domestic-pigs-for-both-human-food-potential-therapeutic-uses-301192244.html", "https://www.prnewswire.com/news-releases/lilly-announces-opening-of-patient-enrollment-for-new-ideas-imaging-dementia--evidence-for-amyloid-scanning-study-301192195.html", "https://www.prnewswire.com/news-releases/american-college-of-cardiology-to-collaborate-with-amgen-veradigm-to-optimize-acs-care-301193175.html", "https://www.prnewswire.com/news-releases/retinalgenix-has-engaged-new-york-investor-relations-firm-amato-and-partners-llc-301193177.html", "https://www.prnewswire.com/news-releases/matica-biotechnology-inc-announces-plans-to-construct-gmp-facility-for-viral-vector-production-301193262.html", "https://www.prnewswire.com/news-releases/as-2020-ends-economic-impact-of-pandemic-is-top-of-mind-for-americans-trust-in-vaccines-grows-confidence-in-government-wanes-301193227.html", "https://www.prnewswire.com/news-releases/new-report-shows-youth-e-cigarette-use-remains-at-epidemic-levels-and-harm-perceptions-of-vaping-significantly-rise-among-teens-301193256.html", "https://www.prnewswire.com/news-releases/kineta-announces-first-participant-dosed-in-phase-1-clinical-trial-of-kcp506-a-novel-non-opioid-for-the-treatment-of-chronic-pain-301193261.html", "https://www.prnewswire.com/news-releases/tive-sichert-sich-12-millionen-dollar-series-a-kapitalfinanzierung-804914052.html", "https://www.prnewswire.com/news-releases/lovelace-biomedical-presents-on-lessons-learned-from-sars-cov-2-animal-models-301193332.html", "https://www.prnewswire.com/news-releases/inland-empire-health-plan-hosts-community-toy-giveaway-301193264.html", "https://www.prnewswire.com/news-releases/blue-cross-blue-shield-of-massachusetts-covers-covid-19-vaccines-at-no-cost-to-members-301193340.html", "https://www.prnewswire.com/news-releases/ena-urges-emergency-nurses-to-receive-covid-19-vaccine-301193317.html", "https://www.prnewswire.com/news-releases/pharmacy-organizations-welcome-fda-authorization-of-covid-vaccine-we-stand-ready-to-serve-301191527.html", "https://www.prnewswire.com/news-releases/fda-takes-key-action-in-fight-against-covid-19-by-issuing-emergency-use-authorization-for-first-covid-19-vaccine-301191524.html", "https://www.prnewswire.com/news-releases/tceb-leveraging-mice-personnel-to-support-governments-special-arrangement-for-the-entry-of-overseas-investors-301191801.html", "https://www.prnewswire.com/news-releases/senhwa-biosciencess-positive-topline-cholangiocarcinoma-data-abstract-accepted-by-2021-asco-gastrointestinal-cancers-symposium-301191717.html", "https://www.prnewswire.com/news-releases/liberty-health-sciences-opens-28th-dispensary-in-lake-city-continuing-the-companys-expansion-across-florida-301191494.html", "https://www.prnewswire.com/news-releases/kintor-proxalutamides-covid-19-clinical-trial-shows-significant-reduction-in-hospitalization-and-ventilation-rates-301191525.html", "https://www.prnewswire.com/news-releases/survey-covid-19-pandemic-influencing-consumer-healthcare-behavior-301191637.html", "https://www.prnewswire.com/news-releases/gannex-received-us-fda-fast-track-designation-for-its-nash-drug-candidate-asc42an-fxr-agonist-301191684.html", "https://www.prnewswire.com/news-releases/two-new-tests-could-lower-the-coronavirus-mortality-rate-by-improving-treatment-for-severely-ill-covid-19-patients-301191614.html", "https://www.prnewswire.com/news-releases/key-discoveries-in-cancer-treatment-to-be-presented-during-the-virtual-2020-aacc-annual-scientific-meeting-301191618.html", "https://www.prnewswire.com/news-releases/hummingbird-bioscience-announces-collaboration-with-tempus-to-harness-ai-driven-precision-medicine-to-accelerate-clinical-development-of-hmbd-001-in-her3-driven-cancers-301191839.html", "https://www.prnewswire.com/news-releases/synlogic-announces-advancement-of-synb1891-to-combination-arm-dosing-with-pd-l1-checkpoint-inhibitor-in-the-on-going-phase-1-study-for-the-treatment-of-solid-tumors-and-lymphoma-301191596.html", "https://www.prnewswire.com/news-releases/efemoral-medical-announces-successful-first-in-human-use-of-the-efemoral-vascular-scaffold-system-301191645.html", "https://www.prnewswire.com/news-releases/neuraxpharm-establishes-operations-in-the-republic-of-ireland-through-the-acquisition-of-medinutrix-301191407.html", "https://www.prnewswire.com/news-releases/genetic-toxicology-testing-market-worth-2-0-billion-by-2025--exclusive-report-by-marketsandmarkets-301191933.html", "https://www.prnewswire.com/news-releases/canadian-pilot-study-suggests-prescription-icosapent-ethyl-vascepa-might-improve-symptoms-of-covid-19-and-reduce-inflammation-301191627.html", "https://www.prnewswire.com/news-releases/brainstorm-announces-nurown-expanded-access-program-301191923.html", "https://www.prnewswire.com/news-releases/novo-holdings-creates-new-rare-bleeding-disorder-company-hemab-301191387.html", "https://www.prnewswire.com/news-releases/immunoprecise-and-litevax-advance-sars-cov-2-vaccine-candidate-301191989.html", "https://www.prnewswire.com/news-releases/codagenix-and-serum-institute-of-india-announce-commencement-of-first-in-human-trial-of-covi-vac-a-single-dose-intranasal-live-attenuated-vaccine-for-covid-19-301191756.html", "https://www.prnewswire.com/news-releases/sonalasense-pioneers-sonodynamic-therapy-a-first-in-class-noninvasive-therapy-for-lethal-brain-cancers-enters-into-a-collaboration-and-license-agreement-with-insightec-and-a-collaboration-agreement-with-ivy-brain-tumor-center-to-301191661.html", "https://www.prnewswire.com/news-releases/locanabio-announces-100-million-series-b-financing-to-advance-portfolio-of-novel-rna-targeted-gene-therapies-for-neurodegenerative-neuromuscular-and-retinal-diseases-301191356.html", "https://www.prnewswire.com/news-releases/mindmed-announces-successful-completion-of-pre-ind-meeting-with-the-fda-for-project-lucy-301191722.html", "https://www.prnewswire.com/news-releases/robotics-specialist-german-bionic-receives-us-20-million-in-series-a-financing-301191442.html", "https://www.prnewswire.com/news-releases/crh-medical-corporation-announces-completion-of-majority-acquisition-of-fdhs-anesthesia-llc-301191425.html", "https://www.prnewswire.com/news-releases/jellyvision-welcomes-new-leaders-to-drive-next-phase-of-growth-301188610.html", "https://www.prnewswire.com/news-releases/anabios-awarded-sbir-grant-by-nihncats-for-developing-novel-pain-therapeutics-301193396.html", "https://www.prnewswire.com/news-releases/trumbull-ct-internist-now-offers-the-hybrid-choice-concierge-program-from-concierge-choice-physicians-301193462.html", "https://www.prnewswire.com/news-releases/corvent-medical-announces-strategic-partnership-with-siemens-healthineers-for-distribtuion-of-the-respond-19-ventilator-301191936.html", "https://www.prnewswire.com/news-releases/rafael-holdings-reports-first-quarter-fiscal-year-2021-results-301193482.html", "https://www.prnewswire.com/news-releases/rob-gronkowski-and-floyd-mayweather-endorsed-brand-snow-announces-impressive-dental-approval-rating-301193686.html", "https://www.prnewswire.com/news-releases/precigen-provides-latest-clinical-developments-at-virtual-rd-update-event-301193612.html", "https://www.prnewswire.com/news-releases/sonoma-recovery-service-dba-olympia-house-olympia-house---notice-of-data-breach-301193622.html", "https://www.prnewswire.com/news-releases/novartis-announces-positive-fda-advisory-committee-recommendation-for-use-of-entresto-to-treat-patients-with-hfpef-301193607.html", "https://www.prnewswire.com/news-releases/viatris-inc-recommends-caution-on-trc-capital-corps-attempt-to-acquire-shares-at-a-significant-discount-via-mini-tender-offer-301193589.html", "https://www.prnewswire.com/news-releases/diamyd-medical-and-critical-path-institute-announce-data-sharing-collaboration-to-develop-advanced-drug-development-tools-in-type-1-diabetes-301193791.html", "https://www.prnewswire.com/news-releases/historically-black-medical-school-partners-with-national-health-system-to-train-more-black-physicians-301193858.html", "https://www.prnewswire.com/news-releases/chipscreen-and-hisun-reach-a-strategic-cooperation-301193850.html", "https://www.prnewswire.com/news-releases/vivace-therapeutics-announces-30-million-series-c-financing-to-fund-clinical-programs-targeting-the-hippo-pathway-301193909.html", "https://www.prnewswire.com/news-releases/biolinerx-announces-final-results-from-phase-2a-combatkeynote-202-triple-combination-study-of-motixafortide-in-second-line-metastatic-pancreatic-cancer-pdac-301193912.html", "https://www.prnewswire.com/news-releases/neuron23-closes-113-5-million-series-a-and-b-financing-led-by-westlake-village-biopartners-kleiner-perkins-and-redmile-group-301192555.html", "https://www.prnewswire.com/news-releases/peripheral-nop-agonist-addressing-chronic-peripheral-neuropathic-pain-enters-clinical-development-301193868.html", "https://www.prnewswire.com/news-releases/meharry-medical-college-methodist-le-bonheur-healthcare-and-university-of-memphis-announce-historic-collaboration-to-diversify-provider-pipeline-and-advance-health-care-education-301192344.html", "https://www.prnewswire.com/news-releases/american-association-of-nurse-practitioners-applauds-approval-of-covid-19-vaccine-urges-public-to-get-vaccinated-301192313.html", "https://www.prnewswire.com/news-releases/new-acquisition-expands-chiro-one-further-into-indianapolis-301192309.html", "https://www.prnewswire.com/news-releases/very-real-help-announces-grant-from-the-national-institute-on-drug-abuse-301192405.html", "https://www.prnewswire.com/news-releases/boston-scientific-announces-stipulation-of-dismissal-of-nevro-corporations-patent-infringement-case-in-california-301192472.html", "https://www.prnewswire.com/news-releases/arrival-of-first-covid-19-vaccine-marks-major-step-forward-but-limited-supplies-logistics-pose-challenges-for-hospitals-301192434.html", "https://www.prnewswire.com/news-releases/nevro-announces-agreement-to-conclude-its-patent-lawsuit-in-the-northern-district-of-california-against-boston-scientific-301192402.html", "https://www.prnewswire.com/news-releases/eucrates-biomedical-acquisition-corp-announces-the-separate-trading-of-its-ordinary-shares-and-redeemable-warrants-301192430.html", "https://www.prnewswire.com/news-releases/photoacoustic-imaging-market-to-279-3-million-by-2030-says-ps-intelligence-301192635.html", "https://www.prnewswire.com/news-releases/westlake-village-biopartners-launches-two-new-funds-totaling-500-million-to-advance-transformative-treatments-301192552.html", "https://www.prnewswire.com/news-releases/kbr-wins-industry-innovation-award-for-uk-military-training-solution-301192470.html", "https://www.prnewswire.com/news-releases/glycostem-announces-treatment-of-first-patient-in-pivotal-phase-iiia-trial-of-onkord-in-patients-with-acute-myeloid-leukemia-301192245.html", "https://www.prnewswire.com/news-releases/agplenus-announces-reaching-a-lead-stage-in-its-novel-mode-of-action-herbicide-program-301192730.html", "https://www.prnewswire.com/news-releases/cyxone-has-filed-an-ind-in-the-us-with-rabeximod-following-positive-feed-back-from-pre-ind-meeting-with-the-fda-301192673.html", "https://www.prnewswire.com/news-releases/gmax-zhengzhou-manufacturing-site-breaks-ground-301192606.html", "https://www.prnewswire.com/news-releases/lantern-pharma-announces-scientific--preclinical-data-indicating-blood-brain-barrier-permeability-for-drug-candidate-lp-184-in-glioblastoma-and-potentially-other-cns-cancers-301192777.html", "https://www.prnewswire.com/news-releases/minervax-raises-upsized-eur-47-4m-usd-57m-series-b-to-advance-its-novel-group-b-streptococcus-vaccine-through-mid-stage-clinical-trials-301192579.html", "https://www.prnewswire.com/news-releases/novo-holdings-repair-impact-fund-supports-upsized-minervax-eur-47-4m-series-b-financing-to-advance-novel-vaccine-against-group-b-streptococcus-301192662.html", "https://www.prnewswire.com/news-releases/nference-completes-60m-series-c-to-accelerate-and-expand-augmented-intelligence-for-life-sciences-301192787.html", "https://www.prnewswire.com/news-releases/acelyrin-launches-with-funding-from-westlake-village-biopartners-301192553.html", "https://www.prnewswire.com/news-releases/lilly-announces-agreement-to-acquire-prevail-therapeutics-301192753.html", "https://www.prnewswire.com/news-releases/centene-signs-definitive-agreement-to-acquire-pantherx-rare-pharmacy-pantherx-301192725.html", "https://www.prnewswire.com/news-releases/odyssey-investment-partners-to-acquire-protective-industrial-products-inc-301192742.html", "https://www.prnewswire.com/news-releases/palatin-technologies-announces-positive-results-from-its-phase-2-study-of-pl9643-in-patients-with-dry-eye-disease-301192765.html", "https://www.prnewswire.com/news-releases/almirall-announces-fda-approval-of-klisyri-tirbanibulin-a-new-innovative-topical-treatment-for-actinic-keratosis-301192829.html", "https://www.prnewswire.com/news-releases/qualigen-therapeutics-inc-announces-12-million-registered-direct-offering-301194240.html", "https://www.prnewswire.com/news-releases/preludedx-presents-new-data-at-sabcs-spotlight-session-re-classifying-patients-meeting-rtog-9804-low-risk-criteria-as-elevated-risk-using-dcisionrt-301192744.html", "https://www.prnewswire.com/news-releases/ivantis-recognized-for-innovation-excellence-and-company-culture-301194216.html", "https://www.prnewswire.com/news-releases/flowmetric-life-sciences-inc-receives-accreditation-from-the-college-of-american-pathologists-cap-for-its-clinical-laboratory-301193666.html", "https://www.prnewswire.com/news-releases/approximately-12-million-blacks-say-they-will-take-the-vaccine-heres-why-301194350.html", "https://www.prnewswire.com/news-releases/stramsen-biotech-inc-announces-six-drug--medicine-candidates-currently-in-early-stage-clinical-trials-301194288.html", "https://www.prnewswire.com/news-releases/covance-labcorps-drug-development-business-acclaimed-by-frost--sullivan-for-its-unmatched-breadth-of-services-to-support-clinical-trials-301194321.html", "https://www.prnewswire.com/news-releases/amphivena-therapeutics-announces-first-patient-dosed-in-the-phase-1-dose-expansion-of-amv564-301194326.html", "https://www.prnewswire.com/news-releases/czi-supports-community-driven-solutions-to-advance-racial-equity-strengthen-tribal-identity-and-improve-youth-well-being-301193768.html", "https://www.prnewswire.com/news-releases/advanced-bifurcation-systems-announces-first-closing-of-series-a-financing-301194633.html", "https://www.prnewswire.com/news-releases/harbour-biomed-completes-its-global-offering-and-listing-on-the-hong-kong-stock-exchange-301194369.html", "https://www.prnewswire.com/news-releases/eip-pharma-announces-publication-of-preclinical-results-demonstrating-potential-of-neflamapimod-to-promote-functional-recovery-after-ischemic-stroke-301194583.html", "https://www.prnewswire.com/news-releases/briotech-inc-announces-new-distribution-agreement-for-briohocl-and-briowhish-in-romania-as-part-of-its-european-expansion-301194613.html", "https://www.prnewswire.com/news-releases/i-peace-inc-and-avery-therapeutics-announce-collaboration-to-bring-ipsc-derived-cell-therapy-for-heart-failure-to-the-clinic-301194638.html", "https://www.prnewswire.com/news-releases/dmed-completed-a-us100-million-series-c-financing-301194727.html", "https://www.prnewswire.com/news-releases/arcline-investment-management-acquires-engineering-by-design-301194640.html", "https://www.prnewswire.com/news-releases/future-uncertainty-hangs-heavy-in-cigna-covid-19-study-301194746.html", "https://www.prnewswire.com/news-releases/scotlands-nhs-greater-glasgow-and-clyde-health-board-seeks-better-use-of-data-and-increased-participation-in-clinical-trials-by-joining-trinetx-network-301194653.html", "https://www.prnewswire.com/news-releases/glycostem-and-ghent-university-sign-license-agreement-on-nk-cell-therapy-technology-301194945.html", "https://www.prnewswire.com/news-releases/evofem-biosciences-provides-update-on-pivotal-phase-3-trial-of-evo100-for-prevention-of-chlamydia-and-gonorrhea-301194717.html", "https://www.prnewswire.com/news-releases/medicure-enters-the-us-online-pharmacy-world-with-acquisition-of-marley-drug-301194963.html", "https://www.prnewswire.com/news-releases/h1-closes-58-million-series-b-co-led-by-ivp-and-menlo-ventures-301194866.html", "https://www.prnewswire.com/news-releases/lantern-pharma-announces-collaboration-with-world-leading-brain-cancer-program-at-johns-hopkins-to-further-develop-lp-184-as-therapy-for-glioblastoma-301194949.html", "https://www.prnewswire.com/news-releases/farapulses-pivotal-trial-to-assess-its-leading-pulsed-field-ablation-system-for-the-treatment-of-atrial-fibrillation-receives-fda-conditional-approval-301194652.html", "https://www.prnewswire.com/news-releases/leading-biosciences-and-seneca-biopharma-announce-merger-301194885.html", "https://www.prnewswire.com/news-releases/open-care-announces-immubio-platform-based-on-nanoparticle-science-currently-developing-potential-break-through-covid-19-immunisation-301194999.html", "https://www.prnewswire.com/news-releases/us-radiology-selects-volpara-health-to-drive-quality-breast-imaging-across-the-network-301194738.html", "https://www.prnewswire.com/news-releases/blueprint-medicines-submits-supplemental-new-drug-application-to-fda-for-ayvakit-avapritinib-for-the-treatment-of-advanced-systemic-mastocytosis-301194719.html", "https://www.prnewswire.com/news-releases/state-of-indiana-launches-expedited-eligibility-for-programs-like-structured-family-caregiving--a-support-program-for-hoosiers-caring-for-loved-ones-at-home-during-the-covid-crisis-301194741.html", "https://www.prnewswire.com/news-releases/diameter-health-closes-18m-series-b-to-accelerate-vision-to-improve-health-data-interoperability-301195015.html", "https://www.prnewswire.com/news-releases/moleculin-announces-fda-permission-to-begin-clinical-study-of-annamycin-for-sarcoma-lung-metastases-301194951.html", "https://www.prnewswire.com/news-releases/cohere-health-and-aaos-enter-into-formal-collaboration-301194748.html", "https://www.prnewswire.com/news-releases/rheos-medicines-and-patientslikeme-announce-strategic-collaboration-to-investigate-underlying-metabolic-drivers-of-immune-mediated-disease-301194446.html", "https://www.prnewswire.com/news-releases/biohavens-rimegepant-for-preventive-treatment-of-migraine-published-in-the-lancet-301193664.html", "https://www.prnewswire.com/news-releases/curai-health-secures-27-5-million-in-series-b-funding-to-make-virtual-primary-care-accessible-for-everyone-301193657.html", "https://www.prnewswire.com/news-releases/aahrpp-accredits-three-more-research-organizations-harvard-university-tampa-general-hospital-and-castle-irb-301193892.html", "https://www.prnewswire.com/news-releases/galmed-to-add-open-label-part-to-armor-study-first-read-out-expected-in-q4-2021-301194933.html", "https://www.prnewswire.com/news-releases/new-data-confirms-smithnephew-technology-as-the-best-performing-cementless-construct-for-total-hip-arthroplasty-301193948.html", "https://www.prnewswire.com/news-releases/hemoshear-therapeutics-hst5040-receives-us-orphan-drug-designations-for-treatment-of-methylmalonic-acidemia-and-propionic-acidemia-301193648.html", "https://www.prnewswire.com/news-releases/thermo-fisher-expands-clinical-and-commercial-capabilities-for-plasmid-dna-manufacturing-301193950.html", "https://www.prnewswire.com/news-releases/protagonist-therapeutics-announces-first-subject-dosed-in-phase-1-study-of-oral-il-23-receptor-antagonist-pn-235-jnj-77242113-301193448.html", "https://www.prnewswire.com/news-releases/creative-medical-technology-holdings-announces-successful-application-of-immcelz-immunotherapy-for-treatment-of-stroke-301193921.html", "https://www.prnewswire.com/news-releases/aethlon-medical-announces-first-patient-treated-in-first-in-human-clinical-trial-of-hemopurifier-in-head-and-neck-cancer-301193962.html", "https://www.prnewswire.com/news-releases/hawkeye-systems-announces-letter-of-intent-to-acquire-ikon-supplies-301193808.html", "https://www.prnewswire.com/news-releases/nutriband-inc-records-record-375-year-over-year-increase-in-third-quarter-revenues-and-record-69-increase-for-its-nine-month-revenues-301194019.html", "https://www.prnewswire.com/news-releases/durect-corporation-announces-dur-928-granted-fda-fast-track-designation-for-treatment-of-alcoholic-hepatitis-301193994.html", "https://www.prnewswire.com/news-releases/knox-lane-announces-strategic-investment-in-fingerpaint-301194020.html", "https://www.prnewswire.com/news-releases/hope-on-the-horizon-psychedelics-offer-potential-for-transforming-mental-health-treatments-301193844.html", "https://www.prnewswire.com/news-releases/canadian-government-agency-removes-barrier-for-psilocybin-therapy-301193836.html", "https://www.prnewswire.com/news-releases/ginkgo-bioworks-acquires-biotechnology-startup-novogys-microbial-engineering-platform-301194122.html", "https://www.prnewswire.com/news-releases/soligenix-announces-20-million-strategic-convertible-debt-financing-agreement-with-pontifax-medison-debt-financing-301194111.html", "https://www.prnewswire.com/news-releases/penn-dental-medicine-among-wolf-administration-awardees-to-battle-covid-19-301193717.html", "https://www.prnewswire.com/news-releases/aditum-bio-launches-third-company-anteris-bio-in-collaboration-with-trialspark-301194113.html", "https://www.prnewswire.com/news-releases/prime-therapeutics-and-takeda-agree-to-outcomes-based-arrangement-for-hemophilia-a-treatment-advate-antihemophilic-factor-recombinant-301194060.html", "https://www.prnewswire.com/news-releases/sterling-healthcare-logistics-enhances-portfolio-with-the-acquisition-of-abs-vaccines-301193882.html", "https://www.prnewswire.com/news-releases/metabolomics-market-worth-4-1-billion-by-2025--exclusive-report-by-marketsandmarkets-301193916.html", "https://www.prnewswire.com/news-releases/truyo-an-intraedge-company-secures-investment-from-intel-301193779.html", "https://www.prnewswire.com/news-releases/pressure-biosciences-pct-platform-at-forefront-in-generating-pivotal-findings-by-diverse-covid-19-research-teams-in-usa-china-and-europe-301195100.html", "https://www.prnewswire.com/news-releases/avista-capital-partners-to-acquire-solmetex-llc-301194070.html", "https://www.prnewswire.com/news-releases/vitality-gains-momentum-as-employers-and-health-plans-invest-in-health-301194168.html", "https://www.prnewswire.com/news-releases/eversana-and-experic-announce-strategic-partnership-to-optimize-end-to-end-contract-manufacturing-and-commercialization-services-for-life-sciences-industry-301194905.html", "https://www.prnewswire.com/news-releases/biolase-announces-exclusive-collaboration-with-bmw-performance-center-west-301195162.html", "https://www.prnewswire.com/news-releases/global-sarcoma-drugs-market-size-could-reach-1-2-billion-by-2023--301194825.html", "https://www.prnewswire.com/news-releases/fda-approves-gsks-benlysta-as-the-first-medicine-for-adult-patients-with-active-lupus-nephritis-in-the-us-301195182.html", "https://www.prnewswire.com/news-releases/therapeutic-solutions-international-files-investigational-new-drug-application-ind-with-fda-for-treatment-of-chronic-traumatic-encephalopathy-using-clinically-validated-jadicell-universal-donor-stem-cell-301195175.html", "https://www.prnewswire.com/news-releases/gt-biopharma-and-cytovance-biologics-announce-milestone-achievement-301195206.html", "https://www.prnewswire.com/news-releases/recent-challenges-demand-innovative-approaches-to-surface-disinfections-301194874.html", "https://www.prnewswire.com/news-releases/oscar-closes-2020-with-140-million-new-funding-round-led-by-tiger-global-management-301194915.html", "https://www.prnewswire.com/news-releases/glioblastoma-multiforme-gbm-treatments-advancing-as-fda-steps-up-measures-due-to-rising-incidences-301194827.html", "https://www.prnewswire.com/news-releases/wheelhouse-invests-in-connected-fitness-sensation-clmbr-301195168.html", "https://www.prnewswire.com/news-releases/cns-pharmaceuticals-announces-fda-approval-of-ind-application-for-its-brain-cancer-drug-candidate-berubicin-301194766.html", "https://www.prnewswire.com/news-releases/ampion-demonstrates-safety-in-covid-19-patients-and-initiates-global-clinical-trial-for-intravenous-ampion-301195209.html", "https://www.prnewswire.com/news-releases/allterum-therapeutics-completes-series-seed-offering-builds-team-with-addition-of-philip-breitfeld-as-chief-medical-officer-301194588.html", "https://www.prnewswire.com/news-releases/lupus-foundation-of-america-sees-big-win-with-fda-approval-of-benlysta-for-lupus-nephritis-301195309.html", "https://www.prnewswire.com/news-releases/pacific6-enterprises-announces-investment-in-detact-diagnostics-301195332.html", "https://www.prnewswire.com/news-releases/texas-woman-recognized-as-nhas-one-millionth-certification-helps-in-covid-vaccine-study-301195310.html", "https://www.prnewswire.com/news-releases/cct-research-expands-clinical-research-capabilities-to-las-vegas-301195327.html", "https://www.prnewswire.com/news-releases/lra-pleased-to-share-gsks-benlysta-belimumab-is-first-lupus-nephritis-treatment-approved-by-fda-301195383.html", "https://www.prnewswire.com/news-releases/nanoform-and-herantis-partner-to-look-for-opportunities-to-enhance-bbb-penetration-of-cdnf-and-xcdnf-molecules-301195411.html", "https://www.prnewswire.com/news-releases/-10-million-grant-from-exact-sciences-to-support-stand-up-to-cancer-initiative-to-improve-colorectal-cancer-screening-and-prevention-878991618.html", "https://www.prnewswire.com/news-releases/gryphon-investors-acquires-prn-a-leading-western-us-physical-therapy-operator-301195438.html", "https://www.prnewswire.com/news-releases/igenomix-expands-its-presence-in-north-america-with-the-acquisition-of-access-genomics-canada-301195448.html", "https://www.prnewswire.com/news-releases/florida-treatment-center-acquires-license-to-treat-primary-mental-health-301195501.html", "https://www.prnewswire.com/news-releases/first-rct-duplicate-findings-published-in-circulation-301195416.html", "https://www.prnewswire.com/news-releases/global-rare-disease-studies-recruitment-and-retention-report-2020-baseline-challenges--perspectives-recruitment-methods-retention-practices-study-data-301195342.html", "https://www.prnewswire.com/news-releases/fda-approves-amgens-riabni-rituximab-arrx-a-biosimilar-to-rituxan-rituximab-301195492.html", "https://www.prnewswire.com/news-releases/auerbach-funds-acquire-70-unit-senior-living-community-in-angels-camp-ca-301195522.html", "https://www.prnewswire.com/news-releases/cns-pharmaceuticals-announces-call-to-discuss-fda-ind-approval-and-phase-2-trial-for-berubicin-301195577.html", "https://www.prnewswire.com/news-releases/self-contained-rapid-adexusdx-covid-19-antibody-fingerstick-test-receives-ce-mark-for-deployment-across-european-union-301195579.html", "https://www.prnewswire.com/news-releases/4front-ventures-completes-sale-leaseback-transaction-generating-proceeds-of-33-million-301195661.html", "https://www.prnewswire.com/news-releases/biomodex-announces-presentation-of-data-at-sfnr-2020-highlighting-benefits-of-patient-specific-rehearsals-in-complex-unruptured-intracranial-aneurysms-301195596.html", "https://www.prnewswire.com/news-releases/fda-approves-labeling-update-for-abbotts-heartmate-3-heart-pump-for-use-in-pediatric-patients-301195626.html", "https://www.prnewswire.com/news-releases/inland-empire-health-plan-unveils-new-mission-in-2020-holiday-message-301195644.html", "https://www.prnewswire.com/news-releases/new-england-journal-of-medicine-publishes-positive-initial-regeneron-antibody-cocktail-results-in-non-hospitalized-patients-with-covid-19-301195460.html", "https://www.prnewswire.com/news-releases/research-on-preventative-nasal-spray-which-protects-against-covid-19-and-common-cold-published-in-leading-peer-reviewed-academic-journals-301195657.html", "https://www.prnewswire.com/news-releases/elsevier-acquires-shadow-health-a-leading-provider-of-best-in-class-healthcare-simulations-301189121.html", "https://www.prnewswire.com/news-releases/enesi-pharma-and-imperial-college-london-collaborate-to-develop-thermostable-rna-vaccines-with-potential-to-eliminate-cold-chain-and-transform-global-vaccination-logistics-for-covid-19-301195362.html", "https://www.prnewswire.com/news-releases/amidst-covid-19-pandemic-medtecs-group-transforms-itself-into-the-worlds-biggest-stockpiling-solutions-provider-301195806.html", "https://www.prnewswire.com/news-releases/enara-bio-relocates-to-the-oxford-science-parks-newest-facility-to-expand-rd-capabilities-in-the-search-for-novel-cancer-immunotherapies-301188684.html", "https://www.prnewswire.com/news-releases/beijing-steps-up-efforts-of-further-opening-up-301195765.html", "https://www.prnewswire.com/news-releases/health-leaders-patient-advocates-governors-states-and-stars-unite-urging-people-to-wear-a-mask-and-sign-up-for-coverage-as-part-of-social-media-blitz-on-get-covered-america-day-on-december-10th-301189063.html", "https://www.prnewswire.com/news-releases/swissmedic-approves-buvidal-for-the-treatment-of-opioid-dependence-301195803.html", "https://www.prnewswire.com/news-releases/valeo-pharma-announces-health-canada-approval-for-redesca-and-redesca-hp-301189205.html", "https://www.prnewswire.com/news-releases/lillys-tirzepatide-significantly-reduced-a1c-and-body-weight-in-people-with-type-2-diabetes-301188988.html", "https://www.prnewswire.com/news-releases/blueprint-secures-3-4-million-seed-round-to-empower-mental-health-clinicians-to-provide-data-driven-patient-care-301188918.html", "https://www.prnewswire.com/news-releases/united-therapeutics-receives-fda-orphan-drug-designation-for-treprostinil-for-the-treatment-of-idiopathic-pulmonary-fibrosis-301189016.html", "https://www.prnewswire.com/news-releases/medical-ingenuities-receives-fda-510k-clearance-for-ph-band-301189088.html", "https://www.prnewswire.com/news-releases/save-the-date-calliditas-to-host-a-capital-markets-day-in-stockholm-sweden-on-january-20-2021-301189349.html", "https://www.prnewswire.com/news-releases/wellness-natural-inc-unveils-new-corporate-strategy-following-simplyprotein-acquisition-in-the-us-and-canada-301188893.html", "https://www.prnewswire.com/news-releases/skillpower-named-finalist-in-us-army-xtechbolt-competition-301189166.html", "https://www.prnewswire.com/news-releases/early-cytosorb-initiation-improves-hemodynamic-stabilization-and-survival-in-new-septic-shock-study-301189179.html", "https://www.prnewswire.com/news-releases/alpha-cognition-receives-japanese-patent-for-alzheimers-disease-drug-alpha-1062-further-strengthening-patent-portfolio-301189066.html", "https://www.prnewswire.com/news-releases/intec-pharma-announces-cannabinoid-research-collaboration-with-gw-pharma-301187976.html", "https://www.prnewswire.com/news-releases/regenxbio-announces-positive-interim-data-and-update-for-phase-iii-trial-of-rgx-121-for-the-treatment-of-mps-ii-301189001.html", "https://www.prnewswire.com/news-releases/actinium-highlights-presence-at-targeted-radiopharmaceuticals-summit-301189267.html", "https://www.prnewswire.com/news-releases/hundreds-of-iga-nephropathy-patients-share-experience-with-fda-professionals-drug-makers-301189292.html", "https://www.prnewswire.com/news-releases/thermo-fisher-scientific-further-expands-global-footprint-for-drug-product-development-and-commercial-manufacturing-301189315.html", "https://www.prnewswire.com/news-releases/reneo-pharmaceuticals-raises-95-million-in-series-b-financing-co-led-by-novo-ventures-and-abingworth-301189026.html", "https://www.prnewswire.com/news-releases/inovios-vgx-3100-demonstrates-positive-phase-2-efficacy-in-treatment-of-precancerous-anal-dysplasia-caused-by-hpv-1618-301189067.html", "https://www.prnewswire.com/news-releases/over-4-1-million-raised-for-st-jude-childrens-research-hospital-during-live-two-day-broadcast-of-st-jude-promesa-y-esperanza-promise-and-hope-on-univisions-uforia-301189273.html", "https://www.prnewswire.com/news-releases/former-nfl-superstar-demarcus-ware-launches-new-fitness-app-called-driven-to-win-301188970.html", "https://www.prnewswire.com/news-releases/institute-of-life-iaso-euromediterranean-institute-for-quality-and-safety-in-health-services-and-temos-hellas-certification-of-clinical-results-and-success-rates-of-the-institute-of-life-iaso-assisted-reproduction-unit-301189384.html", "https://www.prnewswire.com/news-releases/pack-health-announces-partnership-with-pennington-biomedical-research-center-301189322.html", "https://www.prnewswire.com/news-releases/how-acute-respiratory-distress-syndrome-ards-may-be-affecting-covid-19-patients-301189093.html", "https://www.prnewswire.com/news-releases/kineta-presents-new-preclinical-data-at-esmo-virtual-congress-2020-on-its-vista-antagonist-antibodies-301189438.html", "https://www.prnewswire.com/news-releases/kazia-presents-further-paxalisib-data-at-sno-confirming-earlier-positive-safety-and-efficacy-signals-in-glioblastoma-301175393.html", "https://www.prnewswire.com/news-releases/blue-cross-and-blue-shield-of-illinois-offering-new-comprehensive-kidney-care-program-to-help-improve-member-health-301175385.html", "https://www.prnewswire.com/news-releases/third-phase-of-benefitfocus-open-enrollment-success-in-the-era-of-covid-offers-guidance-on-evaluating-oe-effectiveness-301175405.html", "https://www.prnewswire.com/news-releases/its-a-knockout---coinsbit-adds-aevolves-biomedical-avex-token-to-its-award-winning-cryptocurrency-exchange-301189124.html", "https://www.prnewswire.com/news-releases/isofol-reaches-440-patients-in-global-phase-iii-agent-study-301189445.html", "https://www.prnewswire.com/news-releases/encompass-health-exploring-strategic-alternatives-for-home-health-and-hospice-business-301189441.html", "https://www.prnewswire.com/news-releases/nevro-announces-abstract-presentations-for-pdn-and-nsrbp-trials-have-been-accepted-for-the-late-breaking-trials-plenary-session-at-nans-2021-conference-301175275.html", "https://www.prnewswire.com/news-releases/seqirus-presents-real-world-data-for-cell-based-quadrivalent-seasonal-influenza-vaccine-qivc-at-eswi-2020-301189389.html", "https://www.prnewswire.com/news-releases/establishment-of-boao-winhealth-rare-disease-medical-center-in-hainan-province-301174744.html", "https://www.prnewswire.com/news-releases/clarivate-identifies-global-scientific-pioneers-with-annual-highly-cited-researchers-list-301175567.html", "https://www.prnewswire.com/news-releases/disrupt-disparities-3-0-pandemic-hitting-older-nyers-of-color-hardest-in-food-insecurity-rent-affordability-nursing-homes-301175488.html", "https://www.prnewswire.com/news-releases/change-in-use-of-proceeds-from-the-global-offering-for-expansion-of-rd-portfolio-into-hepatitis-b-clinical-cure-and-nash-301175645.html", "https://www.prnewswire.com/news-releases/cipla-launches-covi-g-for-covid-19-rapid-antibody-detection-301175624.html", "https://www.prnewswire.com/news-releases/coronavirus-covid-19-update-fda-authorizes-first-covid-19-test-for-self-testing-at-home-301175512.html", "https://www.prnewswire.com/news-releases/regent-pacific-announces-important-commercialisation-progress-on-fortacintm--senstendtm-301175471.html", "https://www.prnewswire.com/news-releases/oblique-therapeutics-ab-raises-98-msek-in-a-private-placement-investment-round-301175774.html", "https://www.prnewswire.com/news-releases/ambetters-my-health-pays-helps-members-achieve-millions-of-dollars-in-value-301175657.html", "https://www.prnewswire.com/news-releases/biolinerx-announces-initiation-of-phase-1b-clinical-trial-in-patients-with-acute-respiratory-distress-syndrome-ards-secondary-to-covid-19-and-other-respiratory-viral-infections-301175813.html", "https://www.prnewswire.com/news-releases/milestone-pharmaceuticals-announces-first-patient-enrolled-in-rapid-a-pivotal-phase-3-study-of-etripamil-in-psvt-301175428.html", "https://www.prnewswire.com/news-releases/umoja-biopharma-launches-with-53m-series-a-financing-to-develop-fully-integrated-scalable-in-vivo-immunotherapy-platform-301175250.html", "https://www.prnewswire.com/news-releases/epidermolysis-bullosa-market-size-is-anticipated-to-accelerate-with-a-cagr-of-5-67-in-the-7mm-for-the-study-period-2017-30--301175658.html", "https://www.prnewswire.com/news-releases/biolinerx-to-report-third-quarter-2020-results-on-november-23-2020-301175789.html", "https://www.prnewswire.com/news-releases/qbiotics-stelfonta-receives-fda-approval-for-canine-mast-cell-tumours-301175448.html", "https://www.prnewswire.com/news-releases/csafe-global-launches-an-industry-first-real-time-shipment-visibility-301180629.html", "https://www.prnewswire.com/news-releases/twinstrand-biosciences-licenses-duplex-sequencing-technology-to-foundation-medicine-301175553.html", "https://www.prnewswire.com/news-releases/elevation-oncology-announces-65m-series-b-financing-and-promotion-of-founder-shawn-m-leland-to-chief-executive-officer-301175788.html", "https://www.prnewswire.com/news-releases/inmed-pharmaceuticals-and-baymedica-announce-collaboration-for-manufacturing-and-testing-of-novel-cannabinoid-therapeutics-301175714.html", "https://www.prnewswire.com/news-releases/sybridge-technologies-completes-acquisition-of-x-cell-tool-and-mold-inc-301175824.html", "https://www.prnewswire.com/news-releases/prediction-for-post-pandemic-merger--acquisition-boom-in-healthcare-consolidation-301182187.html", "https://www.prnewswire.com/news-releases/supercom-launches-new-1-2-million-national-electronic-monitoring-project-in-europe-301182590.html", "https://www.prnewswire.com/news-releases/copd-foundation-and-blue-marble-health-enter-a-strategic-partnership-to-promote-virtual-pulmonary-rehabilitation-to-healthcare-systems-challenged-to-deliver-services-during-covid-301182037.html", "https://www.prnewswire.com/news-releases/codagenix-inc-completes-dosing-for-phase-1-trial-of-live-attenuated-intranasal-vaccine-for-respiratory-syncytial-virus-rsv-301182228.html", "https://www.prnewswire.com/news-releases/volition-launches-nuq-vet-cancer-screening-test-in-the-us-301182311.html", "https://www.prnewswire.com/news-releases/sk-life-science-presents-latest-cenobamate-data-at-the-american-epilepsy-society-aes2020-virtual-event-301182628.html", "https://www.prnewswire.com/news-releases/the-biotech-breakthrough-transforming-mental-health-301182177.html", "https://www.prnewswire.com/news-releases/regulus-therapeutics-announces-private-placement-of-equity-301182570.html", "https://www.prnewswire.com/news-releases/omniseq-receives-iso-certification-for-quality-management-systems-301182465.html", "https://www.prnewswire.com/news-releases/abfero-to-receive--2m-eurostars-funding-for-parkinsons-disease-therapy-301182276.html", "https://www.prnewswire.com/news-releases/therapeutic-solutions-international-announces-positive-quadramune-clinical-trial-data-301182688.html", "https://www.prnewswire.com/news-releases/celularity-announces-positive-dmc-safety-review-and-continuation-of-its-phase-iii-cynk-001-covid-19-study-301182553.html", "https://www.prnewswire.com/news-releases/ehealth-releases-half-time-report-on-open-enrollment-costs-and-trends-for-aca-health-insurance-consumers-301182643.html", "https://www.prnewswire.com/news-releases/menarini-ricerche-announces-sel24men1703-pharmacodynamic-data-from-the-dose-escalation-part-of-diamond-01-trial-301182271.html", "https://www.prnewswire.com/news-releases/renovia-presents-at-piper-sandler-healthcare-conference-301182653.html", "https://www.prnewswire.com/news-releases/grammy-winner-and-business-entrepreneur-pitbull-invests-in-new-connected-fitness-equipment-clmbr-301182382.html", "https://www.prnewswire.com/news-releases/olive-attracts-additional-225-5mm-investment-to-fast-track-ai-workforce-for-healthcare-301182069.html", "https://www.prnewswire.com/news-releases/anixa-biosciences-announces-licensing-agreement-with-cleveland-clinic-for-ovarian-cancer-vaccine-technology-301182646.html", "https://www.prnewswire.com/news-releases/gurnick-academy-collaborates-with-radnet-301179266.html", "https://www.prnewswire.com/news-releases/family-practitioner-from-lincoln-ca-now-offers-the-hybrid-choice-concierge-program-from-concierge-choice-physicians-301182212.html", "https://www.prnewswire.com/news-releases/pharmaventures-advises-gpcr-therapeutics-on-their-acquisition-of-burixafor-301179049.html", "https://www.prnewswire.com/news-releases/aridis-pharmaceuticals-to-host-fireside-chat-with-analysts-to-discuss-2021-outlook-for-its-lead-programs-and-novel-mab-discovery-platform-on-december-4th-2020-301179175.html", "https://www.prnewswire.com/news-releases/the-firmament-group-invests-in-angstrom-technology-301182635.html", "https://www.prnewswire.com/news-releases/fda-approves-first-drug-to-treat-rare-metabolic-disorder-301179353.html", "https://www.prnewswire.com/news-releases/omron-strengthens-engagement-with-alivecor-with-series-e-investment-reinforces-cross-company-alliance-for-remote-cardiovascular-condition-management-301179414.html", "https://www.prnewswire.com/news-releases/new-centre-for-medicines-research-cmr-clinical-factbook-from-clarivate-highlights-increasing-cost-and-complexity-of-phase-ii-trials-301179441.html", "https://www.prnewswire.com/news-releases/biomarin-24-hour-deadline-alert-former-louisiana-attorney-general-and-kahn-swick--foti-llc-remind-investors-with-losses-in-excess-of-100-000-of-deadline-in-class-action-lawsuit-against-biomarin-pharmaceutical-inc---bmrn-301179388.html", "https://www.prnewswire.com/news-releases/reithera-announces-its-grad-cov2-covid-19-vaccine-candidate-is-well-tolerated-and-induces-clear-immune-responses-in-healthy-subjects-aged-18-55-years-301179423.html", "https://www.prnewswire.com/news-releases/datalink-receives-growth-equity-investment-from-investor-group-led-by-dws-301179490.html", "https://www.prnewswire.com/news-releases/synthetic-biologics-announces-extension-of-compliance-plan-period-by-nyse-american-301179348.html", "https://www.prnewswire.com/news-releases/jubilant-therapeutics-announces-upcoming-presentation-at-2020-ash-virtual-annual-meeting-301179634.html", "https://www.prnewswire.com/news-releases/bausch-health-initiates-second-phase-3-study-for-nov03-investigational-treatment-for-dry-eye-disease-associated-with-meibomian-gland-dysfunction-301179260.html", "https://www.prnewswire.com/news-releases/sutro-biopharma-to-host-a-virtual-kol-event-to-provide-clinical-update-on-antibody-drug-conjugate-stro-002-in-ovarian-cancer-301179245.html", "https://www.prnewswire.com/news-releases/f-star-therapeutics-announces-clearance-of-clinical-trial-application-for-fs222-301179692.html", "https://www.prnewswire.com/news-releases/myos-corp-receives-a-new-patent-from-the-united-states-patent-and-trademark-office-significantly-enhancing-its-musculoskeletal-health-intellectual-property-portfolio-301179661.html", "https://www.prnewswire.com/news-releases/ovation-science-seeks-greater-us-distribution-as-the-cannabis-market-continues-to-grow-301179342.html", "https://www.prnewswire.com/news-releases/arcadia-biosciences-rkda-signs-hemp-distribution-agreement-with-tritium-3h-301179507.html", "https://www.prnewswire.com/news-releases/reasons-why-our-volunteer-driver-service-is-more-dependable-than-most-301179519.html", "https://www.prnewswire.com/news-releases/mother-raw-raises-6-1-million-in-series-a-funding-to-encourage-everyone-everywhere-to-eat-more-plants-301179554.html", "https://www.prnewswire.com/news-releases/oramed-initiates-phase-3-trial-of-oral-insulin-301179301.html", "https://www.prnewswire.com/news-releases/global-cbd-industry-projected-to-accelerate-to-23-6-billion-over-the-next-five-years-301179412.html", "https://www.prnewswire.com/news-releases/neurelis-announces-12-poster-presentations-for-the-annual-meeting-of-the-american-epilepsy-society-301186690.html", "https://www.prnewswire.com/news-releases/pharmaengine-inc-et-sentinel-oncology-limited-concluent-une-entente-exclusive-de-collaboration-et-de-licence-pour-le-produit-sol-578-un-inhibiteur-de-chk1-888637950.html", "https://www.prnewswire.com/news-releases/coronavirus-covid-19-update-fda-authorizes-first-covid-19-and-flu-combination-test-for-use-with-home-collected-samples-301186791.html", "https://www.prnewswire.com/news-releases/lipocine-provides-new-regulatory-update-on-tlando-301186755.html", "https://www.prnewswire.com/news-releases/st-josephs-childrens-hospital-first-hospital-in-west-central-florida-to-implant-new-device-to-repair-life-threatening-heart-defect-in-premature-babies-301186785.html", "https://www.prnewswire.com/news-releases/disease-free-survival-data-from-captivate-study-demonstrate-benefit-of-imbruvica-ibrutinib-based-regimen-as-fixed-duration-first-line-treatment-for-patients-with-chronic-lymphocytic-leukemia-301186838.html", "https://www.prnewswire.com/news-releases/hematologists-play-vital-role-in-advancing-covid-19-research-potential-treatments-301186829.html", "https://www.prnewswire.com/news-releases/sumitomo-dainippon-pharma-oncology-presents-findings-from-phase-2-zella-201-clinical-study-evaluating-investigational-agent-alvocidib-in-patients-with-acute-myeloid-leukemia-at-62nd-ash-annual-meeting-301186807.html", "https://www.prnewswire.com/news-releases/shareholder-alert--pomerantz-law-firm-reminds-shareholders-with-losses-on-their-investment-in-mesoblast-limited-of-class-action-law-suit-and-upcoming-deadline---meso-301186853.html", "https://www.prnewswire.com/news-releases/imbruvica-ibrutinib-plus-venclextavenclyxto-venetoclax-combination-shows-high-rates-of-disease-free-survival-one-year-post-treatment-in-previously-untreated-patients-with-chronic-lymphocytic-leukemia-cll-301186821.html", "https://www.prnewswire.com/news-releases/loxo-oncology-at-lilly-announces-updated-data-from-the-phase-12-bruin-clinical-trial-for-loxo-305-in-mantle-cell-lymphoma-and-non-hodgkin-lymphomas-at-the-american-society-of-hematology-ash-annual-meeting-301186733.html", "https://www.prnewswire.com/news-releases/new-data-from-mavoric-trial-sheds-light-on-key-characteristics-of-long-term-poteligeo-mogamulizumab-kpkc-responders-with-specific-subtypes-of-cutaneous-t-cell-lymphoma-301186837.html", "https://www.prnewswire.com/news-releases/updated-results-from-the-phase-1-study-of-the-bcmaxcd3-bispecific-teclistamab-show-preliminary-efficacy-in-patients-with-heavily-pretreated-relapsed-or-refractory-multiple-myeloma-301186848.html", "https://www.prnewswire.com/news-releases/abbvie-presents-extended-follow-up-data-for-fixed-duration-treatment-venclextavenclyxto-venetoclax-in-chronic-lymphocytic-leukemia-cll-301186833.html", "https://www.prnewswire.com/news-releases/sysmex-inostics-presents-data-at-the-american-society-of-hematology-annual-meeting-demonstrating-exquisite-sensitivity-of-safeseq-ngs-technology-for-detection-of-measurable-residual-disease-in-acute-myeloid-leukemia-301186647.html", "https://www.prnewswire.com/news-releases/novartis-analyses-confirm-benefit-of-kymriah-with-clinically-meaningful-rates-of-complete-response-seen-in-patients-with-certain-advanced-lymphomas-301186828.html", "https://www.prnewswire.com/news-releases/poseida-therapeutics-provides-update-on-phase-1-trial-of-p-bcma-101-at-the-2020-american-society-of-hematology-annual-meeting-301186752.html", "https://www.prnewswire.com/news-releases/bioniz-announces-positive-clinical-data-of-bnz-1-first-anti-cytokine-therapy-to-demonstrate-efficacy-in-treating-refractory-cutaneous-t-cell-lymphoma-301186824.html", "https://www.prnewswire.com/news-releases/janssen-presents-first-data-from-the-phase-1-study-of-the-gprc5dxcd3-bispecific-talquetamab-in-patients-with-relapsed-or-refractory-multiple-myeloma-301186851.html", "https://www.prnewswire.com/news-releases/gracell-biotechnologies-announces-presentation-of-first-in-human-data-of-gc012f-a-first-in-class-fastcar-enabled-dual-targeting-bmcacd19-car-t-cell-therapy-for-patients-with-relapsed-or-refractory-multiple-myeloma-at-2020-ash-ann-301186804.html", "https://www.prnewswire.com/news-releases/cti-biopharma-announces-presentation-of-data-supporting-pacritinibs-potential-benefit-in-preventing-acute-gvhd-at-the-62nd-american-society-of-hematology-meeting-301186889.html", "https://www.prnewswire.com/news-releases/novel-aml-patient-selection-assay-for-amv564-amphivenas-lead-therapeutic-in-hematology-presented-at-the-62nd-american-society-of-hematology-ash-2020-annual-meeting-301186856.html", "https://www.prnewswire.com/news-releases/sierra-oncology-presents-long-term-overall-survival-and-sustained-efficacy-outcomes-data-for-momelotinib-at-ash-annual-meeting-301186721.html", "https://www.prnewswire.com/news-releases/amgen-to-present-first-clinical-data-for-bcma-targeted-half-life-extended-bite-therapy-amg-701-at-ash-2020-301186776.html", "https://www.prnewswire.com/news-releases/early-deep-durable-responses-of-ciltacabtagene-autoleucel-cilta-cel-observed-in-phase-1b2-cartitude-1-study-show-potential-of-bcma-car-t-in-treatment-of-heavily-pretreated-patients-with-multiple-myeloma-301186843.html", "https://www.prnewswire.com/news-releases/regenerons-bcmaxcd3-bispecific-antibody-regn5458-shows-deep-and-durable-responses-in-patients-with-heavily-pretreated-multiple-myeloma-in-phase-1-301186836.html", "https://www.prnewswire.com/news-releases/protagonist-announces-updated-phase-2-data-presented-at-ash-annual-meeting-supporting-long-term-efficacy-of-hepcidin-mimetic-ptg-300-in-the-treatment-of-polycythemia-vera-301186903.html", "https://www.prnewswire.com/news-releases/genome-editing-and-cellular-therapies-show-promise-for-treating-blood-disorders-cancers-301186839.html", "https://www.prnewswire.com/news-releases/pharmaengine-inc-y-sentinel-oncology-limited-llegan-a-un-acuerdo-de-colaboracion-exclusivo-889946435.html", "https://www.prnewswire.com/news-releases/carsgen-therapeutics-presents-updated-multiple-myeloma-cell-therapy-data-at-the-62nd-american-society-of-hematology-ash-annual-meeting-and-exposition-301186864.html", "https://www.prnewswire.com/news-releases/antengene-announces-acceptance-of-ind-application-in-china-for-atg-010-selinexor-in-combination-with-r-gdp-sr-gdp-for-the-treatment-of-rrdlbcl-in-a-global-phase-23-study-301186932.html", "https://www.prnewswire.com/news-releases/new-wave-n2-logics-launches-new-website-as-they-explore-further-downstream-growth-opportunities-301186995.html", "https://www.prnewswire.com/news-releases/cardiff-oncology-presents-data-at-ash-demonstrating-the-safety-and-anti-leukemic-activity-of-onvansertib-in-patients-with-relapsedrefractory-aml-301186834.html", "https://www.prnewswire.com/news-releases/bergenbio-presents-updated-clinical-data-from-two-phase-ii-studies-of-bemcentinib-in-aml-and-mds-patients-at-ash-2020-301186909.html", "https://www.prnewswire.com/news-releases/new-data-demonstrate-long-term-benefit-of-imbruvica-ibrutinib-as-first-line-treatment-for-high-risk-chronic-lymphocytic-leukemia-301186899.html", "https://www.prnewswire.com/news-releases/syndax-pharmaceuticals-announces-additional-positive-data-from-phase-1-trial-of-axatilimab-in-patients-with-cgvhd-301186859.html", "https://www.prnewswire.com/news-releases/oncopeptides-presents-new-data-from-phase-2-anchor-combination-study-in-multiple-myeloma-at-american-society-of-hematology-meeting-ash-301186963.html", "https://www.prnewswire.com/news-releases/roivant-unveils-targeted-protein-degradation-platform-301186928.html", "https://www.prnewswire.com/news-releases/record-date-for-reverse-share-split-in-bioinvent-international-determined-301187076.html", "https://www.prnewswire.com/news-releases/combined-data-from-multiple-phase-3-studies-of-imbruvica-ibrutinib-show-efficacy-and-safety-in-high-risk-previously-untreated-chronic-lymphocytic-leukemia-cll-and-real-world-data-indicating-low-biomarker-testing-rates-for-th-301186846.html", "https://www.prnewswire.com/news-releases/the-mullings-group-opens-london-office-to-service-talent-acquisitions-for-growing-medtech-clientele-in-uk-eu-and-middle-east-301186805.html", "https://www.prnewswire.com/news-releases/neurorx-and-relief-therapeutics-meet-165-patient-enrollment-target-in-phase-2b3-trial-of-rlf-100-for-critical-covid-19-with-respiratory-failure-301186934.html", "https://www.prnewswire.com/news-releases/jw-therapeutics-presents-data-from-pivotal-trial-of-relma-cel-at-the-62nd-ash-annual-meeting-301187142.html", "https://www.prnewswire.com/news-releases/new-abstracts-on-the-use-of-blue-light-cystoscopy-with-cysview-presented-at-suo-301187056.html", "https://www.prnewswire.com/news-releases/coronavirus-covid-19-update-fda-authorizes-drug-combination-for-treatment-of-covid-19-301177726.html", "https://www.prnewswire.com/news-releases/baricitinib-receives-emergency-use-authorization-from-the-fda-for-the-treatment-of-hospitalized-patients-with-covid-19-301177712.html", "https://www.prnewswire.com/news-releases/the-community-and-law-enforcement-collaboration-project-named-a-mutual-of-america-2020-community-partnership-award-winner-301177720.html", "https://www.prnewswire.com/news-releases/healthfirst-offers-new-shopping-and-enrollment-experience-for-2020-301177717.html", "https://www.prnewswire.com/news-releases/chop-researchers-reverse-severe-lymphatic-disorder-in-patient-with-noonan-syndrome-by-targeting-genetic-pathway-301177697.html", "https://www.prnewswire.com/news-releases/sosei-heptares-covid-19-program-identifies-potent-broad-spectrum-anti-viral-small-molecules-for-further-development-301177877.html", "https://www.prnewswire.com/news-releases/carsgen-therapeutics-to-present-multiple-myeloma-cell-therapy-data-at-the-62nd-american-society-of-hematology-ash-annual-meeting-and-exposition-in-december-301177792.html", "https://www.prnewswire.com/news-releases/quantum-health-announces-growth-investment-from-warburg-pincus-and-great-hill-partners-301177728.html", "https://www.prnewswire.com/news-releases/eisai-to-present-new-investigational-data-on-lenvima-lenvatinib-in-thyroid-cancer-and-osteosarcoma-at-esmo-asia-2020-301177770.html", "https://www.prnewswire.com/news-releases/healthverity-and-medidata-announce-strategic-partnership-to-advance-real-world-evidence-during-and-after-clinical-trials-301177757.html", "https://www.prnewswire.com/news-releases/nec-laboratories-europe-and-cyber-valley-research-institutions-sign-memorandum-of-understanding-for-future-ai-collaboration-301177903.html", "https://www.prnewswire.com/news-releases/stealth-biotherapeutics-announces-3-2-million-registered-direct-offering-301177823.html", "https://www.prnewswire.com/news-releases/glycostem-initiates-phase-iiia-pivotal-trial-to-evaluate-the-safety-and-efficacy-of-onkord-in-patients-with-acute-myeloid-leukemia-aml-301177987.html", "https://www.prnewswire.com/news-releases/butterfly-network-a-global-leader-in-democratizing-medical-imaging-to-be-listed-on-nyse-through-a-merger-with-longview-acquisition-corp-301177892.html", "https://www.prnewswire.com/news-releases/theracell-announces-royalty-milestone-from-licensing-301177786.html", "https://www.prnewswire.com/news-releases/redhill-biopharma-initiates-phase-3-study-of-rhb-204-for-first-line-treatment-of-ntm-disease-301177950.html", "https://www.prnewswire.com/news-releases/time-selects-trialjectorys-ai-powered-clinical-trial-matching-platform-for-100-best-inventions-of-2020-list-301177815.html", "https://www.prnewswire.com/news-releases/massachusetts-based-businesses-of-merck-kgaa-darmstadt-germany-named-to-the-boston-globes-top-places-to-work-list-301174935.html", "https://www.prnewswire.com/news-releases/inovio-presents-clinical-results-of-its-dna-medicines-ino-5401--ino-9012-in-novel-combination-with-pd-1-inhibitor-libtayo-cemiplimab-in-the-treatment-of-newly-diagnosed-glioblastoma-multiforme-at-society-for-neuro-oncology-202-301177899.html", "https://www.prnewswire.com/news-releases/novel-antioxidant-seen-as-an-effective-strategy-for-peripheral-artery-disease-301176579.html", "https://www.prnewswire.com/news-releases/psychedelics-transition-from-experimental-treatment-to-major-pharmaceutical-industry-301177739.html", "https://www.prnewswire.com/news-releases/neurotrope-inc-approves-spin-off-of-neurotrope-bioscience-inc-and-sets-record-and-distribution-dates-301178020.html", "https://www.prnewswire.com/news-releases/karyopharm-reports-positive-phase-3-seal-data-in-oral-presentation-at-the-connective-tissue-oncology-society-2020-annual-meeting-301177797.html", "https://www.prnewswire.com/news-releases/q-biomeds-strontium89-advertisement-unfinished-business-selected-for-prestigious-ads-of-the-worlds-best-creative-campaigns-301177706.html", "https://www.prnewswire.com/news-releases/celularity-announces-dosing-of-first-patient-in-phase-i-study-of-human-placental-hematopoietic-stem-cell-derived-natural-killer-cells-cynk-001-in-adults-with-recurrent-glioblastoma-multiforme-gbm-and-e-poster-presentation-at-t-301179595.html", "https://www.prnewswire.com/news-releases/navifus-highlights-clinical-trial-data-and-device-capabilities-at-virtual-international-focused-ultrasound-symposium-301179784.html", "https://www.prnewswire.com/news-releases/with-the-acas-open-enrollment-period-underway-ehealth-survey-explores-enrollees-sentiments-on-coronavirus-and-health-reform-301179621.html", "https://www.prnewswire.com/news-releases/elevian-announces-15-million-equity-financing-301179606.html", "https://www.prnewswire.com/news-releases/tolmar-publishes-fensolvi--leuprolide-acetate-for-injectable-suspension-safety-and-efficacy-data-in-journal-of-clinical-endocrinology-and-metabolism-301179761.html", "https://www.prnewswire.com/news-releases/physical-rehabilitation-network-acquires-californias-morgan-hill-physical-therapy-inc-301179472.html", "https://www.prnewswire.com/news-releases/centinel-spine-recognized-as-top-orthopedic-company-in-2020-301179777.html", "https://www.prnewswire.com/news-releases/program-for-oncopeptides-virtual-capital-markets-day-on-november-30-is-published-301179789.html", "https://www.prnewswire.com/news-releases/new-biopledge-bleach-and-alcohol-free-daily-disinfectant-approved-by-epa-for-use-against-covid-19-virus-301179644.html", "https://www.prnewswire.com/news-releases/phoenix-molecular-designs-announces-first-patient-dosed-in-phase-1b-clinical-trial-of-pmd-026-taking-aim-at-triple-negative-breast-cancer-301179433.html", "https://www.prnewswire.com/news-releases/medalliance-announces-successful-completion-of-enrolment-in-isabella-clinical-trial-for-the-treatment-of-failing-av-fistulas-in-hemodialysis-patients-301179801.html", "https://www.prnewswire.com/news-releases/local-health-plan-funds-program-to-address-young-adult-homelessness-301179839.html", "https://www.prnewswire.com/news-releases/neurorx-and-relief-announce-initial-successful-results-from-expanded-access-use-of-rlf-100-aviptadil-in-patients-with-critical-covid-19-and-severe-comorbidity-72-survival-seen-in-icu-patients-301179820.html", "https://www.prnewswire.com/news-releases/integral-molecular-announces-best-in-class-antibodies-against-complex-oncology-target-claudin-18-2--301179934.html", "https://www.prnewswire.com/news-releases/paramit-corporation-expands-capabilities-and-geographic-footprint-with-acquisition-of-emphysys-inc-301180044.html", "https://www.prnewswire.com/news-releases/milstein-medical-asian-american-partnership-foundation-announces-2020-grant-awards-301180106.html", "https://www.prnewswire.com/news-releases/actinium-presents-interim-data-from-actimab-a-clag-m-phase-1-combination-trial-at-the-62nd-american-society-of-hematology-annual-meeting-301187079.html", "https://www.prnewswire.com/news-releases/phosplatin-therapeutics-presents-phase-i-dose-escalation-data-of-pt-112-in-patients-with-relapsed--refractory-multiple-myeloma-at-ash-annual-meeting-301186983.html", "https://www.prnewswire.com/news-releases/lovelace-biomedical-report-evaluates-medical-cannabis-and-traumatic-brain-injury-tbi-301187062.html", "https://www.prnewswire.com/news-releases/redhill-biopharma-extends-talicia-unrestricted-national-and-regional-commercial-coverage-to-over-40-million-additional-americans-301187188.html", "https://www.prnewswire.com/news-releases/myos-corp-enters-into-agreement-with-a-leading-hong-kong-supplement-distributor-smart-supplement-ltd-to-distribute-yolked-sports-nutrition-products-in-hong-kong-and-southeast-asian-countries-301186955.html", "https://www.prnewswire.com/news-releases/milliporesigma-expands-production-capacities-301186622.html", "https://www.prnewswire.com/news-releases/actinium-highlights-iomab-b-safety-data-presented-at-the-62nd-american-society-of-hematology-annual-meeting-301187100.html", "https://www.prnewswire.com/news-releases/pharmabcine-to-present-new-interim-data-from-its-ongoing-mtnbc-trial-at-sabcs-2020-301186396.html", "https://www.prnewswire.com/news-releases/inovio-doses-first-subject-in-phase-2-segment-of-its-innovate-phase-23-clinical-trial-for-ino-4800-its-dna-medicine-to-prevent-covid-19-301187002.html", "https://www.prnewswire.com/news-releases/nci-gives-the-green-light-to-new-gastric-cancer-research-program-301187300.html", "https://www.prnewswire.com/news-releases/centivo-raises-34-million-in-series-b-round-to-help-employers-deliver-affordable-high-quality-healthcare-to-their-employees-301187020.html", "https://www.prnewswire.com/news-releases/blueprint-medicines-data-presented-at-62nd-ash-annual-meeting-and-exposition-highlight-broad-commitment-to-advance-patient-care-in-systemic-mastocytosis-301186960.html", "https://www.prnewswire.com/news-releases/seqirus-presents-new-late-breaking-data-at-eswi-2020-highlighting-benefits-of-mf59-adjuvanted-seasonal-influenza-vaccine-301187248.html", "https://www.prnewswire.com/news-releases/palm-vein-scanner-market-worth-1-150-million-by-2025--exclusive-report-by-marketsandmarkets-301187127.html", "https://www.prnewswire.com/news-releases/johns-hopkins-launches-unique-collaboration-with-walter-reed-national-military-medical-center-301187307.html", "https://www.prnewswire.com/news-releases/actinium-announces-positive-interim-results-from-iomab-b-pivotal-phase-3-sierra-trial-at-75-of-total-patient-enrollment-at-the-62nd-american-society-of-hematology-annual-meeting-301187116.html", "https://www.prnewswire.com/news-releases/amgen-and-novartis-partner-with-karamo-brown-to-support-and-empower-people-living-with-migraine-301186712.html", "https://www.prnewswire.com/news-releases/kenota-health-raises-11m-in-funding-to-bring-point-of-care-allergy-testing-to-healthcare-clinics-301187327.html", "https://www.prnewswire.com/news-releases/seqirus-presents-new-data-at-eswi-2020-demonstrating-safety-and-immunogenicity-of-adjuvanted-cell-based-pandemic-influenza-a-h5n1-vaccine-301187253.html", "https://www.prnewswire.com/news-releases/absolute-dental-group-closes-acquisition-of-aces-dental-301187107.html", "https://www.prnewswire.com/news-releases/menarini-announces-results-from-new-preclinical-studies-on-men1611-for-the-treatment-of-breast-cancer-at-the-2020-san-antonio-breast-cancer-symposium-301186852.html", "https://www.prnewswire.com/news-releases/relmada-therapeutics-announces-initiation-of-phase-3-program-for-rel-1017-as-adjunctive-treatment-for-patients-with-major-depressive-disorder-301187305.html", "https://www.prnewswire.com/news-releases/viracta-therapeutics-announces-presentation-of-updated-phase-2-data-at-ash-2020-and-productive-outcome-of-its-recent-end-of-phase-2-meeting-with-the-fda-301187296.html", "https://www.prnewswire.com/news-releases/novartis-and-amgen-partner-with-karamo-brown-to-support-and-empower-people-living-with-migraine-301186801.html", "https://www.prnewswire.com/news-releases/avacen-medical-announces-results-from-type-2-diabetes-clinical-study-301187346.html", "https://www.prnewswire.com/news-releases/through-strategic-collaboration-with-genscript-probio-initium-therapeutics-plans-to-utilize-genscript-probios-berkeley-lights-beacon-platform-to-expand-their-antibody-drug-pipeline-301187311.html", "https://www.prnewswire.com/news-releases/global-microbiomes-market-insights--forecast-2020-2024---progressing-product-pipeline-increasing-product-licensing-contracts--inclining-microbiome-research-and-development-activities-301187179.html", "https://www.prnewswire.com/news-releases/postera-enters-a-multi-year-strategic-partnership-with-pfizer-inc-to-advance-machine-learning-for-drug-discovery-301187340.html", "https://www.prnewswire.com/news-releases/data-from-the-andromeda-study-show-hematologic-response-for-darzalex-faspro-daratumumab-and-hyaluronidase-fihj-in-newly-diagnosed-light-chain-al-amyloidosis-301187390.html", "https://www.prnewswire.com/news-releases/redhill-biopharma-expands-us-based-manufacturing-capacity-of-opaganib-for-covid-19-301180645.html", "https://www.prnewswire.com/news-releases/altais-clinical-services-and-brown--toland-physicians-combine-forces-to-accelerate-improvement-of-physician-and-patient-experiences-301180397.html", "https://www.prnewswire.com/news-releases/loxo-oncology-at-lilly-announces-updated-data-from-the-phase-12-bruin-clinical-trial-for-loxo-305-in-chronic-lymphocytic-leukemia-and-small-lymphocytic-lymphoma-at-the-american-society-of-hematology-annual-meeting-301186873.html", "https://www.prnewswire.com/news-releases/postera-and-neurolucent-collaborate-on-identifying-small-molecule-therapeutics-for-alzheimers-disease-301180684.html", "https://www.prnewswire.com/news-releases/bioinvent-and-cantargia-sign-manufacturing-agreement-for-monoclonal-antibody-can10-301180932.html", "https://www.prnewswire.com/news-releases/approval-of-phase-iii-clinical-trial-of-atg-016-eltanexor-a-second-generation-selective-inhibitor-of-nuclear-export-sine-in-mainland-china-for-the-treatment-of-myelodysplastic-syndrome-301180877.html", "https://www.prnewswire.com/news-releases/fairchild-medical-center-provides-notice-of-data-event-301180780.html", "https://www.prnewswire.com/news-releases/senhwa-announces-multiple-ind-application-submissions-to-us-fda-and-health-canada-for-the-treatment-of-solid-tumors-with-brca2-or-palb2-mutations-301180879.html", "https://www.prnewswire.com/news-releases/crescita-therapeutics-announces-approval-of-normal-course-issuer-bid-301180979.html", "https://www.prnewswire.com/news-releases/global-4-5-billion-human-microbiome-market-to-2027-the-human-microbiome---a-new-frontier-in-drug-discovery-301180963.html", "https://www.prnewswire.com/news-releases/new-wave-enters-into-partnership-with-the-university-of-west-indies-mona-jamaica-for-medicinal-drug-discovery-301180939.html", "https://www.prnewswire.com/news-releases/nicolab-ready-to-revolutionize-us-stroke-care-following-fda-clearance-301181042.html", "https://www.prnewswire.com/news-releases/aphria-inc-expands-510-vape-offerings-across-its-award-winning-adult-use-brand-portfolio-301181037.html", "https://www.prnewswire.com/news-releases/haoma-medica-completes-first-in-human-trial-for-naquinate-a-novel-treatment-in-development-for-osteoporosis-301181026.html", "https://www.prnewswire.com/news-releases/worldwide-male-infertility-industry-to-2027---players-include-sanofi-bayer--endo-pharmaceuticals-among-others-301180981.html", "https://www.prnewswire.com/news-releases/breakthrough-in-aml-treatment-goldenbiotech-reports-new-drug-trial-of-antroquinonol--outperforms-listing-drugs-in-relapsed-acute-myeloid-leukemia-301181008.html", "https://www.prnewswire.com/news-releases/resolutions-at-the-extraordinary-general-meeting-in-bioinvent-on-november-27-2020-301181123.html", "https://www.prnewswire.com/news-releases/grunenthal-agrees-to-acquire-european-rights-to-crestor-rosuvastatin-from-astrazeneca-301182268.html", "https://www.prnewswire.com/news-releases/nanoform-launches-technology-for-biologics-and-sets-new-near-term-business-target-for-2021-301181087.html", "https://www.prnewswire.com/news-releases/nanoform-finland-plc-interim-report-january---september-2020-november-27th-2020-at-0800-am-finnish-time-301181091.html", "https://www.prnewswire.com/news-releases/bioinvent-strengthens-investor-relations-301181105.html", "https://www.prnewswire.com/news-releases/astellas-receives-approval-of-evrenzo-roxadustat-in-japan-for-the-treatment-of-anemia-of-chronic-kidney-disease-in-adult-patients-not-on-dialysis-301181047.html", "https://www.prnewswire.com/news-releases/global-orphan-drug-rare-disease-drug-market-sales-clinical-trials-market-size-insight-2026-301182253.html", "https://www.prnewswire.com/news-releases/actimed-therapeutics-granted-broad-us-patent-covering-rights-to-acm002-s-oxprenolol-for-treating-cancer-cachexia-301181585.html", "https://www.prnewswire.com/news-releases/sierra-oncology-to-host-kol-panel-event-to-discuss-updated-phase-3-myelofibrosis-data-presented-at-ash-301182114.html", "https://www.prnewswire.com/news-releases/caris-life-sciences-announces-vall-dhebron-institute-of-oncology-joins-its-precision-oncology-alliance-301182246.html", "https://www.prnewswire.com/news-releases/panaxia-continues-its-upward-trend-ends-q3-with-record-revenues-of-16-8-million-and-300-growth-over-the-previous-year-301182323.html", "https://www.prnewswire.com/news-releases/destination-pet-completes-acquisition-of-exceptional-pets-301182308.html", "https://www.prnewswire.com/news-releases/zimmer-biomet-completes-acquisition-of-ae-medical-corporation-301182046.html", "https://www.prnewswire.com/news-releases/genetworx-labs-launches-new-all-in-one-test-that-detects-covid-19flursv-301182405.html", "https://www.prnewswire.com/news-releases/three-posters-on-sel24men1703-including-pharmacodynamic-data-from-the-dose-escalation-part-of-diamond-01-trial-to-be-published-at-american-society-of-hematology-ash-annual-meeting-301182476.html", "https://www.prnewswire.com/news-releases/aeglea-biotherapeutics-receives-fda-rare-pediatric-disease-designation-for-acn00177-for-the-treatment-of-homocystinuria-301182095.html", "https://www.prnewswire.com/news-releases/regenxbio-announces-dosing-of-first-patient-in-phase-iii-trial-of-rgx-111-for-the-treatment-of-mucopolysaccharidosis-type-i-301181991.html", "https://www.prnewswire.com/news-releases/vigeneron-and-wuxi-advanced-therapies-enter-strategic-manufacturing-partnership-for-next-generation-ophthalmic-gene-therapy-301181301.html", "https://www.prnewswire.com/news-releases/new-data-show-impedimeds-lymphedema-prevention-program-reduces-incidence-of-chronic-lymphedema-in-breast-cancer-patients-and-survivors-301182437.html", "https://www.prnewswire.com/news-releases/sight-sciences-announces-substantial-crossover-raise-301182136.html", "https://www.prnewswire.com/news-releases/moleculin-announces-fda-approves-3-rare-pediatric-disease-designations-for-wp1066-301182314.html", "https://www.prnewswire.com/news-releases/dova-announces-doptelet-avatrombopag-data-presentations-at-upcoming-62nd-american-society-of-hematology-annual-meeting-and-exposition-301179444.html", "https://www.prnewswire.com/news-releases/tris-announces-us-district-court-upholds-validity-of-quillivant-xr-patents-rules-teva-infringes-tris-patents-301182085.html", "https://www.prnewswire.com/news-releases/protalix-biotherapeutics-and-chiesi-global-rare-diseases-announce-extension-of-pdufa-date-for-pegunigalsidase-alfa-for-the-proposed-treatment-of-fabry-disease-301181112.html", "https://www.prnewswire.com/news-releases/sedana-medical-submits-market-approval-application-for-the-drug-sedaconda-301181145.html", "https://www.prnewswire.com/news-releases/eluminex-biosciences-an-ophthalmology-focused-biotechnology-company-announces-closing-of-50-million-series-a-financing-301181102.html", "https://www.prnewswire.com/news-releases/neurotherapia-announces-completion-of-phase-1a-clinical-trial-301179041.html", "https://www.prnewswire.com/news-releases/technological-advancements-in-manufacturing-boost-the-cell-and-gene-therapy-market-says-frost--sullivan-301180608.html", "https://www.prnewswire.com/news-releases/number-of-shares-and-votes-in-oncopeptides-301181437.html", "https://www.prnewswire.com/news-releases/behaviorsoft-announces-strategic-partnership-with-tellus-301181365.html", "https://www.prnewswire.com/news-releases/dupixent-dupilumab-approved-by-european-commission-as-first-and-only-biologic-medicine-for-children-aged-6-to-11-years-with-severe-atopic-dermatitis-301181374.html", "https://www.prnewswire.com/news-releases/colchicine-shows-promise-as-a-treatment-for-at-home-covid-19-patients----recruitment-of-participants-in-the-colcorona-phase-3-study-likely-to-end-in-2020-301181297.html", "https://www.prnewswire.com/news-releases/syndax-pharmaceuticals-to-host-axatilimab-conference-call-and-webcast-featuring-two-cgvhd-experts-301181335.html", "https://www.prnewswire.com/news-releases/w-l-gore--associates-announces-encouraging-six-month-results-with-its-novel-biosynthetic-tissue-valve-301180050.html", "https://www.prnewswire.com/news-releases/ptc-therapeutics-announces-initiation-of-global-phase-3-clinical-trial-to-evaluate-vatiquinone-in-friedreich-ataxia-301181396.html", "https://www.prnewswire.com/news-releases/cti-biopharma-announces-publication-of-article-highlighting-pacritinib-data-from-the-pac203-phase-2-study-in-myelofibrosis-in-blood-advances-301181337.html", "https://www.prnewswire.com/news-releases/luminultra-expands-testing-capacity-including-range-of-covid-19-offerings-with-acquisition-of-source-molecular-corporation-301181221.html", "https://www.prnewswire.com/news-releases/ars-announces-acceptance-of-market-authorization-application-submission-to-european-medicines-agency-for-neffy-ars-1-epinephrine-nasal-spray-301180753.html", "https://www.prnewswire.com/news-releases/ptc-therapeutics-announces-key-regulatory-designations-for-ptc596-to-advance-treatment-of-two-rare-oncology-indications-301175743.html", "https://www.prnewswire.com/news-releases/this-ancient-aztec-medicine-could-be-a-gamechanger-for-mental-health-301181255.html", "https://www.prnewswire.com/news-releases/pionyr-immunotherapeutics-initiates-phase-1-clinical-study-of-py314-301175564.html", "https://www.prnewswire.com/news-releases/moberg-pharma-obtains-positive-decision-from-the-swedish-tax-agency-regarding-the-lex-asea-distribution-of-the-shares-in-oncozenge-301181582.html", "https://www.prnewswire.com/news-releases/pharvaris-announces-80-million-series-c-financing-to-advance-novel-oral-bradykinin-b2-receptor-antagonists-for-the-treatment-of-hae-301175711.html", "https://www.prnewswire.com/news-releases/endo-announces-expiration-of-hart-scott-rodino-waiting-period-for-biospecifics-tender-offer-301175494.html", "https://www.prnewswire.com/news-releases/black-womens-health-imperative-announces-the-rare-disease-diversity-coalitions-rise-for-rare-campaign-301175776.html", "https://www.prnewswire.com/news-releases/nuvasive-expands-proprietary-porous-peek-portfolio-with-cohere-xlif-interbody-301175609.html", "https://www.prnewswire.com/news-releases/obsidian-therapeutics--md-anderson-announce-strategic-collaboration-to-accelerate-advancement-of-novel-engineered-tumor-infiltrating-lymphocyte-therapy-cytotil-for-solid-tumors-301175800.html", "https://www.prnewswire.com/news-releases/emd-seronos-embracing-carers-announces-study-results-on-covid-19-and-caregivers-301175963.html", "https://www.prnewswire.com/news-releases/acelrx-pharmaceuticals-announces-commentary-in-practical-pain-management-on-previously-published-clinical-data-on-preoperative-administration-of-dsuvia-301175809.html", "https://www.prnewswire.com/news-releases/dr-amir-talaei-khoei-calls-for-collaboration-in-ai-and-vaccine-development-for-covid-19-301175924.html", "https://www.prnewswire.com/news-releases/truecare-is-first-federally-qualified-health-center-fqhc-in-san-diego-county-to-launch-ochin-epic-electronic-health-record-ehr-system-301175975.html", "https://www.prnewswire.com/news-releases/spring-health-raises-76-million-in-series-b-financing-301176026.html", "https://www.prnewswire.com/news-releases/purdue-university-receives-3dp-equipment-from-aprecia-pharmaceuticals-301175986.html", "https://www.prnewswire.com/news-releases/healint-starts-third-virtual-clinical-trial-amid-covid-19-pandemic-301175965.html", "https://www.prnewswire.com/news-releases/oncosec-provides-highlights-from-analyst--investor-day-and-sitc-2020-and-announces-keynote-695-reaches-full-enrollment-301175940.html", "https://www.prnewswire.com/news-releases/increased-research-and-development-activities-driving-expansion-of-global-hemophilia-treatment-drugs-market-tmr-301175895.html", "https://www.prnewswire.com/news-releases/amerilife-acquires-american-benefits-exchange-301176047.html", "https://www.prnewswire.com/news-releases/truth-initiative-and-blue-shield-of-california-team-up-to-help-millions-quit-tobacco-301176035.html", "https://www.prnewswire.com/news-releases/camargo-client-incannex-healthcare-seeks-expedited-pre-ind-meeting-emergency-use-authorization-for-anti-inflammatory-covid-19-treatment-301182728.html", "https://www.prnewswire.com/news-releases/cogent-biosciences-announces-final-results-from-plx9486-phase-12-study-in-advanced-gist-patients-at-ctos-2020-301175793.html", "https://www.prnewswire.com/news-releases/pr-dental-strategies-data-used-in-pediatric-silver-diamine-fluoride-study-301182736.html", "https://www.prnewswire.com/news-releases/enterprise-medical-recruiting-launches-partnership-with-academic-orthopedic-consortium-301181863.html", "https://www.prnewswire.com/news-releases/telehealth-claim-lines-increase-2-980-percent-nationally-when-comparing-september-2019-to-september-2020--301180934.html", "https://www.prnewswire.com/news-releases/dragonfly-therapeutics-announces-merck-opt-in-of-trinket-immunotherapy-candidate-for-patients-with-solid-tumors-301182720.html", "https://www.prnewswire.com/news-releases/spectrum-plastics-group-increases-sterile-medical-flexible-packaging-capabilities-with-its-acquisition-of-peelmaster-medical-packaging-301182067.html", "https://www.prnewswire.com/news-releases/nexion-health-extends-its-loving-patient-care-approach-through-acquisition-of-nine-facilities-in-texas-301182801.html", "https://www.prnewswire.com/news-releases/eisai-to-present-new-seizure-freedom-and-real-world-clinical-practice-data-evaluating-fycompa-across-diverse-patient-types-at-upcoming-aes-2020-annual-meeting-301182876.html", "https://www.prnewswire.com/news-releases/covid-19-antibody-tests-used-in-vaccine-clinical-trials-now-available-worldwide-301182827.html", "https://www.prnewswire.com/news-releases/maplewood-senior-living-partners-with-renowned-new-york-university-neuroscientist-dr-wendy-suzuki-for-a-brain-health-pilot-program-at-newtown-community-301182749.html", "https://www.prnewswire.com/news-releases/bora-pharmaceuticals-completes-acquisition-of-former-gsk-facility-301182811.html", "https://www.prnewswire.com/news-releases/novartis-announces-fda-approval-of-xolair-omalizumab-for-adults-with-nasal-polyps-301182847.html", "https://www.prnewswire.com/news-releases/fda-approves-first-psma-targeted-pet-imaging-drug-for-men-with-prostate-cancer-301182950.html", "https://www.prnewswire.com/news-releases/the-association-of-black-cardiologists-unveils-diversity-scorecard-initiative-301183059.html", "https://www.prnewswire.com/news-releases/gateway-health-and-the-boys--girls-clubs-of-western-pennsylvania-carve-out-career-path-for-local-teens-301182971.html", "https://www.prnewswire.com/news-releases/karyopharm-announces-investor-and-analyst-event-at-the-american-society-of-hematology-2020-annual-meeting-301183034.html", "https://www.prnewswire.com/news-releases/leaders-of-wisconsins-two-medical-schools-urge-everyone-to-take-action-during-the-covid-19-outbreak-301183112.html", "https://www.prnewswire.com/news-releases/i-mab-files-shelf-registration-statement-for-pipe-investors-301183076.html", "https://www.prnewswire.com/news-releases/in-the-lab-st-jude-scientists-identify-possible-covid-19-treatment-301176562.html", "https://www.prnewswire.com/news-releases/neodynamics-receives-first-uk-order-of-pulse-biopsy-system-neonavia-301176799.html", "https://www.prnewswire.com/news-releases/nordic-nanovector-completes-enrolment-into-second-safety-cohort-of-follicular-lymphoma-patients-in-archer-1-phase-1b-betalutinrituximab-combination-trial-301176748.html", "https://www.prnewswire.com/news-releases/lucaspye-bio-named-by-business-worldwide-magazine-as-one-of-the-top-innovative-companies-to-watch-in-2020-301176265.html", "https://www.prnewswire.com/news-releases/neodynamics-ab-publ-third-quarter-2020-301176812.html", "https://www.prnewswire.com/news-releases/oncopeptides-interim-report-q3-2020-301176786.html", "https://www.prnewswire.com/news-releases/casi-pharmaceuticals-announces-partner-juventas-completes-65-million-financing-and-initiates-registration-study-for-cnct19-cd19-car-t-301176618.html", "https://www.prnewswire.com/news-releases/male-contraceptive-initiative-invests-1-million-in-contraline-to-conduct-clinical-trial-for-long-lasting-non-hormonal-male-contraceptive-301176536.html", "https://www.prnewswire.com/news-releases/synox-therapeutics-raises-37m-in-series-a-financing-301176422.html", "https://www.prnewswire.com/news-releases/medicure-announces-settlement-of-patent-infringement-action-301176527.html", "https://www.prnewswire.com/news-releases/asc40-tvb-2640-phase-2-nash-trial-completed-patient-enrollment-in-china-301176538.html", "https://www.prnewswire.com/news-releases/nordic-nanovector-asa-results-for-the-third-quarter-2020-301176750.html", "https://www.prnewswire.com/news-releases/phosplatin-therapeutics-announces-presentation-of-data-from-phase-i-study-of-pt-112-in-patients-with-relapsed-or-refractory-multiple-myeloma-at-the-ash-annual-meeting-301176824.html", "https://www.prnewswire.com/news-releases/as-the-pandemic-surges-coalition-of-americas-premier-health-organizations-and-many-states-join-together-with-get-covered-2021-in-push-to-promote-covid-19-safety-and-health-insurance-enrollment-301176764.html", "https://www.prnewswire.com/news-releases/centene-is-proud-to-support-rural-healthcare-providers-and-members-on-national-rural-health-day-301176826.html", "https://www.prnewswire.com/news-releases/new-harris-poll-survey-finds-vast-majority-of-people-living-with-hereditary-angioedema-hae-value-efficacy-and-specific-correction-of-c1-inh-deficiency-when-choosing-an-hae-therapy-301176574.html", "https://www.prnewswire.com/news-releases/sifi-completes-enrollment-of-the-phase-iii-study-of-polihexanide-0-08-for-the-treatment-of-acanthamoeba-keratitis-301176005.html", "https://www.prnewswire.com/news-releases/redhill-announces-unanimous-dsmb-recommendation-to-continue-phase-23-covid-19-study-with-opaganib-301176893.html", "https://www.prnewswire.com/news-releases/sobi-and-apellis-announce-first-patient-dosed-in-potentially-registrational-als-study-of-pegcetacoplan-301177005.html", "https://www.prnewswire.com/news-releases/lilly-and-ypsomed-collaborate-to-advance-an-automated-insulin-delivery-system-for-people-with-diabetes-301176401.html", "https://www.prnewswire.com/news-releases/obi-pharma-announces-presentations-at-esmo-asia-2020-virtual-annual-meeting-for-obi-833-a-novel-anti-globo-h-targeted-therapeutic-cancer-vaccine-301176759.html", "https://www.prnewswire.com/news-releases/clearlake-capital-to-acquire-nthrives-technology-division-301176847.html", "https://www.prnewswire.com/news-releases/sifi-completa-la-inscripcion-del-estudio-fase-iii-de-polihexanida-0-08-para-el-tratamiento-de-la-queratitis-acanthamoeba-872566887.html", "https://www.prnewswire.com/news-releases/maitri-health-technologies-announces-commencement-of-trading-on-canadian-securities-exchange-301176682.html", "https://www.prnewswire.com/news-releases/cns-pharmaceuticals-and-wpd-pharmaceuticals-to-contribute-sponsorship-to-2020-sno-virtual-meeting-301176680.html", "https://www.prnewswire.com/news-releases/apprenticeio-raises-24m-series-b-led-by-insight-partners-to-scale-intelligent-pharma-manufacturing-system-301176723.html", "https://www.prnewswire.com/news-releases/imcs-group-announces-follow-on-investment-from-the-hartford-investment-management-group-301176873.html", "https://www.prnewswire.com/news-releases/moleculin-announces-new-data-demonstrating-synergistic-antitumor-activity-of-annamycin-combination-with-ara-c-in-aml-301176835.html", "https://www.prnewswire.com/news-releases/arisglobal-recognized-as-a-major-contender-in-everest-groups-clinical-development-platform-vendors-peak-matrix-assessment-2020-301176237.html", "https://www.prnewswire.com/news-releases/vesper-healthcare-acquisition-corp-announces-the-separate-trading-of-its-class-a-common-stock-and-warrants-commencing-november-20-2020-301176659.html", "https://www.prnewswire.com/news-releases/acurx-announces-positive-phase-2a-clinical-trial-results-for-ibezapolstat-in-c-difficile-infection-at-prominent-international-conference-301176862.html", "https://www.prnewswire.com/news-releases/gh-research-ltd-announces-completion-of-phase-1-clinical-study-with-gh001-5-methoxy-nn-dimethyltryptamine-in-healthy-volunteers-and-updates-on-further-progress-301176992.html", "https://www.prnewswire.com/news-releases/kintara-therapeutics-reports-10-months-progression-free-survival-in-newly-diagnosed-mgmt-unmethylated-gbm-from-ongoing-md-anderson-cancer-center-phase-2-study-301176868.html", "https://www.prnewswire.com/news-releases/bend-financial-selected-as-premier-hsa-provider-for-tufts-health-plan-members-and-employees-301176094.html", "https://www.prnewswire.com/news-releases/rhythm-management-group-ranked-number-142-fastest-growing-company-in-north-america-on-deloittes-2020-technology-fast-500-301176046.html", "https://www.prnewswire.com/news-releases/summit-receives-investment-from-u-of-colorado-anschutz-medical-campus-cdi-fund-301176168.html", "https://www.prnewswire.com/news-releases/evommune-inc-raises-12-5m-in-seed-funding-to-accelerate-the-development-of-transformative-medicines-for-chronic-inflammatory-diseases-301176135.html", "https://www.prnewswire.com/news-releases/aledade-voted-best-tech-for-good-by-washington-tech-community-in-timmys-301176292.html", "https://www.prnewswire.com/news-releases/invent-medical-corporation-receives-eua-approval-for-hft-150-heated-high-flow-system-301176212.html", "https://www.prnewswire.com/news-releases/to-bolster-the-voice-of-the-rare-community-in-state-government-nord-launches-project-rdac-announces-inaugural-meeting-on-december-16-301176178.html", "https://www.prnewswire.com/news-releases/the-law-offices-of-frank-r-cruz-announces-the-filing-of-a-securities-class-action-on-behalf-of-intercept-pharmaceuticals-inc-icpt-investors-301175720.html", "https://www.prnewswire.com/news-releases/redhawk-reports-year-end-results-301176301.html", "https://www.prnewswire.com/news-releases/rosen-leading-trial-attorneys-reminds-reata-pharmaceuticals-inc-investors-of-important-deadline-in-securities-class-action-encourages-investors-with-losses-in-excess-of-100k-to-contact-firm---reta-301176402.html", "https://www.prnewswire.com/news-releases/ucb-unleashes-the-power-of-data-in-new-collaboration-301176327.html", "https://www.prnewswire.com/news-releases/targovax-announces-impressive-objective-responses-as-well-as-effects-on-non-injected-lesions-in-oncos-102-trial-in-anti-pd1-refractory-melanoma-patients-301183284.html", "https://www.prnewswire.com/news-releases/jacobs-launches-one-million-lives-free-mental-health-check-in-tool-301183319.html", "https://www.prnewswire.com/news-releases/regent-pacifics-strategic-partner-receives-approval-from-nmpa-to-submit-ind-application-301183458.html", "https://www.prnewswire.com/news-releases/castrate-resistant-prostate-cancer-market-size-worth-16-2-billion-by-2027-grand-view-research-inc-301183394.html", "https://www.prnewswire.com/news-releases/aronora-announces-clinical-data-to-be-presented-at-the-62nd-american-society-of-hematology-annual-meeting-301183158.html", "https://www.prnewswire.com/news-releases/fda-approves-hetlioz-tasimelteon-for-the-treatment-of-nighttime-sleep-disturbances-in-smith-magenis-syndrome-301183162.html", "https://www.prnewswire.com/news-releases/mivi-neuroscience-announces-first-patient-enrolled-in-evaq-clinical-study-for-ischemic-stroke-treatment-301183209.html", "https://www.prnewswire.com/news-releases/pharos-capitals-family-treatment-network-acquires-catalyst-behavioral-solutions-301183453.html", "https://www.prnewswire.com/news-releases/protagonists-hepcidin-mimetic-candidate-ptg-300-receives-fast-track-designation-from-the-us-food-and-drug-administration-for-development-in-the-treatment-of-polycythemia-vera-301183452.html", "https://www.prnewswire.com/news-releases/bd-to-invest-1-2-billion-in-pre-fillable-syringe-manufacturing-capacity-over-next-four-years-301183196.html", "https://www.prnewswire.com/news-releases/ascentage-pharma-announces-clearances-in-china-and-the-us-for-the-phase-iia-study-of-apg-115-single-agent-or-in-combination-with-apg-2575-for-the-treatment-of-relapsed-or-refractory-t-cell-prolymphocytic-leukemia-301183180.html", "https://www.prnewswire.com/news-releases/numinus-and-maps-public-benefit-corporation-announce-collaboration-agreement-to-seek-approval-of-mdma-assisted-psychotherapy-for-ptsd-single-arm-open-label-trial-301183224.html", "https://www.prnewswire.com/news-releases/tubulis-forms-strategic-partnership-with-wuxi-biologics-and-wuxi-sta-to-advance-new-generation-of-antibody-drug-conjugates-towards-clinical-evaluation-301183406.html", "https://www.prnewswire.com/news-releases/regulus-therapeutics-collaborates-with-bio-techne-for-biomarker-development-301183166.html", "https://www.prnewswire.com/news-releases/insmed-announces-initiation-of-phase-3-aspen-study-of-brensocatib-in-patients-with-bronchiectasis-301183121.html", "https://www.prnewswire.com/news-releases/bd-to-invest-1-2-billion-in-pre-fillable-syringe-manufacturing-capacity-over-next-four-years-301183330.html", "https://www.prnewswire.com/news-releases/gryphons-smile-brands-completes-acquisition-of-midwest-dental-301183441.html", "https://www.prnewswire.com/news-releases/rutgers-cancer-institute-of-new-jersey-to-present-expansive-new-hematology-data-at-the-62nd-ash-annual-meeting-and-exposition-301183219.html", "https://www.prnewswire.com/news-releases/renovorx-continues-with-strong-momentum-and-reaches-milestone-of-100th-patient-enrolled-in-its-phase-iii-tiger-pac-clinical-trial-301183331.html", "https://www.prnewswire.com/news-releases/hum-by-colgate-and-headspace-team-up-to-help-people-stress-less-and-smile-more-301183268.html", "https://www.prnewswire.com/news-releases/abbotts-freestyle-libre-2-now-approved-for-adults-and-children-with-diabetes-in-canada-featuring-unsurpassed-14-day-accuracy-and-optional-alarms-301183446.html", "https://www.prnewswire.com/news-releases/nice-pak-announces-plans-to-construct-new-facility-in-mooresville-301183597.html", "https://www.prnewswire.com/news-releases/oramed-initiates-phase-2-nash-trial-of-oral-insulin-301183628.html", "https://www.prnewswire.com/news-releases/hamilton-rykers-talentgro-division-partners-in-dol-grant-to-help-create-and-expand-healthcare-apprenticeships-301183352.html", "https://www.prnewswire.com/news-releases/judith-montero-psyd-joins-cenexel-clinical-research-as-director-of-clinical-assessments-301183171.html", "https://www.prnewswire.com/news-releases/segmed-raises-2-million-seed-round-to-advance-dataset-sharing-for-medical-ai-301183642.html", "https://www.prnewswire.com/news-releases/curis-to-host-virtual-event-to-discuss-ca-4948-clinical-data-301183710.html", "https://www.prnewswire.com/news-releases/wuxi-apptec-applauded-by-frost--sullivan-for-its-unmatched-breadth-of-expertise-in-facilitating-early-stage-innovation-and-clinical-research-301183648.html", "https://www.prnewswire.com/news-releases/increase-in-long-term-care-costs-in-arizona-mirror-national-trends-covid-19-pressures-future-costs-301178695.html", "https://www.prnewswire.com/news-releases/endo-completes-acquisition-of-biospecifics-301183698.html", "https://www.prnewswire.com/news-releases/increase-in-long-term-care-costs-in-florida-mirror-national-trends-covid-19-pressures-future-costs-301178727.html", "https://www.prnewswire.com/news-releases/neurotrope-and-metuchen-pharmaceuticals-announce-completion-of-merger-forming-petros-pharmaceuticals-301183662.html", "https://www.prnewswire.com/news-releases/biospecifics-announces-completion-of-acquisition-by-endo-pharmaceuticals-301183768.html", "https://www.prnewswire.com/news-releases/covid-19-vaccine-education-and-equity-project-launches-to-further-inclusion-and-dialogue-around-potential-covid-19-vaccines-301183266.html", "https://www.prnewswire.com/news-releases/increase-in-long-term-care-costs-in-ohio-mirror-national-trends-covid-19-pressures-future-costs-301178699.html", "https://www.prnewswire.com/news-releases/taiho-oncology-and-astex-pharmaceuticals-to-present-data-in-myelodysplastic-syndromes-at-the-62nd-ash-annual-meeting-and-exposition-301182654.html", "https://www.prnewswire.com/news-releases/increase-in-long-term-care-costs-in-georgia-mirror-national-trends-covid-19-pressures-future-costs-301178706.html", "https://www.prnewswire.com/news-releases/increase-in-long-term-care-costs-in-missouri-mirror-national-trends-covid-19-pressures-future-costs-301178729.html", "https://www.prnewswire.com/news-releases/increase-in-long-term-care-costs-in-virginia-mirror-national-trends-covid-19-pressures-future-costs-301178715.html", "https://www.prnewswire.com/news-releases/genworth-17th-annual-cost-of-care-survey--covid-19-exacerbates-already-rising-long-term-care-costs-care-providers-foresee-additional-rate-hikes-in-2021-301183279.html", "https://www.prnewswire.com/news-releases/increase-in-long-term-care-costs-in-tennessee-mirror-national-trends-covid-19-pressures-future-costs-301178703.html", "https://www.prnewswire.com/news-releases/increase-in-long-term-care-costs-in-new-jersey-mirror-national-trends-covid-19-pressures-future-costs-301178771.html", "https://www.prnewswire.com/news-releases/increase-in-long-term-care-costs-in-oregon-surpass-national-trends-covid-19-pressures-future-costs-301180386.html", "https://www.prnewswire.com/news-releases/increase-in-long-term-care-costs-in-new-york-mirror-national-trends-covid-19-pressures-future-costs-301178725.html", "https://www.prnewswire.com/news-releases/increase-in-long-term-care-costs-in-washington-mirror-national-trends-covid-19-pressures-future-costs-301178691.html", "https://www.prnewswire.com/news-releases/increase-in-long-term-care-costs-in-wyoming-surpass-national-trends-covid-19-pressures-future-costs-301180390.html", "https://www.prnewswire.com/news-releases/increase-in-long-term-care-costs-in-south-dakota-mirror-national-trends-covid-19-pressures-future-costs-301178696.html", "https://www.prnewswire.com/news-releases/increase-in-long-term-care-costs-in-nebraska-mirror-national-trends-covid-19-pressures-future-costs-301178716.html", "https://www.prnewswire.com/news-releases/increase-in-long-term-care-costs-in-arkansas-surpass-national-trends-covid-19-pressures-future-costs-301180335.html", "https://www.prnewswire.com/news-releases/increase-in-long-term-care-costs-in-michigan-surpass-national-trends-covid-19-pressures-future-costs-301180451.html", "https://www.prnewswire.com/news-releases/increase-in-long-term-care-costs-in-pennsylvania-mirror-national-trends-covid-19-pressures-future-costs-301178713.html", "https://www.prnewswire.com/news-releases/increase-in-long-term-care-costs-in-kansas-far-surpass-national-trends-covid-19-pressures-future-costs-301178722.html", "https://www.prnewswire.com/news-releases/increase-in-long-term-care-costs-in-wisconsin-mirror-national-trends-covid-19-pressures-future-costs-301178693.html", "https://www.prnewswire.com/news-releases/increase-in-long-term-care-costs-in-nevada-far-surpass-national-trends-covid-19-pressures-future-costs-301178731.html", "https://www.prnewswire.com/news-releases/nanoform-makes-us-tv-debut-in-advancements-with-ted-danson-cnbc-301183766.html", "https://www.prnewswire.com/news-releases/increase-in-long-term-care-costs-in-mississippi-mirror-national-trends-covid-19-pressures-future-costs-301178718.html", "https://www.prnewswire.com/news-releases/increase-in-long-term-care-costs-in-montana-far-surpass-national-trends-covid-19-pressures-future-costs-301178724.html", "https://www.prnewswire.com/news-releases/new-pharma-trials-making-big-gains-in-fight-against-triple-negative-breast-cancer-tnbc-301183429.html", "https://www.prnewswire.com/news-releases/increase-in-long-term-care-costs-in-north-dakota-surpass-national-trends-covid-19-pressures-future-costs-301180380.html", "https://www.prnewswire.com/news-releases/increase-in-long-term-care-costs-in-hawaii-surpass-national-trends-covid-19-pressures-future-costs-301180392.html", "https://www.prnewswire.com/news-releases/increase-in-long-term-care-costs-in-minnesota-far-surpass-national-trends-covid-19-pressures-future-costs-301178720.html", "https://www.prnewswire.com/news-releases/increase-in-long-term-care-costs-in-colorado-surpass-national-trends-covid-19-pressures-future-costs-301180420.html", "https://www.prnewswire.com/news-releases/increase-in-long-term-care-costs-in-delaware-surpass-national-trends-covid-19-pressures-future-costs-301180423.html", "https://www.prnewswire.com/news-releases/increase-in-long-term-care-costs-in-oklahoma-surpass-national-trends-covid-19-pressures-future-costs-301180359.html", "https://www.prnewswire.com/news-releases/increase-in-long-term-care-costs-in-west-virginia-surpass-national-trends-covid-19-pressures-future-costs-301180372.html", "https://www.prnewswire.com/news-releases/increase-in-long-term-care-costs-in-maryland-surpass-national-trends-covid-19-pressures-future-costs-301180399.html", "https://www.prnewswire.com/news-releases/increase-in-long-term-care-costs-in-kentucky-surpass-national-trends-covid-19-pressures-future-costs-301180421.html", "https://www.prnewswire.com/news-releases/increase-in-long-term-care-costs-in-california-surpass-national-trends-covid-19-pressures-future-costs-301180406.html", "https://www.prnewswire.com/news-releases/increase-in-long-term-care-costs-in-connecticut-surpass-national-trends-covid-19-pressures-future-costs-301180412.html", "https://www.prnewswire.com/news-releases/ampios-phase-i-study-for-inhaled-ampion-advances-to-completing-enrollment-of-covid-19-patients-with-respiratory-distress-301183745.html", "https://www.prnewswire.com/news-releases/increase-in-long-term-care-costs-in-massachusetts-surpass-national-trends-covid-19-pressures-future-costs-301180394.html", "https://www.prnewswire.com/news-releases/therapeutic-solutions-international-announces-clinical-trial-assessing-kaihani-score-proprietary-biomarker-based-assay-for-quantifying-gambling-addiction-301183823.html", "https://www.prnewswire.com/news-releases/increase-in-long-term-care-costs-in-iowa-mixed-covid-19-pressures-future-costs-301180443.html", "https://www.prnewswire.com/news-releases/increase-in-long-term-care-costs-in-south-carolina-surpass-national-trends-covid-19-pressures-future-costs-301180422.html", "https://www.prnewswire.com/news-releases/increase-in-long-term-care-costs-in-utah-mixed-covid-19-pressures-future-costs-301180465.html", "https://www.prnewswire.com/news-releases/increase-in-long-term-care-costs-in-idaho-mixed-covid-19-pressures-future-costs-301180462.html", "https://www.prnewswire.com/news-releases/increase-in-long-term-care-costs-in-washington-area-dc-surpass-national-trends-covid-19-pressures-future-costs-301180428.html", "https://www.prnewswire.com/news-releases/increase-in-long-term-care-costs-in-illinois-surpass-national-trends-covid-19-pressures-future-costs-301180408.html", "https://www.prnewswire.com/news-releases/increase-in-long-term-care-costs-in-alabama-mixed-covid-19-pressures-future-costs-301180449.html", "https://www.prnewswire.com/news-releases/increase-in-long-term-care-costs-in-vermont-mixed-covid-19-pressures-future-costs-301180454.html", "https://www.prnewswire.com/news-releases/increase-in-long-term-care-costs-in-indiana-mixed-covid-19-pressures-future-costs-301180446.html", "https://www.prnewswire.com/news-releases/increase-in-long-term-care-costs-in-alaska-mixed-covid-19-pressures-future-costs-301180442.html", "https://www.prnewswire.com/news-releases/increase-in-long-term-care-costs-in-louisiana-mixed-covid-19-pressures-future-costs-301180464.html", "https://www.prnewswire.com/news-releases/increase-in-long-term-care-costs-in-new-mexico-mixed-covid-19-pressures-future-costs-301180459.html", "https://www.prnewswire.com/news-releases/increase-in-long-term-care-costs-in-rhode-island-mixed-covid-19-pressures-future-costs-301180466.html", "https://www.prnewswire.com/news-releases/increase-in-long-term-care-costs-in-north-carolina-mixed-covid-19-pressures-future-costs-301180435.html", "https://www.prnewswire.com/news-releases/global-surgical-sealants-and-adhesives-market-2020-2025-growing-use-of-technologically-advanced-products-301183771.html", "https://www.prnewswire.com/news-releases/china-biologic-enters-into-definitive-merger-agreement-for-going-private-transaction-301177142.html", "https://www.prnewswire.com/news-releases/cambridge-massachusetts-to-breathe-easier-with-red-barn-healthcare-tool-for-air-purification-technology-301176909.html", "https://www.prnewswire.com/news-releases/increase-in-long-term-care-costs-in-maine-mixed-covid-19-pressures-future-costs-301180463.html", "https://www.prnewswire.com/news-releases/increase-in-long-term-care-costs-in-texas-mixed-covid-19-pressures-future-costs-301180469.html", "https://www.prnewswire.com/news-releases/increase-in-long-term-care-costs-in-new-hampshire-mixed-covid-19-pressures-future-costs-301180450.html", "https://www.prnewswire.com/news-releases/cryolife-to-host-webcast-discussing-proact-xa-clinical-trial-on-december-7-2020-301176974.html", "https://www.prnewswire.com/news-releases/varian-and-the-cincinnati-childrensuc-health-proton-therapy-center-announce-initial-patient-treated-in-the-fast-01-first-human-clinical-trial-of-flash-therapy-for-cancer-301176678.html", "https://www.prnewswire.com/news-releases/global-acute-myeloid-leukemia-therapeutics-market-could-exceed-3-5-billion-by-2027--301176776.html", "https://www.prnewswire.com/news-releases/syngene-and-deerfield-discovery-and-development-3dc-sign-5-year-strategic-collaboration-301177023.html", "https://www.prnewswire.com/news-releases/icahn-school-of-medicine-at-mount-sinai-and-boehringer-ingelheim-collaborate-on-first-study-to-evaluate-nintedanib-in-patients-with-fibrosing-ild-following-covid-19-infection-301176742.html", "https://www.prnewswire.com/news-releases/topical-nitric-oxide-serum-improves-aesthetics-for-aging-skin-acne-scars-and-wound-care-301177230.html", "https://www.prnewswire.com/news-releases/martis-capital-makes-growth-investment-in-dcn-dx-301176998.html", "https://www.prnewswire.com/news-releases/seelos-therapeutics-receives-us-orphan-drug-designation-for-sls-005-trehalose-in-amyotrophic-lateral-sclerosis-301176560.html", "https://www.prnewswire.com/news-releases/bct-partners-announces-acquisition-of-critical-measures-301177172.html", "https://www.prnewswire.com/news-releases/tvmbio-introduces-new-tool-to-fight-covid-pandemic-and-potentially-stop-lockdowns-smart-covid-card-helps-individual-users-verify-negative-disease-status-keeping-communities-businesses-and-employers-safe-through-data-sharing-301177058.html", "https://www.prnewswire.com/news-releases/lumiata-healthcare-underwriting-models-wins-prestigious-iaai-deployed-application-award-301176664.html", "https://www.prnewswire.com/news-releases/crowdcomfort-closes-financing-round-to-support-return-to-work-strategies-during-covid-19-301177013.html", "https://www.prnewswire.com/news-releases/elevar-therapeutics-presents-safety-and-efficacy-results-of-rivoceranib-apatinib-in-combination-with-nivolumab-at-the-2020-connective-tissue-oncology-society-ctos-annual-meeting-301176783.html", "https://www.prnewswire.com/news-releases/oncolytics-biotech-announces-positive-clinical-results-against-glioblastoma-multiforme-at-the-2020-society-of-neuro-oncology-annual-meeting-301176875.html", "https://www.prnewswire.com/news-releases/volpara-wins-absolute-it-supreme-scale-ups-award-301176757.html", "https://www.prnewswire.com/news-releases/the-need-for-precise-testing-capabilities-is-clear-as-cases-surge-301176887.html", "https://www.prnewswire.com/news-releases/tikun-olam-continues-to-expand-national-footprint-announces-collaboration-with-pincanna-to-produce-medical--adult-use-cannabis-products-in-michigan-301176496.html", "https://www.prnewswire.com/news-releases/eversana-and-healthjump-partner-to-deepen-integration-of-predictive-patient-services-and-enhance-rwd-based-patient-outcomes-301177116.html", "https://www.prnewswire.com/news-releases/jay-z-and-novak-djokovic-climb-to-new-heights-with-investment-in-clmbr-301177176.html", "https://www.prnewswire.com/news-releases/allos-pharma-secures-exclusive-license-on-arbaclofen-in-fragile-x-syndrome-301177029.html", "https://www.prnewswire.com/news-releases/covis-group-announces-data-for-ciraparantag-published-in-blood-the-journal-of-the-american-society-of-hematology-301177291.html", "https://www.prnewswire.com/news-releases/national-cannabis-risk-management-association-enhances-its-marketing-and-membership-strategies-with-new-additions-to-the-team-301183842.html", "https://www.prnewswire.com/news-releases/traditions-health-acquires-harbor-light-hospice-301183872.html", "https://www.prnewswire.com/news-releases/evolution-capital-partners-invests-in-long-term-care-services-provider-301183955.html", "https://www.prnewswire.com/news-releases/czi-awards-nearly-32-million-and-announces-new-funding-opportunity-to-advance-biomedical-imaging-301183939.html", "https://www.prnewswire.com/news-releases/apex-innovative-sciences-pioneers-continuity-strategy-in-clinical-site-services-during-covid-19-301183942.html", "https://www.prnewswire.com/news-releases/gary-l-reasor-md-is-recognized-by-continental-whos-who-301185038.html", "https://www.prnewswire.com/news-releases/disc-medicine-to-present-at-the-virtual-62nd-american-society-of-hematology-annual-meeting-301185107.html", "https://www.prnewswire.com/news-releases/life-saving-insulin-now-available-at-free-or-no-cost-to-people-living-in-stanislaus-and-merced-counties-301185146.html", "https://www.prnewswire.com/news-releases/lilly-announces-650-000-additional-doses-of-neutralizing-antibody-bamlanivimab-ly-cov555-purchased-by-us-government-to-treat-covid-19--301185111.html", "https://www.prnewswire.com/news-releases/american-association-of-nurse-anesthetists-urges-hhs-to-permanently-remove-barriers-to-crna-practice-301185126.html", "https://www.prnewswire.com/news-releases/global-conventional-and-alternative-pain-treatment-markets-report-2020-2025-with-profiles-of-abbott-laboratories-baxter-international-eli-lilly--co-glaxosmithkline-and-johnson--johnson-301183951.html", "https://www.prnewswire.com/news-releases/resolve-therapeutics-publishes-positive-sjogrens-syndrome-clinical-trial-results-301185315.html", "https://www.prnewswire.com/news-releases/subtle-medical-raises-12-2-million-in-series-a-funding-to-expand-its-ai-imaging-solutions-301176773.html", "https://www.prnewswire.com/news-releases/limacorporate-announces-fda-approval-for-an-ide-study-on-smr-stemless-reverse-shoulder-system-301176470.html", "https://www.prnewswire.com/news-releases/jazz-pharmaceuticals-and-pharmamar-announce-results-of-atlantis-phase-3-study-evaluating-zepzelca-in-combination-with-doxorubicin-for-patients-with-small-cell-lung-cancer-following-one-prior-platinum-containing-line-301185390.html", "https://www.prnewswire.com/news-releases/rebus-biosystems-inc-announces-20-million-series-b-financing-to-support-commercialization-of-automated-spatial-omics-solution-301176647.html", "https://www.prnewswire.com/news-releases/new-data-at-ash-to-reinforce-breadth-of-novartis-hematology-portfolio-across-multiple-blood-cancers-and-serious-hematologic-diseases-301177350.html", "https://www.prnewswire.com/news-releases/mitochondrial-targeted-antioxidant-protects-genomes-against-dna-damage-in-exercising-humans-301176561.html", "https://www.prnewswire.com/news-releases/day-one-announces-preliminary-phase-1-results-for-day101-in-pediatric-low-grade-glioma-receipt-of-breakthrough-therapy-designation-btd-and-new-phase-2-study-301176708.html", "https://www.prnewswire.com/news-releases/fusion-robotics-awarded-best-spine-technology-by-orthopedics-this-week-301176660.html", "https://www.prnewswire.com/news-releases/mim-software-inc-announces-collaboration-with-peter-maccallum-cancer-centre-to-improve-patient-management-301177378.html", "https://www.prnewswire.com/news-releases/world-back-to-works-covid-19-rt-pcr-pooled-testing-option-helps-reduce-cost-and-provides-rapid-results-301177411.html", "https://www.prnewswire.com/news-releases/stanford-childrens-health-launches-virtual-hiv-prevention-program-301176049.html", "https://www.prnewswire.com/news-releases/wellspark-health-announces-collaboration-with-silver-fern-healthcare-301177457.html", "https://www.prnewswire.com/news-releases/experts-issue-recommendations-for-equitable-distribution-of-covid-19-vaccine-301177443.html", "https://www.prnewswire.com/news-releases/in-2021--americans-will-spend-an-average-of-5-952year-for-health-insurance-301177534.html", "https://www.prnewswire.com/news-releases/inland-empire-health-plan-receives-health-equity-award-for-engaging-communication-301177513.html", "https://www.prnewswire.com/news-releases/the-university-of-verona-and-intraop-announce-pancfort-trial-for-pancreatic-cancer-301177519.html", "https://www.prnewswire.com/news-releases/centinel-spine-wins-2020-spine-technology-award-for-its-two-level-indication-for-the-prodisc-l-total-disc-replacement-system-301177412.html", "https://www.prnewswire.com/news-releases/lovelace-biomedical-research-shows-cell-injury-caused-by-contents-in-e-cig-vapor-301185227.html", "https://www.prnewswire.com/news-releases/crh-medical-receives-tsx-approval-for-renewal-of-normal-course-issuer-bid-301176661.html", "https://www.prnewswire.com/news-releases/penn-foundation-to-join-st-lukes-university-health-network-301177598.html", "https://www.prnewswire.com/news-releases/new-healthcare-workers-rock-song-and-music-video-captures-spirit-of-frontline-healthcare-workers-around-the-world-treating-the-latest-covid-19-surge-301177609.html", "https://www.prnewswire.com/news-releases/actinium-highlights-clinical-data-to-be-presented-at-the-upcoming-62nd-american-society-of-hematology-annual-meeting-301185566.html", "https://www.prnewswire.com/news-releases/felixhealthcareai-scales-engineering-team-to-support-strong-growth-301185224.html", "https://www.prnewswire.com/news-releases/macerich-earns-bureau-veritas-safeguard-certification-for-key-retail-properties-301185523.html", "https://www.prnewswire.com/news-releases/inspira-technologies-files-us-patent-application-for-its-innovative-respiratory-support-technology-engages-leading-us-investment-bank-for-nasdaq-listing-301185563.html", "https://www.prnewswire.com/news-releases/antengene-submits-ndas-for-xpovio-selinexor-in-multiple-apac-markets-for-rrmm-and-rrdlbcl-301185519.html", "https://www.prnewswire.com/news-releases/evercommerce-acquires-my-pt-hub-a-leading-personal-training-and-fitness-engagement-platform-301185240.html", "https://www.prnewswire.com/news-releases/initiation-of-first-unicar-cellular-immunotherapy-study-in-advanced-solid-tumors-301185515.html", "https://www.prnewswire.com/news-releases/hub-international-chooses-simplifya-for-ongoing-cannabis-license-verification-of-cannabis-clients-301185592.html", "https://www.prnewswire.com/news-releases/eversana-and-arisglobal-announce-strategic-partnership-to-transform-drug-safety-automation-and-advance-integrated-compliance-models-301185230.html", "https://www.prnewswire.com/news-releases/weill-cornell-medicine-newyork-presbyterian-hospital-and-illumina-collaborate-on-scalable-clinical-whole-genome-sequencing-initiative-301183999.html", "https://www.prnewswire.com/news-releases/amplyx-announces-upcoming-virtual-data-presentations-at-62nd-american-society-of-hematology-ash-annual-meeting-301185316.html", "https://www.prnewswire.com/news-releases/janssen-submits-application-to-us-fda-seeking-approval-of-amivantamab-for-the-treatment-of-patients-with-metastatic-non-small-cell-lung-cancer-with-egfr-exon-20-insertion-mutations-301185216.html", "https://www.prnewswire.com/news-releases/neuroone-medical-technologies-corporation-announces-first-human-commercial-use-of-its-evo-cortical-electrode-at-mayo-clinic-301185612.html", "https://www.prnewswire.com/news-releases/f-star-therapeutics-announces-first-patient-dosed-in-first-in-class-fs120-phase-1-clinical-trial-301185664.html", "https://www.prnewswire.com/news-releases/sectra-signs-enterprise-imaging-contract-at-dayton-childrens-hospital-301185567.html", "https://www.prnewswire.com/news-releases/monetizing-api-infrastructure-through-efficiency-focused-and-transformed-value-models-301185625.html", "https://www.prnewswire.com/news-releases/development-of-advanced-novel-aml-drugs-target-increasing-cases-of-acute-myeloid-leukemia-301185495.html", "https://www.prnewswire.com/news-releases/sirnaomics-to-initiate-phase-i-study-of-stp705-in-treatment-of-primary-and-metastatic-liver-cancer-301185237.html", "https://www.prnewswire.com/news-releases/everlywell-announces-175-million-financing-to-expand-consumer-lab-testing-and-digital-health-offerings-301185355.html", "https://www.prnewswire.com/news-releases/the-ridge-ohio-partners-with-iheartmedia-to-launch-brief-podcast-spots-to-be-featured-during-the-bill-cunningham-show-301185196.html", "https://www.prnewswire.com/news-releases/inovio-expands-global-manufacturing-consortium-for-its-covid-19-vaccine-candidate-ino-4800-with-addition-of-kaneka-eurogentec-sa-301185408.html", "https://www.prnewswire.com/news-releases/orsini-specialty-pharmacy-expands-partnership-with-alnylam-pharmaceuticals-as-a-limited-distribution-partner-for-oxlumo-lumasiran-301185683.html", "https://www.prnewswire.com/news-releases/inhibikase-advances-development-program-for-multiple-system-atrophy-msa-based-on-demonstration-of-key-role-of-c-abl-kinase-in-msa-neurodegeneration-301185418.html", "https://www.prnewswire.com/news-releases/advanced-dermatology-and-cosmetic-surgery-announces-the-acquisition-of-colorado-dermatology-specialists-301185267.html", "https://www.prnewswire.com/news-releases/advanced-dermatology-and-cosmetic-surgery-announces-the-acquisition-of-nielsen-dermatology-301185392.html", "https://www.prnewswire.com/news-releases/grantees-awarded-as-part-of-the-breast-cancer-research-project-between-nccn-and-lilly-oncology-301185634.html", "https://www.prnewswire.com/news-releases/telemis-annual-revenue-figures-keep-climbing-despite-challenging-economic-landscape-301185792.html", "https://www.prnewswire.com/news-releases/consolidation-of-clinics-mds-and-hospitals-into-integrated-systems-is-accelerating-301185476.html", "https://www.prnewswire.com/news-releases/pure-jamaicans-pharma-division-seven10-nears-start-of-exportation-of-pharmaceutical-cannabis-ingredients-to-mexico-with-mexican-senates-approval-of-cannabis-legislation-301185654.html", "https://www.prnewswire.com/news-releases/global-market-for-cannabinoid-based-pharmaceuticals-expected-to-reach-50-billion-by-2029-301185483.html", "https://www.prnewswire.com/news-releases/ortho-regenerative-technologies-completes-non-brokered-3-0-million-private-placement-301185762.html", "https://www.prnewswire.com/news-releases/how-an-ancient-medicine-is-taking-on-the-16-trillion-pharmaceutical-industry-301185440.html", "https://www.prnewswire.com/news-releases/mitsubishi-tanabe-pharma-america-announces-presentations-of-als-data-at-virtual-31st-international-symposium-on-alsmnd-301185772.html", "https://www.prnewswire.com/news-releases/worldwide-industry-for-residential-substance-abuse-and-mental-health-facilities-to-2030---identify-growth-segments-for-investment-301185757.html", "https://www.prnewswire.com/news-releases/olive-acquires-verata-health-to-accelerate-artificial-intelligence-technology-for-healthcare-providers-and-payers-301185294.html", "https://www.prnewswire.com/news-releases/california-association-of-realtors-partners-with-bend-to-offer-hsas-to-members-301185401.html", "https://www.prnewswire.com/news-releases/aspect-imaging-lauded-by-frost--sullivan-for-its-revolutionary-embrace-neonatal-mri-system-that-addresses-the-key-medical-imaging-challenges-of-neonatologists-301185220.html", "https://www.prnewswire.com/news-releases/senhwa-announces-the-first-patient-enrolled-in-an-investigator-initiated-trial-of-silmitasertib-as-a-treatment-for-covid-19-301185813.html", "https://www.prnewswire.com/news-releases/inland-empire-health-plan-supports-450-activities-and-events-in-2020-301185851.html", "https://www.prnewswire.com/news-releases/endari-granted-orphan-drug-status-in-switzerland-301185910.html", "https://www.prnewswire.com/news-releases/stella-ventures-announces-investment-in-seae-ventures-301185938.html", "https://www.prnewswire.com/news-releases/wcg-acquires-trifecta-a-global-leader-in-clinical-trial-site-communications-301186039.html", "https://www.prnewswire.com/news-releases/pantherx-rare-pharmacy-chosen-as-partner-by-alnylam-pharmaceuticals-for-oxlumo-lumasiran-for-the-treatment-of-primary-hyperoxaluria-type-1-ph1-to-lower-urinary-oxalate-levels-301186046.html", "https://www.prnewswire.com/news-releases/engene-receives-fast-track-designation-for-eg-70-for-the-treatment-of-non-muscle-invasive-bladder-cancer-301186052.html", "https://www.prnewswire.com/news-releases/burns--levinson-closes-strategic-growth-investment-for-ga-foods-301186112.html", "https://www.prnewswire.com/news-releases/cytosorbents-lanceert-internationale-campagne-om-100-000-in-te-zamelen-voor-de-wereldwijde-humanitaire-organisatie-care-890025926.html", "https://www.prnewswire.com/news-releases/inland-empire-health-plan-provides-flu-shots-and-groceries-to-community-301178170.html", "https://www.prnewswire.com/news-releases/i-peace-inc-obtains-irb-approval-for-production-of-clinical-and-research-grade-ipscs-for-commercial-use-301185996.html", "https://www.prnewswire.com/news-releases/amgen-to-webcast-investor-call-at-ash-2020-301186063.html", "https://www.prnewswire.com/news-releases/time-is-running-out-in-medicares-annual-enrollment-period-301178155.html", "https://www.prnewswire.com/news-releases/brooks-announces-the-acquisition-of-trans-hit-biomarkers-301186140.html", "https://www.prnewswire.com/news-releases/yourmedicare-donates-1m-meals-to-feeding-america-301178144.html", "https://www.prnewswire.com/news-releases/worldwide-industry-for-proteomics-to-2025---key-drivers-and-challenges-301177979.html", "https://www.prnewswire.com/news-releases/f-star-therapeutics-completes-combination-with-spring-bank-pharmaceuticals-301178198.html", "https://www.prnewswire.com/news-releases/global-glycobiology-market-2020-to-2025---by-type-of-enzyme-type-of-kit-application-end-user-and-region-301178052.html", "https://www.prnewswire.com/news-releases/not-for-profit-foundation-provides-seed-grants-to-top-research-programs-301178169.html", "https://www.prnewswire.com/news-releases/vg-acquisition-corp-announces-the-separate-trading-of-its-class-a-ordinary-shares-and-warrants-commencing-november-23-2020-301178276.html", "https://www.prnewswire.com/news-releases/aridis-pharmaceuticals-announces-third-quarter-2020-results-301178291.html", "https://www.prnewswire.com/news-releases/eisai-announces-new-investigational-data-from-study-211-evaluating-the-starting-dose-of-lenvima-lenvatinib-in-differentiated-thyroid-cancer-at-esmo-asia-2020-301178302.html", "https://www.prnewswire.com/news-releases/first-ever-treatment-for-rare-rapid-aging-disease-progeria-receives-us-fda-approval-301178346.html", "https://www.prnewswire.com/news-releases/coronavirus-covid-19-update-fda-authorizes-monoclonal-antibodies-for-treatment-of-covid-19-301178466.html", "https://www.prnewswire.com/news-releases/fda-approves-first-treatment-for-hutchinson-gilford-progeria-syndrome-and-some-progeroid-laminopathies-301178337.html", "https://www.prnewswire.com/news-releases/regenerons-regen-cov2-is-first-antibody-cocktail-for-covid-19-to-receive-fda-emergency-use-authorization-301178464.html", "https://www.prnewswire.com/news-releases/eiger-biopharmaceuticals-announces-fda-approval-of-zokinvy-lonafarnib-the-first-treatment-for-hutchinson-gilford-progeria-syndrome-and-processing-deficient-progeroid-laminopathies-301178343.html", "https://www.prnewswire.com/news-releases/lillys-neutralizing-antibody-bamlanivimab-ly-cov555-receives-interim-authorization-from-health-canada-as-a-treatment-for-covid-19-301178310.html", "https://www.prnewswire.com/news-releases/correlia-biosystems-closes-7m-series-a-to-enable-product-launch-301178325.html", "https://www.prnewswire.com/news-releases/the-arnold--itkin-foundation-donates-110-000-to-the-monarch-school-301178366.html", "https://www.prnewswire.com/news-releases/innovent-releases-phase-3-results-of-tyvyt-sintilimab-injection-in-combination-with-byvasda-bevacizumab-biosimilar-injection-as-first-line-treatment-in-patients-with-advanced-hepatocellular-carcinoma-hcc-at-esmo-asia-virtu-301178480.html", "https://www.prnewswire.com/news-releases/innovent-announces-nmpa-granted-new-indication-approval-for-sulinno-adalimumab-injection-in-china-for-the-treatment-of-polyarticular-juvenile-idiopathic-arthritis-301178781.html", "https://www.prnewswire.com/news-releases/panaxia-and-neuraxpharm-expand-strategic-collaboration-to-france-with-medical-cannabis-301178531.html", "https://www.prnewswire.com/news-releases/ascentage-pharma-receives-approvals-for-two-phase-ibii-clinical-studies-of-the-bcl-2-inhibitor-apg-2575-for-the-treatment-of-waldenstrom-macroglobulinemia-and-multiple-myeloma-in-china-301178783.html", "https://www.prnewswire.com/news-releases/sutro-biopharma-announces-encouraging-interim-data-on-stro-002-phase-1-dose-escalation-study-for-patients-with-ovarian-cancer-301186160.html", "https://www.prnewswire.com/news-releases/foxg1-research-foundation-to-pioneer-a-machine-learning-approach-to-accelerate-rare-disease-research-with-support-from-the-chan-zuckerberg-initiative-301178435.html", "https://www.prnewswire.com/news-releases/ad-council-launches-50-million-fund-for-national-covid-19-vaccine-education-effort-301178537.html", "https://www.prnewswire.com/news-releases/isd-immunotech-a-novo-seeds-portfolio-company-enters-strategic-research-collaboration-for-the-development-of-a-novel-lupus-treatment-301178103.html", "https://www.prnewswire.com/news-releases/us-fda-approves-guerbets-optiray-ioversol-injection-imaging-bulk-package-301186226.html", "https://www.prnewswire.com/news-releases/approved-ind-for-alligator-biosciences-cd40-targeting-antibody-mitazalimab-301186398.html", "https://www.prnewswire.com/news-releases/full-sail-university-and-adventhealth-university-named-a-winner-at-iitsecs-annual-iron-dev-competition-301186239.html", "https://www.prnewswire.com/news-releases/subcutaneously-administered-pd-l1-antibody-asc22-envafolimab-is-safe-and-well-tolerated-in-phase-iia-hbv-study-301186235.html", "https://www.prnewswire.com/news-releases/global-infrared-imaging-technology-market-2020-2027-thermal-imaging-as-promising-fever-screening-method-to-dodge-covid-19-storm-301185969.html", "https://www.prnewswire.com/news-releases/tevard-biosciences-and-zogenix-announce-collaboration-to-advance-novel-gene-therapies-for-dravet-syndrome-and-other-genetic-epilepsies-301186221.html", "https://www.prnewswire.com/news-releases/cellular-biomedicine-group-announces-data-to-be-presented-at-2020-ash-annual-meeting-301186475.html", "https://www.prnewswire.com/news-releases/angiocrine-bioscience-announces-oral-presentation-of-ab-205-data-during-the-62nd-annual-meeting-of-the-american-society-of-hematology-ash-301185313.html", "https://www.prnewswire.com/news-releases/polygiene-and-eye-care-innovator-body-doctor-now-increase-the-range-of-soothing-eye-compresses-and-face-masks-301186395.html", "https://www.prnewswire.com/news-releases/ptc-announces-translarna-approval-in-russia-for-the-treatment-of-duchenne-muscular-dystrophy-301186438.html", "https://www.prnewswire.com/news-releases/addus-homecare-completes-acquisition-of-queen-city-hospice-llc-and-affiliate-301186511.html", "https://www.prnewswire.com/news-releases/i-mab-accelerates-clinical-development-of-anti-cd47-monoclonal-antibody-lemzoparlimab-in-the-us-and-china-301186473.html", "https://www.prnewswire.com/news-releases/lilly-and-unitedhealth-group-partner-on-pragmatic-study-of-neutralizing-antibody-bamlanivimab-ly-cov555-for-covid-19-301186265.html", "https://www.prnewswire.com/news-releases/global-acromegaly-and-gigantism-markets-to-2029-top-selling-drug-to-enter-the-market-will-be-camurus-octreotide-la-301186479.html", "https://www.prnewswire.com/news-releases/ucb-demonstrates-commitment-to-science-and-discovery-across-its-epilepsy-portfolio-at-the-american-epilepsy-societys-virtual-event-aes2020-301186406.html", "https://www.prnewswire.com/news-releases/rigel-announces-two-posters-highlighting-tavalisse-at-the-62nd-ash-annual-meeting--exposition-301186305.html", "https://www.prnewswire.com/news-releases/the-medical-opportunity-flying-under-wall-streets-radar-301186274.html", "https://www.prnewswire.com/news-releases/bulletin-from-the-extraordinary-general-meeting-in-oncopeptides-ab-publ-301186581.html", "https://www.prnewswire.com/news-releases/olympus-grows-respiratory-portfolio-with-acquisition-of-veran-medical-technologies-inc-301186561.html", "https://www.prnewswire.com/news-releases/new-studies-call-attention-to-effects-of-structural-inequities-on-health-in-america-301186619.html", "https://www.prnewswire.com/news-releases/data-from-the-apollo-study-show-clinically-meaningful-response-with-darzalex-faspro-daratumumab-and-hyaluronidase-fihj-regimen-after-first-or-subsequent-relapse-in-multiple-myeloma-301186644.html", "https://www.prnewswire.com/news-releases/global-15-2-billion-pharmaceutical-packaging-equipment-market-to-2027-covid-19-to-restructure-the-pharmaceutical-supply-chain-management-301186485.html", "https://www.prnewswire.com/news-releases/cytosorbents-startet-internationale-kampagne-will-100-000-dollar-fur-die-weltweit-tatige-humanitare-organisation-care-sammeln-829039618.html", "https://www.prnewswire.com/news-releases/clinical-trials-offer-opportunities-to-change-practice-to-improve-prevention-and-treatment-of-blood-disorders-301186655.html", "https://www.prnewswire.com/news-releases/la-care-and-blue-shield-promise-unveil-new-community-resource-center-in-metro-la-mark-opening-with-drive-thru-and-walk-up-food-pantry-301186576.html", "https://www.prnewswire.com/news-releases/l-a-care-and-blue-shield-promise-unveil-new-community-resource-center-in-metro-l-a-mark-opening-with-drive-thru-and-walk-up-food-pantry-807125121.html", "https://www.prnewswire.com/news-releases/global-charities-join-forces-to-drive-forward-new-drug-for-parkinsons-301178988.html", "https://www.prnewswire.com/news-releases/national-institute-of-allergy-and-infectious-disease-niaid-selects-metabolon-inc-for-covid-19-study-301178577.html", "https://www.prnewswire.com/news-releases/neurana-pharmaceuticals-announces-publication-in-the-journal-of-pain-research-301178979.html", "https://www.prnewswire.com/news-releases/frontage-laboratories-in-exton-is-offering-covid-19-rt-pcr-and-igm-antibody-testing-with-fast-turnaround-time-301178850.html", "https://www.prnewswire.com/news-releases/advarra-acquires-longboat-a-leading-provider-of-site-training-protocol-compliance-and-patient-engagement-solutions-301178680.html", "https://www.prnewswire.com/news-releases/atai-life-sciences-announces-closing-of-125-million-series-c-financing-round-301178915.html", "https://www.prnewswire.com/news-releases/pulmonary-fibrosis-researcher-wins-nih-award-301178965.html", "https://www.prnewswire.com/news-releases/fda-expands-approval-of-influenza-treatment-to-post-exposure-prevention-301179053.html", "https://www.prnewswire.com/news-releases/equality-health-expands-value-based-care-model-into-texas-301178995.html", "https://www.prnewswire.com/news-releases/new-medical-school-campus-slated-for-temple-texas-301178996.html", "https://www.prnewswire.com/news-releases/viatris-inc-announces-fda-tentative-approval-of-a-pediatric-formulation-of-dolutegravir-dtg-under-pepfar-301179208.html", "https://www.prnewswire.com/news-releases/frontline-mna-nurses-and-healthcare-professionals-voice-concerns-regarding-hospital-preparedness-and-policies-in-response-to-covid-19-second-surge-301179108.html", "https://www.prnewswire.com/news-releases/psoriatic-arthritis-disease-overview-epidemiology-and-disease-management-forecasts-301179096.html", "https://www.prnewswire.com/news-releases/armor-health-invests-in-correctional-healthcares-first-ever-chief-infection-prevention-officer-301178546.html", "https://www.prnewswire.com/news-releases/brainstorm-to-present-nurown-phase-3-clinical-trial-results-at-31st-international-symposium-on-alsmnd-301178803.html", "https://www.prnewswire.com/news-releases/wellcare-of-florida-earns-high-marks-in-cms-2021-star-ratings-report-301178280.html", "https://www.prnewswire.com/news-releases/wellcare-of-california-earns-high-marks-in-cms-2021-star-ratings-report-301178203.html", "https://www.prnewswire.com/news-releases/oneoncology-partners-with-genentech-to-bring-personalized-cancer-research-to-patients-at-community-oncology-sites-301178283.html", "https://www.prnewswire.com/news-releases/the-valens-company-receives-health-canada-license-amendment-to-commence-operations-at-second-white-label-and-custom-manufacturing-facility-in-kelowna-301179283.html", "https://www.prnewswire.com/news-releases/ipa-selects-polytope-formulations-for-pre-clinical-studies-301178805.html", "https://www.prnewswire.com/news-releases/health-net-earns-high-marks-in-cms-2021-star-ratings-report-301178277.html", "https://www.prnewswire.com/news-releases/canopy-growth-announces-completion-of-study-on-the-long-term-effects-of-cbd-301178311.html", "https://www.prnewswire.com/news-releases/gemvax--kael-reports-further-positive-data-from-gv1001-phase-ii-alzheimers-disease-trial-301178368.html", "https://www.prnewswire.com/news-releases/actinium-highlights-foundational-patents-covering-the-composition-of-apamistamab-antibody-and-iomab-b-antibody-radiation-conjugate-for-targeted-conditioning-until-2037-and-recent-eu-patent-activity-301178595.html", "https://www.prnewswire.com/news-releases/bio-me-and-siolta-therapeutics-to-collaborate-on-developing-microbiome-based-pediatric-allergy-and-asthma-test-301178828.html", "https://www.prnewswire.com/news-releases/eiger-biopharmaceuticals-sells-priority-review-voucher-for-95-million-301178619.html", "https://www.prnewswire.com/news-releases/blueprint-medicines-to-present-broad-range-of-data-reinforcing-commitment-to-advance-patient-care-in-systemic-mastocytosis-at-62nd-ash-annual-meeting-and-exposition-301178542.html", "https://www.prnewswire.com/news-releases/inovio-announces-dosing-of-first-subject-in-phase-12-clinical-trial-for-ino-3107-its-dna-medicine-to-treat-a-rare-disease-recurrent-respiratory-papillomatosis-rrp-301178618.html", "https://www.prnewswire.com/news-releases/amgen-to-transition-development-and-commercial-rights-for-omecamtiv-mecarbil-and-amg-594-to-cytokinetics-301178604.html", "https://www.prnewswire.com/news-releases/3sbio-inc-received-milestone-payment-of-usd-4-million-upon-commencement-of-phase-iii-clinical-program-of-sel-212-301178849.html", "https://www.prnewswire.com/news-releases/proceeds-from-priority-review-voucher-sale-will-fund-search-for-cure-for-the-rapid-aging-disease-progeria-301178837.html", "https://www.prnewswire.com/news-releases/valencia-technologies-announces-best-in-category-prize-for-oab-at-the-ics-2020-meeting-for-the-ecoin-peripheral-neurostimulator-301178645.html", "https://www.prnewswire.com/news-releases/halozyme-raises-full-year-2020-guidance-301178597.html", "https://www.prnewswire.com/news-releases/rigel-and-medison-announce-health-canada-approval-of-tavalisse-an-oral-medication-for-the-treatment-of-adults-with-chronic-immune-thrombocytopenia-301178615.html", "https://www.prnewswire.com/news-releases/arizona-biotech-company-successfully-completes-pre-clinical-testing-for-vaccine-alternative-to-prevent-covid-19-infection-ready-for-human-trials-301178419.html", "https://www.prnewswire.com/news-releases/signify-health-acquires-patientblox-to-accelerate-prospective-episode-of-care-payment-models-advance-transition-to-value-based-care-301178579.html", "https://www.prnewswire.com/news-releases/anixa-biosciences-and-cleveland-clinic-file-ind-application-for-breast-cancer-vaccine-301178420.html", "https://www.prnewswire.com/news-releases/national-comprehensive-cancer-network-adds-inqovi-decitabine-and-cedazuridine-tablets-to-its-clinical-practice-guidelines-in-oncology-for-myelodysplastic-syndromes-301178152.html", "https://www.prnewswire.com/news-releases/neurelis-completes-pre-ind-meeting-with-fda-to-establish-clinical-development-program-for-nrl-4-in-the-treatment-of-acute-agitation-associated-with-schizophrenia-and-bipolar-1-mania-in-adults-301178508.html", "https://www.prnewswire.com/news-releases/persephone-biosciences-initiates-the-argonaut-study-of-gut-microbiome-linked-immune-modulation-in-cancer-treatment-response-301178470.html", "https://www.prnewswire.com/news-releases/maplight-therapeutics-announces-completion-of-dosing-in-phase-1-study-of-therapy-for-social-deficit-in-autism-spectrum-disorder-301178418.html", "https://www.prnewswire.com/news-releases/rapid-medical-expands-comaneci-ce-mark-indication-to-include-vasospasm-treatment-301178697.html", "https://www.prnewswire.com/news-releases/more-stringent-testing-is-needed-as-regions-head-for-more-lockdowns-301178624.html", "https://www.prnewswire.com/news-releases/nuvaira-announces-published-two-year-results-in-copd-patients-treated-with-targeted-lung-denervation-301178227.html", "https://www.prnewswire.com/news-releases/cigna-affordable-care-act-health-plans-to-expand-into-63-new-counties-across-north-carolina-for-2021-301178386.html", "https://www.prnewswire.com/news-releases/biocytogen-enters-into-renmabrenlite-licensing-agreement-with-xencor-301186725.html", "https://www.prnewswire.com/news-releases/biocytogen-entre-dans-un-accord-de-licence-renlite-tm-renlite-tm-avec-xencor-858849946.html", "https://www.prnewswire.com/news-releases/nuvaira-anuncia-resultados-publicados-de-dos-anos-en-pacientes-con-epoc-tratados-con-denervacion-pulmonar-dirigida-889028479.html", "https://www.prnewswire.com/news-releases/precigen-presents-new-data-supporting-the-safety-clinical-activity-expansion-and-persistence-of--prgn-3006-ultracar-t-at-the-62nd-ash-annual-meeting-and-exposition-301186957.html", "https://www.prnewswire.com/news-releases/sierra-oncology-announces-momelotinib-data-for-intermediate--high-risk-myelofibrosis-patients-with-lower-baseline-platelet-counts-301186719.html", "https://www.prnewswire.com/news-releases/new-darzalex-daratumumab-data-from-griffin-study-show-deeper-and-longer-responses-in-patients-with-newly-diagnosed-multiple-myeloma-301187387.html", "https://www.prnewswire.com/news-releases/jill-and-eddie-vedder-and-friends-raise-more-than-1-8-million-for-eb-research-partnership-to-find-a-cure-for-epidermolysis-bullosa-301178879.html", "https://www.prnewswire.com/news-releases/sutro-biopharma-presents-data-from-ongoing-phase-1-dose-escalation-study-for-stro-001-for-the-treatment-of-b-cell-non-hodgkin-lymphoma-at-the-62nd-american-society-of-hematology-annual-meeting-301187393.html", "https://www.prnewswire.com/news-releases/eisai-presents-long-term-seizure-freedom-and-real-world-data-related-to-anti-epileptic-drug-fycompa-at-the-aes-2020-annual-meeting-301187397.html", "https://www.prnewswire.com/news-releases/venice-family-clinic-and-ucla-collaborate-to-reduce-food-insecurity-during-the-pandemic-delivering-nearly-13-000-free-meals-weekly-to-people-in-need-301187208.html", "https://www.prnewswire.com/news-releases/protagonist-announces-results-of-large-scale-analysis-of-current-treatment-patterns-revealing-significant-opportunity-to-improve-the-standard-of-care-for-patients-with-polycythemia-vera-across-broad-population-categories-301187391.html", "https://www.prnewswire.com/news-releases/survey-finds-telehealth-is-convenient-alternative-to-in-person-hcp-visits-will-likely-continue-beyond-the-pandemic-301187425.html", "https://www.prnewswire.com/news-releases/data-published-in-nature-cancer-highlight-preclinical-proof-of-concept-of-bolt-biotherapeutics-boltbody-isac-platform-301187427.html", "https://www.prnewswire.com/news-releases/new-study-shows-race-may-not-be-needed-to-accurately-estimate-kidney-function-301187492.html", "https://www.prnewswire.com/news-releases/ground-breaking-human-trial-for-covid-19-ultra-rapid-breath-test-begins-in-india-301187497.html", "https://www.prnewswire.com/news-releases/durect-corporation-to-sell-its-lactel-absorbable-polymer-product-line-to-evonik-for-15-million-301187460.html", "https://www.prnewswire.com/news-releases/maternal-anxiety-affects-the-fetal-brain-301187525.html", "https://www.prnewswire.com/news-releases/theresa-yuraszeck-joins-applied-biomath-llc-as-director-of-pharmacometrics-and-clinical-pharmacology-301187506.html", "https://www.prnewswire.com/news-releases/karyopharm-presents-xpovio-selinexor-data-in-multiple-myeloma-and-diffuse-large-b-cell-lymphoma-at-the-american-society-of-hematology-2020-annual-meeting-301187571.html", "https://www.prnewswire.com/news-releases/synlogic-presents-synb8802-for-enteric-hyperoxaluria-at-the-american-institute-of-chemical-engineers-conference-on-microbiome-engineering-301187531.html", "https://www.prnewswire.com/news-releases/curis-announces-updated-preliminary-data-from-ongoing-phase-1-study-of-ca-4948-showing-durable-and-dose-dependent-reductions-in-tumor-burden-in-patients-with-relapsed-or-refractory-non-hodgkins-lymphoma-301187546.html", "https://www.prnewswire.com/news-releases/stonebridge-healthcare-makes-bid-to-acquire-care-new-england-health-system-301187518.html", "https://www.prnewswire.com/news-releases/adaptas-solutions-acquires-cadence-fluidics-301187575.html", "https://www.prnewswire.com/news-releases/traditions-health-acquires-centennial-hospice-301187544.html", "https://www.prnewswire.com/news-releases/adexusdx-covid-19-antibody-test-filed-for-emergency-use-authorization-confirmed-100-accurate-with-bei-panel-301187697.html", "https://www.prnewswire.com/news-releases/worldwide-prostate-cancer-industry-to-2024---rising-public-awareness-towards-prostate-cancer-treatment-is-driving-growth-301187428.html", "https://www.prnewswire.com/news-releases/hoag-brings-groundbreaking-cancer-treatment-technology-to-orange-county-301187615.html", "https://www.prnewswire.com/news-releases/global-71-3-bn-gastrointestinal-drugs-market-to-2027-increasing-investment-in-research-activities-and-growing-pipeline-of-gi-candidates-301187447.html", "https://www.prnewswire.com/news-releases/karyopharm-announces-presentation-of-new-xpovio-selinexor-data-in-patients-with-acute-myeloid-leukemia-at-the-american-society-of-hematology-2020-annual-meeting-301187650.html", "https://www.prnewswire.com/news-releases/arena-pharmaceuticals-achieves-target-enrollment-for-etrasimod-phase-3-elevate-uc-52-trial-301187942.html", "https://www.prnewswire.com/news-releases/nektar-therapeutics-announces-presentation-of-preclinical-data-for-nktr-255-its-novel-il-15-agonist-at-the-american-society-of-hematology-ash-2020-annual-meeting-301187695.html", "https://www.prnewswire.com/news-releases/supply-chain-readies-to-deliver-9-million-covid-19-vaccines-per-day-marking-2021-as-the-year-of-cold-chain-logistics-301188077.html", "https://www.prnewswire.com/news-releases/statement-of-support-for-us-fda-science--evidence-based-review-and-approval-of-covid-19-vaccines-for-use-in-the-us-301187696.html", "https://www.prnewswire.com/news-releases/researchers-see-promising-results-reversing-covid-19--ards--related-lung-damage-using-apelindx-broad-spectrum-cbd-inhaler-301188187.html", "https://www.prnewswire.com/news-releases/open-book-extracts-acquires-us-patent-for-smokable-applications-of-terpenoids-301188268.html", "https://www.prnewswire.com/news-releases/why-psychedelic-drugs-market-is-expected-to-see-overwhelming-growth-in-coming-years-301187938.html", "https://www.prnewswire.com/news-releases/health-crisis-induced-post-traumatic-stress-disorder-creates-growing-need-for-treatment-options-301187941.html", "https://www.prnewswire.com/news-releases/cyxone-receives-regulatory-approval-to-initiate-a-clinical-phase-2-study-with-rabeximod-in-covid-19-patients-301188427.html", "https://www.prnewswire.com/news-releases/ixlayer-technology-selected-for-chan-zuckerberg-biohub-and-stanford-medicine-covid-19-research-collaboration-301187878.html", "https://www.prnewswire.com/news-releases/vivalnk-expands-medical-data-platform-as-it-experiences-rapid-growth-in-remote-patient-monitoring-worldwide-301187984.html", "https://www.prnewswire.com/news-releases/sendaride-commended-by-frost--sullivan-for-leading-the-evolution-toward-complex-healthcare-mobility-with-its-advanced-nemt-platform-301186906.html", "https://www.prnewswire.com/news-releases/as-vaccine-distribution-begins-npta-launches-the-nations-most-affordable-accessible--scalable-immunization-administration-training-program-301188396.html", "https://www.prnewswire.com/news-releases/amgens-sotorasib-granted-breakthrough-therapy-designation-for-advanced-or-metastatic-non-small-cell-lung-cancer-patients-with-kras-g12c-mutation-301187803.html", "https://www.prnewswire.com/news-releases/ampio-pharmaceuticals-inc-to-host-its-annual-meeting-on-december-12-2020-301188429.html", "https://www.prnewswire.com/news-releases/piramal-pharma-solutions-invests-32-million-to-expand-its-riverview-michigan-facility-for-additional-capacity-in-potent-and-non-potent-api-development-and-manufacturing-301188022.html", "https://www.prnewswire.com/news-releases/boost-biomes-announces-extension-of-series-a-with-new-investor-universal-materials-incubator-301187215.html", "https://www.prnewswire.com/news-releases/aicure-launches-new-data-dashboards-to-improve-visibility-into-patient-behavior-and-site-performance-301187777.html", "https://www.prnewswire.com/news-releases/citius-pharmaceuticals-subsidiary-novecite-announces-data-from-a-study-of-induced-mesenchymal-stem-cell-i-msc-therapy-in-an-in-vivo-model-of-acute-respiratory-distress-syndrome-ards-301188345.html", "https://www.prnewswire.com/news-releases/remedy-health-media-acquires-patient-power-301188334.html", "https://www.prnewswire.com/news-releases/keystone-healthcare-invests-in-talent-and-technology-for-growth-in-2021-301188494.html", "https://www.prnewswire.com/news-releases/caris-life-sciences-publishes-new-data-in-clinical-cancer-research-demonstrating-71-difference-in-overall-survival-for-mcrc-patients-using-its-ai-based-mi-folfoxai-predictor-301188480.html", "https://www.prnewswire.com/news-releases/innovent-announces-parsaclisib-treatment-results-in-high-rate-of-rapid-and-durable-responses-in-patients-with-relapsed-or-refractory-b-cell-non-hodgkin-lymphomas-301187349.html", "https://www.prnewswire.com/news-releases/ellipsis-health-partners-with-menlo-college-for-voice-based-student-behavioral-health-symptom-identification-301188488.html", "https://www.prnewswire.com/news-releases/compugroup-medical-acquires-schuyler-house-and-its-successful-laboratory-information-system-schuylab-301187746.html", "https://www.prnewswire.com/news-releases/novartis-investigational-stamp-inhibitor-asciminib-abl001-shows-superior-mmr-rate-to-bosulif-in-chronic-myeloid-leukemia-trial-301188521.html", "https://www.prnewswire.com/news-releases/aruvants-data-presented-in-oral-presentation-at-the-62nd-american-society-of-hematology-ash-annual-meeting-demonstrates-promise-of-aru-1801-as-a-potentially-curative-treatment-for-sickle-cell-disease-301187701.html", "https://www.prnewswire.com/news-releases/bluejay-diagnostics-inc-announces-collaboration-agreement-with-toray-industries-inc-to-develop-point-of-care-test-for-covid-19-patient-triage-301186847.html", "https://www.prnewswire.com/news-releases/ascentage-pharma-announces-positive-data-from-pivotal-phase-ii-studies-of-hqp1351-olverembatinib-in-patients-with-tki-resistant-chronic-myeloid-leukemia-cml-at-2020-american-society-of-hematology-ash-annual-meeting-301187820.html", "https://www.prnewswire.com/news-releases/carrier-signs-definitive-agreement-to-sell-remaining-stake-in-beijer-ref-ab-301187750.html", "https://www.prnewswire.com/news-releases/irlab-strengthens-patent-protection-for-phase-iibiii-drug-candidate-mesdopetam-301188036.html", "https://www.prnewswire.com/news-releases/hadassah-medical-center-and-neurogenesis-announce-groundbreaking-results-from-a-phase-2-study-in-progressive-multiple-sclerosis-treated-with-ng-01-autologous-cells-therapy-301187619.html", "https://www.prnewswire.com/news-releases/vicore-pharma-reports-positive-top-line-data-from-the-attract-clinical-study-in-patients-with-covid-19-301188014.html", "https://www.prnewswire.com/news-releases/remix-therapeutics-launches-with-81-million-financing-to-develop-small-molecule-therapies-designed-to-reprogram-rna-processing-301187843.html", "https://www.prnewswire.com/news-releases/nuance-pharma-closes-series-d-financing-301188075.html", "https://www.prnewswire.com/news-releases/nuance-pharma-closes-series-d-financing-301188025.html", "https://www.prnewswire.com/news-releases/mind-cure-announces-its-research-program-with-psychedelic-compounds-301187785.html", "https://www.prnewswire.com/news-releases/thisismbc-perseverance-campaign-from-eisai-and-metavivor-captures-the-joys-difficulties-and-realities-faced-by-people-living-with-metastatic-breast-cancer-301188296.html", "https://www.prnewswire.com/news-releases/curis-announces-positive-preliminary-data-from-ongoing-phase-1-study-of-ca-4948-monotherapy-in-patients-with-relapsed-or-refractory-acute-myeloid-leukemia-and-myelodysplastic-syndromes-301188059.html", "https://www.prnewswire.com/news-releases/centene-completes-acquisition-of-apixio-301188081.html", "https://www.prnewswire.com/news-releases/dcisionrt-by-preludedx-identifies-subset-of-rtog-9804-low-risk-criteria-dcis-patients-who-experienced-84-relative-benefit-with-radiation-301188211.html", "https://www.prnewswire.com/news-releases/peijia-medical-successfully-commenced-animal-study-for-its-mitral-valve-edge-to-edge-repair-product-301187933.html", "https://www.prnewswire.com/news-releases/novaliq-announces-first-patient-randomized-in-the-phase-3-trial-essence-2-of-cyclasol-topical-ophthalmic-solution-for-the-treatment-of-dry-eye-disease-301187240.html", "https://www.prnewswire.com/news-releases/soligenix-demonstrates-extended-protection-with-its-rivax-ricin-toxin-vaccine-301187774.html", "https://www.prnewswire.com/news-releases/abcam-reveals-new-cell-engineering-facility-in-bay-area-301188225.html", "https://www.prnewswire.com/news-releases/ix-biopharma-receives-positive-ema-scientific-advice-for-waferminetm-301187988.html", "https://www.prnewswire.com/news-releases/brainbox-solutions-announces-first-close-in-23-million-in-series-a-financing-to-support-development-and-pivotal-clinical-trial-of-breakthrough-concussion-diagnosticprognostic-test-301187824.html", "https://www.prnewswire.com/news-releases/actinium-reports-67-percent-overall-response-rate-in-first-cohort-in-actimab-a-venetoclax-combination-trial-in-relapsed-and-refractory-aml-at-ash-301188136.html", "https://www.prnewswire.com/news-releases/ascentage-pharma-announces-first-patient-dosed-in-europe-in-the-phase-ibii-study-of-the-bcl-2-inhibitor-apg-2575-in-patients-with-relapsedrefractory-chronic-lymphocytic-leukemiasmall-lymphocytic-lymphoma-301180210.html", "https://www.prnewswire.com/news-releases/rosen-a-leading-law-firm-reminds-intercept-pharmaceuticals-inc-investors-of-important-january-4-deadline-in-securities-class-action-encourages-investors-with-losses-in-excess-of-100k-to-contact-firm--icpt-301180146.html", "https://www.prnewswire.com/news-releases/life-time-and-other-minnesota-health-and-fitness-operators-call-for-walz-administration-to-reconsider-closure-of-health-clubs-301180198.html", "https://www.prnewswire.com/news-releases/henlius-adalimumab-biosimilar-approved-by-nmpa-301187891.html", "https://www.prnewswire.com/news-releases/rhovacs-prostate-cancer-drug-candidate-rv001-is-granted-fast-track-designation-by-the-fda-301180409.html", "https://www.prnewswire.com/news-releases/janssen-korea-ltd-and-johnson--johnson-innovation-announce-awardees-of-the-seoul-innovation-quickfire-challenge-on-healthcare-for-the-new-normal-in-collaboration-with-the-seoul-metropolitan-government-and-korea-health-industry-d-301178248.html", "https://www.prnewswire.com/news-releases/inmed-announces-election-of-directors-301180215.html", "https://www.prnewswire.com/news-releases/medalliance-anuncia-la-finalizacion-con-exito-de-la-inscripcion-en-el-ensayo-clinico-isabella-para-el-tratamiento-de-fistulas-av-disfuncionales-en-pacientes-en-hemodialisis-805195407.html", "https://www.prnewswire.com/news-releases/first-elastomeric-respirator-without-exhalation-valve-approved-by-niosh-301180276.html", "https://www.prnewswire.com/news-releases/karyopharm-announces-ongoing-phase-3-siendo-study-of-xpovio-selinexor-in-patients-with-endometrial-cancer-passes-planned-interim-futility-analysis-data-and-safety-monitoring-board-recommends-the-study-should-proceed-as-planned-301180263.html", "https://www.prnewswire.com/news-releases/results-published-from-2-year-study-of-229-wounds-treated-in-an-nhs-clinic-show-fluorescence-point-of-care-imaging-improved-wound-healing-rates-by-23-301179993.html", "https://www.prnewswire.com/news-releases/inmed-announces-results-of-initial-phase-1-clinical-trial-of-inm-755-cbn-cream-in-healthy-subjects-301180502.html", "https://www.prnewswire.com/news-releases/aledade-primary-care-acos-collaboration-with-blue-cross-and-blue-shield-of-kansas-delivers-high-quality-care-and-achieves-significant-savings-301180158.html", "https://www.prnewswire.com/news-releases/polycythemia-vera-market-assumed-to-rise-with-a-significant-cagr-of-9-28-during-the-study-period-2017-30-301180553.html", "https://www.prnewswire.com/news-releases/eiger-biopharmaceuticals-announces-fda-approval-of-zokinvy-lonafarnib-the-first-treatment-for-hutchinson-gilford-progeria-syndrome-and-processing-deficient-progeroid-laminopathies-301180247.html", "https://www.prnewswire.com/news-releases/insurecom-finds-americas-best-health-insurers-surveying-2-200-consumers-301188224.html", "https://www.prnewswire.com/news-releases/sirtex-medical-and-china-grand-pharmaceutical-announce-sir-spheres-y-90-resin-microspheres-milestone-301180624.html", "https://www.prnewswire.com/news-releases/ampio-updates-regulatory-and-clinical-trial-events-301180238.html", "https://www.prnewswire.com/news-releases/tikcro-technologies-announces-2020-annual-general-meeting-301180599.html", "https://www.prnewswire.com/news-releases/gene-therapy-for-hemophilia-b-found-safe-and-effective-in-first-phase-iii-trial-301188620.html", "https://www.prnewswire.com/news-releases/om1-giant-cell-arteritis-registry-reaches-more-than-5-000-patients-prospectively-followed-with-deep-clinical-data-301188577.html", "https://www.prnewswire.com/news-releases/next-frontier-brands-acquires-treehouse-biotech-301188567.html", "https://www.prnewswire.com/news-releases/ghit-fund-announces-new-investments-a-total-of-230-million-yen-in-drugs-for-malaria-and-chagas-disease-301188623.html", "https://www.prnewswire.com/news-releases/chop-researchers-find-elevated-biomarker-related-to-blood-vessel-damage-in-all-children-with-sars-cov-2-regardless-of-disease-severity-301188608.html", "https://www.prnewswire.com/news-releases/filti-launches-nf95-respirator-to-protect-americans-from-harmful-airborne-particles-301188761.html", "https://www.prnewswire.com/news-releases/asciminib-found-safe-and-effective-for-hard-to-treat-chronic-myeloid-leukemia-301188619.html", "https://www.prnewswire.com/news-releases/interim-healthcare-inc-launches-national-made-for-this-campaign-to-recruit-home-healthcare-workers-301188717.html", "https://www.prnewswire.com/news-releases/qebr-acquires-gen-x-fitness-water-301188670.html", "https://www.prnewswire.com/news-releases/freespira-finalizes-10-million-financing-to-support-commercialization-of-digital-therapeutic-for-treatment-of-panic-disorder-and-ptsd-301188637.html", "https://www.prnewswire.com/news-releases/ert-introduces-data-insights-to-improve-study-efficiency-and-effectiveness-301188813.html", "https://www.prnewswire.com/news-releases/neurana-pharmaceuticals-announces-top-line-results-from-tolperisone-phase-1-cns-effects-study-301188774.html", "https://www.prnewswire.com/news-releases/antengene-announces-collaboration-with-applied-biomath-llc-for-systems-pharmacology-modeling-in-oncology-301188049.html", "https://www.prnewswire.com/news-releases/applied-biomath-llc-announces-collaboration-with-antengene-for-systems-pharmacology-modeling-in-oncology-301188861.html", "https://www.prnewswire.com/news-releases/precigen-to-host-rd-update-virtual-event-on-december-15th-to-share-latest-clinical-developments-301188801.html", "https://www.prnewswire.com/news-releases/lipocine-announces-deletion-of-unauthorized-changes-to-companys-website-301188971.html", "https://www.prnewswire.com/news-releases/neurotrope-inc-completes-independent-spin-off-of-neurotrope-bioscience-inc-and-is-renamed-synaptogenix-inc-301188806.html", "https://www.prnewswire.com/news-releases/new-clinical-trial-data-demonstrates-bd-libertas-wearable-injector-as-a-drug-delivery-system-301189047.html", "https://www.prnewswire.com/news-releases/ionis-highlights-achievements-commercial-strategy-and-technology-advancements-at-investor-day-301188979.html", "https://www.prnewswire.com/news-releases/new-publication-from-i-spy-2-trial-highlights-signateras-ability-to-predict-treatment-outcomes-in-neoadjuvant-breast-cancer-patients-301181472.html", "https://www.prnewswire.com/news-releases/lipocine-announces-tentative-approval-of-tlando-301188975.html", "https://www.prnewswire.com/news-releases/citius-announces-results-of-study-that-mino-lok-eradicates-s-aureus-biofilm-more-effectively-and-expeditiously-than-components-301180863.html", "https://www.prnewswire.com/news-releases/harvards-wyss-institute-licenses-its-erapid-technology-to-the-iq-group-global-to-accelerate-the-development-of-covid-19-diagnostics-301180686.html", "https://www.prnewswire.com/news-releases/m12-invests-in-the-future-of-virtual-health-with-andor-health-301181284.html", "https://www.prnewswire.com/news-releases/taiwan-based-enterprises-ap-biosciences-and-luminx-novel-cancer-treatments-301181187.html", "https://www.prnewswire.com/news-releases/population-council-et-duchesnay-annoncent-un-nouvel-accord-de-licence-internationale-pour-annovera-r--878500187.html", "https://www.prnewswire.com/news-releases/hiv-like-virus-edited-out-of-primate-genome-301181680.html", "https://www.prnewswire.com/news-releases/signant-health-acquires-virtrial-to-enhance-its-digital-enablement-of-clinical-research-sites-and-evidence-generation-capabilities-301181547.html", "https://www.prnewswire.com/news-releases/milliman-acquires-dental-actuarial-analytics-expanding-its-dental-consulting-services-to-include-competitive-provider-network-assessments-301181644.html", "https://www.prnewswire.com/news-releases/jetdoc-and-rick-ross-announce-strategic-partnership-301181345.html", "https://www.prnewswire.com/news-releases/titan-pharmaceuticals-announces-reverse-stock-split-301181721.html", "https://www.prnewswire.com/news-releases/headspace-and-kevin-harts-laugh-out-loud-partner-on-a-groundbreaking-content-collaboration-301181418.html", "https://www.prnewswire.com/news-releases/atlantis-academy-coral-springs-expands-to-meet-growing-enrollment-301181724.html", "https://www.prnewswire.com/news-releases/covid-19-vaccine--therapeutics-clinical-trial-analysis-report-2020-regulatory-framework-for-covid-19-therapeutics-and-vaccines-marketing-approvals-301181737.html", "https://www.prnewswire.com/news-releases/amgen-announces-new-data-being-presented-at-ash-2020-301180878.html", "https://www.prnewswire.com/news-releases/fyllo-releases-the-first-study-showing-cannabis-consumer-data-is-foundational-for-mainstream-marketers-301181728.html", "https://www.prnewswire.com/news-releases/worlds-leading-life-science-companies-now-enrolling-community-a-global-platform-trial-for-hospitalized-patients-with-covid-19-301181830.html", "https://www.prnewswire.com/news-releases/ionis-announces-astrazenecas-initiation-of-the-phase-2b-clinical-study-of-its-antisense-medicine-targeting-pcsk9-to-lower-ldl-cholesterol-301181930.html", "https://www.prnewswire.com/news-releases/nordic-nanovector-completes-patient-enrolment-into-phase-1-trial-of-betalutin-in-diffuse-large-b-cell-lymphoma-301182172.html", "https://www.prnasia.com/story/215847-1.shtml", "https://www.prnewswire.com/news-releases/teligent-takes-strategic-steps-to-recapitalize-and-position-business-for-success-301216880.html", "https://www.prnasia.com/story/57300-1.shtml", "https://www.prnewswire.com/news-releases/everest-medicines-initiates-submission-of-new-drug-application-in-singapore-for-sacituzumab-govitecan-hziy-for-the-treatment-of-metastatic-triple-negative-breast-cancer-301202007.html", "https://www.prnasia.com/story/221469-1.shtml", "https://www.prnasia.com/story/53697-1.shtml", "https://www.prnewswire.com/news-releases/thermo-fisher-scientific-to-acquire-point-of-care-molecular-diagnostics-provider-mesa-biotech-301210467.html", "https://www.prnasia.com/story/55706-1.shtml", "https://www.prnewswire.com/news-releases/citius-pharmaceuticals-announces-closing-of-20-0-million-private-placement-offering-priced-at-the-market-301216476.html", "https://www.prnasia.com/story/215752-1.shtml", "https://www.prnasia.com/story/223787-1.shtml", "https://www.prnewswire.com/news-releases/the-worldwide-pharmaceutical-membrane-filtration-industry-is-estimated-to-reach-10-2-billion-by-2025--301210720.html", "https://www.prnasia.com/story/215817-1.shtml", "https://www.prnewswire.com/news-releases/depuy-synthes-receives-510k-fda-clearance-for-velys-robotic-assisted-solution-designed-for-use-with-the-attune-total-knee-system-301210276.html", "https://www.prnewswire.com/news-releases/the-little-known-tech-that-could-transform-healthcare-301210441.html", "https://www.prnewswire.com/news-releases/imvax-announces-publication-of-phase-1b-clinical-trial-of-igv-001-for-patients-with-newly-diagnosed-glioblastoma-in-clinical-cancer-research-301215325.html", "https://www.prnasia.com/story/223837-1.shtml", "https://www.prnewswire.com/news-releases/aimls-health-gauge-announces-successful-proof-of-concept-deployment-and-findings-for-study-funded-by-the-bill-and-melinda-gates-foundation-301215129.html", "https://www.prnasia.com/story/215900-1.shtml", "https://www.prnasia.com/story/221444-1.shtml", "https://www.prnewswire.com/news-releases/jazz-pharmaceuticals-announces-initiation-of-biologics-license-application-submission-for-jzp-458-for-the-treatment-of-acute-lymphoblastic-leukemia-or-lymphoblastic-lymphoma-301196718.html", "https://www.prnewswire.com/news-releases/pieces-acquires-bowtie-business-intelligence-to-fuel-continued-growth-and-fulfill-data-driven-mission-of-creating-healthier-communities-301212186.html", "https://www.prnewswire.com/news-releases/sumitomo-dainippon-pharma-oncology-announces-first-patient-dosed-in-phase-12-study-of-tp-0184-for-the-treatment-of-anemia-in-patients-with-low-or-intermediate-risk-myelodysplastic-syndromes-301209572.html", "https://www.prnasia.com/story/223689-1.shtml", "https://www.prnasia.com/story/223677-1.shtml", "https://www.prnasia.com/story/30304-1.shtml", "https://www.prnewswire.com/news-releases/vero-biotech-secures-50-million-funding-from-runway-growth-capital-301210525.html", "https://www.prnasia.com/story/57609-1.shtml", "https://www.prnewswire.com/news-releases/aikido-pharma-secures-early-interest-in-next-generation-radiotherapy-301218840.html", "https://www.prnasia.com/story/216027-1.shtml", "https://www.prnewswire.com/news-releases/immunexpress-presents-data-further-demonstrating-septicyte-rapid-performance-at-the-society-of-critical-care-medicines-50th-annual-critical-care-congress-301218950.html", "https://www.prnasia.com/story/307275-1.shtml", "https://www.prnasia.com/story/307328-1.shtml", "https://www.prnasia.com/story/304893-1.shtml", "https://www.prnewswire.com/news-releases/future-meat-technologies-reduces-cost-of-cultured-chicken-breast-below-10-301218910.html", "https://www.prnasia.com/story/307291-1.shtml", "https://www.prnasia.com/story/307344-1.shtml", "https://www.prnewswire.com/news-releases/creative-medical-technology-holdings-identifies-and-files-patent-on-novel-mechanism-of-immcelz-therapeutic-activity-301218826.html", "https://www.prnasia.com/story/307297-1.shtml", "https://www.prnewswire.com/news-releases/lilly-partners-with-area-health-systems-to-help-enable-access-to-important-antibody-infusion-therapies-for-covid-19-patients-301218598.html", "https://www.prnewswire.com/news-releases/positive-early-study-results-help-pave-wave-for-titan-pharmaceuticals-to-move-forward-with-its-jt-09-proneura-development-program-301218731.html", "https://www.prnasia.com/story/304869-1.shtml", "https://www.prnewswire.com/news-releases/atcc-announces-award-of-hiv-reagent-program-301218842.html", "https://www.prnasia.com/story/307377-1.shtml", "https://www.prnasia.com/story/307393-1.shtml", "https://www.prnasia.com/story/307273-1.shtml", "https://www.prnasia.com/story/307280-1.shtml", "https://www.prnewswire.com/news-releases/welsh-carson-anderson--stowe-commits-250-million-in-a-strategic-partnership-with-kiniciti-a-newly-formed-platform-investing-in-cell-and-gene-therapy-companies-301218733.html", "https://www.prnewswire.com/news-releases/moleculin-signs-agreement-with-catalyst-clinical-research-to-begin-sarcoma-trial-301218801.html", "https://cnmobile.prnasia.com/story/307351-1.shtml", "https://www.prnewswire.com/news-releases/galderma-receives-fda-approval-for-restylane-defyne-for-chin-augmentation-301218796.html", "https://www.prnewswire.com/news-releases/q-biomed-expands-strontium89-reach-through-agreement-with-urogpo-the-largest-group-purchasing-organization-for-independent-urology-clinics-in-the-us-301218687.html", "https://www.prnasia.com/story/307313-1.shtml", "https://cnmobile.prnasia.com/story/307413-1.shtml", "https://www.prnasia.com/story/304775-1.shtml", "https://www.prnewswire.com/news-releases/march-of-dimes-names-dr-michael-georgieff-as-2020-agnes-higgins-award-recipient-301218629.html", "https://www.prnasia.com/story/307294-1.shtml", "https://cnmobile.prnasia.com/story/304789-1.shtml", "https://www.prnasia.com/story/302344-1.shtml", "https://www.prnasia.com/story/304872-1.shtml", "https://www.prnasia.com/story/302374-1.shtml", "https://www.prnasia.com/story/304895-1.shtml", "https://www.prnewswire.com/news-releases/marizyme-inc-strengthens-senior-management-team-with-two-appointments-roger-schaller-evp-commercial-operations-and-amy-chandler-evp-regulatory-affairs-and-quality-management-systems-301218809.html", "https://www.prnasia.com/story/304980-1.shtml", "https://www.prnasia.com/story/302281-1.shtml", "https://www.prnewswire.com/news-releases/annexus-health-launches-financial-assistance-cycle-management-outsourcing-services-amid-ongoing-expansion-301218626.html", "https://www.prnasia.com/story/302352-1.shtml", "https://www.prnewswire.com/news-releases/introducing-ismartoffice-the-first-ai-driven-dental-practice-management-and-marketing-3-in-1-integrated-solution-301218959.html", "https://www.prnasia.com/story/302354-1.shtml", "https://www.prnasia.com/story/304938-1.shtml", "https://www.prnasia.com/story/302441-1.shtml", "https://www.prnasia.com/story/300484-1.shtml", "https://www.prnewswire.com/news-releases/neogen-relaunches-fda-approved-thyrokare-tablets-for-dogs-301218994.html", "https://www.prnasia.com/story/304925-1.shtml", "https://www.prnasia.com/story/302405-1.shtml", "https://www.prnasia.com/story/302315-1.shtml", "https://www.prnewswire.com/news-releases/choroideremia-research-foundation-supports-new-research-to-expand-knowledge-of-this-rare-inherited-retinal-disease-301218905.html", "https://www.prnasia.com/story/302355-1.shtml", "https://www.prnewswire.com/news-releases/smart-study-finds-22q11-2-microdeletion-prevalence-much-higher-than-expected-301218829.html", "https://www.prnasia.com/story/304984-1.shtml", "https://www.prnasia.com/story/304928-1.shtml", "https://www.prnewswire.com/news-releases/cadwell-industries-inc-acquires-the-sleepmate-line-of-sleep-diagnostic-sensors-from-ambu-as-301217406.html", "https://www.prnasia.com/story/300473-1.shtml", "https://www.prnewswire.com/news-releases/ampio-announces-early-positive-data-in-phase-1-trial-of-inhaled-ampion-in-covid-19-respiratory-distress-301219046.html", "https://www.prnasia.com/story/304436-1.shtml", "https://www.prnasia.com/story/304415-1.shtml", "https://www.prnasia.com/story/300522-1.shtml", "https://www.prnewswire.com/news-releases/migraine-patients-with-high-deductible-commercial-healthcare-plans-to-benefit-from-upsher-smiths-expanded-access-pathways-program-301218581.html", "https://www.prnasia.com/story/304322-1.shtml", "https://www.prnasia.com/story/300603-1.shtml", "https://www.prnasia.com/story/300489-1.shtml", "https://www.prnewswire.com/news-releases/therapeutic-solutions-international-reports-therapeutic-efficacy-of-stemvacs-derived-exosomes-in-regression-of-glioma-301219050.html", "https://www.prnasia.com/story/302442-1.shtml", "https://www.prnasia.com/story/304419-1.shtml", "https://www.prnasia.com/story/300666-1.shtml", "https://www.prnasia.com/story/304434-1.shtml", "https://www.prnewswire.com/news-releases/college-and-covid-survey-reveals-pain-and-persistence-301219069.html", "https://www.prnewswire.com/news-releases/hope-community-resources-deploys-fieldcentric-a-mobile-first-employee-engagement-and-work-portal-to-direct-support-teams-serving-individuals-with-disabilities-and-complex-medical-conditions-in-communities-across-alaska-301218509.html", "https://www.prnasia.com/story/300642-1.shtml", "https://cnmobile.prnasia.com/story/304345-1.shtml", "https://www.prnasia.com/story/300638-1.shtml", "https://cnmobile.prnasia.com/story/304346-1.shtml", "https://www.prnewswire.com/news-releases/new-dupixent-dupilumab-data-showcasing-improvements-across-four-type-2-inflammatory-diseases-to-be-presented-at-2021-aaaai-annual-meeting-301219091.html", "https://www.prnasia.com/story/300630-1.shtml", "https://www.prnasia.com/story/302233-1.shtml", "https://www.prnasia.com/story/300616-1.shtml", "https://www.prnasia.com/story/301736-1.shtml", "https://www.prnasia.com/story/301742-1.shtml", "https://www.prnasia.com/story/301797-1.shtml", "https://www.prnasia.com/story/300622-1.shtml", "https://www.prnasia.com/story/301900-1.shtml", "https://www.prnewswire.com/news-releases/new-haven---a-texas-based-senior-living-company-acquires-memory-care-facility-in-kerrville-texas-301219177.html", "https://www.prnasia.com/story/301946-1.shtml", "https://www.prnasia.com/story/301833-1.shtml", "https://www.prnasia.com/story/301765-1.shtml", "https://www.prnasia.com/story/302257-1.shtml", "https://www.prnasia.com/story/301862-1.shtml", "https://www.prnewswire.com/news-releases/new-study-shows-african-american-families-overwhelmingly-want-a-choice-in-their-childrens-public-school-regardless-of-geographic-boundaries-301219180.html", "https://www.prnasia.com/story/301739-1.shtml", "https://www.prnasia.com/story/301877-1.shtml", "https://www.prnasia.com/story/301840-1.shtml", "https://www.prnasia.com/story/297655-1.shtml", "https://www.prnasia.com/story/293238-1.shtml", "https://www.prnasia.com/story/297627-1.shtml", "https://www.prnasia.com/story/293333-1.shtml", "https://www.prnasia.com/story/293361-1.shtml", "https://www.prnewswire.com/news-releases/life-biosciences-appoints-joan-mannick-md-to-lead-its-research-and-development-301219323.html", "https://www.prnasia.com/story/297628-1.shtml", "https://www.prnasia.com/story/293241-1.shtml", "https://www.prnasia.com/story/297636-1.shtml", "https://www.prnasia.com/story/293317-1.shtml", "https://www.prnasia.com/story/297619-1.shtml", "https://www.prnasia.com/story/297605-1.shtml", "https://www.prnasia.com/story/293198-1.shtml", "https://www.prnasia.com/story/297609-1.shtml", "https://www.prnewswire.com/news-releases/inland-empire-health-plan-celebrates-top-workplace-award-301219239.html", "https://www.prnasia.com/story/297653-1.shtml", "https://www.prnasia.com/story/293330-1.shtml", "https://www.prnasia.com/story/297642-1.shtml", "https://cnmobile.prnasia.com/story/297616-1.shtml", "https://www.prnasia.com/story/293371-1.shtml", "https://www.prnasia.com/story/299250-1.shtml", "https://www.prnasia.com/story/299359-1.shtml", "https://www.prnewswire.com/news-releases/ilias-biologics-announces-the-2nd-poc-study-showing-anti-inflammatory-effects-of-ilb202-on-preterm-birth-301218930.html", "https://www.prnasia.com/story/299270-1.shtml", "https://www.prnasia.com/story/299369-1.shtml", "https://www.prnasia.com/story/299342-1.shtml", "https://www.prnasia.com/story/297631-1.shtml", "https://www.prnewswire.com/news-releases/lipocine-announces-uspto-declaration-of-interference-between-lipocine-and-clarus-patent-applications-301208039.html", "https://www.prnasia.com/story/299336-1.shtml", "https://www.prnasia.com/story/299436-1.shtml", "https://www.prnasia.com/story/299524-1.shtml", "https://www.prnasia.com/story/299587-1.shtml", "https://www.prnasia.com/story/299227-1.shtml", "https://www.prnasia.com/story/299550-1.shtml", "https://www.prnasia.com/story/299357-1.shtml", "https://www.prnasia.com/story/299408-1.shtml", "https://www.prnasia.com/story/299589-1.shtml", "https://www.prnasia.com/story/299417-1.shtml", "https://www.prnewswire.com/news-releases/exacis-biotherapeutics-announces-its-launch-and-mrna-technology-in-licensing-for-targeted-car-nk-and-car-t-cell-cancer-therapies-301202174.html", "https://www.prnasia.com/story/299290-1.shtml", "https://www.prnewswire.com/news-releases/10-million-grant-from-exact-sciences-to-support-stand-up-to-cancer-initiative-to-improve-colorectal-cancer-screening-and-prevention-301194743.html", "https://www.prnewswire.com/news-releases/cedar-gate-technologies-acquires-deerwalk-301193611.html", "https://www.prnasia.com/story/299577-1.shtml", "https://www.prnasia.com/story/296474-1.shtml", "https://www.prnasia.com/story/296521-1.shtml", "https://www.prnasia.com/story/296532-1.shtml", "https://www.prnasia.com/story/299544-1.shtml", "https://www.prnasia.com/story/296471-1.shtml", "https://www.prnasia.com/story/296484-1.shtml", "https://www.prnewswire.com/news-releases/biohavens-nurtec-odt-partners-with-the-rick-ware-racing-team-in-the-2021-nascar-cup-series-301183822.html", "https://www.prnasia.com/story/296523-1.shtml", "https://www.prnasia.com/story/299443-1.shtml", "https://www.prnasia.com/story/296548-1.shtml", "https://www.prnasia.com/story/299500-1.shtml", "https://www.prnasia.com/story/299619-1.shtml", "https://www.prnasia.com/story/296589-1.shtml", "https://www.prnasia.com/story/296540-1.shtml", "https://www.prnasia.com/story/296469-1.shtml", "https://www.prnasia.com/story/299632-1.shtml", "https://www.prnasia.com/story/293124-1.shtml", "https://www.prnasia.com/story/293131-1.shtml", "https://www.prnasia.com/story/293114-1.shtml", "https://www.prnasia.com/story/296619-1.shtml", "https://www.prnasia.com/story/296604-1.shtml", "https://www.prnasia.com/story/293070-1.shtml", "https://www.prnewswire.com/news-releases/blueprint-medicines-announces-fda-approval-of-gavreto-pralsetinib-for-the-treatment-of-patients-with-advanced-or-metastatic-ret-mutant-and-ret-fusion-positive-thyroid-cancer-301183017.html", "https://www.prnasia.com/story/293142-1.shtml", "https://www.prnasia.com/story/293058-1.shtml", "https://www.prnasia.com/story/293127-1.shtml", "https://www.prnewswire.com/news-releases/highmark-members-embrace-larks-ai-driven-chronic-conditions-coaching-301182092.html", "https://www.prnasia.com/story/293148-1.shtml", "https://www.prnasia.com/story/283238-1.shtml", "https://www.prnasia.com/story/296626-1.shtml", "https://cnmobile.prnasia.com/story/293099-1.shtml", "https://www.prnasia.com/story/293081-1.shtml", "https://www.prnasia.com/story/293087-1.shtml", "https://www.prnasia.com/story/293116-1.shtml", "https://www.prnasia.com/story/279500-1.shtml", "https://www.prnasia.com/story/283308-1.shtml", "https://www.prnasia.com/story/283274-1.shtml", "https://www.prnasia.com/story/279502-1.shtml", "https://www.prnasia.com/story/280354-1.shtml", "https://www.prnasia.com/story/283969-1.shtml", "https://www.prnasia.com/story/283315-1.shtml", "https://www.prnasia.com/story/280356-1.shtml", "https://www.prnasia.com/story/280401-1.shtml", "https://www.prnasia.com/story/280383-1.shtml", "https://www.prnasia.com/story/280385-1.shtml", "https://www.prnasia.com/story/279574-1.shtml", "https://www.prnasia.com/story/284102-1.shtml", "https://www.prnasia.com/story/279524-1.shtml", "https://www.prnasia.com/story/284190-1.shtml", "https://www.prnasia.com/story/284162-1.shtml", "https://www.prnasia.com/story/284221-1.shtml", "https://www.prnasia.com/story/279576-1.shtml", "https://www.prnasia.com/story/279537-1.shtml", "https://www.prnasia.com/story/284085-1.shtml", "https://www.prnasia.com/story/284101-1.shtml", "https://www.prnasia.com/story/284192-1.shtml", "https://www.prnasia.com/story/279508-1.shtml", "https://www.prnasia.com/story/279546-1.shtml", "https://www.prnasia.com/story/279555-1.shtml", "https://www.prnasia.com/story/284062-1.shtml", "https://cnmobile.prnasia.com/story/284159-1.shtml", "https://www.prnasia.com/story/284179-1.shtml", "https://www.prnasia.com/story/284089-1.shtml", "https://www.prnasia.com/story/284182-1.shtml", "https://www.prnasia.com/story/272673-1.shtml", "https://www.prnasia.com/story/272697-1.shtml", "https://www.prnasia.com/story/280284-1.shtml", "https://www.prnasia.com/story/274804-1.shtml", "https://www.prnasia.com/story/272681-1.shtml", "https://cnmobile.prnasia.com/story/284228-1.shtml", "https://www.prnasia.com/story/284225-1.shtml", "https://www.prnasia.com/story/272626-1.shtml", "https://www.prnasia.com/story/274940-1.shtml", "https://cnmobile.prnasia.com/story/280319-1.shtml", "https://www.prnasia.com/story/274965-1.shtml", "https://www.prnasia.com/story/274923-1.shtml", "https://www.prnasia.com/story/274873-1.shtml", "https://www.prnasia.com/story/274944-1.shtml", "https://www.prnasia.com/story/274858-1.shtml", "https://www.prnasia.com/story/279458-1.shtml", "https://www.prnasia.com/story/279453-1.shtml", "https://www.prnasia.com/story/274929-1.shtml", "https://cnmobile.prnasia.com/story/272632-1.shtml", "https://www.prnasia.com/story/274969-1.shtml", "https://www.prnasia.com/story/275077-1.shtml", "https://www.prnasia.com/story/266519-1.shtml", "https://www.prnasia.com/story/275018-1.shtml", "https://www.prnasia.com/story/266585-1.shtml", "https://www.prnasia.com/story/266531-1.shtml", "https://www.prnasia.com/story/266709-1.shtml", "https://www.prnasia.com/story/272616-1.shtml", "https://www.prnasia.com/story/274975-1.shtml", "https://www.prnasia.com/story/266210-1.shtml", "https://www.prnasia.com/story/262329-1.shtml", "https://www.prnasia.com/story/266116-1.shtml", "https://www.prnasia.com/story/266051-1.shtml", "https://www.prnasia.com/story/262301-1.shtml", "https://www.prnasia.com/story/262376-1.shtml", "https://www.prnasia.com/story/266228-1.shtml", "https://www.prnasia.com/story/262353-1.shtml", "https://www.prnasia.com/story/266222-1.shtml", "https://www.prnasia.com/story/266098-1.shtml", "https://www.prnasia.com/story/266170-1.shtml", "https://www.prnasia.com/story/262461-1.shtml", "https://www.prnasia.com/story/263857-1.shtml", "https://www.prnasia.com/story/263852-1.shtml", "https://www.prnasia.com/story/262843-1.shtml", "https://www.prnasia.com/story/266458-1.shtml", "https://www.prnasia.com/story/266229-1.shtml", "https://www.prnasia.com/story/264227-1.shtml", "https://www.prnasia.com/story/264318-1.shtml", "https://www.prnasia.com/story/266474-1.shtml", "https://www.prnasia.com/story/264741-1.shtml", "https://www.prnasia.com/story/264731-1.shtml", "https://www.prnasia.com/story/264752-1.shtml", "https://www.prnasia.com/story/264773-1.shtml", "https://www.prnasia.com/story/264799-1.shtml", "https://www.prnasia.com/story/264681-1.shtml", "https://www.prnasia.com/story/264692-1.shtml", "https://www.prnasia.com/story/264629-1.shtml", "https://www.prnasia.com/story/264088-1.shtml", "https://www.prnasia.com/story/264854-1.shtml", "https://www.prnasia.com/story/269897-1.shtml", "https://www.prnasia.com/story/269716-1.shtml", "https://www.prnasia.com/story/264821-1.shtml", "https://www.prnasia.com/story/269707-1.shtml", "https://www.prnasia.com/story/264658-1.shtml", "https://www.prnasia.com/story/269792-1.shtml", "https://www.prnasia.com/story/269898-1.shtml", "https://www.prnasia.com/story/269728-1.shtml", "https://cnmobile.prnasia.com/story/264710-1.shtml", "https://www.prnasia.com/story/264624-1.shtml", "https://www.prnasia.com/story/269699-1.shtml", "https://www.prnasia.com/story/269969-1.shtml", "https://www.prnasia.com/story/269763-1.shtml", "https://www.prnasia.com/story/265758-1.shtml", "https://www.prnasia.com/story/269912-1.shtml", "https://www.prnasia.com/story/265761-1.shtml", "https://www.prnasia.com/story/269925-1.shtml", "https://www.prnasia.com/story/265781-1.shtml", "https://www.prnasia.com/story/265775-1.shtml", "https://www.prnasia.com/story/269854-1.shtml", "https://www.prnasia.com/story/269719-1.shtml", "https://www.prnasia.com/story/265817-1.shtml", "https://www.prnasia.com/story/252806-1.shtml", "https://www.prnasia.com/story/265943-1.shtml", "https://www.prnasia.com/story/270038-1.shtml", "https://www.prnasia.com/story/265771-1.shtml", "https://www.prnasia.com/story/266000-1.shtml", "https://www.prnasia.com/story/270035-1.shtml", "https://www.prnasia.com/story/252726-1.shtml", "https://www.prnasia.com/story/252789-1.shtml", "https://www.prnasia.com/story/266002-1.shtml", "https://www.prnasia.com/story/265935-1.shtml", "https://www.prnasia.com/story/252694-1.shtml", "https://www.prnasia.com/story/265922-1.shtml", "https://cnmobile.prnasia.com/story/252748-1.shtml", "https://www.prnasia.com/story/265852-1.shtml", "https://www.prnasia.com/story/252807-1.shtml", "https://www.prnasia.com/story/261681-1.shtml", "https://www.prnasia.com/story/261656-1.shtml", "https://www.prnasia.com/story/261538-1.shtml", "https://www.prnasia.com/story/261721-1.shtml", "https://www.prnasia.com/story/261567-1.shtml", "https://www.prnasia.com/story/252824-1.shtml", "https://www.prnasia.com/story/252907-1.shtml", "https://www.prnasia.com/story/261546-1.shtml", "https://www.prnasia.com/story/252830-1.shtml", "https://www.prnasia.com/story/261714-1.shtml", "https://www.prnasia.com/story/252864-1.shtml", "https://www.prnasia.com/story/248257-1.shtml", "https://www.prnasia.com/story/261554-1.shtml", "https://www.prnasia.com/story/261345-1.shtml", "https://www.prnasia.com/story/261641-1.shtml", "https://www.prnasia.com/story/261377-1.shtml", "https://www.prnasia.com/story/261372-1.shtml", "https://www.prnasia.com/story/249905-1.shtml", "https://www.prnasia.com/story/249696-1.shtml", "https://www.prnasia.com/story/249763-1.shtml", "https://www.prnasia.com/story/249738-1.shtml", "https://www.prnasia.com/story/249710-1.shtml", "https://www.prnasia.com/story/250171-1.shtml", "https://www.prnasia.com/story/249703-1.shtml", "https://www.prnasia.com/story/251826-1.shtml", "https://www.prnasia.com/story/251838-1.shtml", "https://www.prnasia.com/story/244110-1.shtml", "https://www.prnasia.com/story/250317-1.shtml", "https://www.prnasia.com/story/251639-1.shtml", "https://www.prnasia.com/story/250376-1.shtml", "https://www.prnasia.com/story/248330-1.shtml", "https://www.prnasia.com/story/248522-1.shtml", "https://www.prnasia.com/story/248553-1.shtml", "https://www.prnasia.com/story/248337-1.shtml", "https://www.prnasia.com/story/248609-1.shtml", "https://www.prnasia.com/story/248302-1.shtml", "https://www.prnasia.com/story/248499-1.shtml", "https://www.prnasia.com/story/244288-1.shtml", "https://www.prnasia.com/story/244204-1.shtml", "https://www.prnasia.com/story/248371-1.shtml", "https://www.prnasia.com/story/244189-1.shtml", "https://www.prnasia.com/story/244251-1.shtml", "https://www.prnasia.com/story/244148-1.shtml", "https://cnmobile.prnasia.com/story/248590-1.shtml", "https://www.prnasia.com/story/244279-1.shtml", "https://www.prnasia.com/story/244248-1.shtml", "https://www.prnasia.com/story/244369-1.shtml", "https://www.prnasia.com/story/244842-1.shtml", "https://www.prnasia.com/story/244287-1.shtml", "https://www.prnasia.com/story/244857-1.shtml", "https://www.prnasia.com/story/244438-1.shtml", "https://www.prnasia.com/story/244162-1.shtml", "https://www.prnasia.com/story/244243-1.shtml", "https://www.prnasia.com/story/244642-1.shtml", "https://www.prnasia.com/story/244663-1.shtml", "https://www.prnasia.com/story/244432-1.shtml", "https://www.prnasia.com/story/244601-1.shtml", "https://www.prnasia.com/story/244650-1.shtml", "https://www.prnasia.com/story/244214-1.shtml", "https://www.prnasia.com/story/244444-1.shtml", "https://www.prnasia.com/story/245326-1.shtml", "https://www.prnasia.com/story/245409-1.shtml", "https://www.prnasia.com/story/245465-1.shtml", "https://www.prnasia.com/story/245523-1.shtml", "https://www.prnasia.com/story/251292-1.shtml", "https://www.prnasia.com/story/245603-1.shtml", "https://www.prnasia.com/story/245539-1.shtml", "https://www.prnasia.com/story/251395-1.shtml", "https://www.prnasia.com/story/244887-1.shtml", "https://www.prnasia.com/story/251261-1.shtml", "https://www.prnasia.com/story/251611-1.shtml", "https://www.prnasia.com/story/251422-1.shtml", "https://www.prnasia.com/story/246360-1.shtml", "https://www.prnasia.com/story/246153-1.shtml", "https://www.prnasia.com/story/246253-1.shtml", "https://www.prnasia.com/story/246239-1.shtml", "https://www.prnasia.com/story/251578-1.shtml", "https://www.prnasia.com/story/246146-1.shtml", "https://www.prnasia.com/story/251957-1.shtml", "https://www.prnasia.com/story/246149-1.shtml", "https://www.prnasia.com/story/246142-1.shtml", "https://www.prnasia.com/story/246264-1.shtml", "https://www.prnasia.com/story/252038-1.shtml", "https://www.prnasia.com/story/246800-1.shtml", "https://www.prnasia.com/story/246281-1.shtml", "https://www.prnasia.com/story/251919-1.shtml", "https://www.prnasia.com/story/246758-1.shtml", "https://www.prnasia.com/story/246846-1.shtml", "https://www.prnasia.com/story/246820-1.shtml", "https://www.prnasia.com/story/246783-1.shtml", "https://www.prnasia.com/story/252041-1.shtml", "https://www.prnasia.com/story/252629-1.shtml", "https://www.prnasia.com/story/246909-1.shtml", "https://www.prnasia.com/story/246850-1.shtml", "https://www.prnasia.com/story/252651-1.shtml", "https://www.prnasia.com/story/246837-1.shtml", "https://www.prnasia.com/story/251967-1.shtml", "https://www.prnasia.com/story/246757-1.shtml", "https://cnmobile.prnasia.com/story/246896-1.shtml", "https://www.prnasia.com/story/246843-1.shtml", "https://www.prnasia.com/story/247489-1.shtml", "https://www.prnasia.com/story/247706-1.shtml", "https://www.prnasia.com/story/247611-1.shtml", "https://www.prnasia.com/story/247608-1.shtml", "https://www.prnasia.com/story/247749-1.shtml", "https://www.prnasia.com/story/247774-1.shtml", "https://www.prnasia.com/story/247609-1.shtml", "https://www.prnasia.com/story/240382-1.shtml", "https://www.prnasia.com/story/247710-1.shtml", "https://www.prnasia.com/story/240450-1.shtml", "https://cnmobile.prnasia.com/story/247708-1.shtml", "https://www.prnasia.com/story/240302-1.shtml", "https://www.prnasia.com/story/240353-1.shtml", "https://www.prnasia.com/story/247765-1.shtml", "https://www.prnasia.com/story/242576-1.shtml", "https://www.prnasia.com/story/240400-1.shtml", "https://www.prnasia.com/story/242561-1.shtml", "https://www.prnasia.com/story/240481-1.shtml", "https://www.prnasia.com/story/242632-1.shtml", "https://www.prnasia.com/story/238475-1.shtml", "https://www.prnasia.com/story/242514-1.shtml", "https://www.prnasia.com/story/240465-1.shtml", "https://www.prnasia.com/story/242665-1.shtml", "https://www.prnasia.com/story/232594-1.shtml", "https://www.prnasia.com/story/242439-1.shtml", "https://www.prnasia.com/story/242674-1.shtml", "https://www.prnasia.com/story/242515-1.shtml", "https://www.prnasia.com/story/232839-1.shtml", "https://www.prnasia.com/story/238420-1.shtml", "https://www.prnasia.com/story/232825-1.shtml", "https://cnmobile.prnasia.com/story/232563-1.shtml", "https://www.prnasia.com/story/232727-1.shtml", "https://www.prnasia.com/story/232889-1.shtml", "https://www.prnasia.com/story/238891-1.shtml", "https://www.prnasia.com/story/232733-1.shtml", "https://www.prnasia.com/story/232827-1.shtml", "https://www.prnasia.com/story/238923-1.shtml", "https://www.prnasia.com/story/238988-1.shtml", "https://www.prnasia.com/story/232793-1.shtml", "https://www.prnasia.com/story/238781-1.shtml", "https://www.prnasia.com/story/238894-1.shtml", "https://www.prnasia.com/story/232799-1.shtml", "https://www.prnasia.com/story/233250-1.shtml", "https://www.prnasia.com/story/238779-1.shtml", "https://www.prnasia.com/story/238982-1.shtml", "https://www.prnasia.com/story/238683-1.shtml", "https://www.prnasia.com/story/241265-1.shtml", "https://www.prnasia.com/story/241276-1.shtml", "https://www.prnasia.com/story/233459-1.shtml", "https://www.prnasia.com/story/241320-1.shtml", "https://www.prnasia.com/story/241120-1.shtml", "https://www.prnasia.com/story/241268-1.shtml", "https://www.prnasia.com/story/233514-1.shtml", "https://www.prnasia.com/story/241338-1.shtml", "https://www.prnasia.com/story/241356-1.shtml", "https://www.prnasia.com/story/233496-1.shtml", "https://www.prnasia.com/story/241272-1.shtml", "https://www.prnasia.com/story/241228-1.shtml", "https://www.prnasia.com/story/241140-1.shtml", "https://www.prnasia.com/story/241186-1.shtml", "https://www.prnasia.com/story/233284-1.shtml", "https://www.prnasia.com/story/233269-1.shtml", "https://cnmobile.prnasia.com/story/241376-1.shtml", "https://www.prnasia.com/story/241425-1.shtml", "https://www.prnasia.com/story/233382-1.shtml", "https://www.prnasia.com/story/242750-1.shtml", "https://www.prnasia.com/story/241419-1.shtml", "https://www.prnasia.com/story/242244-1.shtml", "https://www.prnasia.com/story/242350-1.shtml", "https://www.prnasia.com/story/241426-1.shtml", "https://www.prnasia.com/story/242312-1.shtml", "https://www.prnasia.com/story/242344-1.shtml", "https://www.prnasia.com/story/242176-1.shtml", "https://www.prnasia.com/story/242271-1.shtml", "https://www.prnasia.com/story/242230-1.shtml", "https://www.prnasia.com/story/242316-1.shtml", "https://www.prnasia.com/story/242305-1.shtml", "https://www.prnasia.com/story/242236-1.shtml", "https://cnmobile.prnasia.com/story/242424-1.shtml", "https://www.prnasia.com/story/242136-1.shtml", "https://www.prnasia.com/story/242201-1.shtml", "https://www.prnasia.com/story/222742-1.shtml", "https://www.prnasia.com/story/242788-1.shtml", "https://www.prnasia.com/story/222739-1.shtml", "https://www.prnasia.com/story/242859-1.shtml", "https://www.prnasia.com/story/242863-1.shtml", "https://www.prnasia.com/story/222851-1.shtml", "https://www.prnasia.com/story/242846-1.shtml", "https://www.prnasia.com/story/222809-1.shtml", "https://www.prnasia.com/story/223294-1.shtml", "https://www.prnasia.com/story/222899-1.shtml", "https://www.prnasia.com/story/242853-1.shtml", "https://www.prnasia.com/story/242836-1.shtml", "https://www.prnasia.com/story/222925-1.shtml", "https://www.prnasia.com/story/242776-1.shtml", "https://www.prnasia.com/story/222781-1.shtml", "https://cnmobile.prnasia.com/story/242855-1.shtml", "https://www.prnasia.com/story/222814-1.shtml", "https://www.prnasia.com/story/225028-1.shtml", "https://www.prnasia.com/story/223351-1.shtml", "https://www.prnasia.com/story/223389-1.shtml", "https://www.prnasia.com/story/223334-1.shtml", "https://www.prnasia.com/story/223464-1.shtml", "https://www.prnasia.com/story/223411-1.shtml", "https://www.prnasia.com/story/223383-1.shtml", "https://www.prnasia.com/story/222812-1.shtml", "https://www.prnasia.com/story/222804-1.shtml", "https://www.prnasia.com/story/223396-1.shtml", "https://www.prnasia.com/story/216614-1.shtml", "https://www.prnasia.com/story/216707-1.shtml", "https://www.prnasia.com/story/216620-1.shtml", "https://www.prnasia.com/story/225063-1.shtml", "https://www.prnasia.com/story/216618-1.shtml", "https://www.prnasia.com/story/218120-1.shtml", "https://www.prnasia.com/story/216754-1.shtml", "https://www.prnasia.com/story/216705-1.shtml", "https://www.prnasia.com/story/216785-1.shtml", "https://www.prnasia.com/story/218161-1.shtml", "https://www.prnasia.com/story/216752-1.shtml", "https://www.prnasia.com/story/216723-1.shtml", "https://www.prnasia.com/story/219726-1.shtml", "https://cnmobile.prnasia.com/story/218085-1.shtml", "https://www.prnasia.com/story/218163-1.shtml", "https://www.prnasia.com/story/219615-1.shtml", "https://www.prnasia.com/story/218236-1.shtml", "https://www.prnasia.com/story/218284-1.shtml", "https://www.prnasia.com/story/218251-1.shtml", "https://www.prnasia.com/story/219900-1.shtml", "https://www.prnasia.com/story/220050-1.shtml", "https://www.prnasia.com/story/218263-1.shtml", "https://www.prnasia.com/story/220043-1.shtml", "https://www.prnasia.com/story/219948-1.shtml", "https://www.prnasia.com/story/219809-1.shtml", "https://www.prnasia.com/story/220080-1.shtml", "https://www.prnasia.com/story/219943-1.shtml", "https://www.prnasia.com/story/219871-1.shtml", "https://cnmobile.prnasia.com/story/219833-1.shtml", "https://www.prnasia.com/story/215115-1.shtml", "https://www.prnasia.com/story/204740-1.shtml", "https://www.prnasia.com/story/199171-1.shtml", "https://www.prnasia.com/story/215082-1.shtml", "https://www.prnasia.com/story/215046-1.shtml", "https://www.prnasia.com/story/204706-1.shtml", "https://www.prnasia.com/story/215163-1.shtml", "https://www.prnasia.com/story/204693-1.shtml", "https://www.prnasia.com/story/215026-1.shtml", "https://www.prnasia.com/story/215126-1.shtml", "https://www.prnasia.com/story/215179-1.shtml", "https://www.prnasia.com/story/204701-1.shtml", "https://www.prnasia.com/story/204781-1.shtml", "https://www.prnasia.com/story/215060-1.shtml", "https://www.prnasia.com/story/199327-1.shtml", "https://www.prnasia.com/story/215129-1.shtml", "https://www.prnasia.com/story/199322-1.shtml", "https://www.prnasia.com/story/199199-1.shtml", "https://www.prnasia.com/story/199343-1.shtml", "https://www.prnasia.com/story/199020-1.shtml", "https://www.prnasia.com/story/205101-1.shtml", "https://www.prnasia.com/story/198974-1.shtml", "https://www.prnasia.com/story/198548-1.shtml", "https://www.prnasia.com/story/198920-1.shtml", "https://www.prnasia.com/story/198965-1.shtml", "https://www.prnasia.com/story/199244-1.shtml", "https://www.prnasia.com/story/205105-1.shtml", "https://www.prnasia.com/story/198547-1.shtml", "https://www.prnasia.com/story/199355-1.shtml", "https://www.prnasia.com/story/198509-1.shtml", "https://www.prnasia.com/story/199051-1.shtml", "https://www.prnasia.com/story/199101-1.shtml", "https://www.prnasia.com/story/198983-1.shtml", "https://www.prnasia.com/story/207677-1.shtml", "https://www.prnasia.com/story/207684-1.shtml", "https://www.prnasia.com/story/199165-1.shtml", "https://www.prnasia.com/story/207680-1.shtml", "https://www.prnasia.com/story/207468-1.shtml", "https://www.prnasia.com/story/207405-1.shtml", "https://www.prnasia.com/story/207538-1.shtml", "https://www.prnasia.com/story/207541-1.shtml", "https://www.prnasia.com/story/207399-1.shtml", "https://www.prnasia.com/story/207667-1.shtml", "https://www.prnasia.com/story/207706-1.shtml", "https://www.prnasia.com/story/199161-1.shtml", "https://www.prnasia.com/story/207574-1.shtml", "https://www.prnasia.com/story/207575-1.shtml", "https://www.prnasia.com/story/207413-1.shtml", "https://www.prnasia.com/story/207519-1.shtml", "https://www.prnasia.com/story/207525-1.shtml", "https://www.prnasia.com/story/207419-1.shtml", "https://www.prnasia.com/story/207846-1.shtml", "https://www.prnasia.com/story/207774-1.shtml", "https://www.prnasia.com/story/207922-1.shtml", "https://www.prnasia.com/story/207770-1.shtml", "https://www.prnasia.com/story/201168-1.shtml", "https://www.prnasia.com/story/208012-1.shtml", "https://www.prnasia.com/story/201267-1.shtml", "https://www.prnasia.com/story/208068-1.shtml", "https://www.prnasia.com/story/208962-1.shtml", "https://www.prnasia.com/story/208082-1.shtml", "https://www.prnasia.com/story/207863-1.shtml", "https://www.prnasia.com/story/201373-1.shtml", "https://www.prnasia.com/story/207954-1.shtml", "https://www.prnasia.com/story/201469-1.shtml", "https://www.prnasia.com/story/207801-1.shtml", "https://www.prnasia.com/story/201344-1.shtml", "https://www.prnasia.com/story/201530-1.shtml", "https://www.prnasia.com/story/201214-1.shtml", "https://www.prnasia.com/story/209189-1.shtml", "https://www.prnasia.com/story/209320-1.shtml", "https://www.prnasia.com/story/201556-1.shtml", "https://www.prnasia.com/story/209066-1.shtml", "https://www.prnasia.com/story/201557-1.shtml", "https://www.prnasia.com/story/209262-1.shtml", "https://www.prnasia.com/story/209304-1.shtml", "https://www.prnasia.com/story/201543-1.shtml", "https://www.prnasia.com/story/201536-1.shtml", "https://www.prnasia.com/story/209297-1.shtml", "https://www.prnasia.com/story/203539-1.shtml", "https://www.prnasia.com/story/201962-1.shtml", "https://www.prnasia.com/story/209404-1.shtml", "https://cnmobile.prnasia.com/story/209306-1.shtml", "https://www.prnasia.com/story/203420-1.shtml", "https://www.prnasia.com/story/209326-1.shtml", "https://www.prnasia.com/story/203671-1.shtml", "https://www.prnasia.com/story/191110-1.shtml", "https://www.prnasia.com/story/203536-1.shtml", "https://www.prnasia.com/story/209580-1.shtml", "https://www.prnasia.com/story/203735-1.shtml", "https://www.prnasia.com/story/203428-1.shtml", "https://www.prnasia.com/story/203633-1.shtml", "https://www.prnasia.com/story/191138-1.shtml", "https://www.prnasia.com/story/203537-1.shtml", "https://www.prnasia.com/story/203730-1.shtml", "https://www.prnasia.com/story/191418-1.shtml", "https://www.prnasia.com/story/191374-1.shtml", "https://www.prnasia.com/story/203747-1.shtml", "https://www.prnasia.com/story/203561-1.shtml", "https://www.prnasia.com/story/179929-1.shtml", "https://www.prnasia.com/story/191275-1.shtml", "https://www.prnasia.com/story/191481-1.shtml", "https://www.prnasia.com/story/191002-1.shtml", "https://www.prnasia.com/story/180057-1.shtml", "https://cnmobile.prnasia.com/story/191184-1.shtml", "https://www.prnasia.com/story/179885-1.shtml", "https://www.prnasia.com/story/179839-1.shtml", "https://www.prnasia.com/story/181050-1.shtml", "https://www.prnasia.com/story/179874-1.shtml", "https://www.prnasia.com/story/180148-1.shtml", "https://www.prnasia.com/story/180067-1.shtml", "https://www.prnasia.com/story/180277-1.shtml", "https://www.prnasia.com/story/192868-1.shtml", "https://www.prnasia.com/story/179991-1.shtml", "https://www.prnasia.com/story/191090-1.shtml", "https://www.prnasia.com/story/179728-1.shtml", "https://cnmobile.prnasia.com/story/191010-1.shtml", "https://www.prnasia.com/story/180293-1.shtml", "https://www.prnasia.com/story/179935-1.shtml", "https://www.prnasia.com/story/181135-1.shtml", "https://www.prnasia.com/story/181019-1.shtml", "https://www.prnasia.com/story/192753-1.shtml", "https://www.prnasia.com/story/181118-1.shtml", "https://www.prnasia.com/story/181321-1.shtml", "https://www.prnasia.com/story/181099-1.shtml", "https://www.prnasia.com/story/193087-1.shtml", "https://www.prnasia.com/story/193100-1.shtml", "https://www.prnasia.com/story/181278-1.shtml", "https://www.prnasia.com/story/181265-1.shtml", "https://www.prnasia.com/story/192952-1.shtml", "https://www.prnasia.com/story/192911-1.shtml", "https://www.prnasia.com/story/192960-1.shtml", "https://www.prnasia.com/story/193211-1.shtml", "https://www.prnasia.com/story/181928-1.shtml", "https://www.prnasia.com/story/192889-1.shtml", "https://www.prnasia.com/story/181152-1.shtml", "https://www.prnasia.com/story/193021-1.shtml", "https://www.prnasia.com/story/192973-1.shtml", "https://www.prnasia.com/story/192941-1.shtml", "https://www.prnasia.com/story/182030-1.shtml", "https://www.prnasia.com/story/182168-1.shtml", "https://www.prnasia.com/story/181353-1.shtml", "https://www.prnasia.com/story/181947-1.shtml", "https://www.prnasia.com/story/194593-1.shtml", "https://www.prnasia.com/story/182245-1.shtml", "https://www.prnasia.com/story/194723-1.shtml", "https://www.prnasia.com/story/194661-1.shtml", "https://www.prnasia.com/story/181956-1.shtml", "https://www.prnasia.com/story/181965-1.shtml", "https://www.prnasia.com/story/194799-1.shtml", "https://www.prnasia.com/story/182013-1.shtml", "https://www.prnasia.com/story/182415-1.shtml", "https://www.prnasia.com/story/194684-1.shtml", "https://www.prnasia.com/story/194870-1.shtml", "https://www.prnasia.com/story/194894-1.shtml", "https://www.prnasia.com/story/194638-1.shtml", "https://www.prnasia.com/story/194900-1.shtml", "https://www.prnasia.com/story/194604-1.shtml", "https://www.prnasia.com/story/175531-1.shtml", "https://www.prnasia.com/story/175513-1.shtml", "https://www.prnasia.com/story/175267-1.shtml", "https://www.prnasia.com/story/196566-1.shtml", "https://www.prnasia.com/story/196418-1.shtml", "https://www.prnasia.com/story/196592-1.shtml", "https://www.prnasia.com/story/196447-1.shtml", "https://www.prnasia.com/story/162750-1.shtml", "https://www.prnasia.com/story/162531-1.shtml", "https://www.prnasia.com/story/162656-1.shtml", "https://www.prnasia.com/story/162435-1.shtml", "https://www.prnasia.com/story/171377-1.shtml", "https://www.prnasia.com/story/175645-1.shtml", "https://www.prnasia.com/story/162535-1.shtml", "https://www.prnasia.com/story/162764-1.shtml", "https://www.prnasia.com/story/171337-1.shtml", "https://www.prnasia.com/story/174826-1.shtml", "https://www.prnasia.com/story/174815-1.shtml", "https://www.prnasia.com/story/162463-1.shtml", "https://www.prnasia.com/story/171296-1.shtml", "https://www.prnasia.com/story/175750-1.shtml", "https://www.prnasia.com/story/174944-1.shtml", "https://www.prnasia.com/story/162936-1.shtml", "https://www.prnasia.com/story/174963-1.shtml", "https://www.prnasia.com/story/163062-1.shtml", "https://www.prnasia.com/story/175082-1.shtml", "https://www.prnasia.com/story/162954-1.shtml", "https://www.prnasia.com/story/174994-1.shtml", "https://www.prnasia.com/story/141865-1.shtml", "https://www.prnasia.com/story/174946-1.shtml", "https://www.prnasia.com/story/174941-1.shtml", "https://www.prnasia.com/story/141476-1.shtml", "https://cnmobile.prnasia.com/story/141688-1.shtml", "https://www.prnasia.com/story/174930-1.shtml", "https://www.prnasia.com/story/141981-1.shtml", "https://www.prnasia.com/story/141368-1.shtml", "https://www.prnasia.com/story/141357-1.shtml", "https://www.prnasia.com/story/175192-1.shtml", "https://www.prnasia.com/story/175247-1.shtml", "https://www.prnasia.com/story/145406-1.shtml", "https://www.prnasia.com/story/145700-1.shtml", "https://www.prnasia.com/story/157833-1.shtml", "https://www.prnasia.com/story/157677-1.shtml", "https://www.prnasia.com/story/157477-1.shtml", "https://www.prnasia.com/story/145657-1.shtml", "https://www.prnasia.com/story/145407-1.shtml", "https://www.prnasia.com/story/145522-1.shtml", "https://www.prnasia.com/story/157335-1.shtml", "https://cnmobile.prnasia.com/story/145607-1.shtml", "https://www.prnasia.com/story/157741-1.shtml", "https://www.prnasia.com/story/145523-1.shtml", "https://www.prnasia.com/story/145923-1.shtml", "https://www.prnasia.com/story/146485-1.shtml", "https://www.prnasia.com/story/119876-1.shtml", "https://www.prnasia.com/story/146577-1.shtml", "https://www.prnasia.com/story/146081-1.shtml", "https://www.prnasia.com/story/119958-1.shtml", "https://www.prnasia.com/story/119823-1.shtml", "https://www.prnasia.com/story/146132-1.shtml", "https://www.prnasia.com/story/146520-1.shtml", "https://www.prnasia.com/story/146425-1.shtml", "https://www.prnasia.com/story/146461-1.shtml", "https://www.prnasia.com/story/120310-1.shtml", "https://www.prnasia.com/story/120355-1.shtml", "https://www.prnasia.com/story/145902-1.shtml", "https://cnmobile.prnasia.com/story/145989-1.shtml", "https://www.prnasia.com/story/120425-1.shtml", "https://www.prnasia.com/story/120876-1.shtml", "https://www.prnasia.com/story/120480-1.shtml", "https://www.prnasia.com/story/120075-1.shtml", "https://www.prnasia.com/story/120431-1.shtml", "https://www.prnasia.com/story/120801-1.shtml", "https://www.prnasia.com/story/120321-1.shtml", "https://cnmobile.prnasia.com/story/120195-1.shtml", "https://www.prnasia.com/story/120451-1.shtml", "https://www.prnasia.com/story/130973-1.shtml", "https://www.prnasia.com/story/120624-1.shtml", "https://www.prnasia.com/story/131227-1.shtml", "https://www.prnasia.com/story/130738-1.shtml", "https://www.prnasia.com/story/120628-1.shtml", "https://www.prnasia.com/story/131338-1.shtml", "https://www.prnasia.com/story/130774-1.shtml", "https://www.prnasia.com/story/120674-1.shtml", "https://www.prnasia.com/story/131185-1.shtml", "https://www.prnasia.com/story/131398-1.shtml", "https://www.prnasia.com/story/131173-1.shtml", "https://www.prnasia.com/story/131135-1.shtml", "https://www.prnasia.com/story/132246-1.shtml", "https://www.prnasia.com/story/130987-1.shtml", "https://www.prnasia.com/story/132258-1.shtml", "https://www.prnasia.com/story/132242-1.shtml", "https://www.prnasia.com/story/131563-1.shtml", "https://www.prnasia.com/story/132297-1.shtml", "https://www.prnasia.com/story/119735-1.shtml", "https://www.prnasia.com/story/119736-1.shtml", "https://www.prnasia.com/story/132216-1.shtml", "https://www.prnasia.com/story/132126-1.shtml", "https://www.prnasia.com/story/132144-1.shtml", "https://www.prnasia.com/story/103434-1.shtml", "https://www.prnasia.com/story/103374-1.shtml", "https://www.prnasia.com/story/104689-1.shtml", "https://www.prnasia.com/story/132384-1.shtml", "https://cnmobile.prnasia.com/story/132389-1.shtml", "https://www.prnasia.com/story/104991-1.shtml", "https://www.prnasia.com/story/104952-1.shtml", "https://www.prnasia.com/story/104913-1.shtml", "https://www.prnasia.com/story/104982-1.shtml", "https://www.prnasia.com/story/103361-1.shtml", "https://www.prnasia.com/story/104068-1.shtml", "https://www.prnasia.com/story/103495-1.shtml", "https://www.prnasia.com/story/88904-1.shtml", "https://www.prnasia.com/story/88762-1.shtml", "https://www.prnasia.com/story/88567-1.shtml", "https://www.prnasia.com/story/103888-1.shtml", "https://www.prnasia.com/story/88587-1.shtml", "https://www.prnasia.com/story/88701-1.shtml", "https://www.prnasia.com/story/103996-1.shtml", "https://www.prnasia.com/story/92359-1.shtml", "https://www.prnasia.com/story/92201-1.shtml", "https://www.prnasia.com/story/78464-1.shtml", "https://www.prnasia.com/story/92224-1.shtml", "https://www.prnasia.com/story/92581-1.shtml", "https://www.prnasia.com/story/78381-1.shtml", "https://www.prnasia.com/story/92414-1.shtml", "https://cnmobile.prnasia.com/story/92177-1.shtml", "https://www.prnasia.com/story/78537-1.shtml", "https://www.prnasia.com/story/92208-1.shtml", "https://www.prnasia.com/story/80974-1.shtml", "https://www.prnasia.com/story/81001-1.shtml", "https://www.prnasia.com/story/81467-1.shtml", "https://www.prnasia.com/story/81122-1.shtml", "https://www.prnasia.com/story/79446-1.shtml", "https://www.prnasia.com/story/81121-1.shtml", "https://www.prnasia.com/story/79293-1.shtml", "https://www.prnasia.com/story/82917-1.shtml", "https://www.prnasia.com/story/80629-1.shtml", "https://www.prnasia.com/story/82969-1.shtml", "https://www.prnasia.com/story/80912-1.shtml", "https://www.prnasia.com/story/82873-1.shtml", "https://www.prnasia.com/story/79576-1.shtml", "https://www.prnasia.com/story/81623-1.shtml", "https://www.prnasia.com/story/81080-1.shtml", "https://cnmobile.prnasia.com/story/79644-1.shtml", "https://www.prnasia.com/story/81144-1.shtml", "https://www.prnasia.com/story/79557-1.shtml", "https://www.prnasia.com/story/78818-1.shtml", "https://www.prnasia.com/story/81515-1.shtml", "https://www.prnasia.com/story/83204-1.shtml", "https://www.prnasia.com/story/63065-1.shtml", "https://www.prnasia.com/story/83336-1.shtml", "https://www.prnasia.com/story/63145-1.shtml", "https://www.prnasia.com/story/62684-1.shtml", "https://www.prnasia.com/story/62530-1.shtml", "https://www.prnasia.com/story/83866-1.shtml", "https://www.prnasia.com/story/30080-1.shtml", "https://www.prnasia.com/story/54425-1.shtml", "https://www.prnasia.com/story/57123-1.shtml", "https://cnmobile.prnasia.com/story/29934-1.shtml", "https://www.prnasia.com/story/54119-1.shtml", "https://www.prnasia.com/story/54538-1.shtml", "https://www.prnasia.com/story/58940-1.shtml", "https://www.prnasia.com/story/57437-1.shtml", "https://www.prnasia.com/story/57483-1.shtml", "https://www.prnasia.com/story/55733-1.shtml", "https://www.prnasia.com/story/57355-1.shtml", "https://www.prnasia.com/story/55723-1.shtml", "https://www.prnasia.com/story/35185-1.shtml", "https://www.prnasia.com/story/57638-1.shtml", "https://www.prnasia.com/story/35041-1.shtml", "https://www.prnasia.com/story/35504-1.shtml", "https://www.prnasia.com/story/34987-1.shtml", "https://www.prnasia.com/story/35039-1.shtml", "https://www.prnasia.com/story/35243-1.shtml", "https://www.prnasia.com/story/59390-1.shtml", "https://www.prnasia.com/story/59032-1.shtml", "https://www.prnasia.com/story/59595-1.shtml", "https://www.prnasia.com/story/19820-1.shtml", "https://www.prnasia.com/story/59684-1.shtml", "https://www.prnasia.com/story/19732-1.shtml", "https://www.prnasia.com/story/19788-1.shtml", "https://www.prnasia.com/story/20410-1.shtml", "https://www.prnasia.com/story/23965-1.shtml", "https://www.prnasia.com/story/20274-1.shtml", "https://www.prnasia.com/story/20054-1.shtml", "https://www.prnasia.com/story/20099-1.shtml", "https://www.prnasia.com/story/1958-1.shtml", "https://www.prnasia.com/story/26401-1.shtml", "https://www.prnasia.com/story/24365-1.shtml", "https://www.prnasia.com/story/1633-1.shtml", "https://www.prnasia.com/story/26279-1.shtml", "https://www.prnasia.com/story/24177-1.shtml", "https://www.prnasia.com/story/26259-1.shtml", "https://www.prnasia.com/story/1409-1.shtml", "https://www.prnasia.com/story/24678-1.shtml", "https://www.prnasia.com/story/29178-1.shtml", "https://www.prnasia.com/story/28996-1.shtml", "https://www.prnasia.com/story/29286-1.shtml", "https://www.prnasia.com/story/29353-1.shtml", "https://www.prnasia.com/story/26654-1.shtml", "https://www.prnasia.com/story/29026-1.shtml", "https://www.prnasia.com/story/29472-1.shtml", "https://www.prnasia.com/story/26828-1.shtml", "https://www.prnasia.com/story/29104-1.shtml", "https://www.prnasia.com/story/6744-1.shtml", "https://cnmobile.prnasia.com/story/26625-1.shtml", "https://cnmobile.prnasia.com/story/26432-1.shtml", "https://cnmobile.prnasia.com/story/29105-1.shtml", "https://www.prnasia.com/story/7161-1.shtml", "https://www.prnasia.com/story/819-1.shtml", "https://www.prnasia.com/story/29838-1.shtml", "https://www.prnasia.com/story/10401-1.shtml", "https://www.prnasia.com/story/10283-1.shtml", "https://www.prnasia.com/story/10357-1.shtml", "https://www.prnasia.com/story/7355-1.shtml", "https://www.prnasia.com/story/7422-1.shtml", "https://www.prnasia.com/story/855-1.shtml", "https://www.prnasia.com/story/912-1.shtml", "https://www.prnasia.com/story/6795-1.shtml", "https://www.prnasia.com/story/7360-1.shtml", "https://www.prnasia.com/story/6790-1.shtml", "https://www.prnasia.com/story/7526-1.shtml", "https://www.prnasia.com/story/838-1.shtml", "https://www.prnasia.com/story/29763-1.shtml", "https://www.prnasia.com/story/29868-1.shtml", "https://cnmobile.prnasia.com/story/11472-1.shtml", "https://www.prnasia.com/story/29783-1.shtml", "https://www.prnasia.com/story/10414-1.shtml", "https://www.prnasia.com/story/29821-1.shtml", "https://www.prnasia.com/story/281732-1.shtml", "https://www.prnasia.com/story/10827-1.shtml", "https://www.prnasia.com/story/281041-1.shtml", "https://www.prnasia.com/story/283264-1.shtml", "https://www.prnasia.com/story/283249-1.shtml", "https://www.prnasia.com/story/281550-1.shtml", "https://cnmobile.prnasia.com/story/10599-1.shtml", "https://www.prnasia.com/story/282276-1.shtml", "https://www.prnasia.com/story/281666-1.shtml", "https://www.prnasia.com/story/283060-1.shtml", "https://www.prnasia.com/story/14349-1.shtml", "https://www.prnasia.com/story/14383-1.shtml", "https://www.prnasia.com/story/280849-1.shtml", "https://www.prnasia.com/story/281257-1.shtml", "https://www.prnasia.com/story/281272-1.shtml", "https://www.prnasia.com/story/303772-1.shtml", "https://www.prnasia.com/story/14409-1.shtml", "https://www.prnasia.com/story/303676-1.shtml", "https://www.prnasia.com/story/303754-1.shtml", "https://www.prnasia.com/story/303844-1.shtml", "https://www.prnasia.com/story/260792-1.shtml", "https://www.prnasia.com/story/14662-1.shtml", "https://www.prnasia.com/story/303496-1.shtml", "https://www.prnasia.com/story/303487-1.shtml", "https://www.prnasia.com/story/303657-1.shtml", "https://cnmobile.prnasia.com/story/14669-1.shtml", "https://www.prnasia.com/story/303898-1.shtml", "https://www.prnasia.com/story/261703-1.shtml", "https://www.prnasia.com/story/261807-1.shtml", "https://www.prnasia.com/story/14759-1.shtml", "https://www.prnasia.com/story/266512-1.shtml", "https://www.prnasia.com/story/261464-1.shtml", "https://www.prnasia.com/story/261512-1.shtml", "https://www.prnasia.com/story/266156-1.shtml", "https://www.prnasia.com/story/262055-1.shtml", "https://www.prnasia.com/story/261856-1.shtml", "https://www.prnasia.com/story/265362-1.shtml", "https://www.prnasia.com/story/307419-1.shtml", "https://www.prnasia.com/story/261784-1.shtml", "https://www.prnasia.com/story/266580-1.shtml", "https://www.prnasia.com/story/268999-1.shtml", "https://www.prnasia.com/story/269115-1.shtml", "https://www.prnasia.com/story/269774-1.shtml", "https://www.prnasia.com/story/268887-1.shtml", "https://www.prnasia.com/story/269715-1.shtml", "https://www.prnasia.com/story/266917-1.shtml", "https://www.prnasia.com/story/266861-1.shtml", "https://www.prnasia.com/story/266574-1.shtml", "https://www.prnasia.com/story/265585-1.shtml", "https://www.prnasia.com/story/269908-1.shtml", "https://www.prnasia.com/story/270234-1.shtml", "https://www.prnasia.com/story/269266-1.shtml", "https://www.prnasia.com/story/220772-1.shtml", "https://www.prnasia.com/story/270212-1.shtml", "https://www.prnasia.com/story/269133-1.shtml", "https://www.prnasia.com/story/262535-1.shtml", "https://www.prnasia.com/story/221743-1.shtml", "https://www.prnasia.com/story/266825-1.shtml", "https://www.prnasia.com/story/269338-1.shtml", "https://www.prnasia.com/story/222264-1.shtml", "https://www.prnasia.com/story/270537-1.shtml", "https://www.prnasia.com/story/275867-1.shtml", "https://www.prnasia.com/story/221864-1.shtml", "https://www.prnasia.com/story/221329-1.shtml", "https://www.prnasia.com/story/277042-1.shtml", "https://www.prnasia.com/story/221262-1.shtml", "https://www.prnasia.com/story/222207-1.shtml", "https://cnmobile.prnasia.com/story/269851-1.shtml", "https://www.prnasia.com/story/222053-1.shtml", "https://www.prnasia.com/story/221383-1.shtml", "https://www.prnasia.com/story/274826-1.shtml", "https://www.prnasia.com/story/277084-1.shtml", "https://www.prnasia.com/story/274607-1.shtml", "https://www.prnasia.com/story/222358-1.shtml", "https://www.prnasia.com/story/270531-1.shtml", "https://www.prnasia.com/story/229578-1.shtml", "https://www.prnasia.com/story/222178-1.shtml", "https://cnmobile.prnasia.com/story/274806-1.shtml", "https://www.prnasia.com/story/274906-1.shtml", "https://www.prnasia.com/story/230842-1.shtml", "https://www.prnasia.com/story/276975-1.shtml", "https://cnmobile.prnasia.com/story/275494-1.shtml", "https://www.prnasia.com/story/229010-1.shtml", "https://www.prnasia.com/story/229946-1.shtml", "https://www.prnasia.com/story/230861-1.shtml", "https://www.prnasia.com/story/233258-1.shtml", "https://www.prnasia.com/story/233687-1.shtml", "https://www.prnasia.com/story/228371-1.shtml", "https://www.prnasia.com/story/228221-1.shtml", "https://www.prnasia.com/story/234677-1.shtml", "https://cnmobile.prnasia.com/story/234995-1.shtml", "https://www.prnasia.com/story/230760-1.shtml", "https://cnmobile.prnasia.com/story/228642-1.shtml", "https://www.prnasia.com/story/227993-1.shtml", "https://www.prnasia.com/story/234310-1.shtml", "https://cnmobile.prnasia.com/story/228324-1.shtml", "https://www.prnasia.com/story/234447-1.shtml", "https://www.prnasia.com/story/210489-1.shtml", "https://www.prnasia.com/story/210523-1.shtml", "https://www.prnasia.com/story/210505-1.shtml", "https://cnmobile.prnasia.com/story/233245-1.shtml", "https://www.prnasia.com/story/235122-1.shtml", "https://www.prnasia.com/story/210465-1.shtml", "https://www.prnasia.com/story/235019-1.shtml", "https://www.prnasia.com/story/233254-1.shtml", "https://www.prnasia.com/story/234479-1.shtml", "https://www.prnasia.com/story/210494-1.shtml", "https://www.prnasia.com/story/234483-1.shtml", "https://www.prnasia.com/story/244605-1.shtml", "https://www.prnasia.com/story/244806-1.shtml", "https://www.prnasia.com/story/210394-1.shtml", "https://www.prnasia.com/story/244332-1.shtml", "https://www.prnasia.com/story/234036-1.shtml", "https://www.prnasia.com/story/210540-1.shtml", "https://www.prnasia.com/story/244559-1.shtml", "https://www.prnasia.com/story/245657-1.shtml", "https://www.prnasia.com/story/244696-1.shtml", "https://www.prnasia.com/story/244518-1.shtml", "https://www.prnasia.com/story/244924-1.shtml", "https://www.prnasia.com/story/244067-1.shtml", "https://www.prnasia.com/story/244888-1.shtml", "https://www.prnasia.com/story/245198-1.shtml", "https://www.prnasia.com/story/211962-1.shtml", "https://www.prnasia.com/story/244515-1.shtml", "https://www.prnasia.com/story/211869-1.shtml", "https://www.prnasia.com/story/245383-1.shtml", "https://www.prnasia.com/story/210533-1.shtml", "https://www.prnasia.com/story/245051-1.shtml", "https://www.prnasia.com/story/245436-1.shtml", "https://www.prnasia.com/story/212341-1.shtml", "https://www.prnasia.com/story/245229-1.shtml", "https://www.prnasia.com/story/212200-1.shtml", "https://www.prnasia.com/story/212363-1.shtml", "https://www.prnasia.com/story/212133-1.shtml", "https://www.prnasia.com/story/212238-1.shtml", "https://www.prnasia.com/story/212418-1.shtml", "https://www.prnasia.com/story/212358-1.shtml", "https://cnmobile.prnasia.com/story/245119-1.shtml", "https://www.prnasia.com/story/213593-1.shtml", "https://www.prnasia.com/story/212419-1.shtml", "https://www.prnasia.com/story/213612-1.shtml", "https://www.prnasia.com/story/212156-1.shtml", "https://www.prnasia.com/story/212402-1.shtml", "https://www.prnasia.com/story/212574-1.shtml", "https://www.prnasia.com/story/213828-1.shtml", "https://cnmobile.prnasia.com/story/212532-1.shtml", "https://cnmobile.prnasia.com/story/213625-1.shtml", "https://www.prnasia.com/story/214010-1.shtml", "https://www.prnasia.com/story/213996-1.shtml", "https://www.prnasia.com/story/214116-1.shtml", "https://www.prnasia.com/story/214210-1.shtml", "https://www.prnasia.com/story/214201-1.shtml", "https://www.prnasia.com/story/214232-1.shtml", "https://www.prnasia.com/story/185504-1.shtml", "https://www.prnasia.com/story/196970-1.shtml", "https://www.prnasia.com/story/197335-1.shtml", "https://www.prnasia.com/story/196950-1.shtml", "https://www.prnasia.com/story/196932-1.shtml", "https://www.prnasia.com/story/196908-1.shtml", "https://www.prnasia.com/story/199439-1.shtml", "https://www.prnasia.com/story/198877-1.shtml", "https://www.prnasia.com/story/197169-1.shtml", "https://www.prnasia.com/story/197626-1.shtml", "https://www.prnasia.com/story/197091-1.shtml", "https://www.prnasia.com/story/198527-1.shtml", "https://www.prnasia.com/story/199781-1.shtml", "https://www.prnasia.com/story/185638-1.shtml", "https://cnmobile.prnasia.com/story/197393-1.shtml", "https://www.prnasia.com/story/185549-1.shtml", "https://www.prnasia.com/story/198927-1.shtml", "https://cnmobile.prnasia.com/story/199062-1.shtml", "https://www.prnasia.com/story/199857-1.shtml", "https://www.prnasia.com/story/186236-1.shtml", "https://www.prnasia.com/story/185764-1.shtml", "https://www.prnasia.com/story/185927-1.shtml", "https://www.prnasia.com/story/201280-1.shtml", "https://www.prnasia.com/story/186031-1.shtml", "https://www.prnasia.com/story/182404-1.shtml", "https://www.prnasia.com/story/182006-1.shtml", "https://cnmobile.prnasia.com/story/182266-1.shtml", "https://www.prnasia.com/story/182237-1.shtml", "https://www.prnasia.com/story/207154-1.shtml", "https://www.prnasia.com/story/184173-1.shtml", "https://www.prnasia.com/story/183735-1.shtml", "https://www.prnasia.com/story/206879-1.shtml", "https://www.prnasia.com/story/207356-1.shtml", "https://www.prnasia.com/story/207484-1.shtml", "https://www.prnasia.com/story/184059-1.shtml", "https://www.prnasia.com/story/186560-1.shtml", "https://www.prnasia.com/story/207583-1.shtml", "https://www.prnasia.com/story/207540-1.shtml", "https://www.prnasia.com/story/186371-1.shtml", "https://www.prnasia.com/story/188589-1.shtml", "https://www.prnasia.com/story/186641-1.shtml", "https://www.prnasia.com/story/186268-1.shtml", "https://www.prnasia.com/story/186429-1.shtml", "https://www.prnasia.com/story/188630-1.shtml", "https://www.prnasia.com/story/154155-1.shtml", "https://www.prnasia.com/story/188561-1.shtml", "https://www.prnasia.com/story/165559-1.shtml", "https://www.prnasia.com/story/165173-1.shtml", "https://www.prnasia.com/story/165429-1.shtml", "https://www.prnasia.com/story/146827-1.shtml", "https://www.prnasia.com/story/149345-1.shtml", "https://www.prnasia.com/story/149130-1.shtml", "https://www.prnasia.com/story/165276-1.shtml", "https://www.prnasia.com/story/148249-1.shtml", "https://www.prnasia.com/story/148421-1.shtml", "https://www.prnasia.com/story/154291-1.shtml", "https://www.prnasia.com/story/149333-1.shtml", "https://www.prnasia.com/story/154577-1.shtml", "https://www.prnasia.com/story/154221-1.shtml", "https://www.prnasia.com/story/154414-1.shtml", "https://www.prnasia.com/story/149326-1.shtml", "https://www.prnasia.com/story/149470-1.shtml", "https://www.prnasia.com/story/154506-1.shtml", "https://www.prnasia.com/story/154171-1.shtml", "https://www.prnasia.com/story/154417-1.shtml", "https://www.prnasia.com/story/303619-1.shtml", "https://www.prnasia.com/story/154523-1.shtml", "https://www.prnasia.com/story/303589-1.shtml", "https://www.prnasia.com/story/303734-1.shtml", "https://www.prnasia.com/story/158651-1.shtml", "https://www.prnasia.com/story/303692-1.shtml", "https://www.prnasia.com/story/306153-1.shtml", "https://www.prnasia.com/story/306203-1.shtml", "https://www.prnasia.com/story/303778-1.shtml", "https://www.prnasia.com/story/303641-1.shtml", "https://www.prnasia.com/story/303660-1.shtml", "https://www.prnasia.com/story/303650-1.shtml", "https://www.prnasia.com/story/303659-1.shtml", "https://www.prnasia.com/story/306266-1.shtml", "https://www.prnasia.com/story/304185-1.shtml", "https://www.prnasia.com/story/304211-1.shtml", "https://www.prnasia.com/story/306354-1.shtml", "https://www.prnasia.com/story/304238-1.shtml", "https://www.prnasia.com/story/306219-1.shtml", "https://www.prnasia.com/story/304192-1.shtml", "https://www.prnasia.com/story/304244-1.shtml", "https://www.prnasia.com/story/306224-1.shtml", "https://www.prnasia.com/story/306238-1.shtml", "https://www.prnasia.com/story/304248-1.shtml", "https://www.prnasia.com/story/304222-1.shtml", "https://www.prnasia.com/story/306374-1.shtml", "https://cnmobile.prnasia.com/story/304229-1.shtml", "https://www.prnasia.com/story/304188-1.shtml", "https://www.prnasia.com/story/304201-1.shtml", "https://www.prnasia.com/story/303841-1.shtml", "https://www.prnasia.com/story/304053-1.shtml", "https://www.prnasia.com/story/304080-1.shtml", "https://www.prnasia.com/story/303919-1.shtml", "https://www.prnasia.com/story/304026-1.shtml", "https://www.prnasia.com/story/303862-1.shtml", "https://www.prnasia.com/story/303979-1.shtml", "https://www.prnasia.com/story/304137-1.shtml", "https://www.prnasia.com/story/304105-1.shtml", "https://www.prnasia.com/story/303888-1.shtml", "https://www.prnasia.com/story/304004-1.shtml", "https://www.prnasia.com/story/304016-1.shtml", "https://www.prnasia.com/story/304267-1.shtml", "https://www.prnasia.com/story/303785-1.shtml", "https://www.prnasia.com/story/303984-1.shtml", "https://www.prnasia.com/story/303816-1.shtml", "https://www.prnasia.com/story/303878-1.shtml", "https://cnmobile.prnasia.com/story/303802-1.shtml", "https://cnmobile.prnasia.com/story/303872-1.shtml", "https://www.prnasia.com/story/304184-1.shtml", "https://www.prnasia.com/story/304081-1.shtml", "https://www.prnasia.com/story/304155-1.shtml", "https://www.prnasia.com/story/304509-1.shtml", "https://www.prnasia.com/story/304452-1.shtml", "https://www.prnasia.com/story/304159-1.shtml", "https://www.prnasia.com/story/304522-1.shtml", "https://www.prnasia.com/story/304157-1.shtml", "https://www.prnasia.com/story/307047-1.shtml", "https://www.prnasia.com/story/304486-1.shtml", "https://www.prnasia.com/story/304166-1.shtml", "https://www.prnasia.com/story/304440-1.shtml", "https://www.prnasia.com/story/304145-1.shtml", "https://www.prnasia.com/story/304442-1.shtml", "https://www.prnasia.com/story/304150-1.shtml", "https://www.prnasia.com/story/304490-1.shtml", "https://www.prnasia.com/story/304435-1.shtml", "https://www.prnasia.com/story/304575-1.shtml", "https://www.prnasia.com/story/304565-1.shtml", "https://cnmobile.prnasia.com/story/304505-1.shtml", "https://cnmobile.prnasia.com/story/304149-1.shtml", "https://www.prnasia.com/story/307240-1.shtml", "https://www.prnasia.com/story/307184-1.shtml", "https://www.prnasia.com/story/307186-1.shtml", "https://www.prnasia.com/story/307083-1.shtml", "https://www.prnasia.com/story/304668-1.shtml", "https://www.prnasia.com/story/304582-1.shtml", "https://www.prnasia.com/story/307132-1.shtml", "https://www.prnasia.com/story/307165-1.shtml", "https://www.prnasia.com/story/304672-1.shtml", "https://www.prnasia.com/story/307072-1.shtml", "https://www.prnasia.com/story/304664-1.shtml", "https://www.prnasia.com/story/307206-1.shtml", "https://www.prnasia.com/story/304690-1.shtml", "https://www.prnasia.com/story/307176-1.shtml", "https://www.prnasia.com/story/307255-1.shtml", "https://www.prnasia.com/story/306739-1.shtml", "https://www.prnasia.com/story/305119-1.shtml", "https://www.prnasia.com/story/305143-1.shtml", "https://www.prnasia.com/story/304726-1.shtml", "https://www.prnasia.com/story/306755-1.shtml", "https://www.prnasia.com/story/305097-1.shtml", "https://www.prnasia.com/story/305127-1.shtml", "https://www.prnasia.com/story/305160-1.shtml", "https://www.prnasia.com/story/304727-1.shtml", "https://cnmobile.prnasia.com/story/304736-1.shtml", "https://www.prnasia.com/story/306779-1.shtml", "https://cnmobile.prnasia.com/story/305204-1.shtml", "https://www.prnasia.com/story/305146-1.shtml", "https://www.prnasia.com/story/305212-1.shtml", "https://cnmobile.prnasia.com/story/306785-1.shtml", "https://www.prnasia.com/story/304725-1.shtml", "https://www.prnasia.com/story/305116-1.shtml", "https://www.prnasia.com/story/307019-1.shtml", "https://www.prnasia.com/story/305317-1.shtml", "https://www.prnasia.com/story/306967-1.shtml", "https://www.prnasia.com/story/306891-1.shtml", "https://www.prnasia.com/story/305403-1.shtml", "https://www.prnasia.com/story/305293-1.shtml", "https://www.prnasia.com/story/305343-1.shtml", "https://www.prnasia.com/story/305349-1.shtml", "https://www.prnasia.com/story/305316-1.shtml", "https://www.prnasia.com/story/305287-1.shtml", "https://www.prnasia.com/story/305331-1.shtml", "https://www.prnasia.com/story/305482-1.shtml", "https://www.prnasia.com/story/306819-1.shtml", "https://www.prnasia.com/story/305394-1.shtml", "https://www.prnasia.com/story/306963-1.shtml", "https://www.prnasia.com/story/305504-1.shtml", "https://www.prnasia.com/story/305282-1.shtml", "https://www.prnasia.com/story/305586-1.shtml", "https://www.prnasia.com/story/305540-1.shtml", "https://www.prnasia.com/story/305397-1.shtml", "https://www.prnasia.com/story/305654-1.shtml", "https://www.prnasia.com/story/305437-1.shtml", "https://www.prnasia.com/story/305648-1.shtml", "https://www.prnasia.com/story/305623-1.shtml", "https://www.prnasia.com/story/305591-1.shtml", "https://www.prnasia.com/story/305843-1.shtml", "https://www.prnasia.com/story/305564-1.shtml", "https://www.prnasia.com/story/305573-1.shtml", "https://www.prnasia.com/story/305792-1.shtml", "https://www.prnasia.com/story/305672-1.shtml", "https://www.prnasia.com/story/305510-1.shtml", "https://www.prnasia.com/story/299775-1.shtml", "https://www.prnasia.com/story/305915-1.shtml", "https://www.prnasia.com/story/299765-1.shtml", "https://www.prnasia.com/story/305706-1.shtml", "https://www.prnasia.com/story/305900-1.shtml", "https://www.prnasia.com/story/299731-1.shtml", "https://www.prnasia.com/story/305901-1.shtml", "https://www.prnasia.com/story/305720-1.shtml", "https://www.prnasia.com/story/305876-1.shtml", "https://www.prnasia.com/story/299889-1.shtml", "https://www.prnasia.com/story/305951-1.shtml", "https://www.prnasia.com/story/299781-1.shtml", "https://www.prnasia.com/story/299709-1.shtml", "https://www.prnasia.com/story/305977-1.shtml", "https://www.prnasia.com/story/305942-1.shtml", "https://www.prnasia.com/story/299875-1.shtml", "https://www.prnasia.com/story/305933-1.shtml", "https://www.prnasia.com/story/299678-1.shtml", "https://www.prnasia.com/story/299887-1.shtml", "https://www.prnasia.com/story/299788-1.shtml", "https://www.prnasia.com/story/306021-1.shtml", "https://www.prnasia.com/story/299801-1.shtml", "https://cnmobile.prnasia.com/story/305930-1.shtml", "https://www.prnasia.com/story/299906-1.shtml", "https://www.prnasia.com/story/300164-1.shtml", "https://www.prnasia.com/story/306022-1.shtml", "https://www.prnasia.com/story/306018-1.shtml", "https://www.prnasia.com/story/300154-1.shtml", "https://www.prnasia.com/story/299931-1.shtml", "https://www.prnasia.com/story/299935-1.shtml", "https://www.prnasia.com/story/299959-1.shtml", "https://www.prnasia.com/story/300071-1.shtml", "https://www.prnasia.com/story/300053-1.shtml", "https://www.prnasia.com/story/299937-1.shtml", "https://www.prnasia.com/story/306388-1.shtml", "https://www.prnasia.com/story/300226-1.shtml", "https://www.prnasia.com/story/306389-1.shtml", "https://www.prnasia.com/story/306492-1.shtml", "https://www.prnasia.com/story/306455-1.shtml", "https://www.prnasia.com/story/306461-1.shtml", "https://www.prnasia.com/story/306391-1.shtml", "https://www.prnasia.com/story/300023-1.shtml", "https://www.prnasia.com/story/300359-1.shtml", "https://www.prnasia.com/story/306509-1.shtml", "https://www.prnasia.com/story/306550-1.shtml", "https://www.prnasia.com/story/300247-1.shtml", "https://www.prnasia.com/story/300285-1.shtml", "https://www.prnasia.com/story/306387-1.shtml", "https://www.prnasia.com/story/300422-1.shtml", "https://www.prnasia.com/story/300434-1.shtml", "https://www.prnasia.com/story/306595-1.shtml", "https://www.prnasia.com/story/306557-1.shtml", "https://www.prnasia.com/story/300432-1.shtml", "https://www.prnasia.com/story/300272-1.shtml", "https://cnmobile.prnasia.com/story/300348-1.shtml", "https://www.prnasia.com/story/300421-1.shtml", "https://www.prnasia.com/story/300376-1.shtml", "https://www.prnasia.com/story/297120-1.shtml", "https://www.prnasia.com/story/306655-1.shtml", "https://www.prnasia.com/story/306662-1.shtml", "https://www.prnasia.com/story/297152-1.shtml", "https://www.prnasia.com/story/306703-1.shtml", "https://www.prnasia.com/story/297233-1.shtml", "https://www.prnasia.com/story/306679-1.shtml", "https://www.prnasia.com/story/297223-1.shtml", "https://www.prnasia.com/story/297213-1.shtml", "https://www.prnasia.com/story/297185-1.shtml", "https://www.prnasia.com/story/297113-1.shtml", "https://www.prnasia.com/story/306642-1.shtml", "https://www.prnasia.com/story/306692-1.shtml", "https://www.prnasia.com/story/297219-1.shtml", "https://cnmobile.prnasia.com/story/297125-1.shtml", "https://www.prnasia.com/story/297714-1.shtml", "https://www.prnasia.com/story/297694-1.shtml", "https://www.prnasia.com/story/300805-1.shtml", "https://www.prnasia.com/story/297720-1.shtml", "https://www.prnasia.com/story/297683-1.shtml", "https://www.prnasia.com/story/297717-1.shtml", "https://www.prnasia.com/story/297686-1.shtml", "https://www.prnasia.com/story/297680-1.shtml", "https://www.prnasia.com/story/300742-1.shtml", "https://www.prnasia.com/story/297684-1.shtml", "https://www.prnasia.com/story/297696-1.shtml", "https://www.prnasia.com/story/300727-1.shtml", "https://www.prnasia.com/story/300708-1.shtml", "https://www.prnasia.com/story/300725-1.shtml", "https://www.prnasia.com/story/297691-1.shtml", "https://cnmobile.prnasia.com/story/297685-1.shtml", "https://www.prnasia.com/story/300706-1.shtml", "https://www.prnasia.com/story/297724-1.shtml", "https://www.prnasia.com/story/297712-1.shtml", "https://www.prnasia.com/story/297672-1.shtml", "https://www.prnasia.com/story/297736-1.shtml", "https://www.prnasia.com/story/297737-1.shtml", "https://www.prnasia.com/story/297741-1.shtml", "https://www.prnasia.com/story/300832-1.shtml", "https://www.prnasia.com/story/297739-1.shtml", "https://www.prnasia.com/story/300849-1.shtml", "https://www.prnasia.com/story/297725-1.shtml", "https://www.prnasia.com/story/300875-1.shtml", "https://www.prnasia.com/story/300920-1.shtml", "https://www.prnasia.com/story/300893-1.shtml", "https://www.prnasia.com/story/300831-1.shtml", "https://www.prnasia.com/story/297751-1.shtml", "https://www.prnasia.com/story/297760-1.shtml", "https://www.prnasia.com/story/297726-1.shtml", "https://www.prnasia.com/story/297742-1.shtml", "https://www.prnasia.com/story/297752-1.shtml", "https://www.prnasia.com/story/301127-1.shtml", "https://www.prnasia.com/story/297745-1.shtml", "https://www.prnasia.com/story/301032-1.shtml", "https://www.prnasia.com/story/297754-1.shtml", "https://www.prnasia.com/story/300976-1.shtml", "https://www.prnasia.com/story/297762-1.shtml", "https://www.prnasia.com/story/301062-1.shtml", "https://www.prnasia.com/story/301031-1.shtml", "https://www.prnasia.com/story/301036-1.shtml", "https://www.prnasia.com/story/300970-1.shtml", "https://www.prnasia.com/story/297750-1.shtml", "https://www.prnasia.com/story/301261-1.shtml", "https://www.prnasia.com/story/301019-1.shtml", "https://www.prnasia.com/story/301353-1.shtml", "https://www.prnasia.com/story/301401-1.shtml", "https://www.prnasia.com/story/301349-1.shtml", "https://www.prnasia.com/story/296904-1.shtml", "https://www.prnasia.com/story/296952-1.shtml", "https://www.prnasia.com/story/296839-1.shtml", "https://www.prnasia.com/story/301342-1.shtml", "https://www.prnasia.com/story/296877-1.shtml", "https://www.prnasia.com/story/301439-1.shtml", "https://www.prnasia.com/story/297081-1.shtml", "https://www.prnasia.com/story/301561-1.shtml", "https://www.prnasia.com/story/301555-1.shtml", "https://www.prnasia.com/story/296963-1.shtml", "https://www.prnasia.com/story/296902-1.shtml", "https://www.prnasia.com/story/301496-1.shtml", "https://www.prnasia.com/story/296837-1.shtml", "https://www.prnasia.com/story/296918-1.shtml", "https://www.prnasia.com/story/297084-1.shtml", "https://www.prnasia.com/story/297026-1.shtml", "https://www.prnasia.com/story/301574-1.shtml", "https://www.prnasia.com/story/297340-1.shtml", "https://www.prnasia.com/story/297366-1.shtml", "https://www.prnasia.com/story/301634-1.shtml", "https://www.prnasia.com/story/301732-1.shtml", "https://www.prnasia.com/story/301515-1.shtml", "https://cnmobile.prnasia.com/story/301549-1.shtml", "https://www.prnasia.com/story/301608-1.shtml", "https://www.prnasia.com/story/301623-1.shtml", "https://www.prnasia.com/story/301544-1.shtml", "https://www.prnasia.com/story/301607-1.shtml", "https://www.prnasia.com/story/301721-1.shtml", "https://www.prnasia.com/story/297419-1.shtml", "https://www.prnasia.com/story/297426-1.shtml", "https://www.prnasia.com/story/301686-1.shtml", "https://www.prnasia.com/story/297443-1.shtml", "https://www.prnasia.com/story/297398-1.shtml", "https://www.prnasia.com/story/297404-1.shtml", "https://www.prnasia.com/story/297397-1.shtml", "https://www.prnasia.com/story/297381-1.shtml", "https://www.prnasia.com/story/297440-1.shtml", "https://www.prnasia.com/story/297369-1.shtml", "https://www.prnasia.com/story/302030-1.shtml", "https://www.prnasia.com/story/297448-1.shtml", "https://www.prnasia.com/story/302125-1.shtml", "https://www.prnasia.com/story/301952-1.shtml", "https://www.prnasia.com/story/302124-1.shtml", "https://www.prnasia.com/story/297368-1.shtml", "https://www.prnasia.com/story/302038-1.shtml", "https://www.prnasia.com/story/302126-1.shtml", "https://www.prnasia.com/story/297499-1.shtml", "https://www.prnasia.com/story/301986-1.shtml", "https://www.prnasia.com/story/301979-1.shtml", "https://www.prnasia.com/story/297453-1.shtml", "https://www.prnasia.com/story/297468-1.shtml", "https://www.prnasia.com/story/297463-1.shtml", "https://www.prnasia.com/story/302445-1.shtml", "https://www.prnasia.com/story/297576-1.shtml", "https://www.prnasia.com/story/302184-1.shtml", "https://www.prnasia.com/story/297494-1.shtml", "https://www.prnasia.com/story/302492-1.shtml", "https://www.prnasia.com/story/297491-1.shtml", "https://www.prnasia.com/story/297523-1.shtml", "https://www.prnasia.com/story/302488-1.shtml", "https://www.prnasia.com/story/302448-1.shtml", "https://www.prnasia.com/story/302451-1.shtml", "https://www.prnasia.com/story/297456-1.shtml", "https://www.prnasia.com/story/302514-1.shtml", "https://www.prnasia.com/story/302482-1.shtml", "https://www.prnasia.com/story/297512-1.shtml", "https://www.prnasia.com/story/302462-1.shtml", "https://cnmobile.prnasia.com/story/297541-1.shtml", "https://www.prnasia.com/story/297510-1.shtml", "https://www.prnasia.com/story/297587-1.shtml", "https://www.prnasia.com/story/297545-1.shtml", "https://www.prnasia.com/story/302727-1.shtml", "https://www.prnasia.com/story/302686-1.shtml", "https://www.prnasia.com/story/302556-1.shtml", "https://www.prnasia.com/story/302681-1.shtml", "https://www.prnasia.com/story/302623-1.shtml", "https://www.prnasia.com/story/302651-1.shtml", "https://www.prnasia.com/story/302604-1.shtml", "https://www.prnasia.com/story/302738-1.shtml", "https://www.prnasia.com/story/302644-1.shtml", "https://www.prnasia.com/story/302522-1.shtml", "https://www.prnasia.com/story/302765-1.shtml", "https://www.prnasia.com/story/302518-1.shtml", "https://www.prnasia.com/story/297775-1.shtml", "https://www.prnasia.com/story/297774-1.shtml", "https://www.prnasia.com/story/297777-1.shtml", "https://www.prnasia.com/story/302999-1.shtml", "https://www.prnasia.com/story/302974-1.shtml", "https://www.prnasia.com/story/297781-1.shtml", "https://www.prnasia.com/story/302906-1.shtml", "https://www.prnasia.com/story/297768-1.shtml", "https://www.prnasia.com/story/302892-1.shtml", "https://www.prnasia.com/story/302951-1.shtml", "https://www.prnasia.com/story/297776-1.shtml", "https://www.prnasia.com/story/297788-1.shtml", "https://www.prnasia.com/story/297785-1.shtml", "https://www.prnasia.com/story/302946-1.shtml", "https://cnmobile.prnasia.com/story/297786-1.shtml", "https://www.prnasia.com/story/297778-1.shtml", "https://www.prnasia.com/story/303354-1.shtml", "https://www.prnasia.com/story/297795-1.shtml", "https://www.prnasia.com/story/303267-1.shtml", "https://www.prnasia.com/story/297806-1.shtml", "https://www.prnasia.com/story/297787-1.shtml", "https://www.prnasia.com/story/303201-1.shtml", "https://www.prnasia.com/story/297823-1.shtml", "https://www.prnasia.com/story/297799-1.shtml", "https://www.prnasia.com/story/297816-1.shtml", "https://www.prnasia.com/story/297810-1.shtml", "https://www.prnasia.com/story/303111-1.shtml", "https://www.prnasia.com/story/297814-1.shtml", "https://www.prnasia.com/story/303304-1.shtml", "https://www.prnasia.com/story/303102-1.shtml", "https://www.prnasia.com/story/297813-1.shtml", "https://cnmobile.prnasia.com/story/303152-1.shtml", "https://cnmobile.prnasia.com/story/297821-1.shtml", "https://cnmobile.prnasia.com/story/297789-1.shtml", "https://www.prnasia.com/story/297869-1.shtml", "https://cnmobile.prnasia.com/story/303217-1.shtml", "https://www.prnasia.com/story/297872-1.shtml", "https://www.prnasia.com/story/303362-1.shtml", "https://www.prnasia.com/story/303473-1.shtml", "https://www.prnasia.com/story/297854-1.shtml", "https://www.prnasia.com/story/303520-1.shtml", "https://www.prnasia.com/story/297877-1.shtml", "https://www.prnasia.com/story/297868-1.shtml", "https://www.prnasia.com/story/303516-1.shtml", "https://www.prnasia.com/story/303395-1.shtml", "https://www.prnasia.com/story/303546-1.shtml", "https://www.prnasia.com/story/303381-1.shtml", "https://www.prnasia.com/story/303522-1.shtml", "https://www.prnasia.com/story/297845-1.shtml", "https://www.prnasia.com/story/303494-1.shtml", "https://www.prnasia.com/story/297850-1.shtml", "https://www.prnasia.com/story/303506-1.shtml", "https://www.prnasia.com/story/303536-1.shtml", "https://www.prnasia.com/story/297824-1.shtml", "https://www.prnasia.com/story/297864-1.shtml", "https://www.prnasia.com/story/303461-1.shtml", "https://www.prnasia.com/story/298032-1.shtml", "https://www.prnasia.com/story/303409-1.shtml", "https://www.prnasia.com/story/297931-1.shtml", "https://www.prnasia.com/story/303415-1.shtml", "https://www.prnasia.com/story/298143-1.shtml", "https://www.prnasia.com/story/298103-1.shtml", "https://www.prnasia.com/story/298171-1.shtml", "https://www.prnasia.com/story/298020-1.shtml", "https://www.prnasia.com/story/297905-1.shtml", "https://www.prnasia.com/story/297902-1.shtml", "https://www.prnasia.com/story/297959-1.shtml", "https://www.prnasia.com/story/298242-1.shtml", "https://www.prnasia.com/story/297901-1.shtml", "https://cnmobile.prnasia.com/story/297911-1.shtml", "https://www.prnasia.com/story/298231-1.shtml", "https://www.prnasia.com/story/297939-1.shtml", "https://cnmobile.prnasia.com/story/297928-1.shtml", "https://www.prnasia.com/story/298336-1.shtml", "https://www.prnasia.com/story/298301-1.shtml", "https://www.prnasia.com/story/293689-1.shtml", "https://cnmobile.prnasia.com/story/298151-1.shtml", "https://www.prnasia.com/story/294012-1.shtml", "https://www.prnasia.com/story/298351-1.shtml", "https://www.prnasia.com/story/293612-1.shtml", "https://www.prnasia.com/story/298271-1.shtml", "https://www.prnasia.com/story/293799-1.shtml", "https://www.prnasia.com/story/300696-1.shtml", "https://www.prnasia.com/story/293671-1.shtml", "https://www.prnasia.com/story/293738-1.shtml", "https://www.prnasia.com/story/293828-1.shtml", "https://cnmobile.prnasia.com/story/293647-1.shtml", "https://www.prnasia.com/story/298339-1.shtml", "https://www.prnasia.com/story/293966-1.shtml", "https://www.prnasia.com/story/298536-1.shtml", "https://www.prnasia.com/story/298508-1.shtml", "https://www.prnasia.com/story/298357-1.shtml", "https://www.prnasia.com/story/298528-1.shtml", "https://www.prnasia.com/story/298359-1.shtml", "https://www.prnasia.com/story/295982-1.shtml", "https://www.prnasia.com/story/296065-1.shtml", "https://www.prnasia.com/story/298414-1.shtml", "https://www.prnasia.com/story/296030-1.shtml", "https://www.prnasia.com/story/298451-1.shtml", "https://www.prnasia.com/story/296013-1.shtml", "https://www.prnasia.com/story/295984-1.shtml", "https://www.prnasia.com/story/296026-1.shtml", "https://www.prnasia.com/story/295983-1.shtml", "https://www.prnasia.com/story/298605-1.shtml", "https://www.prnasia.com/story/296009-1.shtml", "https://www.prnasia.com/story/298689-1.shtml", "https://www.prnasia.com/story/298870-1.shtml", "https://www.prnasia.com/story/298819-1.shtml", "https://www.prnasia.com/story/298670-1.shtml", "https://www.prnasia.com/story/298806-1.shtml", "https://www.prnasia.com/story/298737-1.shtml", "https://www.prnasia.com/story/298749-1.shtml", "https://cnmobile.prnasia.com/story/298679-1.shtml", "https://www.prnasia.com/story/298744-1.shtml", "https://www.prnasia.com/story/298950-1.shtml", "https://www.prnasia.com/story/298835-1.shtml", "https://www.prnasia.com/story/298830-1.shtml", "https://www.prnasia.com/story/298792-1.shtml", "https://www.prnasia.com/story/298652-1.shtml", "https://www.prnasia.com/story/299079-1.shtml", "https://www.prnasia.com/story/293377-1.shtml", "https://www.prnasia.com/story/293550-1.shtml", "https://www.prnasia.com/story/293535-1.shtml", "https://www.prnasia.com/story/293463-1.shtml", "https://www.prnasia.com/story/298955-1.shtml", "https://www.prnasia.com/story/293543-1.shtml", "https://www.prnasia.com/story/293378-1.shtml", "https://www.prnasia.com/story/299057-1.shtml", "https://www.prnasia.com/story/299064-1.shtml", "https://www.prnasia.com/story/294062-1.shtml", "https://www.prnasia.com/story/294041-1.shtml", "https://www.prnasia.com/story/293549-1.shtml", "https://www.prnasia.com/story/299033-1.shtml", "https://www.prnasia.com/story/293545-1.shtml", "https://www.prnasia.com/story/294271-1.shtml", "https://www.prnasia.com/story/294255-1.shtml", "https://www.prnasia.com/story/294205-1.shtml", "https://www.prnasia.com/story/294267-1.shtml", "https://www.prnasia.com/story/294244-1.shtml", "https://www.prnasia.com/story/290281-1.shtml", "https://www.prnasia.com/story/290265-1.shtml", "https://www.prnasia.com/story/290218-1.shtml", "https://www.prnasia.com/story/294214-1.shtml", "https://www.prnasia.com/story/290192-1.shtml", "https://cnmobile.prnasia.com/story/294287-1.shtml", "https://www.prnasia.com/story/290255-1.shtml", "https://www.prnasia.com/story/294222-1.shtml", "https://www.prnasia.com/story/290134-1.shtml", "https://www.prnasia.com/story/294369-1.shtml", "https://www.prnasia.com/story/290085-1.shtml", "https://www.prnasia.com/story/294299-1.shtml", "https://www.prnasia.com/story/294311-1.shtml", "https://www.prnasia.com/story/294347-1.shtml", "https://www.prnasia.com/story/294351-1.shtml", "https://www.prnasia.com/story/290309-1.shtml", "https://www.prnasia.com/story/290263-1.shtml", "https://www.prnasia.com/story/290284-1.shtml", "https://www.prnasia.com/story/294340-1.shtml", "https://www.prnasia.com/story/294417-1.shtml", "https://www.prnasia.com/story/291465-1.shtml", "https://www.prnasia.com/story/294403-1.shtml", "https://www.prnasia.com/story/291421-1.shtml", "https://www.prnasia.com/story/294445-1.shtml", "https://www.prnasia.com/story/294576-1.shtml", "https://www.prnasia.com/story/294398-1.shtml", "https://www.prnasia.com/story/294490-1.shtml", "https://www.prnasia.com/story/294466-1.shtml", "https://www.prnasia.com/story/294453-1.shtml", "https://www.prnasia.com/story/294574-1.shtml", "https://www.prnasia.com/story/294401-1.shtml", "https://www.prnasia.com/story/291455-1.shtml", "https://www.prnasia.com/story/294485-1.shtml", "https://www.prnasia.com/story/291444-1.shtml", "https://www.prnasia.com/story/294423-1.shtml", "https://www.prnasia.com/story/294560-1.shtml", "https://www.prnasia.com/story/291583-1.shtml", "https://www.prnasia.com/story/291466-1.shtml", "https://www.prnasia.com/story/291481-1.shtml", "https://www.prnasia.com/story/291502-1.shtml", "https://www.prnasia.com/story/291594-1.shtml", "https://www.prnasia.com/story/294717-1.shtml", "https://www.prnasia.com/story/294975-1.shtml", "https://cnmobile.prnasia.com/story/291604-1.shtml", "https://www.prnasia.com/story/291537-1.shtml", "https://www.prnasia.com/story/291555-1.shtml", "https://www.prnasia.com/story/294946-1.shtml", "https://www.prnasia.com/story/289630-1.shtml", "https://www.prnasia.com/story/294947-1.shtml", "https://www.prnasia.com/story/289608-1.shtml", "https://www.prnasia.com/story/289759-1.shtml", "https://www.prnasia.com/story/295118-1.shtml", "https://www.prnasia.com/story/295110-1.shtml", "https://www.prnasia.com/story/295046-1.shtml", "https://cnmobile.prnasia.com/story/294987-1.shtml", "https://www.prnasia.com/story/295103-1.shtml", "https://cnmobile.prnasia.com/story/294979-1.shtml", "https://www.prnasia.com/story/295044-1.shtml", "https://www.prnasia.com/story/289734-1.shtml", "https://www.prnasia.com/story/295124-1.shtml", "https://www.prnasia.com/story/289719-1.shtml", "https://www.prnasia.com/story/289758-1.shtml", "https://www.prnasia.com/story/289718-1.shtml", "https://www.prnasia.com/story/295055-1.shtml", "https://www.prnasia.com/story/289757-1.shtml", "https://www.prnasia.com/story/289634-1.shtml", "https://www.prnasia.com/story/289684-1.shtml", "https://www.prnasia.com/story/295143-1.shtml", "https://www.prnasia.com/story/295140-1.shtml", "https://www.prnasia.com/story/289768-1.shtml", "https://www.prnasia.com/story/289848-1.shtml", "https://www.prnasia.com/story/289780-1.shtml", "https://www.prnasia.com/story/295165-1.shtml", "https://www.prnasia.com/story/295212-1.shtml", "https://www.prnasia.com/story/289834-1.shtml", "https://www.prnasia.com/story/289943-1.shtml", "https://www.prnasia.com/story/289888-1.shtml", "https://www.prnasia.com/story/289806-1.shtml", "https://www.prnasia.com/story/289941-1.shtml", "https://www.prnasia.com/story/289872-1.shtml", "https://www.prnasia.com/story/290016-1.shtml", "https://www.prnasia.com/story/289910-1.shtml", "https://www.prnasia.com/story/289771-1.shtml", "https://www.prnasia.com/story/289814-1.shtml", "https://www.prnasia.com/story/289960-1.shtml", "https://www.prnasia.com/story/289830-1.shtml", "https://www.prnasia.com/story/295197-1.shtml", "https://www.prnasia.com/story/289861-1.shtml", "https://www.prnasia.com/story/295400-1.shtml", "https://www.prnasia.com/story/295432-1.shtml", "https://www.prnasia.com/story/295301-1.shtml", "https://www.prnasia.com/story/295332-1.shtml", "https://www.prnasia.com/story/290407-1.shtml", "https://www.prnasia.com/story/290437-1.shtml", "https://www.prnasia.com/story/290507-1.shtml", "https://www.prnasia.com/story/295271-1.shtml", "https://www.prnasia.com/story/295368-1.shtml", "https://www.prnasia.com/story/290524-1.shtml", "https://www.prnasia.com/story/290521-1.shtml", "https://www.prnasia.com/story/295242-1.shtml", "https://www.prnasia.com/story/295231-1.shtml", "https://www.prnasia.com/story/290458-1.shtml", "https://www.prnasia.com/story/290481-1.shtml", "https://www.prnasia.com/story/290522-1.shtml", "https://www.prnasia.com/story/295732-1.shtml", "https://www.prnasia.com/story/295792-1.shtml", "https://www.prnasia.com/story/290563-1.shtml", "https://www.prnasia.com/story/295818-1.shtml", "https://www.prnasia.com/story/295727-1.shtml", "https://www.prnasia.com/story/295839-1.shtml", "https://www.prnasia.com/story/295664-1.shtml", "https://www.prnasia.com/story/295867-1.shtml", "https://www.prnasia.com/story/295704-1.shtml", "https://www.prnasia.com/story/290564-1.shtml", "https://www.prnasia.com/story/295478-1.shtml", "https://www.prnasia.com/story/295744-1.shtml", "https://www.prnasia.com/story/295871-1.shtml", "https://www.prnasia.com/story/295973-1.shtml", "https://www.prnasia.com/story/295907-1.shtml", "https://www.prnasia.com/story/295745-1.shtml", "https://www.prnasia.com/story/295881-1.shtml", "https://www.prnasia.com/story/290916-1.shtml", "https://www.prnasia.com/story/290770-1.shtml", "https://www.prnasia.com/story/290610-1.shtml", "https://www.prnasia.com/story/290956-1.shtml", "https://www.prnasia.com/story/290690-1.shtml", "https://www.prnasia.com/story/290817-1.shtml", "https://cnmobile.prnasia.com/story/295980-1.shtml", "https://www.prnasia.com/story/290771-1.shtml", "https://www.prnasia.com/story/290991-1.shtml", "https://www.prnasia.com/story/290997-1.shtml", "https://www.prnasia.com/story/291111-1.shtml", "https://www.prnasia.com/story/290911-1.shtml", "https://www.prnasia.com/story/296165-1.shtml", "https://www.prnasia.com/story/296238-1.shtml", "https://www.prnasia.com/story/296129-1.shtml", "https://www.prnasia.com/story/291174-1.shtml", "https://www.prnasia.com/story/291014-1.shtml", "https://www.prnasia.com/story/296202-1.shtml", "https://www.prnasia.com/story/291090-1.shtml", "https://www.prnasia.com/story/296232-1.shtml", "https://www.prnasia.com/story/296094-1.shtml", "https://www.prnasia.com/story/296151-1.shtml", "https://www.prnasia.com/story/296213-1.shtml", "https://www.prnasia.com/story/296217-1.shtml", "https://www.prnasia.com/story/296173-1.shtml", "https://www.prnasia.com/story/296157-1.shtml", "https://cnmobile.prnasia.com/story/291049-1.shtml", "https://www.prnasia.com/story/296089-1.shtml", "https://www.prnasia.com/story/291269-1.shtml", "https://www.prnasia.com/story/291310-1.shtml", "https://www.prnasia.com/story/291181-1.shtml", "https://www.prnasia.com/story/291209-1.shtml", "https://www.prnasia.com/story/296140-1.shtml", "https://www.prnasia.com/story/296267-1.shtml", "https://www.prnasia.com/story/291394-1.shtml", "https://www.prnasia.com/story/296287-1.shtml", "https://www.prnasia.com/story/296389-1.shtml", "https://www.prnasia.com/story/291370-1.shtml", "https://cnmobile.prnasia.com/story/291261-1.shtml", "https://www.prnasia.com/story/291203-1.shtml", "https://www.prnasia.com/story/296317-1.shtml", "https://www.prnasia.com/story/291349-1.shtml", "https://www.prnasia.com/story/296337-1.shtml", "https://www.prnasia.com/story/291687-1.shtml", "https://www.prnasia.com/story/291403-1.shtml", "https://www.prnasia.com/story/291695-1.shtml", "https://www.prnasia.com/story/291683-1.shtml", "https://www.prnasia.com/story/291774-1.shtml", "https://www.prnasia.com/story/296723-1.shtml", "https://www.prnasia.com/story/296661-1.shtml", "https://www.prnasia.com/story/296448-1.shtml", "https://www.prnasia.com/story/296654-1.shtml", "https://www.prnasia.com/story/291842-1.shtml", "https://www.prnasia.com/story/296834-1.shtml", "https://cnmobile.prnasia.com/story/296640-1.shtml", "https://cnmobile.prnasia.com/story/291772-1.shtml", "https://www.prnasia.com/story/291780-1.shtml", "https://www.prnasia.com/story/296753-1.shtml", "https://www.prnasia.com/story/296741-1.shtml", "https://www.prnasia.com/story/292078-1.shtml", "https://www.prnasia.com/story/292123-1.shtml", "https://www.prnasia.com/story/292136-1.shtml", "https://www.prnasia.com/story/296827-1.shtml", "https://www.prnasia.com/story/292076-1.shtml", "https://www.prnasia.com/story/296779-1.shtml", "https://www.prnasia.com/story/292124-1.shtml", "https://www.prnasia.com/story/286049-1.shtml", "https://www.prnasia.com/story/292085-1.shtml", "https://www.prnasia.com/story/292137-1.shtml", "https://www.prnasia.com/story/292095-1.shtml", "https://www.prnasia.com/story/285973-1.shtml", "https://www.prnasia.com/story/286012-1.shtml", "https://cnmobile.prnasia.com/story/292000-1.shtml", "https://www.prnasia.com/story/285984-1.shtml", "https://www.prnasia.com/story/285991-1.shtml", "https://www.prnasia.com/story/286074-1.shtml", "https://www.prnasia.com/story/291954-1.shtml", "https://www.prnasia.com/story/292075-1.shtml", "https://www.prnasia.com/story/286048-1.shtml", "https://www.prnasia.com/story/286047-1.shtml", "https://www.prnasia.com/story/292201-1.shtml", "https://cnmobile.prnasia.com/story/285983-1.shtml", "https://www.prnasia.com/story/292203-1.shtml", "https://www.prnasia.com/story/292219-1.shtml", "https://cnmobile.prnasia.com/story/286044-1.shtml", "https://www.prnasia.com/story/286121-1.shtml", "https://www.prnasia.com/story/292156-1.shtml", "https://www.prnasia.com/story/286170-1.shtml", "https://www.prnasia.com/story/286155-1.shtml", "https://www.prnasia.com/story/286127-1.shtml", "https://www.prnasia.com/story/286161-1.shtml", "https://www.prnasia.com/story/292163-1.shtml", "https://www.prnasia.com/story/292193-1.shtml", "https://www.prnasia.com/story/292254-1.shtml", "https://www.prnasia.com/story/286223-1.shtml", "https://cnmobile.prnasia.com/story/292246-1.shtml", "https://www.prnasia.com/story/286270-1.shtml", "https://www.prnasia.com/story/292345-1.shtml", "https://www.prnasia.com/story/292229-1.shtml", "https://www.prnasia.com/story/286292-1.shtml", "https://www.prnasia.com/story/286333-1.shtml", "https://www.prnasia.com/story/292353-1.shtml", "https://www.prnasia.com/story/292439-1.shtml", "https://www.prnasia.com/story/292413-1.shtml", "https://www.prnasia.com/story/286327-1.shtml", "https://www.prnasia.com/story/292427-1.shtml", "https://www.prnasia.com/story/286280-1.shtml", "https://www.prnasia.com/story/292396-1.shtml", "https://www.prnasia.com/story/292387-1.shtml", "https://www.prnasia.com/story/286308-1.shtml", "https://www.prnasia.com/story/286313-1.shtml", "https://www.prnasia.com/story/292348-1.shtml", "https://www.prnasia.com/story/292421-1.shtml", "https://www.prnasia.com/story/286239-1.shtml", "https://www.prnasia.com/story/292422-1.shtml", "https://www.prnasia.com/story/292303-1.shtml", "https://www.prnasia.com/story/292447-1.shtml", "https://www.prnasia.com/story/286457-1.shtml", "https://www.prnasia.com/story/286337-1.shtml", "https://www.prnasia.com/story/286475-1.shtml", "https://www.prnasia.com/story/292361-1.shtml", "https://www.prnasia.com/story/292522-1.shtml", "https://www.prnasia.com/story/286339-1.shtml", "https://www.prnasia.com/story/292529-1.shtml", "https://www.prnasia.com/story/286581-1.shtml", "https://www.prnasia.com/story/286472-1.shtml", "https://www.prnasia.com/story/292584-1.shtml", "https://www.prnasia.com/story/286571-1.shtml", "https://www.prnasia.com/story/292603-1.shtml", "https://www.prnasia.com/story/292599-1.shtml", "https://www.prnasia.com/story/286390-1.shtml", "https://www.prnasia.com/story/292454-1.shtml", "https://www.prnasia.com/story/292623-1.shtml", "https://www.prnasia.com/story/286730-1.shtml", "https://www.prnasia.com/story/292665-1.shtml", "https://www.prnasia.com/story/292722-1.shtml", "https://www.prnasia.com/story/286729-1.shtml", "https://www.prnasia.com/story/286830-1.shtml", "https://www.prnasia.com/story/286704-1.shtml", "https://www.prnasia.com/story/286750-1.shtml", "https://www.prnasia.com/story/286728-1.shtml", "https://www.prnasia.com/story/292625-1.shtml", "https://www.prnasia.com/story/292727-1.shtml", "https://www.prnasia.com/story/286832-1.shtml", "https://www.prnasia.com/story/292618-1.shtml", "https://www.prnasia.com/story/292681-1.shtml", "https://www.prnasia.com/story/292730-1.shtml", "https://www.prnasia.com/story/292804-1.shtml", "https://www.prnasia.com/story/292869-1.shtml", "https://www.prnasia.com/story/292834-1.shtml", "https://www.prnasia.com/story/286893-1.shtml", "https://www.prnasia.com/story/286964-1.shtml", "https://www.prnasia.com/story/286908-1.shtml", "https://www.prnasia.com/story/292865-1.shtml", "https://www.prnasia.com/story/286900-1.shtml", "https://www.prnasia.com/story/292885-1.shtml", "https://www.prnasia.com/story/286935-1.shtml", "https://www.prnasia.com/story/286890-1.shtml", "https://www.prnasia.com/story/292734-1.shtml", "https://www.prnasia.com/story/286880-1.shtml", "https://www.prnasia.com/story/292846-1.shtml", "https://www.prnasia.com/story/286946-1.shtml", "https://www.prnasia.com/story/292908-1.shtml", "https://www.prnasia.com/story/286902-1.shtml", "https://www.prnasia.com/story/292909-1.shtml", "https://www.prnasia.com/story/286933-1.shtml", "https://www.prnasia.com/story/292911-1.shtml", "https://www.prnasia.com/story/287011-1.shtml", "https://www.prnasia.com/story/292968-1.shtml", "https://www.prnasia.com/story/292947-1.shtml", "https://www.prnasia.com/story/292935-1.shtml", "https://www.prnasia.com/story/287023-1.shtml", "https://www.prnasia.com/story/292922-1.shtml", "https://www.prnasia.com/story/287072-1.shtml", "https://www.prnasia.com/story/292942-1.shtml", "https://www.prnasia.com/story/292953-1.shtml", "https://www.prnasia.com/story/287013-1.shtml", "https://www.prnasia.com/story/292969-1.shtml", "https://www.prnasia.com/story/292982-1.shtml", "https://www.prnasia.com/story/292986-1.shtml", "https://www.prnasia.com/story/287050-1.shtml", "https://www.prnasia.com/story/292891-1.shtml", "https://www.prnasia.com/story/285137-1.shtml", "https://www.prnasia.com/story/285123-1.shtml", "https://www.prnasia.com/story/287083-1.shtml", "https://www.prnasia.com/story/287234-1.shtml", "https://www.prnasia.com/story/293026-1.shtml", "https://www.prnasia.com/story/287028-1.shtml", "https://www.prnasia.com/story/287239-1.shtml", "https://www.prnasia.com/story/287287-1.shtml", "https://www.prnasia.com/story/285166-1.shtml", "https://www.prnasia.com/story/285209-1.shtml", "https://www.prnasia.com/story/287208-1.shtml", "https://www.prnasia.com/story/287292-1.shtml", "https://www.prnasia.com/story/285104-1.shtml", "https://www.prnasia.com/story/287248-1.shtml", "https://www.prnasia.com/story/285159-1.shtml", "https://www.prnasia.com/story/285134-1.shtml", "https://www.prnasia.com/story/285122-1.shtml", "https://www.prnasia.com/story/287349-1.shtml", "https://www.prnasia.com/story/285210-1.shtml", "https://www.prnasia.com/story/285185-1.shtml", "https://www.prnasia.com/story/287382-1.shtml", "https://www.prnasia.com/story/287373-1.shtml", "https://www.prnasia.com/story/287501-1.shtml", "https://www.prnasia.com/story/287477-1.shtml", "https://www.prnasia.com/story/282568-1.shtml", "https://www.prnasia.com/story/282598-1.shtml", "https://cnmobile.prnasia.com/story/287506-1.shtml", "https://www.prnasia.com/story/282570-1.shtml", "https://www.prnasia.com/story/282706-1.shtml", "https://www.prnasia.com/story/287353-1.shtml", "https://www.prnasia.com/story/282708-1.shtml", "https://www.prnasia.com/story/282647-1.shtml", "https://www.prnasia.com/story/282560-1.shtml", "https://www.prnasia.com/story/282733-1.shtml", "https://www.prnasia.com/story/282582-1.shtml", "https://www.prnasia.com/story/282605-1.shtml", "https://www.prnasia.com/story/287634-1.shtml", "https://www.prnasia.com/story/287533-1.shtml", "https://www.prnasia.com/story/287525-1.shtml", "https://www.prnasia.com/story/287638-1.shtml", "https://www.prnasia.com/story/287623-1.shtml", "https://www.prnasia.com/story/287670-1.shtml", "https://www.prnasia.com/story/287675-1.shtml", "https://www.prnasia.com/story/287650-1.shtml", "https://www.prnasia.com/story/287537-1.shtml", "https://www.prnasia.com/story/282793-1.shtml", "https://www.prnasia.com/story/282847-1.shtml", "https://www.prnasia.com/story/282778-1.shtml", "https://www.prnasia.com/story/283016-1.shtml", "https://www.prnasia.com/story/282943-1.shtml", "https://www.prnasia.com/story/282887-1.shtml", "https://www.prnasia.com/story/283006-1.shtml", "https://www.prnasia.com/story/287818-1.shtml", "https://www.prnasia.com/story/287838-1.shtml", "https://www.prnasia.com/story/287801-1.shtml", "https://www.prnasia.com/story/283054-1.shtml", "https://www.prnasia.com/story/282988-1.shtml", "https://www.prnasia.com/story/282961-1.shtml", "https://cnmobile.prnasia.com/story/283007-1.shtml", "https://www.prnasia.com/story/287715-1.shtml", "https://www.prnasia.com/story/287944-1.shtml", "https://www.prnasia.com/story/287971-1.shtml", "https://www.prnasia.com/story/283071-1.shtml", "https://www.prnasia.com/story/287985-1.shtml", "https://www.prnasia.com/story/283131-1.shtml", "https://www.prnasia.com/story/287920-1.shtml", "https://www.prnasia.com/story/283167-1.shtml", "https://www.prnasia.com/story/283083-1.shtml", "https://www.prnasia.com/story/283157-1.shtml", "https://www.prnasia.com/story/283082-1.shtml", "https://www.prnasia.com/story/287919-1.shtml", "https://www.prnasia.com/story/283124-1.shtml", "https://www.prnasia.com/story/283073-1.shtml", "https://www.prnasia.com/story/287914-1.shtml", "https://www.prnasia.com/story/283077-1.shtml", "https://cnmobile.prnasia.com/story/283127-1.shtml", "https://cnmobile.prnasia.com/story/283149-1.shtml", "https://www.prnasia.com/story/288068-1.shtml", "https://www.prnasia.com/story/287911-1.shtml", "https://www.prnasia.com/story/288160-1.shtml", "https://www.prnasia.com/story/288126-1.shtml", "https://www.prnasia.com/story/288158-1.shtml", "https://www.prnasia.com/story/283197-1.shtml", "https://www.prnasia.com/story/288050-1.shtml", "https://cnmobile.prnasia.com/story/283061-1.shtml", "https://www.prnasia.com/story/288211-1.shtml", "https://www.prnasia.com/story/288055-1.shtml", "https://www.prnasia.com/story/288303-1.shtml", "https://www.prnasia.com/story/288356-1.shtml", "https://www.prnasia.com/story/288358-1.shtml", "https://www.prnasia.com/story/288281-1.shtml", "https://www.prnasia.com/story/288449-1.shtml", "https://www.prnasia.com/story/288229-1.shtml", "https://www.prnasia.com/story/288299-1.shtml", "https://www.prnasia.com/story/283370-1.shtml", "https://www.prnasia.com/story/288427-1.shtml", "https://www.prnasia.com/story/288272-1.shtml", "https://www.prnasia.com/story/283336-1.shtml", "https://www.prnasia.com/story/288228-1.shtml", "https://www.prnasia.com/story/283437-1.shtml", "https://www.prnasia.com/story/283427-1.shtml", "https://www.prnasia.com/story/283467-1.shtml", "https://www.prnasia.com/story/288224-1.shtml", "https://www.prnasia.com/story/283408-1.shtml", "https://www.prnasia.com/story/288529-1.shtml", "https://www.prnasia.com/story/283447-1.shtml", "https://www.prnasia.com/story/288644-1.shtml", "https://www.prnasia.com/story/288630-1.shtml", "https://www.prnasia.com/story/283439-1.shtml", "https://cnmobile.prnasia.com/story/288450-1.shtml", "https://www.prnasia.com/story/288697-1.shtml", "https://www.prnasia.com/story/283455-1.shtml", "https://www.prnasia.com/story/288584-1.shtml", "https://www.prnasia.com/story/288692-1.shtml", "https://www.prnasia.com/story/288903-1.shtml", "https://www.prnasia.com/story/288703-1.shtml", "https://www.prnasia.com/story/288741-1.shtml", "https://www.prnasia.com/story/288848-1.shtml", "https://www.prnasia.com/story/288501-1.shtml", "https://www.prnasia.com/story/288831-1.shtml", "https://www.prnasia.com/story/288846-1.shtml", "https://www.prnasia.com/story/288733-1.shtml", "https://www.prnasia.com/story/283628-1.shtml", "https://www.prnasia.com/story/283488-1.shtml", "https://www.prnasia.com/story/288845-1.shtml", "https://www.prnasia.com/story/283642-1.shtml", "https://www.prnasia.com/story/283593-1.shtml", "https://www.prnasia.com/story/283571-1.shtml", "https://www.prnasia.com/story/283560-1.shtml", "https://www.prnasia.com/story/283694-1.shtml", "https://www.prnasia.com/story/283736-1.shtml", "https://www.prnasia.com/story/288943-1.shtml", "https://www.prnasia.com/story/288927-1.shtml", "https://www.prnasia.com/story/289008-1.shtml", "https://www.prnasia.com/story/283588-1.shtml", "https://www.prnasia.com/story/288970-1.shtml", "https://cnmobile.prnasia.com/story/283616-1.shtml", "https://cnmobile.prnasia.com/story/288989-1.shtml", "https://www.prnasia.com/story/288930-1.shtml", "https://www.prnasia.com/story/283643-1.shtml", "https://www.prnasia.com/story/289072-1.shtml", "https://www.prnasia.com/story/289053-1.shtml", "https://www.prnasia.com/story/283793-1.shtml", "https://www.prnasia.com/story/283859-1.shtml", "https://www.prnasia.com/story/283830-1.shtml", "https://www.prnasia.com/story/289090-1.shtml", "https://www.prnasia.com/story/283919-1.shtml", "https://www.prnasia.com/story/289030-1.shtml", "https://www.prnasia.com/story/289040-1.shtml", "https://www.prnasia.com/story/283917-1.shtml", "https://www.prnasia.com/story/283827-1.shtml", "https://www.prnasia.com/story/283840-1.shtml", "https://www.prnasia.com/story/289115-1.shtml", "https://www.prnasia.com/story/283893-1.shtml", "https://www.prnasia.com/story/283757-1.shtml", "https://www.prnasia.com/story/289120-1.shtml", "https://www.prnasia.com/story/283880-1.shtml", "https://www.prnasia.com/story/289331-1.shtml", "https://www.prnasia.com/story/289319-1.shtml", "https://www.prnasia.com/story/289194-1.shtml", "https://www.prnasia.com/story/283911-1.shtml", "https://www.prnasia.com/story/289330-1.shtml", "https://www.prnasia.com/story/289273-1.shtml", "https://www.prnasia.com/story/289347-1.shtml", "https://www.prnasia.com/story/289190-1.shtml", "https://www.prnasia.com/story/289496-1.shtml", "https://www.prnasia.com/story/289461-1.shtml", "https://www.prnasia.com/story/289453-1.shtml", "https://www.prnasia.com/story/289420-1.shtml", "https://www.prnasia.com/story/289220-1.shtml", "https://www.prnasia.com/story/289476-1.shtml", "https://www.prnasia.com/story/289251-1.shtml", "https://www.prnasia.com/story/289443-1.shtml", "https://www.prnasia.com/story/289515-1.shtml", "https://www.prnasia.com/story/284512-1.shtml", "https://www.prnasia.com/story/289376-1.shtml", "https://www.prnasia.com/story/289512-1.shtml", "https://www.prnasia.com/story/289505-1.shtml", "https://www.prnasia.com/story/284567-1.shtml", "https://www.prnasia.com/story/284414-1.shtml", "https://www.prnasia.com/story/280017-1.shtml", "https://www.prnasia.com/story/284621-1.shtml", "https://www.prnasia.com/story/280061-1.shtml", "https://www.prnasia.com/story/280112-1.shtml", "https://www.prnasia.com/story/280000-1.shtml", "https://www.prnasia.com/story/284717-1.shtml", "https://www.prnasia.com/story/280005-1.shtml", "https://www.prnasia.com/story/280082-1.shtml", "https://www.prnasia.com/story/280030-1.shtml", "https://www.prnasia.com/story/279996-1.shtml", "https://www.prnasia.com/story/280065-1.shtml", "https://www.prnasia.com/story/284625-1.shtml", "https://www.prnasia.com/story/280051-1.shtml", "https://www.prnasia.com/story/280029-1.shtml", "https://www.prnasia.com/story/284795-1.shtml", "https://www.prnasia.com/story/284823-1.shtml", "https://www.prnasia.com/story/281951-1.shtml", "https://www.prnasia.com/story/284824-1.shtml", "https://www.prnasia.com/story/281991-1.shtml", "https://www.prnasia.com/story/284812-1.shtml", "https://www.prnasia.com/story/281986-1.shtml", "https://www.prnasia.com/story/284850-1.shtml", "https://www.prnasia.com/story/281987-1.shtml", "https://www.prnasia.com/story/284799-1.shtml", "https://www.prnasia.com/story/282012-1.shtml", "https://www.prnasia.com/story/284918-1.shtml", "https://cnmobile.prnasia.com/story/284801-1.shtml", "https://www.prnasia.com/story/282017-1.shtml", "https://cnmobile.prnasia.com/story/284905-1.shtml", "https://www.prnasia.com/story/281988-1.shtml", "https://www.prnasia.com/story/282015-1.shtml", "https://www.prnasia.com/story/284902-1.shtml", "https://www.prnasia.com/story/282068-1.shtml", "https://www.prnasia.com/story/284942-1.shtml", "https://www.prnasia.com/story/282060-1.shtml", "https://www.prnasia.com/story/284864-1.shtml", "https://www.prnasia.com/story/282050-1.shtml", "https://www.prnasia.com/story/281784-1.shtml", "https://www.prnasia.com/story/285018-1.shtml", "https://www.prnasia.com/story/281794-1.shtml", "https://cnmobile.prnasia.com/story/284949-1.shtml", "https://www.prnasia.com/story/285074-1.shtml", "https://www.prnasia.com/story/281904-1.shtml", "https://www.prnasia.com/story/281718-1.shtml", "https://www.prnasia.com/story/281815-1.shtml", "https://www.prnasia.com/story/281869-1.shtml", "https://www.prnasia.com/story/281822-1.shtml", "https://www.prnasia.com/story/281891-1.shtml", "https://www.prnasia.com/story/281760-1.shtml", "https://www.prnasia.com/story/285037-1.shtml", "https://www.prnasia.com/story/285278-1.shtml", "https://www.prnasia.com/story/281885-1.shtml", "https://www.prnasia.com/story/281808-1.shtml", "https://www.prnasia.com/story/285307-1.shtml", "https://www.prnasia.com/story/285299-1.shtml", "https://www.prnasia.com/story/285258-1.shtml", "https://www.prnasia.com/story/281501-1.shtml", "https://www.prnasia.com/story/281478-1.shtml", "https://www.prnasia.com/story/281544-1.shtml", "https://www.prnasia.com/story/281540-1.shtml", "https://www.prnasia.com/story/285466-1.shtml", "https://www.prnasia.com/story/281572-1.shtml", "https://www.prnasia.com/story/281557-1.shtml", "https://www.prnasia.com/story/281657-1.shtml", "https://www.prnasia.com/story/281569-1.shtml", "https://www.prnasia.com/story/285525-1.shtml", "https://www.prnasia.com/story/285631-1.shtml", "https://www.prnasia.com/story/281591-1.shtml", "https://www.prnasia.com/story/281715-1.shtml", "https://www.prnasia.com/story/285499-1.shtml", "https://www.prnasia.com/story/285577-1.shtml", "https://www.prnasia.com/story/285490-1.shtml", "https://www.prnasia.com/story/285660-1.shtml", "https://www.prnasia.com/story/285568-1.shtml", "https://www.prnasia.com/story/279632-1.shtml", "https://www.prnasia.com/story/279611-1.shtml", "https://www.prnasia.com/story/285678-1.shtml", "https://www.prnasia.com/story/285589-1.shtml", "https://www.prnasia.com/story/285671-1.shtml", "https://www.prnasia.com/story/281685-1.shtml", "https://www.prnasia.com/story/279624-1.shtml", "https://www.prnasia.com/story/285729-1.shtml", "https://www.prnasia.com/story/279618-1.shtml", "https://www.prnasia.com/story/285860-1.shtml", "https://www.prnasia.com/story/276667-1.shtml", "https://www.prnasia.com/story/279736-1.shtml", "https://www.prnasia.com/story/285723-1.shtml", "https://www.prnasia.com/story/285778-1.shtml", "https://www.prnasia.com/story/279750-1.shtml", "https://www.prnasia.com/story/276686-1.shtml", "https://www.prnasia.com/story/285762-1.shtml", "https://www.prnasia.com/story/279687-1.shtml", "https://www.prnasia.com/story/279714-1.shtml", "https://www.prnasia.com/story/285684-1.shtml", "https://www.prnasia.com/story/279664-1.shtml", "https://www.prnasia.com/story/285774-1.shtml", "https://cnmobile.prnasia.com/story/279767-1.shtml", "https://www.prnasia.com/story/285767-1.shtml", "https://www.prnasia.com/story/276704-1.shtml", "https://www.prnasia.com/story/276785-1.shtml", "https://www.prnasia.com/story/285915-1.shtml", "https://www.prnasia.com/story/276816-1.shtml", "https://www.prnasia.com/story/276755-1.shtml", "https://www.prnasia.com/story/285939-1.shtml", "https://www.prnasia.com/story/276748-1.shtml", "https://www.prnasia.com/story/276774-1.shtml", "https://www.prnasia.com/story/279901-1.shtml", "https://www.prnasia.com/story/276799-1.shtml", "https://www.prnasia.com/story/279937-1.shtml", "https://www.prnasia.com/story/277710-1.shtml", "https://www.prnasia.com/story/279923-1.shtml", "https://www.prnasia.com/story/277787-1.shtml", "https://www.prnasia.com/story/279829-1.shtml", "https://www.prnasia.com/story/277789-1.shtml", "https://www.prnasia.com/story/279973-1.shtml", "https://www.prnasia.com/story/279866-1.shtml", "https://www.prnasia.com/story/279942-1.shtml", "https://www.prnasia.com/story/279873-1.shtml", "https://www.prnasia.com/story/277779-1.shtml", "https://cnmobile.prnasia.com/story/277806-1.shtml", "https://www.prnasia.com/story/277012-1.shtml", "https://www.prnasia.com/story/277026-1.shtml", "https://www.prnasia.com/story/277933-1.shtml", "https://www.prnasia.com/story/277834-1.shtml", "https://www.prnasia.com/story/280145-1.shtml", "https://www.prnasia.com/story/276993-1.shtml", "https://www.prnasia.com/story/277889-1.shtml", "https://www.prnasia.com/story/277079-1.shtml", "https://www.prnasia.com/story/277014-1.shtml", "https://www.prnasia.com/story/276985-1.shtml", "https://www.prnasia.com/story/277091-1.shtml", "https://www.prnasia.com/story/277927-1.shtml", "https://www.prnasia.com/story/280266-1.shtml", "https://www.prnasia.com/story/277098-1.shtml", "https://www.prnasia.com/story/277120-1.shtml", "https://www.prnasia.com/story/277347-1.shtml", "https://www.prnasia.com/story/280168-1.shtml", "https://www.prnasia.com/story/280174-1.shtml", "https://www.prnasia.com/story/280120-1.shtml", "https://www.prnasia.com/story/280180-1.shtml", "https://www.prnasia.com/story/277348-1.shtml", "https://www.prnasia.com/story/277323-1.shtml", "https://www.prnasia.com/story/277099-1.shtml", "https://www.prnasia.com/story/277369-1.shtml", "https://www.prnasia.com/story/280196-1.shtml", "https://www.prnasia.com/story/277366-1.shtml", "https://www.prnasia.com/story/277353-1.shtml", "https://www.prnasia.com/story/280272-1.shtml", "https://www.prnasia.com/story/277438-1.shtml", "https://www.prnasia.com/story/277395-1.shtml", "https://www.prnasia.com/story/276428-1.shtml", "https://www.prnasia.com/story/276414-1.shtml", "https://www.prnasia.com/story/276372-1.shtml", "https://www.prnasia.com/story/277416-1.shtml", "https://www.prnasia.com/story/276534-1.shtml", "https://www.prnasia.com/story/280445-1.shtml", "https://www.prnasia.com/story/280577-1.shtml", "https://www.prnasia.com/story/276527-1.shtml", "https://www.prnasia.com/story/280591-1.shtml", "https://www.prnasia.com/story/280523-1.shtml", "https://cnmobile.prnasia.com/story/276379-1.shtml", "https://www.prnasia.com/story/280567-1.shtml", "https://www.prnasia.com/story/276373-1.shtml", "https://www.prnasia.com/story/280663-1.shtml", "https://www.prnasia.com/story/280741-1.shtml", "https://www.prnasia.com/story/280711-1.shtml", "https://www.prnasia.com/story/280603-1.shtml", "https://www.prnasia.com/story/280576-1.shtml", "https://www.prnasia.com/story/280670-1.shtml", "https://www.prnasia.com/story/280469-1.shtml", "https://www.prnasia.com/story/280794-1.shtml", "https://www.prnasia.com/story/276505-1.shtml", "https://www.prnasia.com/story/280738-1.shtml", "https://www.prnasia.com/story/280696-1.shtml", "https://www.prnasia.com/story/280749-1.shtml", "https://www.prnasia.com/story/280625-1.shtml", "https://www.prnasia.com/story/276558-1.shtml", "https://www.prnasia.com/story/280901-1.shtml", "https://www.prnasia.com/story/280902-1.shtml", "https://www.prnasia.com/story/280720-1.shtml", "https://cnmobile.prnasia.com/story/280709-1.shtml", "https://www.prnasia.com/story/280812-1.shtml", "https://www.prnasia.com/story/280811-1.shtml", "https://www.prnasia.com/story/280895-1.shtml", "https://www.prnasia.com/story/280911-1.shtml", "https://www.prnasia.com/story/276645-1.shtml", "https://www.prnasia.com/story/276601-1.shtml", "https://cnmobile.prnasia.com/story/280910-1.shtml", "https://www.prnasia.com/story/276649-1.shtml", "https://www.prnasia.com/story/280832-1.shtml", "https://www.prnasia.com/story/280920-1.shtml", "https://www.prnasia.com/story/280891-1.shtml", "https://www.prnasia.com/story/280915-1.shtml", "https://www.prnasia.com/story/281034-1.shtml", "https://cnmobile.prnasia.com/story/276630-1.shtml", "https://www.prnasia.com/story/280974-1.shtml", "https://www.prnasia.com/story/281003-1.shtml", "https://www.prnasia.com/story/280987-1.shtml", "https://www.prnasia.com/story/281175-1.shtml", "https://www.prnasia.com/story/281114-1.shtml", "https://www.prnasia.com/story/280925-1.shtml", "https://www.prnasia.com/story/280979-1.shtml", "https://www.prnasia.com/story/281014-1.shtml", "https://www.prnasia.com/story/281128-1.shtml", "https://www.prnasia.com/story/281245-1.shtml", "https://www.prnasia.com/story/281046-1.shtml", "https://www.prnasia.com/story/280946-1.shtml", "https://www.prnasia.com/story/281315-1.shtml", "https://www.prnasia.com/story/281305-1.shtml", "https://www.prnasia.com/story/281314-1.shtml", "https://www.prnasia.com/story/281327-1.shtml", "https://www.prnasia.com/story/276944-1.shtml", "https://www.prnasia.com/story/276922-1.shtml", "https://www.prnasia.com/story/281358-1.shtml", "https://www.prnasia.com/story/276897-1.shtml", "https://www.prnasia.com/story/281341-1.shtml", "https://www.prnasia.com/story/281359-1.shtml", "https://www.prnasia.com/story/281348-1.shtml", "https://www.prnasia.com/story/281317-1.shtml", "https://www.prnasia.com/story/281340-1.shtml", "https://www.prnasia.com/story/276917-1.shtml", "https://www.prnasia.com/story/281410-1.shtml", "https://www.prnasia.com/story/281408-1.shtml", "https://www.prnasia.com/story/276826-1.shtml", "https://www.prnasia.com/story/281411-1.shtml", "https://www.prnasia.com/story/281396-1.shtml", "https://www.prnasia.com/story/277232-1.shtml", "https://www.prnasia.com/story/281471-1.shtml", "https://www.prnasia.com/story/277248-1.shtml", "https://www.prnasia.com/story/277278-1.shtml", "https://www.prnasia.com/story/277286-1.shtml", "https://www.prnasia.com/story/281409-1.shtml", "https://www.prnasia.com/story/277145-1.shtml", "https://www.prnasia.com/story/281454-1.shtml", "https://cnmobile.prnasia.com/story/277254-1.shtml", "https://cnmobile.prnasia.com/story/277242-1.shtml", "https://www.prnasia.com/story/277173-1.shtml", "https://www.prnasia.com/story/281399-1.shtml", "https://cnmobile.prnasia.com/story/277265-1.shtml", "https://www.prnasia.com/story/277318-1.shtml", "https://www.prnasia.com/story/277230-1.shtml", "https://www.prnasia.com/story/277575-1.shtml", "https://www.prnasia.com/story/277602-1.shtml", "https://www.prnasia.com/story/277505-1.shtml", "https://www.prnasia.com/story/277530-1.shtml", "https://www.prnasia.com/story/277276-1.shtml", "https://www.prnasia.com/story/277527-1.shtml", "https://www.prnasia.com/story/282172-1.shtml", "https://www.prnasia.com/story/277512-1.shtml", "https://www.prnasia.com/story/277313-1.shtml", "https://www.prnasia.com/story/282145-1.shtml", "https://www.prnasia.com/story/282140-1.shtml", "https://www.prnasia.com/story/282187-1.shtml", "https://www.prnasia.com/story/277685-1.shtml", "https://www.prnasia.com/story/282371-1.shtml", "https://www.prnasia.com/story/277971-1.shtml", "https://www.prnasia.com/story/277692-1.shtml", "https://www.prnasia.com/story/282188-1.shtml", "https://www.prnasia.com/story/282100-1.shtml", "https://www.prnasia.com/story/277705-1.shtml", "https://www.prnasia.com/story/282264-1.shtml", "https://www.prnasia.com/story/277959-1.shtml", "https://www.prnasia.com/story/282233-1.shtml", "https://www.prnasia.com/story/277979-1.shtml", "https://www.prnasia.com/story/282143-1.shtml", "https://www.prnasia.com/story/282395-1.shtml", "https://www.prnasia.com/story/282422-1.shtml", "https://www.prnasia.com/story/277965-1.shtml", "https://www.prnasia.com/story/282290-1.shtml", "https://www.prnasia.com/story/282510-1.shtml", "https://www.prnasia.com/story/278119-1.shtml", "https://www.prnasia.com/story/278166-1.shtml", "https://www.prnasia.com/story/282552-1.shtml", "https://www.prnasia.com/story/277994-1.shtml", "https://www.prnasia.com/story/277992-1.shtml", "https://www.prnasia.com/story/282440-1.shtml", "https://www.prnasia.com/story/282453-1.shtml", "https://www.prnasia.com/story/278208-1.shtml", "https://www.prnasia.com/story/282401-1.shtml", "https://www.prnasia.com/story/282404-1.shtml", "https://www.prnasia.com/story/282448-1.shtml", "https://www.prnasia.com/story/282471-1.shtml", "https://www.prnasia.com/story/282532-1.shtml", "https://www.prnasia.com/story/282546-1.shtml", "https://www.prnasia.com/story/278368-1.shtml", "https://www.prnasia.com/story/278289-1.shtml", "https://www.prnasia.com/story/282458-1.shtml", "https://www.prnasia.com/story/278335-1.shtml", "https://www.prnasia.com/story/278339-1.shtml", "https://www.prnasia.com/story/278364-1.shtml", "https://www.prnasia.com/story/282502-1.shtml", "https://www.prnasia.com/story/278341-1.shtml", "https://www.prnasia.com/story/278318-1.shtml", "https://www.prnasia.com/story/278291-1.shtml", "https://www.prnasia.com/story/278229-1.shtml", "https://www.prnasia.com/story/273634-1.shtml", "https://www.prnasia.com/story/278362-1.shtml", "https://www.prnasia.com/story/278402-1.shtml", "https://www.prnasia.com/story/278306-1.shtml", "https://www.prnasia.com/story/273622-1.shtml", "https://cnmobile.prnasia.com/story/278375-1.shtml", "https://www.prnasia.com/story/273595-1.shtml", "https://www.prnasia.com/story/278575-1.shtml", "https://www.prnasia.com/story/278589-1.shtml", "https://www.prnasia.com/story/273509-1.shtml", "https://www.prnasia.com/story/278628-1.shtml", "https://www.prnasia.com/story/278715-1.shtml", "https://www.prnasia.com/story/273667-1.shtml", "https://www.prnasia.com/story/278712-1.shtml", "https://www.prnasia.com/story/278622-1.shtml", "https://www.prnasia.com/story/278707-1.shtml", "https://www.prnasia.com/story/274433-1.shtml", "https://www.prnasia.com/story/278730-1.shtml", "https://www.prnasia.com/story/273645-1.shtml", "https://www.prnasia.com/story/278778-1.shtml", "https://www.prnasia.com/story/278661-1.shtml", "https://www.prnasia.com/story/278769-1.shtml", "https://www.prnasia.com/story/278793-1.shtml", "https://www.prnasia.com/story/274533-1.shtml", "https://www.prnasia.com/story/278421-1.shtml", "https://www.prnasia.com/story/278437-1.shtml", "https://www.prnasia.com/story/278485-1.shtml", "https://www.prnasia.com/story/278531-1.shtml", "https://www.prnasia.com/story/278479-1.shtml", "https://www.prnasia.com/story/278528-1.shtml", "https://www.prnasia.com/story/278457-1.shtml", "https://www.prnasia.com/story/278473-1.shtml", "https://www.prnasia.com/story/278446-1.shtml", "https://www.prnasia.com/story/274594-1.shtml", "https://www.prnasia.com/story/278546-1.shtml", "https://www.prnasia.com/story/274558-1.shtml", "https://www.prnasia.com/story/273675-1.shtml", "https://www.prnasia.com/story/273818-1.shtml", "https://www.prnasia.com/story/273734-1.shtml", "https://www.prnasia.com/story/273821-1.shtml", "https://www.prnasia.com/story/273847-1.shtml", "https://www.prnasia.com/story/273798-1.shtml", "https://www.prnasia.com/story/278855-1.shtml", "https://www.prnasia.com/story/273765-1.shtml", "https://www.prnasia.com/story/278882-1.shtml", "https://www.prnasia.com/story/278841-1.shtml", "https://cnmobile.prnasia.com/story/278824-1.shtml", "https://www.prnasia.com/story/278913-1.shtml", "https://www.prnasia.com/story/278560-1.shtml", "https://www.prnasia.com/story/273914-1.shtml", "https://www.prnasia.com/story/278969-1.shtml", "https://www.prnasia.com/story/279296-1.shtml", "https://www.prnasia.com/story/278937-1.shtml", "https://www.prnasia.com/story/273850-1.shtml", "https://www.prnasia.com/story/273970-1.shtml", "https://www.prnasia.com/story/274007-1.shtml", "https://www.prnasia.com/story/274040-1.shtml", "https://www.prnasia.com/story/279302-1.shtml", "https://www.prnasia.com/story/279382-1.shtml", "https://www.prnasia.com/story/279362-1.shtml", "https://www.prnasia.com/story/279408-1.shtml", "https://www.prnasia.com/story/278918-1.shtml", "https://www.prnasia.com/story/278958-1.shtml", "https://www.prnasia.com/story/279444-1.shtml", "https://www.prnasia.com/story/274116-1.shtml", "https://www.prnasia.com/story/279325-1.shtml", "https://www.prnasia.com/story/279365-1.shtml", "https://www.prnasia.com/story/279301-1.shtml", "https://www.prnasia.com/story/279017-1.shtml", "https://www.prnasia.com/story/279019-1.shtml", "https://www.prnasia.com/story/279057-1.shtml", "https://www.prnasia.com/story/274126-1.shtml", "https://www.prnasia.com/story/278974-1.shtml", "https://www.prnasia.com/story/279026-1.shtml", "https://www.prnasia.com/story/274067-1.shtml", "https://www.prnasia.com/story/279153-1.shtml", "https://www.prnasia.com/story/274147-1.shtml", "https://www.prnasia.com/story/279077-1.shtml", "https://cnmobile.prnasia.com/story/279229-1.shtml", "https://www.prnasia.com/story/272343-1.shtml", "https://www.prnasia.com/story/279128-1.shtml", "https://www.prnasia.com/story/272402-1.shtml", "https://www.prnasia.com/story/274714-1.shtml", "https://www.prnasia.com/story/274712-1.shtml", "https://www.prnasia.com/story/274701-1.shtml", "https://www.prnasia.com/story/274648-1.shtml", "https://www.prnasia.com/story/274699-1.shtml", "https://www.prnasia.com/story/272424-1.shtml", "https://www.prnasia.com/story/270576-1.shtml", "https://www.prnasia.com/story/270400-1.shtml", "https://www.prnasia.com/story/270467-1.shtml", "https://www.prnasia.com/story/270585-1.shtml", "https://www.prnasia.com/story/270892-1.shtml", "https://www.prnasia.com/story/270399-1.shtml", "https://www.prnasia.com/story/274749-1.shtml", "https://www.prnasia.com/story/270571-1.shtml", "https://www.prnasia.com/story/270855-1.shtml", "https://www.prnasia.com/story/274733-1.shtml", "https://www.prnasia.com/story/270589-1.shtml", "https://www.prnasia.com/story/270831-1.shtml", "https://www.prnasia.com/story/270574-1.shtml", "https://www.prnasia.com/story/271036-1.shtml", "https://www.prnasia.com/story/270933-1.shtml", "https://www.prnasia.com/story/270798-1.shtml", "https://www.prnasia.com/story/271167-1.shtml", "https://www.prnasia.com/story/271025-1.shtml", "https://www.prnasia.com/story/270875-1.shtml", "https://www.prnasia.com/story/271298-1.shtml", "https://www.prnasia.com/story/271454-1.shtml", "https://www.prnasia.com/story/271306-1.shtml", "https://www.prnasia.com/story/271449-1.shtml", "https://www.prnasia.com/story/271190-1.shtml", "https://www.prnasia.com/story/271029-1.shtml", "https://www.prnasia.com/story/271194-1.shtml", "https://www.prnasia.com/story/270990-1.shtml", "https://www.prnasia.com/story/271340-1.shtml", "https://www.prnasia.com/story/275135-1.shtml", "https://www.prnasia.com/story/275139-1.shtml", "https://www.prnasia.com/story/275138-1.shtml", "https://www.prnasia.com/story/275199-1.shtml", "https://www.prnasia.com/story/275114-1.shtml", "https://www.prnasia.com/story/275126-1.shtml", "https://www.prnasia.com/story/271628-1.shtml", "https://www.prnasia.com/story/271570-1.shtml", "https://www.prnasia.com/story/271670-1.shtml", "https://www.prnasia.com/story/271643-1.shtml", "https://www.prnasia.com/story/275416-1.shtml", "https://www.prnasia.com/story/275351-1.shtml", "https://www.prnasia.com/story/275356-1.shtml", "https://www.prnasia.com/story/275333-1.shtml", "https://www.prnasia.com/story/275473-1.shtml", "https://www.prnasia.com/story/271753-1.shtml", "https://www.prnasia.com/story/271746-1.shtml", "https://www.prnasia.com/story/271680-1.shtml", "https://www.prnasia.com/story/275552-1.shtml", "https://www.prnasia.com/story/271686-1.shtml", "https://www.prnasia.com/story/271787-1.shtml", "https://www.prnasia.com/story/275615-1.shtml", "https://www.prnasia.com/story/271773-1.shtml", "https://www.prnasia.com/story/275550-1.shtml", "https://www.prnasia.com/story/275465-1.shtml", "https://www.prnasia.com/story/275591-1.shtml", "https://www.prnasia.com/story/271821-1.shtml", "https://www.prnasia.com/story/275610-1.shtml", "https://www.prnasia.com/story/275701-1.shtml", "https://www.prnasia.com/story/271825-1.shtml", "https://www.prnasia.com/story/275618-1.shtml", "https://www.prnasia.com/story/271930-1.shtml", "https://www.prnasia.com/story/271993-1.shtml", "https://www.prnasia.com/story/275671-1.shtml", "https://www.prnasia.com/story/275774-1.shtml", "https://www.prnasia.com/story/271937-1.shtml", "https://www.prnasia.com/story/275896-1.shtml", "https://www.prnasia.com/story/275724-1.shtml", "https://www.prnasia.com/story/275794-1.shtml", "https://www.prnasia.com/story/275786-1.shtml", "https://www.prnasia.com/story/275929-1.shtml", "https://cnmobile.prnasia.com/story/275781-1.shtml", "https://www.prnasia.com/story/275857-1.shtml", "https://www.prnasia.com/story/275891-1.shtml", "https://www.prnasia.com/story/275818-1.shtml", "https://www.prnasia.com/story/275755-1.shtml", "https://www.prnasia.com/story/275928-1.shtml", "https://www.prnasia.com/story/275751-1.shtml", "https://www.prnasia.com/story/275913-1.shtml", "https://www.prnasia.com/story/275984-1.shtml", "https://www.prnasia.com/story/275814-1.shtml", "https://www.prnasia.com/story/275965-1.shtml", "https://www.prnasia.com/story/276039-1.shtml", "https://www.prnasia.com/story/276030-1.shtml", "https://www.prnasia.com/story/275956-1.shtml", "https://www.prnasia.com/story/276002-1.shtml", "https://www.prnasia.com/story/271996-1.shtml", "https://www.prnasia.com/story/272110-1.shtml", "https://www.prnasia.com/story/276086-1.shtml", "https://www.prnasia.com/story/276189-1.shtml", "https://www.prnasia.com/story/276061-1.shtml", "https://www.prnasia.com/story/272203-1.shtml", "https://www.prnasia.com/story/272174-1.shtml", "https://www.prnasia.com/story/276185-1.shtml", "https://www.prnasia.com/story/272219-1.shtml", "https://www.prnasia.com/story/272149-1.shtml", "https://www.prnasia.com/story/272136-1.shtml", "https://www.prnasia.com/story/276184-1.shtml", "https://www.prnasia.com/story/276204-1.shtml", "https://www.prnasia.com/story/276094-1.shtml", "https://cnmobile.prnasia.com/story/276170-1.shtml", "https://www.prnasia.com/story/276077-1.shtml", "https://www.prnasia.com/story/272179-1.shtml", "https://www.prnasia.com/story/276220-1.shtml", "https://cnmobile.prnasia.com/story/276054-1.shtml", "https://www.prnasia.com/story/276118-1.shtml", "https://www.prnasia.com/story/272244-1.shtml", "https://www.prnasia.com/story/272286-1.shtml", "https://www.prnasia.com/story/276353-1.shtml", "https://www.prnasia.com/story/276264-1.shtml", "https://www.prnasia.com/story/276323-1.shtml", "https://www.prnasia.com/story/272568-1.shtml", "https://www.prnasia.com/story/272727-1.shtml", "https://www.prnasia.com/story/272746-1.shtml", "https://www.prnasia.com/story/272609-1.shtml", "https://www.prnasia.com/story/272744-1.shtml", "https://cnmobile.prnasia.com/story/272518-1.shtml", "https://cnmobile.prnasia.com/story/272594-1.shtml", "https://www.prnasia.com/story/266339-1.shtml", "https://www.prnasia.com/story/272793-1.shtml", "https://www.prnasia.com/story/266383-1.shtml", "https://www.prnasia.com/story/272858-1.shtml", "https://www.prnasia.com/story/266392-1.shtml", "https://www.prnasia.com/story/266446-1.shtml", "https://www.prnasia.com/story/266322-1.shtml", "https://www.prnasia.com/story/266433-1.shtml", "https://www.prnasia.com/story/272895-1.shtml", "https://www.prnasia.com/story/266352-1.shtml", "https://www.prnasia.com/story/266320-1.shtml", "https://www.prnasia.com/story/266428-1.shtml", "https://www.prnasia.com/story/272849-1.shtml", "https://www.prnasia.com/story/266425-1.shtml", "https://www.prnasia.com/story/266342-1.shtml", "https://www.prnasia.com/story/272917-1.shtml", "https://www.prnasia.com/story/272865-1.shtml", "https://www.prnasia.com/story/272995-1.shtml", "https://www.prnasia.com/story/266391-1.shtml", "https://www.prnasia.com/story/272899-1.shtml", "https://www.prnasia.com/story/272953-1.shtml", "https://www.prnasia.com/story/272980-1.shtml", "https://cnmobile.prnasia.com/story/266377-1.shtml", "https://www.prnasia.com/story/273222-1.shtml", "https://www.prnasia.com/story/272952-1.shtml", "https://www.prnasia.com/story/273084-1.shtml", "https://www.prnasia.com/story/273053-1.shtml", "https://www.prnasia.com/story/272957-1.shtml", "https://www.prnasia.com/story/273090-1.shtml", "https://www.prnasia.com/story/272971-1.shtml", "https://www.prnasia.com/story/273266-1.shtml", "https://www.prnasia.com/story/273169-1.shtml", "https://www.prnasia.com/story/273384-1.shtml", "https://www.prnasia.com/story/273396-1.shtml", "https://www.prnasia.com/story/273246-1.shtml", "https://www.prnasia.com/story/273409-1.shtml", "https://www.prnasia.com/story/273313-1.shtml", "https://www.prnasia.com/story/273447-1.shtml", "https://www.prnasia.com/story/273258-1.shtml", "https://www.prnasia.com/story/273397-1.shtml", "https://www.prnasia.com/story/267203-1.shtml", "https://cnmobile.prnasia.com/story/273351-1.shtml", "https://www.prnasia.com/story/273420-1.shtml", "https://www.prnasia.com/story/267159-1.shtml", "https://www.prnasia.com/story/267358-1.shtml", "https://www.prnasia.com/story/267337-1.shtml", "https://www.prnasia.com/story/267341-1.shtml", "https://www.prnasia.com/story/267578-1.shtml", "https://www.prnasia.com/story/267349-1.shtml", "https://www.prnasia.com/story/267453-1.shtml", "https://www.prnasia.com/story/267357-1.shtml", "https://www.prnasia.com/story/267503-1.shtml", "https://www.prnasia.com/story/267361-1.shtml", "https://www.prnasia.com/story/267557-1.shtml", "https://cnmobile.prnasia.com/story/267263-1.shtml", "https://www.prnasia.com/story/267568-1.shtml", "https://www.prnasia.com/story/267646-1.shtml", "https://www.prnasia.com/story/267582-1.shtml", "https://www.prnasia.com/story/267488-1.shtml", "https://www.prnasia.com/story/267414-1.shtml", "https://www.prnasia.com/story/267454-1.shtml", "https://www.prnasia.com/story/267381-1.shtml", "https://www.prnasia.com/story/267530-1.shtml", "https://www.prnasia.com/story/267706-1.shtml", "https://www.prnasia.com/story/263507-1.shtml", "https://www.prnasia.com/story/263478-1.shtml", "https://www.prnasia.com/story/267818-1.shtml", "https://www.prnasia.com/story/263609-1.shtml", "https://www.prnasia.com/story/267673-1.shtml", "https://www.prnasia.com/story/263607-1.shtml", "https://www.prnasia.com/story/263485-1.shtml", "https://www.prnasia.com/story/267678-1.shtml", "https://www.prnasia.com/story/263565-1.shtml", "https://www.prnasia.com/story/267866-1.shtml", "https://www.prnasia.com/story/263488-1.shtml", "https://www.prnasia.com/story/267874-1.shtml", "https://www.prnasia.com/story/263559-1.shtml", "https://www.prnasia.com/story/263626-1.shtml", "https://www.prnasia.com/story/268049-1.shtml", "https://www.prnasia.com/story/268029-1.shtml", "https://cnmobile.prnasia.com/story/267885-1.shtml", "https://www.prnasia.com/story/268328-1.shtml", "https://www.prnasia.com/story/268208-1.shtml", "https://www.prnasia.com/story/268314-1.shtml", "https://www.prnasia.com/story/263621-1.shtml", "https://www.prnasia.com/story/268327-1.shtml", "https://www.prnasia.com/story/268326-1.shtml", "https://www.prnasia.com/story/268201-1.shtml", "https://www.prnasia.com/story/268190-1.shtml", "https://www.prnasia.com/story/268181-1.shtml", "https://www.prnasia.com/story/264883-1.shtml", "https://www.prnasia.com/story/268074-1.shtml", "https://www.prnasia.com/story/264879-1.shtml", "https://cnmobile.prnasia.com/story/268362-1.shtml", "https://www.prnasia.com/story/268524-1.shtml", "https://www.prnasia.com/story/268523-1.shtml", "https://www.prnasia.com/story/265010-1.shtml", "https://www.prnasia.com/story/268581-1.shtml", "https://www.prnasia.com/story/264975-1.shtml", "https://cnmobile.prnasia.com/story/268578-1.shtml", "https://www.prnasia.com/story/268649-1.shtml", "https://www.prnasia.com/story/268425-1.shtml", "https://www.prnasia.com/story/264974-1.shtml", "https://cnmobile.prnasia.com/story/265040-1.shtml", "https://www.prnasia.com/story/268783-1.shtml", "https://www.prnasia.com/story/268819-1.shtml", "https://www.prnasia.com/story/268748-1.shtml", "https://www.prnasia.com/story/268717-1.shtml", "https://www.prnasia.com/story/268726-1.shtml", "https://cnmobile.prnasia.com/story/268838-1.shtml", "https://www.prnasia.com/story/262172-1.shtml", "https://www.prnasia.com/story/262148-1.shtml", "https://www.prnasia.com/story/262139-1.shtml", "https://www.prnasia.com/story/268885-1.shtml", "https://www.prnasia.com/story/262105-1.shtml", "https://www.prnasia.com/story/262142-1.shtml", "https://www.prnasia.com/story/268925-1.shtml", "https://www.prnasia.com/story/262073-1.shtml", "https://www.prnasia.com/story/262153-1.shtml", "https://www.prnasia.com/story/262138-1.shtml", "https://www.prnasia.com/story/262065-1.shtml", "https://www.prnasia.com/story/268862-1.shtml", "https://www.prnasia.com/story/262179-1.shtml", "https://www.prnasia.com/story/268899-1.shtml", "https://www.prnasia.com/story/262146-1.shtml", "https://www.prnasia.com/story/268901-1.shtml", "https://www.prnasia.com/story/269062-1.shtml", "https://www.prnasia.com/story/268863-1.shtml", "https://www.prnasia.com/story/268905-1.shtml", "https://www.prnasia.com/story/269017-1.shtml", "https://www.prnasia.com/story/269183-1.shtml", "https://www.prnasia.com/story/269018-1.shtml", "https://www.prnasia.com/story/269215-1.shtml", "https://www.prnasia.com/story/269089-1.shtml", "https://www.prnasia.com/story/262476-1.shtml", "https://www.prnasia.com/story/269056-1.shtml", "https://www.prnasia.com/story/269046-1.shtml", "https://www.prnasia.com/story/262529-1.shtml", "https://www.prnasia.com/story/268978-1.shtml", "https://www.prnasia.com/story/269129-1.shtml", "https://www.prnasia.com/story/269160-1.shtml", "https://www.prnasia.com/story/269067-1.shtml", "https://www.prnasia.com/story/269108-1.shtml", "https://www.prnasia.com/story/268972-1.shtml", "https://www.prnasia.com/story/269039-1.shtml", "https://www.prnasia.com/story/269240-1.shtml", "https://www.prnasia.com/story/262646-1.shtml", "https://www.prnasia.com/story/269247-1.shtml", "https://www.prnasia.com/story/269253-1.shtml", "https://www.prnasia.com/story/262585-1.shtml", "https://www.prnasia.com/story/269323-1.shtml", "https://www.prnasia.com/story/262643-1.shtml", "https://www.prnasia.com/story/269286-1.shtml", "https://www.prnasia.com/story/269219-1.shtml", "https://www.prnasia.com/story/262751-1.shtml", "https://www.prnasia.com/story/262598-1.shtml", "https://www.prnasia.com/story/269262-1.shtml", "https://www.prnasia.com/story/262791-1.shtml", "https://www.prnasia.com/story/269244-1.shtml", "https://cnmobile.prnasia.com/story/262768-1.shtml", "https://cnmobile.prnasia.com/story/269222-1.shtml", "https://www.prnasia.com/story/262783-1.shtml", "https://cnmobile.prnasia.com/story/262653-1.shtml", "https://www.prnasia.com/story/269268-1.shtml", "https://www.prnasia.com/story/269464-1.shtml", "https://www.prnasia.com/story/269572-1.shtml", "https://www.prnasia.com/story/269381-1.shtml", "https://www.prnasia.com/story/263080-1.shtml", "https://www.prnasia.com/story/263083-1.shtml", "https://www.prnasia.com/story/269382-1.shtml", "https://www.prnasia.com/story/263072-1.shtml", "https://www.prnasia.com/story/269450-1.shtml", "https://www.prnasia.com/story/269611-1.shtml", "https://www.prnasia.com/story/269401-1.shtml", "https://www.prnasia.com/story/263038-1.shtml", "https://www.prnasia.com/story/269409-1.shtml", "https://www.prnasia.com/story/269522-1.shtml", "https://www.prnasia.com/story/269595-1.shtml", "https://www.prnasia.com/story/269348-1.shtml", "https://www.prnasia.com/story/269632-1.shtml", "https://www.prnasia.com/story/269477-1.shtml", "https://cnmobile.prnasia.com/story/269577-1.shtml", "https://www.prnasia.com/story/269562-1.shtml", "https://www.prnasia.com/story/270252-1.shtml", "https://www.prnasia.com/story/263238-1.shtml", "https://www.prnasia.com/story/270224-1.shtml", "https://www.prnasia.com/story/270263-1.shtml", "https://www.prnasia.com/story/270058-1.shtml", "https://www.prnasia.com/story/270259-1.shtml", "https://www.prnasia.com/story/270192-1.shtml", "https://www.prnasia.com/story/270112-1.shtml", "https://www.prnasia.com/story/263143-1.shtml", "https://www.prnasia.com/story/270132-1.shtml", "https://www.prnasia.com/story/263138-1.shtml", "https://www.prnasia.com/story/263139-1.shtml", "https://www.prnasia.com/story/270241-1.shtml", "https://www.prnasia.com/story/270162-1.shtml", "https://www.prnasia.com/story/263118-1.shtml", "https://www.prnasia.com/story/270327-1.shtml", "https://www.prnasia.com/story/270247-1.shtml", "https://www.prnasia.com/story/263220-1.shtml", "https://www.prnasia.com/story/263296-1.shtml", "https://www.prnasia.com/story/263470-1.shtml", "https://www.prnasia.com/story/263292-1.shtml", "https://www.prnasia.com/story/263412-1.shtml", "https://www.prnasia.com/story/263354-1.shtml", "https://www.prnasia.com/story/257707-1.shtml", "https://www.prnasia.com/story/263447-1.shtml", "https://www.prnasia.com/story/257650-1.shtml", "https://www.prnasia.com/story/263415-1.shtml", "https://www.prnasia.com/story/257652-1.shtml", "https://www.prnasia.com/story/263245-1.shtml", "https://www.prnasia.com/story/263300-1.shtml", "https://www.prnasia.com/story/263454-1.shtml", "https://www.prnasia.com/story/263688-1.shtml", "https://www.prnasia.com/story/257908-1.shtml", "https://www.prnasia.com/story/263794-1.shtml", "https://www.prnasia.com/story/257919-1.shtml", "https://www.prnasia.com/story/263804-1.shtml", "https://www.prnasia.com/story/258022-1.shtml", "https://www.prnasia.com/story/263827-1.shtml", "https://www.prnasia.com/story/263704-1.shtml", "https://www.prnasia.com/story/263802-1.shtml", "https://www.prnasia.com/story/263841-1.shtml", "https://www.prnasia.com/story/263646-1.shtml", "https://www.prnasia.com/story/263723-1.shtml", "https://www.prnasia.com/story/257976-1.shtml", "https://www.prnasia.com/story/263797-1.shtml", "https://www.prnasia.com/story/263758-1.shtml", "https://www.prnasia.com/story/258035-1.shtml", "https://www.prnasia.com/story/257539-1.shtml", "https://www.prnasia.com/story/257384-1.shtml", "https://cnmobile.prnasia.com/story/257449-1.shtml", "https://www.prnasia.com/story/264427-1.shtml", "https://www.prnasia.com/story/264453-1.shtml", "https://www.prnasia.com/story/257481-1.shtml", "https://www.prnasia.com/story/264494-1.shtml", "https://www.prnasia.com/story/264384-1.shtml", "https://www.prnasia.com/story/257513-1.shtml", "https://www.prnasia.com/story/258188-1.shtml", "https://www.prnasia.com/story/264565-1.shtml", "https://www.prnasia.com/story/264404-1.shtml", "https://www.prnasia.com/story/264431-1.shtml", "https://www.prnasia.com/story/264522-1.shtml", "https://www.prnasia.com/story/258187-1.shtml", "https://www.prnasia.com/story/258399-1.shtml", "https://www.prnasia.com/story/258357-1.shtml", "https://www.prnasia.com/story/258325-1.shtml", "https://www.prnasia.com/story/258328-1.shtml", "https://www.prnasia.com/story/264519-1.shtml", "https://www.prnasia.com/story/258146-1.shtml", "https://www.prnasia.com/story/258372-1.shtml", "https://www.prnasia.com/story/258314-1.shtml", "https://www.prnasia.com/story/258268-1.shtml", "https://www.prnasia.com/story/258156-1.shtml", "https://www.prnasia.com/story/258294-1.shtml", "https://www.prnasia.com/story/258168-1.shtml", "https://cnmobile.prnasia.com/story/258210-1.shtml", "https://www.prnasia.com/story/258456-1.shtml", "https://www.prnasia.com/story/258081-1.shtml", "https://www.prnasia.com/story/258403-1.shtml", "https://www.prnasia.com/story/258445-1.shtml", "https://www.prnasia.com/story/258490-1.shtml", "https://www.prnasia.com/story/258224-1.shtml", "https://www.prnasia.com/story/258439-1.shtml", "https://www.prnasia.com/story/258602-1.shtml", "https://www.prnasia.com/story/258510-1.shtml", "https://www.prnasia.com/story/258643-1.shtml", "https://www.prnasia.com/story/258502-1.shtml", "https://www.prnasia.com/story/265089-1.shtml", "https://www.prnasia.com/story/258583-1.shtml", "https://www.prnasia.com/story/258450-1.shtml", "https://www.prnasia.com/story/258482-1.shtml", "https://www.prnasia.com/story/258610-1.shtml", "https://www.prnasia.com/story/265120-1.shtml", "https://www.prnasia.com/story/258586-1.shtml", "https://www.prnasia.com/story/258513-1.shtml", "https://www.prnasia.com/story/265350-1.shtml", "https://www.prnasia.com/story/265292-1.shtml", "https://www.prnasia.com/story/258505-1.shtml", "https://www.prnasia.com/story/258570-1.shtml", "https://www.prnasia.com/story/265294-1.shtml", "https://www.prnasia.com/story/258569-1.shtml", "https://www.prnasia.com/story/265297-1.shtml", "https://www.prnasia.com/story/258623-1.shtml", "https://www.prnasia.com/story/265318-1.shtml", "https://www.prnasia.com/story/265278-1.shtml", "https://www.prnasia.com/story/258777-1.shtml", "https://www.prnasia.com/story/265207-1.shtml", "https://cnmobile.prnasia.com/story/265358-1.shtml", "https://www.prnasia.com/story/265214-1.shtml", "https://www.prnasia.com/story/258737-1.shtml", "https://www.prnasia.com/story/258845-1.shtml", "https://www.prnasia.com/story/258708-1.shtml", "https://www.prnasia.com/story/265490-1.shtml", "https://www.prnasia.com/story/258710-1.shtml", "https://www.prnasia.com/story/258801-1.shtml", "https://www.prnasia.com/story/258987-1.shtml", "https://www.prnasia.com/story/265457-1.shtml", "https://www.prnasia.com/story/258893-1.shtml", "https://www.prnasia.com/story/258983-1.shtml", "https://www.prnasia.com/story/265519-1.shtml", "https://www.prnasia.com/story/265434-1.shtml", "https://www.prnasia.com/story/265681-1.shtml", "https://www.prnasia.com/story/265639-1.shtml", "https://www.prnasia.com/story/265541-1.shtml", "https://www.prnasia.com/story/265607-1.shtml", "https://www.prnasia.com/story/265544-1.shtml", "https://www.prnasia.com/story/259058-1.shtml", "https://www.prnasia.com/story/259193-1.shtml", "https://cnmobile.prnasia.com/story/259303-1.shtml", "https://www.prnasia.com/story/265665-1.shtml", "https://www.prnasia.com/story/259216-1.shtml", "https://www.prnasia.com/story/259337-1.shtml", "https://www.prnasia.com/story/253122-1.shtml", "https://www.prnasia.com/story/259349-1.shtml", "https://www.prnasia.com/story/253187-1.shtml", "https://www.prnasia.com/story/253109-1.shtml", "https://www.prnasia.com/story/259445-1.shtml", "https://www.prnasia.com/story/253132-1.shtml", "https://www.prnasia.com/story/259380-1.shtml", "https://www.prnasia.com/story/259509-1.shtml", "https://www.prnasia.com/story/259475-1.shtml", "https://www.prnasia.com/story/253103-1.shtml", "https://www.prnasia.com/story/259359-1.shtml", "https://cnmobile.prnasia.com/story/259494-1.shtml", "https://www.prnasia.com/story/259321-1.shtml", "https://www.prnasia.com/story/259370-1.shtml", "https://www.prnasia.com/story/253151-1.shtml", "https://www.prnasia.com/story/259561-1.shtml", "https://www.prnasia.com/story/259894-1.shtml", "https://www.prnasia.com/story/259809-1.shtml", "https://www.prnasia.com/story/259932-1.shtml", "https://www.prnasia.com/story/253259-1.shtml", "https://www.prnasia.com/story/259847-1.shtml", "https://www.prnasia.com/story/253309-1.shtml", "https://www.prnasia.com/story/259984-1.shtml", "https://www.prnasia.com/story/253200-1.shtml", "https://cnmobile.prnasia.com/story/259852-1.shtml", "https://www.prnasia.com/story/259514-1.shtml", "https://www.prnasia.com/story/259896-1.shtml", "https://www.prnasia.com/story/253290-1.shtml", "https://www.prnasia.com/story/259927-1.shtml", "https://www.prnasia.com/story/259748-1.shtml", "https://www.prnasia.com/story/260045-1.shtml", "https://www.prnasia.com/story/259851-1.shtml", "https://www.prnasia.com/story/259928-1.shtml", "https://www.prnasia.com/story/260208-1.shtml", "https://www.prnasia.com/story/260112-1.shtml", "https://www.prnasia.com/story/259995-1.shtml", "https://www.prnasia.com/story/253045-1.shtml", "https://www.prnasia.com/story/260076-1.shtml", "https://www.prnasia.com/story/252945-1.shtml", "https://www.prnasia.com/story/253005-1.shtml", "https://www.prnasia.com/story/260215-1.shtml", "https://www.prnasia.com/story/252930-1.shtml", "https://www.prnasia.com/story/260206-1.shtml", "https://www.prnasia.com/story/253064-1.shtml", "https://www.prnasia.com/story/252975-1.shtml", "https://www.prnasia.com/story/260105-1.shtml", "https://www.prnasia.com/story/252936-1.shtml", "https://www.prnasia.com/story/253009-1.shtml", "https://www.prnasia.com/story/253058-1.shtml", "https://www.prnasia.com/story/260433-1.shtml", "https://www.prnasia.com/story/260233-1.shtml", "https://www.prnasia.com/story/260358-1.shtml", "https://www.prnasia.com/story/260326-1.shtml", "https://www.prnasia.com/story/260240-1.shtml", "https://www.prnasia.com/story/260302-1.shtml", "https://cnmobile.prnasia.com/story/252937-1.shtml", "https://www.prnasia.com/story/260418-1.shtml", "https://www.prnasia.com/story/260481-1.shtml", "https://www.prnasia.com/story/260653-1.shtml", "https://www.prnasia.com/story/260649-1.shtml", "https://cnmobile.prnasia.com/story/260408-1.shtml", "https://www.prnasia.com/story/260374-1.shtml", "https://www.prnasia.com/story/260412-1.shtml", "https://www.prnasia.com/story/260840-1.shtml", "https://www.prnasia.com/story/260532-1.shtml", "https://www.prnasia.com/story/260712-1.shtml", "https://www.prnasia.com/story/260625-1.shtml", "https://www.prnasia.com/story/260822-1.shtml", "https://www.prnasia.com/story/260999-1.shtml", "https://www.prnasia.com/story/260800-1.shtml", "https://www.prnasia.com/story/260936-1.shtml", "https://www.prnasia.com/story/260654-1.shtml", "https://www.prnasia.com/story/261020-1.shtml", "https://www.prnasia.com/story/253346-1.shtml", "https://www.prnasia.com/story/253332-1.shtml", "https://www.prnasia.com/story/261059-1.shtml", "https://www.prnasia.com/story/260787-1.shtml", "https://www.prnasia.com/story/260775-1.shtml", "https://www.prnasia.com/story/260845-1.shtml", "https://www.prnasia.com/story/260914-1.shtml", "https://www.prnasia.com/story/260823-1.shtml", "https://www.prnasia.com/story/253345-1.shtml", "https://www.prnasia.com/story/253552-1.shtml", "https://www.prnasia.com/story/253571-1.shtml", "https://www.prnasia.com/story/260952-1.shtml", "https://www.prnasia.com/story/261124-1.shtml", "https://www.prnasia.com/story/253444-1.shtml", "https://www.prnasia.com/story/253572-1.shtml", "https://www.prnasia.com/story/253574-1.shtml", "https://www.prnasia.com/story/261136-1.shtml", "https://www.prnasia.com/story/253573-1.shtml", "https://www.prnasia.com/story/253506-1.shtml", "https://www.prnasia.com/story/261321-1.shtml", "https://www.prnasia.com/story/261102-1.shtml", "https://www.prnasia.com/story/253800-1.shtml", "https://www.prnasia.com/story/253583-1.shtml", "https://www.prnasia.com/story/253823-1.shtml", "https://www.prnasia.com/story/253597-1.shtml", "https://www.prnasia.com/story/253690-1.shtml", "https://www.prnasia.com/story/253883-1.shtml", "https://www.prnasia.com/story/254135-1.shtml", "https://www.prnasia.com/story/254263-1.shtml", "https://www.prnasia.com/story/253647-1.shtml", "https://www.prnasia.com/story/253901-1.shtml", "https://www.prnasia.com/story/253636-1.shtml", "https://cnmobile.prnasia.com/story/261341-1.shtml", "https://www.prnasia.com/story/254436-1.shtml", "https://www.prnasia.com/story/261811-1.shtml", "https://www.prnasia.com/story/262028-1.shtml", "https://www.prnasia.com/story/254278-1.shtml", "https://www.prnasia.com/story/254446-1.shtml", "https://www.prnasia.com/story/261736-1.shtml", "https://www.prnasia.com/story/262042-1.shtml", "https://www.prnasia.com/story/254421-1.shtml", "https://www.prnasia.com/story/254291-1.shtml", "https://www.prnasia.com/story/261777-1.shtml", "https://www.prnasia.com/story/254443-1.shtml", "https://www.prnasia.com/story/254403-1.shtml", "https://www.prnasia.com/story/261904-1.shtml", "https://www.prnasia.com/story/261905-1.shtml", "https://www.prnasia.com/story/254469-1.shtml", "https://www.prnasia.com/story/254601-1.shtml", "https://www.prnasia.com/story/247854-1.shtml", "https://www.prnasia.com/story/247788-1.shtml", "https://www.prnasia.com/story/254586-1.shtml", "https://www.prnasia.com/story/254507-1.shtml", "https://www.prnasia.com/story/254544-1.shtml", "https://www.prnasia.com/story/254458-1.shtml", "https://www.prnasia.com/story/247797-1.shtml", "https://www.prnasia.com/story/254582-1.shtml", "https://www.prnasia.com/story/254510-1.shtml", "https://www.prnasia.com/story/247893-1.shtml", "https://www.prnasia.com/story/247933-1.shtml", "https://www.prnasia.com/story/247855-1.shtml", "https://www.prnasia.com/story/247821-1.shtml", "https://www.prnasia.com/story/254513-1.shtml", "https://www.prnasia.com/story/254549-1.shtml", "https://www.prnasia.com/story/254589-1.shtml", "https://www.prnasia.com/story/247834-1.shtml", "https://www.prnasia.com/story/254829-1.shtml", "https://www.prnasia.com/story/254793-1.shtml", "https://www.prnasia.com/story/254956-1.shtml", "https://www.prnasia.com/story/254910-1.shtml", "https://www.prnasia.com/story/254612-1.shtml", "https://www.prnasia.com/story/254839-1.shtml", "https://www.prnasia.com/story/254717-1.shtml", "https://www.prnasia.com/story/254863-1.shtml", "https://www.prnasia.com/story/254690-1.shtml", "https://www.prnasia.com/story/254906-1.shtml", "https://www.prnasia.com/story/247978-1.shtml", "https://www.prnasia.com/story/254613-1.shtml", "https://www.prnasia.com/story/247993-1.shtml", "https://www.prnasia.com/story/254929-1.shtml", "https://www.prnasia.com/story/254837-1.shtml", "https://www.prnasia.com/story/254974-1.shtml", "https://www.prnasia.com/story/255187-1.shtml", "https://www.prnasia.com/story/254915-1.shtml", "https://www.prnasia.com/story/255244-1.shtml", "https://www.prnasia.com/story/255044-1.shtml", "https://www.prnasia.com/story/255252-1.shtml", "https://www.prnasia.com/story/255116-1.shtml", "https://www.prnasia.com/story/254998-1.shtml", "https://www.prnasia.com/story/254962-1.shtml", "https://www.prnasia.com/story/254957-1.shtml", "https://www.prnasia.com/story/255200-1.shtml", "https://www.prnasia.com/story/255237-1.shtml", "https://cnmobile.prnasia.com/story/255025-1.shtml", "https://www.prnasia.com/story/255397-1.shtml", "https://www.prnasia.com/story/254987-1.shtml", "https://www.prnasia.com/story/255209-1.shtml", "https://www.prnasia.com/story/255411-1.shtml", "https://www.prnasia.com/story/252388-1.shtml", "https://www.prnasia.com/story/252416-1.shtml", "https://www.prnasia.com/story/252524-1.shtml", "https://www.prnasia.com/story/252449-1.shtml", "https://www.prnasia.com/story/252537-1.shtml", "https://www.prnasia.com/story/252423-1.shtml", "https://www.prnasia.com/story/255424-1.shtml", "https://www.prnasia.com/story/252473-1.shtml", "https://www.prnasia.com/story/255536-1.shtml", "https://www.prnasia.com/story/252446-1.shtml", "https://www.prnasia.com/story/252497-1.shtml", "https://www.prnasia.com/story/255416-1.shtml", "https://www.prnasia.com/story/252515-1.shtml", "https://www.prnasia.com/story/255684-1.shtml", "https://www.prnasia.com/story/255457-1.shtml", "https://www.prnasia.com/story/255672-1.shtml", "https://www.prnasia.com/story/255779-1.shtml", "https://www.prnasia.com/story/255766-1.shtml", "https://www.prnasia.com/story/255477-1.shtml", "https://www.prnasia.com/story/255415-1.shtml", "https://www.prnasia.com/story/255869-1.shtml", "https://www.prnasia.com/story/255576-1.shtml", "https://www.prnasia.com/story/255977-1.shtml", "https://www.prnasia.com/story/255570-1.shtml", "https://www.prnasia.com/story/256068-1.shtml", "https://www.prnasia.com/story/255914-1.shtml", "https://www.prnasia.com/story/255748-1.shtml", "https://www.prnasia.com/story/255639-1.shtml", "https://www.prnasia.com/story/248019-1.shtml", "https://www.prnasia.com/story/255842-1.shtml", "https://www.prnasia.com/story/248018-1.shtml", "https://www.prnasia.com/story/255929-1.shtml", "https://www.prnasia.com/story/255571-1.shtml", "https://www.prnasia.com/story/255925-1.shtml", "https://www.prnasia.com/story/248109-1.shtml", "https://www.prnasia.com/story/248151-1.shtml", "https://www.prnasia.com/story/248234-1.shtml", "https://www.prnasia.com/story/248016-1.shtml", "https://www.prnasia.com/story/248174-1.shtml", "https://www.prnasia.com/story/248155-1.shtml", "https://www.prnasia.com/story/256128-1.shtml", "https://www.prnasia.com/story/248127-1.shtml", "https://www.prnasia.com/story/248022-1.shtml", "https://www.prnasia.com/story/256241-1.shtml", "https://www.prnasia.com/story/256137-1.shtml", "https://www.prnasia.com/story/256224-1.shtml", "https://www.prnasia.com/story/248159-1.shtml", "https://www.prnasia.com/story/256072-1.shtml", "https://www.prnasia.com/story/256142-1.shtml", "https://www.prnasia.com/story/256618-1.shtml", "https://www.prnasia.com/story/256237-1.shtml", "https://www.prnasia.com/story/256466-1.shtml", "https://www.prnasia.com/story/256377-1.shtml", "https://www.prnasia.com/story/256242-1.shtml", "https://www.prnasia.com/story/256516-1.shtml", "https://www.prnasia.com/story/256533-1.shtml", "https://www.prnasia.com/story/256304-1.shtml", "https://cnmobile.prnasia.com/story/256251-1.shtml", "https://www.prnasia.com/story/256465-1.shtml", "https://www.prnasia.com/story/256394-1.shtml", "https://www.prnasia.com/story/256202-1.shtml", "https://www.prnasia.com/story/256495-1.shtml", "https://www.prnasia.com/story/256255-1.shtml", "https://www.prnasia.com/story/248713-1.shtml", "https://www.prnasia.com/story/256563-1.shtml", "https://www.prnasia.com/story/248822-1.shtml", "https://www.prnasia.com/story/256711-1.shtml", "https://www.prnasia.com/story/249541-1.shtml", "https://www.prnasia.com/story/248849-1.shtml", "https://www.prnasia.com/story/248645-1.shtml", "https://www.prnasia.com/story/248829-1.shtml", "https://www.prnasia.com/story/248990-1.shtml", "https://www.prnasia.com/story/248729-1.shtml", "https://www.prnasia.com/story/248861-1.shtml", "https://www.prnasia.com/story/256658-1.shtml", "https://www.prnasia.com/story/248856-1.shtml", "https://www.prnasia.com/story/248781-1.shtml", "https://www.prnasia.com/story/249059-1.shtml", "https://www.prnasia.com/story/249085-1.shtml", "https://www.prnasia.com/story/249338-1.shtml", "https://www.prnasia.com/story/249596-1.shtml", "https://www.prnasia.com/story/249068-1.shtml", "https://www.prnasia.com/story/249088-1.shtml", "https://www.prnasia.com/story/249044-1.shtml", "https://www.prnasia.com/story/256774-1.shtml", "https://www.prnasia.com/story/249082-1.shtml", "https://www.prnasia.com/story/249048-1.shtml", "https://www.prnasia.com/story/249382-1.shtml", "https://www.prnasia.com/story/249666-1.shtml", "https://www.prnasia.com/story/249113-1.shtml", "https://www.prnasia.com/story/256719-1.shtml", "https://www.prnasia.com/story/249282-1.shtml", "https://cnmobile.prnasia.com/story/256752-1.shtml", "https://www.prnasia.com/story/249124-1.shtml", "https://www.prnasia.com/story/256959-1.shtml", "https://www.prnasia.com/story/249103-1.shtml", "https://www.prnasia.com/story/257162-1.shtml", "https://www.prnasia.com/story/256947-1.shtml", "https://www.prnasia.com/story/256843-1.shtml", "https://www.prnasia.com/story/257040-1.shtml", "https://www.prnasia.com/story/257066-1.shtml", "https://cnmobile.prnasia.com/story/256965-1.shtml", "https://www.prnasia.com/story/257036-1.shtml", "https://www.prnasia.com/story/256995-1.shtml", "https://www.prnasia.com/story/256784-1.shtml", "https://www.prnasia.com/story/256808-1.shtml", "https://cnmobile.prnasia.com/story/257107-1.shtml", "https://cnmobile.prnasia.com/story/256942-1.shtml", "https://www.prnasia.com/story/256799-1.shtml", "https://www.prnasia.com/story/257088-1.shtml", "https://www.prnasia.com/story/243061-1.shtml", "https://www.prnasia.com/story/257237-1.shtml", "https://www.prnasia.com/story/243035-1.shtml", "https://www.prnasia.com/story/242930-1.shtml", "https://www.prnasia.com/story/242942-1.shtml", "https://www.prnasia.com/story/243249-1.shtml", "https://www.prnasia.com/story/242866-1.shtml", "https://www.prnasia.com/story/243325-1.shtml", "https://www.prnasia.com/story/242900-1.shtml", "https://www.prnasia.com/story/243000-1.shtml", "https://www.prnasia.com/story/243173-1.shtml", "https://www.prnasia.com/story/242925-1.shtml", "https://www.prnasia.com/story/243064-1.shtml", "https://www.prnasia.com/story/243434-1.shtml", "https://www.prnasia.com/story/243421-1.shtml", "https://www.prnasia.com/story/243345-1.shtml", "https://www.prnasia.com/story/243402-1.shtml", "https://www.prnasia.com/story/243104-1.shtml", "https://www.prnasia.com/story/243384-1.shtml", "https://www.prnasia.com/story/243288-1.shtml", "https://www.prnasia.com/story/243414-1.shtml", "https://www.prnasia.com/story/243247-1.shtml", "https://www.prnasia.com/story/250393-1.shtml", "https://www.prnasia.com/story/250404-1.shtml", "https://www.prnasia.com/story/250763-1.shtml", "https://www.prnasia.com/story/250634-1.shtml", "https://www.prnasia.com/story/250944-1.shtml", "https://www.prnasia.com/story/251255-1.shtml", "https://www.prnasia.com/story/251258-1.shtml", "https://www.prnasia.com/story/251213-1.shtml", "https://www.prnasia.com/story/243556-1.shtml", "https://www.prnasia.com/story/243502-1.shtml", "https://www.prnasia.com/story/243525-1.shtml", "https://www.prnasia.com/story/243470-1.shtml", "https://www.prnasia.com/story/251250-1.shtml", "https://www.prnasia.com/story/243714-1.shtml", "https://www.prnasia.com/story/243706-1.shtml", "https://www.prnasia.com/story/243666-1.shtml", "https://www.prnasia.com/story/243676-1.shtml", "https://www.prnasia.com/story/243795-1.shtml", "https://www.prnasia.com/story/243613-1.shtml", "https://www.prnasia.com/story/243551-1.shtml", "https://www.prnasia.com/story/243944-1.shtml", "https://www.prnasia.com/story/243842-1.shtml", "https://www.prnasia.com/story/244962-1.shtml", "https://www.prnasia.com/story/243828-1.shtml", "https://www.prnasia.com/story/244929-1.shtml", "https://www.prnasia.com/story/244955-1.shtml", "https://cnmobile.prnasia.com/story/243627-1.shtml", "https://www.prnasia.com/story/243759-1.shtml", "https://www.prnasia.com/story/243945-1.shtml", "https://www.prnasia.com/story/244018-1.shtml", "https://www.prnasia.com/story/244954-1.shtml", "https://www.prnasia.com/story/243814-1.shtml", "https://www.prnasia.com/story/243932-1.shtml", "https://www.prnasia.com/story/243922-1.shtml", "https://www.prnasia.com/story/243705-1.shtml", "https://www.prnasia.com/story/252045-1.shtml", "https://www.prnasia.com/story/244968-1.shtml", "https://www.prnasia.com/story/245275-1.shtml", "https://www.prnasia.com/story/252380-1.shtml", "https://www.prnasia.com/story/245152-1.shtml", "https://www.prnasia.com/story/245174-1.shtml", "https://www.prnasia.com/story/252267-1.shtml", "https://www.prnasia.com/story/252317-1.shtml", "https://www.prnasia.com/story/245140-1.shtml", "https://www.prnasia.com/story/252162-1.shtml", "https://www.prnasia.com/story/245751-1.shtml", "https://www.prnasia.com/story/245588-1.shtml", "https://www.prnasia.com/story/245686-1.shtml", "https://www.prnasia.com/story/245806-1.shtml", "https://www.prnasia.com/story/245700-1.shtml", "https://www.prnasia.com/story/245796-1.shtml", "https://www.prnasia.com/story/245719-1.shtml", "https://www.prnasia.com/story/245795-1.shtml", "https://www.prnasia.com/story/245771-1.shtml", "https://www.prnasia.com/story/245970-1.shtml", "https://www.prnasia.com/story/245831-1.shtml", "https://www.prnasia.com/story/245689-1.shtml", "https://www.prnasia.com/story/245883-1.shtml", "https://www.prnasia.com/story/245859-1.shtml", "https://www.prnasia.com/story/245885-1.shtml", "https://www.prnasia.com/story/245894-1.shtml", "https://www.prnasia.com/story/245878-1.shtml", "https://www.prnasia.com/story/246009-1.shtml", "https://www.prnasia.com/story/245927-1.shtml", "https://www.prnasia.com/story/241831-1.shtml", "https://www.prnasia.com/story/246381-1.shtml", "https://www.prnasia.com/story/241980-1.shtml", "https://www.prnasia.com/story/242108-1.shtml", "https://www.prnasia.com/story/246066-1.shtml", "https://www.prnasia.com/story/242100-1.shtml", "https://www.prnasia.com/story/241783-1.shtml", "https://www.prnasia.com/story/246365-1.shtml", "https://www.prnasia.com/story/246361-1.shtml", "https://www.prnasia.com/story/241938-1.shtml", "https://www.prnasia.com/story/246065-1.shtml", "https://www.prnasia.com/story/246374-1.shtml", "https://www.prnasia.com/story/246058-1.shtml", "https://www.prnasia.com/story/241840-1.shtml", "https://www.prnasia.com/story/242030-1.shtml", "https://www.prnasia.com/story/241863-1.shtml", "https://www.prnasia.com/story/241990-1.shtml", "https://www.prnasia.com/story/242081-1.shtml", "https://cnmobile.prnasia.com/story/246432-1.shtml", "https://www.prnasia.com/story/246418-1.shtml", "https://www.prnasia.com/story/231979-1.shtml", "https://www.prnasia.com/story/232084-1.shtml", "https://www.prnasia.com/story/232117-1.shtml", "https://www.prnasia.com/story/231954-1.shtml", "https://www.prnasia.com/story/232182-1.shtml", "https://www.prnasia.com/story/246929-1.shtml", "https://www.prnasia.com/story/232267-1.shtml", "https://www.prnasia.com/story/246496-1.shtml", "https://www.prnasia.com/story/246450-1.shtml", "https://www.prnasia.com/story/232053-1.shtml", "https://www.prnasia.com/story/232015-1.shtml", "https://www.prnasia.com/story/246913-1.shtml", "https://www.prnasia.com/story/232024-1.shtml", "https://www.prnasia.com/story/246566-1.shtml", "https://www.prnasia.com/story/246548-1.shtml", "https://www.prnasia.com/story/247035-1.shtml", "https://www.prnasia.com/story/247133-1.shtml", "https://www.prnasia.com/story/247180-1.shtml", "https://www.prnasia.com/story/238292-1.shtml", "https://www.prnasia.com/story/246961-1.shtml", "https://www.prnasia.com/story/247182-1.shtml", "https://www.prnasia.com/story/238191-1.shtml", "https://www.prnasia.com/story/238282-1.shtml", "https://www.prnasia.com/story/238048-1.shtml", "https://www.prnasia.com/story/238072-1.shtml", "https://www.prnasia.com/story/247164-1.shtml", "https://www.prnasia.com/story/238298-1.shtml", "https://cnmobile.prnasia.com/story/238068-1.shtml", "https://www.prnasia.com/story/247284-1.shtml", "https://www.prnasia.com/story/247198-1.shtml", "https://www.prnasia.com/story/246959-1.shtml", "https://www.prnasia.com/story/247200-1.shtml", "https://www.prnasia.com/story/247211-1.shtml", "https://www.prnasia.com/story/246945-1.shtml", "https://www.prnasia.com/story/238354-1.shtml", "https://www.prnasia.com/story/239041-1.shtml", "https://www.prnasia.com/story/247434-1.shtml", "https://www.prnasia.com/story/239272-1.shtml", "https://www.prnasia.com/story/247326-1.shtml", "https://www.prnasia.com/story/239230-1.shtml", "https://www.prnasia.com/story/239298-1.shtml", "https://www.prnasia.com/story/239046-1.shtml", "https://www.prnasia.com/story/239288-1.shtml", "https://www.prnasia.com/story/240722-1.shtml", "https://cnmobile.prnasia.com/story/239340-1.shtml", "https://www.prnasia.com/story/240682-1.shtml", "https://www.prnasia.com/story/239223-1.shtml", "https://www.prnasia.com/story/240620-1.shtml", "https://www.prnasia.com/story/240645-1.shtml", "https://www.prnasia.com/story/240539-1.shtml", "https://www.prnasia.com/story/240710-1.shtml", "https://www.prnasia.com/story/240595-1.shtml", "https://www.prnasia.com/story/240567-1.shtml", "https://www.prnasia.com/story/239429-1.shtml", "https://www.prnasia.com/story/240725-1.shtml", "https://cnmobile.prnasia.com/story/240621-1.shtml", "https://www.prnasia.com/story/239555-1.shtml", "https://www.prnasia.com/story/240681-1.shtml", "https://www.prnasia.com/story/239619-1.shtml", "https://www.prnasia.com/story/239983-1.shtml", "https://www.prnasia.com/story/239421-1.shtml", "https://www.prnasia.com/story/240012-1.shtml", "https://www.prnasia.com/story/239721-1.shtml", "https://www.prnasia.com/story/239927-1.shtml", "https://www.prnasia.com/story/239899-1.shtml", "https://www.prnasia.com/story/239635-1.shtml", "https://cnmobile.prnasia.com/story/239451-1.shtml", "https://www.prnasia.com/story/239545-1.shtml", "https://www.prnasia.com/story/239878-1.shtml", "https://www.prnasia.com/story/239642-1.shtml", "https://www.prnasia.com/story/240729-1.shtml", "https://www.prnasia.com/story/240167-1.shtml", "https://cnmobile.prnasia.com/story/239944-1.shtml", "https://www.prnasia.com/story/239953-1.shtml", "https://www.prnasia.com/story/240754-1.shtml", "https://www.prnasia.com/story/240049-1.shtml", "https://www.prnasia.com/story/241002-1.shtml", "https://www.prnasia.com/story/240855-1.shtml", "https://www.prnasia.com/story/240730-1.shtml", "https://www.prnasia.com/story/240924-1.shtml", "https://www.prnasia.com/story/241096-1.shtml", "https://www.prnasia.com/story/241093-1.shtml", "https://cnmobile.prnasia.com/story/240081-1.shtml", "https://www.prnasia.com/story/240956-1.shtml", "https://www.prnasia.com/story/240817-1.shtml", "https://www.prnasia.com/story/241466-1.shtml", "https://cnmobile.prnasia.com/story/240244-1.shtml", "https://www.prnasia.com/story/240237-1.shtml", "https://www.prnasia.com/story/241441-1.shtml", "https://www.prnasia.com/story/241523-1.shtml", "https://www.prnasia.com/story/241640-1.shtml", "https://www.prnasia.com/story/241524-1.shtml", "https://www.prnasia.com/story/241013-1.shtml", "https://www.prnasia.com/story/241112-1.shtml", "https://www.prnasia.com/story/241528-1.shtml", "https://www.prnasia.com/story/237713-1.shtml", "https://www.prnasia.com/story/241535-1.shtml", "https://www.prnasia.com/story/237882-1.shtml", "https://www.prnasia.com/story/241569-1.shtml", "https://www.prnasia.com/story/241674-1.shtml", "https://www.prnasia.com/story/241496-1.shtml", "https://www.prnasia.com/story/237753-1.shtml", "https://www.prnasia.com/story/237931-1.shtml", "https://www.prnasia.com/story/237837-1.shtml", "https://www.prnasia.com/story/237807-1.shtml", "https://www.prnasia.com/story/237856-1.shtml", "https://www.prnasia.com/story/237838-1.shtml", "https://cnmobile.prnasia.com/story/237631-1.shtml", "https://www.prnasia.com/story/228465-1.shtml", "https://www.prnasia.com/story/228436-1.shtml", "https://www.prnasia.com/story/228451-1.shtml", "https://www.prnasia.com/story/228541-1.shtml", "https://www.prnasia.com/story/228444-1.shtml", "https://www.prnasia.com/story/232356-1.shtml", "https://www.prnasia.com/story/228378-1.shtml", "https://www.prnasia.com/story/228708-1.shtml", "https://www.prnasia.com/story/232304-1.shtml", "https://www.prnasia.com/story/232441-1.shtml", "https://www.prnasia.com/story/232379-1.shtml", "https://www.prnasia.com/story/228706-1.shtml", "https://www.prnasia.com/story/228496-1.shtml", "https://www.prnasia.com/story/232497-1.shtml", "https://www.prnasia.com/story/232394-1.shtml", "https://www.prnasia.com/story/232520-1.shtml", "https://www.prnasia.com/story/237318-1.shtml", "https://www.prnasia.com/story/237370-1.shtml", "https://www.prnasia.com/story/237312-1.shtml", "https://www.prnasia.com/story/232470-1.shtml", "https://www.prnasia.com/story/228681-1.shtml", "https://www.prnasia.com/story/237379-1.shtml", "https://cnmobile.prnasia.com/story/232474-1.shtml", "https://www.prnasia.com/story/237536-1.shtml", "https://www.prnasia.com/story/232518-1.shtml", "https://www.prnasia.com/story/237517-1.shtml", "https://www.prnasia.com/story/229046-1.shtml", "https://www.prnasia.com/story/237486-1.shtml", "https://www.prnasia.com/story/229099-1.shtml", "https://www.prnasia.com/story/229184-1.shtml", "https://www.prnasia.com/story/237549-1.shtml", "https://www.prnasia.com/story/229246-1.shtml", "https://www.prnasia.com/story/229011-1.shtml", "https://www.prnasia.com/story/237402-1.shtml", "https://www.prnasia.com/story/229093-1.shtml", "https://www.prnasia.com/story/237447-1.shtml", "https://www.prnasia.com/story/229152-1.shtml", "https://www.prnasia.com/story/229125-1.shtml", "https://www.prnasia.com/story/229192-1.shtml", "https://cnmobile.prnasia.com/story/237483-1.shtml", "https://www.prnasia.com/story/233119-1.shtml", "https://www.prnasia.com/story/229494-1.shtml", "https://www.prnasia.com/story/233093-1.shtml", "https://www.prnasia.com/story/232977-1.shtml", "https://www.prnasia.com/story/237464-1.shtml", "https://www.prnasia.com/story/232894-1.shtml", "https://www.prnasia.com/story/233223-1.shtml", "https://www.prnasia.com/story/233009-1.shtml", "https://www.prnasia.com/story/233011-1.shtml", "https://www.prnasia.com/story/233575-1.shtml", "https://www.prnasia.com/story/233086-1.shtml", "https://www.prnasia.com/story/233171-1.shtml", "https://www.prnasia.com/story/233182-1.shtml", "https://www.prnasia.com/story/233538-1.shtml", "https://www.prnasia.com/story/233613-1.shtml", "https://www.prnasia.com/story/233621-1.shtml", "https://www.prnasia.com/story/233622-1.shtml", "https://www.prnasia.com/story/233705-1.shtml", "https://www.prnasia.com/story/233635-1.shtml", "https://www.prnasia.com/story/233180-1.shtml", "https://www.prnasia.com/story/229889-1.shtml", "https://www.prnasia.com/story/230001-1.shtml", "https://www.prnasia.com/story/229820-1.shtml", "https://www.prnasia.com/story/229884-1.shtml", "https://www.prnasia.com/story/233729-1.shtml", "https://www.prnasia.com/story/233805-1.shtml", "https://www.prnasia.com/story/229764-1.shtml", "https://www.prnasia.com/story/229722-1.shtml", "https://www.prnasia.com/story/229969-1.shtml", "https://www.prnasia.com/story/233745-1.shtml", "https://www.prnasia.com/story/229900-1.shtml", "https://www.prnasia.com/story/230052-1.shtml", "https://cnmobile.prnasia.com/story/233749-1.shtml", "https://www.prnasia.com/story/229874-1.shtml", "https://cnmobile.prnasia.com/story/233796-1.shtml", "https://www.prnasia.com/story/233798-1.shtml", "https://www.prnasia.com/story/233889-1.shtml", "https://www.prnasia.com/story/233992-1.shtml", "https://cnmobile.prnasia.com/story/230021-1.shtml", "https://www.prnasia.com/story/234009-1.shtml", "https://www.prnasia.com/story/233958-1.shtml", "https://www.prnasia.com/story/230302-1.shtml", "https://www.prnasia.com/story/234042-1.shtml", "https://www.prnasia.com/story/234051-1.shtml", "https://www.prnasia.com/story/230145-1.shtml", "https://www.prnasia.com/story/233921-1.shtml", "https://www.prnasia.com/story/233953-1.shtml", "https://www.prnasia.com/story/230297-1.shtml", "https://www.prnasia.com/story/230139-1.shtml", "https://www.prnasia.com/story/230185-1.shtml", "https://www.prnasia.com/story/233956-1.shtml", "https://www.prnasia.com/story/233967-1.shtml", "https://www.prnasia.com/story/230443-1.shtml", "https://www.prnasia.com/story/234057-1.shtml", "https://www.prnasia.com/story/230388-1.shtml", "https://www.prnasia.com/story/233963-1.shtml", "https://www.prnasia.com/story/233857-1.shtml", "https://www.prnasia.com/story/226676-1.shtml", "https://www.prnasia.com/story/230410-1.shtml", "https://www.prnasia.com/story/234092-1.shtml", "https://www.prnasia.com/story/226825-1.shtml", "https://www.prnasia.com/story/230398-1.shtml", "https://cnmobile.prnasia.com/story/230318-1.shtml", "https://www.prnasia.com/story/234226-1.shtml", "https://www.prnasia.com/story/234334-1.shtml", "https://www.prnasia.com/story/234220-1.shtml", "https://www.prnasia.com/story/234107-1.shtml", "https://www.prnasia.com/story/234094-1.shtml", "https://www.prnasia.com/story/227234-1.shtml", "https://www.prnasia.com/story/227250-1.shtml", "https://www.prnasia.com/story/227284-1.shtml", "https://www.prnasia.com/story/227191-1.shtml", "https://www.prnasia.com/story/227273-1.shtml", "https://www.prnasia.com/story/234545-1.shtml", "https://www.prnasia.com/story/227314-1.shtml", "https://www.prnasia.com/story/227310-1.shtml", "https://www.prnasia.com/story/234585-1.shtml", "https://www.prnasia.com/story/227188-1.shtml", "https://www.prnasia.com/story/234469-1.shtml", "https://www.prnasia.com/story/234458-1.shtml", "https://www.prnasia.com/story/234372-1.shtml", "https://www.prnasia.com/story/234643-1.shtml", "https://www.prnasia.com/story/234290-1.shtml", "https://www.prnasia.com/story/234529-1.shtml", "https://www.prnasia.com/story/227192-1.shtml", "https://www.prnasia.com/story/234441-1.shtml", "https://www.prnasia.com/story/227213-1.shtml", "https://www.prnasia.com/story/234492-1.shtml", "https://www.prnasia.com/story/227444-1.shtml", "https://www.prnasia.com/story/227482-1.shtml", "https://www.prnasia.com/story/227374-1.shtml", "https://www.prnasia.com/story/234627-1.shtml", "https://www.prnasia.com/story/227581-1.shtml", "https://www.prnasia.com/story/227372-1.shtml", "https://www.prnasia.com/story/227383-1.shtml", "https://www.prnasia.com/story/234831-1.shtml", "https://www.prnasia.com/story/234697-1.shtml", "https://www.prnasia.com/story/227621-1.shtml", "https://www.prnasia.com/story/234813-1.shtml", "https://www.prnasia.com/story/234667-1.shtml", "https://www.prnasia.com/story/234946-1.shtml", "https://www.prnasia.com/story/235112-1.shtml", "https://www.prnasia.com/story/234818-1.shtml", "https://www.prnasia.com/story/234973-1.shtml", "https://www.prnasia.com/story/235027-1.shtml", "https://cnmobile.prnasia.com/story/227632-1.shtml", "https://www.prnasia.com/story/235100-1.shtml", "https://www.prnasia.com/story/227847-1.shtml", "https://www.prnasia.com/story/235104-1.shtml", "https://www.prnasia.com/story/227895-1.shtml", "https://www.prnasia.com/story/227818-1.shtml", "https://www.prnasia.com/story/228023-1.shtml", "https://www.prnasia.com/story/228014-1.shtml", "https://www.prnasia.com/story/227999-1.shtml", "https://www.prnasia.com/story/227977-1.shtml", "https://www.prnasia.com/story/235450-1.shtml", "https://www.prnasia.com/story/235379-1.shtml", "https://www.prnasia.com/story/228070-1.shtml", "https://www.prnasia.com/story/235297-1.shtml", "https://www.prnasia.com/story/235412-1.shtml", "https://www.prnasia.com/story/235347-1.shtml", "https://cnmobile.prnasia.com/story/227991-1.shtml", "https://www.prnasia.com/story/227962-1.shtml", "https://www.prnasia.com/story/235128-1.shtml", "https://www.prnasia.com/story/228175-1.shtml", "https://www.prnasia.com/story/235351-1.shtml", "https://www.prnasia.com/story/228237-1.shtml", "https://www.prnasia.com/story/235213-1.shtml", "https://www.prnasia.com/story/228180-1.shtml", "https://www.prnasia.com/story/228114-1.shtml", "https://www.prnasia.com/story/235325-1.shtml", "https://www.prnasia.com/story/228125-1.shtml", "https://www.prnasia.com/story/235447-1.shtml", "https://www.prnasia.com/story/228200-1.shtml", "https://www.prnasia.com/story/235567-1.shtml", "https://www.prnasia.com/story/228279-1.shtml", "https://www.prnasia.com/story/235585-1.shtml", "https://www.prnasia.com/story/235838-1.shtml", "https://www.prnasia.com/story/228277-1.shtml", "https://www.prnasia.com/story/228251-1.shtml", "https://www.prnasia.com/story/236070-1.shtml", "https://www.prnasia.com/story/236078-1.shtml", "https://www.prnasia.com/story/235909-1.shtml", "https://www.prnasia.com/story/235942-1.shtml", "https://www.prnasia.com/story/235669-1.shtml", "https://www.prnasia.com/story/235562-1.shtml", "https://www.prnasia.com/story/236107-1.shtml", "https://www.prnasia.com/story/235948-1.shtml", "https://www.prnasia.com/story/236055-1.shtml", "https://www.prnasia.com/story/235578-1.shtml", "https://www.prnasia.com/story/235952-1.shtml", "https://cnmobile.prnasia.com/story/235960-1.shtml", "https://www.prnasia.com/story/235704-1.shtml", "https://www.prnasia.com/story/236134-1.shtml", "https://www.prnasia.com/story/236516-1.shtml", "https://www.prnasia.com/story/236246-1.shtml", "https://www.prnasia.com/story/236519-1.shtml", "https://www.prnasia.com/story/236117-1.shtml", "https://www.prnasia.com/story/236721-1.shtml", "https://www.prnasia.com/story/236761-1.shtml", "https://www.prnasia.com/story/236108-1.shtml", "https://www.prnasia.com/story/236659-1.shtml", "https://www.prnasia.com/story/236687-1.shtml", "https://www.prnasia.com/story/236614-1.shtml", "https://www.prnasia.com/story/236742-1.shtml", "https://www.prnasia.com/story/236548-1.shtml", "https://www.prnasia.com/story/236642-1.shtml", "https://www.prnasia.com/story/236612-1.shtml", "https://www.prnasia.com/story/228730-1.shtml", "https://www.prnasia.com/story/236869-1.shtml", "https://www.prnasia.com/story/228835-1.shtml", "https://www.prnasia.com/story/228936-1.shtml", "https://www.prnasia.com/story/228822-1.shtml", "https://www.prnasia.com/story/237178-1.shtml", "https://www.prnasia.com/story/228918-1.shtml", "https://www.prnasia.com/story/228906-1.shtml", "https://www.prnasia.com/story/228763-1.shtml", "https://www.prnasia.com/story/237067-1.shtml", "https://www.prnasia.com/story/236898-1.shtml", "https://www.prnasia.com/story/228972-1.shtml", "https://www.prnasia.com/story/237198-1.shtml", "https://www.prnasia.com/story/237257-1.shtml", "https://www.prnasia.com/story/237094-1.shtml", "https://www.prnasia.com/story/229512-1.shtml", "https://www.prnasia.com/story/216930-1.shtml", "https://www.prnasia.com/story/229641-1.shtml", "https://www.prnasia.com/story/216846-1.shtml", "https://www.prnasia.com/story/237218-1.shtml", "https://www.prnasia.com/story/229610-1.shtml", "https://www.prnasia.com/story/237236-1.shtml", "https://cnmobile.prnasia.com/story/237311-1.shtml", "https://www.prnasia.com/story/216851-1.shtml", "https://www.prnasia.com/story/229627-1.shtml", "https://www.prnasia.com/story/237209-1.shtml", "https://www.prnasia.com/story/229563-1.shtml", "https://www.prnasia.com/story/229680-1.shtml", "https://www.prnasia.com/story/229647-1.shtml", "https://www.prnasia.com/story/217000-1.shtml", "https://www.prnasia.com/story/230609-1.shtml", "https://www.prnasia.com/story/216967-1.shtml", "https://www.prnasia.com/story/230550-1.shtml", "https://www.prnasia.com/story/217061-1.shtml", "https://www.prnasia.com/story/230732-1.shtml", "https://www.prnasia.com/story/217101-1.shtml", "https://www.prnasia.com/story/230479-1.shtml", "https://www.prnasia.com/story/230480-1.shtml", "https://www.prnasia.com/story/230478-1.shtml", "https://www.prnasia.com/story/217053-1.shtml", "https://www.prnasia.com/story/230692-1.shtml", "https://www.prnasia.com/story/230488-1.shtml", "https://www.prnasia.com/story/217054-1.shtml", "https://www.prnasia.com/story/221121-1.shtml", "https://www.prnasia.com/story/220962-1.shtml", "https://www.prnasia.com/story/221005-1.shtml", "https://www.prnasia.com/story/220940-1.shtml", "https://www.prnasia.com/story/216963-1.shtml", "https://www.prnasia.com/story/221268-1.shtml", "https://www.prnasia.com/story/221087-1.shtml", "https://www.prnasia.com/story/230785-1.shtml", "https://www.prnasia.com/story/230978-1.shtml", "https://www.prnasia.com/story/230883-1.shtml", "https://www.prnasia.com/story/230781-1.shtml", "https://www.prnasia.com/story/221079-1.shtml", "https://cnmobile.prnasia.com/story/221213-1.shtml", "https://www.prnasia.com/story/230857-1.shtml", "https://www.prnasia.com/story/221279-1.shtml", "https://www.prnasia.com/story/220987-1.shtml", "https://www.prnasia.com/story/230987-1.shtml", "https://www.prnasia.com/story/231015-1.shtml", "https://www.prnasia.com/story/230811-1.shtml", "https://www.prnasia.com/story/231133-1.shtml", "https://www.prnasia.com/story/220964-1.shtml", "https://www.prnasia.com/story/231266-1.shtml", "https://www.prnasia.com/story/231062-1.shtml", "https://www.prnasia.com/story/231289-1.shtml", "https://www.prnasia.com/story/231105-1.shtml", "https://www.prnasia.com/story/231301-1.shtml", "https://www.prnasia.com/story/231198-1.shtml", "https://www.prnasia.com/story/231644-1.shtml", "https://www.prnasia.com/story/231273-1.shtml", "https://www.prnasia.com/story/231136-1.shtml", "https://www.prnasia.com/story/231109-1.shtml", "https://www.prnasia.com/story/231270-1.shtml", "https://www.prnasia.com/story/231197-1.shtml", "https://www.prnasia.com/story/231271-1.shtml", "https://www.prnasia.com/story/231222-1.shtml", "https://www.prnasia.com/story/231615-1.shtml", "https://www.prnasia.com/story/231878-1.shtml", "https://www.prnasia.com/story/220321-1.shtml", "https://www.prnasia.com/story/231725-1.shtml", "https://www.prnasia.com/story/220141-1.shtml", "https://www.prnasia.com/story/220180-1.shtml", "https://www.prnasia.com/story/220098-1.shtml", "https://www.prnasia.com/story/220175-1.shtml", "https://www.prnasia.com/story/231787-1.shtml", "https://www.prnasia.com/story/220182-1.shtml", "https://www.prnasia.com/story/231936-1.shtml", "https://www.prnasia.com/story/220364-1.shtml", "https://cnmobile.prnasia.com/story/231683-1.shtml", "https://www.prnasia.com/story/231953-1.shtml", "https://cnmobile.prnasia.com/story/220251-1.shtml", "https://cnmobile.prnasia.com/story/231776-1.shtml", "https://www.prnasia.com/story/223057-1.shtml", "https://www.prnasia.com/story/222929-1.shtml", "https://www.prnasia.com/story/231726-1.shtml", "https://www.prnasia.com/story/223000-1.shtml", "https://www.prnasia.com/story/222987-1.shtml", "https://www.prnasia.com/story/231949-1.shtml", "https://www.prnasia.com/story/216302-1.shtml", "https://www.prnasia.com/story/223128-1.shtml", "https://www.prnasia.com/story/216353-1.shtml", "https://www.prnasia.com/story/216171-1.shtml", "https://www.prnasia.com/story/223038-1.shtml", "https://www.prnasia.com/story/223095-1.shtml", "https://www.prnasia.com/story/223239-1.shtml", "https://www.prnasia.com/story/223179-1.shtml", "https://www.prnasia.com/story/220480-1.shtml", "https://www.prnasia.com/story/223077-1.shtml", "https://www.prnasia.com/story/223081-1.shtml", "https://www.prnasia.com/story/216346-1.shtml", "https://www.prnasia.com/story/216298-1.shtml", "https://www.prnasia.com/story/216321-1.shtml", "https://www.prnasia.com/story/223046-1.shtml", "https://www.prnasia.com/story/223157-1.shtml", "https://www.prnasia.com/story/222999-1.shtml", "https://www.prnasia.com/story/216561-1.shtml", "https://www.prnasia.com/story/221868-1.shtml", "https://www.prnasia.com/story/216524-1.shtml", "https://www.prnasia.com/story/216240-1.shtml", "https://www.prnasia.com/story/222094-1.shtml", "https://www.prnasia.com/story/216438-1.shtml", "https://www.prnasia.com/story/222169-1.shtml", "https://www.prnasia.com/story/223941-1.shtml", "https://www.prnasia.com/story/222035-1.shtml", "https://www.prnasia.com/story/221959-1.shtml", "https://www.prnasia.com/story/221878-1.shtml", "https://www.prnasia.com/story/222203-1.shtml", "https://www.prnasia.com/story/222092-1.shtml", "https://www.prnasia.com/story/216406-1.shtml", "https://www.prnasia.com/story/224221-1.shtml", "https://cnmobile.prnasia.com/story/222103-1.shtml", "https://www.prnasia.com/story/224060-1.shtml", "https://www.prnasia.com/story/224134-1.shtml", "https://www.prnasia.com/story/224098-1.shtml", "https://www.prnasia.com/story/221973-1.shtml", "https://www.prnasia.com/story/224140-1.shtml", "https://cnmobile.prnasia.com/story/222134-1.shtml", "https://www.prnasia.com/story/224045-1.shtml", "https://www.prnasia.com/story/221962-1.shtml", "https://cnmobile.prnasia.com/story/222194-1.shtml", "https://cnmobile.prnasia.com/story/222051-1.shtml", "https://www.prnasia.com/story/223542-1.shtml", "https://www.prnasia.com/story/224021-1.shtml", "https://www.prnasia.com/story/223511-1.shtml", "https://www.prnasia.com/story/223547-1.shtml", "https://www.prnasia.com/story/223554-1.shtml", "https://www.prnasia.com/story/221656-1.shtml", "https://www.prnasia.com/story/221648-1.shtml", "https://www.prnasia.com/story/223465-1.shtml", "https://www.prnasia.com/story/221679-1.shtml", "https://www.prnasia.com/story/221662-1.shtml", "https://www.prnasia.com/story/218336-1.shtml", "https://www.prnasia.com/story/221698-1.shtml", "https://www.prnasia.com/story/221561-1.shtml", "https://www.prnasia.com/story/218449-1.shtml", "https://www.prnasia.com/story/223608-1.shtml", "https://www.prnasia.com/story/218378-1.shtml", "https://www.prnasia.com/story/223635-1.shtml", "https://www.prnasia.com/story/221819-1.shtml", "https://www.prnasia.com/story/223595-1.shtml", "https://www.prnasia.com/story/218323-1.shtml", "https://www.prnasia.com/story/223649-1.shtml", "https://www.prnasia.com/story/221738-1.shtml", "https://www.prnasia.com/story/221699-1.shtml", "https://www.prnasia.com/story/221633-1.shtml", "https://www.prnasia.com/story/221771-1.shtml", "https://www.prnasia.com/story/218531-1.shtml", "https://www.prnasia.com/story/221792-1.shtml", "https://www.prnasia.com/story/218581-1.shtml", "https://www.prnasia.com/story/221704-1.shtml", "https://www.prnasia.com/story/218313-1.shtml", "https://www.prnasia.com/story/222359-1.shtml", "https://www.prnasia.com/story/218549-1.shtml", "https://www.prnasia.com/story/222247-1.shtml", "https://www.prnasia.com/story/222312-1.shtml", "https://www.prnasia.com/story/218490-1.shtml", "https://www.prnasia.com/story/218513-1.shtml", "https://www.prnasia.com/story/221355-1.shtml", "https://www.prnasia.com/story/222426-1.shtml", "https://www.prnasia.com/story/218756-1.shtml", "https://www.prnasia.com/story/222507-1.shtml", "https://www.prnasia.com/story/222320-1.shtml", "https://cnmobile.prnasia.com/story/222326-1.shtml", "https://www.prnasia.com/story/222559-1.shtml", "https://www.prnasia.com/story/221455-1.shtml", "https://www.prnasia.com/story/221433-1.shtml", "https://www.prnasia.com/story/222501-1.shtml", "https://www.prnasia.com/story/222473-1.shtml", "https://www.prnasia.com/story/221442-1.shtml", "https://www.prnasia.com/story/215836-1.shtml", "https://www.prnasia.com/story/221421-1.shtml", "https://www.prnasia.com/story/221398-1.shtml", "https://www.prnasia.com/story/222581-1.shtml", "https://www.prnasia.com/story/221348-1.shtml", "https://cnmobile.prnasia.com/story/222709-1.shtml", "https://www.prnasia.com/story/221360-1.shtml", "https://www.prnasia.com/story/221518-1.shtml", "https://www.prnasia.com/story/223771-1.shtml", "https://www.prnasia.com/story/223810-1.shtml", "https://www.prnasia.com/story/223715-1.shtml", "https://www.prnasia.com/story/221412-1.shtml", "https://www.prnasia.com/story/215764-1.shtml", "https://www.prnasia.com/story/221509-1.shtml", "https://www.prnasia.com/story/215845-1.shtml", "https://www.prnasia.com/story/224360-1.shtml", "https://www.prnasia.com/story/215990-1.shtml", "https://www.prnasia.com/story/224305-1.shtml", "https://www.prnasia.com/story/223898-1.shtml", "https://www.prnasia.com/story/215880-1.shtml", "https://www.prnasia.com/story/224321-1.shtml", "https://www.prnasia.com/story/224476-1.shtml", "https://www.prnasia.com/story/223933-1.shtml", "https://www.prnasia.com/story/224438-1.shtml", "https://www.prnasia.com/story/224406-1.shtml", "https://www.prnasia.com/story/224317-1.shtml", "https://www.prnasia.com/story/224514-1.shtml", "https://www.prnasia.com/story/224551-1.shtml", "https://www.prnasia.com/story/224423-1.shtml", "https://www.prnasia.com/story/224397-1.shtml", "https://www.prnasia.com/story/224328-1.shtml", "https://www.prnasia.com/story/224515-1.shtml", "https://www.prnasia.com/story/217108-1.shtml", "https://www.prnasia.com/story/224936-1.shtml", "https://www.prnasia.com/story/225021-1.shtml", "https://www.prnasia.com/story/224941-1.shtml", "https://www.prnasia.com/story/224492-1.shtml", "https://www.prnasia.com/story/217349-1.shtml", "https://www.prnasia.com/story/224671-1.shtml", "https://www.prnasia.com/story/224654-1.shtml", "https://www.prnasia.com/story/224680-1.shtml", "https://www.prnasia.com/story/217372-1.shtml", "https://www.prnasia.com/story/217377-1.shtml", "https://www.prnasia.com/story/217347-1.shtml", "https://www.prnasia.com/story/217111-1.shtml", "https://www.prnasia.com/story/224875-1.shtml", "https://www.prnasia.com/story/225026-1.shtml", "https://www.prnasia.com/story/224972-1.shtml", "https://www.prnasia.com/story/225472-1.shtml", "https://www.prnasia.com/story/225668-1.shtml", "https://www.prnasia.com/story/225574-1.shtml", "https://www.prnasia.com/story/217388-1.shtml", "https://www.prnasia.com/story/225644-1.shtml", "https://www.prnasia.com/story/225449-1.shtml", "https://www.prnasia.com/story/225700-1.shtml", "https://www.prnasia.com/story/225525-1.shtml", "https://www.prnasia.com/story/225732-1.shtml", "https://www.prnasia.com/story/225691-1.shtml", "https://www.prnasia.com/story/225736-1.shtml", "https://www.prnasia.com/story/225784-1.shtml", "https://www.prnasia.com/story/225650-1.shtml", "https://www.prnasia.com/story/225610-1.shtml", "https://cnmobile.prnasia.com/story/225568-1.shtml", "https://www.prnasia.com/story/217511-1.shtml", "https://www.prnasia.com/story/225565-1.shtml", "https://www.prnasia.com/story/217465-1.shtml", "https://www.prnasia.com/story/225977-1.shtml", "https://www.prnasia.com/story/217489-1.shtml", "https://www.prnasia.com/story/217399-1.shtml", "https://www.prnasia.com/story/225944-1.shtml", "https://www.prnasia.com/story/225963-1.shtml", "https://www.prnasia.com/story/225833-1.shtml", "https://www.prnasia.com/story/217728-1.shtml", "https://www.prnasia.com/story/217632-1.shtml", "https://www.prnasia.com/story/226164-1.shtml", "https://www.prnasia.com/story/217564-1.shtml", "https://www.prnasia.com/story/226196-1.shtml", "https://www.prnasia.com/story/226153-1.shtml", "https://www.prnasia.com/story/226194-1.shtml", "https://www.prnasia.com/story/217813-1.shtml", "https://www.prnasia.com/story/217744-1.shtml", "https://www.prnasia.com/story/226180-1.shtml", "https://www.prnasia.com/story/217646-1.shtml", "https://www.prnasia.com/story/226216-1.shtml", "https://www.prnasia.com/story/217949-1.shtml", "https://www.prnasia.com/story/217784-1.shtml", "https://www.prnasia.com/story/226195-1.shtml", "https://www.prnasia.com/story/217942-1.shtml", "https://www.prnasia.com/story/226333-1.shtml", "https://www.prnasia.com/story/226505-1.shtml", "https://www.prnasia.com/story/226412-1.shtml", "https://www.prnasia.com/story/226529-1.shtml", "https://www.prnasia.com/story/226330-1.shtml", "https://www.prnasia.com/story/226428-1.shtml", "https://www.prnasia.com/story/218820-1.shtml", "https://www.prnasia.com/story/218905-1.shtml", "https://www.prnasia.com/story/219235-1.shtml", "https://www.prnasia.com/story/219333-1.shtml", "https://www.prnasia.com/story/219169-1.shtml", "https://www.prnasia.com/story/219005-1.shtml", "https://www.prnasia.com/story/219289-1.shtml", "https://www.prnasia.com/story/219321-1.shtml", "https://www.prnasia.com/story/219294-1.shtml", "https://www.prnasia.com/story/218853-1.shtml", "https://www.prnasia.com/story/218880-1.shtml", "https://www.prnasia.com/story/219232-1.shtml", "https://www.prnasia.com/story/226597-1.shtml", "https://www.prnasia.com/story/218907-1.shtml", "https://www.prnasia.com/story/218855-1.shtml", "https://www.prnasia.com/story/220620-1.shtml", "https://www.prnasia.com/story/219412-1.shtml", "https://www.prnasia.com/story/219447-1.shtml", "https://www.prnasia.com/story/220657-1.shtml", "https://www.prnasia.com/story/219075-1.shtml", "https://www.prnasia.com/story/219379-1.shtml", "https://www.prnasia.com/story/220666-1.shtml", "https://www.prnasia.com/story/219482-1.shtml", "https://www.prnasia.com/story/220701-1.shtml", "https://www.prnasia.com/story/220755-1.shtml", "https://www.prnasia.com/story/208455-1.shtml", "https://cnmobile.prnasia.com/story/219470-1.shtml", "https://www.prnasia.com/story/220743-1.shtml", "https://www.prnasia.com/story/220585-1.shtml", "https://www.prnasia.com/story/220825-1.shtml", "https://www.prnasia.com/story/220878-1.shtml", "https://www.prnasia.com/story/208466-1.shtml", "https://www.prnasia.com/story/208602-1.shtml", "https://www.prnasia.com/story/208633-1.shtml", "https://www.prnasia.com/story/208905-1.shtml", "https://www.prnasia.com/story/208803-1.shtml", "https://www.prnasia.com/story/212740-1.shtml", "https://www.prnasia.com/story/208945-1.shtml", "https://www.prnasia.com/story/208835-1.shtml", "https://www.prnasia.com/story/212583-1.shtml", "https://www.prnasia.com/story/208901-1.shtml", "https://www.prnasia.com/story/212615-1.shtml", "https://www.prnasia.com/story/210740-1.shtml", "https://www.prnasia.com/story/212675-1.shtml", "https://www.prnasia.com/story/210694-1.shtml", "https://www.prnasia.com/story/212711-1.shtml", "https://www.prnasia.com/story/212620-1.shtml", "https://www.prnasia.com/story/212825-1.shtml", "https://www.prnasia.com/story/210671-1.shtml", "https://www.prnasia.com/story/212667-1.shtml", "https://www.prnasia.com/story/210616-1.shtml", "https://www.prnasia.com/story/210844-1.shtml", "https://www.prnasia.com/story/211167-1.shtml", "https://www.prnasia.com/story/210600-1.shtml", "https://www.prnasia.com/story/210582-1.shtml", "https://www.prnasia.com/story/211250-1.shtml", "https://www.prnasia.com/story/211268-1.shtml", "https://www.prnasia.com/story/210723-1.shtml", "https://www.prnasia.com/story/211439-1.shtml", "https://www.prnasia.com/story/211258-1.shtml", "https://www.prnasia.com/story/210937-1.shtml", "https://www.prnasia.com/story/211429-1.shtml", "https://www.prnasia.com/story/210862-1.shtml", "https://www.prnasia.com/story/210936-1.shtml", "https://www.prnasia.com/story/210933-1.shtml", "https://www.prnasia.com/story/211363-1.shtml", "https://www.prnasia.com/story/204864-1.shtml", "https://www.prnasia.com/story/204878-1.shtml", "https://www.prnasia.com/story/210943-1.shtml", "https://www.prnasia.com/story/211028-1.shtml", "https://www.prnasia.com/story/205628-1.shtml", "https://www.prnasia.com/story/204881-1.shtml", "https://www.prnasia.com/story/205603-1.shtml", "https://www.prnasia.com/story/211041-1.shtml", "https://www.prnasia.com/story/210991-1.shtml", "https://www.prnasia.com/story/204973-1.shtml", "https://www.prnasia.com/story/205067-1.shtml", "https://cnmobile.prnasia.com/story/210988-1.shtml", "https://www.prnasia.com/story/211057-1.shtml", "https://www.prnasia.com/story/205794-1.shtml", "https://www.prnasia.com/story/205581-1.shtml", "https://www.prnasia.com/story/211542-1.shtml", "https://www.prnasia.com/story/205821-1.shtml", "https://www.prnasia.com/story/211590-1.shtml", "https://www.prnasia.com/story/205896-1.shtml", "https://www.prnasia.com/story/211642-1.shtml", "https://www.prnasia.com/story/205887-1.shtml", "https://www.prnasia.com/story/205802-1.shtml", "https://www.prnasia.com/story/211574-1.shtml", "https://www.prnasia.com/story/211539-1.shtml", "https://www.prnasia.com/story/205751-1.shtml", "https://www.prnasia.com/story/212125-1.shtml", "https://www.prnasia.com/story/211963-1.shtml", "https://www.prnasia.com/story/211742-1.shtml", "https://www.prnasia.com/story/212096-1.shtml", "https://www.prnasia.com/story/211874-1.shtml", "https://www.prnasia.com/story/211909-1.shtml", "https://www.prnasia.com/story/212012-1.shtml", "https://www.prnasia.com/story/211719-1.shtml", "https://www.prnasia.com/story/212119-1.shtml", "https://www.prnasia.com/story/211876-1.shtml", "https://www.prnasia.com/story/212126-1.shtml", "https://www.prnasia.com/story/211796-1.shtml", "https://www.prnasia.com/story/212040-1.shtml", "https://www.prnasia.com/story/212278-1.shtml", "https://www.prnasia.com/story/212259-1.shtml", "https://www.prnasia.com/story/212304-1.shtml", "https://www.prnasia.com/story/212269-1.shtml", "https://www.prnasia.com/story/210172-1.shtml", "https://www.prnasia.com/story/212316-1.shtml", "https://www.prnasia.com/story/210221-1.shtml", "https://www.prnasia.com/story/212314-1.shtml", "https://www.prnasia.com/story/210492-1.shtml", "https://www.prnasia.com/story/212265-1.shtml", "https://www.prnasia.com/story/210304-1.shtml", "https://www.prnasia.com/story/212326-1.shtml", "https://www.prnasia.com/story/212395-1.shtml", "https://www.prnasia.com/story/212218-1.shtml", "https://www.prnasia.com/story/212298-1.shtml", "https://cnmobile.prnasia.com/story/210461-1.shtml", "https://www.prnasia.com/story/212520-1.shtml", "https://www.prnasia.com/story/210460-1.shtml", "https://www.prnasia.com/story/210567-1.shtml", "https://www.prnasia.com/story/213566-1.shtml", "https://www.prnasia.com/story/212440-1.shtml", "https://www.prnasia.com/story/213741-1.shtml", "https://www.prnasia.com/story/213801-1.shtml", "https://www.prnasia.com/story/212350-1.shtml", "https://www.prnasia.com/story/212518-1.shtml", "https://www.prnasia.com/story/213691-1.shtml", "https://www.prnasia.com/story/213619-1.shtml", "https://www.prnasia.com/story/212339-1.shtml", "https://www.prnasia.com/story/213685-1.shtml", "https://www.prnasia.com/story/212514-1.shtml", "https://www.prnasia.com/story/213704-1.shtml", "https://www.prnasia.com/story/213688-1.shtml", "https://www.prnasia.com/story/213813-1.shtml", "https://www.prnasia.com/story/213011-1.shtml", "https://www.prnasia.com/story/206306-1.shtml", "https://www.prnasia.com/story/206320-1.shtml", "https://www.prnasia.com/story/212882-1.shtml", "https://www.prnasia.com/story/206268-1.shtml", "https://www.prnasia.com/story/205939-1.shtml", "https://www.prnasia.com/story/205902-1.shtml", "https://www.prnasia.com/story/212896-1.shtml", "https://www.prnasia.com/story/212921-1.shtml", "https://www.prnasia.com/story/206103-1.shtml", "https://www.prnasia.com/story/205996-1.shtml", "https://www.prnasia.com/story/205933-1.shtml", "https://www.prnasia.com/story/213018-1.shtml", "https://www.prnasia.com/story/212867-1.shtml", "https://www.prnasia.com/story/206324-1.shtml", "https://www.prnasia.com/story/213180-1.shtml", "https://www.prnasia.com/story/212854-1.shtml", "https://www.prnasia.com/story/213433-1.shtml", "https://www.prnasia.com/story/213082-1.shtml", "https://www.prnasia.com/story/213247-1.shtml", "https://www.prnasia.com/story/213314-1.shtml", "https://www.prnasia.com/story/213909-1.shtml", "https://www.prnasia.com/story/213351-1.shtml", "https://www.prnasia.com/story/213060-1.shtml", "https://www.prnasia.com/story/213867-1.shtml", "https://www.prnasia.com/story/213858-1.shtml", "https://www.prnasia.com/story/213159-1.shtml", "https://www.prnasia.com/story/213975-1.shtml", "https://www.prnasia.com/story/213401-1.shtml", "https://www.prnasia.com/story/213958-1.shtml", "https://www.prnasia.com/story/213202-1.shtml", "https://www.prnasia.com/story/213053-1.shtml", "https://www.prnasia.com/story/206347-1.shtml", "https://www.prnasia.com/story/206375-1.shtml", "https://www.prnasia.com/story/214096-1.shtml", "https://www.prnasia.com/story/213499-1.shtml", "https://www.prnasia.com/story/213990-1.shtml", "https://www.prnasia.com/story/214140-1.shtml", "https://www.prnasia.com/story/213983-1.shtml", "https://www.prnasia.com/story/206454-1.shtml", "https://www.prnasia.com/story/206389-1.shtml", "https://www.prnasia.com/story/206627-1.shtml", "https://www.prnasia.com/story/214126-1.shtml", "https://www.prnasia.com/story/206669-1.shtml", "https://www.prnasia.com/story/214197-1.shtml", "https://www.prnasia.com/story/206571-1.shtml", "https://www.prnasia.com/story/214368-1.shtml", "https://www.prnasia.com/story/206734-1.shtml", "https://www.prnasia.com/story/214252-1.shtml", "https://www.prnasia.com/story/206703-1.shtml", "https://www.prnasia.com/story/214175-1.shtml", "https://www.prnasia.com/story/206711-1.shtml", "https://www.prnasia.com/story/206775-1.shtml", "https://www.prnasia.com/story/214200-1.shtml", "https://www.prnasia.com/story/214539-1.shtml", "https://www.prnasia.com/story/206778-1.shtml", "https://www.prnasia.com/story/214220-1.shtml", "https://www.prnasia.com/story/214457-1.shtml", "https://www.prnasia.com/story/214521-1.shtml", "https://www.prnasia.com/story/206704-1.shtml", "https://www.prnasia.com/story/206736-1.shtml", "https://www.prnasia.com/story/214503-1.shtml", "https://www.prnasia.com/story/214846-1.shtml", "https://www.prnasia.com/story/214566-1.shtml", "https://www.prnasia.com/story/214914-1.shtml", "https://www.prnasia.com/story/206870-1.shtml", "https://www.prnasia.com/story/206881-1.shtml", "https://www.prnasia.com/story/206941-1.shtml", "https://www.prnasia.com/story/215013-1.shtml", "https://www.prnasia.com/story/215025-1.shtml", "https://www.prnasia.com/story/214758-1.shtml", "https://www.prnasia.com/story/214987-1.shtml", "https://www.prnasia.com/story/206987-1.shtml", "https://www.prnasia.com/story/206905-1.shtml", "https://www.prnasia.com/story/214952-1.shtml", "https://www.prnasia.com/story/214827-1.shtml", "https://www.prnasia.com/story/214869-1.shtml", "https://www.prnasia.com/story/207027-1.shtml", "https://www.prnasia.com/story/214570-1.shtml", "https://www.prnasia.com/story/214910-1.shtml", "https://www.prnasia.com/story/207370-1.shtml", "https://www.prnasia.com/story/207062-1.shtml", "https://www.prnasia.com/story/207292-1.shtml", "https://www.prnasia.com/story/207157-1.shtml", "https://www.prnasia.com/story/215246-1.shtml", "https://www.prnasia.com/story/207172-1.shtml", "https://www.prnasia.com/story/215311-1.shtml", "https://www.prnasia.com/story/215723-1.shtml", "https://www.prnasia.com/story/207301-1.shtml", "https://www.prnasia.com/story/215257-1.shtml", "https://www.prnasia.com/story/215506-1.shtml", "https://www.prnasia.com/story/198154-1.shtml", "https://www.prnasia.com/story/198176-1.shtml", "https://www.prnasia.com/story/215700-1.shtml", "https://www.prnasia.com/story/198062-1.shtml", "https://www.prnasia.com/story/209711-1.shtml", "https://www.prnasia.com/story/198324-1.shtml", "https://www.prnasia.com/story/209869-1.shtml", "https://www.prnasia.com/story/209846-1.shtml", "https://www.prnasia.com/story/198450-1.shtml", "https://www.prnasia.com/story/209784-1.shtml", "https://www.prnasia.com/story/209700-1.shtml", "https://www.prnasia.com/story/198135-1.shtml", "https://www.prnasia.com/story/209716-1.shtml", "https://www.prnasia.com/story/209819-1.shtml", "https://www.prnasia.com/story/209677-1.shtml", "https://www.prnasia.com/story/209812-1.shtml", "https://www.prnasia.com/story/188109-1.shtml", "https://cnmobile.prnasia.com/story/198484-1.shtml", "https://www.prnasia.com/story/209894-1.shtml", "https://www.prnasia.com/story/209834-1.shtml", "https://www.prnasia.com/story/188138-1.shtml", "https://www.prnasia.com/story/188311-1.shtml", "https://www.prnasia.com/story/199411-1.shtml", "https://www.prnasia.com/story/188427-1.shtml", "https://www.prnasia.com/story/188537-1.shtml", "https://www.prnasia.com/story/200106-1.shtml", "https://www.prnasia.com/story/188382-1.shtml", "https://www.prnasia.com/story/199851-1.shtml", "https://www.prnasia.com/story/188463-1.shtml", "https://www.prnasia.com/story/199662-1.shtml", "https://cnmobile.prnasia.com/story/199426-1.shtml", "https://www.prnasia.com/story/188548-1.shtml", "https://www.prnasia.com/story/199922-1.shtml", "https://www.prnasia.com/story/199468-1.shtml", "https://www.prnasia.com/story/200401-1.shtml", "https://www.prnasia.com/story/200236-1.shtml", "https://www.prnasia.com/story/200365-1.shtml", "https://www.prnasia.com/story/199736-1.shtml", "https://www.prnasia.com/story/200239-1.shtml", "https://www.prnasia.com/story/200354-1.shtml", "https://www.prnasia.com/story/200561-1.shtml", "https://www.prnasia.com/story/200421-1.shtml", "https://www.prnasia.com/story/200126-1.shtml", "https://www.prnasia.com/story/200667-1.shtml", "https://www.prnasia.com/story/200240-1.shtml", "https://www.prnasia.com/story/200692-1.shtml", "https://www.prnasia.com/story/200705-1.shtml", "https://www.prnasia.com/story/200490-1.shtml", "https://www.prnasia.com/story/200775-1.shtml", "https://www.prnasia.com/story/200968-1.shtml", "https://www.prnasia.com/story/200740-1.shtml", "https://www.prnasia.com/story/200754-1.shtml", "https://www.prnasia.com/story/201123-1.shtml", "https://www.prnasia.com/story/188791-1.shtml", "https://www.prnasia.com/story/201136-1.shtml", "https://www.prnasia.com/story/201031-1.shtml", "https://www.prnasia.com/story/200711-1.shtml", "https://www.prnasia.com/story/189311-1.shtml", "https://www.prnasia.com/story/201110-1.shtml", "https://www.prnasia.com/story/189283-1.shtml", "https://www.prnasia.com/story/189708-1.shtml", "https://www.prnasia.com/story/189263-1.shtml", "https://www.prnasia.com/story/189941-1.shtml", "https://www.prnasia.com/story/189259-1.shtml", "https://www.prnasia.com/story/189723-1.shtml", "https://cnmobile.prnasia.com/story/189022-1.shtml", "https://www.prnasia.com/story/189270-1.shtml", "https://www.prnasia.com/story/189978-1.shtml", "https://www.prnasia.com/story/190491-1.shtml", "https://www.prnasia.com/story/201619-1.shtml", "https://www.prnasia.com/story/190115-1.shtml", "https://www.prnasia.com/story/190249-1.shtml", "https://www.prnasia.com/story/201780-1.shtml", "https://www.prnasia.com/story/201577-1.shtml", "https://cnmobile.prnasia.com/story/201640-1.shtml", "https://www.prnasia.com/story/201642-1.shtml", "https://www.prnasia.com/story/201579-1.shtml", "https://www.prnasia.com/story/201901-1.shtml", "https://www.prnasia.com/story/201726-1.shtml", "https://www.prnasia.com/story/201569-1.shtml", "https://www.prnasia.com/story/201638-1.shtml", "https://cnmobile.prnasia.com/story/190215-1.shtml", "https://www.prnasia.com/story/202445-1.shtml", "https://www.prnasia.com/story/190630-1.shtml", "https://www.prnasia.com/story/203132-1.shtml", "https://www.prnasia.com/story/202971-1.shtml", "https://www.prnasia.com/story/202472-1.shtml", "https://www.prnasia.com/story/202823-1.shtml", "https://www.prnasia.com/story/190763-1.shtml", "https://www.prnasia.com/story/202961-1.shtml", "https://www.prnasia.com/story/202619-1.shtml", "https://www.prnasia.com/story/202993-1.shtml", "https://www.prnasia.com/story/203120-1.shtml", "https://www.prnasia.com/story/202811-1.shtml", "https://www.prnasia.com/story/202760-1.shtml", "https://cnmobile.prnasia.com/story/203051-1.shtml", "https://www.prnasia.com/story/190973-1.shtml", "https://www.prnasia.com/story/190503-1.shtml", "https://cnmobile.prnasia.com/story/203145-1.shtml", "https://www.prnasia.com/story/191544-1.shtml", "https://www.prnasia.com/story/191885-1.shtml", "https://www.prnasia.com/story/203320-1.shtml", "https://www.prnasia.com/story/203308-1.shtml", "https://www.prnasia.com/story/191938-1.shtml", "https://www.prnasia.com/story/191866-1.shtml", "https://cnmobile.prnasia.com/story/203368-1.shtml", "https://www.prnasia.com/story/191641-1.shtml", "https://www.prnasia.com/story/203250-1.shtml", "https://www.prnasia.com/story/192014-1.shtml", "https://cnmobile.prnasia.com/story/191524-1.shtml", "https://www.prnasia.com/story/203403-1.shtml", "https://www.prnasia.com/story/192180-1.shtml", "https://www.prnasia.com/story/192175-1.shtml", "https://www.prnasia.com/story/203992-1.shtml", "https://www.prnasia.com/story/203972-1.shtml", "https://www.prnasia.com/story/203899-1.shtml", "https://www.prnasia.com/story/192419-1.shtml", "https://www.prnasia.com/story/203943-1.shtml", "https://www.prnasia.com/story/203898-1.shtml", "https://www.prnasia.com/story/192373-1.shtml", "https://www.prnasia.com/story/192664-1.shtml", "https://www.prnasia.com/story/192441-1.shtml", "https://www.prnasia.com/story/192389-1.shtml", "https://www.prnasia.com/story/192289-1.shtml", "https://www.prnasia.com/story/192532-1.shtml", "https://www.prnasia.com/story/203801-1.shtml", "https://www.prnasia.com/story/204012-1.shtml", "https://www.prnasia.com/story/204237-1.shtml", "https://www.prnasia.com/story/204242-1.shtml", "https://www.prnasia.com/story/192483-1.shtml", "https://www.prnasia.com/story/204257-1.shtml", "https://www.prnasia.com/story/204280-1.shtml", "https://www.prnasia.com/story/193212-1.shtml", "https://www.prnasia.com/story/204206-1.shtml", "https://www.prnasia.com/story/193314-1.shtml", "https://www.prnasia.com/story/204207-1.shtml", "https://www.prnasia.com/story/204134-1.shtml", "https://www.prnasia.com/story/204300-1.shtml", "https://www.prnasia.com/story/193517-1.shtml", "https://www.prnasia.com/story/193799-1.shtml", "https://www.prnasia.com/story/193238-1.shtml", "https://www.prnasia.com/story/193915-1.shtml", "https://www.prnasia.com/story/193740-1.shtml", "https://www.prnasia.com/story/193845-1.shtml", "https://www.prnasia.com/story/193584-1.shtml", "https://www.prnasia.com/story/194036-1.shtml", "https://www.prnasia.com/story/194049-1.shtml", "https://www.prnasia.com/story/193660-1.shtml", "https://www.prnasia.com/story/193572-1.shtml", "https://www.prnasia.com/story/194119-1.shtml", "https://www.prnasia.com/story/194214-1.shtml", "https://cnmobile.prnasia.com/story/194164-1.shtml", "https://www.prnasia.com/story/194147-1.shtml", "https://cnmobile.prnasia.com/story/194075-1.shtml", "https://www.prnasia.com/story/195229-1.shtml", "https://www.prnasia.com/story/194249-1.shtml", "https://www.prnasia.com/story/195448-1.shtml", "https://www.prnasia.com/story/183906-1.shtml", "https://www.prnasia.com/story/194954-1.shtml", "https://www.prnasia.com/story/184000-1.shtml", "https://www.prnasia.com/story/194914-1.shtml", "https://www.prnasia.com/story/195217-1.shtml", "https://cnmobile.prnasia.com/story/195188-1.shtml", "https://www.prnasia.com/story/183999-1.shtml", "https://cnmobile.prnasia.com/story/195145-1.shtml", "https://cnmobile.prnasia.com/story/195061-1.shtml", "https://www.prnasia.com/story/183964-1.shtml", "https://www.prnasia.com/story/184102-1.shtml", "https://www.prnasia.com/story/195562-1.shtml", "https://www.prnasia.com/story/184223-1.shtml", "https://www.prnasia.com/story/183938-1.shtml", "https://www.prnasia.com/story/184066-1.shtml", "https://www.prnasia.com/story/195651-1.shtml", "https://www.prnasia.com/story/184028-1.shtml", "https://www.prnasia.com/story/195540-1.shtml", "https://www.prnasia.com/story/196054-1.shtml", "https://www.prnasia.com/story/196233-1.shtml", "https://www.prnasia.com/story/195749-1.shtml", "https://www.prnasia.com/story/195687-1.shtml", "https://www.prnasia.com/story/195760-1.shtml", "https://www.prnasia.com/story/184254-1.shtml", "https://www.prnasia.com/story/179196-1.shtml", "https://www.prnasia.com/story/195825-1.shtml", "https://www.prnasia.com/story/178960-1.shtml", "https://www.prnasia.com/story/178829-1.shtml", "https://www.prnasia.com/story/195678-1.shtml", "https://www.prnasia.com/story/179249-1.shtml", "https://www.prnasia.com/story/196982-1.shtml", "https://www.prnasia.com/story/179445-1.shtml", "https://www.prnasia.com/story/179520-1.shtml", "https://www.prnasia.com/story/179626-1.shtml", "https://www.prnasia.com/story/196764-1.shtml", "https://www.prnasia.com/story/179518-1.shtml", "https://www.prnasia.com/story/197154-1.shtml", "https://www.prnasia.com/story/197466-1.shtml", "https://www.prnasia.com/story/197573-1.shtml", "https://www.prnasia.com/story/197266-1.shtml", "https://www.prnasia.com/story/197524-1.shtml", "https://www.prnasia.com/story/197177-1.shtml", "https://www.prnasia.com/story/197629-1.shtml", "https://www.prnasia.com/story/197645-1.shtml", "https://www.prnasia.com/story/197376-1.shtml", "https://www.prnasia.com/story/197670-1.shtml", "https://www.prnasia.com/story/197505-1.shtml", "https://www.prnasia.com/story/180471-1.shtml", "https://www.prnasia.com/story/197712-1.shtml", "https://www.prnasia.com/story/180501-1.shtml", "https://cnmobile.prnasia.com/story/180316-1.shtml", "https://www.prnasia.com/story/180294-1.shtml", "https://www.prnasia.com/story/167685-1.shtml", "https://www.prnasia.com/story/168013-1.shtml", "https://www.prnasia.com/story/181000-1.shtml", "https://www.prnasia.com/story/168148-1.shtml", "https://cnmobile.prnasia.com/story/167859-1.shtml", "https://www.prnasia.com/story/167747-1.shtml", "https://www.prnasia.com/story/181513-1.shtml", "https://www.prnasia.com/story/181601-1.shtml", "https://www.prnasia.com/story/182548-1.shtml", "https://www.prnasia.com/story/182733-1.shtml", "https://www.prnasia.com/story/182817-1.shtml", "https://www.prnasia.com/story/168180-1.shtml", "https://cnmobile.prnasia.com/story/181664-1.shtml", "https://www.prnasia.com/story/182596-1.shtml", "https://www.prnasia.com/story/183035-1.shtml", "https://www.prnasia.com/story/183630-1.shtml", "https://www.prnasia.com/story/183515-1.shtml", "https://www.prnasia.com/story/182930-1.shtml", "https://www.prnasia.com/story/182940-1.shtml", "https://www.prnasia.com/story/168216-1.shtml", "https://www.prnasia.com/story/183626-1.shtml", "https://www.prnasia.com/story/182961-1.shtml", "https://www.prnasia.com/story/183461-1.shtml", "https://www.prnasia.com/story/183274-1.shtml", "https://www.prnasia.com/story/183686-1.shtml", "https://www.prnasia.com/story/183057-1.shtml", "https://www.prnasia.com/story/182943-1.shtml", "https://www.prnasia.com/story/183655-1.shtml", "https://www.prnasia.com/story/168465-1.shtml", "https://www.prnasia.com/story/183074-1.shtml", "https://www.prnasia.com/story/168745-1.shtml", "https://www.prnasia.com/story/183112-1.shtml", "https://www.prnasia.com/story/168658-1.shtml", "https://www.prnasia.com/story/169592-1.shtml", "https://www.prnasia.com/story/168332-1.shtml", "https://www.prnasia.com/story/169265-1.shtml", "https://www.prnasia.com/story/168778-1.shtml", "https://www.prnasia.com/story/168896-1.shtml", "https://www.prnasia.com/story/169472-1.shtml", "https://www.prnasia.com/story/168421-1.shtml", "https://www.prnasia.com/story/168792-1.shtml", "https://www.prnasia.com/story/184749-1.shtml", "https://www.prnasia.com/story/169045-1.shtml", "https://www.prnasia.com/story/168939-1.shtml", "https://www.prnasia.com/story/184325-1.shtml", "https://www.prnasia.com/story/168615-1.shtml", "https://www.prnasia.com/story/184592-1.shtml", "https://www.prnasia.com/story/169727-1.shtml", "https://www.prnasia.com/story/184392-1.shtml", "https://www.prnasia.com/story/184539-1.shtml", "https://www.prnasia.com/story/184688-1.shtml", "https://www.prnasia.com/story/184754-1.shtml", "https://www.prnasia.com/story/185788-1.shtml", "https://www.prnasia.com/story/185644-1.shtml", "https://www.prnasia.com/story/185711-1.shtml", "https://www.prnasia.com/story/185241-1.shtml", "https://www.prnasia.com/story/185491-1.shtml", "https://www.prnasia.com/story/185424-1.shtml", "https://www.prnasia.com/story/185803-1.shtml", "https://www.prnasia.com/story/185200-1.shtml", "https://www.prnasia.com/story/184871-1.shtml", "https://www.prnasia.com/story/185661-1.shtml", "https://www.prnasia.com/story/185236-1.shtml", "https://www.prnasia.com/story/185510-1.shtml", "https://www.prnasia.com/story/185730-1.shtml", "https://www.prnasia.com/story/170047-1.shtml", "https://www.prnasia.com/story/170114-1.shtml", "https://www.prnasia.com/story/170635-1.shtml", "https://www.prnasia.com/story/171016-1.shtml", "https://www.prnasia.com/story/170213-1.shtml", "https://www.prnasia.com/story/170777-1.shtml", "https://www.prnasia.com/story/170682-1.shtml", "https://www.prnasia.com/story/170463-1.shtml", "https://www.prnasia.com/story/185929-1.shtml", "https://www.prnasia.com/story/186283-1.shtml", "https://www.prnasia.com/story/186143-1.shtml", "https://www.prnasia.com/story/186536-1.shtml", "https://www.prnasia.com/story/186248-1.shtml", "https://www.prnasia.com/story/186570-1.shtml", "https://www.prnasia.com/story/186377-1.shtml", "https://www.prnasia.com/story/186305-1.shtml", "https://www.prnasia.com/story/186386-1.shtml", "https://www.prnasia.com/story/185934-1.shtml", "https://www.prnasia.com/story/186311-1.shtml", "https://www.prnasia.com/story/185898-1.shtml", "https://www.prnasia.com/story/186906-1.shtml", "https://www.prnasia.com/story/172229-1.shtml", "https://www.prnasia.com/story/186686-1.shtml", "https://www.prnasia.com/story/172448-1.shtml", "https://www.prnasia.com/story/172045-1.shtml", "https://www.prnasia.com/story/186876-1.shtml", "https://www.prnasia.com/story/186596-1.shtml", "https://www.prnasia.com/story/172367-1.shtml", "https://www.prnasia.com/story/187053-1.shtml", "https://www.prnasia.com/story/172306-1.shtml", "https://www.prnasia.com/story/172328-1.shtml", "https://www.prnasia.com/story/186909-1.shtml", "https://www.prnasia.com/story/172474-1.shtml", "https://www.prnasia.com/story/187060-1.shtml", "https://www.prnasia.com/story/187140-1.shtml", "https://www.prnasia.com/story/187063-1.shtml", "https://www.prnasia.com/story/172597-1.shtml", "https://www.prnasia.com/story/172880-1.shtml", "https://www.prnasia.com/story/187542-1.shtml", "https://www.prnasia.com/story/187095-1.shtml", "https://www.prnasia.com/story/172594-1.shtml", "https://www.prnasia.com/story/173062-1.shtml", "https://www.prnasia.com/story/187127-1.shtml", "https://www.prnasia.com/story/187388-1.shtml", "https://www.prnasia.com/story/172634-1.shtml", "https://www.prnasia.com/story/187837-1.shtml", "https://www.prnasia.com/story/187970-1.shtml", "https://www.prnasia.com/story/187852-1.shtml", "https://www.prnasia.com/story/188012-1.shtml", "https://www.prnasia.com/story/173563-1.shtml", "https://www.prnasia.com/story/187949-1.shtml", "https://www.prnasia.com/story/187664-1.shtml", "https://www.prnasia.com/story/173532-1.shtml", "https://www.prnasia.com/story/187691-1.shtml", "https://www.prnasia.com/story/187796-1.shtml", "https://www.prnasia.com/story/173315-1.shtml", "https://www.prnasia.com/story/188034-1.shtml", "https://www.prnasia.com/story/173702-1.shtml", "https://www.prnasia.com/story/173335-1.shtml", "https://www.prnasia.com/story/187955-1.shtml", "https://www.prnasia.com/story/165393-1.shtml", "https://www.prnasia.com/story/173942-1.shtml", "https://www.prnasia.com/story/174072-1.shtml", "https://www.prnasia.com/story/173914-1.shtml", "https://www.prnasia.com/story/174000-1.shtml", "https://www.prnasia.com/story/165350-1.shtml", "https://www.prnasia.com/story/165513-1.shtml", "https://www.prnasia.com/story/165371-1.shtml", "https://www.prnasia.com/story/165392-1.shtml", "https://www.prnasia.com/story/165436-1.shtml", "https://www.prnasia.com/story/165477-1.shtml", "https://www.prnasia.com/story/173988-1.shtml", "https://www.prnasia.com/story/165458-1.shtml", "https://www.prnasia.com/story/165185-1.shtml", "https://www.prnasia.com/story/165412-1.shtml", "https://www.prnasia.com/story/173706-1.shtml", "https://www.prnasia.com/story/174495-1.shtml", "https://www.prnasia.com/story/174099-1.shtml", "https://www.prnasia.com/story/165724-1.shtml", "https://www.prnasia.com/story/174418-1.shtml", "https://www.prnasia.com/story/165981-1.shtml", "https://www.prnasia.com/story/174401-1.shtml", "https://www.prnasia.com/story/174436-1.shtml", "https://www.prnasia.com/story/165769-1.shtml", "https://www.prnasia.com/story/174349-1.shtml", "https://www.prnasia.com/story/174345-1.shtml", "https://www.prnasia.com/story/165627-1.shtml", "https://www.prnasia.com/story/165744-1.shtml", "https://www.prnasia.com/story/165632-1.shtml", "https://www.prnasia.com/story/166026-1.shtml", "https://www.prnasia.com/story/159814-1.shtml", "https://www.prnasia.com/story/159758-1.shtml", "https://www.prnasia.com/story/164746-1.shtml", "https://www.prnasia.com/story/159846-1.shtml", "https://www.prnasia.com/story/159733-1.shtml", "https://www.prnasia.com/story/159537-1.shtml", "https://www.prnasia.com/story/164767-1.shtml", "https://www.prnasia.com/story/164810-1.shtml", "https://cnmobile.prnasia.com/story/164741-1.shtml", "https://www.prnasia.com/story/176196-1.shtml", "https://www.prnasia.com/story/164916-1.shtml", "https://www.prnasia.com/story/176173-1.shtml", "https://www.prnasia.com/story/164762-1.shtml", "https://www.prnasia.com/story/176742-1.shtml", "https://www.prnasia.com/story/164953-1.shtml", "https://www.prnasia.com/story/176513-1.shtml", "https://www.prnasia.com/story/176060-1.shtml", "https://www.prnasia.com/story/158931-1.shtml", "https://www.prnasia.com/story/176353-1.shtml", "https://www.prnasia.com/story/176402-1.shtml", "https://www.prnasia.com/story/159258-1.shtml", "https://www.prnasia.com/story/176525-1.shtml", "https://www.prnasia.com/story/176514-1.shtml", "https://www.prnasia.com/story/158979-1.shtml", "https://www.prnasia.com/story/158898-1.shtml", "https://www.prnasia.com/story/159358-1.shtml", "https://www.prnasia.com/story/177418-1.shtml", "https://www.prnasia.com/story/177024-1.shtml", "https://www.prnasia.com/story/177527-1.shtml", "https://www.prnasia.com/story/177635-1.shtml", "https://www.prnasia.com/story/177489-1.shtml", "https://www.prnasia.com/story/177368-1.shtml", "https://www.prnasia.com/story/177664-1.shtml", "https://www.prnasia.com/story/176950-1.shtml", "https://www.prnasia.com/story/177451-1.shtml", "https://www.prnasia.com/story/177595-1.shtml", "https://www.prnasia.com/story/177453-1.shtml", "https://www.prnasia.com/story/177385-1.shtml", "https://www.prnasia.com/story/178210-1.shtml", "https://www.prnasia.com/story/177701-1.shtml", "https://www.prnasia.com/story/177898-1.shtml", "https://www.prnasia.com/story/178640-1.shtml", "https://www.prnasia.com/story/178083-1.shtml", "https://www.prnasia.com/story/178649-1.shtml", "https://www.prnasia.com/story/178616-1.shtml", "https://www.prnasia.com/story/178096-1.shtml", "https://www.prnasia.com/story/178770-1.shtml", "https://www.prnasia.com/story/178707-1.shtml", "https://cnmobile.prnasia.com/story/178518-1.shtml", "https://cnmobile.prnasia.com/story/159960-1.shtml", "https://www.prnasia.com/story/178019-1.shtml", "https://www.prnasia.com/story/160622-1.shtml", "https://www.prnasia.com/story/160279-1.shtml", "https://www.prnasia.com/story/160387-1.shtml", "https://www.prnasia.com/story/160426-1.shtml", "https://www.prnasia.com/story/148005-1.shtml", "https://www.prnasia.com/story/160614-1.shtml", "https://www.prnasia.com/story/147894-1.shtml", "https://www.prnasia.com/story/160287-1.shtml", "https://www.prnasia.com/story/178696-1.shtml", "https://www.prnasia.com/story/147828-1.shtml", "https://www.prnasia.com/story/160317-1.shtml", "https://cnmobile.prnasia.com/story/147781-1.shtml", "https://www.prnasia.com/story/159970-1.shtml", "https://www.prnasia.com/story/160564-1.shtml", "https://www.prnasia.com/story/147969-1.shtml", "https://www.prnasia.com/story/161212-1.shtml", "https://www.prnasia.com/story/160735-1.shtml", "https://www.prnasia.com/story/160687-1.shtml", "https://www.prnasia.com/story/161502-1.shtml", "https://www.prnasia.com/story/161126-1.shtml", "https://www.prnasia.com/story/161490-1.shtml", "https://www.prnasia.com/story/161291-1.shtml", "https://www.prnasia.com/story/161431-1.shtml", "https://www.prnasia.com/story/148226-1.shtml", "https://cnmobile.prnasia.com/story/148185-1.shtml", "https://www.prnasia.com/story/161996-1.shtml", "https://www.prnasia.com/story/161604-1.shtml", "https://www.prnasia.com/story/161499-1.shtml", "https://www.prnasia.com/story/161547-1.shtml", "https://www.prnasia.com/story/161590-1.shtml", "https://www.prnasia.com/story/162196-1.shtml", "https://cnmobile.prnasia.com/story/161241-1.shtml", "https://cnmobile.prnasia.com/story/161582-1.shtml", "https://www.prnasia.com/story/162198-1.shtml", "https://www.prnasia.com/story/162208-1.shtml", "https://www.prnasia.com/story/162252-1.shtml", "https://www.prnasia.com/story/162330-1.shtml", "https://www.prnasia.com/story/162040-1.shtml", "https://www.prnasia.com/story/151451-1.shtml", "https://www.prnasia.com/story/151901-1.shtml", "https://www.prnasia.com/story/151528-1.shtml", "https://www.prnasia.com/story/162237-1.shtml", "https://www.prnasia.com/story/151562-1.shtml", "https://www.prnasia.com/story/162254-1.shtml", "https://www.prnasia.com/story/162276-1.shtml", "https://www.prnasia.com/story/162300-1.shtml", "https://www.prnasia.com/story/151602-1.shtml", "https://cnmobile.prnasia.com/story/162283-1.shtml", "https://www.prnasia.com/story/152231-1.shtml", "https://www.prnasia.com/story/151512-1.shtml", "https://www.prnasia.com/story/151572-1.shtml", "https://www.prnasia.com/story/151597-1.shtml", "https://www.prnasia.com/story/163298-1.shtml", "https://www.prnasia.com/story/152941-1.shtml", "https://www.prnasia.com/story/163258-1.shtml", "https://www.prnasia.com/story/152446-1.shtml", "https://www.prnasia.com/story/163160-1.shtml", "https://www.prnasia.com/story/152667-1.shtml", "https://www.prnasia.com/story/153241-1.shtml", "https://www.prnasia.com/story/152445-1.shtml", "https://www.prnasia.com/story/152273-1.shtml", "https://www.prnasia.com/story/152644-1.shtml", "https://www.prnasia.com/story/163089-1.shtml", "https://www.prnasia.com/story/153100-1.shtml", "https://www.prnasia.com/story/147220-1.shtml", "https://www.prnasia.com/story/147481-1.shtml", "https://www.prnasia.com/story/163630-1.shtml", "https://www.prnasia.com/story/147457-1.shtml", "https://www.prnasia.com/story/147655-1.shtml", "https://www.prnasia.com/story/164013-1.shtml", "https://www.prnasia.com/story/163864-1.shtml", "https://www.prnasia.com/story/147722-1.shtml", "https://www.prnasia.com/story/164137-1.shtml", "https://www.prnasia.com/story/147492-1.shtml", "https://www.prnasia.com/story/147598-1.shtml", "https://www.prnasia.com/story/148595-1.shtml", "https://www.prnasia.com/story/164092-1.shtml", "https://www.prnasia.com/story/148466-1.shtml", "https://www.prnasia.com/story/163854-1.shtml", "https://www.prnasia.com/story/148579-1.shtml", "https://www.prnasia.com/story/148560-1.shtml", "https://www.prnasia.com/story/148370-1.shtml", "https://www.prnasia.com/story/164226-1.shtml", "https://www.prnasia.com/story/148990-1.shtml", "https://www.prnasia.com/story/148599-1.shtml", "https://www.prnasia.com/story/164470-1.shtml", "https://www.prnasia.com/story/148915-1.shtml", "https://www.prnasia.com/story/164736-1.shtml", "https://www.prnasia.com/story/164256-1.shtml", "https://www.prnasia.com/story/149079-1.shtml", "https://www.prnasia.com/story/149247-1.shtml", "https://www.prnasia.com/story/164697-1.shtml", "https://www.prnasia.com/story/149815-1.shtml", "https://www.prnasia.com/story/149339-1.shtml", "https://www.prnasia.com/story/150063-1.shtml", "https://www.prnasia.com/story/150253-1.shtml", "https://www.prnasia.com/story/150000-1.shtml", "https://www.prnasia.com/story/149704-1.shtml", "https://www.prnasia.com/story/150212-1.shtml", "https://www.prnasia.com/story/150016-1.shtml", "https://cnmobile.prnasia.com/story/150017-1.shtml", "https://www.prnasia.com/story/150819-1.shtml", "https://www.prnasia.com/story/151034-1.shtml", "https://www.prnasia.com/story/150977-1.shtml", "https://www.prnasia.com/story/151030-1.shtml", "https://www.prnasia.com/story/151046-1.shtml", "https://www.prnasia.com/story/166203-1.shtml", "https://www.prnasia.com/story/151273-1.shtml", "https://www.prnasia.com/story/151025-1.shtml", "https://www.prnasia.com/story/151255-1.shtml", "https://www.prnasia.com/story/151072-1.shtml", "https://www.prnasia.com/story/166087-1.shtml", "https://www.prnasia.com/story/151211-1.shtml", "https://www.prnasia.com/story/151241-1.shtml", "https://www.prnasia.com/story/166680-1.shtml", "https://www.prnasia.com/story/166476-1.shtml", "https://www.prnasia.com/story/166971-1.shtml", "https://www.prnasia.com/story/167174-1.shtml", "https://www.prnasia.com/story/166726-1.shtml", "https://www.prnasia.com/story/167063-1.shtml", "https://www.prnasia.com/story/167149-1.shtml", "https://www.prnasia.com/story/166824-1.shtml", "https://www.prnasia.com/story/167161-1.shtml", "https://www.prnasia.com/story/167139-1.shtml", "https://www.prnasia.com/story/167037-1.shtml", "https://www.prnasia.com/story/153407-1.shtml", "https://www.prnasia.com/story/153707-1.shtml", "https://www.prnasia.com/story/153723-1.shtml", "https://www.prnasia.com/story/153772-1.shtml", "https://www.prnasia.com/story/153644-1.shtml", "https://www.prnasia.com/story/167452-1.shtml", "https://www.prnasia.com/story/167493-1.shtml", "https://www.prnasia.com/story/154125-1.shtml", "https://www.prnasia.com/story/167545-1.shtml", "https://www.prnasia.com/story/154059-1.shtml", "https://cnmobile.prnasia.com/story/153915-1.shtml", "https://www.prnasia.com/story/154206-1.shtml", "https://www.prnasia.com/story/154196-1.shtml", "https://www.prnasia.com/story/153980-1.shtml", "https://www.prnasia.com/story/167384-1.shtml", "https://www.prnasia.com/story/154973-1.shtml", "https://www.prnasia.com/story/154945-1.shtml", "https://www.prnasia.com/story/155101-1.shtml", "https://www.prnasia.com/story/155451-1.shtml", "https://www.prnasia.com/story/154238-1.shtml", "https://www.prnasia.com/story/155361-1.shtml", "https://www.prnasia.com/story/155431-1.shtml", "https://www.prnasia.com/story/155338-1.shtml", "https://cnmobile.prnasia.com/story/155218-1.shtml", "https://cnmobile.prnasia.com/story/155208-1.shtml", "https://cnmobile.prnasia.com/story/155198-1.shtml", "https://www.prnasia.com/story/155665-1.shtml", "https://www.prnasia.com/story/156222-1.shtml", "https://www.prnasia.com/story/156192-1.shtml", "https://www.prnasia.com/story/145237-1.shtml", "https://www.prnasia.com/story/145273-1.shtml", "https://www.prnasia.com/story/155571-1.shtml", "https://www.prnasia.com/story/156105-1.shtml", "https://www.prnasia.com/story/145143-1.shtml", "https://www.prnasia.com/story/155510-1.shtml", "https://www.prnasia.com/story/145033-1.shtml", "https://www.prnasia.com/story/156835-1.shtml", "https://www.prnasia.com/story/156767-1.shtml", "https://www.prnasia.com/story/145364-1.shtml", "https://www.prnasia.com/story/156383-1.shtml", "https://www.prnasia.com/story/156775-1.shtml", "https://www.prnasia.com/story/156550-1.shtml", "https://www.prnasia.com/story/156896-1.shtml", "https://www.prnasia.com/story/137497-1.shtml", "https://www.prnasia.com/story/137127-1.shtml", "https://www.prnasia.com/story/137458-1.shtml", "https://www.prnasia.com/story/137252-1.shtml", "https://www.prnasia.com/story/137506-1.shtml", "https://www.prnasia.com/story/157125-1.shtml", "https://www.prnasia.com/story/137491-1.shtml", "https://www.prnasia.com/story/157208-1.shtml", "https://www.prnasia.com/story/137222-1.shtml", "https://www.prnasia.com/story/137357-1.shtml", "https://www.prnasia.com/story/137306-1.shtml", "https://www.prnasia.com/story/137327-1.shtml", "https://www.prnasia.com/story/137517-1.shtml", "https://www.prnasia.com/story/137828-1.shtml", "https://www.prnasia.com/story/158295-1.shtml", "https://www.prnasia.com/story/158610-1.shtml", "https://www.prnasia.com/story/137671-1.shtml", "https://www.prnasia.com/story/158084-1.shtml", "https://www.prnasia.com/story/158078-1.shtml", "https://www.prnasia.com/story/158587-1.shtml", "https://www.prnasia.com/story/137860-1.shtml", "https://www.prnasia.com/story/158338-1.shtml", "https://www.prnasia.com/story/158339-1.shtml", "https://www.prnasia.com/story/158411-1.shtml", "https://www.prnasia.com/story/138151-1.shtml", "https://www.prnasia.com/story/138099-1.shtml", "https://www.prnasia.com/story/138189-1.shtml", "https://www.prnasia.com/story/125495-1.shtml", "https://www.prnasia.com/story/125629-1.shtml", "https://www.prnasia.com/story/125736-1.shtml", "https://www.prnasia.com/story/138536-1.shtml", "https://www.prnasia.com/story/125417-1.shtml", "https://www.prnasia.com/story/125593-1.shtml", "https://www.prnasia.com/story/158592-1.shtml", "https://www.prnasia.com/story/138620-1.shtml", "https://www.prnasia.com/story/126356-1.shtml", "https://www.prnasia.com/story/125991-1.shtml", "https://www.prnasia.com/story/138788-1.shtml", "https://www.prnasia.com/story/138956-1.shtml", "https://www.prnasia.com/story/138739-1.shtml", "https://www.prnasia.com/story/126659-1.shtml", "https://www.prnasia.com/story/126290-1.shtml", "https://www.prnasia.com/story/138964-1.shtml", "https://www.prnasia.com/story/138657-1.shtml", "https://www.prnasia.com/story/138919-1.shtml", "https://www.prnasia.com/story/138735-1.shtml", "https://www.prnasia.com/story/138779-1.shtml", "https://www.prnasia.com/story/126711-1.shtml", "https://www.prnasia.com/story/126997-1.shtml", "https://www.prnasia.com/story/127340-1.shtml", "https://www.prnasia.com/story/127132-1.shtml", "https://cnmobile.prnasia.com/story/139131-1.shtml", "https://www.prnasia.com/story/127079-1.shtml", "https://www.prnasia.com/story/139398-1.shtml", "https://www.prnasia.com/story/126746-1.shtml", "https://www.prnasia.com/story/139330-1.shtml", "https://www.prnasia.com/story/139530-1.shtml", "https://www.prnasia.com/story/126962-1.shtml", "https://www.prnasia.com/story/126874-1.shtml", "https://www.prnasia.com/story/139272-1.shtml", "https://www.prnasia.com/story/139275-1.shtml", "https://www.prnasia.com/story/127490-1.shtml", "https://www.prnasia.com/story/140110-1.shtml", "https://www.prnasia.com/story/127570-1.shtml", "https://www.prnasia.com/story/128221-1.shtml", "https://www.prnasia.com/story/140146-1.shtml", "https://www.prnasia.com/story/139533-1.shtml", "https://www.prnasia.com/story/127714-1.shtml", "https://www.prnasia.com/story/127368-1.shtml", "https://www.prnasia.com/story/128240-1.shtml", "https://www.prnasia.com/story/128052-1.shtml", "https://cnmobile.prnasia.com/story/127925-1.shtml", "https://www.prnasia.com/story/140421-1.shtml", "https://www.prnasia.com/story/140271-1.shtml", "https://www.prnasia.com/story/128312-1.shtml", "https://www.prnasia.com/story/140578-1.shtml", "https://www.prnasia.com/story/140360-1.shtml", "https://www.prnasia.com/story/128761-1.shtml", "https://www.prnasia.com/story/140492-1.shtml", "https://www.prnasia.com/story/128678-1.shtml", "https://www.prnasia.com/story/140210-1.shtml", "https://www.prnasia.com/story/140252-1.shtml", "https://cnmobile.prnasia.com/story/129116-1.shtml", "https://www.prnasia.com/story/140219-1.shtml", "https://www.prnasia.com/story/140817-1.shtml", "https://www.prnasia.com/story/140611-1.shtml", "https://www.prnasia.com/story/140841-1.shtml", "https://www.prnasia.com/story/128755-1.shtml", "https://www.prnasia.com/story/128906-1.shtml", "https://www.prnasia.com/story/129188-1.shtml", "https://www.prnasia.com/story/140894-1.shtml", "https://www.prnasia.com/story/140868-1.shtml", "https://www.prnasia.com/story/140795-1.shtml", "https://www.prnasia.com/story/129290-1.shtml", "https://www.prnasia.com/story/140587-1.shtml", "https://www.prnasia.com/story/129243-1.shtml", "https://www.prnasia.com/story/129395-1.shtml", "https://www.prnasia.com/story/129422-1.shtml", "https://www.prnasia.com/story/129499-1.shtml", "https://www.prnasia.com/story/129860-1.shtml", "https://www.prnasia.com/story/129661-1.shtml", "https://www.prnasia.com/story/129735-1.shtml", "https://www.prnasia.com/story/141015-1.shtml", "https://www.prnasia.com/story/129501-1.shtml", "https://www.prnasia.com/story/129993-1.shtml", "https://www.prnasia.com/story/130069-1.shtml", "https://www.prnasia.com/story/129872-1.shtml", "https://www.prnasia.com/story/129562-1.shtml", "https://www.prnasia.com/story/129805-1.shtml", "https://www.prnasia.com/story/130633-1.shtml", "https://www.prnasia.com/story/130714-1.shtml", "https://www.prnasia.com/story/142063-1.shtml", "https://www.prnasia.com/story/142511-1.shtml", "https://www.prnasia.com/story/131883-1.shtml", "https://www.prnasia.com/story/142804-1.shtml", "https://www.prnasia.com/story/142351-1.shtml", "https://www.prnasia.com/story/131740-1.shtml", "https://www.prnasia.com/story/131994-1.shtml", "https://www.prnasia.com/story/131993-1.shtml", "https://www.prnasia.com/story/142489-1.shtml", "https://www.prnasia.com/story/142398-1.shtml", "https://www.prnasia.com/story/131632-1.shtml", "https://cnmobile.prnasia.com/story/142833-1.shtml", "https://www.prnasia.com/story/142485-1.shtml", "https://www.prnasia.com/story/142905-1.shtml", "https://www.prnasia.com/story/142316-1.shtml", "https://www.prnasia.com/story/143089-1.shtml", "https://www.prnasia.com/story/143626-1.shtml", "https://www.prnasia.com/story/132024-1.shtml", "https://www.prnasia.com/story/143587-1.shtml", "https://www.prnasia.com/story/143781-1.shtml", "https://www.prnasia.com/story/143142-1.shtml", "https://www.prnasia.com/story/143559-1.shtml", "https://www.prnasia.com/story/132038-1.shtml", "https://www.prnasia.com/story/143186-1.shtml", "https://www.prnasia.com/story/143496-1.shtml", "https://www.prnasia.com/story/143683-1.shtml", "https://www.prnasia.com/story/143429-1.shtml", "https://www.prnasia.com/story/143033-1.shtml", "https://www.prnasia.com/story/143836-1.shtml", "https://www.prnasia.com/story/143764-1.shtml", "https://www.prnasia.com/story/143672-1.shtml", "https://www.prnasia.com/story/143614-1.shtml", "https://www.prnasia.com/story/132666-1.shtml", "https://www.prnasia.com/story/143928-1.shtml", "https://www.prnasia.com/story/143995-1.shtml", "https://www.prnasia.com/story/132708-1.shtml", "https://www.prnasia.com/story/132706-1.shtml", "https://cnmobile.prnasia.com/story/143577-1.shtml", "https://www.prnasia.com/story/133023-1.shtml", "https://www.prnasia.com/story/143947-1.shtml", "https://www.prnasia.com/story/143981-1.shtml", "https://www.prnasia.com/story/144237-1.shtml", "https://www.prnasia.com/story/132915-1.shtml", "https://www.prnasia.com/story/133275-1.shtml", "https://www.prnasia.com/story/144758-1.shtml", "https://www.prnasia.com/story/144348-1.shtml", "https://www.prnasia.com/story/144382-1.shtml", "https://www.prnasia.com/story/144530-1.shtml", "https://www.prnasia.com/story/132939-1.shtml", "https://www.prnasia.com/story/133326-1.shtml", "https://www.prnasia.com/story/133661-1.shtml", "https://www.prnasia.com/story/144421-1.shtml", "https://www.prnasia.com/story/144334-1.shtml", "https://www.prnasia.com/story/133436-1.shtml", "https://www.prnasia.com/story/133510-1.shtml", "https://www.prnasia.com/story/144523-1.shtml", "https://www.prnasia.com/story/133757-1.shtml", "https://www.prnasia.com/story/133845-1.shtml", "https://www.prnasia.com/story/133794-1.shtml", "https://www.prnasia.com/story/134048-1.shtml", "https://www.prnasia.com/story/133733-1.shtml", "https://www.prnasia.com/story/133801-1.shtml", "https://www.prnasia.com/story/133962-1.shtml", "https://www.prnasia.com/story/134716-1.shtml", "https://www.prnasia.com/story/134271-1.shtml", "https://www.prnasia.com/story/134715-1.shtml", "https://www.prnasia.com/story/134463-1.shtml", "https://www.prnasia.com/story/135052-1.shtml", "https://www.prnasia.com/story/134516-1.shtml", "https://www.prnasia.com/story/135063-1.shtml", "https://www.prnasia.com/story/135222-1.shtml", "https://www.prnasia.com/story/134579-1.shtml", "https://www.prnasia.com/story/134830-1.shtml", "https://www.prnasia.com/story/135022-1.shtml", "https://www.prnasia.com/story/135180-1.shtml", "https://www.prnasia.com/story/135721-1.shtml", "https://www.prnasia.com/story/135621-1.shtml", "https://www.prnasia.com/story/135787-1.shtml", "https://www.prnasia.com/story/135768-1.shtml", "https://www.prnasia.com/story/135327-1.shtml", "https://www.prnasia.com/story/135872-1.shtml", "https://www.prnasia.com/story/135983-1.shtml", "https://www.prnasia.com/story/135882-1.shtml", "https://www.prnasia.com/story/146788-1.shtml", "https://www.prnasia.com/story/147046-1.shtml", "https://www.prnasia.com/story/136071-1.shtml", "https://www.prnasia.com/story/147119-1.shtml", "https://www.prnasia.com/story/100936-1.shtml", "https://www.prnasia.com/story/101010-1.shtml", "https://www.prnasia.com/story/136256-1.shtml", "https://www.prnasia.com/story/100968-1.shtml", "https://www.prnasia.com/story/101060-1.shtml", "https://www.prnasia.com/story/136221-1.shtml", "https://www.prnasia.com/story/101513-1.shtml", "https://www.prnasia.com/story/136255-1.shtml", "https://www.prnasia.com/story/101457-1.shtml", "https://www.prnasia.com/story/136082-1.shtml", "https://www.prnasia.com/story/136725-1.shtml", "https://www.prnasia.com/story/137101-1.shtml", "https://www.prnasia.com/story/108405-1.shtml", "https://www.prnasia.com/story/136737-1.shtml", "https://cnmobile.prnasia.com/story/108146-1.shtml", "https://www.prnasia.com/story/114275-1.shtml", "https://cnmobile.prnasia.com/story/108123-1.shtml", "https://www.prnasia.com/story/114097-1.shtml", "https://www.prnasia.com/story/114663-1.shtml", "https://www.prnasia.com/story/100205-1.shtml", "https://www.prnasia.com/story/114693-1.shtml", "https://www.prnasia.com/story/108569-1.shtml", "https://www.prnasia.com/story/108474-1.shtml", "https://www.prnasia.com/story/114589-1.shtml", "https://www.prnasia.com/story/108582-1.shtml", "https://www.prnasia.com/story/114375-1.shtml", "https://www.prnasia.com/story/114555-1.shtml", "https://cnmobile.prnasia.com/story/114415-1.shtml", "https://www.prnasia.com/story/100334-1.shtml", "https://www.prnasia.com/story/100841-1.shtml", "https://www.prnasia.com/story/112266-1.shtml", "https://www.prnasia.com/story/102451-1.shtml", "https://www.prnasia.com/story/112162-1.shtml", "https://www.prnasia.com/story/112188-1.shtml", "https://www.prnasia.com/story/103023-1.shtml", "https://www.prnasia.com/story/111515-1.shtml", "https://www.prnasia.com/story/112190-1.shtml", "https://www.prnasia.com/story/112272-1.shtml", "https://www.prnasia.com/story/112315-1.shtml", "https://www.prnasia.com/story/112038-1.shtml", "https://www.prnasia.com/story/103222-1.shtml", "https://www.prnasia.com/story/112370-1.shtml", "https://www.prnasia.com/story/112687-1.shtml", "https://www.prnasia.com/story/111242-1.shtml", "https://www.prnasia.com/story/113173-1.shtml", "https://www.prnasia.com/story/111744-1.shtml", "https://www.prnasia.com/story/113175-1.shtml", "https://www.prnasia.com/story/112025-1.shtml", "https://www.prnasia.com/story/111900-1.shtml", "https://www.prnasia.com/story/113831-1.shtml", "https://www.prnasia.com/story/113509-1.shtml", "https://www.prnasia.com/story/113784-1.shtml", "https://www.prnasia.com/story/113182-1.shtml", "https://www.prnasia.com/story/113422-1.shtml", "https://www.prnasia.com/story/113226-1.shtml", "https://www.prnasia.com/story/116417-1.shtml", "https://www.prnasia.com/story/113549-1.shtml", "https://www.prnasia.com/story/116834-1.shtml", "https://cnmobile.prnasia.com/story/113323-1.shtml", "https://www.prnasia.com/story/116460-1.shtml", "https://www.prnasia.com/story/113345-1.shtml", "https://www.prnasia.com/story/116814-1.shtml", "https://www.prnasia.com/story/115443-1.shtml", "https://www.prnasia.com/story/116929-1.shtml", "https://www.prnasia.com/story/117898-1.shtml", "https://www.prnasia.com/story/116032-1.shtml", "https://www.prnasia.com/story/117076-1.shtml", "https://www.prnasia.com/story/117890-1.shtml", "https://www.prnasia.com/story/117883-1.shtml", "https://www.prnasia.com/story/117080-1.shtml", "https://www.prnasia.com/story/115831-1.shtml", "https://www.prnasia.com/story/115180-1.shtml", "https://www.prnasia.com/story/115691-1.shtml", "https://www.prnasia.com/story/116999-1.shtml", "https://www.prnasia.com/story/118114-1.shtml", "https://www.prnasia.com/story/118262-1.shtml", "https://www.prnasia.com/story/116115-1.shtml", "https://www.prnasia.com/story/118236-1.shtml", "https://www.prnasia.com/story/118178-1.shtml", "https://www.prnasia.com/story/117128-1.shtml", "https://www.prnasia.com/story/117327-1.shtml", "https://www.prnasia.com/story/117823-1.shtml", "https://www.prnasia.com/story/117178-1.shtml", "https://www.prnasia.com/story/119235-1.shtml", "https://www.prnasia.com/story/117452-1.shtml", "https://www.prnasia.com/story/118819-1.shtml", "https://www.prnasia.com/story/117202-1.shtml", "https://www.prnasia.com/story/119248-1.shtml", "https://www.prnasia.com/story/119604-1.shtml", "https://www.prnasia.com/story/117671-1.shtml", "https://www.prnasia.com/story/119630-1.shtml", "https://www.prnasia.com/story/119224-1.shtml", "https://www.prnasia.com/story/121376-1.shtml", "https://www.prnasia.com/story/118869-1.shtml", "https://www.prnasia.com/story/120964-1.shtml", "https://www.prnasia.com/story/105107-1.shtml", "https://www.prnasia.com/story/121026-1.shtml", "https://www.prnasia.com/story/105410-1.shtml", "https://www.prnasia.com/story/121500-1.shtml", "https://www.prnasia.com/story/105117-1.shtml", "https://www.prnasia.com/story/105203-1.shtml", "https://www.prnasia.com/story/105027-1.shtml", "https://www.prnasia.com/story/121713-1.shtml", "https://www.prnasia.com/story/121709-1.shtml", "https://www.prnasia.com/story/105523-1.shtml", "https://www.prnasia.com/story/121856-1.shtml", "https://www.prnasia.com/story/121945-1.shtml", "https://www.prnasia.com/story/122489-1.shtml", "https://www.prnasia.com/story/121965-1.shtml", "https://www.prnasia.com/story/122691-1.shtml", "https://www.prnasia.com/story/121960-1.shtml", "https://www.prnasia.com/story/122711-1.shtml", "https://www.prnasia.com/story/122871-1.shtml", "https://www.prnasia.com/story/122892-1.shtml", "https://www.prnasia.com/story/122707-1.shtml", "https://www.prnasia.com/story/122249-1.shtml", "https://www.prnasia.com/story/122451-1.shtml", "https://www.prnasia.com/story/122437-1.shtml", "https://www.prnasia.com/story/106199-1.shtml", "https://www.prnasia.com/story/105687-1.shtml", "https://www.prnasia.com/story/123117-1.shtml", "https://www.prnasia.com/story/105955-1.shtml", "https://www.prnasia.com/story/122488-1.shtml", "https://www.prnasia.com/story/123495-1.shtml", "https://www.prnasia.com/story/106369-1.shtml", "https://www.prnasia.com/story/123136-1.shtml", "https://www.prnasia.com/story/106522-1.shtml", "https://www.prnasia.com/story/123445-1.shtml", "https://www.prnasia.com/story/123440-1.shtml", "https://www.prnasia.com/story/123944-1.shtml", "https://www.prnasia.com/story/124015-1.shtml", "https://www.prnasia.com/story/123557-1.shtml", "https://www.prnasia.com/story/106601-1.shtml", "https://www.prnasia.com/story/107621-1.shtml", "https://cnmobile.prnasia.com/story/123963-1.shtml", "https://www.prnasia.com/story/125141-1.shtml", "https://www.prnasia.com/story/124977-1.shtml", "https://www.prnasia.com/story/108026-1.shtml", "https://www.prnasia.com/story/124408-1.shtml", "https://www.prnasia.com/story/124773-1.shtml", "https://www.prnasia.com/story/107694-1.shtml", "https://www.prnasia.com/story/99317-1.shtml", "https://www.prnasia.com/story/125197-1.shtml", "https://www.prnasia.com/story/99559-1.shtml", "https://www.prnasia.com/story/99412-1.shtml", "https://www.prnasia.com/story/99406-1.shtml", "https://www.prnasia.com/story/99677-1.shtml", "https://www.prnasia.com/story/90747-1.shtml", "https://www.prnasia.com/story/100085-1.shtml", "https://www.prnasia.com/story/101572-1.shtml", "https://www.prnasia.com/story/99936-1.shtml", "https://cnmobile.prnasia.com/story/100043-1.shtml", "https://www.prnasia.com/story/101784-1.shtml", "https://www.prnasia.com/story/91207-1.shtml", "https://www.prnasia.com/story/101574-1.shtml", "https://www.prnasia.com/story/102409-1.shtml", "https://www.prnasia.com/story/102079-1.shtml", "https://www.prnasia.com/story/102018-1.shtml", "https://www.prnasia.com/story/101720-1.shtml", "https://www.prnasia.com/story/89819-1.shtml", "https://www.prnasia.com/story/89804-1.shtml", "https://www.prnasia.com/story/93890-1.shtml", "https://www.prnasia.com/story/89867-1.shtml", "https://www.prnasia.com/story/89168-1.shtml", "https://www.prnasia.com/story/89648-1.shtml", "https://www.prnasia.com/story/106898-1.shtml", "https://www.prnasia.com/story/107044-1.shtml", "https://www.prnasia.com/story/107428-1.shtml", "https://www.prnasia.com/story/90211-1.shtml", "https://www.prnasia.com/story/107052-1.shtml", "https://www.prnasia.com/story/90084-1.shtml", "https://www.prnasia.com/story/90481-1.shtml", "https://www.prnasia.com/story/90399-1.shtml", "https://www.prnasia.com/story/109023-1.shtml", "https://www.prnasia.com/story/108737-1.shtml", "https://www.prnasia.com/story/91674-1.shtml", "https://www.prnasia.com/story/108842-1.shtml", "https://www.prnasia.com/story/91743-1.shtml", "https://www.prnasia.com/story/92654-1.shtml", "https://www.prnasia.com/story/108627-1.shtml", "https://www.prnasia.com/story/92615-1.shtml", "https://www.prnasia.com/story/92963-1.shtml", "https://www.prnasia.com/story/109361-1.shtml", "https://www.prnasia.com/story/109210-1.shtml", "https://www.prnasia.com/story/109221-1.shtml", "https://www.prnasia.com/story/92833-1.shtml", "https://www.prnasia.com/story/92987-1.shtml", "https://www.prnasia.com/story/93288-1.shtml", "https://www.prnasia.com/story/93337-1.shtml", "https://www.prnasia.com/story/93128-1.shtml", "https://www.prnasia.com/story/93186-1.shtml", "https://www.prnasia.com/story/93078-1.shtml", "https://cnmobile.prnasia.com/story/93422-1.shtml", "https://www.prnasia.com/story/93691-1.shtml", "https://www.prnasia.com/story/93642-1.shtml", "https://www.prnasia.com/story/93658-1.shtml", "https://www.prnasia.com/story/109613-1.shtml", "https://www.prnasia.com/story/110224-1.shtml", "https://www.prnasia.com/story/93594-1.shtml", "https://www.prnasia.com/story/93570-1.shtml", "https://www.prnasia.com/story/93854-1.shtml", "https://www.prnasia.com/story/93856-1.shtml", "https://www.prnasia.com/story/110987-1.shtml", "https://www.prnasia.com/story/110934-1.shtml", "https://www.prnasia.com/story/110597-1.shtml", "https://www.prnasia.com/story/94578-1.shtml", "https://www.prnasia.com/story/94660-1.shtml", "https://www.prnasia.com/story/110618-1.shtml", "https://www.prnasia.com/story/110469-1.shtml", "https://www.prnasia.com/story/111022-1.shtml", "https://www.prnasia.com/story/110627-1.shtml", "https://www.prnasia.com/story/111100-1.shtml", "https://www.prnasia.com/story/111102-1.shtml", "https://www.prnasia.com/story/111132-1.shtml", "https://www.prnasia.com/story/111110-1.shtml", "https://www.prnasia.com/story/94961-1.shtml", "https://www.prnasia.com/story/95222-1.shtml", "https://www.prnasia.com/story/110500-1.shtml", "https://www.prnasia.com/story/95095-1.shtml", "https://www.prnasia.com/story/94848-1.shtml", "https://www.prnasia.com/story/74313-1.shtml", "https://www.prnasia.com/story/94932-1.shtml", "https://cnmobile.prnasia.com/story/95004-1.shtml", "https://www.prnasia.com/story/95989-1.shtml", "https://www.prnasia.com/story/74242-1.shtml", "https://www.prnasia.com/story/96109-1.shtml", "https://www.prnasia.com/story/74337-1.shtml", "https://www.prnasia.com/story/74268-1.shtml", "https://www.prnasia.com/story/96001-1.shtml", "https://www.prnasia.com/story/96099-1.shtml", "https://www.prnasia.com/story/96110-1.shtml", "https://www.prnasia.com/story/74649-1.shtml", "https://www.prnasia.com/story/96208-1.shtml", "https://www.prnasia.com/story/74442-1.shtml", "https://www.prnasia.com/story/96044-1.shtml", "https://cnmobile.prnasia.com/story/74489-1.shtml", "https://www.prnasia.com/story/74682-1.shtml", "https://www.prnasia.com/story/96174-1.shtml", "https://www.prnasia.com/story/97009-1.shtml", "https://www.prnasia.com/story/96217-1.shtml", "https://www.prnasia.com/story/96351-1.shtml", "https://www.prnasia.com/story/96655-1.shtml", "https://www.prnasia.com/story/96798-1.shtml", "https://www.prnasia.com/story/96396-1.shtml", "https://www.prnasia.com/story/96459-1.shtml", "https://www.prnasia.com/story/97048-1.shtml", "https://www.prnasia.com/story/97645-1.shtml", "https://www.prnasia.com/story/97759-1.shtml", "https://www.prnasia.com/story/96967-1.shtml", "https://www.prnasia.com/story/98231-1.shtml", "https://www.prnasia.com/story/97751-1.shtml", "https://www.prnasia.com/story/97866-1.shtml", "https://www.prnasia.com/story/97837-1.shtml", "https://www.prnasia.com/story/98238-1.shtml", "https://www.prnasia.com/story/75452-1.shtml", "https://www.prnasia.com/story/98669-1.shtml", "https://www.prnasia.com/story/75235-1.shtml", "https://www.prnasia.com/story/75225-1.shtml", "https://www.prnasia.com/story/74705-1.shtml", "https://www.prnasia.com/story/98495-1.shtml", "https://www.prnasia.com/story/98634-1.shtml", "https://www.prnasia.com/story/75602-1.shtml", "https://www.prnasia.com/story/98463-1.shtml", "https://cnmobile.prnasia.com/story/75454-1.shtml", "https://www.prnasia.com/story/76847-1.shtml", "https://www.prnasia.com/story/76720-1.shtml", "https://www.prnasia.com/story/98852-1.shtml", "https://www.prnasia.com/story/98960-1.shtml", "https://www.prnasia.com/story/98964-1.shtml", "https://www.prnasia.com/story/76737-1.shtml", "https://www.prnasia.com/story/98882-1.shtml", "https://www.prnasia.com/story/76666-1.shtml", "https://www.prnasia.com/story/98834-1.shtml", "https://www.prnasia.com/story/76813-1.shtml", "https://www.prnasia.com/story/76787-1.shtml", "https://www.prnasia.com/story/99081-1.shtml", "https://www.prnasia.com/story/98948-1.shtml", "https://www.prnasia.com/story/99238-1.shtml", "https://cnmobile.prnasia.com/story/76712-1.shtml", "https://www.prnasia.com/story/71673-1.shtml", "https://www.prnasia.com/story/70933-1.shtml", "https://www.prnasia.com/story/71146-1.shtml", "https://www.prnasia.com/story/77062-1.shtml", "https://www.prnasia.com/story/71502-1.shtml", "https://www.prnasia.com/story/71334-1.shtml", "https://www.prnasia.com/story/76897-1.shtml", "https://www.prnasia.com/story/71129-1.shtml", "https://www.prnasia.com/story/71555-1.shtml", "https://www.prnasia.com/story/71620-1.shtml", "https://www.prnasia.com/story/61910-1.shtml", "https://www.prnasia.com/story/61988-1.shtml", "https://www.prnasia.com/story/61850-1.shtml", "https://www.prnasia.com/story/77308-1.shtml", "https://www.prnasia.com/story/77169-1.shtml", "https://www.prnasia.com/story/77682-1.shtml", "https://www.prnasia.com/story/77486-1.shtml", "https://www.prnasia.com/story/61917-1.shtml", "https://www.prnasia.com/story/62086-1.shtml", "https://www.prnasia.com/story/77381-1.shtml", "https://www.prnasia.com/story/62271-1.shtml", "https://www.prnasia.com/story/78199-1.shtml", "https://www.prnasia.com/story/77982-1.shtml", "https://www.prnasia.com/story/77873-1.shtml", "https://www.prnasia.com/story/78080-1.shtml", "https://cnmobile.prnasia.com/story/77843-1.shtml", "https://www.prnasia.com/story/63483-1.shtml", "https://www.prnasia.com/story/78129-1.shtml", "https://www.prnasia.com/story/63521-1.shtml", "https://www.prnasia.com/story/64242-1.shtml", "https://www.prnasia.com/story/63487-1.shtml", "https://www.prnasia.com/story/63249-1.shtml", "https://www.prnasia.com/story/65021-1.shtml", "https://www.prnasia.com/story/80051-1.shtml", "https://www.prnasia.com/story/65241-1.shtml", "https://www.prnasia.com/story/65028-1.shtml", "https://www.prnasia.com/story/79946-1.shtml", "https://www.prnasia.com/story/64982-1.shtml", "https://www.prnasia.com/story/65016-1.shtml", "https://cnmobile.prnasia.com/story/65003-1.shtml", "https://www.prnasia.com/story/65181-1.shtml", "https://www.prnasia.com/story/65286-1.shtml", "https://www.prnasia.com/story/64743-1.shtml", "https://www.prnasia.com/story/80562-1.shtml", "https://www.prnasia.com/story/80144-1.shtml", "https://www.prnasia.com/story/80510-1.shtml", "https://cnmobile.prnasia.com/story/65297-1.shtml", "https://www.prnasia.com/story/65293-1.shtml", "https://www.prnasia.com/story/65678-1.shtml", "https://www.prnasia.com/story/65492-1.shtml", "https://www.prnasia.com/story/65142-1.shtml", "https://www.prnasia.com/story/66155-1.shtml", "https://www.prnasia.com/story/66593-1.shtml", "https://www.prnasia.com/story/66636-1.shtml", "https://www.prnasia.com/story/66972-1.shtml", "https://www.prnasia.com/story/66784-1.shtml", "https://www.prnasia.com/story/81764-1.shtml", "https://www.prnasia.com/story/67133-1.shtml", "https://www.prnasia.com/story/66933-1.shtml", "https://www.prnasia.com/story/66831-1.shtml", "https://www.prnasia.com/story/81838-1.shtml", "https://www.prnasia.com/story/66822-1.shtml", "https://www.prnasia.com/story/66919-1.shtml", "https://www.prnasia.com/story/66835-1.shtml", "https://www.prnasia.com/story/82176-1.shtml", "https://www.prnasia.com/story/67322-1.shtml", "https://www.prnasia.com/story/82481-1.shtml", "https://www.prnasia.com/story/82639-1.shtml", "https://cnmobile.prnasia.com/story/82099-1.shtml", "https://www.prnasia.com/story/67120-1.shtml", "https://www.prnasia.com/story/82474-1.shtml", "https://www.prnasia.com/story/67865-1.shtml", "https://www.prnasia.com/story/67700-1.shtml", "https://www.prnasia.com/story/67575-1.shtml", "https://www.prnasia.com/story/67989-1.shtml", "https://www.prnasia.com/story/68041-1.shtml", "https://www.prnasia.com/story/67754-1.shtml", "https://www.prnasia.com/story/68019-1.shtml", "https://www.prnasia.com/story/68609-1.shtml", "https://www.prnasia.com/story/67846-1.shtml", "https://www.prnasia.com/story/68610-1.shtml", "https://www.prnasia.com/story/69273-1.shtml", "https://www.prnasia.com/story/68905-1.shtml", "https://www.prnasia.com/story/69185-1.shtml", "https://www.prnasia.com/story/68935-1.shtml", "https://www.prnasia.com/story/69129-1.shtml", "https://www.prnasia.com/story/83995-1.shtml", "https://www.prnasia.com/story/84623-1.shtml", "https://www.prnasia.com/story/68858-1.shtml", "https://www.prnasia.com/story/84868-1.shtml", "https://www.prnasia.com/story/69322-1.shtml", "https://www.prnasia.com/story/84571-1.shtml", "https://www.prnasia.com/story/69710-1.shtml", "https://www.prnasia.com/story/69703-1.shtml", "https://www.prnasia.com/story/69729-1.shtml", "https://www.prnasia.com/story/84758-1.shtml", "https://www.prnasia.com/story/69708-1.shtml", "https://www.prnasia.com/story/85315-1.shtml", "https://www.prnasia.com/story/84999-1.shtml", "https://cnmobile.prnasia.com/story/85150-1.shtml", "https://www.prnasia.com/story/85332-1.shtml", "https://www.prnasia.com/story/85318-1.shtml", "https://www.prnasia.com/story/85483-1.shtml", "https://cnmobile.prnasia.com/story/69734-1.shtml", "https://www.prnasia.com/story/85489-1.shtml", "https://www.prnasia.com/story/85255-1.shtml", "https://www.prnasia.com/story/85551-1.shtml", "https://www.prnasia.com/story/85302-1.shtml", "https://cnmobile.prnasia.com/story/69913-1.shtml", "https://www.prnasia.com/story/85420-1.shtml", "https://www.prnasia.com/story/85809-1.shtml", "https://www.prnasia.com/story/86558-1.shtml", "https://www.prnasia.com/story/86342-1.shtml", "https://www.prnasia.com/story/86333-1.shtml", "https://www.prnasia.com/story/86266-1.shtml", "https://www.prnasia.com/story/70169-1.shtml", "https://www.prnasia.com/story/70214-1.shtml", "https://www.prnasia.com/story/70310-1.shtml", "https://www.prnasia.com/story/86455-1.shtml", "https://www.prnasia.com/story/70198-1.shtml", "https://www.prnasia.com/story/70363-1.shtml", "https://www.prnasia.com/story/86654-1.shtml", "https://www.prnasia.com/story/70821-1.shtml", "https://www.prnasia.com/story/70388-1.shtml", "https://www.prnasia.com/story/86528-1.shtml", "https://www.prnasia.com/story/87197-1.shtml", "https://www.prnasia.com/story/86812-1.shtml", "https://www.prnasia.com/story/71771-1.shtml", "https://www.prnasia.com/story/87204-1.shtml", "https://www.prnasia.com/story/86863-1.shtml", "https://www.prnasia.com/story/71770-1.shtml", "https://www.prnasia.com/story/72056-1.shtml", "https://www.prnasia.com/story/71699-1.shtml", "https://www.prnasia.com/story/87794-1.shtml", "https://www.prnasia.com/story/72161-1.shtml", "https://www.prnasia.com/story/88058-1.shtml", "https://www.prnasia.com/story/72015-1.shtml", "https://www.prnasia.com/story/87819-1.shtml", "https://www.prnasia.com/story/88063-1.shtml", "https://www.prnasia.com/story/87476-1.shtml", "https://www.prnasia.com/story/72624-1.shtml", "https://www.prnasia.com/story/87377-1.shtml", "https://www.prnasia.com/story/72532-1.shtml", "https://www.prnasia.com/story/72474-1.shtml", "https://www.prnasia.com/story/72342-1.shtml", "https://www.prnasia.com/story/72848-1.shtml", "https://www.prnasia.com/story/73309-1.shtml", "https://www.prnasia.com/story/72658-1.shtml", "https://www.prnasia.com/story/73098-1.shtml", "https://www.prnasia.com/story/72973-1.shtml", "https://www.prnasia.com/story/72742-1.shtml", "https://cnmobile.prnasia.com/story/72903-1.shtml", "https://www.prnasia.com/story/73184-1.shtml", "https://www.prnasia.com/story/73196-1.shtml", "https://www.prnasia.com/story/74062-1.shtml", "https://cnmobile.prnasia.com/story/73819-1.shtml", "https://www.prnasia.com/story/73781-1.shtml", "https://www.prnasia.com/story/73773-1.shtml", "https://www.prnasia.com/story/73991-1.shtml", "https://www.prnasia.com/story/73939-1.shtml", "https://www.prnasia.com/story/73929-1.shtml", "https://www.prnasia.com/story/73226-1.shtml", "https://www.prnasia.com/story/74206-1.shtml", "https://www.prnasia.com/story/45635-1.shtml", "https://www.prnasia.com/story/73850-1.shtml", "https://www.prnasia.com/story/46052-1.shtml", "https://www.prnasia.com/story/46078-1.shtml", "https://www.prnasia.com/story/33889-1.shtml", "https://www.prnasia.com/story/33129-1.shtml", "https://www.prnasia.com/story/45820-1.shtml", "https://www.prnasia.com/story/46267-1.shtml", "https://www.prnasia.com/story/33837-1.shtml", "https://cnmobile.prnasia.com/story/46229-1.shtml", "https://www.prnasia.com/story/46425-1.shtml", "https://www.prnasia.com/story/46286-1.shtml", "https://www.prnasia.com/story/33831-1.shtml", "https://www.prnasia.com/story/45550-1.shtml", "https://www.prnasia.com/story/35607-1.shtml", "https://www.prnasia.com/story/35574-1.shtml", "https://cnmobile.prnasia.com/story/33789-1.shtml", "https://www.prnasia.com/story/36364-1.shtml", "https://www.prnasia.com/story/36307-1.shtml", "https://www.prnasia.com/story/46656-1.shtml", "https://www.prnasia.com/story/35477-1.shtml", "https://www.prnasia.com/story/46657-1.shtml", "https://www.prnasia.com/story/36231-1.shtml", "https://www.prnasia.com/story/36348-1.shtml", "https://www.prnasia.com/story/34542-1.shtml", "https://www.prnasia.com/story/50373-1.shtml", "https://www.prnasia.com/story/31728-1.shtml", "https://www.prnasia.com/story/30862-1.shtml", "https://www.prnasia.com/story/31702-1.shtml", "https://www.prnasia.com/story/50869-1.shtml", "https://www.prnasia.com/story/51843-1.shtml", "https://www.prnasia.com/story/31554-1.shtml", "https://www.prnasia.com/story/37152-1.shtml", "https://www.prnasia.com/story/31846-1.shtml", "https://www.prnasia.com/story/51778-1.shtml", "https://www.prnasia.com/story/36884-1.shtml", "https://www.prnasia.com/story/55018-1.shtml", "https://www.prnasia.com/story/59786-1.shtml", "https://www.prnasia.com/story/40951-1.shtml", "https://www.prnasia.com/story/9520-1.shtml", "https://www.prnasia.com/story/60982-1.shtml", "https://www.prnasia.com/story/43057-1.shtml", "https://www.prnasia.com/story/44499-1.shtml", "https://www.prnasia.com/story/60469-1.shtml", "https://www.prnasia.com/story/45221-1.shtml", "https://www.prnasia.com/story/61094-1.shtml", "https://www.prnasia.com/story/59810-1.shtml", "https://cnmobile.prnasia.com/story/15259-1.shtml", "https://www.prnasia.com/story/2513-1.shtml", "https://www.prnasia.com/story/43771-1.shtml", "https://www.prnasia.com/story/2483-1.shtml", "https://www.prnasia.com/story/2639-1.shtml", "https://www.prnasia.com/story/18008-1.shtml", "https://www.prnasia.com/story/14710-1.shtml", "https://www.prnasia.com/story/17023-1.shtml", "https://www.prnasia.com/story/15897-1.shtml", "https://www.prnasia.com/story/5144-1.shtml", "https://www.prnasia.com/story/3731-1.shtml", "https://www.prnasia.com/story/20713-1.shtml", "https://www.prnasia.com/story/24731-1.shtml", "https://www.prnasia.com/story/23951-1.shtml", "https://www.prnasia.com/story/23898-1.shtml", "https://www.prnasia.com/story/3402-1.shtml", "https://www.prnasia.com/story/6182-1.shtml", "https://www.prnasia.com/story/28229-1.shtml", "https://www.prnasia.com/story/11705-1.shtml", "https://www.prnasia.com/story/13498-1.shtml", "https://www.prnasia.com/story/11415-1.shtml", "https://www.prnasia.com/story/11790-1.shtml", "https://www.prnasia.com/story/13061-1.shtml", "https://www.prnasia.com/story/280715-1.shtml", "https://www.prnasia.com/story/248134-1.shtml", "https://www.prnasia.com/story/28311-1.shtml", "https://www.prnasia.com/story/698-1.shtml", "https://www.prnasia.com/story/279089-1.shtml", "https://www.prnasia.com/story/246864-1.shtml", "https://www.prnasia.com/story/280133-1.shtml", "https://www.prnasia.com/story/278625-1.shtml", "https://www.prnasia.com/story/280162-1.shtml", "https://cnmobile.prnasia.com/story/11646-1.shtml", "https://cnmobile.prnasia.com/story/12025-1.shtml", "https://www.prnasia.com/story/12449-1.shtml", "https://www.prnasia.com/story/280431-1.shtml", "https://www.prnasia.com/story/287247-1.shtml", "https://www.prnasia.com/story/250909-1.shtml", "https://www.prnasia.com/story/617-1.shtml", "https://www.prnasia.com/story/249680-1.shtml", "https://www.prnasia.com/story/285875-1.shtml", "https://www.prnasia.com/story/288085-1.shtml", "https://www.prnasia.com/story/290022-1.shtml", "https://www.prnasia.com/story/251361-1.shtml", "https://www.prnasia.com/story/284280-1.shtml", "https://www.prnasia.com/story/253569-1.shtml", "https://www.prnasia.com/story/283795-1.shtml", "https://www.prnasia.com/story/251997-1.shtml", "https://www.prnasia.com/story/287646-1.shtml", "https://www.prnasia.com/story/287105-1.shtml", "https://www.prnasia.com/story/253099-1.shtml", "https://www.prnasia.com/story/288581-1.shtml", "https://www.prnasia.com/story/290574-1.shtml", "https://www.prnasia.com/story/251822-1.shtml", "https://www.prnasia.com/story/250964-1.shtml", "https://cnmobile.prnasia.com/story/289735-1.shtml", "https://www.prnasia.com/story/296269-1.shtml", "https://www.prnasia.com/story/253944-1.shtml", "https://www.prnasia.com/story/285757-1.shtml", "https://www.prnasia.com/story/298423-1.shtml", "https://www.prnasia.com/story/253796-1.shtml", "https://www.prnasia.com/story/259308-1.shtml", "https://www.prnasia.com/story/301243-1.shtml", "https://www.prnasia.com/story/267785-1.shtml", "https://www.prnasia.com/story/301839-1.shtml", "https://www.prnasia.com/story/272915-1.shtml", "https://www.prnasia.com/story/303153-1.shtml", "https://www.prnasia.com/story/260144-1.shtml", "https://www.prnasia.com/story/272311-1.shtml", "https://www.prnasia.com/story/274118-1.shtml", "https://www.prnasia.com/story/260361-1.shtml", "https://www.prnasia.com/story/304304-1.shtml", "https://www.prnasia.com/story/258862-1.shtml", "https://www.prnasia.com/story/225276-1.shtml", "https://www.prnasia.com/story/260121-1.shtml", "https://www.prnasia.com/story/267925-1.shtml", "https://www.prnasia.com/story/306211-1.shtml", "https://cnmobile.prnasia.com/story/297013-1.shtml", "https://www.prnasia.com/story/271585-1.shtml", "https://www.prnasia.com/story/210253-1.shtml", "https://www.prnasia.com/story/306185-1.shtml", "https://www.prnasia.com/story/216998-1.shtml", "https://www.prnasia.com/story/226079-1.shtml", "https://www.prnasia.com/story/216932-1.shtml", "https://www.prnasia.com/story/213095-1.shtml", "https://www.prnasia.com/story/218500-1.shtml", "https://www.prnasia.com/story/216158-1.shtml", "https://www.prnasia.com/story/209828-1.shtml", "https://www.prnasia.com/story/212795-1.shtml", "https://www.prnasia.com/story/216909-1.shtml", "https://www.prnasia.com/story/217131-1.shtml", "https://www.prnasia.com/story/215891-1.shtml", "https://www.prnasia.com/story/210334-1.shtml", "https://www.prnasia.com/story/217176-1.shtml", "https://www.prnasia.com/story/212866-1.shtml", "https://www.prnasia.com/story/211454-1.shtml", "https://www.prnasia.com/story/223445-1.shtml", "https://www.prnasia.com/story/205930-1.shtml", "https://www.prnasia.com/story/237229-1.shtml", "https://www.prnasia.com/story/236874-1.shtml", "https://www.prnasia.com/story/213256-1.shtml", "https://www.prnasia.com/story/238152-1.shtml", "https://www.prnasia.com/story/211849-1.shtml", "https://www.prnasia.com/story/213321-1.shtml", "https://www.prnasia.com/story/237164-1.shtml", "https://www.prnasia.com/story/214768-1.shtml", "https://www.prnasia.com/story/231543-1.shtml", "https://www.prnasia.com/story/240053-1.shtml", "https://www.prnasia.com/story/185299-1.shtml", "https://www.prnasia.com/story/202306-1.shtml", "https://www.prnasia.com/story/201794-1.shtml", "https://www.prnasia.com/story/237031-1.shtml", "https://www.prnasia.com/story/206184-1.shtml", "https://www.prnasia.com/story/225081-1.shtml", "https://www.prnasia.com/story/223999-1.shtml", "https://www.prnasia.com/story/200656-1.shtml", "https://www.prnasia.com/story/184428-1.shtml", "https://www.prnasia.com/story/206092-1.shtml", "https://www.prnasia.com/story/183262-1.shtml", "https://www.prnasia.com/story/205050-1.shtml", "https://www.prnasia.com/story/199987-1.shtml", "https://www.prnasia.com/story/209296-1.shtml", "https://www.prnasia.com/story/187128-1.shtml", "https://www.prnasia.com/story/183434-1.shtml", "https://www.prnasia.com/story/208424-1.shtml", "https://www.prnasia.com/story/209033-1.shtml", "https://www.prnasia.com/story/188482-1.shtml", "https://www.prnasia.com/story/193530-1.shtml", "https://www.prnasia.com/story/209179-1.shtml", "https://www.prnasia.com/story/191634-1.shtml", "https://www.prnasia.com/story/191626-1.shtml", "https://www.prnasia.com/story/208892-1.shtml", "https://www.prnasia.com/story/192020-1.shtml", "https://www.prnasia.com/story/196395-1.shtml", "https://www.prnasia.com/story/156601-1.shtml", "https://www.prnasia.com/story/155986-1.shtml", "https://www.prnasia.com/story/167403-1.shtml", "https://www.prnasia.com/story/151766-1.shtml", "https://cnmobile.prnasia.com/story/156038-1.shtml", "https://www.prnasia.com/story/168446-1.shtml", "https://www.prnasia.com/story/174487-1.shtml", "https://www.prnasia.com/story/169966-1.shtml", "https://www.prnasia.com/story/164791-1.shtml", "https://www.prnasia.com/story/150284-1.shtml", "https://www.prnasia.com/story/173137-1.shtml", "https://www.prnasia.com/story/160704-1.shtml", "https://www.prnasia.com/story/173317-1.shtml", "https://www.prnasia.com/story/173661-1.shtml", "https://www.prnasia.com/story/164140-1.shtml", "https://www.prnasia.com/story/154072-1.shtml", "https://www.prnasia.com/story/178892-1.shtml", "https://www.prnasia.com/story/181150-1.shtml", "https://www.prnasia.com/story/181567-1.shtml", "https://www.prnasia.com/story/161296-1.shtml", "https://www.prnasia.com/story/161651-1.shtml", "https://www.prnasia.com/story/179944-1.shtml", "https://www.prnasia.com/story/179986-1.shtml", "https://www.prnasia.com/story/226106-1.shtml", "https://www.prnasia.com/story/307473-1.shtml", "https://www.prnasia.com/story/226548-1.shtml", "https://www.prnasia.com/story/210599-1.shtml", "https://www.prnasia.com/story/307489-1.shtml", "https://www.prnasia.com/story/297589-1.shtml", "https://www.prnewswire.com/news-releases/dw-healthcare-partners-invests-in-parnell-301219519.html", "https://www.prnasia.com/story/307512-1.shtml", "https://www.prnasia.com/story/217559-1.shtml", "https://www.prnewswire.com/news-releases/alexandria-real-estate-equities-inc-reports-4q20-net-income-per-share--diluted-of-3-26-4q20-ffo-per-share--diluted-as-adjusted-of-1-84-and-operational-excellence-and-strong-flexible-balance-sheet-with-significant-liqui-301219295.html", "https://www.prnasia.com/story/223682-1.shtml", "https://www.prnasia.com/story/304314-1.shtml", "https://cnmobile.prnasia.com/story/219296-1.shtml", "https://www.prnasia.com/story/224858-1.shtml", "https://cnmobile.prnasia.com/story/307508-1.shtml", "https://cnmobile.prnasia.com/story/217779-1.shtml", "https://www.prnewswire.com/news-releases/volpara-acquires-breast-cancer-risk-assessment-company-cra-health-llc-301219514.html", "https://cnmobile.prnasia.com/story/307447-1.shtml", "https://www.prnasia.com/story/307513-1.shtml", "https://www.prnewswire.com/news-releases/inmagene-launched-us-subsidiary-dr-jean-louis-saillot-joined-the-company-301219712.html", "https://www.prnasia.com/story/307475-1.shtml", "https://www.prnasia.com/story/208538-1.shtml", "https://www.prnasia.com/story/283199-1.shtml", "https://www.prnewswire.com/news-releases/kintors-gt20029-ind-for-protac-ar-degrader-was-accepted-by-nmpa-301219621.html", "https://www.prnasia.com/story/212750-1.shtml", "https://www.prnasia.com/story/266805-1.shtml", "https://www.prnasia.com/story/284321-1.shtml", "https://www.prnasia.com/story/266816-1.shtml", "https://www.prnasia.com/story/266851-1.shtml", "https://www.prnasia.com/story/284269-1.shtml", "https://www.prnasia.com/story/266781-1.shtml", "https://www.prnasia.com/story/283206-1.shtml", "https://www.prnasia.com/story/284352-1.shtml", "https://www.prnasia.com/story/283208-1.shtml", "https://www.prnasia.com/story/284353-1.shtml", "https://www.prnasia.com/story/283205-1.shtml", "https://www.prnasia.com/story/262961-1.shtml", "https://www.prnasia.com/story/262900-1.shtml", "https://www.prnasia.com/story/262944-1.shtml", "https://www.prnasia.com/story/262981-1.shtml", "https://www.prnasia.com/story/263891-1.shtml", "https://www.prnasia.com/story/263907-1.shtml", "https://www.prnasia.com/story/262926-1.shtml", "https://www.prnasia.com/story/266926-1.shtml", "https://www.prnasia.com/story/263865-1.shtml", "https://www.prnasia.com/story/263023-1.shtml", "https://www.prnasia.com/story/262994-1.shtml", "https://www.prnasia.com/story/266912-1.shtml", "https://www.prnasia.com/story/262280-1.shtml", "https://www.prnasia.com/story/265697-1.shtml", "https://www.prnasia.com/story/263962-1.shtml", "https://www.prnasia.com/story/263977-1.shtml", "https://www.prnasia.com/story/263001-1.shtml", "https://www.prnasia.com/story/245291-1.shtml", "https://www.prnasia.com/story/265739-1.shtml", "https://www.prnasia.com/story/263997-1.shtml", "https://www.prnasia.com/story/238569-1.shtml", "https://www.prnasia.com/story/245312-1.shtml", "https://www.prnasia.com/story/264011-1.shtml", "https://www.prnasia.com/story/265717-1.shtml", "https://www.prnasia.com/story/263985-1.shtml", "https://www.prnasia.com/story/245325-1.shtml", "https://www.prnasia.com/story/264034-1.shtml", "https://www.prnasia.com/story/246080-1.shtml", "https://www.prnasia.com/story/238479-1.shtml", "https://www.prnasia.com/story/238588-1.shtml", "https://www.prnasia.com/story/238590-1.shtml", "https://www.prnasia.com/story/238490-1.shtml", "https://cnmobile.prnasia.com/story/238515-1.shtml", "https://www.prnasia.com/story/238603-1.shtml", "https://www.prnasia.com/story/238554-1.shtml", "https://www.prnasia.com/story/231353-1.shtml", "https://www.prnasia.com/story/231416-1.shtml", "https://www.prnasia.com/story/238681-1.shtml", "https://www.prnasia.com/story/238610-1.shtml", "https://www.prnasia.com/story/240296-1.shtml", "https://www.prnasia.com/story/231486-1.shtml", "https://www.prnasia.com/story/238629-1.shtml", "https://www.prnasia.com/story/231456-1.shtml", "https://www.prnasia.com/story/231460-1.shtml", "https://www.prnasia.com/story/231413-1.shtml", "https://www.prnasia.com/story/223245-1.shtml", "https://www.prnasia.com/story/231465-1.shtml", "https://cnmobile.prnasia.com/story/238637-1.shtml", "https://www.prnasia.com/story/238613-1.shtml", "https://cnmobile.prnasia.com/story/238661-1.shtml", "https://www.prnasia.com/story/223269-1.shtml", "https://www.prnasia.com/story/231528-1.shtml", "https://www.prnasia.com/story/225107-1.shtml", "https://www.prnasia.com/story/225288-1.shtml", "https://www.prnasia.com/story/225179-1.shtml", "https://www.prnasia.com/story/225343-1.shtml", "https://www.prnasia.com/story/225284-1.shtml", "https://www.prnasia.com/story/205360-1.shtml", "https://www.prnasia.com/story/205128-1.shtml", "https://www.prnasia.com/story/231527-1.shtml", "https://www.prnasia.com/story/225067-1.shtml", "https://www.prnasia.com/story/225136-1.shtml", "https://www.prnasia.com/story/225065-1.shtml", "https://www.prnasia.com/story/205213-1.shtml", "https://cnmobile.prnasia.com/story/205366-1.shtml", "https://www.prnasia.com/story/225117-1.shtml", "https://www.prnasia.com/story/208154-1.shtml", "https://www.prnasia.com/story/198584-1.shtml", "https://www.prnasia.com/story/208417-1.shtml", "https://www.prnasia.com/story/208225-1.shtml", "https://www.prnasia.com/story/208418-1.shtml", "https://www.prnasia.com/story/208128-1.shtml", "https://www.prnasia.com/story/198812-1.shtml", "https://www.prnasia.com/story/208233-1.shtml", "https://cnmobile.prnasia.com/story/208109-1.shtml", "https://www.prnasia.com/story/198756-1.shtml", "https://www.prnasia.com/story/205568-1.shtml", "https://www.prnasia.com/story/208091-1.shtml", "https://www.prnasia.com/story/198611-1.shtml", "https://www.prnasia.com/story/202087-1.shtml", "https://www.prnasia.com/story/198673-1.shtml", "https://www.prnasia.com/story/198630-1.shtml", "https://www.prnasia.com/story/196242-1.shtml", "https://www.prnasia.com/story/174662-1.shtml", "https://www.prnasia.com/story/202152-1.shtml", "https://www.prnasia.com/story/202155-1.shtml", "https://www.prnasia.com/story/198663-1.shtml", "https://www.prnasia.com/story/196250-1.shtml", "https://www.prnasia.com/story/202046-1.shtml", "https://www.prnasia.com/story/198674-1.shtml", "https://www.prnasia.com/story/95333-1.shtml", "https://www.prnasia.com/story/95291-1.shtml", "https://www.prnasia.com/story/171800-1.shtml", "https://www.prnasia.com/story/141249-1.shtml", "https://www.prnasia.com/story/202225-1.shtml", "https://www.prnasia.com/story/95496-1.shtml", "https://www.prnasia.com/story/95892-1.shtml", "https://www.prnasia.com/story/95706-1.shtml", "https://cnmobile.prnasia.com/story/171888-1.shtml", "https://www.prnasia.com/story/95845-1.shtml", "https://www.prnasia.com/story/62437-1.shtml", "https://www.prnasia.com/story/76113-1.shtml", "https://www.prnasia.com/story/56239-1.shtml", "https://www.prnasia.com/story/75884-1.shtml", "https://www.prnasia.com/story/75989-1.shtml", "https://www.prnasia.com/story/76207-1.shtml", "https://www.prnasia.com/story/55939-1.shtml", "https://www.prnasia.com/story/76043-1.shtml", "https://www.prnasia.com/story/56030-1.shtml", "https://www.prnasia.com/story/75967-1.shtml", "https://www.prnasia.com/story/75789-1.shtml", "https://www.prnasia.com/story/75643-1.shtml", "https://www.prnasia.com/story/56187-1.shtml", "https://www.prnasia.com/story/203272-1.shtml", "https://www.prnasia.com/story/203442-1.shtml", "https://www.prnasia.com/story/203181-1.shtml", "https://www.prnasia.com/story/203592-1.shtml", "https://www.prnasia.com/story/56456-1.shtml", "https://www.prnasia.com/story/147098-1.shtml", "https://www.prnasia.com/story/203261-1.shtml", "https://www.prnasia.com/story/203545-1.shtml", "https://www.prnasia.com/story/147253-1.shtml", "https://www.prnasia.com/story/203014-1.shtml", "https://www.prnasia.com/story/203074-1.shtml", "https://www.prnasia.com/story/203012-1.shtml", "https://www.prnasia.com/story/203273-1.shtml", "https://www.prnasia.com/story/147398-1.shtml", "https://www.prnasia.com/story/158756-1.shtml", "https://www.prnasia.com/story/176195-1.shtml", "https://www.prnasia.com/story/176036-1.shtml", "https://www.prnasia.com/story/147693-1.shtml", "https://www.prnasia.com/story/176478-1.shtml", "https://www.prnasia.com/story/176813-1.shtml", "https://www.prnasia.com/story/176187-1.shtml", "https://www.prnasia.com/story/158864-1.shtml", "https://www.prnasia.com/story/159322-1.shtml", "https://www.prnasia.com/story/176158-1.shtml", "https://www.prnasia.com/story/304379-1.shtml", "https://www.prnasia.com/story/158852-1.shtml", "https://www.prnasia.com/story/158916-1.shtml", "https://www.prnasia.com/story/304340-1.shtml", "https://www.prnasia.com/story/304789-1.shtml", "https://www.prnasia.com/story/307256-1.shtml", "https://www.prnasia.com/story/307329-1.shtml", "https://www.prnasia.com/story/304811-1.shtml", "https://www.prnasia.com/story/304345-1.shtml", "https://www.prnasia.com/story/304346-1.shtml", "https://www.prnasia.com/story/307351-1.shtml", "https://www.prnasia.com/story/301790-1.shtml", "https://www.prnasia.com/story/284149-1.shtml", "https://www.prnasia.com/story/293099-1.shtml", "https://www.prnasia.com/story/284055-1.shtml", "https://www.prnasia.com/story/297616-1.shtml", "https://www.prnasia.com/story/284159-1.shtml", "https://www.prnasia.com/story/280319-1.shtml", "https://www.prnasia.com/story/293047-1.shtml", "https://www.prnasia.com/story/272625-1.shtml", "https://www.prnasia.com/story/283316-1.shtml", "https://www.prnasia.com/story/272632-1.shtml", "https://www.prnasia.com/story/284228-1.shtml", "https://www.prnasia.com/story/280331-1.shtml", "https://www.prnasia.com/story/266014-1.shtml", "https://www.prnasia.com/story/264306-1.shtml", "https://www.prnasia.com/story/264818-1.shtml", "https://www.prnasia.com/story/264196-1.shtml", "https://www.prnasia.com/story/252748-1.shtml", "https://www.prnasia.com/story/265778-1.shtml", "https://www.prnasia.com/story/264152-1.shtml", "https://www.prnasia.com/story/248279-1.shtml", "https://www.prnasia.com/story/266048-1.shtml", "https://www.prnasia.com/story/264710-1.shtml", "https://www.prnasia.com/story/264296-1.shtml", "https://www.prnasia.com/story/249861-1.shtml", "https://www.prnasia.com/story/265754-1.shtml", "https://www.prnasia.com/story/249929-1.shtml", "https://cnmobile.prnasia.com/story/250051-1.shtml", "https://www.prnasia.com/story/238878-1.shtml", "https://www.prnasia.com/story/244096-1.shtml", "https://www.prnasia.com/story/244125-1.shtml", "https://www.prnasia.com/story/233509-1.shtml", "https://www.prnasia.com/story/246220-1.shtml", "https://www.prnasia.com/story/242556-1.shtml", "https://www.prnasia.com/story/248384-1.shtml", "https://www.prnasia.com/story/246896-1.shtml", "https://www.prnasia.com/story/244201-1.shtml", "https://www.prnasia.com/story/241440-1.shtml", "https://www.prnasia.com/story/241376-1.shtml", "https://www.prnasia.com/story/247708-1.shtml", "https://www.prnasia.com/story/233521-1.shtml", "https://www.prnasia.com/story/232844-1.shtml", "https://www.prnasia.com/story/244825-1.shtml", "https://www.prnasia.com/story/222905-1.shtml", "https://www.prnasia.com/story/216728-1.shtml", "https://www.prnasia.com/story/218085-1.shtml", "https://www.prnasia.com/story/242855-1.shtml", "https://www.prnasia.com/story/217989-1.shtml", "https://www.prnasia.com/story/219496-1.shtml", "https://www.prnasia.com/story/225055-1.shtml", "https://www.prnasia.com/story/219833-1.shtml", "https://www.prnasia.com/story/242424-1.shtml", "https://www.prnasia.com/story/216736-1.shtml", "https://www.prnasia.com/story/220048-1.shtml", "https://www.prnasia.com/story/219695-1.shtml", "https://www.prnasia.com/story/215113-1.shtml", "https://www.prnasia.com/story/207429-1.shtml", "https://www.prnasia.com/story/204852-1.shtml", "https://www.prnasia.com/story/209306-1.shtml", "https://www.prnasia.com/story/218237-1.shtml", "https://www.prnasia.com/story/207463-1.shtml", "https://www.prnasia.com/story/219586-1.shtml", "https://www.prnasia.com/story/218281-1.shtml", "https://www.prnasia.com/story/209336-1.shtml", "https://www.prnasia.com/story/181343-1.shtml", "https://www.prnasia.com/story/191184-1.shtml", "https://www.prnasia.com/story/181190-1.shtml", "https://www.prnasia.com/story/181172-1.shtml", "https://www.prnasia.com/story/181328-1.shtml", "https://www.prnasia.com/story/194714-1.shtml", "https://www.prnasia.com/story/141688-1.shtml", "https://www.prnasia.com/story/174897-1.shtml", "https://www.prnasia.com/story/196441-1.shtml", "https://www.prnasia.com/story/175333-1.shtml", "https://www.prnasia.com/story/142032-1.shtml", "https://www.prnasia.com/story/146154-1.shtml", "https://www.prnasia.com/story/120195-1.shtml", "https://www.prnasia.com/story/174935-1.shtml", "https://www.prnasia.com/story/194758-1.shtml", "https://www.prnasia.com/story/145607-1.shtml", "https://www.prnasia.com/story/103931-1.shtml", "https://www.prnasia.com/story/89147-1.shtml", "https://www.prnasia.com/story/104295-1.shtml", "https://www.prnasia.com/story/78296-1.shtml", "https://www.prnasia.com/story/80689-1.shtml", "https://www.prnasia.com/story/79644-1.shtml", "https://www.prnasia.com/story/120872-1.shtml", "https://www.prnasia.com/story/92177-1.shtml", "https://www.prnasia.com/story/132389-1.shtml", "https://www.prnasia.com/story/132416-1.shtml", "https://www.prnasia.com/story/62564-1.shtml", "https://www.prnasia.com/story/24433-1.shtml", "https://www.prnasia.com/story/26432-1.shtml", "https://www.prnasia.com/story/29934-1.shtml", "https://www.prnasia.com/story/24406-1.shtml", "https://www.prnasia.com/story/34875-1.shtml", "https://www.prnasia.com/story/35109-1.shtml", "https://www.prnasia.com/story/55883-1.shtml", "https://www.prnasia.com/story/26356-1.shtml", "https://www.prnasia.com/story/1188-1.shtml", "https://www.prnasia.com/story/10599-1.shtml", "https://www.prnasia.com/story/14290-1.shtml", "https://www.prnasia.com/story/11472-1.shtml", "https://www.prnasia.com/story/26679-1.shtml", "https://www.prnasia.com/story/269894-1.shtml", "https://www.prnasia.com/story/29105-1.shtml", "https://www.prnasia.com/story/274806-1.shtml", "https://www.prnasia.com/story/269851-1.shtml", "https://www.prnasia.com/story/26625-1.shtml", "https://www.prnasia.com/story/14579-1.shtml", "https://www.prnasia.com/story/29532-1.shtml", "https://www.prnasia.com/story/14669-1.shtml", "https://www.prnasia.com/story/14351-1.shtml", "https://www.prnasia.com/story/262538-1.shtml", "https://www.prnasia.com/story/220837-1.shtml", "https://www.prnasia.com/story/260841-1.shtml", "https://www.prnasia.com/story/212532-1.shtml", "https://www.prnasia.com/story/233245-1.shtml", "https://www.prnasia.com/story/228324-1.shtml", "https://www.prnasia.com/story/235492-1.shtml", "https://www.prnasia.com/story/228642-1.shtml", "https://www.prnasia.com/story/275494-1.shtml", "https://cnmobile.prnasia.com/story/221103-1.shtml", "https://www.prnasia.com/story/229568-1.shtml", "https://www.prnasia.com/story/213625-1.shtml", "https://www.prnasia.com/story/214301-1.shtml", "https://www.prnasia.com/story/197393-1.shtml", "https://www.prnasia.com/story/199062-1.shtml", "https://www.prnasia.com/story/211974-1.shtml", "https://www.prnasia.com/story/245119-1.shtml", "https://www.prnasia.com/story/188975-1.shtml", "https://www.prnasia.com/story/186869-1.shtml", "https://www.prnasia.com/story/306271-1.shtml", "https://www.prnasia.com/story/188916-1.shtml", "https://www.prnasia.com/story/183744-1.shtml", "https://www.prnasia.com/story/186642-1.shtml", "https://www.prnasia.com/story/186273-1.shtml", "https://www.prnasia.com/story/303608-1.shtml", "https://cnmobile.prnasia.com/story/165317-1.shtml", "https://www.prnasia.com/story/182266-1.shtml", "https://www.prnasia.com/story/206950-1.shtml", "https://www.prnasia.com/story/306285-1.shtml", "https://www.prnasia.com/story/304214-1.shtml", "https://www.prnasia.com/story/304229-1.shtml", "https://www.prnasia.com/story/305402-1.shtml", "https://www.prnasia.com/story/304736-1.shtml", "https://www.prnasia.com/story/306996-1.shtml", "https://www.prnasia.com/story/307095-1.shtml", "https://www.prnasia.com/story/306785-1.shtml", "https://www.prnasia.com/story/305541-1.shtml", "https://www.prnasia.com/story/307209-1.shtml", "https://www.prnasia.com/story/304149-1.shtml", "https://www.prnasia.com/story/305872-1.shtml", "https://www.prnasia.com/story/306767-1.shtml", "https://www.prnasia.com/story/304505-1.shtml", "https://www.prnasia.com/story/307150-1.shtml", "https://www.prnasia.com/story/297335-1.shtml", "https://www.prnasia.com/story/297763-1.shtml", "https://www.prnasia.com/story/305895-1.shtml", "https://www.prnasia.com/story/297267-1.shtml", "https://www.prnasia.com/story/300348-1.shtml", "https://www.prnasia.com/story/301333-1.shtml", "https://www.prnasia.com/story/306001-1.shtml", "https://www.prnasia.com/story/296909-1.shtml", "https://www.prnasia.com/story/296916-1.shtml", "https://www.prnasia.com/story/297708-1.shtml", "https://www.prnasia.com/story/306721-1.shtml", "https://www.prnasia.com/story/306014-1.shtml", "https://www.prnasia.com/story/301396-1.shtml", "https://www.prnasia.com/story/306534-1.shtml", "https://www.prnasia.com/story/302523-1.shtml", "https://www.prnasia.com/story/299914-1.shtml", "https://www.prnasia.com/story/301549-1.shtml", "https://www.prnasia.com/story/297464-1.shtml", "https://www.prnasia.com/story/297210-1.shtml", "https://www.prnasia.com/story/297476-1.shtml", "https://www.prnasia.com/story/297125-1.shtml", "https://www.prnasia.com/story/299767-1.shtml", "https://cnmobile.prnasia.com/story/299912-1.shtml", "https://www.prnasia.com/story/297792-1.shtml", "https://www.prnasia.com/story/302167-1.shtml", "https://www.prnasia.com/story/301658-1.shtml", "https://www.prnasia.com/story/302182-1.shtml", "https://www.prnasia.com/story/303217-1.shtml", "https://www.prnasia.com/story/297541-1.shtml", "https://www.prnasia.com/story/302730-1.shtml", "https://www.prnasia.com/story/303152-1.shtml", "https://www.prnasia.com/story/302097-1.shtml", "https://www.prnasia.com/story/302704-1.shtml", "https://www.prnasia.com/story/303080-1.shtml", "https://www.prnasia.com/story/297879-1.shtml", "https://www.prnasia.com/story/293818-1.shtml", "https://www.prnasia.com/story/298243-1.shtml", "https://www.prnasia.com/story/297821-1.shtml", "https://www.prnasia.com/story/297928-1.shtml", "https://www.prnasia.com/story/293647-1.shtml", "https://www.prnasia.com/story/298327-1.shtml", "https://www.prnasia.com/story/298545-1.shtml", "https://www.prnasia.com/story/298755-1.shtml", "https://www.prnasia.com/story/298679-1.shtml", "https://www.prnasia.com/story/298722-1.shtml", "https://www.prnasia.com/story/294577-1.shtml", "https://www.prnasia.com/story/291604-1.shtml", "https://www.prnasia.com/story/298522-1.shtml", "https://cnmobile.prnasia.com/story/296060-1.shtml", "https://www.prnasia.com/story/293546-1.shtml", "https://www.prnasia.com/story/294332-1.shtml", "https://www.prnasia.com/story/294377-1.shtml", "https://www.prnasia.com/story/298505-1.shtml", "https://www.prnasia.com/story/294987-1.shtml", "https://www.prnasia.com/story/295880-1.shtml", "https://www.prnasia.com/story/295594-1.shtml", "https://www.prnasia.com/story/295036-1.shtml", "https://www.prnasia.com/story/295980-1.shtml", "https://www.prnasia.com/story/295178-1.shtml", "https://www.prnasia.com/story/294979-1.shtml", "https://www.prnasia.com/story/294285-1.shtml", "https://www.prnasia.com/story/290495-1.shtml", "https://www.prnasia.com/story/296640-1.shtml", "https://www.prnasia.com/story/291645-1.shtml", "https://www.prnasia.com/story/291087-1.shtml", "https://www.prnasia.com/story/292000-1.shtml", "https://www.prnasia.com/story/296766-1.shtml", "https://www.prnasia.com/story/286203-1.shtml", "https://www.prnasia.com/story/290867-1.shtml", "https://www.prnasia.com/story/285983-1.shtml", "https://www.prnasia.com/story/285972-1.shtml", "https://www.prnasia.com/story/291994-1.shtml", "https://www.prnasia.com/story/286122-1.shtml", "https://www.prnasia.com/story/296190-1.shtml", "https://www.prnasia.com/story/292246-1.shtml", "https://www.prnasia.com/story/292400-1.shtml", "https://www.prnasia.com/story/291146-1.shtml", "https://www.prnasia.com/story/291772-1.shtml", "https://www.prnasia.com/story/296430-1.shtml", "https://www.prnasia.com/story/286044-1.shtml", "https://www.prnasia.com/story/292233-1.shtml", "https://www.prnasia.com/story/291049-1.shtml", "https://www.prnasia.com/story/291946-1.shtml", "https://www.prnasia.com/story/286174-1.shtml", "https://www.prnasia.com/story/286707-1.shtml", "https://www.prnasia.com/story/286815-1.shtml", "https://www.prnasia.com/story/287242-1.shtml", "https://www.prnasia.com/story/282883-1.shtml", "https://www.prnasia.com/story/285090-1.shtml", "https://www.prnasia.com/story/287859-1.shtml", "https://www.prnasia.com/story/287490-1.shtml", "https://www.prnasia.com/story/282795-1.shtml", "https://www.prnasia.com/story/287338-1.shtml", "https://www.prnasia.com/story/283007-1.shtml", "https://www.prnasia.com/story/283099-1.shtml", "https://www.prnasia.com/story/283355-1.shtml", "https://www.prnasia.com/story/292547-1.shtml", "https://www.prnasia.com/story/283127-1.shtml", "https://www.prnasia.com/story/283149-1.shtml", "https://www.prnasia.com/story/283061-1.shtml", "https://www.prnasia.com/story/289341-1.shtml", "https://www.prnasia.com/story/280040-1.shtml", "https://www.prnasia.com/story/288309-1.shtml", "https://www.prnasia.com/story/284542-1.shtml", "https://www.prnasia.com/story/288450-1.shtml", "https://www.prnasia.com/story/287872-1.shtml", "https://www.prnasia.com/story/288989-1.shtml", "https://cnmobile.prnasia.com/story/288439-1.shtml", "https://www.prnasia.com/story/285010-1.shtml", "https://www.prnasia.com/story/283616-1.shtml", "https://www.prnasia.com/story/280096-1.shtml", "https://www.prnasia.com/story/288542-1.shtml", "https://www.prnasia.com/story/279767-1.shtml", "https://www.prnasia.com/story/284801-1.shtml", "https://www.prnasia.com/story/284905-1.shtml", "https://www.prnasia.com/story/281942-1.shtml", "https://www.prnasia.com/story/284949-1.shtml", "https://www.prnasia.com/story/285045-1.shtml", "https://www.prnasia.com/story/279614-1.shtml", "https://www.prnasia.com/story/285213-1.shtml", "https://www.prnasia.com/story/285496-1.shtml", "https://www.prnasia.com/story/285956-1.shtml", "https://cnmobile.prnasia.com/story/279654-1.shtml", "https://www.prnasia.com/story/280140-1.shtml", "https://www.prnasia.com/story/277325-1.shtml", "https://www.prnasia.com/story/285333-1.shtml", "https://www.prnasia.com/story/277426-1.shtml", "https://www.prnasia.com/story/277429-1.shtml", "https://www.prnasia.com/story/276625-1.shtml", "https://www.prnasia.com/story/281360-1.shtml", "https://www.prnasia.com/story/276926-1.shtml", "https://www.prnasia.com/story/276448-1.shtml", "https://www.prnasia.com/story/280910-1.shtml", "https://www.prnasia.com/story/279895-1.shtml", "https://www.prnasia.com/story/276630-1.shtml", "https://www.prnasia.com/story/277806-1.shtml", "https://www.prnasia.com/story/277237-1.shtml", "https://www.prnasia.com/story/280709-1.shtml", "https://www.prnasia.com/story/277265-1.shtml", "https://www.prnasia.com/story/277522-1.shtml", "https://www.prnasia.com/story/277254-1.shtml", "https://www.prnasia.com/story/277242-1.shtml", "https://www.prnasia.com/story/281137-1.shtml", "https://www.prnasia.com/story/278824-1.shtml", "https://www.prnasia.com/story/278626-1.shtml", "https://www.prnasia.com/story/278375-1.shtml", "https://www.prnasia.com/story/279355-1.shtml", "https://www.prnasia.com/story/277666-1.shtml", "https://www.prnasia.com/story/277241-1.shtml", "https://www.prnasia.com/story/273822-1.shtml", "https://www.prnasia.com/story/273512-1.shtml", "https://www.prnasia.com/story/273824-1.shtml", "https://www.prnasia.com/story/282439-1.shtml", "https://www.prnasia.com/story/279229-1.shtml", "https://www.prnasia.com/story/278915-1.shtml", "https://www.prnasia.com/story/274380-1.shtml", "https://www.prnasia.com/story/272388-1.shtml", "https://www.prnasia.com/story/275134-1.shtml", "https://www.prnasia.com/story/272394-1.shtml", "https://www.prnasia.com/story/271275-1.shtml", "https://www.prnasia.com/story/279414-1.shtml", "https://www.prnasia.com/story/275781-1.shtml", "https://www.prnasia.com/story/276054-1.shtml", "https://www.prnasia.com/story/275996-1.shtml", "https://www.prnasia.com/story/272594-1.shtml", "https://www.prnasia.com/story/276170-1.shtml", "https://cnmobile.prnasia.com/story/276052-1.shtml", "https://www.prnasia.com/story/272721-1.shtml", "https://www.prnasia.com/story/272518-1.shtml", "https://www.prnasia.com/story/272492-1.shtml", "https://www.prnasia.com/story/273176-1.shtml", "https://www.prnasia.com/story/273414-1.shtml", "https://www.prnasia.com/story/267732-1.shtml", "https://cnmobile.prnasia.com/story/275811-1.shtml", "https://www.prnasia.com/story/267340-1.shtml", "https://www.prnasia.com/story/267878-1.shtml", "https://www.prnasia.com/story/273425-1.shtml", "https://www.prnasia.com/story/266416-1.shtml", "https://www.prnasia.com/story/267293-1.shtml", "https://www.prnasia.com/story/267870-1.shtml", "https://www.prnasia.com/story/267749-1.shtml", "https://www.prnasia.com/story/264899-1.shtml", "https://www.prnasia.com/story/268164-1.shtml", "https://www.prnasia.com/story/267411-1.shtml", "https://www.prnasia.com/story/267885-1.shtml", "https://www.prnasia.com/story/268362-1.shtml", "https://www.prnasia.com/story/264915-1.shtml", "https://www.prnasia.com/story/262176-1.shtml", "https://cnmobile.prnasia.com/story/273057-1.shtml", "https://www.prnasia.com/story/262184-1.shtml", "https://www.prnasia.com/story/273351-1.shtml", "https://www.prnasia.com/story/265040-1.shtml", "https://www.prnasia.com/story/268838-1.shtml", "https://www.prnasia.com/story/268578-1.shtml", "https://www.prnasia.com/story/263275-1.shtml", "https://www.prnasia.com/story/269097-1.shtml", "https://www.prnasia.com/story/257797-1.shtml", "https://www.prnasia.com/story/263701-1.shtml", "https://www.prnasia.com/story/268716-1.shtml", "https://www.prnasia.com/story/262653-1.shtml", "https://www.prnasia.com/story/262768-1.shtml", "https://www.prnasia.com/story/262160-1.shtml", "https://www.prnasia.com/story/262734-1.shtml", "https://cnmobile.prnasia.com/story/269064-1.shtml", "https://www.prnasia.com/story/262761-1.shtml", "https://cnmobile.prnasia.com/story/268896-1.shtml", "https://www.prnasia.com/story/265082-1.shtml", "https://www.prnasia.com/story/263727-1.shtml", "https://www.prnasia.com/story/258474-1.shtml", "https://www.prnasia.com/story/263710-1.shtml", "https://www.prnasia.com/story/269222-1.shtml", "https://www.prnasia.com/story/260109-1.shtml", "https://www.prnasia.com/story/259852-1.shtml", "https://www.prnasia.com/story/264337-1.shtml", "https://www.prnasia.com/story/259599-1.shtml", "https://www.prnasia.com/story/257449-1.shtml", "https://www.prnasia.com/story/259494-1.shtml", "https://www.prnasia.com/story/257538-1.shtml", "https://www.prnasia.com/story/258210-1.shtml", "https://cnmobile.prnasia.com/story/258580-1.shtml", "https://www.prnasia.com/story/265636-1.shtml", "https://cnmobile.prnasia.com/story/258809-1.shtml", "https://www.prnasia.com/story/259405-1.shtml", "https://cnmobile.prnasia.com/story/258417-1.shtml", "https://www.prnasia.com/story/259596-1.shtml", "https://www.prnasia.com/story/265358-1.shtml", "https://www.prnasia.com/story/261298-1.shtml", "https://www.prnasia.com/story/261296-1.shtml", "https://www.prnasia.com/story/260583-1.shtml", "https://www.prnasia.com/story/261341-1.shtml", "https://www.prnasia.com/story/252937-1.shtml", "https://www.prnasia.com/story/254495-1.shtml", "https://www.prnasia.com/story/261243-1.shtml", "https://www.prnasia.com/story/253606-1.shtml", "https://www.prnasia.com/story/254285-1.shtml", "https://www.prnasia.com/story/254244-1.shtml", "https://cnmobile.prnasia.com/story/261317-1.shtml", "https://www.prnasia.com/story/253772-1.shtml", "https://www.prnasia.com/story/254198-1.shtml", "https://www.prnasia.com/story/254074-1.shtml", "https://www.prnasia.com/story/262048-1.shtml", "https://www.prnasia.com/story/252486-1.shtml", "https://www.prnasia.com/story/256251-1.shtml", "https://www.prnasia.com/story/255076-1.shtml", "https://www.prnasia.com/story/249263-1.shtml", "https://www.prnasia.com/story/247911-1.shtml", "https://www.prnasia.com/story/255025-1.shtml", "https://www.prnasia.com/story/249047-1.shtml", "https://www.prnasia.com/story/255817-1.shtml", "https://www.prnasia.com/story/255291-1.shtml", "https://www.prnasia.com/story/255316-1.shtml", "https://www.prnasia.com/story/247996-1.shtml", "https://www.prnasia.com/story/255697-1.shtml", "https://www.prnasia.com/story/254820-1.shtml", "https://cnmobile.prnasia.com/story/254874-1.shtml", "https://www.prnasia.com/story/254968-1.shtml", "https://www.prnasia.com/story/254610-1.shtml", "https://www.prnasia.com/story/256212-1.shtml", "https://www.prnasia.com/story/252554-1.shtml", "https://www.prnasia.com/story/256942-1.shtml", "https://www.prnasia.com/story/243310-1.shtml", "https://www.prnasia.com/story/256965-1.shtml", "https://www.prnasia.com/story/243050-1.shtml", "https://www.prnasia.com/story/245636-1.shtml", "https://www.prnasia.com/story/251120-1.shtml", "https://www.prnasia.com/story/243565-1.shtml", "https://www.prnasia.com/story/250894-1.shtml", "https://www.prnasia.com/story/251079-1.shtml", "https://www.prnasia.com/story/252293-1.shtml", "https://www.prnasia.com/story/243627-1.shtml", "https://www.prnasia.com/story/246432-1.shtml", "https://www.prnasia.com/story/238296-1.shtml", "https://www.prnasia.com/story/243951-1.shtml", "https://www.prnasia.com/story/241778-1.shtml", "https://www.prnasia.com/story/252347-1.shtml", "https://www.prnasia.com/story/245782-1.shtml", "https://www.prnasia.com/story/240621-1.shtml", "https://www.prnasia.com/story/238314-1.shtml", "https://www.prnasia.com/story/246484-1.shtml", "https://www.prnasia.com/story/239178-1.shtml", "https://www.prnasia.com/story/246046-1.shtml", "https://www.prnasia.com/story/232247-1.shtml", "https://www.prnasia.com/story/238068-1.shtml", "https://www.prnasia.com/story/246540-1.shtml", "https://www.prnasia.com/story/247310-1.shtml", "https://www.prnasia.com/story/247297-1.shtml", "https://www.prnasia.com/story/240081-1.shtml", "https://www.prnasia.com/story/232283-1.shtml", "https://www.prnasia.com/story/239395-1.shtml", "https://www.prnasia.com/story/239944-1.shtml", "https://www.prnasia.com/story/237742-1.shtml", "https://www.prnasia.com/story/240176-1.shtml", "https://www.prnasia.com/story/237631-1.shtml", "https://www.prnasia.com/story/232324-1.shtml", "https://www.prnasia.com/story/240017-1.shtml", "https://www.prnasia.com/story/240244-1.shtml", "https://www.prnasia.com/story/239451-1.shtml", "https://www.prnasia.com/story/232474-1.shtml", "https://www.prnasia.com/story/232496-1.shtml", "https://www.prnasia.com/story/228484-1.shtml", "https://www.prnasia.com/story/233749-1.shtml", "https://www.prnasia.com/story/237771-1.shtml", "https://www.prnasia.com/story/237483-1.shtml", "https://www.prnasia.com/story/229079-1.shtml", "https://www.prnasia.com/story/233824-1.shtml", "https://www.prnasia.com/story/230021-1.shtml", "https://www.prnasia.com/story/234734-1.shtml", "https://www.prnasia.com/story/227510-1.shtml", "https://www.prnasia.com/story/230215-1.shtml", "https://www.prnasia.com/story/230318-1.shtml", "https://www.prnasia.com/story/230390-1.shtml", "https://www.prnasia.com/story/234740-1.shtml", "https://www.prnasia.com/story/227824-1.shtml", "https://www.prnasia.com/story/227131-1.shtml", "https://www.prnasia.com/story/227991-1.shtml", "https://www.prnasia.com/story/227532-1.shtml", "https://www.prnasia.com/story/227632-1.shtml", "https://www.prnasia.com/story/235960-1.shtml", "https://www.prnasia.com/story/234940-1.shtml", "https://www.prnasia.com/story/227468-1.shtml", "https://www.prnasia.com/story/227335-1.shtml", "https://www.prnasia.com/story/235251-1.shtml", "https://www.prnasia.com/story/234391-1.shtml", "https://www.prnasia.com/story/227741-1.shtml", "https://www.prnasia.com/story/237311-1.shtml", "https://www.prnasia.com/story/230659-1.shtml", "https://www.prnasia.com/story/231853-1.shtml", "https://www.prnasia.com/story/231683-1.shtml", "https://www.prnasia.com/story/230656-1.shtml", "https://www.prnasia.com/story/228915-1.shtml", "https://www.prnasia.com/story/216830-1.shtml", "https://www.prnasia.com/story/221213-1.shtml", "https://www.prnasia.com/story/231275-1.shtml", "https://www.prnasia.com/story/231776-1.shtml", "https://www.prnasia.com/story/231194-1.shtml", "https://www.prnasia.com/story/230763-1.shtml", "https://www.prnasia.com/story/229689-1.shtml", "https://www.prnasia.com/story/231633-1.shtml", "https://www.prnasia.com/story/218661-1.shtml", "https://www.prnasia.com/story/231058-1.shtml", "https://www.prnasia.com/story/220503-1.shtml", "https://www.prnasia.com/story/222709-1.shtml", "https://www.prnasia.com/story/223869-1.shtml", "https://www.prnasia.com/story/217718-1.shtml", "https://www.prnasia.com/story/222051-1.shtml", "https://cnmobile.prnasia.com/story/216426-1.shtml", "https://www.prnasia.com/story/217959-1.shtml", "https://www.prnasia.com/story/222194-1.shtml", "https://www.prnasia.com/story/224464-1.shtml", "https://www.prnasia.com/story/225568-1.shtml", "https://www.prnasia.com/story/217287-1.shtml", "https://www.prnasia.com/story/220634-1.shtml", "https://www.prnasia.com/story/217761-1.shtml", "https://www.prnasia.com/story/220877-1.shtml", "https://www.prnasia.com/story/219470-1.shtml", "https://www.prnasia.com/story/211157-1.shtml", "https://www.prnasia.com/story/211563-1.shtml", "https://www.prnasia.com/story/208728-1.shtml", "https://www.prnasia.com/story/204970-1.shtml", "https://www.prnasia.com/story/226203-1.shtml", "https://www.prnasia.com/story/220696-1.shtml", "https://www.prnasia.com/story/210461-1.shtml", "https://www.prnasia.com/story/210988-1.shtml", "https://www.prnasia.com/story/210463-1.shtml", "https://www.prnasia.com/story/211501-1.shtml", "https://www.prnasia.com/story/212374-1.shtml", "https://www.prnasia.com/story/210265-1.shtml", "https://www.prnasia.com/story/214465-1.shtml", "https://www.prnasia.com/story/212282-1.shtml", "https://www.prnasia.com/story/213752-1.shtml", "https://www.prnasia.com/story/214226-1.shtml", "https://www.prnasia.com/story/206729-1.shtml", "https://www.prnasia.com/story/206718-1.shtml", "https://www.prnasia.com/story/211582-1.shtml", "https://www.prnasia.com/story/188255-1.shtml", "https://www.prnasia.com/story/198342-1.shtml", "https://www.prnasia.com/story/188920-1.shtml", "https://www.prnasia.com/story/188858-1.shtml", "https://www.prnasia.com/story/187572-1.shtml", "https://www.prnasia.com/story/199426-1.shtml", "https://www.prnasia.com/story/200712-1.shtml", "https://www.prnasia.com/story/188366-1.shtml", "https://www.prnasia.com/story/198484-1.shtml", "https://www.prnasia.com/story/215535-1.shtml", "https://www.prnasia.com/story/200426-1.shtml", "https://www.prnasia.com/story/206954-1.shtml", "https://www.prnasia.com/story/201640-1.shtml", "https://www.prnasia.com/story/204378-1.shtml", "https://www.prnasia.com/story/194075-1.shtml", "https://www.prnasia.com/story/195061-1.shtml", "https://www.prnasia.com/story/190476-1.shtml", "https://www.prnasia.com/story/203191-1.shtml", "https://www.prnasia.com/story/189022-1.shtml", "https://www.prnasia.com/story/191524-1.shtml", "https://www.prnasia.com/story/203368-1.shtml", "https://www.prnasia.com/story/204393-1.shtml", "https://www.prnasia.com/story/190215-1.shtml", "https://www.prnasia.com/story/203145-1.shtml", "https://www.prnasia.com/story/192669-1.shtml", "https://www.prnasia.com/story/194164-1.shtml", "https://www.prnasia.com/story/203051-1.shtml", "https://cnmobile.prnasia.com/story/189211-1.shtml", "https://www.prnasia.com/story/201779-1.shtml", "https://www.prnasia.com/story/179623-1.shtml", "https://www.prnasia.com/story/197445-1.shtml", "https://www.prnasia.com/story/168001-1.shtml", "https://www.prnasia.com/story/167859-1.shtml", "https://www.prnasia.com/story/180316-1.shtml", "https://www.prnasia.com/story/195145-1.shtml", "https://www.prnasia.com/story/181664-1.shtml", "https://www.prnasia.com/story/181011-1.shtml", "https://www.prnasia.com/story/197469-1.shtml", "https://www.prnasia.com/story/197982-1.shtml", "https://www.prnasia.com/story/167822-1.shtml", "https://www.prnasia.com/story/181753-1.shtml", "https://www.prnasia.com/story/183685-1.shtml", "https://www.prnasia.com/story/182845-1.shtml", "https://www.prnasia.com/story/186571-1.shtml", "https://www.prnasia.com/story/185818-1.shtml", "https://www.prnasia.com/story/174633-1.shtml", "https://www.prnasia.com/story/186274-1.shtml", "https://www.prnasia.com/story/172940-1.shtml", "https://www.prnasia.com/story/159586-1.shtml", "https://www.prnasia.com/story/189799-1.shtml", "https://www.prnasia.com/story/177373-1.shtml", "https://www.prnasia.com/story/177982-1.shtml", "https://www.prnasia.com/story/147938-1.shtml", "https://www.prnasia.com/story/164775-1.shtml", "https://www.prnasia.com/story/147781-1.shtml", "https://www.prnasia.com/story/177509-1.shtml", "https://www.prnasia.com/story/176347-1.shtml", "https://www.prnasia.com/story/161241-1.shtml", "https://www.prnasia.com/story/178518-1.shtml", "https://www.prnasia.com/story/148185-1.shtml", "https://www.prnasia.com/story/159960-1.shtml", "https://www.prnasia.com/story/148026-1.shtml", "https://www.prnasia.com/story/161582-1.shtml", "https://www.prnasia.com/story/148471-1.shtml", "https://www.prnasia.com/story/164222-1.shtml", "https://www.prnasia.com/story/147663-1.shtml", "https://www.prnasia.com/story/164494-1.shtml", "https://www.prnasia.com/story/163064-1.shtml", "https://www.prnasia.com/story/162283-1.shtml", "https://www.prnasia.com/story/148379-1.shtml", "https://www.prnasia.com/story/149136-1.shtml", "https://www.prnasia.com/story/150911-1.shtml", "https://www.prnasia.com/story/166426-1.shtml", "https://www.prnasia.com/story/166669-1.shtml", "https://www.prnasia.com/story/153915-1.shtml", "https://www.prnasia.com/story/151775-1.shtml", "https://www.prnasia.com/story/150017-1.shtml", "https://www.prnasia.com/story/167506-1.shtml", "https://www.prnasia.com/story/150603-1.shtml", "https://www.prnasia.com/story/166805-1.shtml", "https://www.prnasia.com/story/167236-1.shtml", "https://www.prnasia.com/story/155198-1.shtml", "https://cnmobile.prnasia.com/story/153765-1.shtml", "https://cnmobile.prnasia.com/story/154324-1.shtml", "https://www.prnasia.com/story/155218-1.shtml", "https://www.prnasia.com/story/125562-1.shtml", "https://www.prnasia.com/story/139326-1.shtml", "https://www.prnasia.com/story/126519-1.shtml", "https://www.prnasia.com/story/138070-1.shtml", "https://www.prnasia.com/story/125444-1.shtml", "https://www.prnasia.com/story/158158-1.shtml", "https://www.prnasia.com/story/155208-1.shtml", "https://www.prnasia.com/story/142833-1.shtml", "https://www.prnasia.com/story/143365-1.shtml", "https://www.prnasia.com/story/130097-1.shtml", "https://www.prnasia.com/story/129116-1.shtml", "https://www.prnasia.com/story/128563-1.shtml", "https://www.prnasia.com/story/139480-1.shtml", "https://www.prnasia.com/story/131991-1.shtml", "https://www.prnasia.com/story/127925-1.shtml", "https://www.prnasia.com/story/136039-1.shtml", "https://www.prnasia.com/story/108123-1.shtml", "https://www.prnasia.com/story/134810-1.shtml", "https://www.prnasia.com/story/100117-1.shtml", "https://www.prnasia.com/story/108146-1.shtml", "https://www.prnasia.com/story/136665-1.shtml", "https://www.prnasia.com/story/100378-1.shtml", "https://www.prnasia.com/story/135862-1.shtml", "https://www.prnasia.com/story/137035-1.shtml", "https://www.prnasia.com/story/112027-1.shtml", "https://www.prnasia.com/story/114415-1.shtml", "https://www.prnasia.com/story/102614-1.shtml", "https://www.prnasia.com/story/111543-1.shtml", "https://www.prnasia.com/story/112530-1.shtml", "https://www.prnasia.com/story/113323-1.shtml", "https://www.prnasia.com/story/118660-1.shtml", "https://www.prnasia.com/story/111675-1.shtml", "https://www.prnasia.com/story/117094-1.shtml", "https://www.prnasia.com/story/119211-1.shtml", "https://www.prnasia.com/story/105067-1.shtml", "https://www.prnasia.com/story/120941-1.shtml", "https://www.prnasia.com/story/116464-1.shtml", "https://www.prnasia.com/story/121721-1.shtml", "https://www.prnasia.com/story/121510-1.shtml", "https://www.prnasia.com/story/106420-1.shtml", "https://www.prnasia.com/story/123963-1.shtml", "https://www.prnasia.com/story/107740-1.shtml", "https://www.prnasia.com/story/122421-1.shtml", "https://www.prnasia.com/story/124419-1.shtml", "https://www.prnasia.com/story/91080-1.shtml", "https://www.prnasia.com/story/89350-1.shtml", "https://www.prnasia.com/story/89437-1.shtml", "https://www.prnasia.com/story/91523-1.shtml", "https://www.prnasia.com/story/100043-1.shtml", "https://www.prnasia.com/story/89412-1.shtml", "https://www.prnasia.com/story/89285-1.shtml", "https://www.prnasia.com/story/111103-1.shtml", "https://www.prnasia.com/story/94665-1.shtml", "https://www.prnasia.com/story/74489-1.shtml", "https://www.prnasia.com/story/94852-1.shtml", "https://www.prnasia.com/story/74563-1.shtml", "https://www.prnasia.com/story/93833-1.shtml", "https://www.prnasia.com/story/95004-1.shtml", "https://www.prnasia.com/story/110976-1.shtml", "https://www.prnasia.com/story/96903-1.shtml", "https://www.prnasia.com/story/76957-1.shtml", "https://www.prnasia.com/story/75454-1.shtml", "https://www.prnasia.com/story/75502-1.shtml", "https://www.prnasia.com/story/63642-1.shtml", "https://www.prnasia.com/story/77843-1.shtml", "https://www.prnasia.com/story/75324-1.shtml", "https://www.prnasia.com/story/63349-1.shtml", "https://www.prnasia.com/story/77903-1.shtml", "https://www.prnasia.com/story/76712-1.shtml", "https://www.prnasia.com/story/77663-1.shtml", "https://www.prnasia.com/story/98663-1.shtml", "https://www.prnasia.com/story/62269-1.shtml", "https://www.prnasia.com/story/97988-1.shtml", "https://www.prnasia.com/story/65003-1.shtml", "https://www.prnasia.com/story/65365-1.shtml", "https://www.prnasia.com/story/65297-1.shtml", "https://www.prnasia.com/story/82634-1.shtml", "https://www.prnasia.com/story/83990-1.shtml", "https://www.prnasia.com/story/67256-1.shtml", "https://www.prnasia.com/story/70196-1.shtml", "https://www.prnasia.com/story/65287-1.shtml", "https://www.prnasia.com/story/71989-1.shtml", "https://www.prnasia.com/story/71732-1.shtml", "https://www.prnasia.com/story/69734-1.shtml", "https://www.prnasia.com/story/69913-1.shtml", "https://www.prnasia.com/story/70609-1.shtml", "https://www.prnasia.com/story/69994-1.shtml", "https://www.prnasia.com/story/86106-1.shtml", "https://www.prnasia.com/story/85150-1.shtml", "https://cnmobile.prnasia.com/story/71879-1.shtml", "https://www.prnasia.com/story/86547-1.shtml", "https://www.prnasia.com/story/87426-1.shtml", "https://www.prnasia.com/story/72903-1.shtml", "https://www.prnasia.com/story/15167-1.shtml", "https://www.prnasia.com/story/73571-1.shtml", "https://www.prnasia.com/story/40559-1.shtml", "https://www.prnasia.com/story/46229-1.shtml", "https://www.prnasia.com/story/74000-1.shtml", "https://www.prnasia.com/story/47142-1.shtml", "https://www.prnasia.com/story/73997-1.shtml", "https://www.prnasia.com/story/25624-1.shtml", "https://www.prnasia.com/story/18040-1.shtml", "https://www.prnasia.com/story/36424-1.shtml", "https://www.prnasia.com/story/259934-1.shtml", "https://www.prnasia.com/story/251376-1.shtml", "https://www.prnasia.com/story/226864-1.shtml", "https://www.prnasia.com/story/297013-1.shtml", "https://www.prnasia.com/story/289735-1.shtml", "https://www.prnasia.com/story/209788-1.shtml", "https://www.prnasia.com/story/241762-1.shtml", "https://www.prnasia.com/story/254596-1.shtml", "https://www.prnasia.com/story/11646-1.shtml", "https://www.prnasia.com/story/263236-1.shtml", "https://www.prnasia.com/story/219435-1.shtml", "https://www.prnasia.com/story/12025-1.shtml", "https://www.prnasia.com/story/296318-1.shtml", "https://www.prnasia.com/story/183331-1.shtml", "https://www.prnasia.com/story/226182-1.shtml", "https://www.prnasia.com/story/213299-1.shtml", "https://www.prnasia.com/story/207993-1.shtml", "https://www.prnasia.com/story/156038-1.shtml", "https://www.prnasia.com/story/185156-1.shtml", "https://www.prnasia.com/story/266946-1.shtml", "https://www.prnasia.com/story/307536-1.shtml", "https://www.prnasia.com/story/266933-1.shtml", "https://www.prnewswire.com/news-releases/horiba-acquires-medtest-dx-and-pointe-scientific-to-expand-laboratory-chemistry-offerings-301219806.html", "https://www.prnasia.com/story/171427-1.shtml", "https://www.prnasia.com/story/171623-1.shtml", "https://www.prnasia.com/story/171481-1.shtml", "https://www.prnasia.com/story/284362-1.shtml", "https://www.prnasia.com/story/284380-1.shtml", "https://www.prnasia.com/story/284372-1.shtml", "https://www.prnasia.com/story/171522-1.shtml", "https://www.prnewswire.com/news-releases/ascentage-pharma-released-preclinical-results-of-mdm2-p53-inhibitor-apg-115-in-an-oral-presentation-at-wclc-2020-demonstrating-therapeutic-potential-in-stk11-mutant-non-small-cell-lung-cancer-301219844.html", "https://www.prnewswire.com/news-releases/professional-physical-therapy-continues-growth-with-acquisition-of-optimum-physical-therapy-in-warwick-new-york-301219571.html", "https://www.prnasia.com/story/307543-1.shtml", "https://www.prnasia.com/story/76303-1.shtml", "https://www.prnewswire.com/news-releases/joint-team-from-mit-and-synlogic-named-a-biotechnology-grand-challenge-winner-by-air-force-research-laboratory-301219762.html", "https://www.prnasia.com/story/56519-1.shtml", "https://www.prnasia.com/story/76356-1.shtml", "https://www.prnasia.com/story/307578-1.shtml", "https://www.prnasia.com/story/307549-1.shtml", "https://www.prnewswire.com/news-releases/kodiak-sciences-announces-upcoming-presentation-of-ksi-301-phase-1b-clinical-study-data-at-angiogenesis-exudation-and-degeneration-2021--virtual-edition-301219827.html", "https://www.prnewswire.com/news-releases/janssen-to-highlight-robust-solid-tumor-portfolio-and-pipeline-at-2021-asco-gu-301219971.html", "https://cnmobile.prnasia.com/story/266927-1.shtml", "https://www.prnewswire.com/news-releases/max-biopharma-announces-key-discoveries-regarding-oxysterol-drug-candidates-for-targeting-covid-19-301219698.html", "https://www.prnasia.com/story/266928-1.shtml", "https://www.prnewswire.com/news-releases/gray-matter-analytics-expands-client-engagements-analytics-solutions-in-productive-2020-301219757.html", "https://www.prnewswire.com/news-releases/moleculin-announces-100-survival-achieved-in-osteosarcoma-lung-metastases-animal-model-301219825.html", "https://www.prnewswire.com/news-releases/thread-and-1nhealth-partner-to-optimize-participant-recruitment-in-decentralized-clinical-trials-301219756.html", "https://www.prnasia.com/story/76353-1.shtml", "https://www.prnasia.com/story/56887-1.shtml", "https://www.prnasia.com/story/245294-1.shtml", "https://www.prnasia.com/story/56982-1.shtml", "https://www.prnasia.com/story/307574-1.shtml", "https://www.prnasia.com/story/263880-1.shtml", "https://www.prnasia.com/story/307508-1.shtml", "https://www.prnewswire.com/news-releases/rethink-first-acquires-whil-creating-the-most-comprehensive-behavioral-health-mental-health-and-well-being-solution-on-the-market-301220147.html", "https://www.prnasia.com/story/263919-1.shtml", "https://www.prnasia.com/story/307465-1.shtml", "https://www.prnasia.com/story/307581-1.shtml", "https://www.prnasia.com/story/154942-1.shtml", "https://www.prnasia.com/story/266860-1.shtml", "https://www.prnewswire.com/news-releases/ey-us-announces-new-vaccine-management-solution-powered-by-microsoft-technologies-to-support-safe-secure-and-equitable-distribution-of-covid-19-vaccines-301219546.html", "https://www.prnasia.com/story/262228-1.shtml", "https://www.prnasia.com/story/307438-1.shtml", "https://www.prnewswire.com/news-releases/amyris-announces-breakthrough-clinical-results-for-its-clean-formulation-acne-treatment-301219888.html", "https://www.prnasia.com/story/307447-1.shtml", "https://www.prnewswire.com/news-releases/johnson--johnson-vision-receives-fda-approval-for-next-generation-monofocal-intraocular-lens---tecnis-eyhance-and-tecnis-eyhance-toric-ii-iols---for-the-treatment-of-cataract-patients-301219587.html", "https://www.prnasia.com/story/238515-1.shtml", "https://www.prnasia.com/story/262236-1.shtml", "https://www.prnewswire.com/news-releases/curis-announces-initiation-of-investigator-sponsored-phase-2-lucas-study-of-ca-4948-for-the-treatment-of-anemia-in-patients-with-very-low-low-or-intermediate-risk-myelodysplastic-syndromes-301219908.html", "https://www.prnasia.com/story/56303-1.shtml", "https://cnmobile.prnasia.com/story/307457-1.shtml", "https://www.prnasia.com/story/198842-1.shtml", "https://www.prnasia.com/story/205366-1.shtml", "https://www.prnewswire.com/news-releases/aerocare-announces-completion-of-acquisition-by-adapthealth-301219622.html", "https://www.prnasia.com/story/238661-1.shtml", "https://www.prnasia.com/story/208343-1.shtml", "https://www.prnewswire.com/news-releases/xylyx-bio-and-cellsoft-announce-positive-initial-results-following-strategic-partnership-to-develop-next-generation-in-vitro-platforms-to-accelerate-cancer-drug-discovery-301219912.html", "https://www.prnasia.com/story/243953-1.shtml", "https://www.prnewswire.com/news-releases/hoth-therapeutics-provides-operational-update-on-novel-therapeutic-pipeline-301220003.html", "https://www.prnasia.com/story/240273-1.shtml", "https://www.prnasia.com/story/171888-1.shtml", "https://www.prnewswire.com/news-releases/high-covid-19-vaccine-uptake-proving-critical-for-achieving-individual-and-population-immunity-301219707.html", "https://www.prnewswire.com/news-releases/biovaxys-sars-cov-2-vaccine-candidate-bvx-0320-stimulates-neutralizing-antibodies-to-live-covid-19-virus-301220187.html", "https://cnmobile.prnasia.com/story/238631-1.shtml", "https://www.prnasia.com/story/208109-1.shtml", "https://www.prnewswire.com/news-releases/north-star-holdings-inc-north-star-submits-seven-research-license-applications-with-the-dea-for-cannabis-cultivation-301219445.html", "https://cnmobile.prnasia.com/story/175912-1.shtml", "https://www.prnasia.com/story/238637-1.shtml", "https://www.prnasia.com/story/232563-1.shtml", "https://www.prnasia.com/story/159381-1.shtml", "https://www.prnewswire.com/news-releases/the-ad-council-and-autism-speaks-further-advocacy-for-early-autism-screening-through-latest-awareness-campaign-301219660.html", "https://www.prnewswire.com/news-releases/pmc-capital-acquires-150-year-old-best-in-class-specialty-consumables-ransom--randolph-company-from-dentsply-sirona-301218748.html", "https://www.prnewswire.com/news-releases/premise-health-expands-digital-engagement-and-wellness-capabilities-through-acquisition-of-sonic-boom-wellness-301220135.html", "https://www.prnewswire.com/news-releases/secura-bio-announces-new-data-regarding-the-combination-of-farydak-panobinostat-with-subcutaneous-bortezomib-and-dexamethasone-301219639.html", "https://www.prnewswire.com/news-releases/nad-recommends-nanoceutical-solutions-discontinue-certain-claims-for-nano-glutathione-liquid-dietary-supplement-and-modify-instagram-ad-301219432.html", "https://www.prnewswire.com/news-releases/clubready-announces-acquisition-of-ikizmet-301220110.html", "https://www.prnasia.com/story/283286-1.shtml", "https://www.prnasia.com/story/251443-1.shtml", "https://www.prnasia.com/story/250051-1.shtml", "https://www.prnewswire.com/news-releases/oncosec-strengthens-management-team-with-two-new-appointments-301220049.html", "https://www.prnasia.com/story/264093-1.shtml"]